*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 1 3 # 1 A 29 ASP A 157 ASP^? 20.06 O6 C2E A 301 A 117 LYS A 177 LYS.? 20.27 N7 C2E A 301 A 150 CYH A 158 CYH^? 12.92 O6 C2E A 301 coo 37.97 47.82 5.46 38.65 48.02 7.40 -19.05 -19.29 2.64 -21.12 -19.53 2.92 coo 41.02 51.33 13.36 40.18 47.06 9.99 -13.21 -27.52 5.04 -11.69 -32.72 3.81 coo 39.17 42.30 8.54 40.94 44.26 7.78 -15.53 -18.41 0.03 -15.42 -19.19 -2.71 ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 2 3 # 2 A 29 ASP B 157 ASP^? 20.00 O6 C2E B 301 A 117 LYS B 177 LYS.? 21.12 N7 C2E B 301 A 150 CYH B 158 CYH^? 12.89 O6 C2E B 301 coo 37.97 47.82 5.46 38.65 48.02 7.40 9.70 18.14 -17.54 10.97 18.31 -19.23 coo 41.02 51.33 13.36 40.18 47.06 9.99 8.81 26.59 -11.72 7.46 31.56 -12.94 coo 39.17 42.30 8.54 40.94 44.26 7.78 5.78 17.15 -15.63 3.32 17.67 -16.92 3uao_o00 source 3UAO PUTATIVE ISOCHORISMATASE : 2 hits 3uao_o00 naa= 3 ULMN 4 1bs0_c00 8-AMINO-7-OXONANOATE SYNTHASE user 1 4 # 1 A 133 HIS A 154 HIS^? 21.74 O6 C2E A 301 A 175 GLU A 153 GLU.? 24.63 N7 C2E A 301 A 204 ASP A 152 ASP.? 20.83 C8 C2E A 301 A 236 LYS A 148 LYS^? 21.30 O6 C2E A 301 coo 7.06 3.02 44.15 5.29 1.89 44.11 -16.69 -30.86 2.00 -15.94 -32.47 3.12 coo 5.26 3.96 48.13 7.21 3.45 47.51 -19.21 -34.41 1.40 -17.40 -35.49 1.72 coo 1.26 2.66 46.42 2.28 1.24 45.18 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 1bs0_c00 source 1bs0 8-AMINO-7-OXONANOATE SYNTHASE : 1 hits 1bs0_c00 naa= 4 ULMN 4 1c17_c11 ATP SYNTHASE SUBUNIT C user 1 4 # 1 A 61 ASP A 192 ASP.? 23.17 N2 C2E A 301 M 206 SER A 212 SER.? 13.10 O6 C2E A 301 M 210 ARG A 217 ARG^? 6.70 O6 C2E A 301 M 214 ASN A 208 ASN^? -3.55 N7 C2E A 301s coo 2.15 -17.14 -6.89 2.91 -15.59 -8.10 -26.02 -10.21 -8.74 -27.24 -11.85 -9.23 coo -2.55 -23.32 19.81 -3.48 -21.59 18.38 -4.77 -16.86 9.45 -4.14 -15.23 7.75 coo 1.98 -17.11 17.69 1.79 -15.15 15.33 -3.36 -16.18 0.94 -0.54 -17.39 0.83 coo 8.13 -16.73 20.92 6.75 -15.93 19.51 0.54 -21.32 -2.29 -0.50 -19.83 -3.42 ULMN 4 1c17_c11 ATP SYNTHASE SUBUNIT C user 2 4 # 2 A 61 ASP B 31 ASP~? 18.26 O6 C2E A 301 M 206 SER B 212 SER.? 13.16 O6 C2E B 301 M 210 ARG B 217 ARG^? 6.37 O6 C2E B 301 M 214 ASN B 208 ASN^? -3.47 N7 C2E B 301s coo 2.15 -17.14 -6.89 2.91 -15.59 -8.10 -9.76 -4.11 8.16 -9.75 -6.21 8.42 coo -2.55 -23.32 19.81 -3.48 -21.59 18.38 8.68 16.14 -1.54 8.01 14.57 -3.30 coo 1.98 -17.11 17.69 1.79 -15.15 15.33 0.82 15.44 -4.45 -0.87 16.78 -2.26 coo 8.13 -16.73 20.92 6.75 -15.93 19.51 -4.15 20.35 -2.93 -4.56 18.73 -4.26 ULMN 4 1c17_c11 ATP SYNTHASE SUBUNIT C user 3 4 # 3 A 61 ASP B 192 ASP.? 23.13 N2 C2E B 301 M 206 SER B 212 SER.? 13.16 O6 C2E B 301 M 210 ARG B 217 ARG^? 6.37 O6 C2E B 301 M 214 ASN B 208 ASN^? -3.47 N7 C2E B 301s coo 2.15 -17.14 -6.89 2.91 -15.59 -8.10 3.51 7.73 -28.40 4.69 9.27 -29.24 coo -2.55 -23.32 19.81 -3.48 -21.59 18.38 8.68 16.14 -1.54 8.01 14.57 -3.30 coo 1.98 -17.11 17.69 1.79 -15.15 15.33 0.82 15.44 -4.45 -0.87 16.78 -2.26 coo 8.13 -16.73 20.92 6.75 -15.93 19.51 -4.15 20.35 -2.93 -4.56 18.73 -4.26 1c17_c11 source 1c17 ATP SYNTHASE SUBUNIT C : 3 hits 1c17_c11 naa= 4 ULMN 4 1d3g_c01 DIHYDROOROTATE DEHYDROGENASE user 1 4 # 1 A 149 PHE B 107 PHE^? 14.71 N21 C2E B 301 A 215 SER B 29 SER~? 19.81 N21 C2E B 301 A 218 THR B 129 THR^? 22.45 N21 C2E B 301 A 255 LYS B 67 LYS.? 24.61 N21 C2E A 301 coo 44.60 28.41 9.39 42.46 29.45 10.83 -8.45 6.43 14.58 -5.76 6.49 13.89 coo 38.32 30.82 8.35 40.14 29.77 7.21 -8.69 -0.89 13.28 -8.89 0.42 15.30 coo 39.65 24.77 7.41 41.19 24.89 8.93 -12.76 0.32 15.64 -14.76 -0.03 16.38 coo 36.63 36.86 14.86 40.52 38.40 10.14 -0.41 -2.48 20.16 2.79 -6.43 20.83 1d3g_c01 source 1d3g DIHYDROOROTATE DEHYDROGENASE : 1 hits 1d3g_c01 naa= 4 ULMN 4 1e6e_c00 ADRENODOXIN user 1 4 # 1 A 55 HIS A 64 HIS^? 21.50 N21 C2E B 301 A 159 ASP A 66 ASP.? 23.33 N21 C2E B 301 A 376 ILE A 61 ILE^? 20.52 N21 C2E A 301 A 377 THR B 63 THR^? 19.59 N11 C2E B 301 coo 17.95 58.52 112.81 17.29 59.41 111.03 11.95 7.99 12.22 11.86 9.83 13.23 coo 11.32 57.46 110.35 12.85 58.48 111.39 15.60 9.37 4.44 16.85 10.89 5.23 coo 15.00 65.23 121.40 15.42 63.95 122.00 7.19 -1.23 11.98 7.11 -1.03 13.41 coo 15.65 69.77 121.40 17.38 70.64 120.41 1.98 0.04 13.69 0.05 -0.43 12.85 ULMN 4 1e6e_c00 ADRENODOXIN user 2 4 # 2 A 55 HIS B 64 HIS^? 22.95 N21 C2E A 301 A 159 ASP B 66 ASP.? 24.37 N21 C2E A 301 A 376 ILE B 61 ILE^? 18.58 N21 C2E B 301 A 377 THR A 63 THR^? 19.64 O61 C2E B 301 coo 17.95 58.52 112.81 17.29 59.41 111.03 5.28 -3.23 17.72 6.30 -4.93 18.40 coo 11.32 57.46 110.35 12.85 58.48 111.39 -3.12 -5.44 17.43 -2.91 -6.73 19.08 coo 15.00 65.23 121.40 15.42 63.95 122.00 6.16 5.38 11.59 7.43 5.59 12.25 coo 15.65 69.77 121.40 17.38 70.64 120.41 10.28 3.87 8.02 10.33 3.89 5.86 1e6e_c00 source 1e6e ADRENODOXIN : 2 hits 1e6e_c00 naa= 4 ULMN 4 1e6e_c01 ADRENODOXIN user 1 4 # 1 C 55 HIS A 64 HIS^? 21.50 N21 C2E B 301 C 159 ASP A 66 ASP.? 23.33 N21 C2E B 301 C 376 ILE A 61 ILE^? 20.52 N21 C2E A 301 C 377 THR B 63 THR^? 19.59 N11 C2E B 301 coo -29.07 40.56 142.27 -27.79 41.91 141.29 11.95 7.99 12.22 11.86 9.83 13.23 coo -23.44 38.39 138.46 -25.44 39.03 138.64 15.60 9.37 4.44 16.85 10.89 5.23 coo -37.08 37.01 134.95 -37.09 36.11 136.10 7.19 -1.23 11.98 7.11 -1.03 13.41 coo -39.65 39.67 132.35 -40.33 41.62 133.03 1.98 0.04 13.69 0.05 -0.43 12.85 ULMN 4 1e6e_c01 ADRENODOXIN user 2 4 # 2 C 55 HIS B 64 HIS^? 22.95 N21 C2E A 301 C 159 ASP B 66 ASP.? 24.37 N21 C2E A 301 C 376 ILE B 61 ILE^? 18.58 N21 C2E B 301 C 377 THR A 63 THR^? 19.64 O61 C2E B 301 coo -29.07 40.56 142.27 -27.79 41.91 141.29 5.28 -3.23 17.72 6.30 -4.93 18.40 coo -23.44 38.39 138.46 -25.44 39.03 138.64 -3.12 -5.44 17.43 -2.91 -6.73 19.08 coo -37.08 37.01 134.95 -37.09 36.11 136.10 6.16 5.38 11.59 7.43 5.59 12.25 coo -39.65 39.67 132.35 -40.33 41.62 133.03 10.28 3.87 8.02 10.33 3.89 5.86 1e6e_c01 source 1e6e ADRENODOXIN : 2 hits 1e6e_c01 naa= 4 ULMN 4 1f75_c00 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 1 4 # 1 A 33 ARG A 161 ARG^? 11.81 O6 C2E A 301 A 42 ARG A 217 ARG^? 6.70 O6 C2E A 301 A 197 ARG A 99 ARG.? 13.59 O61 C2E B 301 A 203 ARG B 99 ARG.? 13.88 O61 C2E A 301 coo 23.24 19.51 21.94 24.57 16.76 21.61 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 coo 16.08 17.48 28.78 19.09 16.85 28.49 -3.36 -16.18 0.94 -0.54 -17.39 0.83 coo 28.26 9.63 19.68 28.71 10.56 22.55 -1.29 -2.34 -4.97 -2.19 0.30 -6.23 coo 33.62 12.31 23.18 30.84 12.90 24.36 -4.81 1.09 -3.04 -5.37 -1.84 -3.80 1f75_c00 source 1f75 UNDECAPRENYL PYROPHOSPHATE SYNTHETASE : 1 hits 1f75_c00 naa= 4 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 1 4 # 1 B 33 ARG A 140 ARG.? -3.36 C5 C2E A 301s B 42 ARG A 161 ARG^? 11.81 O6 C2E A 301 B 197 ARG A 165 ARG.? 12.45 N2 C2E A 301 B 203 ARG A 227 ARG~? 9.91 O2' C2E A 301 coo 42.69 1.07 -0.40 42.64 1.65 2.61 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 coo 40.75 3.79 10.50 41.03 0.76 9.97 -4.47 -13.19 -19.45 -6.66 -12.47 -21.46 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 -5.20 -21.14 -18.72 -4.74 -24.14 -19.17 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 2 4 # 2 B 33 ARG A 140 ARG.? -3.36 C5 C2E A 301s B 42 ARG A 227 ARG~? 9.91 O2' C2E A 301 B 197 ARG A 217 ARG^? 6.70 O6 C2E A 301 B 203 ARG A 161 ARG^? 11.81 O6 C2E A 301 coo 42.69 1.07 -0.40 42.64 1.65 2.61 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 -5.20 -21.14 -18.72 -4.74 -24.14 -19.17 coo 40.75 3.79 10.50 41.03 0.76 9.97 -3.36 -16.18 0.94 -0.54 -17.39 0.83 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 3 4 # 3 B 33 ARG B 140 ARG.? -3.40 C5 C2E B 301s B 42 ARG B 161 ARG^? 11.68 O6 C2E B 301 B 197 ARG B 165 ARG.? 10.70 O2' C2E B 301 B 203 ARG B 227 ARG~? 7.56 O2' C2E B 301 coo 42.69 1.07 -0.40 42.64 1.65 2.61 -7.91 11.52 -6.78 -7.96 14.04 -5.01 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 2.96 9.64 -10.71 5.59 9.57 -9.11 coo 40.75 3.79 10.50 41.03 0.76 9.97 -16.44 10.61 -14.72 -19.33 11.67 -14.77 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 -16.01 19.09 -16.09 -16.65 16.54 -14.51 1f75_c01 source 1f75 UNDECAPRENYL PYROPHOSPHATE SYNTHETASE : 3 hits 1f75_c01 naa= 4 ULMN 4 1gox_c01 GLYCOLATE OXIDASE user 1 4 # 1 129 TYR B 179 TYR.? 13.89 O6 C2E B 301 157 ASP B 152 ASP.? 19.99 C8 C2E B 301 254 HIS B 154 HIS^? 20.45 O6 C2E B 301 257 ARG B 155 ARG^? 22.81 O6 C2E B 301 coo 42.78 52.38 24.86 44.83 53.69 23.54 2.36 25.70 -10.99 3.98 25.02 -13.14 coo 49.25 58.21 29.45 50.12 57.23 27.75 2.18 32.86 -17.28 0.63 33.43 -15.93 coo 50.92 56.96 24.04 49.24 56.15 23.09 7.78 28.08 -17.01 9.24 26.69 -16.42 coo 53.31 58.10 18.81 51.90 57.61 16.26 6.63 24.44 -23.88 7.74 21.82 -25.04 1gox_c01 source 1gox GLYCOLATE OXIDASE : 1 hits 1gox_c01 naa= 4 ULMN 4 1im5_c01 180AA LONG HYPOTHETICAL PYRAZINAMIDAuser 1 4 # 1 A 10 ASP A 157 ASP^? 20.06 O6 C2E A 301 A 94 LYS A 177 LYS.? 20.27 N7 C2E A 301 A 129 ALA A 146 ALA^? 17.10 N1 C2E A 301 A 133 CYH A 158 CYH^? 12.92 O6 C2E A 301 coo -0.56 18.37 -15.37 -2.27 17.16 -14.99 -19.05 -19.29 2.64 -21.12 -19.53 2.92 coo -6.74 14.46 -8.32 -5.35 15.99 -13.44 -13.21 -27.52 5.04 -11.69 -32.72 3.81 coo -1.44 19.66 -21.50 -1.39 18.37 -22.30 -18.53 -13.88 -2.80 -19.77 -13.48 -2.02 coo -6.20 18.93 -18.24 -5.37 16.51 -16.99 -15.53 -18.41 0.03 -15.42 -19.19 -2.71 ULMN 4 1im5_c01 180AA LONG HYPOTHETICAL PYRAZINAMIDAuser 2 4 # 2 A 10 ASP B 157 ASP^? 20.00 O6 C2E B 301 A 94 LYS B 177 LYS.? 21.12 N7 C2E B 301 A 129 ALA B 146 ALA^? 17.04 N1 C2E B 301 A 133 CYH B 158 CYH^? 12.89 O6 C2E B 301 coo -0.56 18.37 -15.37 -2.27 17.16 -14.99 9.70 18.14 -17.54 10.97 18.31 -19.23 coo -6.74 14.46 -8.32 -5.35 15.99 -13.44 8.81 26.59 -11.72 7.46 31.56 -12.94 coo -1.44 19.66 -21.50 -1.39 18.37 -22.30 5.20 12.25 -19.11 6.53 11.88 -19.77 coo -6.20 18.93 -18.24 -5.37 16.51 -16.99 5.78 17.15 -15.63 3.32 17.67 -16.92 1im5_c01 source 1im5 180AA LONG HYPOTHETICAL PYRAZINAMIDASE/NICOTIN: 2 hits 1im5_c01 naa= 4 ULMN 4 1kim_c01 THYMIDINE KINASE user 1 4 # 1 B 59 GLY A 102 GLY.? 6.44 O61 C2E A 301 B 83 GLU A 142 GLU^? 10.87 N1 C2E A 301 B 163 ARG A 99 ARG.? 13.59 O61 C2E B 301 B 222 ARG A 140 ARG.? -3.36 C5 C2E A 301s coo 12.62 99.24 38.96 12.68 98.60 38.52 4.07 -8.14 -8.05 4.42 -7.93 -8.77 coo 14.40 90.04 44.78 14.76 92.05 44.57 -5.78 -6.60 -5.54 -5.25 -5.49 -3.81 coo 17.43 90.38 41.69 17.76 92.72 39.75 -1.29 -2.34 -4.97 -2.19 0.30 -6.23 coo 13.56 96.78 47.94 12.87 95.13 45.44 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 ULMN 4 1kim_c01 THYMIDINE KINASE user 2 4 # 2 B 59 GLY A 241 GLY.? 10.63 N2 C2E B 301 B 83 GLU B 138 GLU.? 5.49 O2' C2E B 301 B 163 ARG B 165 ARG.? 10.70 O2' C2E B 301 B 222 ARG B 140 ARG.? -3.40 C5 C2E B 301s coo 12.62 99.24 38.96 12.68 98.60 38.52 -9.65 2.76 -9.37 -9.85 2.02 -9.06 coo 14.40 90.04 44.78 14.76 92.05 44.57 -14.88 11.83 -9.39 -15.29 12.85 -11.20 coo 17.43 90.38 41.69 17.76 92.72 39.75 -16.44 10.61 -14.72 -19.33 11.67 -14.77 coo 13.56 96.78 47.94 12.87 95.13 45.44 -7.91 11.52 -6.78 -7.96 14.04 -5.01 ULMN 4 1kim_c01 THYMIDINE KINASE user 3 4 # 3 B 59 GLY B 241 GLY.? 11.12 N2 C2E A 301 B 83 GLU A 138 GLU.? 5.46 O2' C2E A 301 B 163 ARG A 165 ARG.? 12.45 N2 C2E A 301 B 222 ARG A 140 ARG.? -3.36 C5 C2E A 301s coo 12.62 99.24 38.96 12.68 98.60 38.52 -3.59 -4.49 -13.18 -3.25 -3.75 -13.28 coo 14.40 90.04 44.78 14.76 92.05 44.57 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 coo 17.43 90.38 41.69 17.76 92.72 39.75 -4.47 -13.19 -19.45 -6.66 -12.47 -21.46 coo 13.56 96.78 47.94 12.87 95.13 45.44 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 1kim_c01 source 1kim THYMIDINE KINASE : 3 hits 1kim_c01 naa= 4 ULMN 4 1nkk_c00 PEPTIDOMIMETIC INHIBITOR user 1 4 # 1 A 63 HIS A 215 HIS.? 12.12 O6 C2E A 301 A 132 SER A 212 SER.? 13.10 O6 C2E A 301 A 157 HIS A 214 HIS.? 19.24 O6 C2E A 301 A 165 ARG A 217 ARG^? 6.70 O6 C2E A 301 coo 11.94 40.85 12.92 10.15 41.84 12.44 -8.99 -15.19 5.86 -7.58 -13.77 5.21 coo 8.67 45.38 10.10 8.76 42.96 10.05 -4.77 -16.86 9.45 -4.14 -15.23 7.75 coo 11.06 43.85 17.98 11.22 41.97 17.05 -9.67 -12.41 11.50 -9.18 -11.33 13.22 coo 6.60 37.92 5.74 3.89 37.17 6.93 -3.36 -16.18 0.94 -0.54 -17.39 0.83 ULMN 4 1nkk_c00 PEPTIDOMIMETIC INHIBITOR user 2 4 # 2 A 63 HIS B 215 HIS.? 11.93 O6 C2E B 301 A 132 SER B 212 SER.? 13.16 O6 C2E B 301 A 157 HIS B 214 HIS.? 18.94 O6 C2E B 301 A 165 ARG B 211 ARG^? 16.78 O6 C2E B 301 coo 11.94 40.85 12.92 10.15 41.84 12.44 7.81 14.24 -7.06 6.68 12.76 -6.10 coo 8.67 45.38 10.10 8.76 42.96 10.05 8.68 16.14 -1.54 8.01 14.57 -3.30 coo 11.06 43.85 17.98 11.22 41.97 17.05 13.04 11.66 -4.90 14.49 10.59 -3.83 coo 6.60 37.92 5.74 3.89 37.17 6.93 8.09 22.99 -2.57 10.13 22.73 -4.88 ULMN 4 1nkk_c00 PEPTIDOMIMETIC INHIBITOR user 3 4 # 3 A 63 HIS B 215 HIS.? 11.93 O6 C2E B 301 A 132 SER B 212 SER.? 13.16 O6 C2E B 301 A 157 HIS B 214 HIS.? 18.94 O6 C2E B 301 A 165 ARG B 217 ARG^? 6.37 O6 C2E B 301 coo 11.94 40.85 12.92 10.15 41.84 12.44 7.81 14.24 -7.06 6.68 12.76 -6.10 coo 8.67 45.38 10.10 8.76 42.96 10.05 8.68 16.14 -1.54 8.01 14.57 -3.30 coo 11.06 43.85 17.98 11.22 41.97 17.05 13.04 11.66 -4.90 14.49 10.59 -3.83 coo 6.60 37.92 5.74 3.89 37.17 6.93 0.82 15.44 -4.45 -0.87 16.78 -2.26 1nkk_c00 source 1nkk PEPTIDOMIMETIC INHIBITOR : 3 hits 1nkk_c00 naa= 4 ULMN 4 1nkk_c01 PEPTIDOMIMETIC INHIBITOR user 1 4 # 1 B 363 HIS A 215 HIS.? 12.12 O6 C2E A 301 B 432 SER A 212 SER.? 13.10 O6 C2E A 301 B 457 HIS A 214 HIS.? 19.24 O6 C2E A 301 B 465 ARG A 211 ARG^? 16.62 O6 C2E A 301 coo 35.32 43.47 -12.43 34.69 42.14 -13.92 -8.99 -15.19 5.86 -7.58 -13.77 5.21 coo 32.38 38.39 -14.73 32.14 40.79 -14.95 -4.77 -16.86 9.45 -4.14 -15.23 7.75 coo 40.41 40.81 -13.07 39.42 42.66 -13.07 -9.67 -12.41 11.50 -9.18 -11.33 13.22 coo 27.37 44.86 -17.95 29.55 46.21 -19.65 -4.93 -23.64 8.57 -7.93 -23.17 9.07 ULMN 4 1nkk_c01 PEPTIDOMIMETIC INHIBITOR user 2 4 # 2 B 363 HIS B 215 HIS.? 11.93 O6 C2E B 301 B 432 SER B 212 SER.? 13.16 O6 C2E B 301 B 457 HIS B 214 HIS.? 18.94 O6 C2E B 301 B 465 ARG B 211 ARG^? 16.78 O6 C2E B 301 coo 35.32 43.47 -12.43 34.69 42.14 -13.92 7.81 14.24 -7.06 6.68 12.76 -6.10 coo 32.38 38.39 -14.73 32.14 40.79 -14.95 8.68 16.14 -1.54 8.01 14.57 -3.30 coo 40.41 40.81 -13.07 39.42 42.66 -13.07 13.04 11.66 -4.90 14.49 10.59 -3.83 coo 27.37 44.86 -17.95 29.55 46.21 -19.65 8.09 22.99 -2.57 10.13 22.73 -4.88 1nkk_c01 source 1nkk PEPTIDOMIMETIC INHIBITOR : 2 hits 1nkk_c01 naa= 4 ULMN 4 1nkk_c02 PEPTIDOMIMETIC INHIBITOR user 1 4 # 1 C1063 HIS A 215 HIS.? 12.12 O6 C2E A 301 C1132 SER A 212 SER.? 13.10 O6 C2E A 301 C1157 HIS A 214 HIS.? 19.24 O6 C2E A 301 C1165 ARG A 211 ARG^? 16.62 O6 C2E A 301 coo 35.29 94.34 12.32 34.58 95.70 13.75 -8.99 -15.19 5.86 -7.58 -13.77 5.21 coo 32.69 99.54 14.77 32.37 97.11 14.96 -4.77 -16.86 9.45 -4.14 -15.23 7.75 coo 40.55 96.94 13.18 39.34 95.23 13.09 -9.67 -12.41 11.50 -9.18 -11.33 13.22 coo 27.55 93.06 17.78 29.73 91.78 19.50 -4.93 -23.64 8.57 -7.93 -23.17 9.07 ULMN 4 1nkk_c02 PEPTIDOMIMETIC INHIBITOR user 2 4 # 2 C1063 HIS B 215 HIS.? 11.93 O6 C2E B 301 C1132 SER B 212 SER.? 13.16 O6 C2E B 301 C1157 HIS B 214 HIS.? 18.94 O6 C2E B 301 C1165 ARG B 211 ARG^? 16.78 O6 C2E B 301 coo 35.29 94.34 12.32 34.58 95.70 13.75 7.81 14.24 -7.06 6.68 12.76 -6.10 coo 32.69 99.54 14.77 32.37 97.11 14.96 8.68 16.14 -1.54 8.01 14.57 -3.30 coo 40.55 96.94 13.18 39.34 95.23 13.09 13.04 11.66 -4.90 14.49 10.59 -3.83 coo 27.55 93.06 17.78 29.73 91.78 19.50 8.09 22.99 -2.57 10.13 22.73 -4.88 1nkk_c02 source 1nkk PEPTIDOMIMETIC INHIBITOR : 2 hits 1nkk_c02 naa= 4 ULMN 4 1nkk_c03 PEPTIDOMIMETIC INHIBITOR user 1 4 # 1 D1363 HIS B 215 HIS.? 11.93 O6 C2E B 301 D1432 SER B 212 SER.? 13.16 O6 C2E B 301 D1457 HIS B 214 HIS.? 18.94 O6 C2E B 301 D1465 ARG B 211 ARG^? 16.78 O6 C2E B 301 coo 11.96 97.36 -12.83 10.34 96.27 -12.07 7.81 14.24 -7.06 6.68 12.76 -6.10 coo 8.78 92.76 -9.93 8.91 95.20 -9.86 8.68 16.14 -1.54 8.01 14.57 -3.30 coo 11.29 94.21 -17.79 11.73 95.91 -16.63 13.04 11.66 -4.90 14.49 10.59 -3.83 coo 6.07 100.11 -5.80 4.70 101.59 -8.10 8.09 22.99 -2.57 10.13 22.73 -4.88 1nkk_c03 source 1nkk PEPTIDOMIMETIC INHIBITOR : 1 hits 1nkk_c03 naa= 4 ULMN 4 1og1_c00 T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2user 1 4 # 1 A 147 SER A 97 SER^? 9.23 O61 C2E A 301 A 159 GLU B 142 GLU^? 10.78 N1 C2E B 301 A 184 ARG B 99 ARG.? 13.88 O61 C2E A 301 A 189 GLU A 37 GLU.? 10.20 O61 C2E A 301 coo 53.09 24.63 27.00 51.51 25.19 25.28 5.13 -5.92 -3.45 4.74 -3.92 -4.71 coo 52.64 14.17 18.05 51.99 14.09 16.04 -2.97 5.35 -8.71 -1.84 4.27 -7.29 coo 45.78 18.05 21.49 44.51 17.88 18.72 -4.81 1.09 -3.04 -5.37 -1.84 -3.80 coo 49.07 22.26 28.01 48.95 23.27 26.11 0.90 -3.13 0.80 -0.70 -4.43 0.36 ULMN 4 1og1_c00 T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2user 2 4 # 2 A 147 SER A 166 SER.? -4.62 O2' C2E A 301s A 159 GLU A 142 GLU^? 10.87 N1 C2E A 301 A 184 ARG A 136 ARG.? -3.92 O61 C2E A 301s A 189 GLU A 138 GLU.? 5.46 O2' C2E A 301 coo 53.09 24.63 27.00 51.51 25.19 25.28 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 coo 52.64 14.17 18.05 51.99 14.09 16.04 -5.78 -6.60 -5.54 -5.25 -5.49 -3.81 coo 45.78 18.05 21.49 44.51 17.88 18.72 2.11 -12.17 -9.13 1.08 -10.80 -6.58 coo 49.07 22.26 28.01 48.95 23.27 26.11 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 ULMN 4 1og1_c00 T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2user 3 4 # 3 A 147 SER B 166 SER.? -4.53 O2' C2E B 301s A 159 GLU B 142 GLU^? 10.78 N1 C2E B 301 A 184 ARG B 136 ARG.? -3.89 O61 C2E B 301s A 189 GLU B 138 GLU.? 5.49 O2' C2E B 301 coo 53.09 24.63 27.00 51.51 25.19 25.28 -12.93 16.14 -12.85 -15.09 15.80 -11.81 coo 52.64 14.17 18.05 51.99 14.09 16.04 -2.97 5.35 -8.71 -1.84 4.27 -7.29 coo 45.78 18.05 21.49 44.51 17.88 18.72 -10.39 10.75 -3.93 -7.55 9.68 -3.54 coo 49.07 22.26 28.01 48.95 23.27 26.11 -14.88 11.83 -9.39 -15.29 12.85 -11.20 1og1_c00 source 1og1 T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2 : 3 hits 1og1_c00 naa= 4 ULMN 4 1oh9_c00 ACETYLGLUTAMATE KINASE user 1 4 # 1 A 8 LYS B 243 LYS.? 13.43 N1 C2E B 301 A 11 GLY A 100 GLY.? 9.32 N2 C2E A 301 A 45 GLY A 102 GLY.? 6.44 O61 C2E A 301 A 217 LYS A 243 LYS.? 15.17 N2 C2E A 301 coo 23.95 20.41 42.64 25.99 15.22 44.13 -2.53 1.27 -13.25 2.13 3.70 -10.70 coo 21.78 10.35 42.81 21.85 10.58 42.04 -0.32 -6.55 -10.22 0.00 -7.00 -9.65 coo 27.49 8.11 39.28 26.75 8.17 38.90 4.07 -8.14 -8.05 4.42 -7.93 -8.77 coo 29.45 15.15 50.79 25.80 14.13 47.92 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 1oh9_c00 source 1oh9 ACETYLGLUTAMATE KINASE : 1 hits 1oh9_c00 naa= 4 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 A 151 VAL B 149 VAL^? 14.42 O6 C2E B 301 A 194 GLY B 147 GLY^? 15.80 N1 C2E B 301 A 417 ILE B 114 ILE^? 25.12 N21 C2E B 301 A 457 ALA B 122 ALA^? 20.57 N21 C2E B 301 coo 60.43 93.31 8.03 62.16 94.30 8.93 3.05 21.90 -17.90 3.47 22.36 -15.79 coo 59.34 89.99 13.88 59.24 89.18 13.73 4.21 15.66 -20.42 4.84 15.79 -19.91 coo 39.61 128.90 22.54 40.04 128.24 23.80 7.12 11.07 23.91 6.80 12.46 23.63 coo 43.27 124.32 20.47 43.79 125.29 21.53 5.52 8.84 19.40 4.61 10.05 19.38 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 2 4 # 2 A 151 VAL B 149 VAL^? 14.42 O6 C2E B 301 A 194 GLY B 156 GLY^? 18.58 O6 C2E B 301 A 417 ILE B 114 ILE^? 25.12 N21 C2E B 301 A 457 ALA B 122 ALA^? 20.57 N21 C2E B 301 coo 60.43 93.31 8.03 62.16 94.30 8.93 3.05 21.90 -17.90 3.47 22.36 -15.79 coo 59.34 89.99 13.88 59.24 89.18 13.73 8.27 22.75 -18.03 7.60 22.47 -18.40 coo 39.61 128.90 22.54 40.04 128.24 23.80 7.12 11.07 23.91 6.80 12.46 23.63 coo 43.27 124.32 20.47 43.79 125.29 21.53 5.52 8.84 19.40 4.61 10.05 19.38 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 3 4 # 3 A 151 VAL B 185 VAL^? 12.63 C8 C2E B 301 A 194 GLY B 204 GLY^? 9.25 O4' C2E B 301 A 417 ILE A 93 ILE^? 14.72 N21 C2E A 301 A 457 ALA A 95 ALA^? 10.70 N11 C2E A 301 coo 60.43 93.31 8.03 62.16 94.30 8.93 -2.40 25.76 -15.87 -1.43 24.84 -14.15 coo 59.34 89.99 13.88 59.24 89.18 13.73 -7.72 23.64 -14.81 -6.98 23.95 -14.91 coo 39.61 128.90 22.54 40.04 128.24 23.80 15.99 -7.04 4.14 15.43 -6.28 5.24 coo 43.27 124.32 20.47 43.79 125.29 21.53 10.32 -7.78 0.85 10.35 -6.28 1.11 1pix_c00 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 3 hits 1pix_c00 naa= 4 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 B 151 VAL B 185 VAL^? 12.63 C8 C2E B 301 B 194 GLY B 204 GLY^? 9.25 O4' C2E B 301 B 417 ILE A 93 ILE^? 14.72 N21 C2E A 301 B 457 ALA A 95 ALA^? 10.70 N11 C2E A 301 coo 52.95 126.71 13.21 51.34 125.24 13.19 -2.40 25.76 -15.87 -1.43 24.84 -14.15 coo 50.40 126.23 20.48 50.46 127.00 20.75 -7.72 23.64 -14.81 -6.98 23.95 -14.91 coo 68.38 85.45 19.33 67.41 85.52 20.41 15.99 -7.04 4.14 15.43 -6.28 5.24 coo 65.50 91.13 17.77 64.65 89.88 18.00 10.32 -7.78 0.85 10.35 -6.28 1.11 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 2 4 # 2 B 151 VAL B 185 VAL^? 12.63 C8 C2E B 301 B 194 GLY B 204 GLY^? 9.25 O4' C2E B 301 B 417 ILE B 114 ILE^? 25.12 N21 C2E B 301 B 457 ALA B 122 ALA^? 20.57 N21 C2E B 301 coo 52.95 126.71 13.21 51.34 125.24 13.19 -2.40 25.76 -15.87 -1.43 24.84 -14.15 coo 50.40 126.23 20.48 50.46 127.00 20.75 -7.72 23.64 -14.81 -6.98 23.95 -14.91 coo 68.38 85.45 19.33 67.41 85.52 20.41 7.12 11.07 23.91 6.80 12.46 23.63 coo 65.50 91.13 17.77 64.65 89.88 18.00 5.52 8.84 19.40 4.61 10.05 19.38 1pix_c01 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 2 hits 1pix_c01 naa= 4 ULMN 4 1pma_c00 PROTEASOME user 1 4 # 1 B 1 THR A 198 THR.? 19.32 N2 C2E A 301 B 33 LYS A 148 LYS^? 21.30 O6 C2E A 301 B 47 GLY A 195 GLY.? 22.99 N2 C2E A 301 B 129 SER A 191 SER.? 20.96 N2 C2E A 301 coo 145.45 99.84 111.72 143.76 98.56 112.07 -23.21 -18.00 -10.51 -22.99 -19.75 -9.26 coo 136.79 102.27 111.59 142.67 100.98 109.47 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 coo 140.77 93.29 113.52 140.45 93.77 112.93 -26.58 -15.52 -3.95 -27.20 -15.54 -4.54 coo 148.45 97.25 114.98 149.72 97.25 112.90 -22.97 -12.99 -10.38 -25.12 -13.67 -11.26 1pma_c00 source 1pma PROTEASOME : 1 hits 1pma_c00 naa= 4 ULMN 4 1pma_c01 PROTEASOME user 1 4 # 1 P 1 THR A 198 THR.? 19.32 N2 C2E A 301 P 33 LYS A 148 LYS^? 21.30 O6 C2E A 301 P 47 GLY A 195 GLY.? 22.99 N2 C2E A 301 P 129 SER A 191 SER.? 20.96 N2 C2E A 301 coo 142.15 84.99 86.79 140.56 84.37 88.13 -23.21 -18.00 -10.51 -22.99 -19.75 -9.26 coo 133.38 85.70 85.38 139.26 83.66 84.60 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 coo 138.10 81.91 93.37 137.75 81.71 92.63 -26.58 -15.52 -3.95 -27.20 -15.54 -4.54 coo 145.29 86.16 90.67 146.68 84.74 89.28 -22.97 -12.99 -10.38 -25.12 -13.67 -11.26 1pma_c01 source 1pma PROTEASOME : 1 hits 1pma_c01 naa= 4 ULMN 4 1pma_c02 PROTEASOME user 1 4 # 1 Q 1 THR A 198 THR.? 19.32 N2 C2E A 301 Q 33 LYS A 148 LYS^? 21.30 O6 C2E A 301 Q 47 GLY A 195 GLY.? 22.99 N2 C2E A 301 Q 129 SER A 191 SER.? 20.96 N2 C2E A 301 coo 140.73 55.93 82.67 139.31 56.56 84.17 -23.21 -18.00 -10.51 -22.99 -19.75 -9.26 coo 131.97 54.44 81.72 138.04 53.15 82.45 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 coo 136.89 58.65 89.43 136.55 57.93 89.18 -26.58 -15.52 -3.95 -27.20 -15.54 -4.54 coo 143.72 59.85 83.98 145.20 57.91 84.07 -22.97 -12.99 -10.38 -25.12 -13.67 -11.26 1pma_c02 source 1pma PROTEASOME : 1 hits 1pma_c02 naa= 4 ULMN 4 1pma_c03 PROTEASOME user 1 4 # 1 R 1 THR A 198 THR.? 19.32 N2 C2E A 301 R 33 LYS A 148 LYS^? 21.30 O6 C2E A 301 R 47 GLY A 195 GLY.? 22.99 N2 C2E A 301 R 129 SER A 191 SER.? 20.96 N2 C2E A 301 coo 142.38 34.41 102.60 140.86 35.75 103.29 -23.21 -18.00 -10.51 -22.99 -19.75 -9.26 coo 133.82 32.17 103.65 140.06 32.45 104.82 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 coo 137.84 41.34 104.86 137.70 40.63 105.29 -26.58 -15.52 -3.95 -27.20 -15.54 -4.54 coo 144.81 38.28 100.19 146.44 37.17 101.53 -22.97 -12.99 -10.38 -25.12 -13.67 -11.26 1pma_c03 source 1pma PROTEASOME : 1 hits 1pma_c03 naa= 4 ULMN 4 1pma_c04 PROTEASOME user 1 4 # 1 S 1 THR A 198 THR.? 19.32 N2 C2E A 301 S 33 LYS A 148 LYS^? 21.30 O6 C2E A 301 S 47 GLY A 195 GLY.? 22.99 N2 C2E A 301 S 129 SER A 191 SER.? 20.96 N2 C2E A 301 coo 145.99 36.73 131.50 144.29 37.93 131.05 -23.21 -18.00 -10.51 -22.99 -19.75 -9.26 coo 137.54 35.66 134.42 143.74 36.95 134.69 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 coo 140.84 42.46 127.91 140.66 42.32 128.74 -26.58 -15.52 -3.95 -27.20 -15.54 -4.54 coo 148.11 37.39 126.83 149.93 38.14 128.30 -22.97 -12.99 -10.38 -25.12 -13.67 -11.26 1pma_c04 source 1pma PROTEASOME : 1 hits 1pma_c04 naa= 4 ULMN 4 1pma_c05 PROTEASOME user 1 4 # 1 T 1 THR A 198 THR.? 19.32 N2 C2E A 301 T 33 LYS A 148 LYS^? 21.30 O6 C2E A 301 T 47 GLY A 195 GLY.? 22.99 N2 C2E A 301 T 129 SER A 191 SER.? 20.96 N2 C2E A 301 coo 148.59 61.06 147.60 146.72 61.19 146.49 -23.21 -18.00 -10.51 -22.99 -19.75 -9.26 coo 140.35 62.12 151.02 146.27 63.46 149.54 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 coo 142.85 61.51 141.28 142.70 62.06 141.93 -26.58 -15.52 -3.95 -27.20 -15.54 -4.54 coo 150.80 57.97 144.10 152.46 59.79 144.30 -22.97 -12.99 -10.38 -25.12 -13.67 -11.26 1pma_c05 source 1pma PROTEASOME : 1 hits 1pma_c05 naa= 4 ULMN 4 1pma_c06 PROTEASOME user 1 4 # 1 U 1 THR A 198 THR.? 19.32 N2 C2E A 301 U 33 LYS A 148 LYS^? 21.30 O6 C2E A 301 U 47 GLY A 195 GLY.? 22.99 N2 C2E A 301 U 129 SER A 191 SER.? 20.96 N2 C2E A 301 coo 148.42 89.29 138.93 146.59 88.50 138.15 -23.21 -18.00 -10.51 -22.99 -19.75 -9.26 coo 140.15 91.82 140.86 145.77 92.05 138.33 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 coo 143.01 84.16 135.00 142.77 84.96 134.97 -26.58 -15.52 -3.95 -27.20 -15.54 -4.54 coo 150.85 84.74 138.83 152.35 86.20 137.62 -22.97 -12.99 -10.38 -25.12 -13.67 -11.26 1pma_c06 source 1pma PROTEASOME : 1 hits 1pma_c06 naa= 4 ULMN 4 1pma_c07 PROTEASOME user 1 4 # 1 V 1 THR A 198 THR.? 19.32 N2 C2E A 301 V 33 LYS A 148 LYS^? 21.30 O6 C2E A 301 V 47 GLY A 195 GLY.? 22.99 N2 C2E A 301 V 129 SER A 191 SER.? 20.96 N2 C2E A 301 coo 160.31 31.63 111.03 162.05 32.90 110.99 -23.21 -18.00 -10.51 -22.99 -19.75 -9.26 coo 168.58 29.07 108.83 162.49 30.41 108.07 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 coo 165.30 38.28 111.45 165.51 37.78 110.79 -26.58 -15.52 -3.95 -27.20 -15.54 -4.54 coo 158.15 34.28 114.77 156.42 34.20 113.07 -22.97 -12.99 -10.38 -25.12 -13.67 -11.26 1pma_c07 source 1pma PROTEASOME : 1 hits 1pma_c07 naa= 4 ULMN 4 1pma_c08 PROTEASOME user 1 4 # 1 W 1 THR A 198 THR.? 19.32 N2 C2E A 301 W 33 LYS A 148 LYS^? 21.30 O6 C2E A 301 W 47 GLY A 195 GLY.? 22.99 N2 C2E A 301 W 129 SER A 191 SER.? 20.96 N2 C2E A 301 coo 157.95 45.66 85.32 159.70 46.33 86.38 -23.21 -18.00 -10.51 -22.99 -19.75 -9.26 coo 166.07 44.81 82.01 160.13 46.94 82.57 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 coo 163.23 48.87 90.83 163.39 49.06 90.01 -26.58 -15.52 -3.95 -27.20 -15.54 -4.54 coo 155.60 44.58 89.97 153.89 45.98 88.92 -22.97 -12.99 -10.38 -25.12 -13.67 -11.26 1pma_c08 source 1pma PROTEASOME : 1 hits 1pma_c08 naa= 4 ULMN 4 1pma_c09 PROTEASOME user 1 4 # 1 X 1 THR A 198 THR.? 19.32 N2 C2E A 301 X 33 LYS A 148 LYS^? 21.30 O6 C2E A 301 X 47 GLY A 195 GLY.? 22.99 N2 C2E A 301 X 129 SER A 191 SER.? 20.96 N2 C2E A 301 coo 158.06 74.74 80.29 159.87 74.24 81.32 -23.21 -18.00 -10.51 -22.99 -19.75 -9.26 coo 166.53 76.03 77.46 160.69 77.43 79.50 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 coo 163.43 71.87 86.14 163.64 72.61 85.77 -26.58 -15.52 -3.95 -27.20 -15.54 -4.54 coo 155.48 70.66 82.49 154.03 72.56 83.11 -22.97 -12.99 -10.38 -25.12 -13.67 -11.26 1pma_c09 source 1pma PROTEASOME : 1 hits 1pma_c09 naa= 4 ULMN 4 1pma_c10 PROTEASOME user 1 4 # 1 Y 1 THR A 198 THR.? 19.32 N2 C2E A 301 Y 33 LYS A 148 LYS^? 21.30 O6 C2E A 301 Y 47 GLY A 195 GLY.? 22.99 N2 C2E A 301 Y 129 SER A 191 SER.? 20.96 N2 C2E A 301 coo 161.01 96.61 99.53 162.71 95.26 99.85 -23.21 -18.00 -10.51 -22.99 -19.75 -9.26 coo 169.59 99.02 98.57 163.79 98.75 101.06 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 coo 165.73 89.82 100.87 166.04 90.54 101.24 -26.58 -15.52 -3.95 -27.20 -15.54 -4.54 coo 157.98 92.90 97.78 156.61 93.86 99.58 -22.97 -12.99 -10.38 -25.12 -13.67 -11.26 1pma_c10 source 1pma PROTEASOME : 1 hits 1pma_c10 naa= 4 ULMN 4 1pma_c11 PROTEASOME user 1 4 # 1 Z 1 THR A 198 THR.? 19.32 N2 C2E A 301 Z 33 LYS A 148 LYS^? 21.30 O6 C2E A 301 Z 47 GLY A 195 GLY.? 22.99 N2 C2E A 301 Z 129 SER A 191 SER.? 20.96 N2 C2E A 301 coo 164.44 95.20 128.49 165.90 93.95 127.46 -23.21 -18.00 -10.51 -22.99 -19.75 -9.26 coo 173.04 96.56 129.40 167.10 95.22 131.11 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 coo 168.59 89.38 123.90 168.88 89.54 124.70 -26.58 -15.52 -3.95 -27.20 -15.54 -4.54 coo 161.09 94.40 124.50 159.85 93.81 126.51 -22.97 -12.99 -10.38 -25.12 -13.67 -11.26 1pma_c11 source 1pma PROTEASOME : 1 hits 1pma_c11 naa= 4 ULMN 4 1pma_c12 PROTEASOME user 1 4 # 1 1 1 THR A 198 THR.? 19.32 N2 C2E A 301 1 33 LYS A 148 LYS^? 21.30 O6 C2E A 301 1 47 GLY A 195 GLY.? 22.99 N2 C2E A 301 1 129 SER A 191 SER.? 20.96 N2 C2E A 301 coo 165.64 71.38 145.38 167.12 71.04 143.87 -23.21 -18.00 -10.51 -22.99 -19.75 -9.26 coo 174.42 70.53 146.91 168.32 69.05 146.87 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 coo 169.45 70.72 138.12 169.78 70.22 138.68 -26.58 -15.52 -3.95 -27.20 -15.54 -4.54 coo 162.75 74.36 142.49 161.13 72.65 143.07 -22.97 -12.99 -10.38 -25.12 -13.67 -11.26 1pma_c12 source 1pma PROTEASOME : 1 hits 1pma_c12 naa= 4 ULMN 4 1pma_c13 PROTEASOME user 1 4 # 1 2 1 THR A 198 THR.? 19.32 N2 C2E A 301 2 33 LYS A 148 LYS^? 21.30 O6 C2E A 301 2 47 GLY A 195 GLY.? 22.99 N2 C2E A 301 2 129 SER A 191 SER.? 20.96 N2 C2E A 301 coo 163.80 43.09 137.65 165.35 44.06 136.49 -23.21 -18.00 -10.51 -22.99 -19.75 -9.26 coo 172.39 40.52 137.60 166.18 40.30 136.65 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 coo 168.22 48.11 132.44 168.40 47.27 132.39 -26.58 -15.52 -3.95 -27.20 -15.54 -4.54 coo 161.33 47.56 138.08 159.59 46.11 137.23 -22.97 -12.99 -10.38 -25.12 -13.67 -11.26 1pma_c13 source 1pma PROTEASOME : 1 hits 1pma_c13 naa= 4 ULMN 4 1pma_c14 PROTEASOME user 1 4 # 1 A 35 SER A 166 SER.? -4.62 O2' C2E A 301s A 66 LYS A 205 LYS^? 11.81 O1P C2E A 301 A 80 GLY A 226 GLY~? 11.67 C1' C2E A 301 A 167 SER A 164 SER.? -3.07 N2 C2E A 301s coo 89.76 104.51 121.28 91.03 106.44 121.99 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 coo 99.01 105.66 122.24 93.37 107.22 124.79 -5.45 -27.16 -8.25 -2.71 -32.35 -10.76 coo 91.58 97.09 120.24 92.08 97.51 120.80 -10.93 -22.84 -15.51 -10.72 -22.76 -16.32 coo 85.59 103.89 117.95 84.01 104.68 119.62 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 ULMN 4 1pma_c14 PROTEASOME user 2 4 # 2 A 35 SER B 166 SER.? -4.53 O2' C2E B 301s A 66 LYS B 205 LYS^? -10.36 O1P C2E B 301s A 80 GLY B 226 GLY~? 11.47 O2' C2E B 301 A 167 SER B 164 SER.? -3.05 N2 C2E B 301s coo 89.76 104.51 121.28 91.03 106.44 121.99 -12.93 16.14 -12.85 -15.09 15.80 -11.81 coo 99.01 105.66 122.24 93.37 107.22 124.79 -6.87 25.33 -11.52 -10.34 29.58 -9.49 coo 91.58 97.09 120.24 92.08 97.51 120.80 -10.34 20.15 -19.24 -11.11 20.04 -19.49 coo 85.59 103.89 117.95 84.01 104.68 119.62 -10.30 11.42 -12.93 -10.44 13.17 -11.24 1pma_c14 source 1pma PROTEASOME : 2 hits 1pma_c14 naa= 4 ULMN 4 1pma_c15 PROTEASOME user 1 4 # 1 C 35 SER A 166 SER.? -4.62 O2' C2E A 301s C 66 LYS A 205 LYS^? 11.81 O1P C2E A 301 C 80 GLY A 226 GLY~? 11.67 C1' C2E A 301 C 167 SER A 164 SER.? -3.07 N2 C2E A 301s coo 86.16 90.99 92.80 87.35 92.60 91.45 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 coo 95.08 92.95 91.94 89.21 95.51 92.55 -5.45 -27.16 -8.25 -2.71 -32.35 -10.76 coo 88.54 85.72 97.78 89.01 86.43 97.78 -10.93 -22.84 -15.51 -10.72 -22.76 -16.32 coo 81.98 87.51 91.60 80.26 89.10 92.17 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 ULMN 4 1pma_c15 PROTEASOME user 2 4 # 2 C 35 SER B 166 SER.? -4.53 O2' C2E B 301s C 66 LYS B 205 LYS^? -10.36 O1P C2E B 301s C 80 GLY B 226 GLY~? 11.47 O2' C2E B 301 C 167 SER B 164 SER.? -3.05 N2 C2E B 301s coo 86.16 90.99 92.80 87.35 92.60 91.45 -12.93 16.14 -12.85 -15.09 15.80 -11.81 coo 95.08 92.95 91.94 89.21 95.51 92.55 -6.87 25.33 -11.52 -10.34 29.58 -9.49 coo 88.54 85.72 97.78 89.01 86.43 97.78 -10.34 20.15 -19.24 -11.11 20.04 -19.49 coo 81.98 87.51 91.60 80.26 89.10 92.17 -10.30 11.42 -12.93 -10.44 13.17 -11.24 1pma_c15 source 1pma PROTEASOME : 2 hits 1pma_c15 naa= 4 ULMN 4 1pma_c16 PROTEASOME user 1 4 # 1 D 35 SER A 166 SER.? -4.62 O2' C2E A 301s D 66 LYS A 205 LYS^? 11.81 O1P C2E A 301 D 80 GLY A 226 GLY~? 11.67 C1' C2E A 301 D 167 SER A 164 SER.? -3.07 N2 C2E A 301s coo 84.34 60.07 85.86 85.10 60.44 83.59 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 coo 93.10 61.36 83.03 86.96 63.04 81.84 -5.45 -27.16 -8.25 -2.71 -32.35 -10.76 coo 87.21 60.71 92.95 87.59 61.21 92.34 -10.93 -22.84 -15.51 -10.72 -22.76 -16.32 coo 80.64 56.46 87.95 78.79 57.87 87.31 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 ULMN 4 1pma_c16 PROTEASOME user 2 4 # 2 D 35 SER B 166 SER.? -4.53 O2' C2E B 301s D 66 LYS B 205 LYS^? -10.36 O1P C2E B 301s D 80 GLY B 226 GLY~? 11.47 O2' C2E B 301 D 167 SER B 164 SER.? -3.05 N2 C2E B 301s coo 84.34 60.07 85.86 85.10 60.44 83.59 -12.93 16.14 -12.85 -15.09 15.80 -11.81 coo 93.10 61.36 83.03 86.96 63.04 81.84 -6.87 25.33 -11.52 -10.34 29.58 -9.49 coo 87.21 60.71 92.95 87.59 61.21 92.34 -10.34 20.15 -19.24 -11.11 20.04 -19.49 coo 80.64 56.46 87.95 78.79 57.87 87.31 -10.30 11.42 -12.93 -10.44 13.17 -11.24 1pma_c16 source 1pma PROTEASOME : 2 hits 1pma_c16 naa= 4 ULMN 4 1pma_c17 PROTEASOME user 1 4 # 1 E 35 SER B 166 SER.? -4.53 O2' C2E B 301s E 66 LYS B 205 LYS^? -10.36 O1P C2E B 301s E 80 GLY B 226 GLY~? 11.47 O2' C2E B 301 E 167 SER B 164 SER.? -3.05 N2 C2E B 301s coo 85.87 34.81 105.43 86.85 33.25 103.89 -12.93 16.14 -12.85 -15.09 15.80 -11.81 coo 94.23 34.01 101.89 88.08 33.81 100.38 -6.87 25.33 -11.52 -10.34 29.58 -9.49 coo 88.45 41.00 109.01 88.80 40.87 108.21 -10.34 20.15 -19.24 -11.11 20.04 -19.49 coo 82.37 33.96 109.76 80.42 34.00 108.25 -10.30 11.42 -12.93 -10.44 13.17 -11.24 1pma_c17 source 1pma PROTEASOME : 1 hits 1pma_c17 naa= 4 ULMN 4 1pma_c18 PROTEASOME user 1 4 # 1 F 35 SER A 166 SER.? -4.62 O2' C2E A 301s F 66 LYS A 205 LYS^? 11.81 O1P C2E A 301 F 80 GLY A 226 GLY~? 11.67 C1' C2E A 301 F 167 SER A 164 SER.? -3.07 N2 C2E A 301s coo 89.47 34.70 136.77 90.56 32.53 136.87 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 coo 98.16 32.25 134.54 92.11 30.32 134.15 -5.45 -27.16 -8.25 -2.71 -32.35 -10.76 coo 91.52 41.49 134.05 91.91 40.83 133.64 -10.93 -22.84 -15.51 -10.72 -22.76 -16.32 coo 86.20 37.37 140.32 84.33 36.07 139.50 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 ULMN 4 1pma_c18 PROTEASOME user 2 4 # 2 F 35 SER B 166 SER.? -4.53 O2' C2E B 301s F 66 LYS B 205 LYS^? -10.36 O1P C2E B 301s F 80 GLY B 226 GLY~? 11.47 O2' C2E B 301 F 167 SER B 164 SER.? -3.05 N2 C2E B 301s coo 89.47 34.70 136.77 90.56 32.53 136.87 -12.93 16.14 -12.85 -15.09 15.80 -11.81 coo 98.16 32.25 134.54 92.11 30.32 134.15 -6.87 25.33 -11.52 -10.34 29.58 -9.49 coo 91.52 41.49 134.05 91.91 40.83 133.64 -10.34 20.15 -19.24 -11.11 20.04 -19.49 coo 86.20 37.37 140.32 84.33 36.07 139.50 -10.30 11.42 -12.93 -10.44 13.17 -11.24 1pma_c18 source 1pma PROTEASOME : 2 hits 1pma_c18 naa= 4 ULMN 4 1pma_c19 PROTEASOME user 1 4 # 1 G 35 SER A 166 SER.? -4.62 O2' C2E A 301s G 66 LYS A 205 LYS^? 11.81 O1P C2E A 301 G 80 GLY A 226 GLY~? 11.67 C1' C2E A 301 G 167 SER A 164 SER.? -3.07 N2 C2E A 301s coo 92.48 59.40 156.31 93.79 58.22 157.99 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 coo 101.40 56.92 156.13 95.50 54.88 157.80 -5.45 -27.16 -8.25 -2.71 -32.35 -10.76 coo 93.61 61.72 149.21 94.11 61.04 149.43 -10.93 -22.84 -15.51 -10.72 -22.76 -16.32 coo 88.78 63.56 156.72 86.93 62.01 157.10 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 ULMN 4 1pma_c19 PROTEASOME user 2 4 # 2 G 35 SER B 166 SER.? -4.53 O2' C2E B 301s G 66 LYS B 205 LYS^? -10.36 O1P C2E B 301s G 80 GLY B 226 GLY~? 11.47 O2' C2E B 301 G 167 SER B 164 SER.? -3.05 N2 C2E B 301s coo 92.48 59.40 156.31 93.79 58.22 157.99 -12.93 16.14 -12.85 -15.09 15.80 -11.81 coo 101.40 56.92 156.13 95.50 54.88 157.80 -6.87 25.33 -11.52 -10.34 29.58 -9.49 coo 93.61 61.72 149.21 94.11 61.04 149.43 -10.34 20.15 -19.24 -11.11 20.04 -19.49 coo 88.78 63.56 156.72 86.93 62.01 157.10 -10.30 11.42 -12.93 -10.44 13.17 -11.24 1pma_c19 source 1pma PROTEASOME : 2 hits 1pma_c19 naa= 4 ULMN 4 1pma_c20 PROTEASOME user 1 4 # 1 H 35 SER A 166 SER.? -4.62 O2' C2E A 301s H 66 LYS A 205 LYS^? 11.81 O1P C2E A 301 H 80 GLY A 226 GLY~? 11.67 C1' C2E A 301 H 167 SER A 164 SER.? -3.07 N2 C2E A 301s coo 92.74 90.44 149.58 94.16 91.12 151.38 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 coo 101.80 89.56 150.85 96.21 89.19 153.82 -5.45 -27.16 -8.25 -2.71 -32.35 -10.76 coo 93.72 86.54 143.13 94.26 86.30 143.78 -10.93 -22.84 -15.51 -10.72 -22.76 -16.32 coo 88.57 93.20 146.88 86.86 92.43 148.44 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 ULMN 4 1pma_c20 PROTEASOME user 2 4 # 2 H 35 SER B 166 SER.? -4.53 O2' C2E B 301s H 66 LYS B 205 LYS^? -10.36 O1P C2E B 301s H 80 GLY B 226 GLY~? 11.47 O2' C2E B 301 H 167 SER B 164 SER.? -3.05 N2 C2E B 301s coo 92.74 90.44 149.58 94.16 91.12 151.38 -12.93 16.14 -12.85 -15.09 15.80 -11.81 coo 101.80 89.56 150.85 96.21 89.19 153.82 -6.87 25.33 -11.52 -10.34 29.58 -9.49 coo 93.72 86.54 143.13 94.26 86.30 143.78 -10.34 20.15 -19.24 -11.11 20.04 -19.49 coo 88.57 93.20 146.88 86.86 92.43 148.44 -10.30 11.42 -12.93 -10.44 13.17 -11.24 1pma_c20 source 1pma PROTEASOME : 2 hits 1pma_c20 naa= 4 ULMN 4 1pma_c21 PROTEASOME user 1 4 # 1 I 35 SER A 166 SER.? -4.62 O2' C2E A 301s I 66 LYS A 205 LYS^? 11.81 O1P C2E A 301 I 80 GLY A 226 GLY~? 11.67 C1' C2E A 301 I 167 SER A 164 SER.? -3.07 N2 C2E A 301s coo 216.67 26.97 107.22 215.57 25.04 108.20 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 coo 208.01 25.98 110.24 214.08 24.27 111.46 -5.45 -27.16 -8.25 -2.71 -32.35 -10.76 coo 214.93 34.32 106.43 214.53 33.95 107.10 -10.93 -22.84 -15.51 -10.72 -22.76 -16.32 coo 219.98 27.60 102.95 221.89 26.99 104.30 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 ULMN 4 1pma_c21 PROTEASOME user 2 4 # 2 I 35 SER B 166 SER.? -4.53 O2' C2E B 301s I 66 LYS B 205 LYS^? -10.36 O1P C2E B 301s I 80 GLY B 226 GLY~? 11.47 O2' C2E B 301 I 167 SER B 164 SER.? -3.05 N2 C2E B 301s coo 216.67 26.97 107.22 215.57 25.04 108.20 -12.93 16.14 -12.85 -15.09 15.80 -11.81 coo 208.01 25.98 110.24 214.08 24.27 111.46 -6.87 25.33 -11.52 -10.34 29.58 -9.49 coo 214.93 34.32 106.43 214.53 33.95 107.10 -10.34 20.15 -19.24 -11.11 20.04 -19.49 coo 219.98 27.60 102.95 221.89 26.99 104.30 -10.30 11.42 -12.93 -10.44 13.17 -11.24 1pma_c21 source 1pma PROTEASOME : 2 hits 1pma_c21 naa= 4 ULMN 4 1pma_c22 PROTEASOME user 1 4 # 1 J 35 SER A 166 SER.? -4.62 O2' C2E A 301s J 66 LYS A 205 LYS^? 11.81 O1P C2E A 301 J 80 GLY A 226 GLY~? 11.67 C1' C2E A 301 J 167 SER A 164 SER.? -3.07 N2 C2E A 301s coo 213.55 39.87 78.52 212.15 38.11 77.66 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 coo 204.73 37.66 79.74 210.59 35.12 79.14 -5.45 -27.16 -8.25 -2.71 -32.35 -10.76 coo 212.36 45.21 83.76 211.92 44.47 83.89 -10.93 -22.84 -15.51 -10.72 -22.76 -16.32 coo 217.34 43.17 76.17 219.16 41.55 76.51 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 ULMN 4 1pma_c22 PROTEASOME user 2 4 # 2 J 35 SER B 166 SER.? -4.53 O2' C2E B 301s J 66 LYS B 205 LYS^? -10.36 O1P C2E B 301s J 80 GLY B 226 GLY~? 11.47 O2' C2E B 301 J 167 SER B 164 SER.? -3.05 N2 C2E B 301s coo 213.55 39.87 78.52 212.15 38.11 77.66 -12.93 16.14 -12.85 -15.09 15.80 -11.81 coo 204.73 37.66 79.74 210.59 35.12 79.14 -6.87 25.33 -11.52 -10.34 29.58 -9.49 coo 212.36 45.21 83.76 211.92 44.47 83.89 -10.34 20.15 -19.24 -11.11 20.04 -19.49 coo 217.34 43.17 76.17 219.16 41.55 76.51 -10.30 11.42 -12.93 -10.44 13.17 -11.24 1pma_c22 source 1pma PROTEASOME : 2 hits 1pma_c22 naa= 4 ULMN 4 1pma_c23 PROTEASOME user 1 4 # 1 K 35 SER A 166 SER.? -4.62 O2' C2E A 301s K 66 LYS A 205 LYS^? 11.81 O1P C2E A 301 K 80 GLY A 226 GLY~? 11.67 C1' C2E A 301 K 167 SER A 164 SER.? -3.07 N2 C2E A 301s coo 213.86 70.48 70.36 212.52 70.13 68.37 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 coo 204.71 69.18 69.70 210.34 67.50 67.20 -5.45 -27.16 -8.25 -2.71 -32.35 -10.76 coo 212.56 69.98 77.87 212.03 69.49 77.40 -10.93 -22.84 -15.51 -10.72 -22.76 -16.32 coo 217.85 74.08 71.56 219.45 72.67 70.36 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 ULMN 4 1pma_c23 PROTEASOME user 2 4 # 2 K 35 SER B 166 SER.? -4.53 O2' C2E B 301s K 66 LYS B 205 LYS^? -10.36 O1P C2E B 301s K 80 GLY B 226 GLY~? 11.47 O2' C2E B 301 K 167 SER B 164 SER.? -3.05 N2 C2E B 301s coo 213.86 70.48 70.36 212.52 70.13 68.37 -12.93 16.14 -12.85 -15.09 15.80 -11.81 coo 204.71 69.18 69.70 210.34 67.50 67.20 -6.87 25.33 -11.52 -10.34 29.58 -9.49 coo 212.56 69.98 77.87 212.03 69.49 77.40 -10.34 20.15 -19.24 -11.11 20.04 -19.49 coo 217.85 74.08 71.56 219.45 72.67 70.36 -10.30 11.42 -12.93 -10.44 13.17 -11.24 1pma_c23 source 1pma PROTEASOME : 2 hits 1pma_c23 naa= 4 ULMN 4 1pma_c24 PROTEASOME user 1 4 # 1 L 35 SER A 166 SER.? -4.62 O2' C2E A 301s L 66 LYS A 205 LYS^? 11.81 O1P C2E A 301 L 80 GLY A 226 GLY~? 11.67 C1' C2E A 301 L 167 SER A 164 SER.? -3.07 N2 C2E A 301s coo 216.64 96.16 88.97 215.38 97.58 87.49 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 coo 207.55 96.84 87.56 213.26 97.06 84.64 -5.45 -27.16 -8.25 -2.71 -32.35 -10.76 coo 214.90 90.14 93.16 214.41 90.25 92.47 -10.93 -22.84 -15.51 -10.72 -22.76 -16.32 coo 220.95 97.14 92.21 222.53 97.02 90.36 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 ULMN 4 1pma_c24 PROTEASOME user 2 4 # 2 L 35 SER B 166 SER.? -4.53 O2' C2E B 301s L 66 LYS B 205 LYS^? -10.36 O1P C2E B 301s L 80 GLY B 226 GLY~? 11.47 O2' C2E B 301 L 167 SER B 164 SER.? -3.05 N2 C2E B 301s coo 216.64 96.16 88.97 215.38 97.58 87.49 -12.93 16.14 -12.85 -15.09 15.80 -11.81 coo 207.55 96.84 87.56 213.26 97.06 84.64 -6.87 25.33 -11.52 -10.34 29.58 -9.49 coo 214.90 90.14 93.16 214.41 90.25 92.47 -10.34 20.15 -19.24 -11.11 20.04 -19.49 coo 220.95 97.14 92.21 222.53 97.02 90.36 -10.30 11.42 -12.93 -10.44 13.17 -11.24 1pma_c24 source 1pma PROTEASOME : 2 hits 1pma_c24 naa= 4 ULMN 4 1pma_c25 PROTEASOME user 1 4 # 1 M 35 SER A 166 SER.? -4.62 O2' C2E A 301s M 66 LYS A 205 LYS^? 11.81 O1P C2E A 301 M 80 GLY A 226 GLY~? 11.67 C1' C2E A 301 M 167 SER A 164 SER.? -3.07 N2 C2E A 301s coo 220.44 97.39 120.24 219.28 99.46 120.61 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 coo 211.44 99.73 120.08 217.33 101.48 118.24 -5.45 -27.16 -8.25 -2.71 -32.35 -10.76 coo 217.83 90.43 118.26 217.38 91.08 117.92 -10.93 -22.84 -15.51 -10.72 -22.76 -16.32 coo 224.42 94.96 123.04 226.02 96.08 121.60 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 ULMN 4 1pma_c25 PROTEASOME user 2 4 # 2 M 35 SER B 166 SER.? -4.53 O2' C2E B 301s M 66 LYS B 205 LYS^? -10.36 O1P C2E B 301s M 80 GLY B 226 GLY~? 11.47 O2' C2E B 301 M 167 SER B 164 SER.? -3.05 N2 C2E B 301s coo 220.44 97.39 120.24 219.28 99.46 120.61 -12.93 16.14 -12.85 -15.09 15.80 -11.81 coo 211.44 99.73 120.08 217.33 101.48 118.24 -6.87 25.33 -11.52 -10.34 29.58 -9.49 coo 217.83 90.43 118.26 217.38 91.08 117.92 -10.34 20.15 -19.24 -11.11 20.04 -19.49 coo 224.42 94.96 123.04 226.02 96.08 121.60 -10.30 11.42 -12.93 -10.44 13.17 -11.24 1pma_c25 source 1pma PROTEASOME : 2 hits 1pma_c25 naa= 4 ULMN 4 1pma_c26 PROTEASOME user 1 4 # 1 N 35 SER B 166 SER.? -4.53 O2' C2E B 301s N 66 LYS B 205 LYS^? -10.36 O1P C2E B 301s N 80 GLY B 226 GLY~? 11.47 O2' C2E B 301 N 167 SER B 164 SER.? -3.05 N2 C2E B 301s coo 221.83 73.23 140.73 220.76 74.32 142.57 -12.93 16.14 -12.85 -15.09 15.80 -11.81 coo 213.28 75.80 142.62 219.38 77.84 142.76 -6.87 25.33 -11.52 -10.34 29.58 -9.49 coo 218.97 70.56 134.12 218.60 71.29 134.44 -10.34 20.15 -19.24 -11.11 20.04 -19.49 coo 225.82 69.04 140.40 227.65 70.67 140.39 -10.30 11.42 -12.93 -10.44 13.17 -11.24 1pma_c26 source 1pma PROTEASOME : 1 hits 1pma_c26 naa= 4 ULMN 4 1pma_c27 PROTEASOME user 1 4 # 1 O 35 SER B 166 SER.? -4.53 O2' C2E B 301s O 66 LYS B 205 LYS^? -10.36 O1P C2E B 301s O 80 GLY B 226 GLY~? 11.47 O2' C2E B 301 O 167 SER B 164 SER.? -3.05 N2 C2E B 301s coo 220.45 41.90 135.07 219.57 41.33 137.22 -12.93 16.14 -12.85 -15.09 15.80 -11.81 coo 212.02 42.85 138.43 218.26 43.26 139.85 -6.87 25.33 -11.52 -10.34 29.58 -9.49 coo 217.92 45.71 129.07 217.56 45.95 129.82 -10.34 20.15 -19.24 -11.11 20.04 -19.49 coo 223.94 39.10 131.49 225.85 39.86 132.79 -10.30 11.42 -12.93 -10.44 13.17 -11.24 1pma_c27 source 1pma PROTEASOME : 1 hits 1pma_c27 naa= 4 ULMN 4 1vie_c00 DIHYDROFOLATE REDUCTASE user 1 4 # 1 32 LYS A 177 LYS.? 20.27 N7 C2E A 301 67 GLN A 180 GLN.? 15.88 O1P C2E A 301 68 ILE A 206 ILE^? 8.52 N7 C2E A 301 69 TYR A 179 TYR.? 13.95 N7 C2E A 301 coo 48.90 34.31 31.27 46.88 31.76 27.75 -13.21 -27.52 5.04 -11.69 -32.72 3.81 coo 39.39 36.10 28.84 38.74 37.41 27.29 -4.24 -31.66 0.79 -3.85 -33.35 2.05 coo 37.05 32.93 33.62 35.59 32.79 33.64 -4.69 -26.11 -3.54 -5.49 -25.03 -2.91 coo 42.56 32.62 31.97 42.58 34.44 29.84 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 ULMN 4 1vie_c00 DIHYDROFOLATE REDUCTASE user 2 4 # 2 32 LYS B 177 LYS.? 21.12 N7 C2E B 301 67 GLN B 180 GLN.? 16.04 O1P C2E B 301 68 ILE B 206 ILE^? 8.45 N7 C2E B 301 69 TYR B 179 TYR.? 13.89 O6 C2E B 301 coo 48.90 34.31 31.27 46.88 31.76 27.75 8.81 26.59 -11.72 7.46 31.56 -12.94 coo 39.39 36.10 28.84 38.74 37.41 27.29 1.55 30.21 -5.52 1.56 32.31 -5.18 coo 37.05 32.93 33.62 35.59 32.79 33.64 -3.04 24.79 -8.55 -2.06 23.72 -8.88 coo 42.56 32.62 31.97 42.58 34.44 29.84 2.36 25.70 -10.99 3.98 25.02 -13.14 1vie_c00 source 1vie DIHYDROFOLATE REDUCTASE : 2 hits 1vie_c00 naa= 4 ULMN 4 1x9h_c01 GLUCOSE-6-PHOSPHATE ISOMERASE user 1 4 # 1 B 135 ARG A 165 ARG.? 12.45 N2 C2E A 301 B 203 GLU A 138 GLU.? 5.46 O2' C2E A 301 B 219 HIS A 154 HIS^? 21.74 O6 C2E A 301 B 298 LYS B 243 LYS.? 13.43 N1 C2E B 301 coo 18.36 26.71 24.52 15.92 26.01 22.78 -4.47 -13.19 -19.45 -6.66 -12.47 -21.46 coo 19.67 22.60 23.25 18.70 23.07 25.03 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 coo 46.63 12.38 30.98 47.80 13.39 32.39 -16.69 -30.86 2.00 -15.94 -32.47 3.12 coo 10.17 13.56 26.79 12.26 19.06 29.15 -2.53 1.27 -13.25 2.13 3.70 -10.70 1x9h_c01 source 1x9h GLUCOSE-6-PHOSPHATE ISOMERASE : 1 hits 1x9h_c01 naa= 4 ULMN 4 1xtc_c00 CHOLERA TOXIN user 1 4 # 1 A 7 ARG A 227 ARG~? 9.91 O2' C2E A 301 A 61 SER A 166 SER.? -4.62 O2' C2E A 301s A 110 GLU A 101 GLU.? 9.39 O11 C2E A 301 A 112 GLU A 138 GLU.? 5.46 O2' C2E A 301 coo 40.84 -12.81 5.27 43.40 -12.96 7.11 -5.20 -21.14 -18.72 -4.74 -24.14 -19.17 coo 43.36 -8.81 2.69 45.06 -10.01 1.28 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 coo 50.78 -11.66 -4.90 52.36 -12.10 -6.21 2.77 -8.35 -14.05 3.97 -7.83 -15.72 coo 46.91 -7.83 -2.12 47.28 -9.79 -1.54 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 1xtc_c00 source 1xtc CHOLERA TOXIN : 1 hits 1xtc_c00 naa= 4 ULMN 4 2pgd_c00 6-PHOSPHOGLUCONATE DEHYDROGENASE (6-user 1 4 # 1 130 GLY A 204 GLY^? 9.28 O4' C2E A 301 183 LYS A 231 LYS~? 13.14 O2' C2E A 301 187 ASN A 228 ASN~? 15.04 O2' C2E A 301 190 GLU A 224 GLU~? 15.93 O2' C2E A 301 coo 17.10 29.44 43.85 16.37 29.12 43.58 -8.02 -25.69 -10.66 -8.46 -26.04 -10.07 coo 19.89 26.71 31.12 19.64 27.76 36.18 -11.44 -15.22 -19.18 -8.27 -15.76 -22.64 coo 24.07 30.35 34.20 22.74 29.43 35.67 -12.40 -21.37 -21.10 -11.00 -22.25 -22.44 coo 22.71 35.39 36.78 22.54 33.56 37.82 -8.40 -25.77 -21.72 -8.05 -26.98 -23.42 ULMN 4 2pgd_c00 6-PHOSPHOGLUCONATE DEHYDROGENASE (6-user 2 4 # 2 130 GLY A 204 GLY^? 9.28 O4' C2E A 301 183 LYS A 231 LYS~? 13.14 O2' C2E A 301 187 ASN A 228 ASN~? 15.04 O2' C2E A 301 190 GLU A 225 GLU~? 17.61 C1' C2E A 301 coo 17.10 29.44 43.85 16.37 29.12 43.58 -8.02 -25.69 -10.66 -8.46 -26.04 -10.07 coo 19.89 26.71 31.12 19.64 27.76 36.18 -11.44 -15.22 -19.18 -8.27 -15.76 -22.64 coo 24.07 30.35 34.20 22.74 29.43 35.67 -12.40 -21.37 -21.10 -11.00 -22.25 -22.44 coo 22.71 35.39 36.78 22.54 33.56 37.82 -14.07 -25.95 -18.02 -15.34 -27.27 -16.96 ULMN 4 2pgd_c00 6-PHOSPHOGLUCONATE DEHYDROGENASE (6-user 3 4 # 3 130 GLY A 204 GLY^? 9.28 O4' C2E A 301 183 LYS A 231 LYS~? 13.14 O2' C2E A 301 187 ASN A 229 ASN~? 15.85 N2 C2E A 301 190 GLU A 225 GLU~? 17.61 C1' C2E A 301 coo 17.10 29.44 43.85 16.37 29.12 43.58 -8.02 -25.69 -10.66 -8.46 -26.04 -10.07 coo 19.89 26.71 31.12 19.64 27.76 36.18 -11.44 -15.22 -19.18 -8.27 -15.76 -22.64 coo 24.07 30.35 34.20 22.74 29.43 35.67 -14.86 -20.46 -16.50 -16.06 -21.98 -17.43 coo 22.71 35.39 36.78 22.54 33.56 37.82 -14.07 -25.95 -18.02 -15.34 -27.27 -16.96 ULMN 4 2pgd_c00 6-PHOSPHOGLUCONATE DEHYDROGENASE (6-user 4 4 # 4 130 GLY B 204 GLY^? 9.25 O4' C2E B 301 183 LYS B 231 LYS~? 16.58 O2' C2E B 301 187 ASN B 228 ASN~? 15.22 O2' C2E B 301 190 GLU B 224 GLU~? 16.79 O2' C2E B 301 coo 17.10 29.44 43.85 16.37 29.12 43.58 -7.72 23.64 -14.81 -6.98 23.95 -14.91 coo 19.89 26.71 31.12 19.64 27.76 36.18 -12.77 12.18 -20.95 -18.80 11.50 -22.86 coo 24.07 30.35 34.20 22.74 29.43 35.67 -14.11 18.31 -23.21 -16.11 19.01 -22.96 coo 22.71 35.39 36.78 22.54 33.56 37.82 -16.80 22.93 -20.90 -17.88 24.32 -22.10 2pgd_c00 source 2pgd 6-PHOSPHOGLUCONATE DEHYDROGENASE (6-PGDH) (E.C: 4 hits 2pgd_c00 naa= 4 ULMN 3 1a0j_c12 TRYPSIN user 1 3 # 1 A 57 HIS A 154 HIS^? 21.74 O6 C2E A 301 A 102 ASP A 152 ASP.? 20.83 C8 C2E A 301 A 193 GLY A 176 GLY.? 18.56 O6 C2E A 301 coo 25.57 41.22 61.68 24.18 39.98 62.50 -16.69 -30.86 2.00 -15.94 -32.47 3.12 coo 22.33 45.48 59.73 23.35 43.67 60.06 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo 22.57 32.23 64.13 21.98 32.82 64.22 -14.50 -24.46 6.89 -13.82 -24.67 7.29 1a0j_c12 source 1a0j TRYPSIN : 1 hits 1a0j_c12 naa= 3 ULMN 3 1a0j_c13 TRYPSIN user 1 3 # 1 B 57 HIS A 154 HIS^? 21.74 O6 C2E A 301 B 102 ASP A 152 ASP.? 20.83 C8 C2E A 301 B 193 GLY A 176 GLY.? 18.56 O6 C2E A 301 coo 44.08 45.58 52.81 45.86 46.55 52.85 -16.69 -30.86 2.00 -15.94 -32.47 3.12 coo 43.04 44.75 47.18 43.31 45.51 49.13 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo 50.46 51.91 56.90 50.65 51.62 56.14 -14.50 -24.46 6.89 -13.82 -24.67 7.29 1a0j_c13 source 1a0j TRYPSIN : 1 hits 1a0j_c13 naa= 3 ULMN 3 1a0j_c14 TRYPSIN user 1 3 # 1 C 57 HIS A 154 HIS^? 21.74 O6 C2E A 301 C 102 ASP A 152 ASP.? 20.83 C8 C2E A 301 C 193 GLY A 176 GLY.? 18.56 O6 C2E A 301 coo 34.37 41.18 73.21 34.04 43.09 73.87 -16.69 -30.86 2.00 -15.94 -32.47 3.12 coo 34.89 38.34 78.12 35.11 39.59 76.42 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo 35.43 51.03 72.12 35.20 50.72 72.87 -14.50 -24.46 6.89 -13.82 -24.67 7.29 1a0j_c14 source 1a0j TRYPSIN : 1 hits 1a0j_c14 naa= 3 ULMN 3 1a0j_c15 TRYPSIN user 1 3 # 1 D 57 HIS A 154 HIS^? 21.74 O6 C2E A 301 D 102 ASP A 152 ASP.? 20.83 C8 C2E A 301 D 193 GLY A 176 GLY.? 18.56 O6 C2E A 301 coo 8.19 15.01 95.72 7.78 16.53 97.01 -16.69 -30.86 2.00 -15.94 -32.47 3.12 coo 13.53 16.28 93.98 11.45 16.21 94.40 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo 1.80 21.25 100.04 2.61 21.42 100.18 -14.50 -24.46 6.89 -13.82 -24.67 7.29 1a0j_c15 source 1a0j TRYPSIN : 1 hits 1a0j_c15 naa= 3 ULMN 3 1a41_c01 TOPOISOMERASE I user 1 3 # 1 223 ARG B 161 ARG^? 11.68 O6 C2E B 301 265 HIS B 214 HIS.? 18.94 O6 C2E B 301 274 TYR B 179 TYR.? 13.89 O6 C2E B 301 coo -15.18 55.46 8.55 -14.82 52.98 10.38 2.96 9.64 -10.71 5.59 9.57 -9.11 coo -14.48 45.59 11.18 -14.02 47.49 10.42 13.04 11.66 -4.90 14.49 10.59 -3.83 coo 0.94 52.26 9.16 1.95 54.78 9.91 2.36 25.70 -10.99 3.98 25.02 -13.14 1a41_c01 source 1a41 TOPOISOMERASE I : 1 hits 1a41_c01 naa= 3 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 1 3 # 1 A 115 TYR A 179 TYR.? 13.95 N7 C2E A 301 A 125 HIS A 154 HIS^? 21.74 O6 C2E A 301 A 156 LYS A 148 LYS^? 21.30 O6 C2E A 301 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 -16.69 -30.86 2.00 -15.94 -32.47 3.12 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 2 3 # 2 A 115 TYR B 179 TYR.? 13.89 O6 C2E B 301 A 125 HIS B 154 HIS^? 20.45 O6 C2E B 301 A 156 LYS B 148 LYS^? 21.33 O6 C2E B 301 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 2.36 25.70 -10.99 3.98 25.02 -13.14 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 7.78 28.08 -17.01 9.24 26.69 -16.42 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 4.64 19.42 -20.28 9.89 19.27 -22.17 1a79_c00 source 1a79 TRNA ENDONUCLEASE : 2 hits 1a79_c00 naa= 3 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 1 3 # 1 B 115 TYR A 179 TYR.? 13.95 N7 C2E A 301 B 125 HIS A 154 HIS^? 21.74 O6 C2E A 301 B 156 LYS A 148 LYS^? 21.30 O6 C2E A 301 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 -16.69 -30.86 2.00 -15.94 -32.47 3.12 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 2 3 # 2 B 115 TYR B 179 TYR.? 13.89 O6 C2E B 301 B 125 HIS B 154 HIS^? 20.45 O6 C2E B 301 B 156 LYS B 148 LYS^? 21.33 O6 C2E B 301 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 2.36 25.70 -10.99 3.98 25.02 -13.14 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 7.78 28.08 -17.01 9.24 26.69 -16.42 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 4.64 19.42 -20.28 9.89 19.27 -22.17 1a79_c01 source 1a79 TRNA ENDONUCLEASE : 2 hits 1a79_c01 naa= 3 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 1 3 # 1 C 115 TYR B 179 TYR.? 13.89 O6 C2E B 301 C 125 HIS B 154 HIS^? 20.45 O6 C2E B 301 C 156 LYS B 148 LYS^? 21.33 O6 C2E B 301 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 2.36 25.70 -10.99 3.98 25.02 -13.14 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 7.78 28.08 -17.01 9.24 26.69 -16.42 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 4.64 19.42 -20.28 9.89 19.27 -22.17 1a79_c02 source 1a79 TRNA ENDONUCLEASE : 1 hits 1a79_c02 naa= 3 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 1 3 # 1 D 115 TYR A 179 TYR.? 13.95 N7 C2E A 301 D 125 HIS A 154 HIS^? 21.74 O6 C2E A 301 D 156 LYS A 148 LYS^? 21.30 O6 C2E A 301 coo 54.10 1.42 85.16 54.14 4.17 85.62 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo 61.27 5.43 85.32 62.73 6.38 86.49 -16.69 -30.86 2.00 -15.94 -32.47 3.12 coo 60.28 4.62 76.00 58.35 6.41 80.65 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 2 3 # 2 D 115 TYR B 179 TYR.? 13.89 O6 C2E B 301 D 125 HIS B 154 HIS^? 20.45 O6 C2E B 301 D 156 LYS B 148 LYS^? 21.33 O6 C2E B 301 coo 54.10 1.42 85.16 54.14 4.17 85.62 2.36 25.70 -10.99 3.98 25.02 -13.14 coo 61.27 5.43 85.32 62.73 6.38 86.49 7.78 28.08 -17.01 9.24 26.69 -16.42 coo 60.28 4.62 76.00 58.35 6.41 80.65 4.64 19.42 -20.28 9.89 19.27 -22.17 1a79_c03 source 1a79 TRNA ENDONUCLEASE : 2 hits 1a79_c03 naa= 3 ULMN 3 1aa6_c01 FORMATE DEHYDROGENASE H user 1 3 # 1 44 LYS B 67 LYS.? 24.61 N21 C2E A 301 141 HIS B 106 HIS^? 12.57 N21 C2E B 301 333 ARG B 94 ARG^? 9.81 N31 C2E B 301 coo 69.56 26.03 31.04 72.53 30.39 31.84 -0.41 -2.48 20.16 2.79 -6.43 20.83 coo 85.95 39.62 33.57 84.70 40.34 35.09 -12.23 11.16 12.34 -12.16 12.93 13.45 coo 87.31 36.08 32.89 89.57 36.58 34.95 -10.06 14.66 9.70 -12.88 15.81 9.44 1aa6_c01 source 1aa6 FORMATE DEHYDROGENASE H : 1 hits 1aa6_c01 naa= 3 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 1 3 # 1 22 ASN A 208 ASN^? -3.55 N7 C2E A 301s 63 ARG A 169 ARG^? -4.75 O6 C2E A 301s 255 ARG A 136 ARG.? -3.92 O61 C2E A 301s coo 42.10 13.02 11.14 41.85 11.12 10.23 0.54 -21.32 -2.29 -0.50 -19.83 -3.42 coo 44.36 11.24 3.39 41.81 12.78 4.00 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 coo 38.40 3.83 10.26 40.02 6.30 9.25 2.11 -12.17 -9.13 1.08 -10.80 -6.58 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 2 3 # 2 22 ASN A 208 ASN^? -3.55 N7 C2E A 301s 63 ARG A 217 ARG^? 6.70 O6 C2E A 301 255 ARG A 136 ARG.? -3.92 O61 C2E A 301s coo 42.10 13.02 11.14 41.85 11.12 10.23 0.54 -21.32 -2.29 -0.50 -19.83 -3.42 coo 44.36 11.24 3.39 41.81 12.78 4.00 -3.36 -16.18 0.94 -0.54 -17.39 0.83 coo 38.40 3.83 10.26 40.02 6.30 9.25 2.11 -12.17 -9.13 1.08 -10.80 -6.58 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 3 3 # 3 22 ASN A 208 ASN^? -3.55 N7 C2E A 301s 63 ARG A 217 ARG^? 6.70 O6 C2E A 301 255 ARG A 140 ARG.? -3.36 C5 C2E A 301s coo 42.10 13.02 11.14 41.85 11.12 10.23 0.54 -21.32 -2.29 -0.50 -19.83 -3.42 coo 44.36 11.24 3.39 41.81 12.78 4.00 -3.36 -16.18 0.94 -0.54 -17.39 0.83 coo 38.40 3.83 10.26 40.02 6.30 9.25 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 4 3 # 4 22 ASN B 208 ASN^? -3.47 N7 C2E B 301s 63 ARG B 169 ARG^? -4.70 O6 C2E B 301s 255 ARG B 136 ARG.? -3.89 O61 C2E B 301s coo 42.10 13.02 11.14 41.85 11.12 10.23 -4.15 20.35 -2.93 -4.56 18.73 -4.26 coo 44.36 11.24 3.39 41.81 12.78 4.00 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo 38.40 3.83 10.26 40.02 6.30 9.25 -10.39 10.75 -3.93 -7.55 9.68 -3.54 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 5 3 # 5 22 ASN B 208 ASN^? -3.47 N7 C2E B 301s 63 ARG B 217 ARG^? 6.37 O6 C2E B 301 255 ARG B 57 ARG^? 8.07 N21 C2E B 301 coo 42.10 13.02 11.14 41.85 11.12 10.23 -4.15 20.35 -2.93 -4.56 18.73 -4.26 coo 44.36 11.24 3.39 41.81 12.78 4.00 0.82 15.44 -4.45 -0.87 16.78 -2.26 coo 38.40 3.83 10.26 40.02 6.30 9.25 -1.35 19.32 8.13 -4.26 20.09 8.70 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 6 3 # 6 22 ASN B 208 ASN^? -3.47 N7 C2E B 301s 63 ARG B 217 ARG^? 6.37 O6 C2E B 301 255 ARG B 136 ARG.? -3.89 O61 C2E B 301s coo 42.10 13.02 11.14 41.85 11.12 10.23 -4.15 20.35 -2.93 -4.56 18.73 -4.26 coo 44.36 11.24 3.39 41.81 12.78 4.00 0.82 15.44 -4.45 -0.87 16.78 -2.26 coo 38.40 3.83 10.26 40.02 6.30 9.25 -10.39 10.75 -3.93 -7.55 9.68 -3.54 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 7 3 # 7 22 ASN B 208 ASN^? -3.47 N7 C2E B 301s 63 ARG B 217 ARG^? 6.37 O6 C2E B 301 255 ARG B 140 ARG.? -3.40 C5 C2E B 301s coo 42.10 13.02 11.14 41.85 11.12 10.23 -4.15 20.35 -2.93 -4.56 18.73 -4.26 coo 44.36 11.24 3.39 41.81 12.78 4.00 0.82 15.44 -4.45 -0.87 16.78 -2.26 coo 38.40 3.83 10.26 40.02 6.30 9.25 -7.91 11.52 -6.78 -7.96 14.04 -5.01 1aj0_c00 source 1aj0 DIHYDROPTEROATE SYNTHASE : 7 hits 1aj0_c00 naa= 3 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 1 3 # 1 252 THR A 178 THR.? 17.14 O6 C2E A 301 350 PHE A 170 PHE^? 8.91 O6 C2E A 301 357 CYH A 158 CYH^? 12.92 O6 C2E A 301 coo 17.85 20.47 14.62 16.85 19.84 12.80 -9.47 -27.26 4.39 -8.59 -27.66 6.32 coo 7.92 21.96 13.27 8.57 20.30 15.42 -10.47 -19.67 -2.91 -9.94 -22.37 -2.52 coo 8.82 20.77 7.90 10.59 19.75 9.80 -15.53 -18.41 0.03 -15.42 -19.19 -2.71 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 2 3 # 2 252 THR A 203 THR^? 13.87 C1' C2E A 301 350 PHE A 170 PHE^? 8.91 O6 C2E A 301 357 CYH A 168 CYH^? -6.21 C2 C2E A 301s coo 17.85 20.47 14.62 16.85 19.84 12.80 -11.63 -25.21 -11.66 -12.74 -26.43 -13.05 coo 7.92 21.96 13.27 8.57 20.30 15.42 -10.47 -19.67 -2.91 -9.94 -22.37 -2.52 coo 8.82 20.77 7.90 10.59 19.75 9.80 -6.81 -16.95 -8.49 -9.12 -18.59 -8.00 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 3 3 # 3 252 THR B 47 THR^? 21.06 N21 C2E B 301 350 PHE B 54 PHE^? 17.95 N21 C2E B 301 357 CYH B 56 CYH^? 14.73 N21 C2E B 301 coo 17.85 20.47 14.62 16.85 19.84 12.80 -7.68 18.64 22.99 -9.83 18.75 22.86 coo 7.92 21.96 13.27 8.57 20.30 15.42 -1.86 22.37 18.66 0.47 22.95 17.25 coo 8.82 20.77 7.90 10.59 19.75 9.80 -0.90 19.58 13.61 0.17 17.94 15.62 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 4 3 # 4 252 THR B 178 THR.? 16.80 O6 C2E B 301 350 PHE B 170 PHE^? 8.84 O6 C2E B 301 357 CYH B 158 CYH^? 12.89 O6 C2E B 301 coo 17.85 20.47 14.62 16.85 19.84 12.80 6.21 26.30 -8.92 7.28 26.85 -7.15 coo 7.92 21.96 13.27 8.57 20.30 15.42 0.78 18.23 -12.65 0.68 20.98 -12.20 coo 8.82 20.77 7.90 10.59 19.75 9.80 5.78 17.15 -15.63 3.32 17.67 -16.92 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 5 3 # 5 252 THR B 203 THR^? 13.68 C1' C2E B 301 350 PHE B 170 PHE^? 8.84 O6 C2E B 301 357 CYH B 168 CYH^? -6.16 C2 C2E B 301s coo 17.85 20.47 14.62 16.85 19.84 12.80 -6.70 22.59 -18.31 -7.42 23.42 -20.17 coo 7.92 21.96 13.27 8.57 20.30 15.42 0.78 18.23 -12.65 0.68 20.98 -12.20 coo 8.82 20.77 7.90 10.59 19.75 9.80 -5.71 15.10 -12.03 -4.45 16.77 -13.95 1akd_c01 source 1akd CYTOCHROME P450CAM : 5 hits 1akd_c01 naa= 3 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 1 3 # 1 33 ASP A 162 ASP^? -3.09 N1 C2E A 301s 187 GLU A 101 GLU.? 9.39 O11 C2E A 301 229 LYS A 137 LYS.? -4.52 O2' C2E A 301s coo -52.57 56.60 47.75 -51.52 54.87 46.95 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo -45.08 48.37 46.81 -46.53 49.74 45.96 2.77 -8.35 -14.05 3.97 -7.83 -15.72 coo -47.40 44.36 48.48 -50.80 49.18 46.20 4.32 -14.05 -15.33 0.72 -19.17 -16.51 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 2 3 # 2 33 ASP A 162 ASP^? -3.09 N1 C2E A 301s 187 GLU A 138 GLU.? 5.46 O2' C2E A 301 229 LYS A 137 LYS.? -4.52 O2' C2E A 301s coo -52.57 56.60 47.75 -51.52 54.87 46.95 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 coo -47.40 44.36 48.48 -50.80 49.18 46.20 4.32 -14.05 -15.33 0.72 -19.17 -16.51 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 3 3 # 3 33 ASP B 162 ASP^? -3.04 N1 C2E B 301s 187 GLU B 101 GLU.? 9.43 O11 C2E B 301 229 LYS B 137 LYS.? -3.23 O3' C2E B 301s coo -52.57 56.60 47.75 -51.52 54.87 46.95 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -14.64 6.09 -5.71 -16.72 5.82 -5.44 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -16.98 12.27 -5.28 -15.90 17.15 -6.49 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 4 3 # 4 33 ASP B 162 ASP^? -3.04 N1 C2E B 301s 187 GLU B 138 GLU.? 5.49 O2' C2E B 301 229 LYS B 137 LYS.? -3.23 O3' C2E B 301s coo -52.57 56.60 47.75 -51.52 54.87 46.95 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -14.88 11.83 -9.39 -15.29 12.85 -11.20 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -16.98 12.27 -5.28 -15.90 17.15 -6.49 1ald_c00 source 1ald ALDOLASE A (E.C.4.1.2.13) : 4 hits 1ald_c00 naa= 3 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 31 ASP~? 17.49 O6 C2E B 301 214 ASP B 80 ASP~? 21.84 N21 C2E B 301 289 ASP A 66 ASP.? 23.33 N21 C2E B 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 10.86 4.60 -5.63 10.78 6.65 -6.14 coo 26.86 59.76 46.36 25.42 58.23 45.92 3.05 24.05 19.78 2.70 26.08 19.35 coo 9.42 68.07 30.27 7.35 68.27 30.10 15.60 9.37 4.44 16.85 10.89 5.23 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 66 ASP.? 23.33 N21 C2E B 301 214 ASP A 162 ASP^? -3.09 N1 C2E A 301s 289 ASP A 31 ASP~? 17.49 O6 C2E B 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 15.60 9.37 4.44 16.85 10.89 5.23 coo 26.86 59.76 46.36 25.42 58.23 45.92 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 9.42 68.07 30.27 7.35 68.27 30.10 10.86 4.60 -5.63 10.78 6.65 -6.14 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP B 31 ASP~? 18.26 O6 C2E A 301 214 ASP A 80 ASP~? 23.66 N21 C2E A 301 289 ASP B 66 ASP.? 24.37 N21 C2E A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -9.76 -4.11 8.16 -9.75 -6.21 8.42 coo 26.86 59.76 46.36 25.42 58.23 45.92 18.53 -17.34 17.76 18.57 -19.44 17.90 coo 9.42 68.07 30.27 7.35 68.27 30.10 -3.12 -5.44 17.43 -2.91 -6.73 19.08 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP B 66 ASP.? 24.37 N21 C2E A 301 214 ASP B 162 ASP^? -3.04 N1 C2E B 301s 289 ASP B 31 ASP~? 18.26 O6 C2E A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -3.12 -5.44 17.43 -2.91 -6.73 19.08 coo 26.86 59.76 46.36 25.42 58.23 45.92 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 9.42 68.07 30.27 7.35 68.27 30.10 -9.76 -4.11 8.16 -9.75 -6.21 8.42 1amy_c01 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 4 hits 1amy_c01 naa= 3 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 66 ASP.? 23.33 N21 C2E B 301 227 GLU B 41 GLU^? 7.72 N21 C2E B 301 289 ASP A 31 ASP~? 17.49 O6 C2E B 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 15.60 9.37 4.44 16.85 10.89 5.23 coo 3.96 55.76 41.24 4.83 57.69 41.17 0.46 14.98 6.85 0.80 16.86 5.93 coo 9.42 68.07 30.27 7.35 68.27 30.10 10.86 4.60 -5.63 10.78 6.65 -6.14 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 183 ASP.? 14.57 O1P C2E A 301 227 GLU A 225 GLU~? 17.61 C1' C2E A 301 289 ASP A 152 ASP.? 20.83 C8 C2E A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -7.06 -30.30 -3.03 -6.77 -31.63 -1.43 coo 3.96 55.76 41.24 4.83 57.69 41.17 -14.07 -25.95 -18.02 -15.34 -27.27 -16.96 coo 9.42 68.07 30.27 7.35 68.27 30.10 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP B 31 ASP~? 18.26 O6 C2E A 301 227 GLU B 37 GLU.? 9.39 O61 C2E B 301 289 ASP B 66 ASP.? 24.37 N21 C2E A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -9.76 -4.11 8.16 -9.75 -6.21 8.42 coo 3.96 55.76 41.24 4.83 57.69 41.17 -0.62 3.88 0.75 -0.32 4.81 -1.12 coo 9.42 68.07 30.27 7.35 68.27 30.10 -3.12 -5.44 17.43 -2.91 -6.73 19.08 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP B 66 ASP.? 24.37 N21 C2E A 301 227 GLU A 41 GLU^? 8.66 N21 C2E A 301 289 ASP B 31 ASP~? 18.26 O6 C2E A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -3.12 -5.44 17.43 -2.91 -6.73 19.08 coo 3.96 55.76 41.24 4.83 57.69 41.17 7.09 -12.35 6.79 6.46 -14.38 6.77 coo 9.42 68.07 30.27 7.35 68.27 30.10 -9.76 -4.11 8.16 -9.75 -6.21 8.42 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP B 152 ASP.? 19.99 C8 C2E B 301 227 GLU B 225 GLU~? 17.01 C1' C2E B 301 289 ASP B 183 ASP.? 14.33 O1P C2E B 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 2.18 32.86 -17.28 0.63 33.43 -15.93 coo 3.96 55.76 41.24 4.83 57.69 41.17 -10.33 22.86 -23.16 -8.91 24.36 -23.62 coo 9.42 68.07 30.27 7.35 68.27 30.10 -1.79 28.84 -10.63 -0.66 30.31 -9.57 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP B 183 ASP.? 14.33 O1P C2E B 301 227 GLU B 225 GLU~? 17.01 C1' C2E B 301 289 ASP B 152 ASP.? 19.99 C8 C2E B 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -1.79 28.84 -10.63 -0.66 30.31 -9.57 coo 3.96 55.76 41.24 4.83 57.69 41.17 -10.33 22.86 -23.16 -8.91 24.36 -23.62 coo 9.42 68.07 30.27 7.35 68.27 30.10 2.18 32.86 -17.28 0.63 33.43 -15.93 1amy_c06 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 6 hits 1amy_c06 naa= 3 ULMN 3 1apx_c00 CYTOSOLIC ASCORBATE PEROXIDASE user 1 3 # 1 A 38 ARG A 94 ARG^? 4.68 N21 C2E A 301 A 42 HIS A 106 HIS^? 11.03 N21 C2E A 301 A 71 ASN A 92 ASN^? 17.86 N21 C2E A 301 coo 15.53 3.67 5.89 15.40 6.73 5.59 12.55 -12.80 -0.72 10.33 -14.85 -0.21 coo 20.65 4.50 6.93 19.74 4.89 5.08 16.26 -9.68 -2.62 15.33 -11.56 -2.56 coo 19.78 9.98 8.03 21.51 8.73 8.26 20.53 -10.46 2.38 22.65 -10.55 2.18 ULMN 3 1apx_c00 CYTOSOLIC ASCORBATE PEROXIDASE user 2 3 # 2 A 38 ARG B 94 ARG^? 9.81 N31 C2E B 301 A 42 HIS B 106 HIS^? 12.57 N21 C2E B 301 A 71 ASN B 92 ASN^? 16.92 N21 C2E B 301 coo 15.53 3.67 5.89 15.40 6.73 5.59 -10.06 14.66 9.70 -12.88 15.81 9.44 coo 20.65 4.50 6.93 19.74 4.89 5.08 -12.23 11.16 12.34 -12.16 12.93 13.45 coo 19.78 9.98 8.03 21.51 8.73 8.26 -10.13 13.62 16.73 -11.46 13.70 18.39 1apx_c00 source 1apx CYTOSOLIC ASCORBATE PEROXIDASE : 2 hits 1apx_c00 naa= 3 ULMN 3 1apx_c01 CYTOSOLIC ASCORBATE PEROXIDASE user 1 3 # 1 B 38 ARG A 94 ARG^? 4.68 N21 C2E A 301 B 42 HIS A 106 HIS^? 11.03 N21 C2E A 301 B 71 ASN A 92 ASN^? 17.86 N21 C2E A 301 coo -9.60 -18.19 23.08 -12.38 -18.82 21.94 12.55 -12.80 -0.72 10.33 -14.85 -0.21 coo -9.36 -23.33 24.70 -10.73 -22.14 25.75 16.26 -9.68 -2.62 15.33 -11.56 -2.56 coo -13.50 -24.69 21.19 -12.38 -25.89 22.55 20.53 -10.46 2.38 22.65 -10.55 2.18 ULMN 3 1apx_c01 CYTOSOLIC ASCORBATE PEROXIDASE user 2 3 # 2 B 38 ARG B 94 ARG^? 9.81 N31 C2E B 301 B 42 HIS B 106 HIS^? 12.57 N21 C2E B 301 B 71 ASN B 92 ASN^? 16.92 N21 C2E B 301 coo -9.60 -18.19 23.08 -12.38 -18.82 21.94 -10.06 14.66 9.70 -12.88 15.81 9.44 coo -9.36 -23.33 24.70 -10.73 -22.14 25.75 -12.23 11.16 12.34 -12.16 12.93 13.45 coo -13.50 -24.69 21.19 -12.38 -25.89 22.55 -10.13 13.62 16.73 -11.46 13.70 18.39 1apx_c01 source 1apx CYTOSOLIC ASCORBATE PEROXIDASE : 2 hits 1apx_c01 naa= 3 ULMN 3 1apx_c02 CYTOSOLIC ASCORBATE PEROXIDASE user 1 3 # 1 C 38 ARG A 94 ARG^? 4.68 N21 C2E A 301 C 42 HIS A 106 HIS^? 11.03 N21 C2E A 301 C 71 ASN A 92 ASN^? 17.86 N21 C2E A 301 coo 30.92 18.62 52.11 32.84 21.02 52.26 12.55 -12.80 -0.72 10.33 -14.85 -0.21 coo 34.83 15.89 54.93 35.12 16.59 52.97 16.26 -9.68 -2.62 15.33 -11.56 -2.56 coo 37.12 20.79 56.54 37.65 18.79 57.02 20.53 -10.46 2.38 22.65 -10.55 2.18 ULMN 3 1apx_c02 CYTOSOLIC ASCORBATE PEROXIDASE user 2 3 # 2 C 38 ARG B 94 ARG^? 9.81 N31 C2E B 301 C 42 HIS B 106 HIS^? 12.57 N21 C2E B 301 C 71 ASN B 92 ASN^? 16.92 N21 C2E B 301 coo 30.92 18.62 52.11 32.84 21.02 52.26 -10.06 14.66 9.70 -12.88 15.81 9.44 coo 34.83 15.89 54.93 35.12 16.59 52.97 -12.23 11.16 12.34 -12.16 12.93 13.45 coo 37.12 20.79 56.54 37.65 18.79 57.02 -10.13 13.62 16.73 -11.46 13.70 18.39 1apx_c02 source 1apx CYTOSOLIC ASCORBATE PEROXIDASE : 2 hits 1apx_c02 naa= 3 ULMN 3 1apx_c03 CYTOSOLIC ASCORBATE PEROXIDASE user 1 3 # 1 D 38 ARG A 94 ARG^? 4.68 N21 C2E A 301 D 42 HIS A 106 HIS^? 11.03 N21 C2E A 301 D 71 ASN A 92 ASN^? 17.86 N21 C2E A 301 coo -6.22 19.15 57.90 -8.28 20.35 55.95 12.55 -12.80 -0.72 10.33 -14.85 -0.21 coo -9.68 15.08 58.37 -9.88 17.07 58.99 16.26 -9.68 -2.62 15.33 -11.56 -2.56 coo -12.42 16.33 53.67 -12.99 14.86 55.12 20.53 -10.46 2.38 22.65 -10.55 2.18 ULMN 3 1apx_c03 CYTOSOLIC ASCORBATE PEROXIDASE user 2 3 # 2 D 38 ARG B 94 ARG^? 9.81 N31 C2E B 301 D 42 HIS B 106 HIS^? 12.57 N21 C2E B 301 D 71 ASN B 92 ASN^? 16.92 N21 C2E B 301 coo -6.22 19.15 57.90 -8.28 20.35 55.95 -10.06 14.66 9.70 -12.88 15.81 9.44 coo -9.68 15.08 58.37 -9.88 17.07 58.99 -12.23 11.16 12.34 -12.16 12.93 13.45 coo -12.42 16.33 53.67 -12.99 14.86 55.12 -10.13 13.62 16.73 -11.46 13.70 18.39 1apx_c03 source 1apx CYTOSOLIC ASCORBATE PEROXIDASE : 2 hits 1apx_c03 naa= 3 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 A 194 SER A 39 SER.? 16.45 O61 C2E A 301 A 292 ASP A 66 ASP.? 23.33 N21 C2E B 301 A 322 HIS A 214 HIS.? 19.24 O6 C2E A 301 coo 36.34 32.23 39.60 36.43 34.62 39.93 2.88 -4.86 8.38 1.14 -3.61 9.53 coo 19.73 19.18 41.39 21.50 18.65 40.34 15.60 9.37 4.44 16.85 10.89 5.23 coo 41.69 45.14 46.60 41.78 47.19 46.18 -9.67 -12.41 11.50 -9.18 -11.33 13.22 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 A 194 SER A 39 SER.? 16.45 O61 C2E A 301 A 292 ASP A 66 ASP.? 23.33 N21 C2E B 301 A 322 HIS A 215 HIS.? 12.12 O6 C2E A 301 coo 36.34 32.23 39.60 36.43 34.62 39.93 2.88 -4.86 8.38 1.14 -3.61 9.53 coo 19.73 19.18 41.39 21.50 18.65 40.34 15.60 9.37 4.44 16.85 10.89 5.23 coo 41.69 45.14 46.60 41.78 47.19 46.18 -8.99 -15.19 5.86 -7.58 -13.77 5.21 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 A 194 SER A 40 SER.? 10.73 O61 C2E A 301 A 292 ASP A 66 ASP.? 23.33 N21 C2E B 301 A 322 HIS A 214 HIS.? 19.24 O6 C2E A 301 coo 36.34 32.23 39.60 36.43 34.62 39.93 3.90 -7.17 5.51 5.27 -5.92 3.90 coo 19.73 19.18 41.39 21.50 18.65 40.34 15.60 9.37 4.44 16.85 10.89 5.23 coo 41.69 45.14 46.60 41.78 47.19 46.18 -9.67 -12.41 11.50 -9.18 -11.33 13.22 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 4 3 # 4 A 194 SER A 40 SER.? 10.73 O61 C2E A 301 A 292 ASP A 66 ASP.? 23.33 N21 C2E B 301 A 322 HIS A 215 HIS.? 12.12 O6 C2E A 301 coo 36.34 32.23 39.60 36.43 34.62 39.93 3.90 -7.17 5.51 5.27 -5.92 3.90 coo 19.73 19.18 41.39 21.50 18.65 40.34 15.60 9.37 4.44 16.85 10.89 5.23 coo 41.69 45.14 46.60 41.78 47.19 46.18 -8.99 -15.19 5.86 -7.58 -13.77 5.21 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 5 3 # 5 A 194 SER B 39 SER.? 15.26 O61 C2E B 301 A 292 ASP B 66 ASP.? 24.37 N21 C2E A 301 A 322 HIS B 214 HIS.? 18.94 O6 C2E B 301 coo 36.34 32.23 39.60 36.43 34.62 39.93 4.72 7.48 5.49 6.81 6.45 4.77 coo 19.73 19.18 41.39 21.50 18.65 40.34 -3.12 -5.44 17.43 -2.91 -6.73 19.08 coo 41.69 45.14 46.60 41.78 47.19 46.18 13.04 11.66 -4.90 14.49 10.59 -3.83 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 6 3 # 6 A 194 SER B 39 SER.? 15.26 O61 C2E B 301 A 292 ASP B 66 ASP.? 24.37 N21 C2E A 301 A 322 HIS B 215 HIS.? 11.93 O6 C2E B 301 coo 36.34 32.23 39.60 36.43 34.62 39.93 4.72 7.48 5.49 6.81 6.45 4.77 coo 19.73 19.18 41.39 21.50 18.65 40.34 -3.12 -5.44 17.43 -2.91 -6.73 19.08 coo 41.69 45.14 46.60 41.78 47.19 46.18 7.81 14.24 -7.06 6.68 12.76 -6.10 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 7 3 # 7 A 194 SER B 40 SER.? 9.12 N11 C2E B 301 A 292 ASP B 66 ASP.? 24.37 N21 C2E A 301 A 322 HIS B 214 HIS.? 18.94 O6 C2E B 301 coo 36.34 32.23 39.60 36.43 34.62 39.93 1.49 9.31 4.61 -0.48 7.96 5.14 coo 19.73 19.18 41.39 21.50 18.65 40.34 -3.12 -5.44 17.43 -2.91 -6.73 19.08 coo 41.69 45.14 46.60 41.78 47.19 46.18 13.04 11.66 -4.90 14.49 10.59 -3.83 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 8 3 # 8 A 194 SER B 40 SER.? 9.12 N11 C2E B 301 A 292 ASP B 66 ASP.? 24.37 N21 C2E A 301 A 322 HIS B 215 HIS.? 11.93 O6 C2E B 301 coo 36.34 32.23 39.60 36.43 34.62 39.93 1.49 9.31 4.61 -0.48 7.96 5.14 coo 19.73 19.18 41.39 21.50 18.65 40.34 -3.12 -5.44 17.43 -2.91 -6.73 19.08 coo 41.69 45.14 46.60 41.78 47.19 46.18 7.81 14.24 -7.06 6.68 12.76 -6.10 1aql_c02 source 1aql BILE-SALT ACTIVATED LIPASE : 8 hits 1aql_c02 naa= 3 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 B 194 SER A 40 SER.? 10.73 O61 C2E A 301 B 292 ASP A 66 ASP.? 23.33 N21 C2E B 301 B 322 HIS A 214 HIS.? 19.24 O6 C2E A 301 coo 35.42 71.28 22.94 36.24 69.06 22.37 3.90 -7.17 5.51 5.27 -5.92 3.90 coo 24.74 78.07 5.59 24.32 79.03 7.46 15.60 9.37 4.44 16.85 10.89 5.23 coo 48.81 64.16 26.34 49.30 62.16 26.73 -9.67 -12.41 11.50 -9.18 -11.33 13.22 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 B 194 SER A 40 SER.? 10.73 O61 C2E A 301 B 292 ASP A 66 ASP.? 23.33 N21 C2E B 301 B 322 HIS A 215 HIS.? 12.12 O6 C2E A 301 coo 35.42 71.28 22.94 36.24 69.06 22.37 3.90 -7.17 5.51 5.27 -5.92 3.90 coo 24.74 78.07 5.59 24.32 79.03 7.46 15.60 9.37 4.44 16.85 10.89 5.23 coo 48.81 64.16 26.34 49.30 62.16 26.73 -8.99 -15.19 5.86 -7.58 -13.77 5.21 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 B 194 SER B 40 SER.? 9.12 N11 C2E B 301 B 292 ASP B 66 ASP.? 24.37 N21 C2E A 301 B 322 HIS B 215 HIS.? 11.93 O6 C2E B 301 coo 35.42 71.28 22.94 36.24 69.06 22.37 1.49 9.31 4.61 -0.48 7.96 5.14 coo 24.74 78.07 5.59 24.32 79.03 7.46 -3.12 -5.44 17.43 -2.91 -6.73 19.08 coo 48.81 64.16 26.34 49.30 62.16 26.73 7.81 14.24 -7.06 6.68 12.76 -6.10 1aql_c03 source 1aql BILE-SALT ACTIVATED LIPASE : 3 hits 1aql_c03 naa= 3 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 B 325 ARG A 161 ARG^? 11.81 O6 C2E A 301 B 342 ASP B 31 ASP~? 18.26 O6 C2E A 301 B 531 ARG A 99 ARG.? 13.59 O61 C2E B 301 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -9.76 -4.11 8.16 -9.75 -6.21 8.42 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -1.29 -2.34 -4.97 -2.19 0.30 -6.23 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 B 325 ARG A 211 ARG^? 16.62 O6 C2E A 301 B 342 ASP A 183 ASP.? 14.57 O1P C2E A 301 B 531 ARG A 217 ARG^? 6.70 O6 C2E A 301 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -4.93 -23.64 8.57 -7.93 -23.17 9.07 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -7.06 -30.30 -3.03 -6.77 -31.63 -1.43 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -3.36 -16.18 0.94 -0.54 -17.39 0.83 1asy_c00 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 2 hits 1asy_c00 naa= 3 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 A 325 ARG A 161 ARG^? 11.81 O6 C2E A 301 A 342 ASP B 31 ASP~? 18.26 O6 C2E A 301 A 531 ARG A 99 ARG.? 13.59 O61 C2E B 301 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -9.76 -4.11 8.16 -9.75 -6.21 8.42 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -1.29 -2.34 -4.97 -2.19 0.30 -6.23 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 A 325 ARG A 161 ARG^? 11.81 O6 C2E A 301 A 342 ASP B 31 ASP~? 18.26 O6 C2E A 301 A 531 ARG B 99 ARG.? 13.88 O61 C2E A 301 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -9.76 -4.11 8.16 -9.75 -6.21 8.42 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -4.81 1.09 -3.04 -5.37 -1.84 -3.80 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 3 3 # 3 A 325 ARG A 211 ARG^? 16.62 O6 C2E A 301 A 342 ASP A 183 ASP.? 14.57 O1P C2E A 301 A 531 ARG A 217 ARG^? 6.70 O6 C2E A 301 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -4.93 -23.64 8.57 -7.93 -23.17 9.07 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -7.06 -30.30 -3.03 -6.77 -31.63 -1.43 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -3.36 -16.18 0.94 -0.54 -17.39 0.83 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 4 3 # 4 A 325 ARG B 169 ARG^? -4.70 O6 C2E B 301s A 342 ASP A 31 ASP~? 17.49 O6 C2E B 301 A 531 ARG B 99 ARG.? 13.88 O61 C2E A 301 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 10.86 4.60 -5.63 10.78 6.65 -6.14 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -4.81 1.09 -3.04 -5.37 -1.84 -3.80 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 5 3 # 5 A 325 ARG B 211 ARG^? 16.78 O6 C2E B 301 A 342 ASP B 183 ASP.? 14.33 O1P C2E B 301 A 531 ARG B 217 ARG^? 6.37 O6 C2E B 301 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 8.09 22.99 -2.57 10.13 22.73 -4.88 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -1.79 28.84 -10.63 -0.66 30.31 -9.57 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 0.82 15.44 -4.45 -0.87 16.78 -2.26 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 6 3 # 6 A 325 ARG B 217 ARG^? 6.37 O6 C2E B 301 A 342 ASP B 183 ASP.? 14.33 O1P C2E B 301 A 531 ARG B 211 ARG^? 16.78 O6 C2E B 301 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 0.82 15.44 -4.45 -0.87 16.78 -2.26 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -1.79 28.84 -10.63 -0.66 30.31 -9.57 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 8.09 22.99 -2.57 10.13 22.73 -4.88 1asy_c01 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 6 hits 1asy_c01 naa= 3 ULMN 3 1ax4_c04 TRYPTOPHANASE user 1 3 # 1 A 130 PHE A 170 PHE^? 8.91 O6 C2E A 301 A 223 ASP A 157 ASP^? 20.06 O6 C2E A 301 A 265 LYS A 197 LYS.? 27.35 N2 C2E A 301 coo 39.74 52.86 65.74 41.15 55.14 66.52 -10.47 -19.67 -2.91 -9.94 -22.37 -2.52 coo 30.70 47.50 67.53 29.83 49.47 67.39 -19.05 -19.29 2.64 -21.12 -19.53 2.92 coo 19.99 54.53 64.11 20.55 58.78 68.33 -26.95 -17.54 -10.03 -31.23 -18.41 -12.60 ULMN 3 1ax4_c04 TRYPTOPHANASE user 2 3 # 2 A 130 PHE A 170 PHE^? 8.91 O6 C2E A 301 A 223 ASP A 162 ASP^? -3.09 N1 C2E A 301s A 265 LYS A 137 LYS.? -4.52 O2' C2E A 301s coo 39.74 52.86 65.74 41.15 55.14 66.52 -10.47 -19.67 -2.91 -9.94 -22.37 -2.52 coo 30.70 47.50 67.53 29.83 49.47 67.39 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 19.99 54.53 64.11 20.55 58.78 68.33 4.32 -14.05 -15.33 0.72 -19.17 -16.51 ULMN 3 1ax4_c04 TRYPTOPHANASE user 3 3 # 3 A 130 PHE A 170 PHE^? 8.91 O6 C2E A 301 A 223 ASP A 162 ASP^? -3.09 N1 C2E A 301s A 265 LYS A 238 LYS^? 19.93 N2 C2E B 301 coo 39.74 52.86 65.74 41.15 55.14 66.52 -10.47 -19.67 -2.91 -9.94 -22.37 -2.52 coo 30.70 47.50 67.53 29.83 49.47 67.39 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 19.99 54.53 64.11 20.55 58.78 68.33 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 ULMN 3 1ax4_c04 TRYPTOPHANASE user 4 3 # 4 A 130 PHE A 222 PHE^? 7.21 N3 C2E A 301 A 223 ASP A 162 ASP^? -3.09 N1 C2E A 301s A 265 LYS A 238 LYS^? 19.93 N2 C2E B 301 coo 39.74 52.86 65.74 41.15 55.14 66.52 -7.93 -20.98 -13.39 -9.02 -18.86 -11.96 coo 30.70 47.50 67.53 29.83 49.47 67.39 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 19.99 54.53 64.11 20.55 58.78 68.33 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 ULMN 3 1ax4_c04 TRYPTOPHANASE user 5 3 # 5 A 130 PHE B 170 PHE^? 8.84 O6 C2E B 301 A 223 ASP B 157 ASP^? 20.00 O6 C2E B 301 A 265 LYS B 197 LYS.? 24.97 N2 C2E B 301 coo 39.74 52.86 65.74 41.15 55.14 66.52 0.78 18.23 -12.65 0.68 20.98 -12.20 coo 30.70 47.50 67.53 29.83 49.47 67.39 9.70 18.14 -17.54 10.97 18.31 -19.23 coo 19.99 54.53 64.11 20.55 58.78 68.33 2.66 14.16 -30.11 -0.83 11.74 -34.04 ULMN 3 1ax4_c04 TRYPTOPHANASE user 6 3 # 6 A 130 PHE B 170 PHE^? 8.84 O6 C2E B 301 A 223 ASP B 162 ASP^? -3.04 N1 C2E B 301s A 265 LYS B 137 LYS.? -3.23 O3' C2E B 301s coo 39.74 52.86 65.74 41.15 55.14 66.52 0.78 18.23 -12.65 0.68 20.98 -12.20 coo 30.70 47.50 67.53 29.83 49.47 67.39 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 19.99 54.53 64.11 20.55 58.78 68.33 -16.98 12.27 -5.28 -15.90 17.15 -6.49 ULMN 3 1ax4_c04 TRYPTOPHANASE user 7 3 # 7 A 130 PHE B 170 PHE^? 8.84 O6 C2E B 301 A 223 ASP B 162 ASP^? -3.04 N1 C2E B 301s A 265 LYS B 238 LYS^? 16.50 N2 C2E A 301 coo 39.74 52.86 65.74 41.15 55.14 66.52 0.78 18.23 -12.65 0.68 20.98 -12.20 coo 30.70 47.50 67.53 29.83 49.47 67.39 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 19.99 54.53 64.11 20.55 58.78 68.33 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 ULMN 3 1ax4_c04 TRYPTOPHANASE user 8 3 # 8 A 130 PHE B 222 PHE^? 7.18 N3 C2E B 301 A 223 ASP B 162 ASP^? -3.04 N1 C2E B 301s A 265 LYS B 238 LYS^? 16.50 N2 C2E A 301 coo 39.74 52.86 65.74 41.15 55.14 66.52 -9.78 18.64 -15.60 -7.86 16.65 -15.65 coo 30.70 47.50 67.53 29.83 49.47 67.39 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 19.99 54.53 64.11 20.55 58.78 68.33 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 ULMN 3 1ax4_c04 TRYPTOPHANASE user 9 3 # 9 A 130 PHE B 239 PHE^? 13.65 N2 C2E A 301 A 223 ASP B 162 ASP^? -3.04 N1 C2E B 301s A 265 LYS B 137 LYS.? -3.23 O3' C2E B 301s coo 39.74 52.86 65.74 41.15 55.14 66.52 -6.49 -1.61 -14.70 -5.93 -2.42 -12.09 coo 30.70 47.50 67.53 29.83 49.47 67.39 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 19.99 54.53 64.11 20.55 58.78 68.33 -16.98 12.27 -5.28 -15.90 17.15 -6.49 1ax4_c04 source 1ax4 TRYPTOPHANASE : 9 hits 1ax4_c04 naa= 3 ULMN 3 1ax4_c05 TRYPTOPHANASE user 1 3 # 1 B 130 PHE A 170 PHE^? 8.91 O6 C2E A 301 B 223 ASP A 157 ASP^? 20.06 O6 C2E A 301 B 265 LYS A 197 LYS.? 27.35 N2 C2E A 301 coo 7.48 54.94 99.62 7.67 52.27 100.42 -10.47 -19.67 -2.91 -9.94 -22.37 -2.52 coo 10.43 61.66 91.81 9.80 60.04 90.61 -19.05 -19.29 2.64 -21.12 -19.53 2.92 coo 5.43 58.06 80.08 8.57 53.00 79.37 -26.95 -17.54 -10.03 -31.23 -18.41 -12.60 ULMN 3 1ax4_c05 TRYPTOPHANASE user 2 3 # 2 B 130 PHE A 170 PHE^? 8.91 O6 C2E A 301 B 223 ASP A 162 ASP^? -3.09 N1 C2E A 301s B 265 LYS A 137 LYS.? -4.52 O2' C2E A 301s coo 7.48 54.94 99.62 7.67 52.27 100.42 -10.47 -19.67 -2.91 -9.94 -22.37 -2.52 coo 10.43 61.66 91.81 9.80 60.04 90.61 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 5.43 58.06 80.08 8.57 53.00 79.37 4.32 -14.05 -15.33 0.72 -19.17 -16.51 ULMN 3 1ax4_c05 TRYPTOPHANASE user 3 3 # 3 B 130 PHE A 170 PHE^? 8.91 O6 C2E A 301 B 223 ASP A 162 ASP^? -3.09 N1 C2E A 301s B 265 LYS A 238 LYS^? 19.93 N2 C2E B 301 coo 7.48 54.94 99.62 7.67 52.27 100.42 -10.47 -19.67 -2.91 -9.94 -22.37 -2.52 coo 10.43 61.66 91.81 9.80 60.04 90.61 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 5.43 58.06 80.08 8.57 53.00 79.37 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 ULMN 3 1ax4_c05 TRYPTOPHANASE user 4 3 # 4 B 130 PHE A 222 PHE^? 7.21 N3 C2E A 301 B 223 ASP A 162 ASP^? -3.09 N1 C2E A 301s B 265 LYS A 238 LYS^? 19.93 N2 C2E B 301 coo 7.48 54.94 99.62 7.67 52.27 100.42 -7.93 -20.98 -13.39 -9.02 -18.86 -11.96 coo 10.43 61.66 91.81 9.80 60.04 90.61 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 5.43 58.06 80.08 8.57 53.00 79.37 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 ULMN 3 1ax4_c05 TRYPTOPHANASE user 5 3 # 5 B 130 PHE B 170 PHE^? 8.84 O6 C2E B 301 B 223 ASP B 157 ASP^? 20.00 O6 C2E B 301 B 265 LYS B 197 LYS.? 24.97 N2 C2E B 301 coo 7.48 54.94 99.62 7.67 52.27 100.42 0.78 18.23 -12.65 0.68 20.98 -12.20 coo 10.43 61.66 91.81 9.80 60.04 90.61 9.70 18.14 -17.54 10.97 18.31 -19.23 coo 5.43 58.06 80.08 8.57 53.00 79.37 2.66 14.16 -30.11 -0.83 11.74 -34.04 ULMN 3 1ax4_c05 TRYPTOPHANASE user 6 3 # 6 B 130 PHE B 170 PHE^? 8.84 O6 C2E B 301 B 223 ASP B 162 ASP^? -3.04 N1 C2E B 301s B 265 LYS B 137 LYS.? -3.23 O3' C2E B 301s coo 7.48 54.94 99.62 7.67 52.27 100.42 0.78 18.23 -12.65 0.68 20.98 -12.20 coo 10.43 61.66 91.81 9.80 60.04 90.61 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 5.43 58.06 80.08 8.57 53.00 79.37 -16.98 12.27 -5.28 -15.90 17.15 -6.49 ULMN 3 1ax4_c05 TRYPTOPHANASE user 7 3 # 7 B 130 PHE B 170 PHE^? 8.84 O6 C2E B 301 B 223 ASP B 162 ASP^? -3.04 N1 C2E B 301s B 265 LYS B 238 LYS^? 16.50 N2 C2E A 301 coo 7.48 54.94 99.62 7.67 52.27 100.42 0.78 18.23 -12.65 0.68 20.98 -12.20 coo 10.43 61.66 91.81 9.80 60.04 90.61 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 5.43 58.06 80.08 8.57 53.00 79.37 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 ULMN 3 1ax4_c05 TRYPTOPHANASE user 8 3 # 8 B 130 PHE B 222 PHE^? 7.18 N3 C2E B 301 B 223 ASP B 162 ASP^? -3.04 N1 C2E B 301s B 265 LYS B 238 LYS^? 16.50 N2 C2E A 301 coo 7.48 54.94 99.62 7.67 52.27 100.42 -9.78 18.64 -15.60 -7.86 16.65 -15.65 coo 10.43 61.66 91.81 9.80 60.04 90.61 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 5.43 58.06 80.08 8.57 53.00 79.37 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 ULMN 3 1ax4_c05 TRYPTOPHANASE user 9 3 # 9 B 130 PHE B 239 PHE^? 13.65 N2 C2E A 301 B 223 ASP B 162 ASP^? -3.04 N1 C2E B 301s B 265 LYS B 137 LYS.? -3.23 O3' C2E B 301s coo 7.48 54.94 99.62 7.67 52.27 100.42 -6.49 -1.61 -14.70 -5.93 -2.42 -12.09 coo 10.43 61.66 91.81 9.80 60.04 90.61 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 5.43 58.06 80.08 8.57 53.00 79.37 -16.98 12.27 -5.28 -15.90 17.15 -6.49 1ax4_c05 source 1ax4 TRYPTOPHANASE : 9 hits 1ax4_c05 naa= 3 ULMN 3 1ax4_c06 TRYPTOPHANASE user 1 3 # 1 C 130 PHE A 170 PHE^? 8.91 O6 C2E A 301 C 223 ASP A 157 ASP^? 20.06 O6 C2E A 301 C 265 LYS A 197 LYS.? 27.35 N2 C2E A 301 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -10.47 -19.67 -2.91 -9.94 -22.37 -2.52 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -19.05 -19.29 2.64 -21.12 -19.53 2.92 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -26.95 -17.54 -10.03 -31.23 -18.41 -12.60 ULMN 3 1ax4_c06 TRYPTOPHANASE user 2 3 # 2 C 130 PHE A 170 PHE^? 8.91 O6 C2E A 301 C 223 ASP A 162 ASP^? -3.09 N1 C2E A 301s C 265 LYS A 137 LYS.? -4.52 O2' C2E A 301s coo -6.55 73.45 23.60 -6.77 71.48 21.66 -10.47 -19.67 -2.91 -9.94 -22.37 -2.52 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo -4.44 67.20 42.32 -7.50 62.41 40.49 4.32 -14.05 -15.33 0.72 -19.17 -16.51 ULMN 3 1ax4_c06 TRYPTOPHANASE user 3 3 # 3 C 130 PHE A 170 PHE^? 8.91 O6 C2E A 301 C 223 ASP A 162 ASP^? -3.09 N1 C2E A 301s C 265 LYS A 238 LYS^? 19.93 N2 C2E B 301 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -10.47 -19.67 -2.91 -9.94 -22.37 -2.52 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 ULMN 3 1ax4_c06 TRYPTOPHANASE user 4 3 # 4 C 130 PHE A 222 PHE^? 7.21 N3 C2E A 301 C 223 ASP A 162 ASP^? -3.09 N1 C2E A 301s C 265 LYS A 238 LYS^? 19.93 N2 C2E B 301 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -7.93 -20.98 -13.39 -9.02 -18.86 -11.96 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 ULMN 3 1ax4_c06 TRYPTOPHANASE user 5 3 # 5 C 130 PHE B 170 PHE^? 8.84 O6 C2E B 301 C 223 ASP B 157 ASP^? 20.00 O6 C2E B 301 C 265 LYS B 197 LYS.? 24.97 N2 C2E B 301 coo -6.55 73.45 23.60 -6.77 71.48 21.66 0.78 18.23 -12.65 0.68 20.98 -12.20 coo -9.52 75.74 33.62 -8.85 73.74 33.93 9.70 18.14 -17.54 10.97 18.31 -19.23 coo -4.44 67.20 42.32 -7.50 62.41 40.49 2.66 14.16 -30.11 -0.83 11.74 -34.04 ULMN 3 1ax4_c06 TRYPTOPHANASE user 6 3 # 6 C 130 PHE B 170 PHE^? 8.84 O6 C2E B 301 C 223 ASP B 162 ASP^? -3.04 N1 C2E B 301s C 265 LYS B 137 LYS.? -3.23 O3' C2E B 301s coo -6.55 73.45 23.60 -6.77 71.48 21.66 0.78 18.23 -12.65 0.68 20.98 -12.20 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -16.98 12.27 -5.28 -15.90 17.15 -6.49 ULMN 3 1ax4_c06 TRYPTOPHANASE user 7 3 # 7 C 130 PHE B 170 PHE^? 8.84 O6 C2E B 301 C 223 ASP B 162 ASP^? -3.04 N1 C2E B 301s C 265 LYS B 238 LYS^? 16.50 N2 C2E A 301 coo -6.55 73.45 23.60 -6.77 71.48 21.66 0.78 18.23 -12.65 0.68 20.98 -12.20 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 ULMN 3 1ax4_c06 TRYPTOPHANASE user 8 3 # 8 C 130 PHE B 222 PHE^? 7.18 N3 C2E B 301 C 223 ASP B 162 ASP^? -3.04 N1 C2E B 301s C 265 LYS B 238 LYS^? 16.50 N2 C2E A 301 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -9.78 18.64 -15.60 -7.86 16.65 -15.65 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 ULMN 3 1ax4_c06 TRYPTOPHANASE user 9 3 # 9 C 130 PHE B 239 PHE^? 13.65 N2 C2E A 301 C 223 ASP B 162 ASP^? -3.04 N1 C2E B 301s C 265 LYS B 137 LYS.? -3.23 O3' C2E B 301s coo -6.55 73.45 23.60 -6.77 71.48 21.66 -6.49 -1.61 -14.70 -5.93 -2.42 -12.09 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -16.98 12.27 -5.28 -15.90 17.15 -6.49 1ax4_c06 source 1ax4 TRYPTOPHANASE : 9 hits 1ax4_c06 naa= 3 ULMN 3 1ax4_c07 TRYPTOPHANASE user 1 3 # 1 D 130 PHE A 170 PHE^? 8.91 O6 C2E A 301 D 223 ASP A 157 ASP^? 20.06 O6 C2E A 301 D 265 LYS A 197 LYS.? 27.35 N2 C2E A 301 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -10.47 -19.67 -2.91 -9.94 -22.37 -2.52 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -19.05 -19.29 2.64 -21.12 -19.53 2.92 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -26.95 -17.54 -10.03 -31.23 -18.41 -12.60 ULMN 3 1ax4_c07 TRYPTOPHANASE user 2 3 # 2 D 130 PHE A 170 PHE^? 8.91 O6 C2E A 301 D 223 ASP A 162 ASP^? -3.09 N1 C2E A 301s D 265 LYS A 137 LYS.? -4.52 O2' C2E A 301s coo -38.60 55.38 52.70 -40.06 57.72 53.04 -10.47 -19.67 -2.91 -9.94 -22.37 -2.52 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo -18.87 56.53 54.79 -19.47 62.22 53.03 4.32 -14.05 -15.33 0.72 -19.17 -16.51 ULMN 3 1ax4_c07 TRYPTOPHANASE user 3 3 # 3 D 130 PHE A 170 PHE^? 8.91 O6 C2E A 301 D 223 ASP A 162 ASP^? -3.09 N1 C2E A 301s D 265 LYS A 238 LYS^? 19.93 N2 C2E B 301 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -10.47 -19.67 -2.91 -9.94 -22.37 -2.52 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 ULMN 3 1ax4_c07 TRYPTOPHANASE user 4 3 # 4 D 130 PHE A 222 PHE^? 7.21 N3 C2E A 301 D 223 ASP A 162 ASP^? -3.09 N1 C2E A 301s D 265 LYS A 238 LYS^? 19.93 N2 C2E B 301 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -7.93 -20.98 -13.39 -9.02 -18.86 -11.96 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 ULMN 3 1ax4_c07 TRYPTOPHANASE user 5 3 # 5 D 130 PHE B 170 PHE^? 8.84 O6 C2E B 301 D 223 ASP B 157 ASP^? 20.00 O6 C2E B 301 D 265 LYS B 197 LYS.? 24.97 N2 C2E B 301 coo -38.60 55.38 52.70 -40.06 57.72 53.04 0.78 18.23 -12.65 0.68 20.98 -12.20 coo -29.46 51.67 48.51 -28.63 53.31 49.56 9.70 18.14 -17.54 10.97 18.31 -19.23 coo -18.87 56.53 54.79 -19.47 62.22 53.03 2.66 14.16 -30.11 -0.83 11.74 -34.04 ULMN 3 1ax4_c07 TRYPTOPHANASE user 6 3 # 6 D 130 PHE B 170 PHE^? 8.84 O6 C2E B 301 D 223 ASP B 162 ASP^? -3.04 N1 C2E B 301s D 265 LYS B 137 LYS.? -3.23 O3' C2E B 301s coo -38.60 55.38 52.70 -40.06 57.72 53.04 0.78 18.23 -12.65 0.68 20.98 -12.20 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -16.98 12.27 -5.28 -15.90 17.15 -6.49 ULMN 3 1ax4_c07 TRYPTOPHANASE user 7 3 # 7 D 130 PHE B 170 PHE^? 8.84 O6 C2E B 301 D 223 ASP B 162 ASP^? -3.04 N1 C2E B 301s D 265 LYS B 238 LYS^? 16.50 N2 C2E A 301 coo -38.60 55.38 52.70 -40.06 57.72 53.04 0.78 18.23 -12.65 0.68 20.98 -12.20 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 ULMN 3 1ax4_c07 TRYPTOPHANASE user 8 3 # 8 D 130 PHE B 222 PHE^? 7.18 N3 C2E B 301 D 223 ASP B 162 ASP^? -3.04 N1 C2E B 301s D 265 LYS B 238 LYS^? 16.50 N2 C2E A 301 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -9.78 18.64 -15.60 -7.86 16.65 -15.65 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 ULMN 3 1ax4_c07 TRYPTOPHANASE user 9 3 # 9 D 130 PHE B 239 PHE^? 13.65 N2 C2E A 301 D 223 ASP B 162 ASP^? -3.04 N1 C2E B 301s D 265 LYS B 137 LYS.? -3.23 O3' C2E B 301s coo -38.60 55.38 52.70 -40.06 57.72 53.04 -6.49 -1.61 -14.70 -5.93 -2.42 -12.09 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -16.98 12.27 -5.28 -15.90 17.15 -6.49 1ax4_c07 source 1ax4 TRYPTOPHANASE : 9 hits 1ax4_c07 naa= 3 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 1 3 # 1 A 40 HIS A 64 HIS^? 21.50 N21 C2E B 301 A 58 GLU B 72 GLU^? 16.96 N21 C2E B 301 A 92 HIS B 38 HIS.? 15.97 O61 C2E B 301 coo 12.70 27.74 1.76 10.77 27.11 1.24 11.95 7.99 12.22 11.86 9.83 13.23 coo 11.38 23.30 3.20 9.27 23.34 3.13 8.42 10.26 11.58 8.84 10.78 9.58 coo 2.67 19.36 1.56 3.51 21.24 1.94 4.87 2.64 4.63 6.30 2.30 3.13 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 2 3 # 2 A 40 HIS B 64 HIS^? 22.95 N21 C2E A 301 A 58 GLU A 72 GLU^? 18.63 N21 C2E A 301 A 92 HIS A 38 HIS.? 16.46 O61 C2E B 301 coo 12.70 27.74 1.76 10.77 27.11 1.24 5.28 -3.23 17.72 6.30 -4.93 18.40 coo 11.38 23.30 3.20 9.27 23.34 3.13 6.69 -5.58 14.73 4.83 -6.56 14.45 coo 2.67 19.36 1.56 3.51 21.24 1.94 1.46 -0.40 7.20 -0.57 -0.26 7.72 1b2m_c00 source 1b2m 5'-R(*GP*(CH2)U)-3' : 2 hits 1b2m_c00 naa= 3 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 1 3 # 1 B 40 HIS A 64 HIS^? 21.50 N21 C2E B 301 B 58 GLU B 72 GLU^? 16.96 N21 C2E B 301 B 92 HIS B 38 HIS.? 15.97 O61 C2E B 301 coo 10.74 36.24 16.20 9.81 34.52 16.97 11.95 7.99 12.22 11.86 9.83 13.23 coo 5.02 36.40 17.74 5.55 34.41 17.37 8.42 10.26 11.58 8.84 10.78 9.58 coo 0.68 29.04 20.43 2.46 29.56 19.46 4.87 2.64 4.63 6.30 2.30 3.13 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 2 3 # 2 B 40 HIS B 64 HIS^? 22.95 N21 C2E A 301 B 58 GLU A 72 GLU^? 18.63 N21 C2E A 301 B 92 HIS A 38 HIS.? 16.46 O61 C2E B 301 coo 10.74 36.24 16.20 9.81 34.52 16.97 5.28 -3.23 17.72 6.30 -4.93 18.40 coo 5.02 36.40 17.74 5.55 34.41 17.37 6.69 -5.58 14.73 4.83 -6.56 14.45 coo 0.68 29.04 20.43 2.46 29.56 19.46 1.46 -0.40 7.20 -0.57 -0.26 7.72 1b2m_c01 source 1b2m 5'-R(*GP*(CH2)U)-3' : 2 hits 1b2m_c01 naa= 3 ULMN 3 1b5d_c00 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 1 3 # 1 A 148 CYH A 207 CYH^? -4.01 O4' C2E A 301s A 179 ASP A 183 ASP.? 14.57 O1P C2E A 301 A 183 GLN A 180 GLN.? 15.88 O1P C2E A 301 coo 21.87 3.71 21.27 20.32 3.55 23.64 -0.78 -24.34 -5.34 -0.81 -23.96 -8.11 coo 17.09 11.24 20.19 17.85 10.05 21.76 -7.06 -30.30 -3.03 -6.77 -31.63 -1.43 coo 19.54 13.23 15.90 21.64 12.89 15.61 -4.24 -31.66 0.79 -3.85 -33.35 2.05 ULMN 3 1b5d_c00 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 2 3 # 2 A 148 CYH B 207 CYH^? -4.01 O1P C2E B 301s A 179 ASP B 183 ASP.? 14.33 O1P C2E B 301 A 183 GLN B 180 GLN.? 16.04 O1P C2E B 301 coo 21.87 3.71 21.27 20.32 3.55 23.64 -6.32 22.95 -5.82 -8.77 22.45 -7.09 coo 17.09 11.24 20.19 17.85 10.05 21.76 -1.79 28.84 -10.63 -0.66 30.31 -9.57 coo 19.54 13.23 15.90 21.64 12.89 15.61 1.55 30.21 -5.52 1.56 32.31 -5.18 1b5d_c00 source 1b5d DEOXYCYTIDYLATE HYDROXYMETHYLASE : 2 hits 1b5d_c00 naa= 3 ULMN 3 1b5d_c01 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 1 3 # 1 B 148 CYH A 207 CYH^? -4.01 O4' C2E A 301s B 179 ASP A 183 ASP.? 14.57 O1P C2E A 301 B 183 GLN A 180 GLN.? 15.88 O1P C2E A 301 coo 30.30 0.93 3.58 31.01 1.18 0.88 -0.78 -24.34 -5.34 -0.81 -23.96 -8.11 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 -7.06 -30.30 -3.03 -6.77 -31.63 -1.43 coo 24.68 -8.53 5.16 25.68 -8.09 7.00 -4.24 -31.66 0.79 -3.85 -33.35 2.05 ULMN 3 1b5d_c01 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 2 3 # 2 B 148 CYH B 207 CYH^? -4.01 O1P C2E B 301s B 179 ASP B 183 ASP.? 14.33 O1P C2E B 301 B 183 GLN B 180 GLN.? 16.04 O1P C2E B 301 coo 30.30 0.93 3.58 31.01 1.18 0.88 -6.32 22.95 -5.82 -8.77 22.45 -7.09 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 -1.79 28.84 -10.63 -0.66 30.31 -9.57 coo 24.68 -8.53 5.16 25.68 -8.09 7.00 1.55 30.21 -5.52 1.56 32.31 -5.18 1b5d_c01 source 1b5d DEOXYCYTIDYLATE HYDROXYMETHYLASE : 2 hits 1b5d_c01 naa= 3 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 1 3 # 1 A 18 HIS A 215 HIS.? 12.12 O6 C2E A 301 A 91 ARG A 211 ARG^? 16.62 O6 C2E A 301 A 129 SER A 212 SER.? 13.10 O6 C2E A 301 coo 24.39 47.01 49.70 26.42 47.04 49.21 -8.99 -15.19 5.86 -7.58 -13.77 5.21 coo 25.98 44.20 42.23 28.53 42.98 43.43 -4.93 -23.64 8.57 -7.93 -23.17 9.07 coo 30.00 49.76 45.68 28.73 48.72 47.47 -4.77 -16.86 9.45 -4.14 -15.23 7.75 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 2 3 # 2 A 18 HIS A 215 HIS.? 12.12 O6 C2E A 301 A 91 ARG A 217 ARG^? 6.70 O6 C2E A 301 A 129 SER A 212 SER.? 13.10 O6 C2E A 301 coo 24.39 47.01 49.70 26.42 47.04 49.21 -8.99 -15.19 5.86 -7.58 -13.77 5.21 coo 25.98 44.20 42.23 28.53 42.98 43.43 -3.36 -16.18 0.94 -0.54 -17.39 0.83 coo 30.00 49.76 45.68 28.73 48.72 47.47 -4.77 -16.86 9.45 -4.14 -15.23 7.75 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 3 3 # 3 A 18 HIS B 215 HIS.? 11.93 O6 C2E B 301 A 91 ARG B 211 ARG^? 16.78 O6 C2E B 301 A 129 SER B 212 SER.? 13.16 O6 C2E B 301 coo 24.39 47.01 49.70 26.42 47.04 49.21 7.81 14.24 -7.06 6.68 12.76 -6.10 coo 25.98 44.20 42.23 28.53 42.98 43.43 8.09 22.99 -2.57 10.13 22.73 -4.88 coo 30.00 49.76 45.68 28.73 48.72 47.47 8.68 16.14 -1.54 8.01 14.57 -3.30 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 4 3 # 4 A 18 HIS B 215 HIS.? 11.93 O6 C2E B 301 A 91 ARG B 217 ARG^? 6.37 O6 C2E B 301 A 129 SER B 212 SER.? 13.16 O6 C2E B 301 coo 24.39 47.01 49.70 26.42 47.04 49.21 7.81 14.24 -7.06 6.68 12.76 -6.10 coo 25.98 44.20 42.23 28.53 42.98 43.43 0.82 15.44 -4.45 -0.87 16.78 -2.26 coo 30.00 49.76 45.68 28.73 48.72 47.47 8.68 16.14 -1.54 8.01 14.57 -3.30 1b6t_c00 source 1b6t PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE : 4 hits 1b6t_c00 naa= 3 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 1 3 # 1 B 18 HIS A 215 HIS.? 12.12 O6 C2E A 301 B 91 ARG A 217 ARG^? 6.70 O6 C2E A 301 B 129 SER A 212 SER.? 13.10 O6 C2E A 301 coo 18.19 17.03 40.71 18.55 17.18 38.64 -8.99 -15.19 5.86 -7.58 -13.77 5.21 coo 25.60 21.10 38.54 23.57 20.93 36.25 -3.36 -16.18 0.94 -0.54 -17.39 0.83 coo 21.33 14.29 34.62 19.25 14.88 35.71 -4.77 -16.86 9.45 -4.14 -15.23 7.75 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 2 3 # 2 B 18 HIS B 106 HIS^? 12.57 N21 C2E B 301 B 91 ARG B 108 ARG^? 23.43 N21 C2E B 301 B 129 SER B 45 SER^? 12.51 N21 C2E B 301 coo 18.19 17.03 40.71 18.55 17.18 38.64 -12.23 11.16 12.34 -12.16 12.93 13.45 coo 25.60 21.10 38.54 23.57 20.93 36.25 -11.69 10.06 21.74 -11.10 10.14 24.76 coo 21.33 14.29 34.62 19.25 14.88 35.71 -6.50 17.30 16.50 -7.95 17.62 14.58 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 3 3 # 3 B 18 HIS B 215 HIS.? 11.93 O6 C2E B 301 B 91 ARG B 211 ARG^? 16.78 O6 C2E B 301 B 129 SER B 212 SER.? 13.16 O6 C2E B 301 coo 18.19 17.03 40.71 18.55 17.18 38.64 7.81 14.24 -7.06 6.68 12.76 -6.10 coo 25.60 21.10 38.54 23.57 20.93 36.25 8.09 22.99 -2.57 10.13 22.73 -4.88 coo 21.33 14.29 34.62 19.25 14.88 35.71 8.68 16.14 -1.54 8.01 14.57 -3.30 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 4 3 # 4 B 18 HIS B 215 HIS.? 11.93 O6 C2E B 301 B 91 ARG B 217 ARG^? 6.37 O6 C2E B 301 B 129 SER B 212 SER.? 13.16 O6 C2E B 301 coo 18.19 17.03 40.71 18.55 17.18 38.64 7.81 14.24 -7.06 6.68 12.76 -6.10 coo 25.60 21.10 38.54 23.57 20.93 36.25 0.82 15.44 -4.45 -0.87 16.78 -2.26 coo 21.33 14.29 34.62 19.25 14.88 35.71 8.68 16.14 -1.54 8.01 14.57 -3.30 1b6t_c01 source 1b6t PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE : 4 hits 1b6t_c01 naa= 3 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 A 145 TYR A 83 TYR~? 30.51 N21 C2E A 301 A 230 ASP A 80 ASP~? 23.66 N21 C2E A 301 A 273 LYS A 53 LYS^? 19.63 N21 C2E A 301 coo 9.23 21.44 106.88 10.18 19.34 105.31 24.52 -15.89 20.76 25.70 -16.30 23.25 coo 1.45 22.80 104.16 2.58 21.02 104.01 18.53 -17.34 17.76 18.57 -19.44 17.90 coo 2.97 11.64 107.87 6.59 15.13 107.03 24.14 -17.55 8.54 24.93 -16.56 3.33 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 3 # 2 A 145 TYR A 179 TYR.? 13.95 N7 C2E A 301 A 230 ASP A 152 ASP.? 20.83 C8 C2E A 301 A 273 LYS A 148 LYS^? 21.30 O6 C2E A 301 coo 9.23 21.44 106.88 10.18 19.34 105.31 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo 1.45 22.80 104.16 2.58 21.02 104.01 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo 2.97 11.64 107.87 6.59 15.13 107.03 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 3 3 # 3 A 145 TYR B 218 TYR^? 10.08 O6 C2E B 301 A 230 ASP B 183 ASP.? 14.33 O1P C2E B 301 A 273 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo 9.23 21.44 106.88 10.18 19.34 105.31 1.42 21.23 -8.42 3.73 22.73 -7.99 coo 1.45 22.80 104.16 2.58 21.02 104.01 -1.79 28.84 -10.63 -0.66 30.31 -9.57 coo 2.97 11.64 107.87 6.59 15.13 107.03 8.81 26.59 -11.72 7.46 31.56 -12.94 1b8g_c04 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 3 hits 1b8g_c04 naa= 3 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 B 145 TYR A 83 TYR~? 30.51 N21 C2E A 301 B 230 ASP A 80 ASP~? 23.66 N21 C2E A 301 B 273 LYS A 53 LYS^? 19.63 N21 C2E A 301 coo 11.81 13.41 73.03 10.00 13.03 75.12 24.52 -15.89 20.76 25.70 -16.30 23.25 coo 19.17 11.01 76.14 17.26 10.42 76.77 18.53 -17.34 17.76 18.57 -19.44 17.90 coo 11.10 2.31 76.60 10.24 7.24 75.62 24.14 -17.55 8.54 24.93 -16.56 3.33 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 3 # 2 B 145 TYR A 179 TYR.? 13.95 N7 C2E A 301 B 230 ASP A 152 ASP.? 20.83 C8 C2E A 301 B 273 LYS A 148 LYS^? 21.30 O6 C2E A 301 coo 11.81 13.41 73.03 10.00 13.03 75.12 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo 19.17 11.01 76.14 17.26 10.42 76.77 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo 11.10 2.31 76.60 10.24 7.24 75.62 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 3 3 # 3 B 145 TYR B 83 TYR~? 26.42 N21 C2E B 301 B 230 ASP B 80 ASP~? 21.84 N21 C2E B 301 B 273 LYS B 53 LYS^? 20.29 N21 C2E B 301 coo 11.81 13.41 73.03 10.00 13.03 75.12 1.26 24.03 25.84 -0.99 25.15 27.02 coo 19.17 11.01 76.14 17.26 10.42 76.77 3.05 24.05 19.78 2.70 26.08 19.35 coo 11.10 2.31 76.60 10.24 7.24 75.62 -7.36 22.58 21.02 -13.56 21.56 20.17 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 4 3 # 4 B 145 TYR B 218 TYR^? 10.08 O6 C2E B 301 B 230 ASP B 183 ASP.? 14.33 O1P C2E B 301 B 273 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo 11.81 13.41 73.03 10.00 13.03 75.12 1.42 21.23 -8.42 3.73 22.73 -7.99 coo 19.17 11.01 76.14 17.26 10.42 76.77 -1.79 28.84 -10.63 -0.66 30.31 -9.57 coo 11.10 2.31 76.60 10.24 7.24 75.62 8.81 26.59 -11.72 7.46 31.56 -12.94 1b8g_c05 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 4 hits 1b8g_c05 naa= 3 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 1 3 # 1 A 88 PHE A 54 PHE^? 19.63 N21 C2E A 301 A 159 ASP A 79 ASP~? 30.21 N21 C2E A 301 A 188 LYS A 75 LYS.? 21.41 N21 C2E A 301 coo 13.91 34.58 14.67 12.95 36.00 12.47 19.69 -16.80 12.43 17.45 -17.09 14.05 coo 20.97 28.40 16.26 20.19 30.15 15.34 19.82 -18.69 22.66 21.43 -19.12 23.96 coo 22.55 41.65 15.60 18.92 37.20 14.63 9.70 -14.41 17.00 6.16 -11.27 19.18 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 2 3 # 2 A 88 PHE A 84 PHE.? 23.41 N21 C2E A 301 A 159 ASP A 79 ASP~? 30.21 N21 C2E A 301 A 188 LYS A 75 LYS.? 21.41 N21 C2E A 301 coo 13.91 34.58 14.67 12.95 36.00 12.47 22.11 -15.87 14.74 23.34 -18.33 14.34 coo 20.97 28.40 16.26 20.19 30.15 15.34 19.82 -18.69 22.66 21.43 -19.12 23.96 coo 22.55 41.65 15.60 18.92 37.20 14.63 9.70 -14.41 17.00 6.16 -11.27 19.18 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 3 3 # 3 A 88 PHE A 199 PHE.? 15.97 N2 C2E A 301 A 159 ASP A 192 ASP.? 23.17 N2 C2E A 301 A 188 LYS A 148 LYS^? 21.30 O6 C2E A 301 coo 13.91 34.58 14.67 12.95 36.00 12.47 -19.51 -15.48 -13.25 -19.97 -12.76 -13.56 coo 20.97 28.40 16.26 20.19 30.15 15.34 -26.02 -10.21 -8.74 -27.24 -11.85 -9.23 coo 22.55 41.65 15.60 18.92 37.20 14.63 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 4 3 # 4 A 88 PHE B 54 PHE^? 17.95 N21 C2E B 301 A 159 ASP B 79 ASP~? 26.97 N21 C2E B 301 A 188 LYS B 75 LYS.? 16.89 N21 C2E B 301 coo 13.91 34.58 14.67 12.95 36.00 12.47 -1.86 22.37 18.66 0.47 22.95 17.25 coo 20.97 28.40 16.26 20.19 30.15 15.34 6.11 26.78 22.67 4.66 27.50 24.05 coo 22.55 41.65 15.60 18.92 37.20 14.63 7.39 19.64 13.02 10.00 17.22 7.78 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 5 3 # 5 A 88 PHE B 84 PHE~? 21.91 N21 C2E B 301 A 159 ASP B 79 ASP~? 26.97 N21 C2E B 301 A 188 LYS B 75 LYS.? 16.89 N21 C2E B 301 coo 13.91 34.58 14.67 12.95 36.00 12.47 -0.90 22.18 22.15 -2.04 24.70 22.44 coo 20.97 28.40 16.26 20.19 30.15 15.34 6.11 26.78 22.67 4.66 27.50 24.05 coo 22.55 41.65 15.60 18.92 37.20 14.63 7.39 19.64 13.02 10.00 17.22 7.78 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 6 3 # 6 A 88 PHE B 199 PHE.? 15.78 N2 C2E B 301 A 159 ASP B 192 ASP.? 23.13 N2 C2E B 301 A 188 LYS B 148 LYS^? 21.33 O6 C2E B 301 coo 13.91 34.58 14.67 12.95 36.00 12.47 -3.38 12.46 -25.06 -2.84 9.73 -25.01 coo 20.97 28.40 16.26 20.19 30.15 15.34 3.51 7.73 -28.40 4.69 9.27 -29.24 coo 22.55 41.65 15.60 18.92 37.20 14.63 4.64 19.42 -20.28 9.89 19.27 -22.17 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 7 3 # 7 A 88 PHE B 199 PHE.? 15.78 N2 C2E B 301 A 159 ASP B 192 ASP.? 23.13 N2 C2E B 301 A 188 LYS B 238 LYS^? 16.50 N2 C2E A 301 coo 13.91 34.58 14.67 12.95 36.00 12.47 -3.38 12.46 -25.06 -2.84 9.73 -25.01 coo 20.97 28.40 16.26 20.19 30.15 15.34 3.51 7.73 -28.40 4.69 9.27 -29.24 coo 22.55 41.65 15.60 18.92 37.20 14.63 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 1b9h_c02 source 1b9h 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHASE : 7 hits 1b9h_c02 naa= 3 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 A 137 ARG A 99 ARG.? 13.59 O61 C2E B 301 A 141 THR A 242 THR.? 12.36 O61 C2E B 301 A 235 ASP A 31 ASP~? 17.49 O6 C2E B 301 coo 6.21 93.81 36.58 4.58 96.33 37.17 -1.29 -2.34 -4.97 -2.19 0.30 -6.23 coo 6.80 92.87 28.33 4.91 92.74 27.40 -9.00 0.35 -6.49 -9.57 0.87 -4.47 coo 12.98 90.36 47.57 11.26 89.62 46.62 10.86 4.60 -5.63 10.78 6.65 -6.14 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 A 137 ARG B 99 ARG.? 13.88 O61 C2E A 301 A 141 THR B 242 THR.? 13.04 O61 C2E A 301 A 235 ASP B 31 ASP~? 18.26 O6 C2E A 301 coo 6.21 93.81 36.58 4.58 96.33 37.17 -4.81 1.09 -3.04 -5.37 -1.84 -3.80 coo 6.80 92.87 28.33 4.91 92.74 27.40 -1.37 -1.91 -11.50 0.71 -2.27 -11.05 coo 12.98 90.36 47.57 11.26 89.62 46.62 -9.76 -4.11 8.16 -9.75 -6.21 8.42 1bd3_c00 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 2 hits 1bd3_c00 naa= 3 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 D 137 ARG A 99 ARG.? 13.59 O61 C2E B 301 D 141 THR A 242 THR.? 12.36 O61 C2E B 301 D 235 ASP A 31 ASP~? 17.49 O6 C2E B 301 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -1.29 -2.34 -4.97 -2.19 0.30 -6.23 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -9.00 0.35 -6.49 -9.57 0.87 -4.47 coo -14.64 87.74 89.51 -12.89 87.43 90.65 10.86 4.60 -5.63 10.78 6.65 -6.14 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 D 137 ARG A 155 ARG^? 21.80 N1 C2E A 301 D 141 THR A 196 THR.? 26.12 N2 C2E A 301 D 235 ASP A 152 ASP.? 20.83 C8 C2E A 301 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -22.65 -25.75 -3.25 -23.90 -23.07 -4.10 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -28.29 -17.75 -6.49 -30.18 -16.67 -6.61 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 D 137 ARG A 155 ARG^? 21.80 N1 C2E A 301 D 141 THR A 198 THR.? 19.32 N2 C2E A 301 D 235 ASP A 152 ASP.? 20.83 C8 C2E A 301 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -22.65 -25.75 -3.25 -23.90 -23.07 -4.10 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -23.21 -18.00 -10.51 -22.99 -19.75 -9.26 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 D 137 ARG B 99 ARG.? 13.88 O61 C2E A 301 D 141 THR B 242 THR.? 13.04 O61 C2E A 301 D 235 ASP B 31 ASP~? 18.26 O6 C2E A 301 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -4.81 1.09 -3.04 -5.37 -1.84 -3.80 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -1.37 -1.91 -11.50 0.71 -2.27 -11.05 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -9.76 -4.11 8.16 -9.75 -6.21 8.42 1bd3_c01 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 4 hits 1bd3_c01 naa= 3 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 C 137 ARG A 99 ARG.? 13.59 O61 C2E B 301 C 141 THR A 242 THR.? 12.36 O61 C2E B 301 C 235 ASP A 31 ASP~? 17.49 O6 C2E B 301 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -1.29 -2.34 -4.97 -2.19 0.30 -6.23 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -9.00 0.35 -6.49 -9.57 0.87 -4.47 coo -13.01 70.96 47.58 -11.44 71.65 46.34 10.86 4.60 -5.63 10.78 6.65 -6.14 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 C 137 ARG B 99 ARG.? 13.88 O61 C2E A 301 C 141 THR B 242 THR.? 13.04 O61 C2E A 301 C 235 ASP B 31 ASP~? 18.26 O6 C2E A 301 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -4.81 1.09 -3.04 -5.37 -1.84 -3.80 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -1.37 -1.91 -11.50 0.71 -2.27 -11.05 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -9.76 -4.11 8.16 -9.75 -6.21 8.42 1bd3_c02 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 2 hits 1bd3_c02 naa= 3 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 B 137 ARG A 99 ARG.? 13.59 O61 C2E B 301 B 141 THR A 242 THR.? 12.36 O61 C2E B 301 B 235 ASP A 31 ASP~? 17.49 O6 C2E B 301 coo 8.13 67.41 100.27 7.18 68.35 97.45 -1.29 -2.34 -4.97 -2.19 0.30 -6.23 coo 8.28 67.78 108.81 6.22 67.65 109.43 -9.00 0.35 -6.49 -9.57 0.87 -4.47 coo 14.55 73.52 89.47 12.81 73.95 90.56 10.86 4.60 -5.63 10.78 6.65 -6.14 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 B 137 ARG A 99 ARG.? 13.59 O61 C2E B 301 B 141 THR B 242 THR.? 13.04 O61 C2E A 301 B 235 ASP B 31 ASP~? 18.26 O6 C2E A 301 coo 8.13 67.41 100.27 7.18 68.35 97.45 -1.29 -2.34 -4.97 -2.19 0.30 -6.23 coo 8.28 67.78 108.81 6.22 67.65 109.43 -1.37 -1.91 -11.50 0.71 -2.27 -11.05 coo 14.55 73.52 89.47 12.81 73.95 90.56 -9.76 -4.11 8.16 -9.75 -6.21 8.42 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 B 137 ARG B 99 ARG.? 13.88 O61 C2E A 301 B 141 THR B 242 THR.? 13.04 O61 C2E A 301 B 235 ASP B 31 ASP~? 18.26 O6 C2E A 301 coo 8.13 67.41 100.27 7.18 68.35 97.45 -4.81 1.09 -3.04 -5.37 -1.84 -3.80 coo 8.28 67.78 108.81 6.22 67.65 109.43 -1.37 -1.91 -11.50 0.71 -2.27 -11.05 coo 14.55 73.52 89.47 12.81 73.95 90.56 -9.76 -4.11 8.16 -9.75 -6.21 8.42 1bd3_c03 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 3 hits 1bd3_c03 naa= 3 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 1 3 # 1 14 ASP A 31 ASP~? 17.49 O6 C2E B 301 16 HIS B 214 HIS.? 18.94 O6 C2E B 301 67 GLY B 219 GLY^? -3.38 N7 C2E B 301s coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 10.86 4.60 -5.63 10.78 6.65 -6.14 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 13.04 11.66 -4.90 14.49 10.59 -3.83 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -3.71 18.46 -7.63 -3.40 19.28 -7.89 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 2 3 # 2 14 ASP A 152 ASP.? 20.83 C8 C2E A 301 16 HIS A 154 HIS^? 21.74 O6 C2E A 301 67 GLY A 167 GLY^? -3.74 N3 C2E A 301s coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -16.69 -30.86 2.00 -15.94 -32.47 3.12 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -5.31 -18.58 -11.54 -5.51 -17.84 -11.78 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 3 3 # 3 14 ASP A 152 ASP.? 20.83 C8 C2E A 301 16 HIS A 154 HIS^? 21.74 O6 C2E A 301 67 GLY A 195 GLY.? 22.99 N2 C2E A 301 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -16.69 -30.86 2.00 -15.94 -32.47 3.12 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -26.58 -15.52 -3.95 -27.20 -15.54 -4.54 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 4 3 # 4 14 ASP B 152 ASP.? 19.99 C8 C2E B 301 16 HIS B 154 HIS^? 20.45 O6 C2E B 301 67 GLY B 167 GLY^? -3.69 N3 C2E B 301s coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 2.18 32.86 -17.28 0.63 33.43 -15.93 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 7.78 28.08 -17.01 9.24 26.69 -16.42 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -9.22 16.51 -12.20 -9.30 15.75 -12.43 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 5 3 # 5 14 ASP B 152 ASP.? 19.99 C8 C2E B 301 16 HIS B 154 HIS^? 20.45 O6 C2E B 301 67 GLY B 195 GLY.? 22.38 N2 C2E B 301 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 2.18 32.86 -17.28 0.63 33.43 -15.93 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 7.78 28.08 -17.01 9.24 26.69 -16.42 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 6.67 11.87 -27.23 6.86 11.52 -27.95 1be1_c02 source 1be1 GLUTAMATE MUTASE : 5 hits 1be1_c02 naa= 3 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 1 3 # 1 28 GLU A 87 GLU.? 30.68 N21 C2E A 301 70 HIS A 113 HIS^? 30.12 N21 C2E A 301 281 HIS A 214 HIS.? 19.24 O6 C2E A 301 coo 66.09 46.17 155.81 66.77 48.19 155.70 22.53 -2.75 18.16 22.63 -1.18 19.56 coo 69.05 50.55 157.03 68.00 52.29 156.51 19.70 2.48 16.98 21.09 4.00 16.57 coo 100.93 36.73 156.02 100.47 38.42 157.18 -9.67 -12.41 11.50 -9.18 -11.33 13.22 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 2 3 # 2 28 GLU A 87 GLU.? 30.68 N21 C2E A 301 70 HIS A 113 HIS^? 30.12 N21 C2E A 301 281 HIS A 215 HIS.? 12.12 O6 C2E A 301 coo 66.09 46.17 155.81 66.77 48.19 155.70 22.53 -2.75 18.16 22.63 -1.18 19.56 coo 69.05 50.55 157.03 68.00 52.29 156.51 19.70 2.48 16.98 21.09 4.00 16.57 coo 100.93 36.73 156.02 100.47 38.42 157.18 -8.99 -15.19 5.86 -7.58 -13.77 5.21 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 3 3 # 3 28 GLU A 87 GLU.? 30.68 N21 C2E A 301 70 HIS A 113 HIS^? 30.12 N21 C2E A 301 281 HIS B 106 HIS^? 12.57 N21 C2E B 301 coo 66.09 46.17 155.81 66.77 48.19 155.70 22.53 -2.75 18.16 22.63 -1.18 19.56 coo 69.05 50.55 157.03 68.00 52.29 156.51 19.70 2.48 16.98 21.09 4.00 16.57 coo 100.93 36.73 156.02 100.47 38.42 157.18 -12.23 11.16 12.34 -12.16 12.93 13.45 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 4 3 # 4 28 GLU B 87 GLU.? 28.79 N21 C2E B 301 70 HIS B 113 HIS^? 28.48 N21 C2E B 301 281 HIS B 215 HIS.? 11.93 O6 C2E B 301 coo 66.09 46.17 155.81 66.77 48.19 155.70 4.21 10.66 27.30 5.56 9.30 28.22 coo 69.05 50.55 157.03 68.00 52.29 156.51 4.95 4.79 25.73 4.34 3.55 27.31 coo 100.93 36.73 156.02 100.47 38.42 157.18 7.81 14.24 -7.06 6.68 12.76 -6.10 1bfd_c00 source 1bfd BENZOYLFORMATE DECARBOXYLASE : 4 hits 1bfd_c00 naa= 3 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 1 3 # 1 A 382 ARG A 99 ARG.? 13.59 O61 C2E B 301 A 451 GLU B 37 GLU.? 9.39 O61 C2E B 301 A 540 GLU A 37 GLU.? 10.20 O61 C2E A 301 coo 79.04 80.20 80.81 79.58 81.40 83.63 -1.29 -2.34 -4.97 -2.19 0.30 -6.23 coo 81.34 87.29 87.22 82.36 86.09 88.61 -0.62 3.88 0.75 -0.32 4.81 -1.12 coo 79.94 80.46 88.84 81.11 81.36 87.27 0.90 -3.13 0.80 -0.70 -4.43 0.36 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 2 3 # 2 A 382 ARG A 140 ARG.? -3.36 C5 C2E A 301s A 451 GLU A 101 GLU.? 9.39 O11 C2E A 301 A 540 GLU A 138 GLU.? 5.46 O2' C2E A 301 coo 79.04 80.20 80.81 79.58 81.40 83.63 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 coo 81.34 87.29 87.22 82.36 86.09 88.61 2.77 -8.35 -14.05 3.97 -7.83 -15.72 coo 79.94 80.46 88.84 81.11 81.36 87.27 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 3 3 # 3 A 382 ARG A 227 ARG~? 9.91 O2' C2E A 301 A 451 GLU A 225 GLU~? 17.61 C1' C2E A 301 A 540 GLU A 224 GLU~? 15.93 O2' C2E A 301 coo 79.04 80.20 80.81 79.58 81.40 83.63 -5.20 -21.14 -18.72 -4.74 -24.14 -19.17 coo 81.34 87.29 87.22 82.36 86.09 88.61 -14.07 -25.95 -18.02 -15.34 -27.27 -16.96 coo 79.94 80.46 88.84 81.11 81.36 87.27 -8.40 -25.77 -21.72 -8.05 -26.98 -23.42 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 4 3 # 4 A 382 ARG B 99 ARG.? 13.88 O61 C2E A 301 A 451 GLU A 37 GLU.? 10.20 O61 C2E A 301 A 540 GLU B 37 GLU.? 9.39 O61 C2E B 301 coo 79.04 80.20 80.81 79.58 81.40 83.63 -4.81 1.09 -3.04 -5.37 -1.84 -3.80 coo 81.34 87.29 87.22 82.36 86.09 88.61 0.90 -3.13 0.80 -0.70 -4.43 0.36 coo 79.94 80.46 88.84 81.11 81.36 87.27 -0.62 3.88 0.75 -0.32 4.81 -1.12 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 5 3 # 5 A 382 ARG B 140 ARG.? -3.40 C5 C2E B 301s A 451 GLU B 101 GLU.? 9.43 O11 C2E B 301 A 540 GLU B 138 GLU.? 5.49 O2' C2E B 301 coo 79.04 80.20 80.81 79.58 81.40 83.63 -7.91 11.52 -6.78 -7.96 14.04 -5.01 coo 81.34 87.29 87.22 82.36 86.09 88.61 -14.64 6.09 -5.71 -16.72 5.82 -5.44 coo 79.94 80.46 88.84 81.11 81.36 87.27 -14.88 11.83 -9.39 -15.29 12.85 -11.20 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 6 3 # 6 A 382 ARG B 227 ARG~? 7.56 O2' C2E B 301 A 451 GLU B 225 GLU~? 17.01 C1' C2E B 301 A 540 GLU B 224 GLU~? 16.79 O2' C2E B 301 coo 79.04 80.20 80.81 79.58 81.40 83.63 -16.01 19.09 -16.09 -16.65 16.54 -14.51 coo 81.34 87.29 87.22 82.36 86.09 88.61 -10.33 22.86 -23.16 -8.91 24.36 -23.62 coo 79.94 80.46 88.84 81.11 81.36 87.27 -16.80 22.93 -20.90 -17.88 24.32 -22.10 1bhg_c04 source 1bhg BETA-GLUCURONIDASE : 6 hits 1bhg_c04 naa= 3 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 1 3 # 1 B 382 ARG A 99 ARG.? 13.59 O61 C2E B 301 B 451 GLU B 37 GLU.? 9.39 O61 C2E B 301 B 540 GLU A 37 GLU.? 10.20 O61 C2E A 301 coo 82.21 41.07 119.14 83.95 40.66 116.59 -1.29 -2.34 -4.97 -2.19 0.30 -6.23 coo 86.52 35.28 112.74 87.08 36.38 110.99 -0.62 3.88 0.75 -0.32 4.81 -1.12 coo 83.38 41.19 112.55 85.47 40.59 112.72 0.90 -3.13 0.80 -0.70 -4.43 0.36 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 2 3 # 2 B 382 ARG A 140 ARG.? -3.36 C5 C2E A 301s B 451 GLU A 101 GLU.? 9.39 O11 C2E A 301 B 540 GLU A 138 GLU.? 5.46 O2' C2E A 301 coo 82.21 41.07 119.14 83.95 40.66 116.59 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 coo 86.52 35.28 112.74 87.08 36.38 110.99 2.77 -8.35 -14.05 3.97 -7.83 -15.72 coo 83.38 41.19 112.55 85.47 40.59 112.72 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 3 3 # 3 B 382 ARG A 165 ARG.? 12.45 N2 C2E A 301 B 451 GLU A 101 GLU.? 9.39 O11 C2E A 301 B 540 GLU A 138 GLU.? 5.46 O2' C2E A 301 coo 82.21 41.07 119.14 83.95 40.66 116.59 -4.47 -13.19 -19.45 -6.66 -12.47 -21.46 coo 86.52 35.28 112.74 87.08 36.38 110.99 2.77 -8.35 -14.05 3.97 -7.83 -15.72 coo 83.38 41.19 112.55 85.47 40.59 112.72 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 4 3 # 4 B 382 ARG A 227 ARG~? 9.91 O2' C2E A 301 B 451 GLU A 225 GLU~? 17.61 C1' C2E A 301 B 540 GLU A 224 GLU~? 15.93 O2' C2E A 301 coo 82.21 41.07 119.14 83.95 40.66 116.59 -5.20 -21.14 -18.72 -4.74 -24.14 -19.17 coo 86.52 35.28 112.74 87.08 36.38 110.99 -14.07 -25.95 -18.02 -15.34 -27.27 -16.96 coo 83.38 41.19 112.55 85.47 40.59 112.72 -8.40 -25.77 -21.72 -8.05 -26.98 -23.42 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 5 3 # 5 B 382 ARG B 99 ARG.? 13.88 O61 C2E A 301 B 451 GLU A 37 GLU.? 10.20 O61 C2E A 301 B 540 GLU B 37 GLU.? 9.39 O61 C2E B 301 coo 82.21 41.07 119.14 83.95 40.66 116.59 -4.81 1.09 -3.04 -5.37 -1.84 -3.80 coo 86.52 35.28 112.74 87.08 36.38 110.99 0.90 -3.13 0.80 -0.70 -4.43 0.36 coo 83.38 41.19 112.55 85.47 40.59 112.72 -0.62 3.88 0.75 -0.32 4.81 -1.12 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 6 3 # 6 B 382 ARG B 140 ARG.? -3.40 C5 C2E B 301s B 451 GLU B 101 GLU.? 9.43 O11 C2E B 301 B 540 GLU B 138 GLU.? 5.49 O2' C2E B 301 coo 82.21 41.07 119.14 83.95 40.66 116.59 -7.91 11.52 -6.78 -7.96 14.04 -5.01 coo 86.52 35.28 112.74 87.08 36.38 110.99 -14.64 6.09 -5.71 -16.72 5.82 -5.44 coo 83.38 41.19 112.55 85.47 40.59 112.72 -14.88 11.83 -9.39 -15.29 12.85 -11.20 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 7 3 # 7 B 382 ARG B 165 ARG.? 10.70 O2' C2E B 301 B 451 GLU B 101 GLU.? 9.43 O11 C2E B 301 B 540 GLU B 138 GLU.? 5.49 O2' C2E B 301 coo 82.21 41.07 119.14 83.95 40.66 116.59 -16.44 10.61 -14.72 -19.33 11.67 -14.77 coo 86.52 35.28 112.74 87.08 36.38 110.99 -14.64 6.09 -5.71 -16.72 5.82 -5.44 coo 83.38 41.19 112.55 85.47 40.59 112.72 -14.88 11.83 -9.39 -15.29 12.85 -11.20 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 8 3 # 8 B 382 ARG B 227 ARG~? 7.56 O2' C2E B 301 B 451 GLU B 225 GLU~? 17.01 C1' C2E B 301 B 540 GLU B 224 GLU~? 16.79 O2' C2E B 301 coo 82.21 41.07 119.14 83.95 40.66 116.59 -16.01 19.09 -16.09 -16.65 16.54 -14.51 coo 86.52 35.28 112.74 87.08 36.38 110.99 -10.33 22.86 -23.16 -8.91 24.36 -23.62 coo 83.38 41.19 112.55 85.47 40.59 112.72 -16.80 22.93 -20.90 -17.88 24.32 -22.10 1bhg_c05 source 1bhg BETA-GLUCURONIDASE : 8 hits 1bhg_c05 naa= 3 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 1 3 # 1 118 ARG A 140 ARG.? -3.36 C5 C2E A 301s 183 LYS A 243 LYS.? 15.17 N2 C2E A 301 317 ARG B 161 ARG^? 11.68 O6 C2E B 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 coo 82.09 117.51 66.37 80.60 114.32 71.44 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo 65.21 120.62 58.76 63.62 123.14 59.66 2.96 9.64 -10.71 5.59 9.57 -9.11 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 2 3 # 2 118 ARG A 155 ARG^? 21.80 N1 C2E A 301 183 LYS A 177 LYS.? 20.27 N7 C2E A 301 317 ARG A 169 ARG^? -4.75 O6 C2E A 301s coo 76.57 109.19 73.41 73.86 110.26 72.16 -22.65 -25.75 -3.25 -23.90 -23.07 -4.10 coo 82.09 117.51 66.37 80.60 114.32 71.44 -13.21 -27.52 5.04 -11.69 -32.72 3.81 coo 65.21 120.62 58.76 63.62 123.14 59.66 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 3 3 # 3 118 ARG A 165 ARG.? 12.45 N2 C2E A 301 183 LYS B 238 LYS^? 16.50 N2 C2E A 301 317 ARG B 99 ARG.? 13.88 O61 C2E A 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 -4.47 -13.19 -19.45 -6.66 -12.47 -21.46 coo 82.09 117.51 66.37 80.60 114.32 71.44 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 coo 65.21 120.62 58.76 63.62 123.14 59.66 -4.81 1.09 -3.04 -5.37 -1.84 -3.80 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 4 3 # 4 118 ARG A 227 ARG~? 9.91 O2' C2E A 301 183 LYS A 137 LYS.? -4.52 O2' C2E A 301s 317 ARG A 161 ARG^? 11.81 O6 C2E A 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 -5.20 -21.14 -18.72 -4.74 -24.14 -19.17 coo 82.09 117.51 66.37 80.60 114.32 71.44 4.32 -14.05 -15.33 0.72 -19.17 -16.51 coo 65.21 120.62 58.76 63.62 123.14 59.66 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 5 3 # 5 118 ARG A 227 ARG~? 9.91 O2' C2E A 301 183 LYS A 137 LYS.? -4.52 O2' C2E A 301s 317 ARG A 217 ARG^? 6.70 O6 C2E A 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 -5.20 -21.14 -18.72 -4.74 -24.14 -19.17 coo 82.09 117.51 66.37 80.60 114.32 71.44 4.32 -14.05 -15.33 0.72 -19.17 -16.51 coo 65.21 120.62 58.76 63.62 123.14 59.66 -3.36 -16.18 0.94 -0.54 -17.39 0.83 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 6 3 # 6 118 ARG A 227 ARG~? 9.91 O2' C2E A 301 183 LYS A 205 LYS^? 11.81 O1P C2E A 301 317 ARG A 155 ARG^? 21.80 N1 C2E A 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 -5.20 -21.14 -18.72 -4.74 -24.14 -19.17 coo 82.09 117.51 66.37 80.60 114.32 71.44 -5.45 -27.16 -8.25 -2.71 -32.35 -10.76 coo 65.21 120.62 58.76 63.62 123.14 59.66 -22.65 -25.75 -3.25 -23.90 -23.07 -4.10 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 7 3 # 7 118 ARG A 227 ARG~? 9.91 O2' C2E A 301 183 LYS A 205 LYS^? 11.81 O1P C2E A 301 317 ARG A 161 ARG^? 11.81 O6 C2E A 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 -5.20 -21.14 -18.72 -4.74 -24.14 -19.17 coo 82.09 117.51 66.37 80.60 114.32 71.44 -5.45 -27.16 -8.25 -2.71 -32.35 -10.76 coo 65.21 120.62 58.76 63.62 123.14 59.66 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 8 3 # 8 118 ARG B 140 ARG.? -3.40 C5 C2E B 301s 183 LYS B 243 LYS.? 13.43 N1 C2E B 301 317 ARG A 161 ARG^? 11.81 O6 C2E A 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 -7.91 11.52 -6.78 -7.96 14.04 -5.01 coo 82.09 117.51 66.37 80.60 114.32 71.44 -2.53 1.27 -13.25 2.13 3.70 -10.70 coo 65.21 120.62 58.76 63.62 123.14 59.66 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 9 3 # 9 118 ARG B 155 ARG^? 22.81 O6 C2E B 301 183 LYS B 177 LYS.? 21.12 N7 C2E B 301 317 ARG B 161 ARG^? 11.68 O6 C2E B 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 6.63 24.44 -23.88 7.74 21.82 -25.04 coo 82.09 117.51 66.37 80.60 114.32 71.44 8.81 26.59 -11.72 7.46 31.56 -12.94 coo 65.21 120.62 58.76 63.62 123.14 59.66 2.96 9.64 -10.71 5.59 9.57 -9.11 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 10 3 # 10 118 ARG B 155 ARG^? 22.81 O6 C2E B 301 183 LYS B 177 LYS.? 21.12 N7 C2E B 301 317 ARG B 169 ARG^? -4.70 O6 C2E B 301s coo 76.57 109.19 73.41 73.86 110.26 72.16 6.63 24.44 -23.88 7.74 21.82 -25.04 coo 82.09 117.51 66.37 80.60 114.32 71.44 8.81 26.59 -11.72 7.46 31.56 -12.94 coo 65.21 120.62 58.76 63.62 123.14 59.66 -0.88 13.03 -7.12 -1.56 12.92 -4.13 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 11 3 # 11 118 ARG B 155 ARG^? 22.81 O6 C2E B 301 183 LYS B 197 LYS.? 24.97 N2 C2E B 301 317 ARG B 161 ARG^? 11.68 O6 C2E B 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 6.63 24.44 -23.88 7.74 21.82 -25.04 coo 82.09 117.51 66.37 80.60 114.32 71.44 2.66 14.16 -30.11 -0.83 11.74 -34.04 coo 65.21 120.62 58.76 63.62 123.14 59.66 2.96 9.64 -10.71 5.59 9.57 -9.11 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 12 3 # 12 118 ARG B 161 ARG^? 11.68 O6 C2E B 301 183 LYS B 148 LYS^? 21.33 O6 C2E B 301 317 ARG B 194 ARG.? 29.24 O11 C2E A 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 2.96 9.64 -10.71 5.59 9.57 -9.11 coo 82.09 117.51 66.37 80.60 114.32 71.44 4.64 19.42 -20.28 9.89 19.27 -22.17 coo 65.21 120.62 58.76 63.62 123.14 59.66 9.25 6.39 -30.72 9.33 3.86 -32.46 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 13 3 # 13 118 ARG B 161 ARG^? 11.68 O6 C2E B 301 183 LYS B 243 LYS.? 13.43 N1 C2E B 301 317 ARG B 165 ARG.? 10.70 O2' C2E B 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 2.96 9.64 -10.71 5.59 9.57 -9.11 coo 82.09 117.51 66.37 80.60 114.32 71.44 -2.53 1.27 -13.25 2.13 3.70 -10.70 coo 65.21 120.62 58.76 63.62 123.14 59.66 -16.44 10.61 -14.72 -19.33 11.67 -14.77 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 14 3 # 14 118 ARG B 194 ARG.? 29.24 O11 C2E A 301 183 LYS B 197 LYS.? 24.97 N2 C2E B 301 317 ARG B 161 ARG^? 11.68 O6 C2E B 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 9.25 6.39 -30.72 9.33 3.86 -32.46 coo 82.09 117.51 66.37 80.60 114.32 71.44 2.66 14.16 -30.11 -0.83 11.74 -34.04 coo 65.21 120.62 58.76 63.62 123.14 59.66 2.96 9.64 -10.71 5.59 9.57 -9.11 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 15 3 # 15 118 ARG B 227 ARG~? 7.56 O2' C2E B 301 183 LYS B 137 LYS.? -3.23 O3' C2E B 301s 317 ARG B 217 ARG^? 6.37 O6 C2E B 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 -16.01 19.09 -16.09 -16.65 16.54 -14.51 coo 82.09 117.51 66.37 80.60 114.32 71.44 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo 65.21 120.62 58.76 63.62 123.14 59.66 0.82 15.44 -4.45 -0.87 16.78 -2.26 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 16 3 # 16 118 ARG B 227 ARG~? 7.56 O2' C2E B 301 183 LYS B 205 LYS^? -10.36 O1P C2E B 301s 317 ARG B 161 ARG^? 11.68 O6 C2E B 301 coo 76.57 109.19 73.41 73.86 110.26 72.16 -16.01 19.09 -16.09 -16.65 16.54 -14.51 coo 82.09 117.51 66.37 80.60 114.32 71.44 -6.87 25.33 -11.52 -10.34 29.58 -9.49 coo 65.21 120.62 58.76 63.62 123.14 59.66 2.96 9.64 -10.71 5.59 9.57 -9.11 1bib_c00 source 1bib BIRA BIFUNCTIONAL PROTEIN (ACTS AS BIOTIN OPER: 16 hits 1bib_c00 naa= 3 ULMN 3 1bmt_c04 METHIONINE SYNTHASE (B12-BINDING DOMuser 1 3 # 1 A 757 ASP A 31 ASP~? 17.49 O6 C2E B 301 A 759 HIS B 214 HIS.? 18.94 O6 C2E B 301 A 810 SER A 29 SER~? 21.07 N11 C2E A 301 coo 30.11 61.02 29.12 29.36 59.77 27.63 10.86 4.60 -5.63 10.78 6.65 -6.14 coo 30.94 56.62 25.28 29.94 54.94 26.14 13.04 11.66 -4.90 14.49 10.59 -3.83 coo 25.05 62.74 29.97 26.88 61.45 29.19 15.02 3.06 -1.55 17.13 2.40 -0.57 1bmt_c04 source 1bmt METHIONINE SYNTHASE (B12-BINDING DOMAINS) (E.C: 1 hits 1bmt_c04 naa= 3 ULMN 3 1bmt_c05 METHIONINE SYNTHASE (B12-BINDING DOMuser 1 3 # 1 B 757 ASP A 31 ASP~? 17.49 O6 C2E B 301 B 759 HIS B 214 HIS.? 18.94 O6 C2E B 301 B 810 SER A 29 SER~? 21.07 N11 C2E A 301 coo -2.30 64.08 6.41 -0.36 64.72 6.26 10.86 4.60 -5.63 10.78 6.65 -6.14 coo 1.96 66.39 3.07 2.10 68.48 3.58 13.04 11.66 -4.90 14.49 10.59 -3.83 coo -1.50 63.90 11.86 -1.31 64.33 9.52 15.02 3.06 -1.55 17.13 2.40 -0.57 1bmt_c05 source 1bmt METHIONINE SYNTHASE (B12-BINDING DOMAINS) (E.C: 1 hits 1bmt_c05 naa= 3 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 1 3 # 1 30 GLY A 176 GLY.? 18.56 O6 C2E A 301 48 HIS A 154 HIS^? 21.74 O6 C2E A 301 99 ASP A 152 ASP.? 20.83 C8 C2E A 301 coo 12.38 5.55 24.25 13.27 5.59 24.39 -14.50 -24.46 6.89 -13.82 -24.67 7.29 coo 18.80 12.68 24.53 17.69 13.54 26.08 -16.69 -30.86 2.00 -15.94 -32.47 3.12 coo 17.07 18.51 26.62 16.67 17.07 28.09 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 2 3 # 2 30 GLY B 176 GLY.? 18.62 O6 C2E B 301 48 HIS B 154 HIS^? 20.45 O6 C2E B 301 99 ASP B 152 ASP.? 19.99 C8 C2E B 301 coo 12.38 5.55 24.25 13.27 5.59 24.39 11.24 23.68 -11.63 11.16 23.89 -10.85 coo 18.80 12.68 24.53 17.69 13.54 26.08 7.78 28.08 -17.01 9.24 26.69 -16.42 coo 17.07 18.51 26.62 16.67 17.07 28.09 2.18 32.86 -17.28 0.63 33.43 -15.93 1bp2_c00 source 1bp2 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSPHATIDE AC: 2 hits 1bp2_c00 naa= 3 ULMN 3 1bqc_c01 BETA-MANNANASE user 1 3 # 1 A 50 ARG A 99 ARG.? 13.59 O61 C2E B 301 A 128 GLU B 37 GLU.? 9.39 O61 C2E B 301 A 225 GLU A 37 GLU.? 10.20 O61 C2E A 301 coo 38.56 19.11 14.83 37.12 21.00 16.76 -1.29 -2.34 -4.97 -2.19 0.30 -6.23 coo 36.48 24.43 22.02 36.86 26.34 21.13 -0.62 3.88 0.75 -0.32 4.81 -1.12 coo 40.16 23.71 17.01 38.52 24.96 17.40 0.90 -3.13 0.80 -0.70 -4.43 0.36 ULMN 3 1bqc_c01 BETA-MANNANASE user 2 3 # 2 A 50 ARG A 140 ARG.? -3.36 C5 C2E A 301s A 128 GLU A 101 GLU.? 9.39 O11 C2E A 301 A 225 GLU A 138 GLU.? 5.46 O2' C2E A 301 coo 38.56 19.11 14.83 37.12 21.00 16.76 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 coo 36.48 24.43 22.02 36.86 26.34 21.13 2.77 -8.35 -14.05 3.97 -7.83 -15.72 coo 40.16 23.71 17.01 38.52 24.96 17.40 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 ULMN 3 1bqc_c01 BETA-MANNANASE user 3 3 # 3 A 50 ARG A 165 ARG.? 12.45 N2 C2E A 301 A 128 GLU A 101 GLU.? 9.39 O11 C2E A 301 A 225 GLU A 138 GLU.? 5.46 O2' C2E A 301 coo 38.56 19.11 14.83 37.12 21.00 16.76 -4.47 -13.19 -19.45 -6.66 -12.47 -21.46 coo 36.48 24.43 22.02 36.86 26.34 21.13 2.77 -8.35 -14.05 3.97 -7.83 -15.72 coo 40.16 23.71 17.01 38.52 24.96 17.40 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 ULMN 3 1bqc_c01 BETA-MANNANASE user 4 3 # 4 A 50 ARG A 227 ARG~? 9.91 O2' C2E A 301 A 128 GLU A 225 GLU~? 17.61 C1' C2E A 301 A 225 GLU A 224 GLU~? 15.93 O2' C2E A 301 coo 38.56 19.11 14.83 37.12 21.00 16.76 -5.20 -21.14 -18.72 -4.74 -24.14 -19.17 coo 36.48 24.43 22.02 36.86 26.34 21.13 -14.07 -25.95 -18.02 -15.34 -27.27 -16.96 coo 40.16 23.71 17.01 38.52 24.96 17.40 -8.40 -25.77 -21.72 -8.05 -26.98 -23.42 ULMN 3 1bqc_c01 BETA-MANNANASE user 5 3 # 5 A 50 ARG B 99 ARG.? 13.88 O61 C2E A 301 A 128 GLU A 37 GLU.? 10.20 O61 C2E A 301 A 225 GLU B 37 GLU.? 9.39 O61 C2E B 301 coo 38.56 19.11 14.83 37.12 21.00 16.76 -4.81 1.09 -3.04 -5.37 -1.84 -3.80 coo 36.48 24.43 22.02 36.86 26.34 21.13 0.90 -3.13 0.80 -0.70 -4.43 0.36 coo 40.16 23.71 17.01 38.52 24.96 17.40 -0.62 3.88 0.75 -0.32 4.81 -1.12 ULMN 3 1bqc_c01 BETA-MANNANASE user 6 3 # 6 A 50 ARG B 165 ARG.? 10.70 O2' C2E B 301 A 128 GLU B 101 GLU.? 9.43 O11 C2E B 301 A 225 GLU B 138 GLU.? 5.49 O2' C2E B 301 coo 38.56 19.11 14.83 37.12 21.00 16.76 -16.44 10.61 -14.72 -19.33 11.67 -14.77 coo 36.48 24.43 22.02 36.86 26.34 21.13 -14.64 6.09 -5.71 -16.72 5.82 -5.44 coo 40.16 23.71 17.01 38.52 24.96 17.40 -14.88 11.83 -9.39 -15.29 12.85 -11.20 ULMN 3 1bqc_c01 BETA-MANNANASE user 7 3 # 7 A 50 ARG B 227 ARG~? 7.56 O2' C2E B 301 A 128 GLU B 225 GLU~? 17.01 C1' C2E B 301 A 225 GLU B 224 GLU~? 16.79 O2' C2E B 301 coo 38.56 19.11 14.83 37.12 21.00 16.76 -16.01 19.09 -16.09 -16.65 16.54 -14.51 coo 36.48 24.43 22.02 36.86 26.34 21.13 -10.33 22.86 -23.16 -8.91 24.36 -23.62 coo 40.16 23.71 17.01 38.52 24.96 17.40 -16.80 22.93 -20.90 -17.88 24.32 -22.10 1bqc_c01 source 1bqc BETA-MANNANASE : 7 hits 1bqc_c01 naa= 3 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 110 GLN^? 27.91 N21 C2E A 301 A 91 LEU A 124 LEU^? 20.37 N21 C2E A 301 A 133 GLU A 87 GLU.? 30.68 N21 C2E A 301 coo 43.58 43.67 66.73 42.32 42.78 68.15 25.06 -2.48 10.09 26.80 -1.25 10.05 coo 38.58 45.09 70.44 38.28 45.21 72.59 17.22 -2.19 9.55 16.79 -4.12 10.40 coo 44.05 36.87 70.65 43.15 38.64 69.97 22.53 -2.75 18.16 22.63 -1.18 19.56 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN A 134 GLN^? 8.75 O11 C2E A 301 A 91 LEU A 135 LEU.? -4.12 N71 C2E A 301s A 133 GLU A 138 GLU.? 5.46 O2' C2E A 301 coo 43.58 43.67 66.73 42.32 42.78 68.15 7.72 -9.60 -13.41 7.57 -9.44 -15.52 coo 38.58 45.09 70.44 38.28 45.21 72.59 6.80 -11.31 -8.06 6.45 -12.31 -6.19 coo 44.05 36.87 70.65 43.15 38.64 69.97 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN B 86 GLN.? 28.67 N21 C2E B 301 A 91 LEU B 81 LEU~? 22.74 N21 C2E B 301 A 133 GLU B 87 GLU.? 28.79 N21 C2E B 301 coo 43.58 43.67 66.73 42.32 42.78 68.15 3.32 16.92 27.38 4.39 16.59 29.20 coo 38.58 45.09 70.44 38.28 45.21 72.59 6.79 20.39 20.97 7.64 18.60 20.14 coo 44.05 36.87 70.65 43.15 38.64 69.97 4.21 10.66 27.30 5.56 9.30 28.22 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN B 110 GLN^? 26.18 N21 C2E B 301 A 91 LEU B 124 LEU^? 18.42 N21 C2E B 301 A 133 GLU B 87 GLU.? 28.79 N21 C2E B 301 coo 43.58 43.67 66.73 42.32 42.78 68.15 -4.18 8.65 25.75 -4.85 7.68 27.53 coo 38.58 45.09 70.44 38.28 45.21 72.59 -0.93 7.11 18.84 -0.27 9.12 18.40 coo 44.05 36.87 70.65 43.15 38.64 69.97 4.21 10.66 27.30 5.56 9.30 28.22 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 5 3 # 5 A 50 GLN B 134 GLN.? 7.53 O11 C2E B 301 A 91 LEU B 135 LEU.? -4.28 N71 C2E B 301s A 133 GLU B 101 GLU.? 9.43 O11 C2E B 301 coo 43.58 43.67 66.73 42.32 42.78 68.15 -17.55 9.98 -0.31 -19.35 10.60 -1.25 coo 38.58 45.09 70.44 38.28 45.21 72.59 -12.05 10.45 0.78 -10.15 11.46 1.00 coo 44.05 36.87 70.65 43.15 38.64 69.97 -14.64 6.09 -5.71 -16.72 5.82 -5.44 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 6 3 # 6 A 50 GLN B 134 GLN.? 7.53 O11 C2E B 301 A 91 LEU B 135 LEU.? -4.28 N71 C2E B 301s A 133 GLU B 138 GLU.? 5.49 O2' C2E B 301 coo 43.58 43.67 66.73 42.32 42.78 68.15 -17.55 9.98 -0.31 -19.35 10.60 -1.25 coo 38.58 45.09 70.44 38.28 45.21 72.59 -12.05 10.45 0.78 -10.15 11.46 1.00 coo 44.05 36.87 70.65 43.15 38.64 69.97 -14.88 11.83 -9.39 -15.29 12.85 -11.20 1bs4_c00 source 1bs4 PEPTIDE DEFORMYLASE : 6 hits 1bs4_c00 naa= 3 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 1 3 # 1 B 550 GLN A 110 GLN^? 27.91 N21 C2E A 301 B 591 LEU A 124 LEU^? 20.37 N21 C2E A 301 B 633 GLU A 87 GLU.? 30.68 N21 C2E A 301 coo 88.06 44.34 57.19 89.06 45.53 55.74 25.06 -2.48 10.09 26.80 -1.25 10.05 coo 86.70 48.66 52.61 87.15 48.69 50.51 17.22 -2.19 9.55 16.79 -4.12 10.40 coo 95.42 44.52 54.43 93.46 45.31 54.70 22.53 -2.75 18.16 22.63 -1.18 19.56 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 2 3 # 2 B 550 GLN A 134 GLN^? 8.75 O11 C2E A 301 B 591 LEU A 135 LEU.? -4.12 N71 C2E A 301s B 633 GLU A 138 GLU.? 5.46 O2' C2E A 301 coo 88.06 44.34 57.19 89.06 45.53 55.74 7.72 -9.60 -13.41 7.57 -9.44 -15.52 coo 86.70 48.66 52.61 87.15 48.69 50.51 6.80 -11.31 -8.06 6.45 -12.31 -6.19 coo 95.42 44.52 54.43 93.46 45.31 54.70 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 3 3 # 3 B 550 GLN B 110 GLN^? 26.18 N21 C2E B 301 B 591 LEU B 124 LEU^? 18.42 N21 C2E B 301 B 633 GLU B 87 GLU.? 28.79 N21 C2E B 301 coo 88.06 44.34 57.19 89.06 45.53 55.74 -4.18 8.65 25.75 -4.85 7.68 27.53 coo 86.70 48.66 52.61 87.15 48.69 50.51 -0.93 7.11 18.84 -0.27 9.12 18.40 coo 95.42 44.52 54.43 93.46 45.31 54.70 4.21 10.66 27.30 5.56 9.30 28.22 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 4 3 # 4 B 550 GLN B 134 GLN.? 7.53 O11 C2E B 301 B 591 LEU B 135 LEU.? -4.28 N71 C2E B 301s B 633 GLU B 101 GLU.? 9.43 O11 C2E B 301 coo 88.06 44.34 57.19 89.06 45.53 55.74 -17.55 9.98 -0.31 -19.35 10.60 -1.25 coo 86.70 48.66 52.61 87.15 48.69 50.51 -12.05 10.45 0.78 -10.15 11.46 1.00 coo 95.42 44.52 54.43 93.46 45.31 54.70 -14.64 6.09 -5.71 -16.72 5.82 -5.44 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 5 3 # 5 B 550 GLN B 134 GLN.? 7.53 O11 C2E B 301 B 591 LEU B 135 LEU.? -4.28 N71 C2E B 301s B 633 GLU B 138 GLU.? 5.49 O2' C2E B 301 coo 88.06 44.34 57.19 89.06 45.53 55.74 -17.55 9.98 -0.31 -19.35 10.60 -1.25 coo 86.70 48.66 52.61 87.15 48.69 50.51 -12.05 10.45 0.78 -10.15 11.46 1.00 coo 95.42 44.52 54.43 93.46 45.31 54.70 -14.88 11.83 -9.39 -15.29 12.85 -11.20 1bs4_c01 source 1bs4 PEPTIDE DEFORMYLASE : 5 hits 1bs4_c01 naa= 3 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 1 3 # 1 C1050 GLN A 86 GLN.? 29.68 N21 C2E A 301 C1091 LEU A 81 LEU~? 24.51 N21 C2E A 301 C1133 GLU A 87 GLU.? 30.68 N21 C2E A 301 coo 68.29 34.44 43.03 66.67 34.74 44.37 24.23 -9.58 18.83 26.07 -10.44 19.45 coo 65.83 38.95 47.05 65.46 38.90 49.20 16.80 -13.04 20.37 15.42 -11.39 20.19 coo 63.14 29.39 46.25 63.84 31.31 45.74 22.53 -2.75 18.16 22.63 -1.18 19.56 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 2 3 # 2 C1050 GLN A 110 GLN^? 27.91 N21 C2E A 301 C1091 LEU A 124 LEU^? 20.37 N21 C2E A 301 C1133 GLU A 87 GLU.? 30.68 N21 C2E A 301 coo 68.29 34.44 43.03 66.67 34.74 44.37 25.06 -2.48 10.09 26.80 -1.25 10.05 coo 65.83 38.95 47.05 65.46 38.90 49.20 17.22 -2.19 9.55 16.79 -4.12 10.40 coo 63.14 29.39 46.25 63.84 31.31 45.74 22.53 -2.75 18.16 22.63 -1.18 19.56 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 3 3 # 3 C1050 GLN A 134 GLN^? 8.75 O11 C2E A 301 C1091 LEU A 135 LEU.? -4.12 N71 C2E A 301s C1133 GLU A 138 GLU.? 5.46 O2' C2E A 301 coo 68.29 34.44 43.03 66.67 34.74 44.37 7.72 -9.60 -13.41 7.57 -9.44 -15.52 coo 65.83 38.95 47.05 65.46 38.90 49.20 6.80 -11.31 -8.06 6.45 -12.31 -6.19 coo 63.14 29.39 46.25 63.84 31.31 45.74 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 4 3 # 4 C1050 GLN B 86 GLN.? 28.67 N21 C2E B 301 C1091 LEU B 81 LEU~? 22.74 N21 C2E B 301 C1133 GLU B 87 GLU.? 28.79 N21 C2E B 301 coo 68.29 34.44 43.03 66.67 34.74 44.37 3.32 16.92 27.38 4.39 16.59 29.20 coo 65.83 38.95 47.05 65.46 38.90 49.20 6.79 20.39 20.97 7.64 18.60 20.14 coo 63.14 29.39 46.25 63.84 31.31 45.74 4.21 10.66 27.30 5.56 9.30 28.22 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 5 3 # 5 C1050 GLN B 110 GLN^? 26.18 N21 C2E B 301 C1091 LEU B 124 LEU^? 18.42 N21 C2E B 301 C1133 GLU B 87 GLU.? 28.79 N21 C2E B 301 coo 68.29 34.44 43.03 66.67 34.74 44.37 -4.18 8.65 25.75 -4.85 7.68 27.53 coo 65.83 38.95 47.05 65.46 38.90 49.20 -0.93 7.11 18.84 -0.27 9.12 18.40 coo 63.14 29.39 46.25 63.84 31.31 45.74 4.21 10.66 27.30 5.56 9.30 28.22 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 6 3 # 6 C1050 GLN B 134 GLN.? 7.53 O11 C2E B 301 C1091 LEU B 135 LEU.? -4.28 N71 C2E B 301s C1133 GLU B 101 GLU.? 9.43 O11 C2E B 301 coo 68.29 34.44 43.03 66.67 34.74 44.37 -17.55 9.98 -0.31 -19.35 10.60 -1.25 coo 65.83 38.95 47.05 65.46 38.90 49.20 -12.05 10.45 0.78 -10.15 11.46 1.00 coo 63.14 29.39 46.25 63.84 31.31 45.74 -14.64 6.09 -5.71 -16.72 5.82 -5.44 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 7 3 # 7 C1050 GLN B 134 GLN.? 7.53 O11 C2E B 301 C1091 LEU B 135 LEU.? -4.28 N71 C2E B 301s C1133 GLU B 138 GLU.? 5.49 O2' C2E B 301 coo 68.29 34.44 43.03 66.67 34.74 44.37 -17.55 9.98 -0.31 -19.35 10.60 -1.25 coo 65.83 38.95 47.05 65.46 38.90 49.20 -12.05 10.45 0.78 -10.15 11.46 1.00 coo 63.14 29.39 46.25 63.84 31.31 45.74 -14.88 11.83 -9.39 -15.29 12.85 -11.20 1bs4_c02 source 1bs4 PEPTIDE DEFORMYLASE : 7 hits 1bs4_c02 naa= 3 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 86 GLN.? 29.68 N21 C2E A 301 A 91 LEU A 81 LEU~? 24.51 N21 C2E A 301 A 133 GLU A 87 GLU.? 30.68 N21 C2E A 301 coo 38.23 53.34 67.59 38.84 53.87 69.56 24.23 -9.58 18.83 26.07 -10.44 19.45 coo 35.40 53.22 73.30 35.37 54.87 74.74 16.80 -13.04 20.37 15.42 -11.39 20.19 coo 45.08 56.04 70.60 43.15 55.19 70.77 22.53 -2.75 18.16 22.63 -1.18 19.56 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN A 110 GLN^? 27.91 N21 C2E A 301 A 91 LEU A 124 LEU^? 20.37 N21 C2E A 301 A 133 GLU A 87 GLU.? 30.68 N21 C2E A 301 coo 38.23 53.34 67.59 38.84 53.87 69.56 25.06 -2.48 10.09 26.80 -1.25 10.05 coo 35.40 53.22 73.30 35.37 54.87 74.74 17.22 -2.19 9.55 16.79 -4.12 10.40 coo 45.08 56.04 70.60 43.15 55.19 70.77 22.53 -2.75 18.16 22.63 -1.18 19.56 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN A 134 GLN^? 8.75 O11 C2E A 301 A 91 LEU A 135 LEU.? -4.12 N71 C2E A 301s A 133 GLU A 138 GLU.? 5.46 O2' C2E A 301 coo 38.23 53.34 67.59 38.84 53.87 69.56 7.72 -9.60 -13.41 7.57 -9.44 -15.52 coo 35.40 53.22 73.30 35.37 54.87 74.74 6.80 -11.31 -8.06 6.45 -12.31 -6.19 coo 45.08 56.04 70.60 43.15 55.19 70.77 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN B 86 GLN.? 28.67 N21 C2E B 301 A 91 LEU B 81 LEU~? 22.74 N21 C2E B 301 A 133 GLU B 87 GLU.? 28.79 N21 C2E B 301 coo 38.23 53.34 67.59 38.84 53.87 69.56 3.32 16.92 27.38 4.39 16.59 29.20 coo 35.40 53.22 73.30 35.37 54.87 74.74 6.79 20.39 20.97 7.64 18.60 20.14 coo 45.08 56.04 70.60 43.15 55.19 70.77 4.21 10.66 27.30 5.56 9.30 28.22 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 5 3 # 5 A 50 GLN B 110 GLN^? 26.18 N21 C2E B 301 A 91 LEU B 124 LEU^? 18.42 N21 C2E B 301 A 133 GLU B 87 GLU.? 28.79 N21 C2E B 301 coo 38.23 53.34 67.59 38.84 53.87 69.56 -4.18 8.65 25.75 -4.85 7.68 27.53 coo 35.40 53.22 73.30 35.37 54.87 74.74 -0.93 7.11 18.84 -0.27 9.12 18.40 coo 45.08 56.04 70.60 43.15 55.19 70.77 4.21 10.66 27.30 5.56 9.30 28.22 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 6 3 # 6 A 50 GLN B 134 GLN.? 7.53 O11 C2E B 301 A 91 LEU B 104 LEU^? 7.52 N31 C2E B 301 A 133 GLU B 101 GLU.? 9.43 O11 C2E B 301 coo 38.23 53.34 67.59 38.84 53.87 69.56 -17.55 9.98 -0.31 -19.35 10.60 -1.25 coo 35.40 53.22 73.30 35.37 54.87 74.74 -12.28 10.43 5.32 -11.64 12.17 6.43 coo 45.08 56.04 70.60 43.15 55.19 70.77 -14.64 6.09 -5.71 -16.72 5.82 -5.44 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 7 3 # 7 A 50 GLN B 134 GLN.? 7.53 O11 C2E B 301 A 91 LEU B 135 LEU.? -4.28 N71 C2E B 301s A 133 GLU B 138 GLU.? 5.49 O2' C2E B 301 coo 38.23 53.34 67.59 38.84 53.87 69.56 -17.55 9.98 -0.31 -19.35 10.60 -1.25 coo 35.40 53.22 73.30 35.37 54.87 74.74 -12.05 10.45 0.78 -10.15 11.46 1.00 coo 45.08 56.04 70.60 43.15 55.19 70.77 -14.88 11.83 -9.39 -15.29 12.85 -11.20 1bsj_c00 source 1bsj PEPTIDE DEFORMYLASE : 7 hits 1bsj_c00 naa= 3 ULMN 3 1bu7_c02 CYTOCHROME P450 user 1 3 # 1 A 268 THR A 47 THR^? 22.10 N21 C2E A 301 A 393 PHE A 54 PHE^? 19.63 N21 C2E A 301 A 400 CYH A 56 CYH^? 16.49 N21 C2E A 301 coo 45.81 71.19 43.26 47.70 70.19 43.25 25.51 -12.99 8.45 26.36 -13.29 6.49 coo 48.54 63.17 48.16 46.74 64.99 49.22 19.69 -16.80 12.43 17.45 -17.09 14.05 coo 53.76 64.39 46.87 52.06 66.55 47.33 14.08 -15.43 10.17 15.14 -13.33 11.76 ULMN 3 1bu7_c02 CYTOCHROME P450 user 2 3 # 2 A 268 THR A 178 THR.? 17.14 O6 C2E A 301 A 393 PHE A 170 PHE^? 8.91 O6 C2E A 301 A 400 CYH A 158 CYH^? 12.92 O6 C2E A 301 coo 45.81 71.19 43.26 47.70 70.19 43.25 -9.47 -27.26 4.39 -8.59 -27.66 6.32 coo 48.54 63.17 48.16 46.74 64.99 49.22 -10.47 -19.67 -2.91 -9.94 -22.37 -2.52 coo 53.76 64.39 46.87 52.06 66.55 47.33 -15.53 -18.41 0.03 -15.42 -19.19 -2.71 ULMN 3 1bu7_c02 CYTOCHROME P450 user 3 3 # 3 A 268 THR A 203 THR^? 13.87 C1' C2E A 301 A 393 PHE A 170 PHE^? 8.91 O6 C2E A 301 A 400 CYH A 168 CYH^? -6.21 C2 C2E A 301s coo 45.81 71.19 43.26 47.70 70.19 43.25 -11.63 -25.21 -11.66 -12.74 -26.43 -13.05 coo 48.54 63.17 48.16 46.74 64.99 49.22 -10.47 -19.67 -2.91 -9.94 -22.37 -2.52 coo 53.76 64.39 46.87 52.06 66.55 47.33 -6.81 -16.95 -8.49 -9.12 -18.59 -8.00 ULMN 3 1bu7_c02 CYTOCHROME P450 user 4 3 # 4 A 268 THR B 47 THR^? 21.06 N21 C2E B 301 A 393 PHE B 54 PHE^? 17.95 N21 C2E B 301 A 400 CYH B 56 CYH^? 14.73 N21 C2E B 301 coo 45.81 71.19 43.26 47.70 70.19 43.25 -7.68 18.64 22.99 -9.83 18.75 22.86 coo 48.54 63.17 48.16 46.74 64.99 49.22 -1.86 22.37 18.66 0.47 22.95 17.25 coo 53.76 64.39 46.87 52.06 66.55 47.33 -0.90 19.58 13.61 0.17 17.94 15.62 ULMN 3 1bu7_c02 CYTOCHROME P450 user 5 3 # 5 A 268 THR B 178 THR.? 16.80 O6 C2E B 301 A 393 PHE B 170 PHE^? 8.84 O6 C2E B 301 A 400 CYH B 158 CYH^? 12.89 O6 C2E B 301 coo 45.81 71.19 43.26 47.70 70.19 43.25 6.21 26.30 -8.92 7.28 26.85 -7.15 coo 48.54 63.17 48.16 46.74 64.99 49.22 0.78 18.23 -12.65 0.68 20.98 -12.20 coo 53.76 64.39 46.87 52.06 66.55 47.33 5.78 17.15 -15.63 3.32 17.67 -16.92 ULMN 3 1bu7_c02 CYTOCHROME P450 user 6 3 # 6 A 268 THR B 203 THR^? 13.68 C1' C2E B 301 A 393 PHE B 170 PHE^? 8.84 O6 C2E B 301 A 400 CYH B 168 CYH^? -6.16 C2 C2E B 301s coo 45.81 71.19 43.26 47.70 70.19 43.25 -6.70 22.59 -18.31 -7.42 23.42 -20.17 coo 48.54 63.17 48.16 46.74 64.99 49.22 0.78 18.23 -12.65 0.68 20.98 -12.20 coo 53.76 64.39 46.87 52.06 66.55 47.33 -5.71 15.10 -12.03 -4.45 16.77 -13.95 1bu7_c02 source 1bu7 CYTOCHROME P450 : 6 hits 1bu7_c02 naa= 3 ULMN 3 1bu7_c03 CYTOCHROME P450 user 1 3 # 1 B 268 THR A 47 THR^? 22.10 N21 C2E A 301 B 393 PHE A 54 PHE^? 19.63 N21 C2E A 301 B 400 CYH A 56 CYH^? 16.49 N21 C2E A 301 coo 37.20 116.32 52.00 35.18 117.07 52.13 25.51 -12.99 8.45 26.36 -13.29 6.49 coo 33.81 121.65 59.26 35.49 119.55 59.81 19.69 -16.80 12.43 17.45 -17.09 14.05 coo 28.79 121.15 57.00 30.51 118.99 56.70 14.08 -15.43 10.17 15.14 -13.33 11.76 ULMN 3 1bu7_c03 CYTOCHROME P450 user 2 3 # 2 B 268 THR A 178 THR.? 17.14 O6 C2E A 301 B 393 PHE A 170 PHE^? 8.91 O6 C2E A 301 B 400 CYH A 158 CYH^? 12.92 O6 C2E A 301 coo 37.20 116.32 52.00 35.18 117.07 52.13 -9.47 -27.26 4.39 -8.59 -27.66 6.32 coo 33.81 121.65 59.26 35.49 119.55 59.81 -10.47 -19.67 -2.91 -9.94 -22.37 -2.52 coo 28.79 121.15 57.00 30.51 118.99 56.70 -15.53 -18.41 0.03 -15.42 -19.19 -2.71 ULMN 3 1bu7_c03 CYTOCHROME P450 user 3 3 # 3 B 268 THR A 203 THR^? 13.87 C1' C2E A 301 B 393 PHE A 170 PHE^? 8.91 O6 C2E A 301 B 400 CYH A 168 CYH^? -6.21 C2 C2E A 301s coo 37.20 116.32 52.00 35.18 117.07 52.13 -11.63 -25.21 -11.66 -12.74 -26.43 -13.05 coo 33.81 121.65 59.26 35.49 119.55 59.81 -10.47 -19.67 -2.91 -9.94 -22.37 -2.52 coo 28.79 121.15 57.00 30.51 118.99 56.70 -6.81 -16.95 -8.49 -9.12 -18.59 -8.00 ULMN 3 1bu7_c03 CYTOCHROME P450 user 4 3 # 4 B 268 THR B 47 THR^? 21.06 N21 C2E B 301 B 393 PHE B 54 PHE^? 17.95 N21 C2E B 301 B 400 CYH B 56 CYH^? 14.73 N21 C2E B 301 coo 37.20 116.32 52.00 35.18 117.07 52.13 -7.68 18.64 22.99 -9.83 18.75 22.86 coo 33.81 121.65 59.26 35.49 119.55 59.81 -1.86 22.37 18.66 0.47 22.95 17.25 coo 28.79 121.15 57.00 30.51 118.99 56.70 -0.90 19.58 13.61 0.17 17.94 15.62 ULMN 3 1bu7_c03 CYTOCHROME P450 user 5 3 # 5 B 268 THR B 178 THR.? 16.80 O6 C2E B 301 B 393 PHE B 170 PHE^? 8.84 O6 C2E B 301 B 400 CYH B 158 CYH^? 12.89 O6 C2E B 301 coo 37.20 116.32 52.00 35.18 117.07 52.13 6.21 26.30 -8.92 7.28 26.85 -7.15 coo 33.81 121.65 59.26 35.49 119.55 59.81 0.78 18.23 -12.65 0.68 20.98 -12.20 coo 28.79 121.15 57.00 30.51 118.99 56.70 5.78 17.15 -15.63 3.32 17.67 -16.92 ULMN 3 1bu7_c03 CYTOCHROME P450 user 6 3 # 6 B 268 THR B 203 THR^? 13.68 C1' C2E B 301 B 393 PHE B 170 PHE^? 8.84 O6 C2E B 301 B 400 CYH B 168 CYH^? -6.16 C2 C2E B 301s coo 37.20 116.32 52.00 35.18 117.07 52.13 -6.70 22.59 -18.31 -7.42 23.42 -20.17 coo 33.81 121.65 59.26 35.49 119.55 59.81 0.78 18.23 -12.65 0.68 20.98 -12.20 coo 28.79 121.15 57.00 30.51 118.99 56.70 -5.71 15.10 -12.03 -4.45 16.77 -13.95 1bu7_c03 source 1bu7 CYTOCHROME P450 : 6 hits 1bu7_c03 naa= 3 ULMN 3 1c54_c00 RIBONUCLEASE SA user 1 3 # 1 A 54 GLU A 159 GLU^? 13.73 O6 C2E A 301 A 65 ARG A 169 ARG^? -4.75 O6 C2E A 301s A 85 HIS A 215 HIS.? 12.12 O6 C2E A 301 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -14.60 -12.52 -1.04 -14.41 -10.88 0.31 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -8.99 -15.19 5.86 -7.58 -13.77 5.21 ULMN 3 1c54_c00 RIBONUCLEASE SA user 2 3 # 2 A 54 GLU A 159 GLU^? 13.73 O6 C2E A 301 A 65 ARG A 217 ARG^? 6.70 O6 C2E A 301 A 85 HIS A 215 HIS.? 12.12 O6 C2E A 301 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -14.60 -12.52 -1.04 -14.41 -10.88 0.31 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -3.36 -16.18 0.94 -0.54 -17.39 0.83 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -8.99 -15.19 5.86 -7.58 -13.77 5.21 ULMN 3 1c54_c00 RIBONUCLEASE SA user 3 3 # 3 A 54 GLU B 159 GLU^? 13.76 O6 C2E B 301 A 65 ARG B 169 ARG^? -4.70 O6 C2E B 301s A 85 HIS B 215 HIS.? 11.93 O6 C2E B 301 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 4.99 11.22 -14.77 6.30 9.86 -13.80 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 7.81 14.24 -7.06 6.68 12.76 -6.10 ULMN 3 1c54_c00 RIBONUCLEASE SA user 4 3 # 4 A 54 GLU B 159 GLU^? 13.76 O6 C2E B 301 A 65 ARG B 217 ARG^? 6.37 O6 C2E B 301 A 85 HIS B 215 HIS.? 11.93 O6 C2E B 301 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 4.99 11.22 -14.77 6.30 9.86 -13.80 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 0.82 15.44 -4.45 -0.87 16.78 -2.26 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 7.81 14.24 -7.06 6.68 12.76 -6.10 1c54_c00 source 1c54 RIBONUCLEASE SA : 4 hits 1c54_c00 naa= 3 ULMN 3 1cbg_c00 CYANOGENIC BETA-GLUCOSIDASE user 1 3 # 1 183 GLU A 224 GLU~? 15.93 O2' C2E A 301 324 ASN A 228 ASN~? 15.04 O2' C2E A 301 397 GLU A 225 GLU~? 17.61 C1' C2E A 301 coo 39.31 34.78 85.95 38.51 34.50 84.04 -8.40 -25.77 -21.72 -8.05 -26.98 -23.42 coo 43.16 34.25 82.88 42.98 32.71 84.39 -12.40 -21.37 -21.10 -11.00 -22.25 -22.44 coo 42.23 29.47 82.87 40.46 30.21 83.67 -14.07 -25.95 -18.02 -15.34 -27.27 -16.96 ULMN 3 1cbg_c00 CYANOGENIC BETA-GLUCOSIDASE user 2 3 # 2 183 GLU A 225 GLU~? 17.61 C1' C2E A 301 324 ASN A 228 ASN~? 15.04 O2' C2E A 301 397 GLU A 224 GLU~? 15.93 O2' C2E A 301 coo 39.31 34.78 85.95 38.51 34.50 84.04 -14.07 -25.95 -18.02 -15.34 -27.27 -16.96 coo 43.16 34.25 82.88 42.98 32.71 84.39 -12.40 -21.37 -21.10 -11.00 -22.25 -22.44 coo 42.23 29.47 82.87 40.46 30.21 83.67 -8.40 -25.77 -21.72 -8.05 -26.98 -23.42 ULMN 3 1cbg_c00 CYANOGENIC BETA-GLUCOSIDASE user 3 3 # 3 183 GLU B 224 GLU~? 16.79 O2' C2E B 301 324 ASN B 223 ASN~? 12.46 O4' C2E B 301 397 GLU B 225 GLU~? 17.01 C1' C2E B 301 coo 39.31 34.78 85.95 38.51 34.50 84.04 -16.80 22.93 -20.90 -17.88 24.32 -22.10 coo 43.16 34.25 82.88 42.98 32.71 84.39 -12.01 24.89 -16.85 -10.55 24.64 -18.38 coo 42.23 29.47 82.87 40.46 30.21 83.67 -10.33 22.86 -23.16 -8.91 24.36 -23.62 ULMN 3 1cbg_c00 CYANOGENIC BETA-GLUCOSIDASE user 4 3 # 4 183 GLU B 224 GLU~? 16.79 O2' C2E B 301 324 ASN B 228 ASN~? 15.22 O2' C2E B 301 397 GLU B 225 GLU~? 17.01 C1' C2E B 301 coo 39.31 34.78 85.95 38.51 34.50 84.04 -16.80 22.93 -20.90 -17.88 24.32 -22.10 coo 43.16 34.25 82.88 42.98 32.71 84.39 -14.11 18.31 -23.21 -16.11 19.01 -22.96 coo 42.23 29.47 82.87 40.46 30.21 83.67 -10.33 22.86 -23.16 -8.91 24.36 -23.62 ULMN 3 1cbg_c00 CYANOGENIC BETA-GLUCOSIDASE user 5 3 # 5 183 GLU B 225 GLU~? 17.01 C1' C2E B 301 324 ASN B 223 ASN~? 12.46 O4' C2E B 301 397 GLU B 224 GLU~? 16.79 O2' C2E B 301 coo 39.31 34.78 85.95 38.51 34.50 84.04 -10.33 22.86 -23.16 -8.91 24.36 -23.62 coo 43.16 34.25 82.88 42.98 32.71 84.39 -12.01 24.89 -16.85 -10.55 24.64 -18.38 coo 42.23 29.47 82.87 40.46 30.21 83.67 -16.80 22.93 -20.90 -17.88 24.32 -22.10 ULMN 3 1cbg_c00 CYANOGENIC BETA-GLUCOSIDASE user 6 3 # 6 183 GLU B 225 GLU~? 17.01 C1' C2E B 301 324 ASN B 228 ASN~? 15.22 O2' C2E B 301 397 GLU B 224 GLU~? 16.79 O2' C2E B 301 coo 39.31 34.78 85.95 38.51 34.50 84.04 -10.33 22.86 -23.16 -8.91 24.36 -23.62 coo 43.16 34.25 82.88 42.98 32.71 84.39 -14.11 18.31 -23.21 -16.11 19.01 -22.96 coo 42.23 29.47 82.87 40.46 30.21 83.67 -16.80 22.93 -20.90 -17.88 24.32 -22.10 1cbg_c00 source 1cbg CYANOGENIC BETA-GLUCOSIDASE : 6 hits 1cbg_c00 naa= 3 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 1 3 # 1 71 ARG A 136 ARG.? -3.92 O61 C2E A 301s 127 ARG A 140 ARG.? -3.36 C5 C2E A 301s 270 GLU A 37 GLU.? 10.20 O61 C2E A 301 coo -0.83 25.63 1.57 0.97 28.05 0.90 2.11 -12.17 -9.13 1.08 -10.80 -6.58 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 0.90 -3.13 0.80 -0.70 -4.43 0.36 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 2 3 # 2 71 ARG A 136 ARG.? -3.92 O61 C2E A 301s 127 ARG A 140 ARG.? -3.36 C5 C2E A 301s 270 GLU A 221 GLU^? -4.32 C4' C2E A 301s coo -0.83 25.63 1.57 0.97 28.05 0.90 2.11 -12.17 -9.13 1.08 -10.80 -6.58 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -2.05 -23.28 -12.44 -0.03 -23.89 -12.66 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 3 3 # 3 71 ARG A 140 ARG.? -3.36 C5 C2E A 301s 127 ARG A 136 ARG.? -3.92 O61 C2E A 301s 270 GLU A 37 GLU.? 10.20 O61 C2E A 301 coo -0.83 25.63 1.57 0.97 28.05 0.90 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 2.11 -12.17 -9.13 1.08 -10.80 -6.58 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 0.90 -3.13 0.80 -0.70 -4.43 0.36 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 4 3 # 4 71 ARG A 140 ARG.? -3.36 C5 C2E A 301s 127 ARG A 136 ARG.? -3.92 O61 C2E A 301s 270 GLU A 221 GLU^? -4.32 C4' C2E A 301s coo -0.83 25.63 1.57 0.97 28.05 0.90 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 2.11 -12.17 -9.13 1.08 -10.80 -6.58 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -2.05 -23.28 -12.44 -0.03 -23.89 -12.66 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 5 3 # 5 71 ARG A 140 ARG.? -3.36 C5 C2E A 301s 127 ARG A 169 ARG^? -4.75 O6 C2E A 301s 270 GLU A 37 GLU.? 10.20 O61 C2E A 301 coo -0.83 25.63 1.57 0.97 28.05 0.90 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 0.90 -3.13 0.80 -0.70 -4.43 0.36 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 6 3 # 6 71 ARG A 140 ARG.? -3.36 C5 C2E A 301s 127 ARG A 169 ARG^? -4.75 O6 C2E A 301s 270 GLU A 221 GLU^? -4.32 C4' C2E A 301s coo -0.83 25.63 1.57 0.97 28.05 0.90 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -2.05 -23.28 -12.44 -0.03 -23.89 -12.66 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 7 3 # 7 71 ARG A 161 ARG^? 11.81 O6 C2E A 301 127 ARG A 169 ARG^? -4.75 O6 C2E A 301s 270 GLU A 37 GLU.? 10.20 O61 C2E A 301 coo -0.83 25.63 1.57 0.97 28.05 0.90 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 0.90 -3.13 0.80 -0.70 -4.43 0.36 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 8 3 # 8 71 ARG A 169 ARG^? -4.75 O6 C2E A 301s 127 ARG A 140 ARG.? -3.36 C5 C2E A 301s 270 GLU A 37 GLU.? 10.20 O61 C2E A 301 coo -0.83 25.63 1.57 0.97 28.05 0.90 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 0.90 -3.13 0.80 -0.70 -4.43 0.36 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 9 3 # 9 71 ARG A 169 ARG^? -4.75 O6 C2E A 301s 127 ARG A 140 ARG.? -3.36 C5 C2E A 301s 270 GLU A 221 GLU^? -4.32 C4' C2E A 301s coo -0.83 25.63 1.57 0.97 28.05 0.90 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -2.05 -23.28 -12.44 -0.03 -23.89 -12.66 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 10 3 # 10 71 ARG A 169 ARG^? -4.75 O6 C2E A 301s 127 ARG A 161 ARG^? 11.81 O6 C2E A 301 270 GLU A 37 GLU.? 10.20 O61 C2E A 301 coo -0.83 25.63 1.57 0.97 28.05 0.90 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 0.90 -3.13 0.80 -0.70 -4.43 0.36 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 11 3 # 11 71 ARG A 169 ARG^? -4.75 O6 C2E A 301s 127 ARG A 217 ARG^? 6.70 O6 C2E A 301 270 GLU A 37 GLU.? 10.20 O61 C2E A 301 coo -0.83 25.63 1.57 0.97 28.05 0.90 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -3.36 -16.18 0.94 -0.54 -17.39 0.83 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 0.90 -3.13 0.80 -0.70 -4.43 0.36 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 12 3 # 12 71 ARG A 217 ARG^? 6.70 O6 C2E A 301 127 ARG A 169 ARG^? -4.75 O6 C2E A 301s 270 GLU A 37 GLU.? 10.20 O61 C2E A 301 coo -0.83 25.63 1.57 0.97 28.05 0.90 -3.36 -16.18 0.94 -0.54 -17.39 0.83 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 0.90 -3.13 0.80 -0.70 -4.43 0.36 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 13 3 # 13 71 ARG B 136 ARG.? -3.89 O61 C2E B 301s 127 ARG B 140 ARG.? -3.40 C5 C2E B 301s 270 GLU B 37 GLU.? 9.39 O61 C2E B 301 coo -0.83 25.63 1.57 0.97 28.05 0.90 -10.39 10.75 -3.93 -7.55 9.68 -3.54 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -7.91 11.52 -6.78 -7.96 14.04 -5.01 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -0.62 3.88 0.75 -0.32 4.81 -1.12 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 14 3 # 14 71 ARG B 136 ARG.? -3.89 O61 C2E B 301s 127 ARG B 140 ARG.? -3.40 C5 C2E B 301s 270 GLU B 221 GLU^? -4.05 C4' C2E B 301s coo -0.83 25.63 1.57 0.97 28.05 0.90 -10.39 10.75 -3.93 -7.55 9.68 -3.54 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -7.91 11.52 -6.78 -7.96 14.04 -5.01 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -11.86 21.10 -10.14 -13.00 21.71 -8.45 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 15 3 # 15 71 ARG B 140 ARG.? -3.40 C5 C2E B 301s 127 ARG B 136 ARG.? -3.89 O61 C2E B 301s 270 GLU B 37 GLU.? 9.39 O61 C2E B 301 coo -0.83 25.63 1.57 0.97 28.05 0.90 -7.91 11.52 -6.78 -7.96 14.04 -5.01 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -10.39 10.75 -3.93 -7.55 9.68 -3.54 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -0.62 3.88 0.75 -0.32 4.81 -1.12 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 16 3 # 16 71 ARG B 140 ARG.? -3.40 C5 C2E B 301s 127 ARG B 169 ARG^? -4.70 O6 C2E B 301s 270 GLU B 37 GLU.? 9.39 O61 C2E B 301 coo -0.83 25.63 1.57 0.97 28.05 0.90 -7.91 11.52 -6.78 -7.96 14.04 -5.01 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -0.62 3.88 0.75 -0.32 4.81 -1.12 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 17 3 # 17 71 ARG B 161 ARG^? 11.68 O6 C2E B 301 127 ARG B 169 ARG^? -4.70 O6 C2E B 301s 270 GLU B 37 GLU.? 9.39 O61 C2E B 301 coo -0.83 25.63 1.57 0.97 28.05 0.90 2.96 9.64 -10.71 5.59 9.57 -9.11 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -0.62 3.88 0.75 -0.32 4.81 -1.12 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 18 3 # 18 71 ARG B 169 ARG^? -4.70 O6 C2E B 301s 127 ARG B 140 ARG.? -3.40 C5 C2E B 301s 270 GLU B 37 GLU.? 9.39 O61 C2E B 301 coo -0.83 25.63 1.57 0.97 28.05 0.90 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -7.91 11.52 -6.78 -7.96 14.04 -5.01 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -0.62 3.88 0.75 -0.32 4.81 -1.12 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 19 3 # 19 71 ARG B 169 ARG^? -4.70 O6 C2E B 301s 127 ARG B 140 ARG.? -3.40 C5 C2E B 301s 270 GLU B 221 GLU^? -4.05 C4' C2E B 301s coo -0.83 25.63 1.57 0.97 28.05 0.90 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -7.91 11.52 -6.78 -7.96 14.04 -5.01 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -11.86 21.10 -10.14 -13.00 21.71 -8.45 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 20 3 # 20 71 ARG B 169 ARG^? -4.70 O6 C2E B 301s 127 ARG B 161 ARG^? 11.68 O6 C2E B 301 270 GLU B 37 GLU.? 9.39 O61 C2E B 301 coo -0.83 25.63 1.57 0.97 28.05 0.90 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 2.96 9.64 -10.71 5.59 9.57 -9.11 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -0.62 3.88 0.75 -0.32 4.81 -1.12 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 21 3 # 21 71 ARG B 169 ARG^? -4.70 O6 C2E B 301s 127 ARG B 217 ARG^? 6.37 O6 C2E B 301 270 GLU B 37 GLU.? 9.39 O61 C2E B 301 coo -0.83 25.63 1.57 0.97 28.05 0.90 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 0.82 15.44 -4.45 -0.87 16.78 -2.26 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -0.62 3.88 0.75 -0.32 4.81 -1.12 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 22 3 # 22 71 ARG B 169 ARG^? -4.70 O6 C2E B 301s 127 ARG B 217 ARG^? 6.37 O6 C2E B 301 270 GLU B 41 GLU^? 7.72 N21 C2E B 301 coo -0.83 25.63 1.57 0.97 28.05 0.90 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 0.82 15.44 -4.45 -0.87 16.78 -2.26 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 0.46 14.98 6.85 0.80 16.86 5.93 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 23 3 # 23 71 ARG B 217 ARG^? 6.37 O6 C2E B 301 127 ARG B 169 ARG^? -4.70 O6 C2E B 301s 270 GLU B 37 GLU.? 9.39 O61 C2E B 301 coo -0.83 25.63 1.57 0.97 28.05 0.90 0.82 15.44 -4.45 -0.87 16.78 -2.26 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -0.62 3.88 0.75 -0.32 4.81 -1.12 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 24 3 # 24 71 ARG B 217 ARG^? 6.37 O6 C2E B 301 127 ARG B 169 ARG^? -4.70 O6 C2E B 301s 270 GLU B 41 GLU^? 7.72 N21 C2E B 301 coo -0.83 25.63 1.57 0.97 28.05 0.90 0.82 15.44 -4.45 -0.87 16.78 -2.26 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 0.46 14.98 6.85 0.80 16.86 5.93 1cbx_c01 source 1cbx CARBOXYPEPTIDASE A (E.C.3.4.17.1) COMPLEX WITH: 24 hits 1cbx_c01 naa= 3 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP A 31 ASP~? 17.49 O6 C2E B 301 264 GLU B 41 GLU^? 7.72 N21 C2E B 301 328 ASP A 66 ASP.? 23.33 N21 C2E B 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 10.86 4.60 -5.63 10.78 6.65 -6.14 coo 59.69 92.71 39.85 58.53 92.03 41.47 0.46 14.98 6.85 0.80 16.86 5.93 coo 45.39 90.72 40.63 45.07 89.14 41.90 15.60 9.37 4.44 16.85 10.89 5.23 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP A 66 ASP.? 23.33 N21 C2E B 301 264 GLU A 37 GLU.? 10.20 O61 C2E A 301 328 ASP A 31 ASP~? 17.49 O6 C2E B 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 15.60 9.37 4.44 16.85 10.89 5.23 coo 59.69 92.71 39.85 58.53 92.03 41.47 0.90 -3.13 0.80 -0.70 -4.43 0.36 coo 45.39 90.72 40.63 45.07 89.14 41.90 10.86 4.60 -5.63 10.78 6.65 -6.14 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 3 3 # 3 229 ASP A 66 ASP.? 23.33 N21 C2E B 301 264 GLU B 37 GLU.? 9.39 O61 C2E B 301 328 ASP A 31 ASP~? 17.49 O6 C2E B 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 15.60 9.37 4.44 16.85 10.89 5.23 coo 59.69 92.71 39.85 58.53 92.03 41.47 -0.62 3.88 0.75 -0.32 4.81 -1.12 coo 45.39 90.72 40.63 45.07 89.14 41.90 10.86 4.60 -5.63 10.78 6.65 -6.14 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 4 3 # 4 229 ASP A 152 ASP.? 20.83 C8 C2E A 301 264 GLU A 221 GLU^? -4.32 C4' C2E A 301s 328 ASP A 183 ASP.? 14.57 O1P C2E A 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo 59.69 92.71 39.85 58.53 92.03 41.47 -2.05 -23.28 -12.44 -0.03 -23.89 -12.66 coo 45.39 90.72 40.63 45.07 89.14 41.90 -7.06 -30.30 -3.03 -6.77 -31.63 -1.43 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 5 3 # 5 229 ASP B 31 ASP~? 18.26 O6 C2E A 301 264 GLU A 41 GLU^? 8.66 N21 C2E A 301 328 ASP B 66 ASP.? 24.37 N21 C2E A 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 -9.76 -4.11 8.16 -9.75 -6.21 8.42 coo 59.69 92.71 39.85 58.53 92.03 41.47 7.09 -12.35 6.79 6.46 -14.38 6.77 coo 45.39 90.72 40.63 45.07 89.14 41.90 -3.12 -5.44 17.43 -2.91 -6.73 19.08 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 6 3 # 6 229 ASP B 66 ASP.? 24.37 N21 C2E A 301 264 GLU A 37 GLU.? 10.20 O61 C2E A 301 328 ASP B 31 ASP~? 18.26 O6 C2E A 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 -3.12 -5.44 17.43 -2.91 -6.73 19.08 coo 59.69 92.71 39.85 58.53 92.03 41.47 0.90 -3.13 0.80 -0.70 -4.43 0.36 coo 45.39 90.72 40.63 45.07 89.14 41.90 -9.76 -4.11 8.16 -9.75 -6.21 8.42 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 7 3 # 7 229 ASP B 66 ASP.? 24.37 N21 C2E A 301 264 GLU B 37 GLU.? 9.39 O61 C2E B 301 328 ASP B 31 ASP~? 18.26 O6 C2E A 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 -3.12 -5.44 17.43 -2.91 -6.73 19.08 coo 59.69 92.71 39.85 58.53 92.03 41.47 -0.62 3.88 0.75 -0.32 4.81 -1.12 coo 45.39 90.72 40.63 45.07 89.14 41.90 -9.76 -4.11 8.16 -9.75 -6.21 8.42 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 8 3 # 8 229 ASP B 152 ASP.? 19.99 C8 C2E B 301 264 GLU B 221 GLU^? -4.05 C4' C2E B 301s 328 ASP B 183 ASP.? 14.33 O1P C2E B 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 2.18 32.86 -17.28 0.63 33.43 -15.93 coo 59.69 92.71 39.85 58.53 92.03 41.47 -11.86 21.10 -10.14 -13.00 21.71 -8.45 coo 45.39 90.72 40.63 45.07 89.14 41.90 -1.79 28.84 -10.63 -0.66 30.31 -9.57 1cdg_c00 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 8 hits 1cdg_c00 naa= 3 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 A 198 GLY A 167 GLY^? -3.74 N3 C2E A 301s A 228 SER A 164 SER.? -3.07 N2 C2E A 301s A 549 ASP A 162 ASP^? -3.09 N1 C2E A 301s coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -5.31 -18.58 -11.54 -5.51 -17.84 -11.78 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 A 198 GLY B 167 GLY^? -3.69 N3 C2E B 301s A 228 SER B 164 SER.? -3.05 N2 C2E B 301s A 549 ASP B 162 ASP^? -3.04 N1 C2E B 301s coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -9.22 16.51 -12.20 -9.30 15.75 -12.43 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -10.30 11.42 -12.93 -10.44 13.17 -11.24 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -3.96 9.86 -10.13 -4.46 11.57 -9.02 1cjy_c00 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 2 hits 1cjy_c00 naa= 3 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 B1198 GLY A 167 GLY^? -3.74 N3 C2E A 301s B1228 SER A 164 SER.? -3.07 N2 C2E A 301s B1549 ASP A 162 ASP^? -3.09 N1 C2E A 301s coo 126.34 72.75 125.66 125.95 73.27 126.11 -5.31 -18.58 -11.54 -5.51 -17.84 -11.78 coo 131.65 74.68 129.41 130.31 72.73 128.82 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 coo 134.72 69.43 130.42 133.03 70.65 130.08 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 B1198 GLY B 167 GLY^? -3.69 N3 C2E B 301s B1228 SER B 164 SER.? -3.05 N2 C2E B 301s B1549 ASP B 162 ASP^? -3.04 N1 C2E B 301s coo 126.34 72.75 125.66 125.95 73.27 126.11 -9.22 16.51 -12.20 -9.30 15.75 -12.43 coo 131.65 74.68 129.41 130.31 72.73 128.82 -10.30 11.42 -12.93 -10.44 13.17 -11.24 coo 134.72 69.43 130.42 133.03 70.65 130.08 -3.96 9.86 -10.13 -4.46 11.57 -9.02 1cjy_c01 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 2 hits 1cjy_c01 naa= 3 ULMN 3 1cns_c00 CHITINASE user 1 3 # 1 A 67 GLU A 41 GLU^? 8.66 N21 C2E A 301 A 89 GLU A 37 GLU.? 10.20 O61 C2E A 301 A 120 SER A 39 SER.? 16.45 O61 C2E A 301 coo -24.35 9.53 67.64 -25.07 11.29 68.60 7.09 -12.35 6.79 6.46 -14.38 6.77 coo -31.18 6.91 75.60 -32.39 8.51 74.91 0.90 -3.13 0.80 -0.70 -4.43 0.36 coo -34.73 8.57 68.21 -33.63 9.08 70.28 2.88 -4.86 8.38 1.14 -3.61 9.53 ULMN 3 1cns_c00 CHITINASE user 2 3 # 2 A 67 GLU A 41 GLU^? 8.66 N21 C2E A 301 A 89 GLU A 37 GLU.? 10.20 O61 C2E A 301 A 120 SER A 97 SER^? 9.23 O61 C2E A 301 coo -24.35 9.53 67.64 -25.07 11.29 68.60 7.09 -12.35 6.79 6.46 -14.38 6.77 coo -31.18 6.91 75.60 -32.39 8.51 74.91 0.90 -3.13 0.80 -0.70 -4.43 0.36 coo -34.73 8.57 68.21 -33.63 9.08 70.28 5.13 -5.92 -3.45 4.74 -3.92 -4.71 ULMN 3 1cns_c00 CHITINASE user 3 3 # 3 A 67 GLU A 41 GLU^? 8.66 N21 C2E A 301 A 89 GLU A 72 GLU^? 18.63 N21 C2E A 301 A 120 SER A 39 SER.? 16.45 O61 C2E A 301 coo -24.35 9.53 67.64 -25.07 11.29 68.60 7.09 -12.35 6.79 6.46 -14.38 6.77 coo -31.18 6.91 75.60 -32.39 8.51 74.91 6.69 -5.58 14.73 4.83 -6.56 14.45 coo -34.73 8.57 68.21 -33.63 9.08 70.28 2.88 -4.86 8.38 1.14 -3.61 9.53 ULMN 3 1cns_c00 CHITINASE user 4 3 # 4 A 67 GLU A 142 GLU^? 10.87 N1 C2E A 301 A 89 GLU A 37 GLU.? 10.20 O61 C2E A 301 A 120 SER A 97 SER^? 9.23 O61 C2E A 301 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -5.78 -6.60 -5.54 -5.25 -5.49 -3.81 coo -31.18 6.91 75.60 -32.39 8.51 74.91 0.90 -3.13 0.80 -0.70 -4.43 0.36 coo -34.73 8.57 68.21 -33.63 9.08 70.28 5.13 -5.92 -3.45 4.74 -3.92 -4.71 ULMN 3 1cns_c00 CHITINASE user 5 3 # 5 A 67 GLU A 142 GLU^? 10.87 N1 C2E A 301 A 89 GLU A 101 GLU.? 9.39 O11 C2E A 301 A 120 SER A 164 SER.? -3.07 N2 C2E A 301s coo -24.35 9.53 67.64 -25.07 11.29 68.60 -5.78 -6.60 -5.54 -5.25 -5.49 -3.81 coo -31.18 6.91 75.60 -32.39 8.51 74.91 2.77 -8.35 -14.05 3.97 -7.83 -15.72 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 ULMN 3 1cns_c00 CHITINASE user 6 3 # 6 A 67 GLU B 41 GLU^? 7.72 N21 C2E B 301 A 89 GLU B 37 GLU.? 9.39 O61 C2E B 301 A 120 SER B 39 SER.? 15.26 O61 C2E B 301 coo -24.35 9.53 67.64 -25.07 11.29 68.60 0.46 14.98 6.85 0.80 16.86 5.93 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -0.62 3.88 0.75 -0.32 4.81 -1.12 coo -34.73 8.57 68.21 -33.63 9.08 70.28 4.72 7.48 5.49 6.81 6.45 4.77 ULMN 3 1cns_c00 CHITINASE user 7 3 # 7 A 67 GLU B 41 GLU^? 7.72 N21 C2E B 301 A 89 GLU B 72 GLU^? 16.96 N21 C2E B 301 A 120 SER B 39 SER.? 15.26 O61 C2E B 301 coo -24.35 9.53 67.64 -25.07 11.29 68.60 0.46 14.98 6.85 0.80 16.86 5.93 coo -31.18 6.91 75.60 -32.39 8.51 74.91 8.42 10.26 11.58 8.84 10.78 9.58 coo -34.73 8.57 68.21 -33.63 9.08 70.28 4.72 7.48 5.49 6.81 6.45 4.77 ULMN 3 1cns_c00 CHITINASE user 8 3 # 8 A 67 GLU B 142 GLU^? 10.78 N1 C2E B 301 A 89 GLU B 37 GLU.? 9.39 O61 C2E B 301 A 120 SER B 97 SER^? 9.09 O61 C2E B 301 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -2.97 5.35 -8.71 -1.84 4.27 -7.29 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -0.62 3.88 0.75 -0.32 4.81 -1.12 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -6.95 5.73 2.13 -8.07 3.68 1.50 ULMN 3 1cns_c00 CHITINASE user 9 3 # 9 A 67 GLU B 142 GLU^? 10.78 N1 C2E B 301 A 89 GLU B 101 GLU.? 9.43 O11 C2E B 301 A 120 SER B 164 SER.? -3.05 N2 C2E B 301s coo -24.35 9.53 67.64 -25.07 11.29 68.60 -2.97 5.35 -8.71 -1.84 4.27 -7.29 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -14.64 6.09 -5.71 -16.72 5.82 -5.44 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -10.30 11.42 -12.93 -10.44 13.17 -11.24 1cns_c00 source 1cns CHITINASE : 9 hits 1cns_c00 naa= 3 ULMN 3 1cns_c01 CHITINASE user 1 3 # 1 B 67 GLU A 101 GLU.? 9.39 O11 C2E A 301 B 89 GLU A 142 GLU^? 10.87 N1 C2E A 301 B 120 SER A 164 SER.? -3.07 N2 C2E A 301s coo 9.89 -17.65 45.79 9.28 -17.39 43.77 2.77 -8.35 -14.05 3.97 -7.83 -15.72 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -5.78 -6.60 -5.54 -5.25 -5.49 -3.81 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 ULMN 3 1cns_c01 CHITINASE user 2 3 # 2 B 67 GLU A 142 GLU^? 10.87 N1 C2E A 301 B 89 GLU A 101 GLU.? 9.39 O11 C2E A 301 B 120 SER A 164 SER.? -3.07 N2 C2E A 301s coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -5.78 -6.60 -5.54 -5.25 -5.49 -3.81 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 2.77 -8.35 -14.05 3.97 -7.83 -15.72 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 ULMN 3 1cns_c01 CHITINASE user 3 3 # 3 B 67 GLU B 101 GLU.? 9.43 O11 C2E B 301 B 89 GLU B 142 GLU^? 10.78 N1 C2E B 301 B 120 SER B 164 SER.? -3.05 N2 C2E B 301s coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -14.64 6.09 -5.71 -16.72 5.82 -5.44 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -2.97 5.35 -8.71 -1.84 4.27 -7.29 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -10.30 11.42 -12.93 -10.44 13.17 -11.24 ULMN 3 1cns_c01 CHITINASE user 4 3 # 4 B 67 GLU B 142 GLU^? 10.78 N1 C2E B 301 B 89 GLU B 101 GLU.? 9.43 O11 C2E B 301 B 120 SER B 164 SER.? -3.05 N2 C2E B 301s coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -2.97 5.35 -8.71 -1.84 4.27 -7.29 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -14.64 6.09 -5.71 -16.72 5.82 -5.44 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -10.30 11.42 -12.93 -10.44 13.17 -11.24 1cns_c01 source 1cns CHITINASE : 4 hits 1cns_c01 naa= 3 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 101 TYR A 218 TYR^? 10.22 O6 C2E A 301 A 173 ASP A 183 ASP.? 14.57 O1P C2E A 301 C 48 ARG A 169 ARG^? -4.75 O6 C2E A 301s coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -6.98 -22.32 0.01 -7.64 -23.76 2.29 coo 24.35 4.55 25.11 25.94 3.23 25.53 -7.06 -30.30 -3.03 -6.77 -31.63 -1.43 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 101 TYR A 218 TYR^? 10.22 O6 C2E A 301 A 173 ASP A 183 ASP.? 14.57 O1P C2E A 301 C 48 ARG A 211 ARG^? 16.62 O6 C2E A 301 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -6.98 -22.32 0.01 -7.64 -23.76 2.29 coo 24.35 4.55 25.11 25.94 3.23 25.53 -7.06 -30.30 -3.03 -6.77 -31.63 -1.43 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -4.93 -23.64 8.57 -7.93 -23.17 9.07 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 101 TYR B 218 TYR^? 10.08 O6 C2E B 301 A 173 ASP B 183 ASP.? 14.33 O1P C2E B 301 C 48 ARG B 169 ARG^? -4.70 O6 C2E B 301s coo 25.00 -3.03 25.68 27.14 -4.51 26.75 1.42 21.23 -8.42 3.73 22.73 -7.99 coo 24.35 4.55 25.11 25.94 3.23 25.53 -1.79 28.84 -10.63 -0.66 30.31 -9.57 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -0.88 13.03 -7.12 -1.56 12.92 -4.13 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 101 TYR B 218 TYR^? 10.08 O6 C2E B 301 A 173 ASP B 183 ASP.? 14.33 O1P C2E B 301 C 48 ARG B 211 ARG^? 16.78 O6 C2E B 301 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 1.42 21.23 -8.42 3.73 22.73 -7.99 coo 24.35 4.55 25.11 25.94 3.23 25.53 -1.79 28.84 -10.63 -0.66 30.31 -9.57 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 8.09 22.99 -2.57 10.13 22.73 -4.88 1cs1_c00 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1cs1_c00 naa= 3 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 48 ARG A 211 ARG^? 16.62 O6 C2E A 301 C 101 TYR A 218 TYR^? 10.22 O6 C2E A 301 C 173 ASP A 183 ASP.? 14.57 O1P C2E A 301 coo 32.27 5.62 48.15 31.93 6.48 51.06 -4.93 -23.64 8.57 -7.93 -23.17 9.07 coo 29.64 3.64 57.39 31.22 5.14 55.65 -6.98 -22.32 0.01 -7.64 -23.76 2.29 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -7.06 -30.30 -3.03 -6.77 -31.63 -1.43 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 48 ARG B 211 ARG^? 16.78 O6 C2E B 301 C 101 TYR B 218 TYR^? 10.08 O6 C2E B 301 C 173 ASP B 183 ASP.? 14.33 O1P C2E B 301 coo 32.27 5.62 48.15 31.93 6.48 51.06 8.09 22.99 -2.57 10.13 22.73 -4.88 coo 29.64 3.64 57.39 31.22 5.14 55.65 1.42 21.23 -8.42 3.73 22.73 -7.99 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -1.79 28.84 -10.63 -0.66 30.31 -9.57 1cs1_c01 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c01 naa= 3 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 48 ARG A 211 ARG^? 16.62 O6 C2E A 301 D 101 TYR A 218 TYR^? 10.22 O6 C2E A 301 D 173 ASP A 183 ASP.? 14.57 O1P C2E A 301 coo 69.08 8.58 32.60 69.70 10.81 30.58 -4.93 -23.64 8.57 -7.93 -23.17 9.07 coo 71.77 11.86 24.26 70.23 12.22 26.56 -6.98 -22.32 0.01 -7.64 -23.76 2.29 coo 71.60 6.14 19.25 70.26 6.87 20.69 -7.06 -30.30 -3.03 -6.77 -31.63 -1.43 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 48 ARG B 211 ARG^? 16.78 O6 C2E B 301 D 101 TYR B 218 TYR^? 10.08 O6 C2E B 301 D 173 ASP B 183 ASP.? 14.33 O1P C2E B 301 coo 69.08 8.58 32.60 69.70 10.81 30.58 8.09 22.99 -2.57 10.13 22.73 -4.88 coo 71.77 11.86 24.26 70.23 12.22 26.56 1.42 21.23 -8.42 3.73 22.73 -7.99 coo 71.60 6.14 19.25 70.26 6.87 20.69 -1.79 28.84 -10.63 -0.66 30.31 -9.57 1cs1_c02 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c02 naa= 3 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 101 TYR A 218 TYR^? 10.22 O6 C2E A 301 B 173 ASP A 183 ASP.? 14.57 O1P C2E A 301 D 48 ARG A 211 ARG^? 16.62 O6 C2E A 301 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -6.98 -22.32 0.01 -7.64 -23.76 2.29 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -7.06 -30.30 -3.03 -6.77 -31.63 -1.43 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -4.93 -23.64 8.57 -7.93 -23.17 9.07 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 101 TYR B 218 TYR^? 10.08 O6 C2E B 301 B 173 ASP B 183 ASP.? 14.33 O1P C2E B 301 D 48 ARG B 211 ARG^? 16.78 O6 C2E B 301 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 1.42 21.23 -8.42 3.73 22.73 -7.99 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -1.79 28.84 -10.63 -0.66 30.31 -9.57 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 8.09 22.99 -2.57 10.13 22.73 -4.88 1cs1_c03 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c03 naa= 3 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 1 3 # 1 A 1 ALA A 230 ALA~? 8.84 N2 C2E A 301 A 74 ASN A 229 ASN~? 15.85 N2 C2E A 301 A 75 GLY A 226 GLY~? 11.67 C1' C2E A 301 coo -1.80 62.71 122.76 -1.88 63.70 123.92 -11.86 -16.98 -15.84 -10.42 -17.26 -15.41 coo 1.20 66.40 122.20 2.03 64.53 121.46 -14.86 -20.46 -16.50 -16.06 -21.98 -17.43 coo 4.68 65.84 125.52 4.11 65.60 126.05 -10.93 -22.84 -15.51 -10.72 -22.76 -16.32 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 2 3 # 2 A 1 ALA B 230 ALA~? 8.79 N2 C2E B 301 A 74 ASN B 229 ASN~? 15.65 N2 C2E B 301 A 75 GLY B 226 GLY~? 11.47 O2' C2E B 301 coo -1.80 62.71 122.76 -1.88 63.70 123.92 -9.83 14.28 -19.75 -10.16 14.73 -18.33 coo 1.20 66.40 122.20 2.03 64.53 121.46 -8.99 17.44 -22.98 -9.26 18.88 -24.54 coo 4.68 65.84 125.52 4.11 65.60 126.05 -10.34 20.15 -19.24 -11.11 20.04 -19.49 1ct9_c04 source 1ct9 ASPARAGINE SYNTHETASE B : 2 hits 1ct9_c04 naa= 3 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 1 3 # 1 B 1 ALA A 230 ALA~? 8.84 N2 C2E A 301 B 74 ASN A 229 ASN~? 15.85 N2 C2E A 301 B 75 GLY A 226 GLY~? 11.67 C1' C2E A 301 coo 39.21 14.97 27.55 40.19 16.01 27.08 -11.86 -16.98 -15.84 -10.42 -17.26 -15.41 coo 43.06 12.94 25.74 42.26 11.81 27.44 -14.86 -20.46 -16.50 -16.06 -21.98 -17.43 coo 46.38 13.54 29.18 46.14 14.29 29.26 -10.93 -22.84 -15.51 -10.72 -22.76 -16.32 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 2 3 # 2 B 1 ALA B 230 ALA~? 8.79 N2 C2E B 301 B 74 ASN B 229 ASN~? 15.65 N2 C2E B 301 B 75 GLY B 226 GLY~? 11.47 O2' C2E B 301 coo 39.21 14.97 27.55 40.19 16.01 27.08 -9.83 14.28 -19.75 -10.16 14.73 -18.33 coo 43.06 12.94 25.74 42.26 11.81 27.44 -8.99 17.44 -22.98 -9.26 18.88 -24.54 coo 46.38 13.54 29.18 46.14 14.29 29.26 -10.34 20.15 -19.24 -11.11 20.04 -19.49 1ct9_c05 source 1ct9 ASPARAGINE SYNTHETASE B : 2 hits 1ct9_c05 naa= 3 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 1 3 # 1 C 1 ALA A 230 ALA~? 8.84 N2 C2E A 301 C 74 ASN A 229 ASN~? 15.85 N2 C2E A 301 C 75 GLY A 226 GLY~? 11.67 C1' C2E A 301 coo 16.14 15.08 36.63 15.28 14.65 37.81 -11.86 -16.98 -15.84 -10.42 -17.26 -15.41 coo 11.60 16.13 36.70 12.80 17.74 35.96 -14.86 -20.46 -16.50 -16.06 -21.98 -17.43 coo 10.99 19.23 40.32 11.50 18.77 40.74 -10.93 -22.84 -15.51 -10.72 -22.76 -16.32 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 2 3 # 2 C 1 ALA B 230 ALA~? 8.79 N2 C2E B 301 C 74 ASN B 229 ASN~? 15.65 N2 C2E B 301 C 75 GLY B 226 GLY~? 11.47 O2' C2E B 301 coo 16.14 15.08 36.63 15.28 14.65 37.81 -9.83 14.28 -19.75 -10.16 14.73 -18.33 coo 11.60 16.13 36.70 12.80 17.74 35.96 -8.99 17.44 -22.98 -9.26 18.88 -24.54 coo 10.99 19.23 40.32 11.50 18.77 40.74 -10.34 20.15 -19.24 -11.11 20.04 -19.49 1ct9_c06 source 1ct9 ASPARAGINE SYNTHETASE B : 2 hits 1ct9_c06 naa= 3 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 1 3 # 1 D 1 ALA A 230 ALA~? 8.84 N2 C2E A 301 D 74 ASN A 229 ASN~? 15.85 N2 C2E A 301 D 75 GLY A 226 GLY~? 11.67 C1' C2E A 301 coo -13.31 41.90 116.45 -13.05 40.39 116.25 -11.86 -16.98 -15.84 -10.42 -17.26 -15.41 coo -16.85 39.36 115.26 -17.55 40.58 116.90 -14.86 -20.46 -16.50 -16.06 -21.98 -17.43 coo -17.65 36.37 119.00 -16.85 36.22 119.00 -10.93 -22.84 -15.51 -10.72 -22.76 -16.32 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 2 3 # 2 D 1 ALA B 230 ALA~? 8.79 N2 C2E B 301 D 74 ASN B 229 ASN~? 15.65 N2 C2E B 301 D 75 GLY B 226 GLY~? 11.47 O2' C2E B 301 coo -13.31 41.90 116.45 -13.05 40.39 116.25 -9.83 14.28 -19.75 -10.16 14.73 -18.33 coo -16.85 39.36 115.26 -17.55 40.58 116.90 -8.99 17.44 -22.98 -9.26 18.88 -24.54 coo -17.65 36.37 119.00 -16.85 36.22 119.00 -10.34 20.15 -19.24 -11.11 20.04 -19.49 1ct9_c07 source 1ct9 ASPARAGINE SYNTHETASE B : 2 hits 1ct9_c07 naa= 3 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 1 3 # 1 A 37 ASP A 152 ASP.? 20.83 C8 C2E A 301 A 56 ILE A 206 ILE^? 8.52 N7 C2E A 301 A 82 TYR A 179 TYR.? 13.95 N7 C2E A 301 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -4.69 -26.11 -3.54 -5.49 -25.03 -2.91 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 2 3 # 2 A 37 ASP B 152 ASP.? 19.99 C8 C2E B 301 A 56 ILE B 206 ILE^? 8.45 N7 C2E B 301 A 82 TYR B 179 TYR.? 13.89 O6 C2E B 301 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 2.18 32.86 -17.28 0.63 33.43 -15.93 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -3.04 24.79 -8.55 -2.06 23.72 -8.88 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 2.36 25.70 -10.99 3.98 25.02 -13.14 1d6o_c00 source 1d6o FK506-BINDING PROTEIN : 2 hits 1d6o_c00 naa= 3 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 1 3 # 1 B 37 ASP B 152 ASP.? 19.99 C8 C2E B 301 B 56 ILE B 206 ILE^? 8.45 N7 C2E B 301 B 82 TYR B 179 TYR.? 13.89 O6 C2E B 301 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 2.18 32.86 -17.28 0.63 33.43 -15.93 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -3.04 24.79 -8.55 -2.06 23.72 -8.88 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 2.36 25.70 -10.99 3.98 25.02 -13.14 1d6o_c01 source 1d6o FK506-BINDING PROTEIN : 1 hits 1d6o_c01 naa= 3 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 A 145 LYS A 243 LYS.? 15.17 N2 C2E A 301 A 177 GLU A 159 GLU^? 13.73 O6 C2E A 301 A 201 LEU A 143 LEU^? 9.42 N2 C2E A 301 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -14.60 -12.52 -1.04 -14.41 -10.88 0.31 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -12.04 -8.63 -7.45 -11.72 -10.69 -8.09 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 A 145 LYS B 243 LYS.? 13.43 N1 C2E B 301 A 177 GLU B 159 GLU^? 13.76 O6 C2E B 301 A 201 LEU B 143 LEU^? 9.46 N2 C2E B 301 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -2.53 1.27 -13.25 2.13 3.70 -10.70 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 4.99 11.22 -14.77 6.30 9.86 -13.80 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -1.65 6.74 -15.30 -2.53 8.70 -15.61 1daa_c00 source 1daa D-AMINO ACID AMINOTRANSFERASE : 2 hits 1daa_c00 naa= 3 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 1 3 # 1 A 132 THR A 172 THR^? 12.93 O6 C2E A 301 A 156 TYR A 179 TYR.? 13.95 N7 C2E A 301 A 160 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo 10.50 56.87 17.73 11.24 57.93 19.43 -12.64 -19.39 3.41 -11.97 -21.32 2.68 coo 11.64 63.07 23.95 11.76 62.47 21.20 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo 5.78 61.30 21.65 8.04 62.89 17.54 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 2 3 # 2 A 132 THR B 172 THR^? 12.75 O6 C2E B 301 A 156 TYR B 179 TYR.? 13.89 O6 C2E B 301 A 160 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo 10.50 56.87 17.73 11.24 57.93 19.43 7.41 18.34 -11.48 6.25 20.16 -11.39 coo 11.64 63.07 23.95 11.76 62.47 21.20 2.36 25.70 -10.99 3.98 25.02 -13.14 coo 5.78 61.30 21.65 8.04 62.89 17.54 8.81 26.59 -11.72 7.46 31.56 -12.94 1db3_c01 source 1db3 GDP-MANNOSE 4,6-DEHYDRATASE : 2 hits 1db3_c01 naa= 3 ULMN 3 1dco_c00 DCOH user 1 3 # 1 A 62 HIS B 214 HIS.? 18.94 O6 C2E B 301 A 63 HIS B 215 HIS.? 11.93 O6 C2E B 301 A 89 ASP A 31 ASP~? 17.49 O6 C2E B 301 coo 49.66 36.74 42.37 48.88 35.30 43.64 13.04 11.66 -4.90 14.49 10.59 -3.83 coo 49.93 35.76 35.94 51.58 36.96 35.47 7.81 14.24 -7.06 6.68 12.76 -6.10 coo 46.15 35.33 47.12 47.46 33.99 46.29 10.86 4.60 -5.63 10.78 6.65 -6.14 1dco_c00 source 1dco DCOH : 1 hits 1dco_c00 naa= 3 ULMN 3 1ddj_c15 PLASMINOGEN user 1 3 # 1 D 603 HIS A 154 HIS^? 21.74 O6 C2E A 301 D 646 ASP A 152 ASP.? 20.83 C8 C2E A 301 D 739 GLY A 182 GLY.? 10.02 O1P C2E A 301 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -16.69 -30.86 2.00 -15.94 -32.47 3.12 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -2.65 -30.55 -5.15 -3.23 -30.14 -4.78 1ddj_c15 source 1ddj PLASMINOGEN : 1 hits 1ddj_c15 naa= 3 ULMN 3 1de3_c00 RIBONUCLEASE ALPHA-SARCIN user 1 3 # 1 A 50 HIS B 64 HIS^? 22.95 N21 C2E A 301 A 96 GLU A 72 GLU^? 18.63 N21 C2E A 301 A 137 HIS A 38 HIS.? 16.46 O61 C2E B 301 coo 1.83 2.95 4.76 1.26 0.98 4.81 5.28 -3.23 17.72 6.30 -4.93 18.40 coo 2.09 -1.43 1.72 1.90 -3.41 2.37 6.69 -5.58 14.73 4.83 -6.56 14.45 coo -3.67 -7.38 4.26 -2.89 -5.51 4.56 1.46 -0.40 7.20 -0.57 -0.26 7.72 1de3_c00 source 1de3 RIBONUCLEASE ALPHA-SARCIN : 1 hits 1de3_c00 naa= 3 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 57 GLU A 37 GLU.? 10.20 O61 C2E A 301 A 226 THR A 172 THR^? 12.93 O6 C2E A 301 A 229 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 0.90 -3.13 0.80 -0.70 -4.43 0.36 coo 7.24 97.46 49.60 8.11 95.69 48.80 -12.64 -19.39 3.41 -11.97 -21.32 2.68 coo 10.53 97.56 43.71 9.33 93.71 47.17 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 57 GLU A 37 GLU.? 10.20 O61 C2E A 301 A 226 THR B 58 THR^? 14.00 N21 C2E B 301 A 229 LYS B 75 LYS.? 16.89 N21 C2E B 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 0.90 -3.13 0.80 -0.70 -4.43 0.36 coo 7.24 97.46 49.60 8.11 95.69 48.80 2.82 14.44 10.97 3.39 13.43 12.79 coo 10.53 97.56 43.71 9.33 93.71 47.17 7.39 19.64 13.02 10.00 17.22 7.78 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 A 57 GLU A 41 GLU^? 8.66 N21 C2E A 301 A 226 THR A 172 THR^? 12.93 O6 C2E A 301 A 229 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 7.09 -12.35 6.79 6.46 -14.38 6.77 coo 7.24 97.46 49.60 8.11 95.69 48.80 -12.64 -19.39 3.41 -11.97 -21.32 2.68 coo 10.53 97.56 43.71 9.33 93.71 47.17 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 A 57 GLU A 72 GLU^? 18.63 N21 C2E A 301 A 226 THR B 58 THR^? 14.00 N21 C2E B 301 A 229 LYS B 75 LYS.? 16.89 N21 C2E B 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 6.69 -5.58 14.73 4.83 -6.56 14.45 coo 7.24 97.46 49.60 8.11 95.69 48.80 2.82 14.44 10.97 3.39 13.43 12.79 coo 10.53 97.56 43.71 9.33 93.71 47.17 7.39 19.64 13.02 10.00 17.22 7.78 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 A 57 GLU A 138 GLU.? 5.46 O2' C2E A 301 A 226 THR A 172 THR^? 12.93 O6 C2E A 301 A 229 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 coo 7.24 97.46 49.60 8.11 95.69 48.80 -12.64 -19.39 3.41 -11.97 -21.32 2.68 coo 10.53 97.56 43.71 9.33 93.71 47.17 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 A 57 GLU A 142 GLU^? 10.87 N1 C2E A 301 A 226 THR A 58 THR^? 15.78 N21 C2E A 301 A 229 LYS A 75 LYS.? 21.41 N21 C2E A 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 -5.78 -6.60 -5.54 -5.25 -5.49 -3.81 coo 7.24 97.46 49.60 8.11 95.69 48.80 9.36 -10.55 10.87 10.66 -9.09 11.81 coo 10.53 97.56 43.71 9.33 93.71 47.17 9.70 -14.41 17.00 6.16 -11.27 19.18 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 A 57 GLU A 142 GLU^? 10.87 N1 C2E A 301 A 226 THR B 63 THR^? 19.59 N11 C2E B 301 A 229 LYS B 67 LYS.? 24.61 N21 C2E A 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 -5.78 -6.60 -5.54 -5.25 -5.49 -3.81 coo 7.24 97.46 49.60 8.11 95.69 48.80 1.98 0.04 13.69 0.05 -0.43 12.85 coo 10.53 97.56 43.71 9.33 93.71 47.17 -0.41 -2.48 20.16 2.79 -6.43 20.83 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 A 57 GLU A 142 GLU^? 10.87 N1 C2E A 301 A 226 THR B 65 THR.? 22.03 N21 C2E A 301 A 229 LYS B 67 LYS.? 24.61 N21 C2E A 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 -5.78 -6.60 -5.54 -5.25 -5.49 -3.81 coo 7.24 97.46 49.60 8.11 95.69 48.80 1.41 -5.60 16.09 2.39 -6.35 17.87 coo 10.53 97.56 43.71 9.33 93.71 47.17 -0.41 -2.48 20.16 2.79 -6.43 20.83 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 A 57 GLU A 225 GLU~? 17.61 C1' C2E A 301 A 226 THR A 245 THR^? 17.40 N2 C2E A 301 A 229 LYS A 243 LYS.? 15.17 N2 C2E A 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 -14.07 -25.95 -18.02 -15.34 -27.27 -16.96 coo 7.24 97.46 49.60 8.11 95.69 48.80 -15.95 -5.02 -9.47 -17.20 -3.30 -9.10 coo 10.53 97.56 43.71 9.33 93.71 47.17 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 A 57 GLU B 37 GLU.? 9.39 O61 C2E B 301 A 226 THR A 58 THR^? 15.78 N21 C2E A 301 A 229 LYS A 75 LYS.? 21.41 N21 C2E A 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 -0.62 3.88 0.75 -0.32 4.81 -1.12 coo 7.24 97.46 49.60 8.11 95.69 48.80 9.36 -10.55 10.87 10.66 -9.09 11.81 coo 10.53 97.56 43.71 9.33 93.71 47.17 9.70 -14.41 17.00 6.16 -11.27 19.18 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 A 57 GLU B 37 GLU.? 9.39 O61 C2E B 301 A 226 THR B 172 THR^? 12.75 O6 C2E B 301 A 229 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 -0.62 3.88 0.75 -0.32 4.81 -1.12 coo 7.24 97.46 49.60 8.11 95.69 48.80 7.41 18.34 -11.48 6.25 20.16 -11.39 coo 10.53 97.56 43.71 9.33 93.71 47.17 8.81 26.59 -11.72 7.46 31.56 -12.94 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 A 57 GLU B 72 GLU^? 16.96 N21 C2E B 301 A 226 THR A 58 THR^? 15.78 N21 C2E A 301 A 229 LYS A 75 LYS.? 21.41 N21 C2E A 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 8.42 10.26 11.58 8.84 10.78 9.58 coo 7.24 97.46 49.60 8.11 95.69 48.80 9.36 -10.55 10.87 10.66 -9.09 11.81 coo 10.53 97.56 43.71 9.33 93.71 47.17 9.70 -14.41 17.00 6.16 -11.27 19.18 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 A 57 GLU B 142 GLU^? 10.78 N1 C2E B 301 A 226 THR A 63 THR^? 19.64 O61 C2E B 301 A 229 LYS A 67 LYS.? 22.91 N21 C2E B 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 -2.97 5.35 -8.71 -1.84 4.27 -7.29 coo 7.24 97.46 49.60 8.11 95.69 48.80 10.28 3.87 8.02 10.33 3.89 5.86 coo 10.53 97.56 43.71 9.33 93.71 47.17 17.01 7.43 8.57 15.28 11.70 10.44 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 A 57 GLU B 142 GLU^? 10.78 N1 C2E B 301 A 226 THR A 65 THR.? 20.67 N21 C2E B 301 A 229 LYS A 67 LYS.? 22.91 N21 C2E B 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 -2.97 5.35 -8.71 -1.84 4.27 -7.29 coo 7.24 97.46 49.60 8.11 95.69 48.80 12.12 9.75 7.64 13.14 10.86 9.19 coo 10.53 97.56 43.71 9.33 93.71 47.17 17.01 7.43 8.57 15.28 11.70 10.44 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 A 57 GLU B 142 GLU^? 10.78 N1 C2E B 301 A 226 THR B 58 THR^? 14.00 N21 C2E B 301 A 229 LYS B 75 LYS.? 16.89 N21 C2E B 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 -2.97 5.35 -8.71 -1.84 4.27 -7.29 coo 7.24 97.46 49.60 8.11 95.69 48.80 2.82 14.44 10.97 3.39 13.43 12.79 coo 10.53 97.56 43.71 9.33 93.71 47.17 7.39 19.64 13.02 10.00 17.22 7.78 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 16 3 # 16 A 57 GLU B 225 GLU~? 17.01 C1' C2E B 301 A 226 THR B 245 THR^? 16.73 N2 C2E B 301 A 229 LYS B 243 LYS.? 13.43 N1 C2E B 301 coo 9.66 102.78 70.07 9.79 101.18 71.42 -10.33 22.86 -23.16 -8.91 24.36 -23.62 coo 7.24 97.46 49.60 8.11 95.69 48.80 -1.10 3.06 -19.39 -0.26 1.10 -19.00 coo 10.53 97.56 43.71 9.33 93.71 47.17 -2.53 1.27 -13.25 2.13 3.70 -10.70 1dfo_c04 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 16 hits 1dfo_c04 naa= 3 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 57 GLU A 37 GLU.? 10.20 O61 C2E A 301 B 226 THR A 172 THR^? 12.93 O6 C2E A 301 B 229 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 0.90 -3.13 0.80 -0.70 -4.43 0.36 coo 20.74 95.78 68.68 19.29 96.84 69.83 -12.64 -19.39 3.41 -11.97 -21.32 2.68 coo 22.32 101.61 71.64 17.89 98.63 71.55 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 57 GLU A 37 GLU.? 10.20 O61 C2E A 301 B 226 THR B 58 THR^? 14.00 N21 C2E B 301 B 229 LYS B 75 LYS.? 16.89 N21 C2E B 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 0.90 -3.13 0.80 -0.70 -4.43 0.36 coo 20.74 95.78 68.68 19.29 96.84 69.83 2.82 14.44 10.97 3.39 13.43 12.79 coo 22.32 101.61 71.64 17.89 98.63 71.55 7.39 19.64 13.02 10.00 17.22 7.78 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 B 57 GLU A 41 GLU^? 8.66 N21 C2E A 301 B 226 THR A 172 THR^? 12.93 O6 C2E A 301 B 229 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 7.09 -12.35 6.79 6.46 -14.38 6.77 coo 20.74 95.78 68.68 19.29 96.84 69.83 -12.64 -19.39 3.41 -11.97 -21.32 2.68 coo 22.32 101.61 71.64 17.89 98.63 71.55 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 B 57 GLU A 72 GLU^? 18.63 N21 C2E A 301 B 226 THR B 58 THR^? 14.00 N21 C2E B 301 B 229 LYS B 75 LYS.? 16.89 N21 C2E B 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 6.69 -5.58 14.73 4.83 -6.56 14.45 coo 20.74 95.78 68.68 19.29 96.84 69.83 2.82 14.44 10.97 3.39 13.43 12.79 coo 22.32 101.61 71.64 17.89 98.63 71.55 7.39 19.64 13.02 10.00 17.22 7.78 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 B 57 GLU A 138 GLU.? 5.46 O2' C2E A 301 B 226 THR A 172 THR^? 12.93 O6 C2E A 301 B 229 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 coo 20.74 95.78 68.68 19.29 96.84 69.83 -12.64 -19.39 3.41 -11.97 -21.32 2.68 coo 22.32 101.61 71.64 17.89 98.63 71.55 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 B 57 GLU A 142 GLU^? 10.87 N1 C2E A 301 B 226 THR A 58 THR^? 15.78 N21 C2E A 301 B 229 LYS A 75 LYS.? 21.41 N21 C2E A 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 -5.78 -6.60 -5.54 -5.25 -5.49 -3.81 coo 20.74 95.78 68.68 19.29 96.84 69.83 9.36 -10.55 10.87 10.66 -9.09 11.81 coo 22.32 101.61 71.64 17.89 98.63 71.55 9.70 -14.41 17.00 6.16 -11.27 19.18 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 B 57 GLU A 142 GLU^? 10.87 N1 C2E A 301 B 226 THR B 63 THR^? 19.59 N11 C2E B 301 B 229 LYS B 67 LYS.? 24.61 N21 C2E A 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 -5.78 -6.60 -5.54 -5.25 -5.49 -3.81 coo 20.74 95.78 68.68 19.29 96.84 69.83 1.98 0.04 13.69 0.05 -0.43 12.85 coo 22.32 101.61 71.64 17.89 98.63 71.55 -0.41 -2.48 20.16 2.79 -6.43 20.83 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 B 57 GLU A 142 GLU^? 10.87 N1 C2E A 301 B 226 THR B 65 THR.? 22.03 N21 C2E A 301 B 229 LYS B 67 LYS.? 24.61 N21 C2E A 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 -5.78 -6.60 -5.54 -5.25 -5.49 -3.81 coo 20.74 95.78 68.68 19.29 96.84 69.83 1.41 -5.60 16.09 2.39 -6.35 17.87 coo 22.32 101.61 71.64 17.89 98.63 71.55 -0.41 -2.48 20.16 2.79 -6.43 20.83 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 B 57 GLU A 225 GLU~? 17.61 C1' C2E A 301 B 226 THR A 245 THR^? 17.40 N2 C2E A 301 B 229 LYS A 243 LYS.? 15.17 N2 C2E A 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 -14.07 -25.95 -18.02 -15.34 -27.27 -16.96 coo 20.74 95.78 68.68 19.29 96.84 69.83 -15.95 -5.02 -9.47 -17.20 -3.30 -9.10 coo 22.32 101.61 71.64 17.89 98.63 71.55 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 B 57 GLU B 37 GLU.? 9.39 O61 C2E B 301 B 226 THR A 58 THR^? 15.78 N21 C2E A 301 B 229 LYS A 75 LYS.? 21.41 N21 C2E A 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 -0.62 3.88 0.75 -0.32 4.81 -1.12 coo 20.74 95.78 68.68 19.29 96.84 69.83 9.36 -10.55 10.87 10.66 -9.09 11.81 coo 22.32 101.61 71.64 17.89 98.63 71.55 9.70 -14.41 17.00 6.16 -11.27 19.18 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 B 57 GLU B 37 GLU.? 9.39 O61 C2E B 301 B 226 THR B 172 THR^? 12.75 O6 C2E B 301 B 229 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 -0.62 3.88 0.75 -0.32 4.81 -1.12 coo 20.74 95.78 68.68 19.29 96.84 69.83 7.41 18.34 -11.48 6.25 20.16 -11.39 coo 22.32 101.61 71.64 17.89 98.63 71.55 8.81 26.59 -11.72 7.46 31.56 -12.94 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 B 57 GLU B 72 GLU^? 16.96 N21 C2E B 301 B 226 THR A 58 THR^? 15.78 N21 C2E A 301 B 229 LYS A 75 LYS.? 21.41 N21 C2E A 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 8.42 10.26 11.58 8.84 10.78 9.58 coo 20.74 95.78 68.68 19.29 96.84 69.83 9.36 -10.55 10.87 10.66 -9.09 11.81 coo 22.32 101.61 71.64 17.89 98.63 71.55 9.70 -14.41 17.00 6.16 -11.27 19.18 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 B 57 GLU B 142 GLU^? 10.78 N1 C2E B 301 B 226 THR A 63 THR^? 19.64 O61 C2E B 301 B 229 LYS A 67 LYS.? 22.91 N21 C2E B 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 -2.97 5.35 -8.71 -1.84 4.27 -7.29 coo 20.74 95.78 68.68 19.29 96.84 69.83 10.28 3.87 8.02 10.33 3.89 5.86 coo 22.32 101.61 71.64 17.89 98.63 71.55 17.01 7.43 8.57 15.28 11.70 10.44 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 B 57 GLU B 142 GLU^? 10.78 N1 C2E B 301 B 226 THR A 65 THR.? 20.67 N21 C2E B 301 B 229 LYS A 67 LYS.? 22.91 N21 C2E B 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 -2.97 5.35 -8.71 -1.84 4.27 -7.29 coo 20.74 95.78 68.68 19.29 96.84 69.83 12.12 9.75 7.64 13.14 10.86 9.19 coo 22.32 101.61 71.64 17.89 98.63 71.55 17.01 7.43 8.57 15.28 11.70 10.44 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 B 57 GLU B 142 GLU^? 10.78 N1 C2E B 301 B 226 THR B 58 THR^? 14.00 N21 C2E B 301 B 229 LYS B 75 LYS.? 16.89 N21 C2E B 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 -2.97 5.35 -8.71 -1.84 4.27 -7.29 coo 20.74 95.78 68.68 19.29 96.84 69.83 2.82 14.44 10.97 3.39 13.43 12.79 coo 22.32 101.61 71.64 17.89 98.63 71.55 7.39 19.64 13.02 10.00 17.22 7.78 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 16 3 # 16 B 57 GLU B 225 GLU~? 17.01 C1' C2E B 301 B 226 THR B 245 THR^? 16.73 N2 C2E B 301 B 229 LYS B 243 LYS.? 13.43 N1 C2E B 301 coo 15.90 87.61 49.61 13.92 86.96 49.36 -10.33 22.86 -23.16 -8.91 24.36 -23.62 coo 20.74 95.78 68.68 19.29 96.84 69.83 -1.10 3.06 -19.39 -0.26 1.10 -19.00 coo 22.32 101.61 71.64 17.89 98.63 71.55 -2.53 1.27 -13.25 2.13 3.70 -10.70 1dfo_c05 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 16 hits 1dfo_c05 naa= 3 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 57 GLU A 37 GLU.? 10.20 O61 C2E A 301 C 226 THR A 172 THR^? 12.93 O6 C2E A 301 C 229 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 0.90 -3.13 0.80 -0.70 -4.43 0.36 coo 22.16 45.88 73.63 23.23 47.70 73.25 -12.64 -19.39 3.41 -11.97 -21.32 2.68 coo 28.90 45.91 73.55 25.22 49.72 72.97 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 57 GLU A 37 GLU.? 10.20 O61 C2E A 301 C 226 THR B 58 THR^? 14.00 N21 C2E B 301 C 229 LYS B 75 LYS.? 16.89 N21 C2E B 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 0.90 -3.13 0.80 -0.70 -4.43 0.36 coo 22.16 45.88 73.63 23.23 47.70 73.25 2.82 14.44 10.97 3.39 13.43 12.79 coo 28.90 45.91 73.55 25.22 49.72 72.97 7.39 19.64 13.02 10.00 17.22 7.78 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 C 57 GLU A 41 GLU^? 8.66 N21 C2E A 301 C 226 THR A 172 THR^? 12.93 O6 C2E A 301 C 229 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 7.09 -12.35 6.79 6.46 -14.38 6.77 coo 22.16 45.88 73.63 23.23 47.70 73.25 -12.64 -19.39 3.41 -11.97 -21.32 2.68 coo 28.90 45.91 73.55 25.22 49.72 72.97 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 C 57 GLU A 72 GLU^? 18.63 N21 C2E A 301 C 226 THR B 58 THR^? 14.00 N21 C2E B 301 C 229 LYS B 75 LYS.? 16.89 N21 C2E B 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 6.69 -5.58 14.73 4.83 -6.56 14.45 coo 22.16 45.88 73.63 23.23 47.70 73.25 2.82 14.44 10.97 3.39 13.43 12.79 coo 28.90 45.91 73.55 25.22 49.72 72.97 7.39 19.64 13.02 10.00 17.22 7.78 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 C 57 GLU A 138 GLU.? 5.46 O2' C2E A 301 C 226 THR A 172 THR^? 12.93 O6 C2E A 301 C 229 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 coo 22.16 45.88 73.63 23.23 47.70 73.25 -12.64 -19.39 3.41 -11.97 -21.32 2.68 coo 28.90 45.91 73.55 25.22 49.72 72.97 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 C 57 GLU A 142 GLU^? 10.87 N1 C2E A 301 C 226 THR A 58 THR^? 15.78 N21 C2E A 301 C 229 LYS A 75 LYS.? 21.41 N21 C2E A 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 -5.78 -6.60 -5.54 -5.25 -5.49 -3.81 coo 22.16 45.88 73.63 23.23 47.70 73.25 9.36 -10.55 10.87 10.66 -9.09 11.81 coo 28.90 45.91 73.55 25.22 49.72 72.97 9.70 -14.41 17.00 6.16 -11.27 19.18 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 C 57 GLU A 142 GLU^? 10.87 N1 C2E A 301 C 226 THR B 63 THR^? 19.59 N11 C2E B 301 C 229 LYS B 67 LYS.? 24.61 N21 C2E A 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 -5.78 -6.60 -5.54 -5.25 -5.49 -3.81 coo 22.16 45.88 73.63 23.23 47.70 73.25 1.98 0.04 13.69 0.05 -0.43 12.85 coo 28.90 45.91 73.55 25.22 49.72 72.97 -0.41 -2.48 20.16 2.79 -6.43 20.83 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 C 57 GLU A 142 GLU^? 10.87 N1 C2E A 301 C 226 THR B 65 THR.? 22.03 N21 C2E A 301 C 229 LYS B 67 LYS.? 24.61 N21 C2E A 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 -5.78 -6.60 -5.54 -5.25 -5.49 -3.81 coo 22.16 45.88 73.63 23.23 47.70 73.25 1.41 -5.60 16.09 2.39 -6.35 17.87 coo 28.90 45.91 73.55 25.22 49.72 72.97 -0.41 -2.48 20.16 2.79 -6.43 20.83 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 C 57 GLU A 225 GLU~? 17.61 C1' C2E A 301 C 226 THR A 245 THR^? 17.40 N2 C2E A 301 C 229 LYS A 243 LYS.? 15.17 N2 C2E A 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 -14.07 -25.95 -18.02 -15.34 -27.27 -16.96 coo 22.16 45.88 73.63 23.23 47.70 73.25 -15.95 -5.02 -9.47 -17.20 -3.30 -9.10 coo 28.90 45.91 73.55 25.22 49.72 72.97 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 C 57 GLU B 37 GLU.? 9.39 O61 C2E B 301 C 226 THR A 58 THR^? 15.78 N21 C2E A 301 C 229 LYS A 75 LYS.? 21.41 N21 C2E A 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 -0.62 3.88 0.75 -0.32 4.81 -1.12 coo 22.16 45.88 73.63 23.23 47.70 73.25 9.36 -10.55 10.87 10.66 -9.09 11.81 coo 28.90 45.91 73.55 25.22 49.72 72.97 9.70 -14.41 17.00 6.16 -11.27 19.18 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 C 57 GLU B 37 GLU.? 9.39 O61 C2E B 301 C 226 THR B 172 THR^? 12.75 O6 C2E B 301 C 229 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 -0.62 3.88 0.75 -0.32 4.81 -1.12 coo 22.16 45.88 73.63 23.23 47.70 73.25 7.41 18.34 -11.48 6.25 20.16 -11.39 coo 28.90 45.91 73.55 25.22 49.72 72.97 8.81 26.59 -11.72 7.46 31.56 -12.94 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 C 57 GLU B 72 GLU^? 16.96 N21 C2E B 301 C 226 THR A 58 THR^? 15.78 N21 C2E A 301 C 229 LYS A 75 LYS.? 21.41 N21 C2E A 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 8.42 10.26 11.58 8.84 10.78 9.58 coo 22.16 45.88 73.63 23.23 47.70 73.25 9.36 -10.55 10.87 10.66 -9.09 11.81 coo 28.90 45.91 73.55 25.22 49.72 72.97 9.70 -14.41 17.00 6.16 -11.27 19.18 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 C 57 GLU B 142 GLU^? 10.78 N1 C2E B 301 C 226 THR A 63 THR^? 19.64 O61 C2E B 301 C 229 LYS A 67 LYS.? 22.91 N21 C2E B 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 -2.97 5.35 -8.71 -1.84 4.27 -7.29 coo 22.16 45.88 73.63 23.23 47.70 73.25 10.28 3.87 8.02 10.33 3.89 5.86 coo 28.90 45.91 73.55 25.22 49.72 72.97 17.01 7.43 8.57 15.28 11.70 10.44 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 C 57 GLU B 142 GLU^? 10.78 N1 C2E B 301 C 226 THR A 65 THR.? 20.67 N21 C2E B 301 C 229 LYS A 67 LYS.? 22.91 N21 C2E B 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 -2.97 5.35 -8.71 -1.84 4.27 -7.29 coo 22.16 45.88 73.63 23.23 47.70 73.25 12.12 9.75 7.64 13.14 10.86 9.19 coo 28.90 45.91 73.55 25.22 49.72 72.97 17.01 7.43 8.57 15.28 11.70 10.44 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 C 57 GLU B 142 GLU^? 10.78 N1 C2E B 301 C 226 THR B 58 THR^? 14.00 N21 C2E B 301 C 229 LYS B 75 LYS.? 16.89 N21 C2E B 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 -2.97 5.35 -8.71 -1.84 4.27 -7.29 coo 22.16 45.88 73.63 23.23 47.70 73.25 2.82 14.44 10.97 3.39 13.43 12.79 coo 28.90 45.91 73.55 25.22 49.72 72.97 7.39 19.64 13.02 10.00 17.22 7.78 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 16 3 # 16 C 57 GLU B 225 GLU~? 17.01 C1' C2E B 301 C 226 THR B 245 THR^? 16.73 N2 C2E B 301 C 229 LYS B 243 LYS.? 13.43 N1 C2E B 301 coo 5.43 40.40 61.63 4.27 41.99 60.90 -10.33 22.86 -23.16 -8.91 24.36 -23.62 coo 22.16 45.88 73.63 23.23 47.70 73.25 -1.10 3.06 -19.39 -0.26 1.10 -19.00 coo 28.90 45.91 73.55 25.22 49.72 72.97 -2.53 1.27 -13.25 2.13 3.70 -10.70 1dfo_c06 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 16 hits 1dfo_c06 naa= 3 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 57 GLU A 37 GLU.? 10.20 O61 C2E A 301 D 226 THR A 172 THR^? 12.93 O6 C2E A 301 D 229 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 0.90 -3.13 0.80 -0.70 -4.43 0.36 coo 11.79 47.62 52.67 10.10 46.51 53.39 -12.64 -19.39 3.41 -11.97 -21.32 2.68 coo 10.05 41.79 49.80 7.94 44.71 53.76 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 57 GLU A 37 GLU.? 10.20 O61 C2E A 301 D 226 THR B 58 THR^? 14.00 N21 C2E B 301 D 229 LYS B 75 LYS.? 16.89 N21 C2E B 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 0.90 -3.13 0.80 -0.70 -4.43 0.36 coo 11.79 47.62 52.67 10.10 46.51 53.39 2.82 14.44 10.97 3.39 13.43 12.79 coo 10.05 41.79 49.80 7.94 44.71 53.76 7.39 19.64 13.02 10.00 17.22 7.78 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 D 57 GLU A 41 GLU^? 8.66 N21 C2E A 301 D 226 THR A 172 THR^? 12.93 O6 C2E A 301 D 229 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 7.09 -12.35 6.79 6.46 -14.38 6.77 coo 11.79 47.62 52.67 10.10 46.51 53.39 -12.64 -19.39 3.41 -11.97 -21.32 2.68 coo 10.05 41.79 49.80 7.94 44.71 53.76 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 D 57 GLU A 72 GLU^? 18.63 N21 C2E A 301 D 226 THR B 58 THR^? 14.00 N21 C2E B 301 D 229 LYS B 75 LYS.? 16.89 N21 C2E B 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 6.69 -5.58 14.73 4.83 -6.56 14.45 coo 11.79 47.62 52.67 10.10 46.51 53.39 2.82 14.44 10.97 3.39 13.43 12.79 coo 10.05 41.79 49.80 7.94 44.71 53.76 7.39 19.64 13.02 10.00 17.22 7.78 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 D 57 GLU A 138 GLU.? 5.46 O2' C2E A 301 D 226 THR A 172 THR^? 12.93 O6 C2E A 301 D 229 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 coo 11.79 47.62 52.67 10.10 46.51 53.39 -12.64 -19.39 3.41 -11.97 -21.32 2.68 coo 10.05 41.79 49.80 7.94 44.71 53.76 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 D 57 GLU A 142 GLU^? 10.87 N1 C2E A 301 D 226 THR A 58 THR^? 15.78 N21 C2E A 301 D 229 LYS A 75 LYS.? 21.41 N21 C2E A 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 -5.78 -6.60 -5.54 -5.25 -5.49 -3.81 coo 11.79 47.62 52.67 10.10 46.51 53.39 9.36 -10.55 10.87 10.66 -9.09 11.81 coo 10.05 41.79 49.80 7.94 44.71 53.76 9.70 -14.41 17.00 6.16 -11.27 19.18 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 D 57 GLU A 142 GLU^? 10.87 N1 C2E A 301 D 226 THR B 63 THR^? 19.59 N11 C2E B 301 D 229 LYS B 67 LYS.? 24.61 N21 C2E A 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 -5.78 -6.60 -5.54 -5.25 -5.49 -3.81 coo 11.79 47.62 52.67 10.10 46.51 53.39 1.98 0.04 13.69 0.05 -0.43 12.85 coo 10.05 41.79 49.80 7.94 44.71 53.76 -0.41 -2.48 20.16 2.79 -6.43 20.83 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 D 57 GLU A 142 GLU^? 10.87 N1 C2E A 301 D 226 THR B 65 THR.? 22.03 N21 C2E A 301 D 229 LYS B 67 LYS.? 24.61 N21 C2E A 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 -5.78 -6.60 -5.54 -5.25 -5.49 -3.81 coo 11.79 47.62 52.67 10.10 46.51 53.39 1.41 -5.60 16.09 2.39 -6.35 17.87 coo 10.05 41.79 49.80 7.94 44.71 53.76 -0.41 -2.48 20.16 2.79 -6.43 20.83 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 D 57 GLU A 225 GLU~? 17.61 C1' C2E A 301 D 226 THR A 245 THR^? 17.40 N2 C2E A 301 D 229 LYS A 243 LYS.? 15.17 N2 C2E A 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 -14.07 -25.95 -18.02 -15.34 -27.27 -16.96 coo 11.79 47.62 52.67 10.10 46.51 53.39 -15.95 -5.02 -9.47 -17.20 -3.30 -9.10 coo 10.05 41.79 49.80 7.94 44.71 53.76 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 D 57 GLU B 37 GLU.? 9.39 O61 C2E B 301 D 226 THR A 58 THR^? 15.78 N21 C2E A 301 D 229 LYS A 75 LYS.? 21.41 N21 C2E A 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 -0.62 3.88 0.75 -0.32 4.81 -1.12 coo 11.79 47.62 52.67 10.10 46.51 53.39 9.36 -10.55 10.87 10.66 -9.09 11.81 coo 10.05 41.79 49.80 7.94 44.71 53.76 9.70 -14.41 17.00 6.16 -11.27 19.18 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 D 57 GLU B 37 GLU.? 9.39 O61 C2E B 301 D 226 THR B 172 THR^? 12.75 O6 C2E B 301 D 229 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 -0.62 3.88 0.75 -0.32 4.81 -1.12 coo 11.79 47.62 52.67 10.10 46.51 53.39 7.41 18.34 -11.48 6.25 20.16 -11.39 coo 10.05 41.79 49.80 7.94 44.71 53.76 8.81 26.59 -11.72 7.46 31.56 -12.94 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 D 57 GLU B 72 GLU^? 16.96 N21 C2E B 301 D 226 THR A 58 THR^? 15.78 N21 C2E A 301 D 229 LYS A 75 LYS.? 21.41 N21 C2E A 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 8.42 10.26 11.58 8.84 10.78 9.58 coo 11.79 47.62 52.67 10.10 46.51 53.39 9.36 -10.55 10.87 10.66 -9.09 11.81 coo 10.05 41.79 49.80 7.94 44.71 53.76 9.70 -14.41 17.00 6.16 -11.27 19.18 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 D 57 GLU B 142 GLU^? 10.78 N1 C2E B 301 D 226 THR A 63 THR^? 19.64 O61 C2E B 301 D 229 LYS A 67 LYS.? 22.91 N21 C2E B 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 -2.97 5.35 -8.71 -1.84 4.27 -7.29 coo 11.79 47.62 52.67 10.10 46.51 53.39 10.28 3.87 8.02 10.33 3.89 5.86 coo 10.05 41.79 49.80 7.94 44.71 53.76 17.01 7.43 8.57 15.28 11.70 10.44 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 D 57 GLU B 142 GLU^? 10.78 N1 C2E B 301 D 226 THR A 65 THR.? 20.67 N21 C2E B 301 D 229 LYS A 67 LYS.? 22.91 N21 C2E B 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 -2.97 5.35 -8.71 -1.84 4.27 -7.29 coo 11.79 47.62 52.67 10.10 46.51 53.39 12.12 9.75 7.64 13.14 10.86 9.19 coo 10.05 41.79 49.80 7.94 44.71 53.76 17.01 7.43 8.57 15.28 11.70 10.44 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 D 57 GLU B 142 GLU^? 10.78 N1 C2E B 301 D 226 THR B 58 THR^? 14.00 N21 C2E B 301 D 229 LYS B 75 LYS.? 16.89 N21 C2E B 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 -2.97 5.35 -8.71 -1.84 4.27 -7.29 coo 11.79 47.62 52.67 10.10 46.51 53.39 2.82 14.44 10.97 3.39 13.43 12.79 coo 10.05 41.79 49.80 7.94 44.71 53.76 7.39 19.64 13.02 10.00 17.22 7.78 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 16 3 # 16 D 57 GLU B 225 GLU~? 17.01 C1' C2E B 301 D 226 THR B 245 THR^? 16.73 N2 C2E B 301 D 229 LYS B 243 LYS.? 13.43 N1 C2E B 301 coo 26.07 55.89 66.14 25.33 56.50 68.01 -10.33 22.86 -23.16 -8.91 24.36 -23.62 coo 11.79 47.62 52.67 10.10 46.51 53.39 -1.10 3.06 -19.39 -0.26 1.10 -19.00 coo 10.05 41.79 49.80 7.94 44.71 53.76 -2.53 1.27 -13.25 2.13 3.70 -10.70 1dfo_c07 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 16 hits 1dfo_c07 naa= 3 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 1 3 # 1 146 TYR A 179 TYR.? 13.95 N7 C2E A 301 150 LYS A 177 LYS.? 20.27 N7 C2E A 301 186 ASN A 208 ASN^? -3.55 N7 C2E A 301s coo 32.88 50.55 24.33 31.89 51.78 26.65 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo 27.04 52.42 22.30 26.88 49.99 27.00 -13.21 -27.52 5.04 -11.69 -32.72 3.81 coo 36.98 50.30 37.29 35.85 50.29 35.50 0.54 -21.32 -2.29 -0.50 -19.83 -3.42 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 2 3 # 2 146 TYR B 179 TYR.? 13.89 O6 C2E B 301 150 LYS B 177 LYS.? 21.12 N7 C2E B 301 186 ASN B 208 ASN^? -3.47 N7 C2E B 301s coo 32.88 50.55 24.33 31.89 51.78 26.65 2.36 25.70 -10.99 3.98 25.02 -13.14 coo 27.04 52.42 22.30 26.88 49.99 27.00 8.81 26.59 -11.72 7.46 31.56 -12.94 coo 36.98 50.30 37.29 35.85 50.29 35.50 -4.15 20.35 -2.93 -4.56 18.73 -4.26 1dhr_c00 source 1dhr DIHYDROPTERIDINE REDUCTASE (DHPR) (E.C.1.6.99.: 2 hits 1dhr_c00 naa= 3 ULMN 3 1do8_c00 MALIC ENZYME user 1 3 # 1 A 112 TYR A 179 TYR.? 13.95 N7 C2E A 301 A 183 LYS A 177 LYS.? 20.27 N7 C2E A 301 A 278 ASP A 157 ASP^? 20.06 O6 C2E A 301 coo 19.43 18.53 42.32 17.66 18.80 40.15 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo 21.92 15.80 36.19 17.64 19.44 36.35 -13.21 -27.52 5.04 -11.69 -32.72 3.81 coo 15.46 19.03 31.40 15.01 18.25 33.31 -19.05 -19.29 2.64 -21.12 -19.53 2.92 ULMN 3 1do8_c00 MALIC ENZYME user 2 3 # 2 A 112 TYR B 179 TYR.? 13.89 O6 C2E B 301 A 183 LYS B 177 LYS.? 21.12 N7 C2E B 301 A 278 ASP B 157 ASP^? 20.00 O6 C2E B 301 coo 19.43 18.53 42.32 17.66 18.80 40.15 2.36 25.70 -10.99 3.98 25.02 -13.14 coo 21.92 15.80 36.19 17.64 19.44 36.35 8.81 26.59 -11.72 7.46 31.56 -12.94 coo 15.46 19.03 31.40 15.01 18.25 33.31 9.70 18.14 -17.54 10.97 18.31 -19.23 1do8_c00 source 1do8 MALIC ENZYME : 2 hits 1do8_c00 naa= 3 ULMN 3 1do8_c01 MALIC ENZYME user 1 3 # 1 B 112 TYR A 179 TYR.? 13.95 N7 C2E A 301 B 183 LYS A 177 LYS.? 20.27 N7 C2E A 301 B 278 ASP A 157 ASP^? 20.06 O6 C2E A 301 coo 58.62 15.99 58.34 60.98 14.60 58.93 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo 60.11 10.60 53.63 62.59 10.74 58.67 -13.21 -27.52 5.04 -11.69 -32.72 3.81 coo 66.50 7.32 58.45 66.26 9.42 58.23 -19.05 -19.29 2.64 -21.12 -19.53 2.92 ULMN 3 1do8_c01 MALIC ENZYME user 2 3 # 2 B 112 TYR B 179 TYR.? 13.89 O6 C2E B 301 B 183 LYS B 177 LYS.? 21.12 N7 C2E B 301 B 278 ASP B 157 ASP^? 20.00 O6 C2E B 301 coo 58.62 15.99 58.34 60.98 14.60 58.93 2.36 25.70 -10.99 3.98 25.02 -13.14 coo 60.11 10.60 53.63 62.59 10.74 58.67 8.81 26.59 -11.72 7.46 31.56 -12.94 coo 66.50 7.32 58.45 66.26 9.42 58.23 9.70 18.14 -17.54 10.97 18.31 -19.23 1do8_c01 source 1do8 MALIC ENZYME : 2 hits 1do8_c01 naa= 3 ULMN 3 1do8_c02 MALIC ENZYME user 1 3 # 1 C 112 TYR A 179 TYR.? 13.95 N7 C2E A 301 C 183 LYS A 177 LYS.? 20.27 N7 C2E A 301 C 278 ASP A 157 ASP^? 20.06 O6 C2E A 301 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 -13.21 -27.52 5.04 -11.69 -32.72 3.81 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 -19.05 -19.29 2.64 -21.12 -19.53 2.92 ULMN 3 1do8_c02 MALIC ENZYME user 2 3 # 2 C 112 TYR B 179 TYR.? 13.89 O6 C2E B 301 C 183 LYS B 177 LYS.? 21.12 N7 C2E B 301 C 278 ASP B 157 ASP^? 20.00 O6 C2E B 301 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 2.36 25.70 -10.99 3.98 25.02 -13.14 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 8.81 26.59 -11.72 7.46 31.56 -12.94 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 9.70 18.14 -17.54 10.97 18.31 -19.23 1do8_c02 source 1do8 MALIC ENZYME : 2 hits 1do8_c02 naa= 3 ULMN 3 1do8_c03 MALIC ENZYME user 1 3 # 1 D 112 TYR A 179 TYR.? 13.95 N7 C2E A 301 D 183 LYS A 177 LYS.? 20.27 N7 C2E A 301 D 278 ASP A 157 ASP^? 20.06 O6 C2E A 301 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 -13.21 -27.52 5.04 -11.69 -32.72 3.81 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 -19.05 -19.29 2.64 -21.12 -19.53 2.92 ULMN 3 1do8_c03 MALIC ENZYME user 2 3 # 2 D 112 TYR B 179 TYR.? 13.89 O6 C2E B 301 D 183 LYS B 177 LYS.? 21.12 N7 C2E B 301 D 278 ASP B 157 ASP^? 20.00 O6 C2E B 301 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 2.36 25.70 -10.99 3.98 25.02 -13.14 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 8.81 26.59 -11.72 7.46 31.56 -12.94 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 9.70 18.14 -17.54 10.97 18.31 -19.23 1do8_c03 source 1do8 MALIC ENZYME : 2 hits 1do8_c03 naa= 3 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 1 3 # 1 E 57 HIS A 154 HIS^? 21.74 O6 C2E A 301 E 102 ASP A 152 ASP.? 20.83 C8 C2E A 301 E 193 GLY A 176 GLY.? 18.56 O6 C2E A 301 coo 11.39 26.86 25.95 9.85 26.64 27.36 -16.69 -30.86 2.00 -15.94 -32.47 3.12 coo 10.90 32.83 25.96 10.83 30.68 25.98 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo 4.57 20.60 30.29 4.74 21.36 30.66 -14.50 -24.46 6.89 -13.82 -24.67 7.29 1ds2_c02 source 1ds2 PROTEINASE B (SGPB : 1 hits 1ds2_c02 naa= 3 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 1 3 # 1 B 141 GLY A 226 GLY~? 11.67 C1' C2E A 301 B 144 GLU A 225 GLU~? 17.61 C1' C2E A 301 B 164 GLU A 224 GLU~? 15.93 O2' C2E A 301 coo 88.87 114.43 152.30 88.45 115.15 152.32 -10.93 -22.84 -15.51 -10.72 -22.76 -16.32 coo 85.20 111.99 152.05 86.60 110.89 150.91 -14.07 -25.95 -18.02 -15.34 -27.27 -16.96 coo 88.14 113.46 145.73 86.79 113.92 147.30 -8.40 -25.77 -21.72 -8.05 -26.98 -23.42 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 2 3 # 2 B 141 GLY B 226 GLY~? 11.47 O2' C2E B 301 B 144 GLU B 225 GLU~? 17.01 C1' C2E B 301 B 164 GLU B 224 GLU~? 16.79 O2' C2E B 301 coo 88.87 114.43 152.30 88.45 115.15 152.32 -10.34 20.15 -19.24 -11.11 20.04 -19.49 coo 85.20 111.99 152.05 86.60 110.89 150.91 -10.33 22.86 -23.16 -8.91 24.36 -23.62 coo 88.14 113.46 145.73 86.79 113.92 147.30 -16.80 22.93 -20.90 -17.88 24.32 -22.10 1dub_c13 source 1dub 2-ENOYL-COA HYDRATASE : 2 hits 1dub_c13 naa= 3 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 1 3 # 1 C 141 GLY A 226 GLY~? 11.67 C1' C2E A 301 C 144 GLU A 225 GLU~? 17.61 C1' C2E A 301 C 164 GLU A 224 GLU~? 15.93 O2' C2E A 301 coo 56.28 104.55 135.84 56.09 105.34 136.05 -10.93 -22.84 -15.51 -10.72 -22.76 -16.32 coo 58.46 103.90 139.48 57.57 102.00 139.16 -14.07 -25.95 -18.02 -15.34 -27.27 -16.96 coo 51.71 102.03 140.09 53.02 103.62 140.54 -8.40 -25.77 -21.72 -8.05 -26.98 -23.42 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 2 3 # 2 C 141 GLY B 226 GLY~? 11.47 O2' C2E B 301 C 144 GLU B 225 GLU~? 17.01 C1' C2E B 301 C 164 GLU B 224 GLU~? 16.79 O2' C2E B 301 coo 56.28 104.55 135.84 56.09 105.34 136.05 -10.34 20.15 -19.24 -11.11 20.04 -19.49 coo 58.46 103.90 139.48 57.57 102.00 139.16 -10.33 22.86 -23.16 -8.91 24.36 -23.62 coo 51.71 102.03 140.09 53.02 103.62 140.54 -16.80 22.93 -20.90 -17.88 24.32 -22.10 1dub_c14 source 1dub 2-ENOYL-COA HYDRATASE : 2 hits 1dub_c14 naa= 3 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 1 3 # 1 D 141 GLY A 226 GLY~? 11.67 C1' C2E A 301 D 144 GLU A 225 GLU~? 17.61 C1' C2E A 301 D 164 GLU A 224 GLU~? 15.93 O2' C2E A 301 coo 86.19 80.64 132.77 86.38 79.85 132.93 -10.93 -22.84 -15.51 -10.72 -22.76 -16.32 coo 84.75 81.24 136.88 85.62 83.14 136.43 -14.07 -25.95 -18.02 -15.34 -27.27 -16.96 coo 91.47 83.05 136.24 90.35 81.38 136.84 -8.40 -25.77 -21.72 -8.05 -26.98 -23.42 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 2 3 # 2 D 141 GLY B 226 GLY~? 11.47 O2' C2E B 301 D 144 GLU B 225 GLU~? 17.01 C1' C2E B 301 D 164 GLU B 224 GLU~? 16.79 O2' C2E B 301 coo 86.19 80.64 132.77 86.38 79.85 132.93 -10.34 20.15 -19.24 -11.11 20.04 -19.49 coo 84.75 81.24 136.88 85.62 83.14 136.43 -10.33 22.86 -23.16 -8.91 24.36 -23.62 coo 91.47 83.05 136.24 90.35 81.38 136.84 -16.80 22.93 -20.90 -17.88 24.32 -22.10 1dub_c15 source 1dub 2-ENOYL-COA HYDRATASE : 2 hits 1dub_c15 naa= 3 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 1 3 # 1 E 141 GLY A 226 GLY~? 11.67 C1' C2E A 301 E 144 GLU A 225 GLU~? 17.61 C1' C2E A 301 E 164 GLU A 224 GLU~? 15.93 O2' C2E A 301 coo 90.07 81.07 170.50 90.23 80.26 170.38 -10.93 -22.84 -15.51 -10.72 -22.76 -16.32 coo 87.05 81.30 167.53 86.38 82.74 168.94 -14.07 -25.95 -18.02 -15.34 -27.27 -16.96 coo 84.40 80.02 173.80 85.08 79.06 172.03 -8.40 -25.77 -21.72 -8.05 -26.98 -23.42 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 2 3 # 2 E 141 GLY B 226 GLY~? 11.47 O2' C2E B 301 E 144 GLU B 225 GLU~? 17.01 C1' C2E B 301 E 164 GLU B 224 GLU~? 16.79 O2' C2E B 301 coo 90.07 81.07 170.50 90.23 80.26 170.38 -10.34 20.15 -19.24 -11.11 20.04 -19.49 coo 87.05 81.30 167.53 86.38 82.74 168.94 -10.33 22.86 -23.16 -8.91 24.36 -23.62 coo 84.40 80.02 173.80 85.08 79.06 172.03 -16.80 22.93 -20.90 -17.88 24.32 -22.10 1dub_c16 source 1dub 2-ENOYL-COA HYDRATASE : 2 hits 1dub_c16 naa= 3 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 1 3 # 1 F 141 GLY A 226 GLY~? 11.67 C1' C2E A 301 F 144 GLU A 225 GLU~? 17.61 C1' C2E A 301 F 164 GLU A 224 GLU~? 15.93 O2' C2E A 301 coo 57.12 70.68 155.10 57.52 69.95 155.02 -10.93 -22.84 -15.51 -10.72 -22.76 -16.32 coo 60.62 73.13 154.21 59.05 74.26 153.35 -14.07 -25.95 -18.02 -15.34 -27.27 -16.96 coo 56.75 71.71 148.46 58.44 71.01 149.54 -8.40 -25.77 -21.72 -8.05 -26.98 -23.42 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 2 3 # 2 F 141 GLY B 226 GLY~? 11.47 O2' C2E B 301 F 144 GLU B 225 GLU~? 17.01 C1' C2E B 301 F 164 GLU B 224 GLU~? 16.79 O2' C2E B 301 coo 57.12 70.68 155.10 57.52 69.95 155.02 -10.34 20.15 -19.24 -11.11 20.04 -19.49 coo 60.62 73.13 154.21 59.05 74.26 153.35 -10.33 22.86 -23.16 -8.91 24.36 -23.62 coo 56.75 71.71 148.46 58.44 71.01 149.54 -16.80 22.93 -20.90 -17.88 24.32 -22.10 1dub_c17 source 1dub 2-ENOYL-COA HYDRATASE : 2 hits 1dub_c17 naa= 3 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 A 131 LYS A 231 LYS~? 13.14 O2' C2E A 301 A 215 LYS A 238 LYS^? 19.93 N2 C2E B 301 A 277 LYS A 243 LYS.? 15.17 N2 C2E A 301 coo 0.50 24.09 51.68 1.51 29.34 52.35 -11.44 -15.22 -19.18 -8.27 -15.76 -22.64 coo 13.06 30.79 51.73 11.40 35.76 53.48 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 coo 13.04 31.88 60.72 10.57 35.34 57.49 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 2 3 # 2 A 131 LYS B 231 LYS~? 16.58 O2' C2E B 301 A 215 LYS B 238 LYS^? 16.50 N2 C2E A 301 A 277 LYS B 243 LYS.? 13.43 N1 C2E B 301 coo 0.50 24.09 51.68 1.51 29.34 52.35 -12.77 12.18 -20.95 -18.80 11.50 -22.86 coo 13.06 30.79 51.73 11.40 35.76 53.48 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 coo 13.04 31.88 60.72 10.57 35.34 57.49 -2.53 1.27 -13.25 2.13 3.70 -10.70 1e19_c00 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 2 hits 1e19_c00 naa= 3 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 B 131 LYS A 231 LYS~? 13.14 O2' C2E A 301 B 215 LYS A 238 LYS^? 19.93 N2 C2E B 301 B 277 LYS A 243 LYS.? 15.17 N2 C2E A 301 coo 6.78 45.91 16.15 7.82 40.81 15.84 -11.44 -15.22 -19.18 -8.27 -15.76 -22.64 coo 17.88 38.77 19.81 16.38 34.23 17.24 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 coo 20.33 37.78 11.20 16.77 34.53 13.47 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 2 3 # 2 B 131 LYS B 231 LYS~? 16.58 O2' C2E B 301 B 215 LYS B 238 LYS^? 16.50 N2 C2E A 301 B 277 LYS B 243 LYS.? 13.43 N1 C2E B 301 coo 6.78 45.91 16.15 7.82 40.81 15.84 -12.77 12.18 -20.95 -18.80 11.50 -22.86 coo 17.88 38.77 19.81 16.38 34.23 17.24 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 coo 20.33 37.78 11.20 16.77 34.53 13.47 -2.53 1.27 -13.25 2.13 3.70 -10.70 1e19_c01 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 2 hits 1e19_c01 naa= 3 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR B 179 TYR.? 13.89 O6 C2E B 301 A 40 ASP B 152 ASP.? 19.99 C8 C2E B 301 A 103 ASP B 183 ASP.? 14.33 O1P C2E B 301 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 2.36 25.70 -10.99 3.98 25.02 -13.14 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 2.18 32.86 -17.28 0.63 33.43 -15.93 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 -1.79 28.84 -10.63 -0.66 30.31 -9.57 1e3v_c02 source 1e3v STEROID DELTA-ISOMERASE : 1 hits 1e3v_c02 naa= 3 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR B 179 TYR.? 13.89 O6 C2E B 301 B 40 ASP B 152 ASP.? 19.99 C8 C2E B 301 B 103 ASP B 183 ASP.? 14.33 O1P C2E B 301 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 2.36 25.70 -10.99 3.98 25.02 -13.14 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 2.18 32.86 -17.28 0.63 33.43 -15.93 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 -1.79 28.84 -10.63 -0.66 30.31 -9.57 1e3v_c03 source 1e3v STEROID DELTA-ISOMERASE : 1 hits 1e3v_c03 naa= 3 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 1 3 # 1 B 41 HIS B 214 HIS.? 18.94 O6 C2E B 301 B 43 HIS B 215 HIS.? 11.93 O6 C2E B 301 B 65 GLU B 159 GLU^? 13.76 O6 C2E B 301 coo 20.15 22.08 34.36 20.84 20.10 34.21 13.04 11.66 -4.90 14.49 10.59 -3.83 coo 19.55 18.91 30.27 18.21 18.65 31.84 7.81 14.24 -7.06 6.68 12.76 -6.10 coo 10.90 21.31 28.81 12.14 22.15 30.31 4.99 11.22 -14.77 6.30 9.86 -13.80 1e7l_c01 source 1e7l RECOMBINATION ENDONUCLEASE VII : 1 hits 1e7l_c01 naa= 3 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 1 3 # 1 A 99 HIS A 154 HIS^? 21.74 O6 C2E A 301 A 177 ASP A 152 ASP.? 20.83 C8 C2E A 301 A 203 LYS A 148 LYS^? 21.30 O6 C2E A 301 coo 8.74 45.76 47.19 9.33 46.93 45.56 -16.69 -30.86 2.00 -15.94 -32.47 3.12 coo 11.68 42.31 52.96 12.05 43.92 51.65 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo 18.07 52.81 49.62 14.17 49.99 48.07 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 1ecx_c02 source 1ecx AMINOTRANSFERASE : 1 hits 1ecx_c02 naa= 3 ULMN 3 1ef8_c00 METHYLMALONYL COA DECARBOXYLASE user 1 3 # 1 A 66 HIS B 154 HIS^? 20.45 O6 C2E B 301 A 110 GLY B 156 GLY^? 18.58 O6 C2E B 301 A 140 TYR B 179 TYR.? 13.89 O6 C2E B 301 coo 24.53 0.12 1.91 23.47 1.90 2.27 7.78 28.08 -17.01 9.24 26.69 -16.42 coo 22.96 1.26 5.85 23.32 1.32 6.60 8.27 22.75 -18.03 7.60 22.47 -18.40 coo 21.28 7.32 1.28 21.07 5.14 3.02 2.36 25.70 -10.99 3.98 25.02 -13.14 1ef8_c00 source 1ef8 METHYLMALONYL COA DECARBOXYLASE : 1 hits 1ef8_c00 naa= 3 ULMN 3 1ef8_c01 METHYLMALONYL COA DECARBOXYLASE user 1 3 # 1 B 66 HIS B 154 HIS^? 20.45 O6 C2E B 301 B 110 GLY B 156 GLY^? 18.58 O6 C2E B 301 B 140 TYR B 179 TYR.? 13.89 O6 C2E B 301 coo 15.25 42.02 9.50 15.08 40.17 8.54 7.78 28.08 -17.01 9.24 26.69 -16.42 coo 16.54 37.86 10.86 17.07 37.78 11.48 8.27 22.75 -18.03 7.60 22.47 -18.40 coo 8.70 35.97 10.91 11.44 36.02 10.35 2.36 25.70 -10.99 3.98 25.02 -13.14 1ef8_c01 source 1ef8 METHYLMALONYL COA DECARBOXYLASE : 1 hits 1ef8_c01 naa= 3 ULMN 3 1ef8_c02 METHYLMALONYL COA DECARBOXYLASE user 1 3 # 1 C 66 HIS B 154 HIS^? 20.45 O6 C2E B 301 C 110 GLY B 156 GLY^? 18.58 O6 C2E B 301 C 140 TYR B 179 TYR.? 13.89 O6 C2E B 301 coo -9.82 10.01 28.41 -9.17 11.02 26.71 7.78 28.08 -17.01 9.24 26.69 -16.42 coo -5.73 12.49 27.77 -5.15 12.61 28.37 8.27 22.75 -18.03 7.60 22.47 -18.40 coo -4.68 8.05 21.05 -4.91 10.19 22.84 2.36 25.70 -10.99 3.98 25.02 -13.14 1ef8_c02 source 1ef8 METHYLMALONYL COA DECARBOXYLASE : 1 hits 1ef8_c02 naa= 3 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 A 107 ASP B 152 ASP.? 19.99 C8 C2E B 301 A 246 ASP B 157 ASP^? 20.00 O6 C2E B 301 A 275 HIS B 154 HIS^? 20.45 O6 C2E B 301 coo 28.44 37.56 46.79 26.87 37.11 48.10 2.18 32.86 -17.28 0.63 33.43 -15.93 coo 22.84 50.35 52.24 23.24 48.32 52.90 9.70 18.14 -17.54 10.97 18.31 -19.23 coo 26.67 42.94 48.26 27.49 41.07 48.73 7.78 28.08 -17.01 9.24 26.69 -16.42 1ehy_c00 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 1 hits 1ehy_c00 naa= 3 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 B 107 ASP A 152 ASP.? 20.83 C8 C2E A 301 B 246 ASP A 157 ASP^? 20.06 O6 C2E A 301 B 275 HIS A 154 HIS^? 21.74 O6 C2E A 301 coo 34.84 56.77 81.62 34.95 54.74 82.03 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo 43.18 49.30 68.39 44.75 49.87 69.78 -19.05 -19.29 2.64 -21.12 -19.53 2.92 coo 38.73 55.10 77.62 36.80 55.01 78.46 -16.69 -30.86 2.00 -15.94 -32.47 3.12 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 B 107 ASP B 152 ASP.? 19.99 C8 C2E B 301 B 246 ASP B 157 ASP^? 20.00 O6 C2E B 301 B 275 HIS B 154 HIS^? 20.45 O6 C2E B 301 coo 34.84 56.77 81.62 34.95 54.74 82.03 2.18 32.86 -17.28 0.63 33.43 -15.93 coo 43.18 49.30 68.39 44.75 49.87 69.78 9.70 18.14 -17.54 10.97 18.31 -19.23 coo 38.73 55.10 77.62 36.80 55.01 78.46 7.78 28.08 -17.01 9.24 26.69 -16.42 1ehy_c01 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 2 hits 1ehy_c01 naa= 3 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 C 107 ASP A 31 ASP~? 17.49 O6 C2E B 301 C 246 ASP B 157 ASP^? 20.00 O6 C2E B 301 C 275 HIS B 214 HIS.? 18.94 O6 C2E B 301 coo 1.90 35.26 72.76 3.20 35.74 71.18 10.86 4.60 -5.63 10.78 6.65 -6.14 coo 12.03 20.33 71.56 10.48 19.25 70.56 9.70 18.14 -17.54 10.97 18.31 -19.23 coo 3.92 29.96 71.75 4.22 31.96 72.31 13.04 11.66 -4.90 14.49 10.59 -3.83 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 C 107 ASP A 152 ASP.? 20.83 C8 C2E A 301 C 246 ASP A 157 ASP^? 20.06 O6 C2E A 301 C 275 HIS A 154 HIS^? 21.74 O6 C2E A 301 coo 1.90 35.26 72.76 3.20 35.74 71.18 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo 12.03 20.33 71.56 10.48 19.25 70.56 -19.05 -19.29 2.64 -21.12 -19.53 2.92 coo 3.92 29.96 71.75 4.22 31.96 72.31 -16.69 -30.86 2.00 -15.94 -32.47 3.12 1ehy_c02 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 2 hits 1ehy_c02 naa= 3 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 D 107 ASP A 152 ASP.? 20.83 C8 C2E A 301 D 246 ASP A 157 ASP^? 20.06 O6 C2E A 301 D 275 HIS A 154 HIS^? 21.74 O6 C2E A 301 coo 37.41 19.89 81.58 37.64 21.98 81.53 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo 23.50 26.43 88.52 24.76 26.47 90.29 -19.05 -19.29 2.64 -21.12 -19.53 2.92 coo 33.16 21.44 85.29 34.07 21.53 83.40 -16.69 -30.86 2.00 -15.94 -32.47 3.12 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 D 107 ASP B 152 ASP.? 19.99 C8 C2E B 301 D 246 ASP B 157 ASP^? 20.00 O6 C2E B 301 D 275 HIS B 154 HIS^? 20.45 O6 C2E B 301 coo 37.41 19.89 81.58 37.64 21.98 81.53 2.18 32.86 -17.28 0.63 33.43 -15.93 coo 23.50 26.43 88.52 24.76 26.47 90.29 9.70 18.14 -17.54 10.97 18.31 -19.23 coo 33.16 21.44 85.29 34.07 21.53 83.40 7.78 28.08 -17.01 9.24 26.69 -16.42 1ehy_c03 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 2 hits 1ehy_c03 naa= 3 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 38 THR A 30 THR~? 18.62 O61 C2E B 301 A 159 LYS A 67 LYS.? 22.91 N21 C2E B 301 A 193 GLU B 72 GLU^? 16.96 N21 C2E B 301 coo -2.58 16.31 54.79 -4.02 14.93 55.64 12.18 5.53 -1.07 11.95 7.63 -0.66 coo 2.10 10.68 61.44 -2.14 13.16 60.61 17.01 7.43 8.57 15.28 11.70 10.44 coo -5.33 11.71 69.72 -4.62 11.92 67.73 8.42 10.26 11.58 8.84 10.78 9.58 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 38 THR A 172 THR^? 12.93 O6 C2E A 301 A 159 LYS A 177 LYS.? 20.27 N7 C2E A 301 A 193 GLU A 153 GLU.? 24.63 N7 C2E A 301 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -12.64 -19.39 3.41 -11.97 -21.32 2.68 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -13.21 -27.52 5.04 -11.69 -32.72 3.81 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -19.21 -34.41 1.40 -17.40 -35.49 1.72 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 38 THR A 196 THR.? 26.12 N2 C2E A 301 A 159 LYS A 148 LYS^? 21.30 O6 C2E A 301 A 193 GLU A 159 GLU^? 13.73 O6 C2E A 301 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -28.29 -17.75 -6.49 -30.18 -16.67 -6.61 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -14.60 -12.52 -1.04 -14.41 -10.88 0.31 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 4 3 # 4 A 38 THR A 198 THR.? 19.32 N2 C2E A 301 A 159 LYS A 148 LYS^? 21.30 O6 C2E A 301 A 193 GLU A 159 GLU^? 13.73 O6 C2E A 301 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -23.21 -18.00 -10.51 -22.99 -19.75 -9.26 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -14.60 -12.52 -1.04 -14.41 -10.88 0.31 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 5 3 # 5 A 38 THR A 242 THR.? 12.36 O61 C2E B 301 A 159 LYS B 243 LYS.? 13.43 N1 C2E B 301 A 193 GLU A 101 GLU.? 9.39 O11 C2E A 301 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -9.00 0.35 -6.49 -9.57 0.87 -4.47 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -2.53 1.27 -13.25 2.13 3.70 -10.70 coo -5.33 11.71 69.72 -4.62 11.92 67.73 2.77 -8.35 -14.05 3.97 -7.83 -15.72 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 6 3 # 6 A 38 THR B 172 THR^? 12.75 O6 C2E B 301 A 159 LYS B 177 LYS.? 21.12 N7 C2E B 301 A 193 GLU B 153 GLU.? 24.55 N7 C2E B 301 coo -2.58 16.31 54.79 -4.02 14.93 55.64 7.41 18.34 -11.48 6.25 20.16 -11.39 coo 2.10 10.68 61.44 -2.14 13.16 60.61 8.81 26.59 -11.72 7.46 31.56 -12.94 coo -5.33 11.71 69.72 -4.62 11.92 67.73 6.34 34.05 -19.47 5.09 35.29 -18.27 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 7 3 # 7 A 38 THR B 198 THR.? 19.53 N2 C2E B 301 A 159 LYS B 148 LYS^? 21.33 O6 C2E B 301 A 193 GLU B 159 GLU^? 13.76 O6 C2E B 301 coo -2.58 16.31 54.79 -4.02 14.93 55.64 0.36 15.27 -27.32 1.27 17.22 -26.97 coo 2.10 10.68 61.44 -2.14 13.16 60.61 4.64 19.42 -20.28 9.89 19.27 -22.17 coo -5.33 11.71 69.72 -4.62 11.92 67.73 4.99 11.22 -14.77 6.30 9.86 -13.80 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 8 3 # 8 A 38 THR B 242 THR.? 13.04 O61 C2E A 301 A 159 LYS A 243 LYS.? 15.17 N2 C2E A 301 A 193 GLU B 101 GLU.? 9.43 O11 C2E B 301 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -1.37 -1.91 -11.50 0.71 -2.27 -11.05 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -14.64 6.09 -5.71 -16.72 5.82 -5.44 1et0_c02 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 8 hits 1et0_c02 naa= 3 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 1 3 # 1 A 34 GLU A 72 GLU^? 18.63 N21 C2E A 301 A 260 ARG A 57 ARG^? 7.03 N21 C2E A 301 A 270 LYS A 75 LYS.? 21.41 N21 C2E A 301 coo 50.99 29.43 12.86 52.11 29.45 14.65 6.69 -5.58 14.73 4.83 -6.56 14.45 coo 39.80 27.50 22.98 42.20 26.56 21.34 10.26 -15.76 6.84 9.68 -16.90 4.07 coo 48.83 21.70 19.50 47.44 24.99 15.25 9.70 -14.41 17.00 6.16 -11.27 19.18 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 2 3 # 2 A 34 GLU A 101 GLU.? 9.39 O11 C2E A 301 A 260 ARG B 99 ARG.? 13.88 O61 C2E A 301 A 270 LYS B 243 LYS.? 13.43 N1 C2E B 301 coo 50.99 29.43 12.86 52.11 29.45 14.65 2.77 -8.35 -14.05 3.97 -7.83 -15.72 coo 39.80 27.50 22.98 42.20 26.56 21.34 -4.81 1.09 -3.04 -5.37 -1.84 -3.80 coo 48.83 21.70 19.50 47.44 24.99 15.25 -2.53 1.27 -13.25 2.13 3.70 -10.70 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 3 3 # 3 A 34 GLU A 159 GLU^? 13.73 O6 C2E A 301 A 260 ARG A 140 ARG.? -3.36 C5 C2E A 301s A 270 LYS A 243 LYS.? 15.17 N2 C2E A 301 coo 50.99 29.43 12.86 52.11 29.45 14.65 -14.60 -12.52 -1.04 -14.41 -10.88 0.31 coo 39.80 27.50 22.98 42.20 26.56 21.34 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 coo 48.83 21.70 19.50 47.44 24.99 15.25 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 4 3 # 4 A 34 GLU B 72 GLU^? 16.96 N21 C2E B 301 A 260 ARG B 57 ARG^? 8.07 N21 C2E B 301 A 270 LYS B 75 LYS.? 16.89 N21 C2E B 301 coo 50.99 29.43 12.86 52.11 29.45 14.65 8.42 10.26 11.58 8.84 10.78 9.58 coo 39.80 27.50 22.98 42.20 26.56 21.34 -1.35 19.32 8.13 -4.26 20.09 8.70 coo 48.83 21.70 19.50 47.44 24.99 15.25 7.39 19.64 13.02 10.00 17.22 7.78 1euy_c00 source 1euy GLUTAMINYL-TRNA SYNTHETASE : 4 hits 1euy_c00 naa= 3 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 1 3 # 1 C 95 ASP A 162 ASP^? -3.09 N1 C2E A 301s C 117 GLU A 159 GLU^? 13.73 O6 C2E A 301 C 131 GLU A 142 GLU^? 10.87 N1 C2E A 301 coo 68.01 56.37 72.57 68.42 56.10 70.51 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 66.59 62.50 67.44 67.57 60.64 67.12 -14.60 -12.52 -1.04 -14.41 -10.88 0.31 coo 69.24 52.27 71.96 69.91 50.26 71.89 -5.78 -6.60 -5.54 -5.25 -5.49 -3.81 1f6d_c02 source 1f6d UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE : 1 hits 1f6d_c02 naa= 3 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 1 3 # 1 B 62 LYS A 67 LYS.? 22.91 N21 C2E B 301 C 105 HIS B 214 HIS.? 18.94 O6 C2E B 301 D 35 ASP A 31 ASP~? 17.49 O6 C2E B 301 coo 38.76 28.25 7.87 36.33 26.41 13.58 17.01 7.43 8.57 15.28 11.70 10.44 coo 34.93 19.72 17.37 34.72 18.17 15.98 13.04 11.66 -4.90 14.49 10.59 -3.83 coo 41.01 23.02 20.83 40.65 24.26 22.55 10.86 4.60 -5.63 10.78 6.65 -6.14 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 2 3 # 2 B 62 LYS A 75 LYS.? 21.41 N21 C2E A 301 C 105 HIS B 64 HIS^? 22.95 N21 C2E A 301 D 35 ASP B 66 ASP.? 24.37 N21 C2E A 301 coo 38.76 28.25 7.87 36.33 26.41 13.58 9.70 -14.41 17.00 6.16 -11.27 19.18 coo 34.93 19.72 17.37 34.72 18.17 15.98 5.28 -3.23 17.72 6.30 -4.93 18.40 coo 41.01 23.02 20.83 40.65 24.26 22.55 -3.12 -5.44 17.43 -2.91 -6.73 19.08 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 3 3 # 3 B 62 LYS B 75 LYS.? 16.89 N21 C2E B 301 C 105 HIS A 64 HIS^? 21.50 N21 C2E B 301 D 35 ASP A 66 ASP.? 23.33 N21 C2E B 301 coo 38.76 28.25 7.87 36.33 26.41 13.58 7.39 19.64 13.02 10.00 17.22 7.78 coo 34.93 19.72 17.37 34.72 18.17 15.98 11.95 7.99 12.22 11.86 9.83 13.23 coo 41.01 23.02 20.83 40.65 24.26 22.55 15.60 9.37 4.44 16.85 10.89 5.23 1f80_c04 source 1f80 ACYL CARRIER PROTEIN : 3 hits 1f80_c04 naa= 3 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 112 PHE A 84 PHE.? 23.41 N21 C2E A 301 A 210 ASP A 79 ASP~? 30.21 N21 C2E A 301 A 244 LYS A 75 LYS.? 21.41 N21 C2E A 301 coo 9.23 46.77 25.11 11.48 48.39 24.76 22.11 -15.87 14.74 23.34 -18.33 14.34 coo 10.51 37.86 19.71 9.07 39.38 20.04 19.82 -18.69 22.66 21.43 -19.12 23.96 coo -1.20 42.34 17.67 3.19 45.13 19.06 9.70 -14.41 17.00 6.16 -11.27 19.18 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 112 PHE A 199 PHE.? 15.97 N2 C2E A 301 A 210 ASP A 192 ASP.? 23.17 N2 C2E A 301 A 244 LYS A 148 LYS^? 21.30 O6 C2E A 301 coo 9.23 46.77 25.11 11.48 48.39 24.76 -19.51 -15.48 -13.25 -19.97 -12.76 -13.56 coo 10.51 37.86 19.71 9.07 39.38 20.04 -26.02 -10.21 -8.74 -27.24 -11.85 -9.23 coo -1.20 42.34 17.67 3.19 45.13 19.06 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 A 112 PHE A 199 PHE.? 15.97 N2 C2E A 301 A 210 ASP A 192 ASP.? 23.17 N2 C2E A 301 A 244 LYS A 238 LYS^? 19.93 N2 C2E B 301 coo 9.23 46.77 25.11 11.48 48.39 24.76 -19.51 -15.48 -13.25 -19.97 -12.76 -13.56 coo 10.51 37.86 19.71 9.07 39.38 20.04 -26.02 -10.21 -8.74 -27.24 -11.85 -9.23 coo -1.20 42.34 17.67 3.19 45.13 19.06 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 A 112 PHE A 222 PHE^? 7.21 N3 C2E A 301 A 210 ASP A 162 ASP^? -3.09 N1 C2E A 301s A 244 LYS A 137 LYS.? -4.52 O2' C2E A 301s coo 9.23 46.77 25.11 11.48 48.39 24.76 -7.93 -20.98 -13.39 -9.02 -18.86 -11.96 coo 10.51 37.86 19.71 9.07 39.38 20.04 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo -1.20 42.34 17.67 3.19 45.13 19.06 4.32 -14.05 -15.33 0.72 -19.17 -16.51 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 A 112 PHE B 85 PHE~? 19.52 N21 C2E B 301 A 210 ASP B 79 ASP~? 26.97 N21 C2E B 301 A 244 LYS B 53 LYS^? 20.29 N21 C2E B 301 coo 9.23 46.77 25.11 11.48 48.39 24.76 3.00 15.73 20.69 2.87 13.51 19.06 coo 10.51 37.86 19.71 9.07 39.38 20.04 6.11 26.78 22.67 4.66 27.50 24.05 coo -1.20 42.34 17.67 3.19 45.13 19.06 -7.36 22.58 21.02 -13.56 21.56 20.17 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 A 112 PHE B 170 PHE^? 8.84 O6 C2E B 301 A 210 ASP B 183 ASP.? 14.33 O1P C2E B 301 A 244 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo 9.23 46.77 25.11 11.48 48.39 24.76 0.78 18.23 -12.65 0.68 20.98 -12.20 coo 10.51 37.86 19.71 9.07 39.38 20.04 -1.79 28.84 -10.63 -0.66 30.31 -9.57 coo -1.20 42.34 17.67 3.19 45.13 19.06 8.81 26.59 -11.72 7.46 31.56 -12.94 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 A 112 PHE B 199 PHE.? 15.78 N2 C2E B 301 A 210 ASP B 192 ASP.? 23.13 N2 C2E B 301 A 244 LYS B 148 LYS^? 21.33 O6 C2E B 301 coo 9.23 46.77 25.11 11.48 48.39 24.76 -3.38 12.46 -25.06 -2.84 9.73 -25.01 coo 10.51 37.86 19.71 9.07 39.38 20.04 3.51 7.73 -28.40 4.69 9.27 -29.24 coo -1.20 42.34 17.67 3.19 45.13 19.06 4.64 19.42 -20.28 9.89 19.27 -22.17 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 A 112 PHE B 199 PHE.? 15.78 N2 C2E B 301 A 210 ASP B 192 ASP.? 23.13 N2 C2E B 301 A 244 LYS B 238 LYS^? 16.50 N2 C2E A 301 coo 9.23 46.77 25.11 11.48 48.39 24.76 -3.38 12.46 -25.06 -2.84 9.73 -25.01 coo 10.51 37.86 19.71 9.07 39.38 20.04 3.51 7.73 -28.40 4.69 9.27 -29.24 coo -1.20 42.34 17.67 3.19 45.13 19.06 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 A 112 PHE B 222 PHE^? 7.18 N3 C2E B 301 A 210 ASP B 162 ASP^? -3.04 N1 C2E B 301s A 244 LYS B 137 LYS.? -3.23 O3' C2E B 301s coo 9.23 46.77 25.11 11.48 48.39 24.76 -9.78 18.64 -15.60 -7.86 16.65 -15.65 coo 10.51 37.86 19.71 9.07 39.38 20.04 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo -1.20 42.34 17.67 3.19 45.13 19.06 -16.98 12.27 -5.28 -15.90 17.15 -6.49 1fc4_c02 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 9 hits 1fc4_c02 naa= 3 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 112 PHE A 84 PHE.? 23.41 N21 C2E A 301 B 210 ASP A 79 ASP~? 30.21 N21 C2E A 301 B 244 LYS A 75 LYS.? 21.41 N21 C2E A 301 coo 8.76 47.85 34.91 11.08 46.36 35.41 22.11 -15.87 14.74 23.34 -18.33 14.34 coo 9.06 56.85 40.30 7.71 55.27 39.90 19.82 -18.69 22.66 21.43 -19.12 23.96 coo -2.38 51.82 41.62 2.07 49.19 40.42 9.70 -14.41 17.00 6.16 -11.27 19.18 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 112 PHE A 199 PHE.? 15.97 N2 C2E A 301 B 210 ASP A 192 ASP.? 23.17 N2 C2E A 301 B 244 LYS A 148 LYS^? 21.30 O6 C2E A 301 coo 8.76 47.85 34.91 11.08 46.36 35.41 -19.51 -15.48 -13.25 -19.97 -12.76 -13.56 coo 9.06 56.85 40.30 7.71 55.27 39.90 -26.02 -10.21 -8.74 -27.24 -11.85 -9.23 coo -2.38 51.82 41.62 2.07 49.19 40.42 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 B 112 PHE A 199 PHE.? 15.97 N2 C2E A 301 B 210 ASP A 192 ASP.? 23.17 N2 C2E A 301 B 244 LYS A 238 LYS^? 19.93 N2 C2E B 301 coo 8.76 47.85 34.91 11.08 46.36 35.41 -19.51 -15.48 -13.25 -19.97 -12.76 -13.56 coo 9.06 56.85 40.30 7.71 55.27 39.90 -26.02 -10.21 -8.74 -27.24 -11.85 -9.23 coo -2.38 51.82 41.62 2.07 49.19 40.42 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 B 112 PHE A 222 PHE^? 7.21 N3 C2E A 301 B 210 ASP A 162 ASP^? -3.09 N1 C2E A 301s B 244 LYS A 137 LYS.? -4.52 O2' C2E A 301s coo 8.76 47.85 34.91 11.08 46.36 35.41 -7.93 -20.98 -13.39 -9.02 -18.86 -11.96 coo 9.06 56.85 40.30 7.71 55.27 39.90 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo -2.38 51.82 41.62 2.07 49.19 40.42 4.32 -14.05 -15.33 0.72 -19.17 -16.51 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 B 112 PHE B 85 PHE~? 19.52 N21 C2E B 301 B 210 ASP B 79 ASP~? 26.97 N21 C2E B 301 B 244 LYS B 53 LYS^? 20.29 N21 C2E B 301 coo 8.76 47.85 34.91 11.08 46.36 35.41 3.00 15.73 20.69 2.87 13.51 19.06 coo 9.06 56.85 40.30 7.71 55.27 39.90 6.11 26.78 22.67 4.66 27.50 24.05 coo -2.38 51.82 41.62 2.07 49.19 40.42 -7.36 22.58 21.02 -13.56 21.56 20.17 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 B 112 PHE B 170 PHE^? 8.84 O6 C2E B 301 B 210 ASP B 183 ASP.? 14.33 O1P C2E B 301 B 244 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo 8.76 47.85 34.91 11.08 46.36 35.41 0.78 18.23 -12.65 0.68 20.98 -12.20 coo 9.06 56.85 40.30 7.71 55.27 39.90 -1.79 28.84 -10.63 -0.66 30.31 -9.57 coo -2.38 51.82 41.62 2.07 49.19 40.42 8.81 26.59 -11.72 7.46 31.56 -12.94 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 B 112 PHE B 199 PHE.? 15.78 N2 C2E B 301 B 210 ASP B 192 ASP.? 23.13 N2 C2E B 301 B 244 LYS B 148 LYS^? 21.33 O6 C2E B 301 coo 8.76 47.85 34.91 11.08 46.36 35.41 -3.38 12.46 -25.06 -2.84 9.73 -25.01 coo 9.06 56.85 40.30 7.71 55.27 39.90 3.51 7.73 -28.40 4.69 9.27 -29.24 coo -2.38 51.82 41.62 2.07 49.19 40.42 4.64 19.42 -20.28 9.89 19.27 -22.17 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 B 112 PHE B 199 PHE.? 15.78 N2 C2E B 301 B 210 ASP B 192 ASP.? 23.13 N2 C2E B 301 B 244 LYS B 238 LYS^? 16.50 N2 C2E A 301 coo 8.76 47.85 34.91 11.08 46.36 35.41 -3.38 12.46 -25.06 -2.84 9.73 -25.01 coo 9.06 56.85 40.30 7.71 55.27 39.90 3.51 7.73 -28.40 4.69 9.27 -29.24 coo -2.38 51.82 41.62 2.07 49.19 40.42 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 B 112 PHE B 222 PHE^? 7.18 N3 C2E B 301 B 210 ASP B 162 ASP^? -3.04 N1 C2E B 301s B 244 LYS B 137 LYS.? -3.23 O3' C2E B 301s coo 8.76 47.85 34.91 11.08 46.36 35.41 -9.78 18.64 -15.60 -7.86 16.65 -15.65 coo 9.06 56.85 40.30 7.71 55.27 39.90 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo -2.38 51.82 41.62 2.07 49.19 40.42 -16.98 12.27 -5.28 -15.90 17.15 -6.49 1fc4_c03 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 9 hits 1fc4_c03 naa= 3 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 136 HIS A 154 HIS^? 21.74 O6 C2E A 301 A 210 ASP A 152 ASP.? 20.83 C8 C2E A 301 A 244 LYS A 148 LYS^? 21.30 O6 C2E A 301 coo 11.28 44.53 18.60 9.91 46.00 19.20 -16.69 -30.86 2.00 -15.94 -32.47 3.12 coo 10.51 37.86 19.71 9.07 39.38 20.04 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo -1.20 42.34 17.67 3.19 45.13 19.06 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 1fc4_c04 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 1 hits 1fc4_c04 naa= 3 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 136 HIS A 154 HIS^? 21.74 O6 C2E A 301 B 210 ASP A 152 ASP.? 20.83 C8 C2E A 301 B 244 LYS A 148 LYS^? 21.30 O6 C2E A 301 coo 10.08 50.18 41.78 8.91 48.61 41.04 -16.69 -30.86 2.00 -15.94 -32.47 3.12 coo 9.06 56.85 40.30 7.71 55.27 39.90 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo -2.38 51.82 41.62 2.07 49.19 40.42 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 1fc4_c05 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 1 hits 1fc4_c05 naa= 3 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 137 TYR A 179 TYR.? 13.95 N7 C2E A 301 A 142 LEU A 150 LEU^? 18.78 C6 C2E A 301 A 165 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -17.48 -27.46 -5.66 -19.45 -26.84 -6.33 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 137 TYR A 179 TYR.? 13.95 N7 C2E A 301 A 142 LEU A 184 LEU^? 13.60 O4' C2E A 301 A 165 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -8.88 -31.15 -8.32 -9.17 -30.73 -10.42 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 A 137 TYR A 179 TYR.? 13.95 N7 C2E A 301 A 142 LEU A 187 LEU^? 11.13 N1 C2E A 301 A 165 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -14.25 -20.95 -7.19 -12.62 -20.87 -5.76 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 A 137 TYR A 179 TYR.? 13.95 N7 C2E A 301 A 142 LEU A 209 LEU^? 10.32 O2P C2E A 301 A 165 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -2.83 -23.18 1.61 -2.23 -24.79 2.93 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 A 137 TYR B 179 TYR.? 13.89 O6 C2E B 301 A 142 LEU B 150 LEU^? 18.79 C6 C2E B 301 A 165 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 2.36 25.70 -10.99 3.98 25.02 -13.14 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 1.48 25.42 -20.64 2.22 24.79 -22.56 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 8.81 26.59 -11.72 7.46 31.56 -12.94 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 A 137 TYR B 179 TYR.? 13.89 O6 C2E B 301 A 142 LEU B 187 LEU^? 11.13 N1 C2E B 301 A 165 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 2.36 25.70 -10.99 3.98 25.02 -13.14 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -1.19 18.96 -18.18 -0.81 19.12 -16.06 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 8.81 26.59 -11.72 7.46 31.56 -12.94 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 A 137 TYR B 179 TYR.? 13.89 O6 C2E B 301 A 142 LEU B 209 LEU^? 10.16 O2P C2E B 301 A 165 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 2.36 25.70 -10.99 3.98 25.02 -13.14 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 0.92 22.25 -4.12 1.18 24.25 -3.33 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 8.81 26.59 -11.72 7.46 31.56 -12.94 1fdy_c00 source 1fdy N-ACETYLNEURAMINATE LYASE : 7 hits 1fdy_c00 naa= 3 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 137 TYR A 179 TYR.? 13.95 N7 C2E A 301 B 142 LEU A 150 LEU^? 18.78 C6 C2E A 301 B 165 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -17.48 -27.46 -5.66 -19.45 -26.84 -6.33 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 137 TYR A 179 TYR.? 13.95 N7 C2E A 301 B 142 LEU A 184 LEU^? 13.60 O4' C2E A 301 B 165 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -8.88 -31.15 -8.32 -9.17 -30.73 -10.42 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 B 137 TYR A 179 TYR.? 13.95 N7 C2E A 301 B 142 LEU A 187 LEU^? 11.13 N1 C2E A 301 B 165 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -14.25 -20.95 -7.19 -12.62 -20.87 -5.76 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 B 137 TYR A 179 TYR.? 13.95 N7 C2E A 301 B 142 LEU A 209 LEU^? 10.32 O2P C2E A 301 B 165 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -2.83 -23.18 1.61 -2.23 -24.79 2.93 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 B 137 TYR B 179 TYR.? 13.89 O6 C2E B 301 B 142 LEU B 150 LEU^? 18.79 C6 C2E B 301 B 165 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 2.36 25.70 -10.99 3.98 25.02 -13.14 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 1.48 25.42 -20.64 2.22 24.79 -22.56 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 8.81 26.59 -11.72 7.46 31.56 -12.94 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 B 137 TYR B 179 TYR.? 13.89 O6 C2E B 301 B 142 LEU B 187 LEU^? 11.13 N1 C2E B 301 B 165 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 2.36 25.70 -10.99 3.98 25.02 -13.14 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -1.19 18.96 -18.18 -0.81 19.12 -16.06 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 8.81 26.59 -11.72 7.46 31.56 -12.94 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 B 137 TYR B 179 TYR.? 13.89 O6 C2E B 301 B 142 LEU B 209 LEU^? 10.16 O2P C2E B 301 B 165 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 2.36 25.70 -10.99 3.98 25.02 -13.14 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 0.92 22.25 -4.12 1.18 24.25 -3.33 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 8.81 26.59 -11.72 7.46 31.56 -12.94 1fdy_c01 source 1fdy N-ACETYLNEURAMINATE LYASE : 7 hits 1fdy_c01 naa= 3 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 137 TYR A 179 TYR.? 13.95 N7 C2E A 301 C 142 LEU A 150 LEU^? 18.78 C6 C2E A 301 C 165 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -17.48 -27.46 -5.66 -19.45 -26.84 -6.33 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 137 TYR A 179 TYR.? 13.95 N7 C2E A 301 C 142 LEU A 184 LEU^? 13.60 O4' C2E A 301 C 165 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -8.88 -31.15 -8.32 -9.17 -30.73 -10.42 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 C 137 TYR A 179 TYR.? 13.95 N7 C2E A 301 C 142 LEU A 187 LEU^? 11.13 N1 C2E A 301 C 165 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -14.25 -20.95 -7.19 -12.62 -20.87 -5.76 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 C 137 TYR A 179 TYR.? 13.95 N7 C2E A 301 C 142 LEU A 209 LEU^? 10.32 O2P C2E A 301 C 165 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -2.83 -23.18 1.61 -2.23 -24.79 2.93 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 C 137 TYR B 179 TYR.? 13.89 O6 C2E B 301 C 142 LEU B 150 LEU^? 18.79 C6 C2E B 301 C 165 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 2.36 25.70 -10.99 3.98 25.02 -13.14 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 1.48 25.42 -20.64 2.22 24.79 -22.56 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 8.81 26.59 -11.72 7.46 31.56 -12.94 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 C 137 TYR B 179 TYR.? 13.89 O6 C2E B 301 C 142 LEU B 184 LEU^? 13.53 O4' C2E B 301 C 165 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 2.36 25.70 -10.99 3.98 25.02 -13.14 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -5.69 29.05 -14.86 -6.97 28.33 -16.45 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 8.81 26.59 -11.72 7.46 31.56 -12.94 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 C 137 TYR B 179 TYR.? 13.89 O6 C2E B 301 C 142 LEU B 187 LEU^? 11.13 N1 C2E B 301 C 165 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 2.36 25.70 -10.99 3.98 25.02 -13.14 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -1.19 18.96 -18.18 -0.81 19.12 -16.06 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 8.81 26.59 -11.72 7.46 31.56 -12.94 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 C 137 TYR B 179 TYR.? 13.89 O6 C2E B 301 C 142 LEU B 209 LEU^? 10.16 O2P C2E B 301 C 165 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 2.36 25.70 -10.99 3.98 25.02 -13.14 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 0.92 22.25 -4.12 1.18 24.25 -3.33 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 8.81 26.59 -11.72 7.46 31.56 -12.94 1fdy_c02 source 1fdy N-ACETYLNEURAMINATE LYASE : 8 hits 1fdy_c02 naa= 3 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 137 TYR A 179 TYR.? 13.95 N7 C2E A 301 D 142 LEU A 150 LEU^? 18.78 C6 C2E A 301 D 165 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -17.48 -27.46 -5.66 -19.45 -26.84 -6.33 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 137 TYR A 179 TYR.? 13.95 N7 C2E A 301 D 142 LEU A 184 LEU^? 13.60 O4' C2E A 301 D 165 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -8.88 -31.15 -8.32 -9.17 -30.73 -10.42 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 D 137 TYR A 179 TYR.? 13.95 N7 C2E A 301 D 142 LEU A 187 LEU^? 11.13 N1 C2E A 301 D 165 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -14.25 -20.95 -7.19 -12.62 -20.87 -5.76 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 D 137 TYR A 179 TYR.? 13.95 N7 C2E A 301 D 142 LEU A 209 LEU^? 10.32 O2P C2E A 301 D 165 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -2.83 -23.18 1.61 -2.23 -24.79 2.93 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 D 137 TYR B 179 TYR.? 13.89 O6 C2E B 301 D 142 LEU B 150 LEU^? 18.79 C6 C2E B 301 D 165 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 2.36 25.70 -10.99 3.98 25.02 -13.14 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 1.48 25.42 -20.64 2.22 24.79 -22.56 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 8.81 26.59 -11.72 7.46 31.56 -12.94 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 D 137 TYR B 179 TYR.? 13.89 O6 C2E B 301 D 142 LEU B 187 LEU^? 11.13 N1 C2E B 301 D 165 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 2.36 25.70 -10.99 3.98 25.02 -13.14 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -1.19 18.96 -18.18 -0.81 19.12 -16.06 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 8.81 26.59 -11.72 7.46 31.56 -12.94 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 D 137 TYR B 179 TYR.? 13.89 O6 C2E B 301 D 142 LEU B 209 LEU^? 10.16 O2P C2E B 301 D 165 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 2.36 25.70 -10.99 3.98 25.02 -13.14 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 0.92 22.25 -4.12 1.18 24.25 -3.33 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 8.81 26.59 -11.72 7.46 31.56 -12.94 1fdy_c03 source 1fdy N-ACETYLNEURAMINATE LYASE : 7 hits 1fdy_c03 naa= 3 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 47 SER A 29 SER~? 21.07 N11 C2E A 301 A 48 THR A 129 THR^? 23.05 N11 C2E A 301 A 165 LYS A 67 LYS.? 22.91 N21 C2E B 301 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 15.02 3.06 -1.55 17.13 2.40 -0.57 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 19.06 1.74 -3.58 20.59 2.04 -5.10 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 17.01 7.43 8.57 15.28 11.70 10.44 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 47 SER B 29 SER~? 19.81 N21 C2E B 301 A 48 THR B 129 THR^? 22.45 N21 C2E B 301 A 165 LYS B 67 LYS.? 24.61 N21 C2E A 301 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 -8.69 -0.89 13.28 -8.89 0.42 15.30 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 -12.76 0.32 15.64 -14.76 -0.03 16.38 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -0.41 -2.48 20.16 2.79 -6.43 20.83 1fdy_c04 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c04 naa= 3 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 47 SER A 29 SER~? 21.07 N11 C2E A 301 B 48 THR A 129 THR^? 23.05 N11 C2E A 301 B 165 LYS A 67 LYS.? 22.91 N21 C2E B 301 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 15.02 3.06 -1.55 17.13 2.40 -0.57 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 19.06 1.74 -3.58 20.59 2.04 -5.10 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 17.01 7.43 8.57 15.28 11.70 10.44 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 47 SER B 29 SER~? 19.81 N21 C2E B 301 B 48 THR B 129 THR^? 22.45 N21 C2E B 301 B 165 LYS B 67 LYS.? 24.61 N21 C2E A 301 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 -8.69 -0.89 13.28 -8.89 0.42 15.30 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 -12.76 0.32 15.64 -14.76 -0.03 16.38 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -0.41 -2.48 20.16 2.79 -6.43 20.83 1fdy_c05 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c05 naa= 3 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 47 SER A 29 SER~? 21.07 N11 C2E A 301 C 48 THR A 129 THR^? 23.05 N11 C2E A 301 C 165 LYS A 67 LYS.? 22.91 N21 C2E B 301 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 15.02 3.06 -1.55 17.13 2.40 -0.57 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 19.06 1.74 -3.58 20.59 2.04 -5.10 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 17.01 7.43 8.57 15.28 11.70 10.44 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 47 SER B 29 SER~? 19.81 N21 C2E B 301 C 48 THR B 129 THR^? 22.45 N21 C2E B 301 C 165 LYS B 67 LYS.? 24.61 N21 C2E A 301 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 -8.69 -0.89 13.28 -8.89 0.42 15.30 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 -12.76 0.32 15.64 -14.76 -0.03 16.38 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -0.41 -2.48 20.16 2.79 -6.43 20.83 1fdy_c06 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c06 naa= 3 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 47 SER A 29 SER~? 21.07 N11 C2E A 301 D 48 THR A 129 THR^? 23.05 N11 C2E A 301 D 165 LYS A 67 LYS.? 22.91 N21 C2E B 301 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 15.02 3.06 -1.55 17.13 2.40 -0.57 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 19.06 1.74 -3.58 20.59 2.04 -5.10 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 17.01 7.43 8.57 15.28 11.70 10.44 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 47 SER B 29 SER~? 19.81 N21 C2E B 301 D 48 THR B 129 THR^? 22.45 N21 C2E B 301 D 165 LYS B 67 LYS.? 24.61 N21 C2E A 301 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 -8.69 -0.89 13.28 -8.89 0.42 15.30 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 -12.76 0.32 15.64 -14.76 -0.03 16.38 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -0.41 -2.48 20.16 2.79 -6.43 20.83 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 D 47 SER B 191 SER.? 20.36 N2 C2E B 301 D 48 THR B 198 THR.? 19.53 N2 C2E B 301 D 165 LYS B 231 LYS~? 16.58 O2' C2E B 301 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 0.31 10.28 -26.42 0.19 10.97 -28.73 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 0.36 15.27 -27.32 1.27 17.22 -26.97 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -12.77 12.18 -20.95 -18.80 11.50 -22.86 1fdy_c07 source 1fdy N-ACETYLNEURAMINATE LYASE : 3 hits 1fdy_c07 naa= 3 ULMN 3 1ff3_c00 PEPTIDE METHIONINE SULFOXIDE REDUCTAuser 1 3 # 1 A 94 GLU B 142 GLU^? 10.78 N1 C2E B 301 A 198 CYH B 207 CYH^? -4.01 O1P C2E B 301s A 206 CYH B 56 CYH^? 14.73 N21 C2E B 301 coo 49.92 26.66 0.19 51.26 25.02 0.19 -2.97 5.35 -8.71 -1.84 4.27 -7.29 coo 51.25 11.31 6.04 51.91 8.58 5.83 -6.32 22.95 -5.82 -8.77 22.45 -7.09 coo 38.98 17.42 20.63 38.42 14.68 20.70 -0.90 19.58 13.61 0.17 17.94 15.62 1ff3_c00 source 1ff3 PEPTIDE METHIONINE SULFOXIDE REDUCTASE : 1 hits 1ff3_c00 naa= 3 ULMN 3 1ff3_c01 PEPTIDE METHIONINE SULFOXIDE REDUCTAuser 1 3 # 1 A 94 GLU B 142 GLU^? 10.78 N1 C2E B 301 A 198 CYH B 207 CYH^? -4.01 O1P C2E B 301s A 206 CYH B 56 CYH^? 14.73 N21 C2E B 301 coo 49.92 26.66 0.19 51.26 25.02 0.19 -2.97 5.35 -8.71 -1.84 4.27 -7.29 coo 51.25 11.31 6.04 51.91 8.58 5.83 -6.32 22.95 -5.82 -8.77 22.45 -7.09 coo 38.98 17.42 20.63 38.42 14.68 20.70 -0.90 19.58 13.61 0.17 17.94 15.62 1ff3_c01 source 1ff3 PEPTIDE METHIONINE SULFOXIDE REDUCTASE : 1 hits 1ff3_c01 naa= 3 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG A 99 ARG.? 13.59 O61 C2E B 301 A 136 GLU B 37 GLU.? 9.39 O61 C2E B 301 A 246 GLU A 37 GLU.? 10.20 O61 C2E A 301 coo 13.48 30.30 107.06 11.75 30.99 109.44 -1.29 -2.34 -4.97 -2.19 0.30 -6.23 coo 9.46 32.37 115.82 8.50 34.20 115.47 -0.62 3.88 0.75 -0.32 4.81 -1.12 coo 11.99 34.33 109.92 10.08 34.19 110.77 0.90 -3.13 0.80 -0.70 -4.43 0.36 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 2 3 # 2 A 45 ARG A 165 ARG.? 12.45 N2 C2E A 301 A 136 GLU A 101 GLU.? 9.39 O11 C2E A 301 A 246 GLU A 138 GLU.? 5.46 O2' C2E A 301 coo 13.48 30.30 107.06 11.75 30.99 109.44 -4.47 -13.19 -19.45 -6.66 -12.47 -21.46 coo 9.46 32.37 115.82 8.50 34.20 115.47 2.77 -8.35 -14.05 3.97 -7.83 -15.72 coo 11.99 34.33 109.92 10.08 34.19 110.77 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 3 3 # 3 A 45 ARG A 227 ARG~? 9.91 O2' C2E A 301 A 136 GLU A 225 GLU~? 17.61 C1' C2E A 301 A 246 GLU A 224 GLU~? 15.93 O2' C2E A 301 coo 13.48 30.30 107.06 11.75 30.99 109.44 -5.20 -21.14 -18.72 -4.74 -24.14 -19.17 coo 9.46 32.37 115.82 8.50 34.20 115.47 -14.07 -25.95 -18.02 -15.34 -27.27 -16.96 coo 11.99 34.33 109.92 10.08 34.19 110.77 -8.40 -25.77 -21.72 -8.05 -26.98 -23.42 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 4 3 # 4 A 45 ARG B 99 ARG.? 13.88 O61 C2E A 301 A 136 GLU A 37 GLU.? 10.20 O61 C2E A 301 A 246 GLU B 37 GLU.? 9.39 O61 C2E B 301 coo 13.48 30.30 107.06 11.75 30.99 109.44 -4.81 1.09 -3.04 -5.37 -1.84 -3.80 coo 9.46 32.37 115.82 8.50 34.20 115.47 0.90 -3.13 0.80 -0.70 -4.43 0.36 coo 11.99 34.33 109.92 10.08 34.19 110.77 -0.62 3.88 0.75 -0.32 4.81 -1.12 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 5 3 # 5 A 45 ARG B 165 ARG.? 10.70 O2' C2E B 301 A 136 GLU B 101 GLU.? 9.43 O11 C2E B 301 A 246 GLU B 138 GLU.? 5.49 O2' C2E B 301 coo 13.48 30.30 107.06 11.75 30.99 109.44 -16.44 10.61 -14.72 -19.33 11.67 -14.77 coo 9.46 32.37 115.82 8.50 34.20 115.47 -14.64 6.09 -5.71 -16.72 5.82 -5.44 coo 11.99 34.33 109.92 10.08 34.19 110.77 -14.88 11.83 -9.39 -15.29 12.85 -11.20 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 6 3 # 6 A 45 ARG B 227 ARG~? 7.56 O2' C2E B 301 A 136 GLU B 225 GLU~? 17.01 C1' C2E B 301 A 246 GLU B 224 GLU~? 16.79 O2' C2E B 301 coo 13.48 30.30 107.06 11.75 30.99 109.44 -16.01 19.09 -16.09 -16.65 16.54 -14.51 coo 9.46 32.37 115.82 8.50 34.20 115.47 -10.33 22.86 -23.16 -8.91 24.36 -23.62 coo 11.99 34.33 109.92 10.08 34.19 110.77 -16.80 22.93 -20.90 -17.88 24.32 -22.10 1fhl_c00 source 1fhl BETA-1,4-GALACTANASE : 6 hits 1fhl_c00 naa= 3 ULMN 3 1fo6_c00 N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLuser 1 3 # 1 A 47 GLU A 221 GLU^? -4.32 C4' C2E A 301s A 127 LYS A 205 LYS^? 11.81 O1P C2E A 301 A 172 CYH A 207 CYH^? -4.01 O4' C2E A 301s coo 14.84 17.73 17.72 12.66 18.02 17.60 -2.05 -23.28 -12.44 -0.03 -23.89 -12.66 coo 13.59 13.62 10.66 10.48 17.11 15.01 -5.45 -27.16 -8.25 -2.71 -32.35 -10.76 coo 10.73 13.80 18.28 9.65 16.43 18.61 -0.78 -24.34 -5.34 -0.81 -23.96 -8.11 ULMN 3 1fo6_c00 N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLuser 2 3 # 2 A 47 GLU B 221 GLU^? -4.05 C4' C2E B 301s A 127 LYS B 205 LYS^? -10.36 O1P C2E B 301s A 172 CYH B 207 CYH^? -4.01 O1P C2E B 301s coo 14.84 17.73 17.72 12.66 18.02 17.60 -11.86 21.10 -10.14 -13.00 21.71 -8.45 coo 13.59 13.62 10.66 10.48 17.11 15.01 -6.87 25.33 -11.52 -10.34 29.58 -9.49 coo 10.73 13.80 18.28 9.65 16.43 18.61 -6.32 22.95 -5.82 -8.77 22.45 -7.09 1fo6_c00 source 1fo6 N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLASE : 2 hits 1fo6_c00 naa= 3 ULMN 3 1fo6_c01 N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLuser 1 3 # 1 B 47 GLU B 221 GLU^? -4.05 C4' C2E B 301s B 127 LYS B 205 LYS^? -10.36 O1P C2E B 301s B 172 CYH B 207 CYH^? -4.01 O1P C2E B 301s coo -11.43 -15.11 20.71 -9.41 -15.34 21.12 -11.86 21.10 -10.14 -13.00 21.71 -8.45 coo -8.59 -13.62 12.98 -6.65 -15.32 18.82 -6.87 25.33 -11.52 -10.34 29.58 -9.49 coo -7.53 -11.08 20.68 -6.56 -13.38 22.13 -6.32 22.95 -5.82 -8.77 22.45 -7.09 1fo6_c01 source 1fo6 N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLASE : 1 hits 1fo6_c01 naa= 3 ULMN 3 1fo6_c02 N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLuser 1 3 # 1 C 47 GLU B 221 GLU^? -4.05 C4' C2E B 301s C 127 LYS B 205 LYS^? -10.36 O1P C2E B 301s C 172 CYH B 207 CYH^? -4.01 O1P C2E B 301s coo -14.75 22.68 45.73 -12.65 22.97 45.86 -11.86 21.10 -10.14 -13.00 21.71 -8.45 coo -13.46 21.30 53.90 -10.36 22.98 48.58 -6.87 25.33 -11.52 -10.34 29.58 -9.49 coo -10.67 18.91 46.59 -9.50 21.20 45.39 -6.32 22.95 -5.82 -8.77 22.45 -7.09 1fo6_c02 source 1fo6 N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLASE : 1 hits 1fo6_c02 naa= 3 ULMN 3 1fo6_c03 N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLuser 1 3 # 1 D 47 GLU A 221 GLU^? -4.32 C4' C2E A 301s D 127 LYS A 205 LYS^? 11.81 O1P C2E A 301 D 172 CYH A 207 CYH^? -4.01 O4' C2E A 301s coo 11.48 -9.38 54.24 9.40 -9.76 53.86 -2.05 -23.28 -12.44 -0.03 -23.89 -12.66 coo 8.59 -5.45 60.90 6.67 -8.84 55.89 -5.45 -27.16 -8.25 -2.71 -32.35 -10.76 coo 7.45 -5.79 52.90 6.67 -8.39 52.10 -0.78 -24.34 -5.34 -0.81 -23.96 -8.11 ULMN 3 1fo6_c03 N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLuser 2 3 # 2 D 47 GLU B 221 GLU^? -4.05 C4' C2E B 301s D 127 LYS B 205 LYS^? -10.36 O1P C2E B 301s D 172 CYH B 207 CYH^? -4.01 O1P C2E B 301s coo 11.48 -9.38 54.24 9.40 -9.76 53.86 -11.86 21.10 -10.14 -13.00 21.71 -8.45 coo 8.59 -5.45 60.90 6.67 -8.84 55.89 -6.87 25.33 -11.52 -10.34 29.58 -9.49 coo 7.45 -5.79 52.90 6.67 -8.39 52.10 -6.32 22.95 -5.82 -8.77 22.45 -7.09 1fo6_c03 source 1fo6 N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLASE : 2 hits 1fo6_c03 naa= 3 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG A 99 ARG.? 13.59 O61 C2E B 301 A 136 GLU B 37 GLU.? 9.39 O61 C2E B 301 A 246 GLU A 37 GLU.? 10.20 O61 C2E A 301 coo 13.94 29.84 106.80 11.67 30.40 108.79 -1.29 -2.34 -4.97 -2.19 0.30 -6.23 coo 9.52 31.97 115.23 8.45 33.74 114.72 -0.62 3.88 0.75 -0.32 4.81 -1.12 coo 11.92 33.82 109.35 10.10 33.50 110.39 0.90 -3.13 0.80 -0.70 -4.43 0.36 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 2 3 # 2 A 45 ARG A 165 ARG.? 12.45 N2 C2E A 301 A 136 GLU A 101 GLU.? 9.39 O11 C2E A 301 A 246 GLU A 138 GLU.? 5.46 O2' C2E A 301 coo 13.94 29.84 106.80 11.67 30.40 108.79 -4.47 -13.19 -19.45 -6.66 -12.47 -21.46 coo 9.52 31.97 115.23 8.45 33.74 114.72 2.77 -8.35 -14.05 3.97 -7.83 -15.72 coo 11.92 33.82 109.35 10.10 33.50 110.39 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 3 3 # 3 A 45 ARG A 227 ARG~? 9.91 O2' C2E A 301 A 136 GLU A 225 GLU~? 17.61 C1' C2E A 301 A 246 GLU A 224 GLU~? 15.93 O2' C2E A 301 coo 13.94 29.84 106.80 11.67 30.40 108.79 -5.20 -21.14 -18.72 -4.74 -24.14 -19.17 coo 9.52 31.97 115.23 8.45 33.74 114.72 -14.07 -25.95 -18.02 -15.34 -27.27 -16.96 coo 11.92 33.82 109.35 10.10 33.50 110.39 -8.40 -25.77 -21.72 -8.05 -26.98 -23.42 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 4 3 # 4 A 45 ARG B 99 ARG.? 13.88 O61 C2E A 301 A 136 GLU A 37 GLU.? 10.20 O61 C2E A 301 A 246 GLU B 37 GLU.? 9.39 O61 C2E B 301 coo 13.94 29.84 106.80 11.67 30.40 108.79 -4.81 1.09 -3.04 -5.37 -1.84 -3.80 coo 9.52 31.97 115.23 8.45 33.74 114.72 0.90 -3.13 0.80 -0.70 -4.43 0.36 coo 11.92 33.82 109.35 10.10 33.50 110.39 -0.62 3.88 0.75 -0.32 4.81 -1.12 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 5 3 # 5 A 45 ARG B 165 ARG.? 10.70 O2' C2E B 301 A 136 GLU B 101 GLU.? 9.43 O11 C2E B 301 A 246 GLU B 138 GLU.? 5.49 O2' C2E B 301 coo 13.94 29.84 106.80 11.67 30.40 108.79 -16.44 10.61 -14.72 -19.33 11.67 -14.77 coo 9.52 31.97 115.23 8.45 33.74 114.72 -14.64 6.09 -5.71 -16.72 5.82 -5.44 coo 11.92 33.82 109.35 10.10 33.50 110.39 -14.88 11.83 -9.39 -15.29 12.85 -11.20 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 6 3 # 6 A 45 ARG B 227 ARG~? 7.56 O2' C2E B 301 A 136 GLU B 225 GLU~? 17.01 C1' C2E B 301 A 246 GLU B 224 GLU~? 16.79 O2' C2E B 301 coo 13.94 29.84 106.80 11.67 30.40 108.79 -16.01 19.09 -16.09 -16.65 16.54 -14.51 coo 9.52 31.97 115.23 8.45 33.74 114.72 -10.33 22.86 -23.16 -8.91 24.36 -23.62 coo 11.92 33.82 109.35 10.10 33.50 110.39 -16.80 22.93 -20.90 -17.88 24.32 -22.10 1fob_c00 source 1fob BETA-1,4-GALACTANASE : 6 hits 1fob_c00 naa= 3 ULMN 3 1fuq_c00 FUMARASE C user 1 3 # 1 A 324 LYS B 67 LYS.? 24.61 N21 C2E A 301 A 331 GLU A 117 GLU.? 32.69 N21 C2E A 301 B 188 HIS B 113 HIS^? 28.48 N21 C2E B 301 coo 130.22 155.23 83.49 125.21 153.71 84.04 -0.41 -2.48 20.16 2.79 -6.43 20.83 coo 120.90 152.23 75.28 120.94 153.09 77.19 9.89 -0.66 27.84 10.27 -2.72 27.95 coo 122.04 152.80 81.06 120.71 154.37 81.46 4.95 4.79 25.73 4.34 3.55 27.31 ULMN 3 1fuq_c00 FUMARASE C user 2 3 # 2 A 324 LYS B 148 LYS^? 21.33 O6 C2E B 301 A 331 GLU B 153 GLU.? 24.55 N7 C2E B 301 B 188 HIS B 154 HIS^? 20.45 O6 C2E B 301 coo 130.22 155.23 83.49 125.21 153.71 84.04 4.64 19.42 -20.28 9.89 19.27 -22.17 coo 120.90 152.23 75.28 120.94 153.09 77.19 6.34 34.05 -19.47 5.09 35.29 -18.27 coo 122.04 152.80 81.06 120.71 154.37 81.46 7.78 28.08 -17.01 9.24 26.69 -16.42 1fuq_c00 source 1fuq FUMARASE C : 2 hits 1fuq_c00 naa= 3 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 1 3 # 1 A 197 ARG A 99 ARG.? 13.59 O61 C2E B 301 A 201 HIS A 38 HIS.? 16.46 O61 C2E B 301 A 204 HIS B 38 HIS.? 15.97 O61 C2E B 301 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -1.29 -2.34 -4.97 -2.19 0.30 -6.23 coo -15.08 14.90 41.58 -16.70 13.64 42.02 1.46 -0.40 7.20 -0.57 -0.26 7.72 coo -15.44 20.23 39.72 -16.43 18.87 38.47 4.87 2.64 4.63 6.30 2.30 3.13 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 2 3 # 2 A 197 ARG A 99 ARG.? 13.59 O61 C2E B 301 A 201 HIS B 38 HIS.? 15.97 O61 C2E B 301 A 204 HIS A 38 HIS.? 16.46 O61 C2E B 301 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -1.29 -2.34 -4.97 -2.19 0.30 -6.23 coo -15.08 14.90 41.58 -16.70 13.64 42.02 4.87 2.64 4.63 6.30 2.30 3.13 coo -15.44 20.23 39.72 -16.43 18.87 38.47 1.46 -0.40 7.20 -0.57 -0.26 7.72 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 3 3 # 3 A 197 ARG B 99 ARG.? 13.88 O61 C2E A 301 A 201 HIS B 38 HIS.? 15.97 O61 C2E B 301 A 204 HIS A 38 HIS.? 16.46 O61 C2E B 301 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -4.81 1.09 -3.04 -5.37 -1.84 -3.80 coo -15.08 14.90 41.58 -16.70 13.64 42.02 4.87 2.64 4.63 6.30 2.30 3.13 coo -15.44 20.23 39.72 -16.43 18.87 38.47 1.46 -0.40 7.20 -0.57 -0.26 7.72 1g8f_c00 source 1g8f SULFATE ADENYLYLTRANSFERASE : 3 hits 1g8f_c00 naa= 3 ULMN 3 1gdo_c00 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 3 # 1 B 1 CYH A 207 CYH^? -4.01 O4' C2E A 301s B 98 ASN A 208 ASN^? -3.55 N7 C2E A 301s B 99 GLY A 219 GLY^? -3.43 N7 C2E A 301s coo 60.40 53.51 86.58 58.33 55.30 85.83 -0.78 -24.34 -5.34 -0.81 -23.96 -8.11 coo 61.33 49.28 88.22 61.64 50.04 86.28 0.54 -21.32 -2.29 -0.50 -19.83 -3.42 coo 60.75 49.64 92.68 61.49 50.04 92.62 -3.71 -19.90 -4.28 -4.11 -20.70 -4.09 ULMN 3 1gdo_c00 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 2 3 # 2 B 1 CYH B 207 CYH^? -4.01 O1P C2E B 301s B 98 ASN B 208 ASN^? -3.47 N7 C2E B 301s B 99 GLY B 219 GLY^? -3.38 N7 C2E B 301s coo 60.40 53.51 86.58 58.33 55.30 85.83 -6.32 22.95 -5.82 -8.77 22.45 -7.09 coo 61.33 49.28 88.22 61.64 50.04 86.28 -4.15 20.35 -2.93 -4.56 18.73 -4.26 coo 60.75 49.64 92.68 61.49 50.04 92.62 -3.71 18.46 -7.63 -3.40 19.28 -7.89 1gdo_c00 source 1gdo GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 2 hits 1gdo_c00 naa= 3 ULMN 3 1gdo_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 3 # 1 D 1 CYH A 207 CYH^? -4.01 O4' C2E A 301s D 98 ASN A 208 ASN^? -3.55 N7 C2E A 301s D 99 GLY A 219 GLY^? -3.43 N7 C2E A 301s coo 45.17 35.76 43.57 47.17 33.90 42.78 -0.78 -24.34 -5.34 -0.81 -23.96 -8.11 coo 44.24 40.01 45.19 43.94 39.25 43.24 0.54 -21.32 -2.29 -0.50 -19.83 -3.42 coo 44.81 39.60 49.65 44.07 39.23 49.57 -3.71 -19.90 -4.28 -4.11 -20.70 -4.09 ULMN 3 1gdo_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 2 3 # 2 D 1 CYH B 207 CYH^? -4.01 O1P C2E B 301s D 98 ASN B 208 ASN^? -3.47 N7 C2E B 301s D 99 GLY B 219 GLY^? -3.38 N7 C2E B 301s coo 45.17 35.76 43.57 47.17 33.90 42.78 -6.32 22.95 -5.82 -8.77 22.45 -7.09 coo 44.24 40.01 45.19 43.94 39.25 43.24 -4.15 20.35 -2.93 -4.56 18.73 -4.26 coo 44.81 39.60 49.65 44.07 39.23 49.57 -3.71 18.46 -7.63 -3.40 19.28 -7.89 1gdo_c01 source 1gdo GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 2 hits 1gdo_c01 naa= 3 ULMN 3 1gdo_c02 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 3 # 1 A 1 CYH A 207 CYH^? -4.01 O4' C2E A 301s A 98 ASN A 208 ASN^? -3.55 N7 C2E A 301s A 99 GLY A 219 GLY^? -3.43 N7 C2E A 301s coo 9.96 -7.64 43.39 12.01 -9.40 42.74 -0.78 -24.34 -5.34 -0.81 -23.96 -8.11 coo 9.26 -3.27 45.14 8.86 -4.02 43.23 0.54 -21.32 -2.29 -0.50 -19.83 -3.42 coo 9.85 -3.74 49.57 9.12 -4.11 49.52 -3.71 -19.90 -4.28 -4.11 -20.70 -4.09 ULMN 3 1gdo_c02 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 2 3 # 2 A 1 CYH B 207 CYH^? -4.01 O1P C2E B 301s A 98 ASN B 208 ASN^? -3.47 N7 C2E B 301s A 99 GLY B 219 GLY^? -3.38 N7 C2E B 301s coo 9.96 -7.64 43.39 12.01 -9.40 42.74 -6.32 22.95 -5.82 -8.77 22.45 -7.09 coo 9.26 -3.27 45.14 8.86 -4.02 43.23 -4.15 20.35 -2.93 -4.56 18.73 -4.26 coo 9.85 -3.74 49.57 9.12 -4.11 49.52 -3.71 18.46 -7.63 -3.40 19.28 -7.89 1gdo_c02 source 1gdo GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 2 hits 1gdo_c02 naa= 3 ULMN 3 1gdo_c03 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 3 # 1 C 1 CYH A 207 CYH^? -4.01 O4' C2E A 301s C 98 ASN A 208 ASN^? -3.55 N7 C2E A 301s C 99 GLY A 219 GLY^? -3.43 N7 C2E A 301s coo 25.27 14.39 86.45 23.28 16.25 85.80 -0.78 -24.34 -5.34 -0.81 -23.96 -8.11 coo 25.97 10.04 88.17 26.35 10.81 86.26 0.54 -21.32 -2.29 -0.50 -19.83 -3.42 coo 25.32 10.47 92.61 26.06 10.86 92.54 -3.71 -19.90 -4.28 -4.11 -20.70 -4.09 ULMN 3 1gdo_c03 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 2 3 # 2 C 1 CYH B 207 CYH^? -4.01 O1P C2E B 301s C 98 ASN B 208 ASN^? -3.47 N7 C2E B 301s C 99 GLY B 219 GLY^? -3.38 N7 C2E B 301s coo 25.27 14.39 86.45 23.28 16.25 85.80 -6.32 22.95 -5.82 -8.77 22.45 -7.09 coo 25.97 10.04 88.17 26.35 10.81 86.26 -4.15 20.35 -2.93 -4.56 18.73 -4.26 coo 25.32 10.47 92.61 26.06 10.86 92.54 -3.71 18.46 -7.63 -3.40 19.28 -7.89 1gdo_c03 source 1gdo GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 2 hits 1gdo_c03 naa= 3 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 3 # 1 A 106 ASN A 28 ASN^? 20.35 O6 C2E B 301 A 108 HIS B 214 HIS.? 18.94 O6 C2E B 301 A 144 ASP A 31 ASP~? 17.49 O6 C2E B 301 coo 51.28 61.14 17.85 51.16 61.61 19.96 15.77 5.79 -5.14 13.72 6.29 -5.09 coo 52.62 57.63 23.12 50.77 57.51 22.26 13.04 11.66 -4.90 14.49 10.59 -3.83 coo 46.65 56.95 20.09 48.42 58.17 20.01 10.86 4.60 -5.63 10.78 6.65 -6.14 1grc_c02 source 1grc GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE (E.C: 1 hits 1grc_c02 naa= 3 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 1 3 # 1 160 LYS A 148 LYS^? 21.30 O6 C2E A 301 210 ARG A 140 ARG.? -3.36 C5 C2E A 301s 225 ARG A 169 ARG^? -4.75 O6 C2E A 301s coo 17.51 28.50 73.42 17.24 23.02 75.86 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 coo 24.74 11.56 73.05 25.29 14.32 71.80 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 coo 27.81 15.44 77.10 25.66 16.50 75.19 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 2 3 # 2 160 LYS A 177 LYS.? 20.27 N7 C2E A 301 210 ARG A 161 ARG^? 11.81 O6 C2E A 301 225 ARG A 169 ARG^? -4.75 O6 C2E A 301s coo 17.51 28.50 73.42 17.24 23.02 75.86 -13.21 -27.52 5.04 -11.69 -32.72 3.81 coo 24.74 11.56 73.05 25.29 14.32 71.80 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 coo 27.81 15.44 77.10 25.66 16.50 75.19 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 3 3 # 3 160 LYS A 177 LYS.? 20.27 N7 C2E A 301 210 ARG A 169 ARG^? -4.75 O6 C2E A 301s 225 ARG A 161 ARG^? 11.81 O6 C2E A 301 coo 17.51 28.50 73.42 17.24 23.02 75.86 -13.21 -27.52 5.04 -11.69 -32.72 3.81 coo 24.74 11.56 73.05 25.29 14.32 71.80 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 coo 27.81 15.44 77.10 25.66 16.50 75.19 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 4 3 # 4 160 LYS A 231 LYS~? 13.14 O2' C2E A 301 210 ARG A 161 ARG^? 11.81 O6 C2E A 301 225 ARG A 169 ARG^? -4.75 O6 C2E A 301s coo 17.51 28.50 73.42 17.24 23.02 75.86 -11.44 -15.22 -19.18 -8.27 -15.76 -22.64 coo 24.74 11.56 73.05 25.29 14.32 71.80 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 coo 27.81 15.44 77.10 25.66 16.50 75.19 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 5 3 # 5 160 LYS A 231 LYS~? 13.14 O2' C2E A 301 210 ARG A 169 ARG^? -4.75 O6 C2E A 301s 225 ARG A 161 ARG^? 11.81 O6 C2E A 301 coo 17.51 28.50 73.42 17.24 23.02 75.86 -11.44 -15.22 -19.18 -8.27 -15.76 -22.64 coo 24.74 11.56 73.05 25.29 14.32 71.80 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 coo 27.81 15.44 77.10 25.66 16.50 75.19 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 6 3 # 6 160 LYS A 238 LYS^? 19.93 N2 C2E B 301 210 ARG A 99 ARG.? 13.59 O61 C2E B 301 225 ARG B 99 ARG.? 13.88 O61 C2E A 301 coo 17.51 28.50 73.42 17.24 23.02 75.86 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 coo 24.74 11.56 73.05 25.29 14.32 71.80 -1.29 -2.34 -4.97 -2.19 0.30 -6.23 coo 27.81 15.44 77.10 25.66 16.50 75.19 -4.81 1.09 -3.04 -5.37 -1.84 -3.80 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 7 3 # 7 160 LYS A 238 LYS^? 19.93 N2 C2E B 301 210 ARG A 169 ARG^? -4.75 O6 C2E A 301s 225 ARG A 140 ARG.? -3.36 C5 C2E A 301s coo 17.51 28.50 73.42 17.24 23.02 75.86 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 coo 24.74 11.56 73.05 25.29 14.32 71.80 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 coo 27.81 15.44 77.10 25.66 16.50 75.19 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 8 3 # 8 160 LYS A 238 LYS^? 19.93 N2 C2E B 301 210 ARG A 169 ARG^? -4.75 O6 C2E A 301s 225 ARG A 161 ARG^? 11.81 O6 C2E A 301 coo 17.51 28.50 73.42 17.24 23.02 75.86 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 coo 24.74 11.56 73.05 25.29 14.32 71.80 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 coo 27.81 15.44 77.10 25.66 16.50 75.19 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 9 3 # 9 160 LYS A 243 LYS.? 15.17 N2 C2E A 301 210 ARG B 161 ARG^? 11.68 O6 C2E B 301 225 ARG B 169 ARG^? -4.70 O6 C2E B 301s coo 17.51 28.50 73.42 17.24 23.02 75.86 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo 24.74 11.56 73.05 25.29 14.32 71.80 2.96 9.64 -10.71 5.59 9.57 -9.11 coo 27.81 15.44 77.10 25.66 16.50 75.19 -0.88 13.03 -7.12 -1.56 12.92 -4.13 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 10 3 # 10 160 LYS A 243 LYS.? 15.17 N2 C2E A 301 210 ARG B 169 ARG^? -4.70 O6 C2E B 301s 225 ARG B 161 ARG^? 11.68 O6 C2E B 301 coo 17.51 28.50 73.42 17.24 23.02 75.86 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo 24.74 11.56 73.05 25.29 14.32 71.80 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo 27.81 15.44 77.10 25.66 16.50 75.19 2.96 9.64 -10.71 5.59 9.57 -9.11 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 11 3 # 11 160 LYS B 148 LYS^? 21.33 O6 C2E B 301 210 ARG B 140 ARG.? -3.40 C5 C2E B 301s 225 ARG B 169 ARG^? -4.70 O6 C2E B 301s coo 17.51 28.50 73.42 17.24 23.02 75.86 4.64 19.42 -20.28 9.89 19.27 -22.17 coo 24.74 11.56 73.05 25.29 14.32 71.80 -7.91 11.52 -6.78 -7.96 14.04 -5.01 coo 27.81 15.44 77.10 25.66 16.50 75.19 -0.88 13.03 -7.12 -1.56 12.92 -4.13 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 12 3 # 12 160 LYS B 177 LYS.? 21.12 N7 C2E B 301 210 ARG B 161 ARG^? 11.68 O6 C2E B 301 225 ARG B 169 ARG^? -4.70 O6 C2E B 301s coo 17.51 28.50 73.42 17.24 23.02 75.86 8.81 26.59 -11.72 7.46 31.56 -12.94 coo 24.74 11.56 73.05 25.29 14.32 71.80 2.96 9.64 -10.71 5.59 9.57 -9.11 coo 27.81 15.44 77.10 25.66 16.50 75.19 -0.88 13.03 -7.12 -1.56 12.92 -4.13 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 13 3 # 13 160 LYS B 177 LYS.? 21.12 N7 C2E B 301 210 ARG B 169 ARG^? -4.70 O6 C2E B 301s 225 ARG B 161 ARG^? 11.68 O6 C2E B 301 coo 17.51 28.50 73.42 17.24 23.02 75.86 8.81 26.59 -11.72 7.46 31.56 -12.94 coo 24.74 11.56 73.05 25.29 14.32 71.80 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo 27.81 15.44 77.10 25.66 16.50 75.19 2.96 9.64 -10.71 5.59 9.57 -9.11 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 14 3 # 14 160 LYS B 231 LYS~? 16.58 O2' C2E B 301 210 ARG B 161 ARG^? 11.68 O6 C2E B 301 225 ARG B 169 ARG^? -4.70 O6 C2E B 301s coo 17.51 28.50 73.42 17.24 23.02 75.86 -12.77 12.18 -20.95 -18.80 11.50 -22.86 coo 24.74 11.56 73.05 25.29 14.32 71.80 2.96 9.64 -10.71 5.59 9.57 -9.11 coo 27.81 15.44 77.10 25.66 16.50 75.19 -0.88 13.03 -7.12 -1.56 12.92 -4.13 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 15 3 # 15 160 LYS B 231 LYS~? 16.58 O2' C2E B 301 210 ARG B 169 ARG^? -4.70 O6 C2E B 301s 225 ARG B 161 ARG^? 11.68 O6 C2E B 301 coo 17.51 28.50 73.42 17.24 23.02 75.86 -12.77 12.18 -20.95 -18.80 11.50 -22.86 coo 24.74 11.56 73.05 25.29 14.32 71.80 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo 27.81 15.44 77.10 25.66 16.50 75.19 2.96 9.64 -10.71 5.59 9.57 -9.11 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 16 3 # 16 160 LYS B 238 LYS^? 16.50 N2 C2E A 301 210 ARG A 99 ARG.? 13.59 O61 C2E B 301 225 ARG B 99 ARG.? 13.88 O61 C2E A 301 coo 17.51 28.50 73.42 17.24 23.02 75.86 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 coo 24.74 11.56 73.05 25.29 14.32 71.80 -1.29 -2.34 -4.97 -2.19 0.30 -6.23 coo 27.81 15.44 77.10 25.66 16.50 75.19 -4.81 1.09 -3.04 -5.37 -1.84 -3.80 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 17 3 # 17 160 LYS B 238 LYS^? 16.50 N2 C2E A 301 210 ARG B 99 ARG.? 13.88 O61 C2E A 301 225 ARG A 99 ARG.? 13.59 O61 C2E B 301 coo 17.51 28.50 73.42 17.24 23.02 75.86 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 coo 24.74 11.56 73.05 25.29 14.32 71.80 -4.81 1.09 -3.04 -5.37 -1.84 -3.80 coo 27.81 15.44 77.10 25.66 16.50 75.19 -1.29 -2.34 -4.97 -2.19 0.30 -6.23 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 18 3 # 18 160 LYS B 238 LYS^? 16.50 N2 C2E A 301 210 ARG B 169 ARG^? -4.70 O6 C2E B 301s 225 ARG B 140 ARG.? -3.40 C5 C2E B 301s coo 17.51 28.50 73.42 17.24 23.02 75.86 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 coo 24.74 11.56 73.05 25.29 14.32 71.80 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo 27.81 15.44 77.10 25.66 16.50 75.19 -7.91 11.52 -6.78 -7.96 14.04 -5.01 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 19 3 # 19 160 LYS B 238 LYS^? 16.50 N2 C2E A 301 210 ARG B 169 ARG^? -4.70 O6 C2E B 301s 225 ARG B 161 ARG^? 11.68 O6 C2E B 301 coo 17.51 28.50 73.42 17.24 23.02 75.86 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 coo 24.74 11.56 73.05 25.29 14.32 71.80 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo 27.81 15.44 77.10 25.66 16.50 75.19 2.96 9.64 -10.71 5.59 9.57 -9.11 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 20 3 # 20 160 LYS B 243 LYS.? 13.43 N1 C2E B 301 210 ARG A 169 ARG^? -4.75 O6 C2E A 301s 225 ARG A 140 ARG.? -3.36 C5 C2E A 301s coo 17.51 28.50 73.42 17.24 23.02 75.86 -2.53 1.27 -13.25 2.13 3.70 -10.70 coo 24.74 11.56 73.05 25.29 14.32 71.80 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 coo 27.81 15.44 77.10 25.66 16.50 75.19 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 21 3 # 21 160 LYS B 243 LYS.? 13.43 N1 C2E B 301 210 ARG A 169 ARG^? -4.75 O6 C2E A 301s 225 ARG A 161 ARG^? 11.81 O6 C2E A 301 coo 17.51 28.50 73.42 17.24 23.02 75.86 -2.53 1.27 -13.25 2.13 3.70 -10.70 coo 24.74 11.56 73.05 25.29 14.32 71.80 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 coo 27.81 15.44 77.10 25.66 16.50 75.19 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 1gsa_c00 source 1gsa GLUTATHIONE SYNTHETASE : 21 hits 1gsa_c00 naa= 3 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 A 189 PHE A 54 PHE^? 19.63 N21 C2E A 301 A 298 ASP A 79 ASP~? 30.21 N21 C2E A 301 A 329 LYS A 75 LYS.? 21.41 N21 C2E A 301 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 19.69 -16.80 12.43 17.45 -17.09 14.05 coo 2.59 0.29 25.55 4.65 0.18 25.07 19.82 -18.69 22.66 21.43 -19.12 23.96 coo 12.42 6.10 23.27 9.95 1.57 20.16 9.70 -14.41 17.00 6.16 -11.27 19.18 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 A 189 PHE A 84 PHE.? 23.41 N21 C2E A 301 A 298 ASP A 79 ASP~? 30.21 N21 C2E A 301 A 329 LYS A 75 LYS.? 21.41 N21 C2E A 301 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 22.11 -15.87 14.74 23.34 -18.33 14.34 coo 2.59 0.29 25.55 4.65 0.18 25.07 19.82 -18.69 22.66 21.43 -19.12 23.96 coo 12.42 6.10 23.27 9.95 1.57 20.16 9.70 -14.41 17.00 6.16 -11.27 19.18 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 A 189 PHE A 85 PHE.? 21.18 N21 C2E A 301 A 298 ASP A 80 ASP~? 23.66 N21 C2E A 301 A 329 LYS A 53 LYS^? 19.63 N21 C2E A 301 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 18.09 -9.55 15.63 16.44 -8.05 13.97 coo 2.59 0.29 25.55 4.65 0.18 25.07 18.53 -17.34 17.76 18.57 -19.44 17.90 coo 12.42 6.10 23.27 9.95 1.57 20.16 24.14 -17.55 8.54 24.93 -16.56 3.33 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 A 189 PHE A 170 PHE^? 8.91 O6 C2E A 301 A 298 ASP A 157 ASP^? 20.06 O6 C2E A 301 A 329 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -10.47 -19.67 -2.91 -9.94 -22.37 -2.52 coo 2.59 0.29 25.55 4.65 0.18 25.07 -19.05 -19.29 2.64 -21.12 -19.53 2.92 coo 12.42 6.10 23.27 9.95 1.57 20.16 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 A 189 PHE B 54 PHE^? 17.95 N21 C2E B 301 A 298 ASP B 79 ASP~? 26.97 N21 C2E B 301 A 329 LYS B 75 LYS.? 16.89 N21 C2E B 301 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -1.86 22.37 18.66 0.47 22.95 17.25 coo 2.59 0.29 25.55 4.65 0.18 25.07 6.11 26.78 22.67 4.66 27.50 24.05 coo 12.42 6.10 23.27 9.95 1.57 20.16 7.39 19.64 13.02 10.00 17.22 7.78 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 A 189 PHE B 84 PHE~? 21.91 N21 C2E B 301 A 298 ASP B 79 ASP~? 26.97 N21 C2E B 301 A 329 LYS B 75 LYS.? 16.89 N21 C2E B 301 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -0.90 22.18 22.15 -2.04 24.70 22.44 coo 2.59 0.29 25.55 4.65 0.18 25.07 6.11 26.78 22.67 4.66 27.50 24.05 coo 12.42 6.10 23.27 9.95 1.57 20.16 7.39 19.64 13.02 10.00 17.22 7.78 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 A 189 PHE B 85 PHE~? 19.52 N21 C2E B 301 A 298 ASP B 80 ASP~? 21.84 N21 C2E B 301 A 329 LYS B 53 LYS^? 20.29 N21 C2E B 301 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 3.00 15.73 20.69 2.87 13.51 19.06 coo 2.59 0.29 25.55 4.65 0.18 25.07 3.05 24.05 19.78 2.70 26.08 19.35 coo 12.42 6.10 23.27 9.95 1.57 20.16 -7.36 22.58 21.02 -13.56 21.56 20.17 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 A 189 PHE B 170 PHE^? 8.84 O6 C2E B 301 A 298 ASP B 157 ASP^? 20.00 O6 C2E B 301 A 329 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 0.78 18.23 -12.65 0.68 20.98 -12.20 coo 2.59 0.29 25.55 4.65 0.18 25.07 9.70 18.14 -17.54 10.97 18.31 -19.23 coo 12.42 6.10 23.27 9.95 1.57 20.16 8.81 26.59 -11.72 7.46 31.56 -12.94 1gtx_c00 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 8 hits 1gtx_c00 naa= 3 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 B 189 PHE A 54 PHE^? 19.63 N21 C2E A 301 B 298 ASP A 79 ASP~? 30.21 N21 C2E A 301 B 329 LYS A 75 LYS.? 21.41 N21 C2E A 301 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 19.69 -16.80 12.43 17.45 -17.09 14.05 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 19.82 -18.69 22.66 21.43 -19.12 23.96 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 9.70 -14.41 17.00 6.16 -11.27 19.18 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 B 189 PHE A 84 PHE.? 23.41 N21 C2E A 301 B 298 ASP A 79 ASP~? 30.21 N21 C2E A 301 B 329 LYS A 75 LYS.? 21.41 N21 C2E A 301 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 22.11 -15.87 14.74 23.34 -18.33 14.34 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 19.82 -18.69 22.66 21.43 -19.12 23.96 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 9.70 -14.41 17.00 6.16 -11.27 19.18 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 B 189 PHE A 85 PHE.? 21.18 N21 C2E A 301 B 298 ASP A 80 ASP~? 23.66 N21 C2E A 301 B 329 LYS A 53 LYS^? 19.63 N21 C2E A 301 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 18.09 -9.55 15.63 16.44 -8.05 13.97 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 18.53 -17.34 17.76 18.57 -19.44 17.90 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 24.14 -17.55 8.54 24.93 -16.56 3.33 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 B 189 PHE A 170 PHE^? 8.91 O6 C2E A 301 B 298 ASP A 157 ASP^? 20.06 O6 C2E A 301 B 329 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -10.47 -19.67 -2.91 -9.94 -22.37 -2.52 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -19.05 -19.29 2.64 -21.12 -19.53 2.92 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 B 189 PHE B 54 PHE^? 17.95 N21 C2E B 301 B 298 ASP B 79 ASP~? 26.97 N21 C2E B 301 B 329 LYS B 75 LYS.? 16.89 N21 C2E B 301 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -1.86 22.37 18.66 0.47 22.95 17.25 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 6.11 26.78 22.67 4.66 27.50 24.05 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 7.39 19.64 13.02 10.00 17.22 7.78 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 B 189 PHE B 84 PHE~? 21.91 N21 C2E B 301 B 298 ASP B 79 ASP~? 26.97 N21 C2E B 301 B 329 LYS B 75 LYS.? 16.89 N21 C2E B 301 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -0.90 22.18 22.15 -2.04 24.70 22.44 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 6.11 26.78 22.67 4.66 27.50 24.05 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 7.39 19.64 13.02 10.00 17.22 7.78 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 B 189 PHE B 85 PHE~? 19.52 N21 C2E B 301 B 298 ASP B 80 ASP~? 21.84 N21 C2E B 301 B 329 LYS B 53 LYS^? 20.29 N21 C2E B 301 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 3.00 15.73 20.69 2.87 13.51 19.06 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 3.05 24.05 19.78 2.70 26.08 19.35 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -7.36 22.58 21.02 -13.56 21.56 20.17 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 B 189 PHE B 170 PHE^? 8.84 O6 C2E B 301 B 298 ASP B 157 ASP^? 20.00 O6 C2E B 301 B 329 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 0.78 18.23 -12.65 0.68 20.98 -12.20 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 9.70 18.14 -17.54 10.97 18.31 -19.23 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 8.81 26.59 -11.72 7.46 31.56 -12.94 1gtx_c01 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 8 hits 1gtx_c01 naa= 3 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 C 189 PHE A 54 PHE^? 19.63 N21 C2E A 301 C 298 ASP A 79 ASP~? 30.21 N21 C2E A 301 C 329 LYS A 75 LYS.? 21.41 N21 C2E A 301 coo 17.41 60.57 64.39 18.40 58.12 65.34 19.69 -16.80 12.43 17.45 -17.09 14.05 coo 24.10 66.43 63.33 24.18 64.30 63.40 19.82 -18.69 22.66 21.43 -19.12 23.96 coo 27.64 56.61 58.17 22.18 57.92 60.36 9.70 -14.41 17.00 6.16 -11.27 19.18 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 C 189 PHE A 84 PHE.? 23.41 N21 C2E A 301 C 298 ASP A 79 ASP~? 30.21 N21 C2E A 301 C 329 LYS A 75 LYS.? 21.41 N21 C2E A 301 coo 17.41 60.57 64.39 18.40 58.12 65.34 22.11 -15.87 14.74 23.34 -18.33 14.34 coo 24.10 66.43 63.33 24.18 64.30 63.40 19.82 -18.69 22.66 21.43 -19.12 23.96 coo 27.64 56.61 58.17 22.18 57.92 60.36 9.70 -14.41 17.00 6.16 -11.27 19.18 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 C 189 PHE A 85 PHE.? 21.18 N21 C2E A 301 C 298 ASP A 80 ASP~? 23.66 N21 C2E A 301 C 329 LYS A 53 LYS^? 19.63 N21 C2E A 301 coo 17.41 60.57 64.39 18.40 58.12 65.34 18.09 -9.55 15.63 16.44 -8.05 13.97 coo 24.10 66.43 63.33 24.18 64.30 63.40 18.53 -17.34 17.76 18.57 -19.44 17.90 coo 27.64 56.61 58.17 22.18 57.92 60.36 24.14 -17.55 8.54 24.93 -16.56 3.33 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 C 189 PHE A 170 PHE^? 8.91 O6 C2E A 301 C 298 ASP A 157 ASP^? 20.06 O6 C2E A 301 C 329 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo 17.41 60.57 64.39 18.40 58.12 65.34 -10.47 -19.67 -2.91 -9.94 -22.37 -2.52 coo 24.10 66.43 63.33 24.18 64.30 63.40 -19.05 -19.29 2.64 -21.12 -19.53 2.92 coo 27.64 56.61 58.17 22.18 57.92 60.36 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 C 189 PHE B 54 PHE^? 17.95 N21 C2E B 301 C 298 ASP B 79 ASP~? 26.97 N21 C2E B 301 C 329 LYS B 75 LYS.? 16.89 N21 C2E B 301 coo 17.41 60.57 64.39 18.40 58.12 65.34 -1.86 22.37 18.66 0.47 22.95 17.25 coo 24.10 66.43 63.33 24.18 64.30 63.40 6.11 26.78 22.67 4.66 27.50 24.05 coo 27.64 56.61 58.17 22.18 57.92 60.36 7.39 19.64 13.02 10.00 17.22 7.78 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 C 189 PHE B 84 PHE~? 21.91 N21 C2E B 301 C 298 ASP B 79 ASP~? 26.97 N21 C2E B 301 C 329 LYS B 75 LYS.? 16.89 N21 C2E B 301 coo 17.41 60.57 64.39 18.40 58.12 65.34 -0.90 22.18 22.15 -2.04 24.70 22.44 coo 24.10 66.43 63.33 24.18 64.30 63.40 6.11 26.78 22.67 4.66 27.50 24.05 coo 27.64 56.61 58.17 22.18 57.92 60.36 7.39 19.64 13.02 10.00 17.22 7.78 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 C 189 PHE B 85 PHE~? 19.52 N21 C2E B 301 C 298 ASP B 80 ASP~? 21.84 N21 C2E B 301 C 329 LYS B 53 LYS^? 20.29 N21 C2E B 301 coo 17.41 60.57 64.39 18.40 58.12 65.34 3.00 15.73 20.69 2.87 13.51 19.06 coo 24.10 66.43 63.33 24.18 64.30 63.40 3.05 24.05 19.78 2.70 26.08 19.35 coo 27.64 56.61 58.17 22.18 57.92 60.36 -7.36 22.58 21.02 -13.56 21.56 20.17 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 C 189 PHE B 170 PHE^? 8.84 O6 C2E B 301 C 298 ASP B 157 ASP^? 20.00 O6 C2E B 301 C 329 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo 17.41 60.57 64.39 18.40 58.12 65.34 0.78 18.23 -12.65 0.68 20.98 -12.20 coo 24.10 66.43 63.33 24.18 64.30 63.40 9.70 18.14 -17.54 10.97 18.31 -19.23 coo 27.64 56.61 58.17 22.18 57.92 60.36 8.81 26.59 -11.72 7.46 31.56 -12.94 1gtx_c02 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 8 hits 1gtx_c02 naa= 3 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 D 189 PHE A 54 PHE^? 19.63 N21 C2E A 301 D 298 ASP A 79 ASP~? 30.21 N21 C2E A 301 D 329 LYS A 75 LYS.? 21.41 N21 C2E A 301 coo 35.44 53.35 83.81 35.65 54.53 81.28 19.69 -16.80 12.43 17.45 -17.09 14.05 coo 29.72 46.46 83.60 30.79 47.36 81.99 19.82 -18.69 22.66 21.43 -19.12 23.96 coo 36.89 44.91 74.55 37.33 48.94 79.01 9.70 -14.41 17.00 6.16 -11.27 19.18 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 D 189 PHE A 84 PHE.? 23.41 N21 C2E A 301 D 298 ASP A 79 ASP~? 30.21 N21 C2E A 301 D 329 LYS A 75 LYS.? 21.41 N21 C2E A 301 coo 35.44 53.35 83.81 35.65 54.53 81.28 22.11 -15.87 14.74 23.34 -18.33 14.34 coo 29.72 46.46 83.60 30.79 47.36 81.99 19.82 -18.69 22.66 21.43 -19.12 23.96 coo 36.89 44.91 74.55 37.33 48.94 79.01 9.70 -14.41 17.00 6.16 -11.27 19.18 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 D 189 PHE A 85 PHE.? 21.18 N21 C2E A 301 D 298 ASP A 80 ASP~? 23.66 N21 C2E A 301 D 329 LYS A 53 LYS^? 19.63 N21 C2E A 301 coo 35.44 53.35 83.81 35.65 54.53 81.28 18.09 -9.55 15.63 16.44 -8.05 13.97 coo 29.72 46.46 83.60 30.79 47.36 81.99 18.53 -17.34 17.76 18.57 -19.44 17.90 coo 36.89 44.91 74.55 37.33 48.94 79.01 24.14 -17.55 8.54 24.93 -16.56 3.33 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 D 189 PHE A 170 PHE^? 8.91 O6 C2E A 301 D 298 ASP A 157 ASP^? 20.06 O6 C2E A 301 D 329 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo 35.44 53.35 83.81 35.65 54.53 81.28 -10.47 -19.67 -2.91 -9.94 -22.37 -2.52 coo 29.72 46.46 83.60 30.79 47.36 81.99 -19.05 -19.29 2.64 -21.12 -19.53 2.92 coo 36.89 44.91 74.55 37.33 48.94 79.01 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 D 189 PHE B 54 PHE^? 17.95 N21 C2E B 301 D 298 ASP B 79 ASP~? 26.97 N21 C2E B 301 D 329 LYS B 75 LYS.? 16.89 N21 C2E B 301 coo 35.44 53.35 83.81 35.65 54.53 81.28 -1.86 22.37 18.66 0.47 22.95 17.25 coo 29.72 46.46 83.60 30.79 47.36 81.99 6.11 26.78 22.67 4.66 27.50 24.05 coo 36.89 44.91 74.55 37.33 48.94 79.01 7.39 19.64 13.02 10.00 17.22 7.78 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 D 189 PHE B 84 PHE~? 21.91 N21 C2E B 301 D 298 ASP B 79 ASP~? 26.97 N21 C2E B 301 D 329 LYS B 75 LYS.? 16.89 N21 C2E B 301 coo 35.44 53.35 83.81 35.65 54.53 81.28 -0.90 22.18 22.15 -2.04 24.70 22.44 coo 29.72 46.46 83.60 30.79 47.36 81.99 6.11 26.78 22.67 4.66 27.50 24.05 coo 36.89 44.91 74.55 37.33 48.94 79.01 7.39 19.64 13.02 10.00 17.22 7.78 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 D 189 PHE B 85 PHE~? 19.52 N21 C2E B 301 D 298 ASP B 80 ASP~? 21.84 N21 C2E B 301 D 329 LYS B 53 LYS^? 20.29 N21 C2E B 301 coo 35.44 53.35 83.81 35.65 54.53 81.28 3.00 15.73 20.69 2.87 13.51 19.06 coo 29.72 46.46 83.60 30.79 47.36 81.99 3.05 24.05 19.78 2.70 26.08 19.35 coo 36.89 44.91 74.55 37.33 48.94 79.01 -7.36 22.58 21.02 -13.56 21.56 20.17 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 D 189 PHE B 170 PHE^? 8.84 O6 C2E B 301 D 298 ASP B 157 ASP^? 20.00 O6 C2E B 301 D 329 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo 35.44 53.35 83.81 35.65 54.53 81.28 0.78 18.23 -12.65 0.68 20.98 -12.20 coo 29.72 46.46 83.60 30.79 47.36 81.99 9.70 18.14 -17.54 10.97 18.31 -19.23 coo 36.89 44.91 74.55 37.33 48.94 79.01 8.81 26.59 -11.72 7.46 31.56 -12.94 1gtx_c03 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 8 hits 1gtx_c03 naa= 3 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 1 3 # 1 A 50 ASP A 80 ASP~? 23.66 N21 C2E A 301 A 327 GLU A 188 GLU^? 19.90 N2 C2E A 301 A 339 ARG A 155 ARG^? 21.80 N1 C2E A 301 coo 85.81 57.99 116.01 86.03 55.86 115.89 18.53 -17.34 17.76 18.57 -19.44 17.90 coo 75.11 41.01 160.30 76.65 40.06 161.41 -20.03 -23.11 -8.39 -21.92 -24.07 -8.27 coo 82.23 40.35 159.87 85.09 40.67 161.01 -22.65 -25.75 -3.25 -23.90 -23.07 -4.10 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 2 3 # 2 A 50 ASP A 80 ASP~? 23.66 N21 C2E A 301 A 327 GLU B 101 GLU.? 9.43 O11 C2E B 301 A 339 ARG B 136 ARG.? -3.89 O61 C2E B 301s coo 85.81 57.99 116.01 86.03 55.86 115.89 18.53 -17.34 17.76 18.57 -19.44 17.90 coo 75.11 41.01 160.30 76.65 40.06 161.41 -14.64 6.09 -5.71 -16.72 5.82 -5.44 coo 82.23 40.35 159.87 85.09 40.67 161.01 -10.39 10.75 -3.93 -7.55 9.68 -3.54 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 3 3 # 3 A 50 ASP A 80 ASP~? 23.66 N21 C2E A 301 A 327 GLU B 101 GLU.? 9.43 O11 C2E B 301 A 339 ARG B 140 ARG.? -3.40 C5 C2E B 301s coo 85.81 57.99 116.01 86.03 55.86 115.89 18.53 -17.34 17.76 18.57 -19.44 17.90 coo 75.11 41.01 160.30 76.65 40.06 161.41 -14.64 6.09 -5.71 -16.72 5.82 -5.44 coo 82.23 40.35 159.87 85.09 40.67 161.01 -7.91 11.52 -6.78 -7.96 14.04 -5.01 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 4 3 # 4 A 50 ASP A 152 ASP.? 20.83 C8 C2E A 301 A 327 GLU B 138 GLU.? 5.49 O2' C2E B 301 A 339 ARG B 136 ARG.? -3.89 O61 C2E B 301s coo 85.81 57.99 116.01 86.03 55.86 115.89 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo 75.11 41.01 160.30 76.65 40.06 161.41 -14.88 11.83 -9.39 -15.29 12.85 -11.20 coo 82.23 40.35 159.87 85.09 40.67 161.01 -10.39 10.75 -3.93 -7.55 9.68 -3.54 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 5 3 # 5 A 50 ASP A 152 ASP.? 20.83 C8 C2E A 301 A 327 GLU B 138 GLU.? 5.49 O2' C2E B 301 A 339 ARG B 140 ARG.? -3.40 C5 C2E B 301s coo 85.81 57.99 116.01 86.03 55.86 115.89 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo 75.11 41.01 160.30 76.65 40.06 161.41 -14.88 11.83 -9.39 -15.29 12.85 -11.20 coo 82.23 40.35 159.87 85.09 40.67 161.01 -7.91 11.52 -6.78 -7.96 14.04 -5.01 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 6 3 # 6 A 50 ASP A 152 ASP.? 20.83 C8 C2E A 301 A 327 GLU B 138 GLU.? 5.49 O2' C2E B 301 A 339 ARG B 165 ARG.? 10.70 O2' C2E B 301 coo 85.81 57.99 116.01 86.03 55.86 115.89 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo 75.11 41.01 160.30 76.65 40.06 161.41 -14.88 11.83 -9.39 -15.29 12.85 -11.20 coo 82.23 40.35 159.87 85.09 40.67 161.01 -16.44 10.61 -14.72 -19.33 11.67 -14.77 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 7 3 # 7 A 50 ASP B 79 ASP~? 26.97 N21 C2E B 301 A 327 GLU B 188 GLU^? 19.78 N2 C2E B 301 A 339 ARG B 155 ARG^? 22.81 O6 C2E B 301 coo 85.81 57.99 116.01 86.03 55.86 115.89 6.11 26.78 22.67 4.66 27.50 24.05 coo 75.11 41.01 160.30 76.65 40.06 161.41 0.34 20.87 -23.80 1.17 21.98 -25.42 coo 82.23 40.35 159.87 85.09 40.67 161.01 6.63 24.44 -23.88 7.74 21.82 -25.04 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 8 3 # 8 A 50 ASP B 80 ASP~? 21.84 N21 C2E B 301 A 327 GLU A 101 GLU.? 9.39 O11 C2E A 301 A 339 ARG A 136 ARG.? -3.92 O61 C2E A 301s coo 85.81 57.99 116.01 86.03 55.86 115.89 3.05 24.05 19.78 2.70 26.08 19.35 coo 75.11 41.01 160.30 76.65 40.06 161.41 2.77 -8.35 -14.05 3.97 -7.83 -15.72 coo 82.23 40.35 159.87 85.09 40.67 161.01 2.11 -12.17 -9.13 1.08 -10.80 -6.58 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 9 3 # 9 A 50 ASP B 80 ASP~? 21.84 N21 C2E B 301 A 327 GLU A 101 GLU.? 9.39 O11 C2E A 301 A 339 ARG A 140 ARG.? -3.36 C5 C2E A 301s coo 85.81 57.99 116.01 86.03 55.86 115.89 3.05 24.05 19.78 2.70 26.08 19.35 coo 75.11 41.01 160.30 76.65 40.06 161.41 2.77 -8.35 -14.05 3.97 -7.83 -15.72 coo 82.23 40.35 159.87 85.09 40.67 161.01 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 10 3 # 10 A 50 ASP B 152 ASP.? 19.99 C8 C2E B 301 A 327 GLU A 138 GLU.? 5.46 O2' C2E A 301 A 339 ARG A 136 ARG.? -3.92 O61 C2E A 301s coo 85.81 57.99 116.01 86.03 55.86 115.89 2.18 32.86 -17.28 0.63 33.43 -15.93 coo 75.11 41.01 160.30 76.65 40.06 161.41 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 coo 82.23 40.35 159.87 85.09 40.67 161.01 2.11 -12.17 -9.13 1.08 -10.80 -6.58 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 11 3 # 11 A 50 ASP B 152 ASP.? 19.99 C8 C2E B 301 A 327 GLU A 138 GLU.? 5.46 O2' C2E A 301 A 339 ARG A 140 ARG.? -3.36 C5 C2E A 301s coo 85.81 57.99 116.01 86.03 55.86 115.89 2.18 32.86 -17.28 0.63 33.43 -15.93 coo 75.11 41.01 160.30 76.65 40.06 161.41 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 coo 82.23 40.35 159.87 85.09 40.67 161.01 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 12 3 # 12 A 50 ASP B 152 ASP.? 19.99 C8 C2E B 301 A 327 GLU A 138 GLU.? 5.46 O2' C2E A 301 A 339 ARG A 165 ARG.? 12.45 N2 C2E A 301 coo 85.81 57.99 116.01 86.03 55.86 115.89 2.18 32.86 -17.28 0.63 33.43 -15.93 coo 75.11 41.01 160.30 76.65 40.06 161.41 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 coo 82.23 40.35 159.87 85.09 40.67 161.01 -4.47 -13.19 -19.45 -6.66 -12.47 -21.46 1hto_c00 source 1hto GLUTAMINE SYNTHETASE : 12 hits 1hto_c00 naa= 3 ULMN 3 1hy3_c00 ESTROGEN SULFOTRANSFERASE user 1 3 # 1 A 47 LYS A 67 LYS.? 22.91 N21 C2E B 301 A 107 HIS A 64 HIS^? 21.50 N21 C2E B 301 A 137 SER A 125 SER.? 23.81 N21 C2E A 301 coo 5.11 -0.55 31.43 1.36 1.90 33.24 17.01 7.43 8.57 15.28 11.70 10.44 coo 6.14 -0.73 24.01 6.05 0.83 25.40 11.95 7.99 12.22 11.86 9.83 13.23 coo 1.06 -1.40 35.67 2.72 0.28 35.10 19.83 1.13 7.98 21.72 -0.16 7.19 ULMN 3 1hy3_c00 ESTROGEN SULFOTRANSFERASE user 2 3 # 2 A 47 LYS B 67 LYS.? 24.61 N21 C2E A 301 A 107 HIS B 64 HIS^? 22.95 N21 C2E A 301 A 137 SER B 125 SER^? 22.05 N21 C2E B 301 coo 5.11 -0.55 31.43 1.36 1.90 33.24 -0.41 -2.48 20.16 2.79 -6.43 20.83 coo 6.14 -0.73 24.01 6.05 0.83 25.40 5.28 -3.23 17.72 6.30 -4.93 18.40 coo 1.06 -1.40 35.67 2.72 0.28 35.10 -3.10 3.96 21.21 -4.91 5.28 22.14 1hy3_c00 source 1hy3 ESTROGEN SULFOTRANSFERASE : 2 hits 1hy3_c00 naa= 3 ULMN 3 1hy3_c01 ESTROGEN SULFOTRANSFERASE user 1 3 # 1 B 47 LYS A 67 LYS.? 22.91 N21 C2E B 301 B 107 HIS A 64 HIS^? 21.50 N21 C2E B 301 B 137 SER A 125 SER.? 23.81 N21 C2E A 301 coo -20.15 -16.49 60.11 -21.92 -14.52 56.18 17.01 7.43 8.57 15.28 11.70 10.44 coo -23.43 -14.78 66.71 -24.10 -15.65 64.93 11.95 7.99 12.22 11.86 9.83 13.23 coo -17.90 -14.30 55.11 -19.49 -15.96 55.90 19.83 1.13 7.98 21.72 -0.16 7.19 ULMN 3 1hy3_c01 ESTROGEN SULFOTRANSFERASE user 2 3 # 2 B 47 LYS B 67 LYS.? 24.61 N21 C2E A 301 B 107 HIS B 64 HIS^? 22.95 N21 C2E A 301 B 137 SER B 125 SER^? 22.05 N21 C2E B 301 coo -20.15 -16.49 60.11 -21.92 -14.52 56.18 -0.41 -2.48 20.16 2.79 -6.43 20.83 coo -23.43 -14.78 66.71 -24.10 -15.65 64.93 5.28 -3.23 17.72 6.30 -4.93 18.40 coo -17.90 -14.30 55.11 -19.49 -15.96 55.90 -3.10 3.96 21.21 -4.91 5.28 22.14 1hy3_c01 source 1hy3 ESTROGEN SULFOTRANSFERASE : 2 hits 1hy3_c01 naa= 3 ULMN 3 1i29_c03 CSDB user 1 3 # 1 A 128 VAL B 132 VAL^? 13.67 C51 C2E B 301 A 200 ASP B 31 ASP~? 18.26 O6 C2E A 301 A 226 LYS B 67 LYS.? 24.61 N21 C2E A 301 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -14.60 5.16 7.52 -13.58 3.51 6.56 coo 24.51 43.28 11.18 25.17 44.50 9.58 -9.76 -4.11 8.16 -9.75 -6.21 8.42 coo 34.47 51.09 7.19 28.58 51.18 7.53 -0.41 -2.48 20.16 2.79 -6.43 20.83 1i29_c03 source 1i29 CSDB : 1 hits 1i29_c03 naa= 3 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 A 14 LYS A 238 LYS^? 19.93 N2 C2E B 301 A 74 LYS A 243 LYS.? 15.17 N2 C2E A 301 A 165 GLU B 138 GLU.? 5.49 O2' C2E B 301 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -14.88 11.83 -9.39 -15.29 12.85 -11.20 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 A 14 LYS A 243 LYS.? 15.17 N2 C2E A 301 A 74 LYS A 238 LYS^? 19.93 N2 C2E B 301 A 165 GLU B 138 GLU.? 5.49 O2' C2E B 301 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -14.88 11.83 -9.39 -15.29 12.85 -11.20 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 3 3 # 3 A 14 LYS B 238 LYS^? 16.50 N2 C2E A 301 A 74 LYS B 243 LYS.? 13.43 N1 C2E B 301 A 165 GLU A 138 GLU.? 5.46 O2' C2E A 301 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -2.53 1.27 -13.25 2.13 3.70 -10.70 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 4 3 # 4 A 14 LYS B 243 LYS.? 13.43 N1 C2E B 301 A 74 LYS B 238 LYS^? 16.50 N2 C2E A 301 A 165 GLU A 138 GLU.? 5.46 O2' C2E A 301 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -2.53 1.27 -13.25 2.13 3.70 -10.70 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 1idt_c00 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 4 hits 1idt_c00 naa= 3 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 B 14 LYS A 238 LYS^? 19.93 N2 C2E B 301 B 74 LYS A 243 LYS.? 15.17 N2 C2E A 301 B 165 GLU B 138 GLU.? 5.49 O2' C2E B 301 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -14.88 11.83 -9.39 -15.29 12.85 -11.20 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 B 14 LYS A 243 LYS.? 15.17 N2 C2E A 301 B 74 LYS A 238 LYS^? 19.93 N2 C2E B 301 B 165 GLU B 138 GLU.? 5.49 O2' C2E B 301 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -14.88 11.83 -9.39 -15.29 12.85 -11.20 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 3 3 # 3 B 14 LYS B 238 LYS^? 16.50 N2 C2E A 301 B 74 LYS B 243 LYS.? 13.43 N1 C2E B 301 B 165 GLU A 138 GLU.? 5.46 O2' C2E A 301 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -2.53 1.27 -13.25 2.13 3.70 -10.70 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 4 3 # 4 B 14 LYS B 243 LYS.? 13.43 N1 C2E B 301 B 74 LYS B 238 LYS^? 16.50 N2 C2E A 301 B 165 GLU A 138 GLU.? 5.46 O2' C2E A 301 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -2.53 1.27 -13.25 2.13 3.70 -10.70 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 1idt_c01 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 4 hits 1idt_c01 naa= 3 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 1 3 # 1 54 ASP A 31 ASP~? 17.49 O6 C2E B 301 158 THR A 129 THR^? 23.05 N11 C2E A 301 317 ASP A 66 ASP.? 23.33 N21 C2E B 301 coo -2.63 8.40 35.07 -3.66 9.81 36.17 10.86 4.60 -5.63 10.78 6.65 -6.14 coo -5.30 12.75 41.86 -4.34 13.05 39.99 19.06 1.74 -3.58 20.59 2.04 -5.10 coo -12.63 17.64 33.66 -10.65 17.90 34.40 15.60 9.37 4.44 16.85 10.89 5.23 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 2 3 # 2 54 ASP A 66 ASP.? 23.33 N21 C2E B 301 158 THR A 63 THR^? 19.64 O61 C2E B 301 317 ASP A 31 ASP~? 17.49 O6 C2E B 301 coo -2.63 8.40 35.07 -3.66 9.81 36.17 15.60 9.37 4.44 16.85 10.89 5.23 coo -5.30 12.75 41.86 -4.34 13.05 39.99 10.28 3.87 8.02 10.33 3.89 5.86 coo -12.63 17.64 33.66 -10.65 17.90 34.40 10.86 4.60 -5.63 10.78 6.65 -6.14 1inp_c02 source 1inp INOSITOL POLYPHOSPHATE 1-PHOSPHATASE (1-PTASE): 2 hits 1inp_c02 naa= 3 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 1 3 # 1 A 14 GLU A 37 GLU.? 10.20 O61 C2E A 301 A 61 GLU A 41 GLU^? 8.66 N21 C2E A 301 A 162 HIS A 38 HIS.? 16.46 O61 C2E B 301 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 0.90 -3.13 0.80 -0.70 -4.43 0.36 coo -4.89 20.85 5.22 -3.95 21.69 6.91 7.09 -12.35 6.79 6.46 -14.38 6.77 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 1.46 -0.40 7.20 -0.57 -0.26 7.72 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 2 3 # 2 A 14 GLU B 37 GLU.? 9.39 O61 C2E B 301 A 61 GLU B 41 GLU^? 7.72 N21 C2E B 301 A 162 HIS B 38 HIS.? 15.97 O61 C2E B 301 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -0.62 3.88 0.75 -0.32 4.81 -1.12 coo -4.89 20.85 5.22 -3.95 21.69 6.91 0.46 14.98 6.85 0.80 16.86 5.93 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 4.87 2.64 4.63 6.30 2.30 3.13 1j53_c00 source 1j53 DNA POLYMERASE III, EPSILON CHAIN : 2 hits 1j53_c00 naa= 3 ULMN 3 1j70_c00 ATP SULPHURYLASE user 1 3 # 1 A 197 ARG A 99 ARG.? 13.59 O61 C2E B 301 A 201 HIS A 38 HIS.? 16.46 O61 C2E B 301 A 204 HIS B 38 HIS.? 15.97 O61 C2E B 301 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -1.29 -2.34 -4.97 -2.19 0.30 -6.23 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 1.46 -0.40 7.20 -0.57 -0.26 7.72 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 4.87 2.64 4.63 6.30 2.30 3.13 ULMN 3 1j70_c00 ATP SULPHURYLASE user 2 3 # 2 A 197 ARG A 99 ARG.? 13.59 O61 C2E B 301 A 201 HIS B 38 HIS.? 15.97 O61 C2E B 301 A 204 HIS A 38 HIS.? 16.46 O61 C2E B 301 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -1.29 -2.34 -4.97 -2.19 0.30 -6.23 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 4.87 2.64 4.63 6.30 2.30 3.13 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 1.46 -0.40 7.20 -0.57 -0.26 7.72 ULMN 3 1j70_c00 ATP SULPHURYLASE user 3 3 # 3 A 197 ARG B 99 ARG.? 13.88 O61 C2E A 301 A 201 HIS A 38 HIS.? 16.46 O61 C2E B 301 A 204 HIS B 38 HIS.? 15.97 O61 C2E B 301 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -4.81 1.09 -3.04 -5.37 -1.84 -3.80 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 1.46 -0.40 7.20 -0.57 -0.26 7.72 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 4.87 2.64 4.63 6.30 2.30 3.13 ULMN 3 1j70_c00 ATP SULPHURYLASE user 4 3 # 4 A 197 ARG B 99 ARG.? 13.88 O61 C2E A 301 A 201 HIS B 38 HIS.? 15.97 O61 C2E B 301 A 204 HIS A 38 HIS.? 16.46 O61 C2E B 301 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -4.81 1.09 -3.04 -5.37 -1.84 -3.80 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 4.87 2.64 4.63 6.30 2.30 3.13 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 1.46 -0.40 7.20 -0.57 -0.26 7.72 1j70_c00 source 1j70 ATP SULPHURYLASE : 4 hits 1j70_c00 naa= 3 ULMN 3 1j70_c01 ATP SULPHURYLASE user 1 3 # 1 B 197 ARG A 99 ARG.? 13.59 O61 C2E B 301 B 201 HIS A 38 HIS.? 16.46 O61 C2E B 301 B 204 HIS B 38 HIS.? 15.97 O61 C2E B 301 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -1.29 -2.34 -4.97 -2.19 0.30 -6.23 coo -8.48 114.03 24.38 -10.47 114.55 23.97 1.46 -0.40 7.20 -0.57 -0.26 7.72 coo -6.99 108.94 26.28 -8.54 109.57 27.55 4.87 2.64 4.63 6.30 2.30 3.13 ULMN 3 1j70_c01 ATP SULPHURYLASE user 2 3 # 2 B 197 ARG A 99 ARG.? 13.59 O61 C2E B 301 B 201 HIS B 38 HIS.? 15.97 O61 C2E B 301 B 204 HIS A 38 HIS.? 16.46 O61 C2E B 301 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -1.29 -2.34 -4.97 -2.19 0.30 -6.23 coo -8.48 114.03 24.38 -10.47 114.55 23.97 4.87 2.64 4.63 6.30 2.30 3.13 coo -6.99 108.94 26.28 -8.54 109.57 27.55 1.46 -0.40 7.20 -0.57 -0.26 7.72 ULMN 3 1j70_c01 ATP SULPHURYLASE user 3 3 # 3 B 197 ARG B 99 ARG.? 13.88 O61 C2E A 301 B 201 HIS B 38 HIS.? 15.97 O61 C2E B 301 B 204 HIS A 38 HIS.? 16.46 O61 C2E B 301 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -4.81 1.09 -3.04 -5.37 -1.84 -3.80 coo -8.48 114.03 24.38 -10.47 114.55 23.97 4.87 2.64 4.63 6.30 2.30 3.13 coo -6.99 108.94 26.28 -8.54 109.57 27.55 1.46 -0.40 7.20 -0.57 -0.26 7.72 1j70_c01 source 1j70 ATP SULPHURYLASE : 3 hits 1j70_c01 naa= 3 ULMN 3 1j70_c02 ATP SULPHURYLASE user 1 3 # 1 C 197 ARG A 99 ARG.? 13.59 O61 C2E B 301 C 201 HIS A 38 HIS.? 16.46 O61 C2E B 301 C 204 HIS B 38 HIS.? 15.97 O61 C2E B 301 coo 30.92 14.23 15.70 28.82 13.90 13.48 -1.29 -2.34 -4.97 -2.19 0.30 -6.23 coo 20.16 5.55 18.86 20.00 7.59 19.34 1.46 -0.40 7.20 -0.57 -0.26 7.72 coo 24.92 3.29 16.90 24.41 4.92 15.69 4.87 2.64 4.63 6.30 2.30 3.13 ULMN 3 1j70_c02 ATP SULPHURYLASE user 2 3 # 2 C 197 ARG A 99 ARG.? 13.59 O61 C2E B 301 C 201 HIS B 38 HIS.? 15.97 O61 C2E B 301 C 204 HIS A 38 HIS.? 16.46 O61 C2E B 301 coo 30.92 14.23 15.70 28.82 13.90 13.48 -1.29 -2.34 -4.97 -2.19 0.30 -6.23 coo 20.16 5.55 18.86 20.00 7.59 19.34 4.87 2.64 4.63 6.30 2.30 3.13 coo 24.92 3.29 16.90 24.41 4.92 15.69 1.46 -0.40 7.20 -0.57 -0.26 7.72 ULMN 3 1j70_c02 ATP SULPHURYLASE user 3 3 # 3 C 197 ARG B 99 ARG.? 13.88 O61 C2E A 301 C 201 HIS B 38 HIS.? 15.97 O61 C2E B 301 C 204 HIS A 38 HIS.? 16.46 O61 C2E B 301 coo 30.92 14.23 15.70 28.82 13.90 13.48 -4.81 1.09 -3.04 -5.37 -1.84 -3.80 coo 20.16 5.55 18.86 20.00 7.59 19.34 4.87 2.64 4.63 6.30 2.30 3.13 coo 24.92 3.29 16.90 24.41 4.92 15.69 1.46 -0.40 7.20 -0.57 -0.26 7.72 1j70_c02 source 1j70 ATP SULPHURYLASE : 3 hits 1j70_c02 naa= 3 ULMN 3 1joa_c00 NADH PEROXIDASE user 1 3 # 1 10 HIS A 106 HIS^? 11.03 N21 C2E A 301 41 SER A 133 SER^? 10.46 O4A C2E A 301 303 ARG A 94 ARG^? 4.68 N21 C2E A 301 coo 62.94 54.74 73.45 64.13 56.17 74.27 16.26 -9.68 -2.62 15.33 -11.56 -2.56 coo 65.67 62.51 70.93 64.56 61.94 68.74 12.55 -8.09 -9.84 13.31 -9.86 -8.34 coo 63.38 52.38 77.01 66.48 52.75 76.49 12.55 -12.80 -0.72 10.33 -14.85 -0.21 ULMN 3 1joa_c00 NADH PEROXIDASE user 2 3 # 2 10 HIS B 106 HIS^? 12.57 N21 C2E B 301 41 SER B 109 SER^? 18.78 N21 C2E B 301 303 ARG B 94 ARG^? 9.81 N31 C2E B 301 coo 62.94 54.74 73.45 64.13 56.17 74.27 -12.23 11.16 12.34 -12.16 12.93 13.45 coo 65.67 62.51 70.93 64.56 61.94 68.74 -6.26 7.92 20.06 -4.06 7.18 19.35 coo 63.38 52.38 77.01 66.48 52.75 76.49 -10.06 14.66 9.70 -12.88 15.81 9.44 ULMN 3 1joa_c00 NADH PEROXIDASE user 3 3 # 3 10 HIS B 106 HIS^? 12.57 N21 C2E B 301 41 SER B 133 SER^? 10.32 O4A C2E B 301 303 ARG B 94 ARG^? 9.81 N31 C2E B 301 coo 62.94 54.74 73.45 64.13 56.17 74.27 -12.23 11.16 12.34 -12.16 12.93 13.45 coo 65.67 62.51 70.93 64.56 61.94 68.74 -16.34 7.76 5.39 -15.62 9.78 6.51 coo 63.38 52.38 77.01 66.48 52.75 76.49 -10.06 14.66 9.70 -12.88 15.81 9.44 1joa_c00 source 1joa NADH PEROXIDASE : 3 hits 1joa_c00 naa= 3 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 1 3 # 1 A 396 ARG A 140 ARG.? -3.36 C5 C2E A 301s A 581 ARG A 161 ARG^? 11.81 O6 C2E A 301 A 713 ARG A 217 ARG^? 6.70 O6 C2E A 301 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -3.36 -16.18 0.94 -0.54 -17.39 0.83 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 2 3 # 2 A 396 ARG A 140 ARG.? -3.36 C5 C2E A 301s A 581 ARG A 217 ARG^? 6.70 O6 C2E A 301 A 713 ARG A 161 ARG^? 11.81 O6 C2E A 301 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -3.36 -16.18 0.94 -0.54 -17.39 0.83 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 3 3 # 3 A 396 ARG A 161 ARG^? 11.81 O6 C2E A 301 A 581 ARG A 140 ARG.? -3.36 C5 C2E A 301s A 713 ARG A 217 ARG^? 6.70 O6 C2E A 301 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -3.36 -16.18 0.94 -0.54 -17.39 0.83 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 4 3 # 4 A 396 ARG A 161 ARG^? 11.81 O6 C2E A 301 A 581 ARG A 217 ARG^? 6.70 O6 C2E A 301 A 713 ARG A 140 ARG.? -3.36 C5 C2E A 301s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -3.36 -16.18 0.94 -0.54 -17.39 0.83 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 5 3 # 5 A 396 ARG A 217 ARG^? 6.70 O6 C2E A 301 A 581 ARG A 140 ARG.? -3.36 C5 C2E A 301s A 713 ARG A 161 ARG^? 11.81 O6 C2E A 301 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -3.36 -16.18 0.94 -0.54 -17.39 0.83 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 6 3 # 6 A 396 ARG A 217 ARG^? 6.70 O6 C2E A 301 A 581 ARG A 161 ARG^? 11.81 O6 C2E A 301 A 713 ARG A 140 ARG.? -3.36 C5 C2E A 301s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -3.36 -16.18 0.94 -0.54 -17.39 0.83 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 7 3 # 7 A 396 ARG B 140 ARG.? -3.40 C5 C2E B 301s A 581 ARG B 217 ARG^? 6.37 O6 C2E B 301 A 713 ARG B 161 ARG^? 11.68 O6 C2E B 301 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 -7.91 11.52 -6.78 -7.96 14.04 -5.01 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 0.82 15.44 -4.45 -0.87 16.78 -2.26 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 2.96 9.64 -10.71 5.59 9.57 -9.11 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 8 3 # 8 A 396 ARG B 161 ARG^? 11.68 O6 C2E B 301 A 581 ARG B 217 ARG^? 6.37 O6 C2E B 301 A 713 ARG B 140 ARG.? -3.40 C5 C2E B 301s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 2.96 9.64 -10.71 5.59 9.57 -9.11 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 0.82 15.44 -4.45 -0.87 16.78 -2.26 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -7.91 11.52 -6.78 -7.96 14.04 -5.01 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 9 3 # 9 A 396 ARG B 217 ARG^? 6.37 O6 C2E B 301 A 581 ARG B 140 ARG.? -3.40 C5 C2E B 301s A 713 ARG B 161 ARG^? 11.68 O6 C2E B 301 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 0.82 15.44 -4.45 -0.87 16.78 -2.26 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 -7.91 11.52 -6.78 -7.96 14.04 -5.01 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 2.96 9.64 -10.71 5.59 9.57 -9.11 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 10 3 # 10 A 396 ARG B 217 ARG^? 6.37 O6 C2E B 301 A 581 ARG B 161 ARG^? 11.68 O6 C2E B 301 A 713 ARG B 140 ARG.? -3.40 C5 C2E B 301s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 0.82 15.44 -4.45 -0.87 16.78 -2.26 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 2.96 9.64 -10.71 5.59 9.57 -9.11 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 -7.91 11.52 -6.78 -7.96 14.04 -5.01 1jqn_c01 source 1jqn PHOSPHOENOLPYRUVATE CARBOXYLASE : 10 hits 1jqn_c01 naa= 3 ULMN 3 1jxa_c02 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 3 # 1 A 1 CYH A 207 CYH^? -4.01 O4' C2E A 301s A 98 ASN A 208 ASN^? -3.55 N7 C2E A 301s A 99 GLY A 219 GLY^? -3.43 N7 C2E A 301s coo -28.39 5.74 -1.35 -27.45 6.62 -3.77 -0.78 -24.34 -5.34 -0.81 -23.96 -8.11 coo -31.76 2.35 -3.84 -31.22 3.45 -2.16 0.54 -21.32 -2.29 -0.50 -19.83 -3.42 coo -29.05 1.23 -7.23 -29.18 1.88 -7.63 -3.71 -19.90 -4.28 -4.11 -20.70 -4.09 ULMN 3 1jxa_c02 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 2 3 # 2 A 1 CYH B 207 CYH^? -4.01 O1P C2E B 301s A 98 ASN B 208 ASN^? -3.47 N7 C2E B 301s A 99 GLY B 219 GLY^? -3.38 N7 C2E B 301s coo -28.39 5.74 -1.35 -27.45 6.62 -3.77 -6.32 22.95 -5.82 -8.77 22.45 -7.09 coo -31.76 2.35 -3.84 -31.22 3.45 -2.16 -4.15 20.35 -2.93 -4.56 18.73 -4.26 coo -29.05 1.23 -7.23 -29.18 1.88 -7.63 -3.71 18.46 -7.63 -3.40 19.28 -7.89 1jxa_c02 source 1jxa GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 2 hits 1jxa_c02 naa= 3 ULMN 3 1jxa_c04 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 3 # 1 C 1 CYH A 207 CYH^? -4.01 O4' C2E A 301s C 98 ASN A 208 ASN^? -3.55 N7 C2E A 301s C 99 GLY A 219 GLY^? -3.43 N7 C2E A 301s coo 4.88 17.74 73.58 7.14 19.23 72.93 -0.78 -24.34 -5.34 -0.81 -23.96 -8.11 coo 8.21 16.91 78.64 7.09 18.75 78.67 0.54 -21.32 -2.29 -0.50 -19.83 -3.42 coo 11.04 18.39 74.90 10.95 17.56 74.65 -3.71 -19.90 -4.28 -4.11 -20.70 -4.09 ULMN 3 1jxa_c04 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 2 3 # 2 C 1 CYH B 207 CYH^? -4.01 O1P C2E B 301s C 98 ASN B 208 ASN^? -3.47 N7 C2E B 301s C 99 GLY B 219 GLY^? -3.38 N7 C2E B 301s coo 4.88 17.74 73.58 7.14 19.23 72.93 -6.32 22.95 -5.82 -8.77 22.45 -7.09 coo 8.21 16.91 78.64 7.09 18.75 78.67 -4.15 20.35 -2.93 -4.56 18.73 -4.26 coo 11.04 18.39 74.90 10.95 17.56 74.65 -3.71 18.46 -7.63 -3.40 19.28 -7.89 1jxa_c04 source 1jxa GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 2 hits 1jxa_c04 naa= 3 ULMN 3 1k4t_c00 5'-D(*AP*AP*AP*AP*AP*GP*AP*CP*TP*T)-user 1 3 # 1 A 488 ARG A 161 ARG^? 11.81 O6 C2E A 301 A 590 ARG A 169 ARG^? -4.75 O6 C2E A 301s A 632 HIS A 215 HIS.? 12.12 O6 C2E A 301 coo 19.23 7.38 20.83 18.34 7.79 23.74 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 coo 23.20 10.66 21.48 21.07 10.68 23.70 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 coo 20.55 9.13 29.66 21.88 8.70 28.08 -8.99 -15.19 5.86 -7.58 -13.77 5.21 ULMN 3 1k4t_c00 5'-D(*AP*AP*AP*AP*AP*GP*AP*CP*TP*T)-user 2 3 # 2 A 488 ARG A 169 ARG^? -4.75 O6 C2E A 301s A 590 ARG A 161 ARG^? 11.81 O6 C2E A 301 A 632 HIS A 215 HIS.? 12.12 O6 C2E A 301 coo 19.23 7.38 20.83 18.34 7.79 23.74 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 coo 23.20 10.66 21.48 21.07 10.68 23.70 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 coo 20.55 9.13 29.66 21.88 8.70 28.08 -8.99 -15.19 5.86 -7.58 -13.77 5.21 ULMN 3 1k4t_c00 5'-D(*AP*AP*AP*AP*AP*GP*AP*CP*TP*T)-user 3 3 # 3 A 488 ARG A 169 ARG^? -4.75 O6 C2E A 301s A 590 ARG A 217 ARG^? 6.70 O6 C2E A 301 A 632 HIS A 215 HIS.? 12.12 O6 C2E A 301 coo 19.23 7.38 20.83 18.34 7.79 23.74 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 coo 23.20 10.66 21.48 21.07 10.68 23.70 -3.36 -16.18 0.94 -0.54 -17.39 0.83 coo 20.55 9.13 29.66 21.88 8.70 28.08 -8.99 -15.19 5.86 -7.58 -13.77 5.21 ULMN 3 1k4t_c00 5'-D(*AP*AP*AP*AP*AP*GP*AP*CP*TP*T)-user 4 3 # 4 A 488 ARG A 217 ARG^? 6.70 O6 C2E A 301 A 590 ARG A 169 ARG^? -4.75 O6 C2E A 301s A 632 HIS A 215 HIS.? 12.12 O6 C2E A 301 coo 19.23 7.38 20.83 18.34 7.79 23.74 -3.36 -16.18 0.94 -0.54 -17.39 0.83 coo 23.20 10.66 21.48 21.07 10.68 23.70 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 coo 20.55 9.13 29.66 21.88 8.70 28.08 -8.99 -15.19 5.86 -7.58 -13.77 5.21 ULMN 3 1k4t_c00 5'-D(*AP*AP*AP*AP*AP*GP*AP*CP*TP*T)-user 5 3 # 5 A 488 ARG B 161 ARG^? 11.68 O6 C2E B 301 A 590 ARG B 169 ARG^? -4.70 O6 C2E B 301s A 632 HIS B 215 HIS.? 11.93 O6 C2E B 301 coo 19.23 7.38 20.83 18.34 7.79 23.74 2.96 9.64 -10.71 5.59 9.57 -9.11 coo 23.20 10.66 21.48 21.07 10.68 23.70 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo 20.55 9.13 29.66 21.88 8.70 28.08 7.81 14.24 -7.06 6.68 12.76 -6.10 ULMN 3 1k4t_c00 5'-D(*AP*AP*AP*AP*AP*GP*AP*CP*TP*T)-user 6 3 # 6 A 488 ARG B 169 ARG^? -4.70 O6 C2E B 301s A 590 ARG B 161 ARG^? 11.68 O6 C2E B 301 A 632 HIS B 215 HIS.? 11.93 O6 C2E B 301 coo 19.23 7.38 20.83 18.34 7.79 23.74 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo 23.20 10.66 21.48 21.07 10.68 23.70 2.96 9.64 -10.71 5.59 9.57 -9.11 coo 20.55 9.13 29.66 21.88 8.70 28.08 7.81 14.24 -7.06 6.68 12.76 -6.10 ULMN 3 1k4t_c00 5'-D(*AP*AP*AP*AP*AP*GP*AP*CP*TP*T)-user 7 3 # 7 A 488 ARG B 169 ARG^? -4.70 O6 C2E B 301s A 590 ARG B 217 ARG^? 6.37 O6 C2E B 301 A 632 HIS B 215 HIS.? 11.93 O6 C2E B 301 coo 19.23 7.38 20.83 18.34 7.79 23.74 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo 23.20 10.66 21.48 21.07 10.68 23.70 0.82 15.44 -4.45 -0.87 16.78 -2.26 coo 20.55 9.13 29.66 21.88 8.70 28.08 7.81 14.24 -7.06 6.68 12.76 -6.10 ULMN 3 1k4t_c00 5'-D(*AP*AP*AP*AP*AP*GP*AP*CP*TP*T)-user 8 3 # 8 A 488 ARG B 217 ARG^? 6.37 O6 C2E B 301 A 590 ARG B 169 ARG^? -4.70 O6 C2E B 301s A 632 HIS B 215 HIS.? 11.93 O6 C2E B 301 coo 19.23 7.38 20.83 18.34 7.79 23.74 0.82 15.44 -4.45 -0.87 16.78 -2.26 coo 23.20 10.66 21.48 21.07 10.68 23.70 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo 20.55 9.13 29.66 21.88 8.70 28.08 7.81 14.24 -7.06 6.68 12.76 -6.10 1k4t_c00 source 1k4t 5'-D(*AP*AP*AP*AP*AP*GP*AP*CP*TP*T)-3' : 8 hits 1k4t_c00 naa= 3 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 A 2 GLU A 159 GLU^? 13.73 O6 C2E A 301 A 56 LYS A 148 LYS^? 21.30 O6 C2E A 301 A 258 ARG A 169 ARG^? -4.75 O6 C2E A 301s coo 42.33 1.56 26.99 42.38 2.91 28.66 -14.60 -12.52 -1.04 -14.41 -10.88 0.31 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 A 2 GLU A 159 GLU^? 13.73 O6 C2E A 301 A 56 LYS A 148 LYS^? 21.30 O6 C2E A 301 A 258 ARG A 217 ARG^? 6.70 O6 C2E A 301 coo 42.33 1.56 26.99 42.38 2.91 28.66 -14.60 -12.52 -1.04 -14.41 -10.88 0.31 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -3.36 -16.18 0.94 -0.54 -17.39 0.83 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 A 2 GLU A 221 GLU^? -4.32 C4' C2E A 301s A 56 LYS A 205 LYS^? 11.81 O1P C2E A 301 A 258 ARG A 136 ARG.? -3.92 O61 C2E A 301s coo 42.33 1.56 26.99 42.38 2.91 28.66 -2.05 -23.28 -12.44 -0.03 -23.89 -12.66 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -5.45 -27.16 -8.25 -2.71 -32.35 -10.76 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 2.11 -12.17 -9.13 1.08 -10.80 -6.58 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 A 2 GLU A 221 GLU^? -4.32 C4' C2E A 301s A 56 LYS A 205 LYS^? 11.81 O1P C2E A 301 A 258 ARG A 140 ARG.? -3.36 C5 C2E A 301s coo 42.33 1.56 26.99 42.38 2.91 28.66 -2.05 -23.28 -12.44 -0.03 -23.89 -12.66 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -5.45 -27.16 -8.25 -2.71 -32.35 -10.76 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 A 2 GLU B 101 GLU.? 9.43 O11 C2E B 301 A 56 LYS B 137 LYS.? -3.23 O3' C2E B 301s A 258 ARG B 99 ARG.? 13.88 O61 C2E A 301 coo 42.33 1.56 26.99 42.38 2.91 28.66 -14.64 6.09 -5.71 -16.72 5.82 -5.44 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -4.81 1.09 -3.04 -5.37 -1.84 -3.80 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 A 2 GLU B 159 GLU^? 13.76 O6 C2E B 301 A 56 LYS B 148 LYS^? 21.33 O6 C2E B 301 A 258 ARG B 169 ARG^? -4.70 O6 C2E B 301s coo 42.33 1.56 26.99 42.38 2.91 28.66 4.99 11.22 -14.77 6.30 9.86 -13.80 coo 38.45 -0.44 19.89 37.36 0.90 25.90 4.64 19.42 -20.28 9.89 19.27 -22.17 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -0.88 13.03 -7.12 -1.56 12.92 -4.13 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 7 3 # 7 A 2 GLU B 159 GLU^? 13.76 O6 C2E B 301 A 56 LYS B 148 LYS^? 21.33 O6 C2E B 301 A 258 ARG B 217 ARG^? 6.37 O6 C2E B 301 coo 42.33 1.56 26.99 42.38 2.91 28.66 4.99 11.22 -14.77 6.30 9.86 -13.80 coo 38.45 -0.44 19.89 37.36 0.90 25.90 4.64 19.42 -20.28 9.89 19.27 -22.17 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 0.82 15.44 -4.45 -0.87 16.78 -2.26 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 8 3 # 8 A 2 GLU B 221 GLU^? -4.05 C4' C2E B 301s A 56 LYS B 205 LYS^? -10.36 O1P C2E B 301s A 258 ARG B 136 ARG.? -3.89 O61 C2E B 301s coo 42.33 1.56 26.99 42.38 2.91 28.66 -11.86 21.10 -10.14 -13.00 21.71 -8.45 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -6.87 25.33 -11.52 -10.34 29.58 -9.49 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -10.39 10.75 -3.93 -7.55 9.68 -3.54 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 9 3 # 9 A 2 GLU B 221 GLU^? -4.05 C4' C2E B 301s A 56 LYS B 205 LYS^? -10.36 O1P C2E B 301s A 258 ARG B 140 ARG.? -3.40 C5 C2E B 301s coo 42.33 1.56 26.99 42.38 2.91 28.66 -11.86 21.10 -10.14 -13.00 21.71 -8.45 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -6.87 25.33 -11.52 -10.34 29.58 -9.49 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -7.91 11.52 -6.78 -7.96 14.04 -5.01 1k82_c00 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 9 hits 1k82_c00 naa= 3 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 B 2 GLU A 159 GLU^? 13.73 O6 C2E A 301 B 56 LYS A 148 LYS^? 21.30 O6 C2E A 301 B 258 ARG A 169 ARG^? -4.75 O6 C2E A 301s coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -14.60 -12.52 -1.04 -14.41 -10.88 0.31 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 coo 2.64 1.83 34.81 1.56 1.13 32.02 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 B 2 GLU A 159 GLU^? 13.73 O6 C2E A 301 B 56 LYS A 148 LYS^? 21.30 O6 C2E A 301 B 258 ARG A 217 ARG^? 6.70 O6 C2E A 301 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -14.60 -12.52 -1.04 -14.41 -10.88 0.31 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 coo 2.64 1.83 34.81 1.56 1.13 32.02 -3.36 -16.18 0.94 -0.54 -17.39 0.83 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 B 2 GLU A 221 GLU^? -4.32 C4' C2E A 301s B 56 LYS A 205 LYS^? 11.81 O1P C2E A 301 B 258 ARG A 136 ARG.? -3.92 O61 C2E A 301s coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -2.05 -23.28 -12.44 -0.03 -23.89 -12.66 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -5.45 -27.16 -8.25 -2.71 -32.35 -10.76 coo 2.64 1.83 34.81 1.56 1.13 32.02 2.11 -12.17 -9.13 1.08 -10.80 -6.58 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 B 2 GLU A 221 GLU^? -4.32 C4' C2E A 301s B 56 LYS A 205 LYS^? 11.81 O1P C2E A 301 B 258 ARG A 140 ARG.? -3.36 C5 C2E A 301s coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -2.05 -23.28 -12.44 -0.03 -23.89 -12.66 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -5.45 -27.16 -8.25 -2.71 -32.35 -10.76 coo 2.64 1.83 34.81 1.56 1.13 32.02 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 B 2 GLU B 101 GLU.? 9.43 O11 C2E B 301 B 56 LYS B 137 LYS.? -3.23 O3' C2E B 301s B 258 ARG B 99 ARG.? 13.88 O61 C2E A 301 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -14.64 6.09 -5.71 -16.72 5.82 -5.44 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo 2.64 1.83 34.81 1.56 1.13 32.02 -4.81 1.09 -3.04 -5.37 -1.84 -3.80 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 B 2 GLU B 159 GLU^? 13.76 O6 C2E B 301 B 56 LYS B 148 LYS^? 21.33 O6 C2E B 301 B 258 ARG B 169 ARG^? -4.70 O6 C2E B 301s coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 4.99 11.22 -14.77 6.30 9.86 -13.80 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 4.64 19.42 -20.28 9.89 19.27 -22.17 coo 2.64 1.83 34.81 1.56 1.13 32.02 -0.88 13.03 -7.12 -1.56 12.92 -4.13 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 7 3 # 7 B 2 GLU B 159 GLU^? 13.76 O6 C2E B 301 B 56 LYS B 148 LYS^? 21.33 O6 C2E B 301 B 258 ARG B 217 ARG^? 6.37 O6 C2E B 301 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 4.99 11.22 -14.77 6.30 9.86 -13.80 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 4.64 19.42 -20.28 9.89 19.27 -22.17 coo 2.64 1.83 34.81 1.56 1.13 32.02 0.82 15.44 -4.45 -0.87 16.78 -2.26 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 8 3 # 8 B 2 GLU B 221 GLU^? -4.05 C4' C2E B 301s B 56 LYS B 205 LYS^? -10.36 O1P C2E B 301s B 258 ARG B 136 ARG.? -3.89 O61 C2E B 301s coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -11.86 21.10 -10.14 -13.00 21.71 -8.45 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -6.87 25.33 -11.52 -10.34 29.58 -9.49 coo 2.64 1.83 34.81 1.56 1.13 32.02 -10.39 10.75 -3.93 -7.55 9.68 -3.54 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 9 3 # 9 B 2 GLU B 221 GLU^? -4.05 C4' C2E B 301s B 56 LYS B 205 LYS^? -10.36 O1P C2E B 301s B 258 ARG B 140 ARG.? -3.40 C5 C2E B 301s coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -11.86 21.10 -10.14 -13.00 21.71 -8.45 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -6.87 25.33 -11.52 -10.34 29.58 -9.49 coo 2.64 1.83 34.81 1.56 1.13 32.02 -7.91 11.52 -6.78 -7.96 14.04 -5.01 1k82_c01 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 9 hits 1k82_c01 naa= 3 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 C 2 GLU A 159 GLU^? 13.73 O6 C2E A 301 C 56 LYS A 148 LYS^? 21.30 O6 C2E A 301 C 258 ARG A 169 ARG^? -4.75 O6 C2E A 301s coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -14.60 -12.52 -1.04 -14.41 -10.88 0.31 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 C 2 GLU A 159 GLU^? 13.73 O6 C2E A 301 C 56 LYS A 148 LYS^? 21.30 O6 C2E A 301 C 258 ARG A 217 ARG^? 6.70 O6 C2E A 301 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -14.60 -12.52 -1.04 -14.41 -10.88 0.31 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -3.36 -16.18 0.94 -0.54 -17.39 0.83 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 C 2 GLU A 221 GLU^? -4.32 C4' C2E A 301s C 56 LYS A 205 LYS^? 11.81 O1P C2E A 301 C 258 ARG A 136 ARG.? -3.92 O61 C2E A 301s coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -2.05 -23.28 -12.44 -0.03 -23.89 -12.66 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -5.45 -27.16 -8.25 -2.71 -32.35 -10.76 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 2.11 -12.17 -9.13 1.08 -10.80 -6.58 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 C 2 GLU A 221 GLU^? -4.32 C4' C2E A 301s C 56 LYS A 205 LYS^? 11.81 O1P C2E A 301 C 258 ARG A 140 ARG.? -3.36 C5 C2E A 301s coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -2.05 -23.28 -12.44 -0.03 -23.89 -12.66 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -5.45 -27.16 -8.25 -2.71 -32.35 -10.76 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 C 2 GLU B 101 GLU.? 9.43 O11 C2E B 301 C 56 LYS B 137 LYS.? -3.23 O3' C2E B 301s C 258 ARG B 99 ARG.? 13.88 O61 C2E A 301 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -14.64 6.09 -5.71 -16.72 5.82 -5.44 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -4.81 1.09 -3.04 -5.37 -1.84 -3.80 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 C 2 GLU B 159 GLU^? 13.76 O6 C2E B 301 C 56 LYS B 148 LYS^? 21.33 O6 C2E B 301 C 258 ARG B 169 ARG^? -4.70 O6 C2E B 301s coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 4.99 11.22 -14.77 6.30 9.86 -13.80 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 4.64 19.42 -20.28 9.89 19.27 -22.17 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -0.88 13.03 -7.12 -1.56 12.92 -4.13 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 7 3 # 7 C 2 GLU B 159 GLU^? 13.76 O6 C2E B 301 C 56 LYS B 148 LYS^? 21.33 O6 C2E B 301 C 258 ARG B 217 ARG^? 6.37 O6 C2E B 301 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 4.99 11.22 -14.77 6.30 9.86 -13.80 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 4.64 19.42 -20.28 9.89 19.27 -22.17 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 0.82 15.44 -4.45 -0.87 16.78 -2.26 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 8 3 # 8 C 2 GLU B 221 GLU^? -4.05 C4' C2E B 301s C 56 LYS B 205 LYS^? -10.36 O1P C2E B 301s C 258 ARG B 136 ARG.? -3.89 O61 C2E B 301s coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -11.86 21.10 -10.14 -13.00 21.71 -8.45 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -6.87 25.33 -11.52 -10.34 29.58 -9.49 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -10.39 10.75 -3.93 -7.55 9.68 -3.54 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 9 3 # 9 C 2 GLU B 221 GLU^? -4.05 C4' C2E B 301s C 56 LYS B 205 LYS^? -10.36 O1P C2E B 301s C 258 ARG B 140 ARG.? -3.40 C5 C2E B 301s coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -11.86 21.10 -10.14 -13.00 21.71 -8.45 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -6.87 25.33 -11.52 -10.34 29.58 -9.49 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -7.91 11.52 -6.78 -7.96 14.04 -5.01 1k82_c02 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 9 hits 1k82_c02 naa= 3 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 D 2 GLU A 159 GLU^? 13.73 O6 C2E A 301 D 56 LYS A 148 LYS^? 21.30 O6 C2E A 301 D 258 ARG A 169 ARG^? -4.75 O6 C2E A 301s coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -14.60 -12.52 -1.04 -14.41 -10.88 0.31 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 D 2 GLU A 159 GLU^? 13.73 O6 C2E A 301 D 56 LYS A 148 LYS^? 21.30 O6 C2E A 301 D 258 ARG A 217 ARG^? 6.70 O6 C2E A 301 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -14.60 -12.52 -1.04 -14.41 -10.88 0.31 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -3.36 -16.18 0.94 -0.54 -17.39 0.83 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 D 2 GLU A 221 GLU^? -4.32 C4' C2E A 301s D 56 LYS A 205 LYS^? 11.81 O1P C2E A 301 D 258 ARG A 136 ARG.? -3.92 O61 C2E A 301s coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -2.05 -23.28 -12.44 -0.03 -23.89 -12.66 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -5.45 -27.16 -8.25 -2.71 -32.35 -10.76 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 2.11 -12.17 -9.13 1.08 -10.80 -6.58 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 D 2 GLU A 221 GLU^? -4.32 C4' C2E A 301s D 56 LYS A 205 LYS^? 11.81 O1P C2E A 301 D 258 ARG A 140 ARG.? -3.36 C5 C2E A 301s coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -2.05 -23.28 -12.44 -0.03 -23.89 -12.66 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -5.45 -27.16 -8.25 -2.71 -32.35 -10.76 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 D 2 GLU B 101 GLU.? 9.43 O11 C2E B 301 D 56 LYS B 137 LYS.? -3.23 O3' C2E B 301s D 258 ARG B 99 ARG.? 13.88 O61 C2E A 301 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -14.64 6.09 -5.71 -16.72 5.82 -5.44 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -4.81 1.09 -3.04 -5.37 -1.84 -3.80 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 D 2 GLU B 159 GLU^? 13.76 O6 C2E B 301 D 56 LYS B 148 LYS^? 21.33 O6 C2E B 301 D 258 ARG B 169 ARG^? -4.70 O6 C2E B 301s coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 4.99 11.22 -14.77 6.30 9.86 -13.80 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 4.64 19.42 -20.28 9.89 19.27 -22.17 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -0.88 13.03 -7.12 -1.56 12.92 -4.13 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 7 3 # 7 D 2 GLU B 159 GLU^? 13.76 O6 C2E B 301 D 56 LYS B 148 LYS^? 21.33 O6 C2E B 301 D 258 ARG B 217 ARG^? 6.37 O6 C2E B 301 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 4.99 11.22 -14.77 6.30 9.86 -13.80 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 4.64 19.42 -20.28 9.89 19.27 -22.17 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 0.82 15.44 -4.45 -0.87 16.78 -2.26 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 8 3 # 8 D 2 GLU B 221 GLU^? -4.05 C4' C2E B 301s D 56 LYS B 205 LYS^? -10.36 O1P C2E B 301s D 258 ARG B 136 ARG.? -3.89 O61 C2E B 301s coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -11.86 21.10 -10.14 -13.00 21.71 -8.45 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -6.87 25.33 -11.52 -10.34 29.58 -9.49 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -10.39 10.75 -3.93 -7.55 9.68 -3.54 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 9 3 # 9 D 2 GLU B 221 GLU^? -4.05 C4' C2E B 301s D 56 LYS B 205 LYS^? -10.36 O1P C2E B 301s D 258 ARG B 140 ARG.? -3.40 C5 C2E B 301s coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -11.86 21.10 -10.14 -13.00 21.71 -8.45 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -6.87 25.33 -11.52 -10.34 29.58 -9.49 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -7.91 11.52 -6.78 -7.96 14.04 -5.01 1k82_c03 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 9 hits 1k82_c03 naa= 3 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 1 3 # 1 A 290 ARG B 94 ARG^? 9.81 N31 C2E B 301 A 351 HIS B 106 HIS^? 12.57 N21 C2E B 301 A 386 LEU B 104 LEU^? 7.52 N31 C2E B 301 coo 57.36 53.34 128.83 58.45 50.56 128.34 -10.06 14.66 9.70 -12.88 15.81 9.44 coo 60.60 50.64 133.59 60.63 48.82 132.56 -12.23 11.16 12.34 -12.16 12.93 13.45 coo 63.28 54.23 126.45 63.53 52.07 126.70 -12.28 10.43 5.32 -11.64 12.17 6.43 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 2 3 # 2 A 290 ARG B 155 ARG^? 22.81 O6 C2E B 301 A 351 HIS B 154 HIS^? 20.45 O6 C2E B 301 A 386 LEU B 150 LEU^? 18.79 C6 C2E B 301 coo 57.36 53.34 128.83 58.45 50.56 128.34 6.63 24.44 -23.88 7.74 21.82 -25.04 coo 60.60 50.64 133.59 60.63 48.82 132.56 7.78 28.08 -17.01 9.24 26.69 -16.42 coo 63.28 54.23 126.45 63.53 52.07 126.70 1.48 25.42 -20.64 2.22 24.79 -22.56 1knp_c00 source 1knp L-ASPARTATE OXIDASE : 2 hits 1knp_c00 naa= 3 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS A 238 LYS^? 19.93 N2 C2E B 301 A 74 LYS A 243 LYS.? 15.17 N2 C2E A 301 A 165 GLU B 138 GLU.? 5.49 O2' C2E B 301 coo 24.97 5.82 58.78 26.79 1.97 55.46 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 coo 19.46 3.44 61.93 23.95 1.12 60.13 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -14.88 11.83 -9.39 -15.29 12.85 -11.20 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 A 14 LYS A 243 LYS.? 15.17 N2 C2E A 301 A 74 LYS A 238 LYS^? 19.93 N2 C2E B 301 A 165 GLU B 138 GLU.? 5.49 O2' C2E B 301 coo 24.97 5.82 58.78 26.79 1.97 55.46 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo 19.46 3.44 61.93 23.95 1.12 60.13 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -14.88 11.83 -9.39 -15.29 12.85 -11.20 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 A 14 LYS B 238 LYS^? 16.50 N2 C2E A 301 A 74 LYS B 243 LYS.? 13.43 N1 C2E B 301 A 165 GLU A 138 GLU.? 5.46 O2' C2E A 301 coo 24.97 5.82 58.78 26.79 1.97 55.46 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 coo 19.46 3.44 61.93 23.95 1.12 60.13 -2.53 1.27 -13.25 2.13 3.70 -10.70 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 A 14 LYS B 243 LYS.? 13.43 N1 C2E B 301 A 74 LYS B 238 LYS^? 16.50 N2 C2E A 301 A 165 GLU A 138 GLU.? 5.46 O2' C2E A 301 coo 24.97 5.82 58.78 26.79 1.97 55.46 -2.53 1.27 -13.25 2.13 3.70 -10.70 coo 19.46 3.44 61.93 23.95 1.12 60.13 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 1kqc_c00 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 4 hits 1kqc_c00 naa= 3 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS A 238 LYS^? 19.93 N2 C2E B 301 B 74 LYS A 243 LYS.? 15.17 N2 C2E A 301 B 165 GLU B 138 GLU.? 5.49 O2' C2E B 301 coo 4.84 5.09 23.75 3.30 1.39 27.48 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 coo 10.43 2.88 20.75 5.72 0.41 23.95 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -14.88 11.83 -9.39 -15.29 12.85 -11.20 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 B 14 LYS A 243 LYS.? 15.17 N2 C2E A 301 B 74 LYS A 238 LYS^? 19.93 N2 C2E B 301 B 165 GLU B 138 GLU.? 5.49 O2' C2E B 301 coo 4.84 5.09 23.75 3.30 1.39 27.48 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo 10.43 2.88 20.75 5.72 0.41 23.95 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -14.88 11.83 -9.39 -15.29 12.85 -11.20 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 B 14 LYS B 238 LYS^? 16.50 N2 C2E A 301 B 74 LYS B 243 LYS.? 13.43 N1 C2E B 301 B 165 GLU A 138 GLU.? 5.46 O2' C2E A 301 coo 4.84 5.09 23.75 3.30 1.39 27.48 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 coo 10.43 2.88 20.75 5.72 0.41 23.95 -2.53 1.27 -13.25 2.13 3.70 -10.70 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 B 14 LYS B 243 LYS.? 13.43 N1 C2E B 301 B 74 LYS B 238 LYS^? 16.50 N2 C2E A 301 B 165 GLU A 138 GLU.? 5.46 O2' C2E A 301 coo 4.84 5.09 23.75 3.30 1.39 27.48 -2.53 1.27 -13.25 2.13 3.70 -10.70 coo 10.43 2.88 20.75 5.72 0.41 23.95 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 1kqc_c01 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 4 hits 1kqc_c01 naa= 3 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 C 14 LYS A 238 LYS^? 19.93 N2 C2E B 301 C 74 LYS A 243 LYS.? 15.17 N2 C2E A 301 C 165 GLU B 138 GLU.? 5.49 O2' C2E B 301 coo 17.59 37.25 25.80 19.64 34.15 21.60 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 coo 12.29 34.52 28.11 16.84 32.47 25.43 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo 12.06 27.10 15.56 13.23 27.02 13.80 -14.88 11.83 -9.39 -15.29 12.85 -11.20 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 C 14 LYS A 243 LYS.? 15.17 N2 C2E A 301 C 74 LYS A 238 LYS^? 19.93 N2 C2E B 301 C 165 GLU B 138 GLU.? 5.49 O2' C2E B 301 coo 17.59 37.25 25.80 19.64 34.15 21.60 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo 12.29 34.52 28.11 16.84 32.47 25.43 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 coo 12.06 27.10 15.56 13.23 27.02 13.80 -14.88 11.83 -9.39 -15.29 12.85 -11.20 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 C 14 LYS B 238 LYS^? 16.50 N2 C2E A 301 C 74 LYS B 243 LYS.? 13.43 N1 C2E B 301 C 165 GLU A 138 GLU.? 5.46 O2' C2E A 301 coo 17.59 37.25 25.80 19.64 34.15 21.60 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 coo 12.29 34.52 28.11 16.84 32.47 25.43 -2.53 1.27 -13.25 2.13 3.70 -10.70 coo 12.06 27.10 15.56 13.23 27.02 13.80 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 C 14 LYS B 243 LYS.? 13.43 N1 C2E B 301 C 74 LYS B 238 LYS^? 16.50 N2 C2E A 301 C 165 GLU A 138 GLU.? 5.46 O2' C2E A 301 coo 17.59 37.25 25.80 19.64 34.15 21.60 -2.53 1.27 -13.25 2.13 3.70 -10.70 coo 12.29 34.52 28.11 16.84 32.47 25.43 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 coo 12.06 27.10 15.56 13.23 27.02 13.80 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 1kqc_c02 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 4 hits 1kqc_c02 naa= 3 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 D 14 LYS A 238 LYS^? 19.93 N2 C2E B 301 D 74 LYS A 243 LYS.? 15.17 N2 C2E A 301 D 165 GLU B 138 GLU.? 5.49 O2' C2E B 301 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -14.88 11.83 -9.39 -15.29 12.85 -11.20 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 D 14 LYS A 243 LYS.? 15.17 N2 C2E A 301 D 74 LYS A 238 LYS^? 19.93 N2 C2E B 301 D 165 GLU B 138 GLU.? 5.49 O2' C2E B 301 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -14.88 11.83 -9.39 -15.29 12.85 -11.20 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 D 14 LYS B 238 LYS^? 16.50 N2 C2E A 301 D 74 LYS B 243 LYS.? 13.43 N1 C2E B 301 D 165 GLU A 138 GLU.? 5.46 O2' C2E A 301 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -2.53 1.27 -13.25 2.13 3.70 -10.70 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 D 14 LYS B 243 LYS.? 13.43 N1 C2E B 301 D 74 LYS B 238 LYS^? 16.50 N2 C2E A 301 D 165 GLU A 138 GLU.? 5.46 O2' C2E A 301 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -2.53 1.27 -13.25 2.13 3.70 -10.70 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 1kqc_c03 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 4 hits 1kqc_c03 naa= 3 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 1 3 # 1 A 94 LYS A 75 LYS.? 21.41 N21 C2E A 301 A 197 HIS A 106 HIS^? 11.03 N21 C2E A 301 A 446 ARG A 94 ARG^? 4.68 N21 C2E A 301 coo 3.26 62.02 109.14 4.83 57.73 107.38 9.70 -14.41 17.00 6.16 -11.27 19.18 coo 9.48 43.28 113.60 10.05 44.21 111.80 16.26 -9.68 -2.62 15.33 -11.56 -2.56 coo 12.14 46.28 115.16 13.57 43.60 115.68 12.55 -12.80 -0.72 10.33 -14.85 -0.21 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 2 3 # 2 A 94 LYS B 75 LYS.? 16.89 N21 C2E B 301 A 197 HIS B 106 HIS^? 12.57 N21 C2E B 301 A 446 ARG B 94 ARG^? 9.81 N31 C2E B 301 coo 3.26 62.02 109.14 4.83 57.73 107.38 7.39 19.64 13.02 10.00 17.22 7.78 coo 9.48 43.28 113.60 10.05 44.21 111.80 -12.23 11.16 12.34 -12.16 12.93 13.45 coo 12.14 46.28 115.16 13.57 43.60 115.68 -10.06 14.66 9.70 -12.88 15.81 9.44 1kqf_c03 source 1kqf FORMATE DEHYDROGENASE, NITRATE-INDUCIBLE, CYTO: 2 hits 1kqf_c03 naa= 3 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 1 3 # 1 255 ASP A 157 ASP^? 20.06 O6 C2E A 301 262 LYS A 177 LYS.? 20.27 N7 C2E A 301 336 ARG A 161 ARG^? 11.81 O6 C2E A 301 coo 61.88 50.78 12.96 63.84 50.60 13.71 -19.05 -19.29 2.64 -21.12 -19.53 2.92 coo 63.59 44.40 18.32 63.20 49.74 17.95 -13.21 -27.52 5.04 -11.69 -32.72 3.81 coo 72.60 57.42 15.86 71.61 56.68 18.70 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 2 3 # 2 255 ASP A 162 ASP^? -3.09 N1 C2E A 301s 262 LYS A 243 LYS.? 15.17 N2 C2E A 301 336 ARG A 165 ARG.? 12.45 N2 C2E A 301 coo 61.88 50.78 12.96 63.84 50.60 13.71 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 63.59 44.40 18.32 63.20 49.74 17.95 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo 72.60 57.42 15.86 71.61 56.68 18.70 -4.47 -13.19 -19.45 -6.66 -12.47 -21.46 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 3 3 # 3 255 ASP B 157 ASP^? 20.00 O6 C2E B 301 262 LYS B 177 LYS.? 21.12 N7 C2E B 301 336 ARG B 161 ARG^? 11.68 O6 C2E B 301 coo 61.88 50.78 12.96 63.84 50.60 13.71 9.70 18.14 -17.54 10.97 18.31 -19.23 coo 63.59 44.40 18.32 63.20 49.74 17.95 8.81 26.59 -11.72 7.46 31.56 -12.94 coo 72.60 57.42 15.86 71.61 56.68 18.70 2.96 9.64 -10.71 5.59 9.57 -9.11 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 4 3 # 4 255 ASP B 162 ASP^? -3.04 N1 C2E B 301s 262 LYS B 243 LYS.? 13.43 N1 C2E B 301 336 ARG B 165 ARG.? 10.70 O2' C2E B 301 coo 61.88 50.78 12.96 63.84 50.60 13.71 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 63.59 44.40 18.32 63.20 49.74 17.95 -2.53 1.27 -13.25 2.13 3.70 -10.70 coo 72.60 57.42 15.86 71.61 56.68 18.70 -16.44 10.61 -14.72 -19.33 11.67 -14.77 1lam_c00 source 1lam LEUCINE AMINOPEPTIDASE : 4 hits 1lam_c00 naa= 3 ULMN 3 1lij_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 146 ALA^? 17.10 N1 C2E A 301 A 317 GLY A 147 GLY^? 15.77 N1 C2E A 301 A 318 ASP A 157 ASP^? 20.06 O6 C2E A 301 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 -18.53 -13.88 -2.80 -19.77 -13.48 -2.02 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 -18.95 -17.47 -3.92 -18.81 -17.49 -3.10 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -19.05 -19.29 2.64 -21.12 -19.53 2.92 ULMN 3 1lij_c01 ADENOSINE KINASE user 2 3 # 2 A 316 ALA B 146 ALA^? 17.04 N1 C2E B 301 A 317 GLY B 147 GLY^? 15.80 N1 C2E B 301 A 318 ASP B 157 ASP^? 20.00 O6 C2E B 301 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 5.20 12.25 -19.11 6.53 11.88 -19.77 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 4.21 15.66 -20.42 4.84 15.79 -19.91 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 9.70 18.14 -17.54 10.97 18.31 -19.23 1lij_c01 source 1lij ADENOSINE KINASE : 2 hits 1lij_c01 naa= 3 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 1 3 # 1 A 123 LYS A 137 LYS.? -4.52 O2' C2E A 301s A 202 SER A 164 SER.? -3.07 N2 C2E A 301s A 226 SER A 166 SER.? -4.62 O2' C2E A 301s coo 1.62 6.10 69.30 3.81 1.25 65.91 4.32 -14.05 -15.33 0.72 -19.17 -16.51 coo 4.43 1.89 61.79 4.31 0.09 63.40 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 2 3 # 2 A 123 LYS A 137 LYS.? -4.52 O2' C2E A 301s A 202 SER A 166 SER.? -4.62 O2' C2E A 301s A 226 SER A 164 SER.? -3.07 N2 C2E A 301s coo 1.62 6.10 69.30 3.81 1.25 65.91 4.32 -14.05 -15.33 0.72 -19.17 -16.51 coo 4.43 1.89 61.79 4.31 0.09 63.40 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 3 3 # 3 A 123 LYS B 67 LYS.? 24.61 N21 C2E A 301 A 202 SER B 125 SER^? 22.05 N21 C2E B 301 A 226 SER B 109 SER^? 18.78 N21 C2E B 301 coo 1.62 6.10 69.30 3.81 1.25 65.91 -0.41 -2.48 20.16 2.79 -6.43 20.83 coo 4.43 1.89 61.79 4.31 0.09 63.40 -3.10 3.96 21.21 -4.91 5.28 22.14 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 -6.26 7.92 20.06 -4.06 7.18 19.35 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 4 3 # 4 A 123 LYS B 137 LYS.? -3.23 O3' C2E B 301s A 202 SER B 164 SER.? -3.05 N2 C2E B 301s A 226 SER B 166 SER.? -4.53 O2' C2E B 301s coo 1.62 6.10 69.30 3.81 1.25 65.91 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo 4.43 1.89 61.79 4.31 0.09 63.40 -10.30 11.42 -12.93 -10.44 13.17 -11.24 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 -12.93 16.14 -12.85 -15.09 15.80 -11.81 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 5 3 # 5 A 123 LYS B 137 LYS.? -3.23 O3' C2E B 301s A 202 SER B 166 SER.? -4.53 O2' C2E B 301s A 226 SER B 164 SER.? -3.05 N2 C2E B 301s coo 1.62 6.10 69.30 3.81 1.25 65.91 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo 4.43 1.89 61.79 4.31 0.09 63.40 -12.93 16.14 -12.85 -15.09 15.80 -11.81 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 -10.30 11.42 -12.93 -10.44 13.17 -11.24 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 6 3 # 6 A 123 LYS B 231 LYS~? 16.58 O2' C2E B 301 A 202 SER B 164 SER.? -3.05 N2 C2E B 301s A 226 SER B 166 SER.? -4.53 O2' C2E B 301s coo 1.62 6.10 69.30 3.81 1.25 65.91 -12.77 12.18 -20.95 -18.80 11.50 -22.86 coo 4.43 1.89 61.79 4.31 0.09 63.40 -10.30 11.42 -12.93 -10.44 13.17 -11.24 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 -12.93 16.14 -12.85 -15.09 15.80 -11.81 1m21_c00 source 1m21 PEPTIDE AMIDASE : 6 hits 1m21_c00 naa= 3 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 1 3 # 1 B 123 LYS A 137 LYS.? -4.52 O2' C2E A 301s B 202 SER A 164 SER.? -3.07 N2 C2E A 301s B 226 SER A 166 SER.? -4.62 O2' C2E A 301s coo 35.67 -0.01 18.11 33.47 4.84 14.73 4.32 -14.05 -15.33 0.72 -19.17 -16.51 coo 32.81 4.27 10.70 32.87 6.07 12.31 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 coo 28.77 6.36 12.44 30.83 7.25 11.75 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 2 3 # 2 B 123 LYS A 137 LYS.? -4.52 O2' C2E A 301s B 202 SER A 166 SER.? -4.62 O2' C2E A 301s B 226 SER A 164 SER.? -3.07 N2 C2E A 301s coo 35.67 -0.01 18.11 33.47 4.84 14.73 4.32 -14.05 -15.33 0.72 -19.17 -16.51 coo 32.81 4.27 10.70 32.87 6.07 12.31 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 coo 28.77 6.36 12.44 30.83 7.25 11.75 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 3 3 # 3 B 123 LYS B 67 LYS.? 24.61 N21 C2E A 301 B 202 SER B 125 SER^? 22.05 N21 C2E B 301 B 226 SER B 109 SER^? 18.78 N21 C2E B 301 coo 35.67 -0.01 18.11 33.47 4.84 14.73 -0.41 -2.48 20.16 2.79 -6.43 20.83 coo 32.81 4.27 10.70 32.87 6.07 12.31 -3.10 3.96 21.21 -4.91 5.28 22.14 coo 28.77 6.36 12.44 30.83 7.25 11.75 -6.26 7.92 20.06 -4.06 7.18 19.35 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 4 3 # 4 B 123 LYS B 137 LYS.? -3.23 O3' C2E B 301s B 202 SER B 164 SER.? -3.05 N2 C2E B 301s B 226 SER B 166 SER.? -4.53 O2' C2E B 301s coo 35.67 -0.01 18.11 33.47 4.84 14.73 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo 32.81 4.27 10.70 32.87 6.07 12.31 -10.30 11.42 -12.93 -10.44 13.17 -11.24 coo 28.77 6.36 12.44 30.83 7.25 11.75 -12.93 16.14 -12.85 -15.09 15.80 -11.81 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 5 3 # 5 B 123 LYS B 137 LYS.? -3.23 O3' C2E B 301s B 202 SER B 166 SER.? -4.53 O2' C2E B 301s B 226 SER B 164 SER.? -3.05 N2 C2E B 301s coo 35.67 -0.01 18.11 33.47 4.84 14.73 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo 32.81 4.27 10.70 32.87 6.07 12.31 -12.93 16.14 -12.85 -15.09 15.80 -11.81 coo 28.77 6.36 12.44 30.83 7.25 11.75 -10.30 11.42 -12.93 -10.44 13.17 -11.24 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 6 3 # 6 B 123 LYS B 231 LYS~? 16.58 O2' C2E B 301 B 202 SER B 164 SER.? -3.05 N2 C2E B 301s B 226 SER B 166 SER.? -4.53 O2' C2E B 301s coo 35.67 -0.01 18.11 33.47 4.84 14.73 -12.77 12.18 -20.95 -18.80 11.50 -22.86 coo 32.81 4.27 10.70 32.87 6.07 12.31 -10.30 11.42 -12.93 -10.44 13.17 -11.24 coo 28.77 6.36 12.44 30.83 7.25 11.75 -12.93 16.14 -12.85 -15.09 15.80 -11.81 1m21_c01 source 1m21 PEPTIDE AMIDASE : 6 hits 1m21_c01 naa= 3 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 152 ASP.? 20.83 C8 C2E A 301 A 265 GLU A 225 GLU~? 17.61 C1' C2E A 301 A 369 ASP A 183 ASP.? 14.57 O1P C2E A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo 17.36 23.57 72.04 18.68 21.92 71.98 -14.07 -25.95 -18.02 -15.34 -27.27 -16.96 coo 12.19 31.08 87.29 11.13 32.66 86.38 -7.06 -30.30 -3.03 -6.77 -31.63 -1.43 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 183 ASP.? 14.57 O1P C2E A 301 A 265 GLU A 225 GLU~? 17.61 C1' C2E A 301 A 369 ASP A 152 ASP.? 20.83 C8 C2E A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -7.06 -30.30 -3.03 -6.77 -31.63 -1.43 coo 17.36 23.57 72.04 18.68 21.92 71.98 -14.07 -25.95 -18.02 -15.34 -27.27 -16.96 coo 12.19 31.08 87.29 11.13 32.66 86.38 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP B 31 ASP~? 18.26 O6 C2E A 301 A 265 GLU A 41 GLU^? 8.66 N21 C2E A 301 A 369 ASP B 66 ASP.? 24.37 N21 C2E A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -9.76 -4.11 8.16 -9.75 -6.21 8.42 coo 17.36 23.57 72.04 18.68 21.92 71.98 7.09 -12.35 6.79 6.46 -14.38 6.77 coo 12.19 31.08 87.29 11.13 32.66 86.38 -3.12 -5.44 17.43 -2.91 -6.73 19.08 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP B 66 ASP.? 24.37 N21 C2E A 301 A 265 GLU A 41 GLU^? 8.66 N21 C2E A 301 A 369 ASP B 31 ASP~? 18.26 O6 C2E A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -3.12 -5.44 17.43 -2.91 -6.73 19.08 coo 17.36 23.57 72.04 18.68 21.92 71.98 7.09 -12.35 6.79 6.46 -14.38 6.77 coo 12.19 31.08 87.29 11.13 32.66 86.38 -9.76 -4.11 8.16 -9.75 -6.21 8.42 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP B 152 ASP.? 19.99 C8 C2E B 301 A 265 GLU B 225 GLU~? 17.01 C1' C2E B 301 A 369 ASP B 183 ASP.? 14.33 O1P C2E B 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 2.18 32.86 -17.28 0.63 33.43 -15.93 coo 17.36 23.57 72.04 18.68 21.92 71.98 -10.33 22.86 -23.16 -8.91 24.36 -23.62 coo 12.19 31.08 87.29 11.13 32.66 86.38 -1.79 28.84 -10.63 -0.66 30.31 -9.57 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP B 183 ASP.? 14.33 O1P C2E B 301 A 265 GLU B 225 GLU~? 17.01 C1' C2E B 301 A 369 ASP B 152 ASP.? 19.99 C8 C2E B 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -1.79 28.84 -10.63 -0.66 30.31 -9.57 coo 17.36 23.57 72.04 18.68 21.92 71.98 -10.33 22.86 -23.16 -8.91 24.36 -23.62 coo 12.19 31.08 87.29 11.13 32.66 86.38 2.18 32.86 -17.28 0.63 33.43 -15.93 1m53_c05 source 1m53 ISOMALTULOSE SYNTHASE : 6 hits 1m53_c05 naa= 3 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP B 31 ASP~? 18.26 O6 C2E A 301 A 279 GLU B 101 GLU.? 9.43 O11 C2E B 301 A 369 ASP B 66 ASP.? 24.37 N21 C2E A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -9.76 -4.11 8.16 -9.75 -6.21 8.42 coo 16.54 46.37 63.94 14.77 45.79 62.95 -14.64 6.09 -5.71 -16.72 5.82 -5.44 coo 12.19 31.08 87.29 11.13 32.66 86.38 -3.12 -5.44 17.43 -2.91 -6.73 19.08 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP B 31 ASP~? 18.26 O6 C2E A 301 A 279 GLU B 142 GLU^? 10.78 N1 C2E B 301 A 369 ASP B 66 ASP.? 24.37 N21 C2E A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -9.76 -4.11 8.16 -9.75 -6.21 8.42 coo 16.54 46.37 63.94 14.77 45.79 62.95 -2.97 5.35 -8.71 -1.84 4.27 -7.29 coo 12.19 31.08 87.29 11.13 32.66 86.38 -3.12 -5.44 17.43 -2.91 -6.73 19.08 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP B 66 ASP.? 24.37 N21 C2E A 301 A 279 GLU A 117 GLU.? 32.69 N21 C2E A 301 A 369 ASP B 31 ASP~? 18.26 O6 C2E A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -3.12 -5.44 17.43 -2.91 -6.73 19.08 coo 16.54 46.37 63.94 14.77 45.79 62.95 9.89 -0.66 27.84 10.27 -2.72 27.95 coo 12.19 31.08 87.29 11.13 32.66 86.38 -9.76 -4.11 8.16 -9.75 -6.21 8.42 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP B 66 ASP.? 24.37 N21 C2E A 301 A 279 GLU B 87 GLU.? 28.79 N21 C2E B 301 A 369 ASP B 31 ASP~? 18.26 O6 C2E A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -3.12 -5.44 17.43 -2.91 -6.73 19.08 coo 16.54 46.37 63.94 14.77 45.79 62.95 4.21 10.66 27.30 5.56 9.30 28.22 coo 12.19 31.08 87.29 11.13 32.66 86.38 -9.76 -4.11 8.16 -9.75 -6.21 8.42 1m53_c06 source 1m53 ISOMALTULOSE SYNTHASE : 4 hits 1m53_c06 naa= 3 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 1 3 # 1 A 10 ASP B 66 ASP.? 24.37 N21 C2E A 301 A 168 ASN B 28 ASN^? 21.32 O6 C2E A 301 A 241 HIS A 214 HIS.? 19.24 O6 C2E A 301 coo 2.16 -17.86 7.84 1.13 -18.57 9.58 -3.12 -5.44 17.43 -2.91 -6.73 19.08 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 -11.70 -4.36 12.92 -10.66 -5.13 11.24 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 -9.67 -12.41 11.50 -9.18 -11.33 13.22 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 2 3 # 2 A 10 ASP B 162 ASP^? -3.04 N1 C2E B 301s A 168 ASN B 144 ASN^? 13.28 N1 C2E B 301 A 241 HIS B 215 HIS.? 11.93 O6 C2E B 301 coo 2.16 -17.86 7.84 1.13 -18.57 9.58 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 3.74 6.70 -14.80 3.60 6.07 -12.77 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 7.81 14.24 -7.06 6.68 12.76 -6.10 1mas_c00 source 1mas INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDROLASE : 2 hits 1mas_c00 naa= 3 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 1 3 # 1 B 10 ASP B 66 ASP.? 24.37 N21 C2E A 301 B 168 ASN B 28 ASN^? 21.32 O6 C2E A 301 B 241 HIS A 214 HIS.? 19.24 O6 C2E A 301 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 -3.12 -5.44 17.43 -2.91 -6.73 19.08 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 -11.70 -4.36 12.92 -10.66 -5.13 11.24 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 -9.67 -12.41 11.50 -9.18 -11.33 13.22 1mas_c01 source 1mas INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDROLASE : 1 hits 1mas_c01 naa= 3 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 1 3 # 1 159 ARG A 165 ARG.? 12.45 N2 C2E A 301 229 SER A 166 SER.? -4.62 O2' C2E A 301s 325 GLU A 138 GLU.? 5.46 O2' C2E A 301 coo 2.54 15.84 18.57 3.24 17.85 16.30 -4.47 -13.19 -19.45 -6.66 -12.47 -21.46 coo 10.17 13.48 15.92 9.61 15.76 15.27 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 coo 5.42 13.04 19.75 5.74 13.81 17.79 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 2 3 # 2 159 ARG B 165 ARG.? 10.70 O2' C2E B 301 229 SER B 164 SER.? -3.05 N2 C2E B 301s 325 GLU B 138 GLU.? 5.49 O2' C2E B 301 coo 2.54 15.84 18.57 3.24 17.85 16.30 -16.44 10.61 -14.72 -19.33 11.67 -14.77 coo 10.17 13.48 15.92 9.61 15.76 15.27 -10.30 11.42 -12.93 -10.44 13.17 -11.24 coo 5.42 13.04 19.75 5.74 13.81 17.79 -14.88 11.83 -9.39 -15.29 12.85 -11.20 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 3 3 # 3 159 ARG B 165 ARG.? 10.70 O2' C2E B 301 229 SER B 166 SER.? -4.53 O2' C2E B 301s 325 GLU B 138 GLU.? 5.49 O2' C2E B 301 coo 2.54 15.84 18.57 3.24 17.85 16.30 -16.44 10.61 -14.72 -19.33 11.67 -14.77 coo 10.17 13.48 15.92 9.61 15.76 15.27 -12.93 16.14 -12.85 -15.09 15.80 -11.81 coo 5.42 13.04 19.75 5.74 13.81 17.79 -14.88 11.83 -9.39 -15.29 12.85 -11.20 1mbb_c00 source 1mbb URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYLGLUCOSAMI: 3 hits 1mbb_c00 naa= 3 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 1 3 # 1 164 LYS A 238 LYS^? 19.93 N2 C2E B 301 166 LYS A 243 LYS.? 15.17 N2 C2E A 301 324 SER B 191 SER.? 20.36 N2 C2E B 301 coo 25.93 8.11 25.51 26.40 7.80 19.66 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 coo 27.27 1.43 25.09 29.18 5.25 22.89 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo 46.32 14.55 19.93 45.95 12.72 21.27 0.31 10.28 -26.42 0.19 10.97 -28.73 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 2 3 # 2 164 LYS B 238 LYS^? 16.50 N2 C2E A 301 166 LYS B 243 LYS.? 13.43 N1 C2E B 301 324 SER A 191 SER.? 20.96 N2 C2E A 301 coo 25.93 8.11 25.51 26.40 7.80 19.66 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 coo 27.27 1.43 25.09 29.18 5.25 22.89 -2.53 1.27 -13.25 2.13 3.70 -10.70 coo 46.32 14.55 19.93 45.95 12.72 21.27 -22.97 -12.99 -10.38 -25.12 -13.67 -11.26 1mdr_c01 source 1mdr MANDELATE RACEMASE (E.C.5.1.2.2) : 2 hits 1mdr_c01 naa= 3 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 1 3 # 1 A 50 ASP A 183 ASP.? 14.57 O1P C2E A 301 A 55 TYR A 218 TYR^? 10.22 O6 C2E A 301 A 84 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo 11.09 42.89 24.44 11.32 42.06 22.49 -7.06 -30.30 -3.03 -6.77 -31.63 -1.43 coo 4.60 40.33 20.42 7.25 39.50 20.05 -6.98 -22.32 0.01 -7.64 -23.76 2.29 coo 9.71 44.83 15.47 10.13 41.43 19.93 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 2 3 # 2 A 50 ASP B 80 ASP~? 21.84 N21 C2E B 301 A 55 TYR B 83 TYR~? 26.42 N21 C2E B 301 A 84 LYS B 53 LYS^? 20.29 N21 C2E B 301 coo 11.09 42.89 24.44 11.32 42.06 22.49 3.05 24.05 19.78 2.70 26.08 19.35 coo 4.60 40.33 20.42 7.25 39.50 20.05 1.26 24.03 25.84 -0.99 25.15 27.02 coo 9.71 44.83 15.47 10.13 41.43 19.93 -7.36 22.58 21.02 -13.56 21.56 20.17 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 3 3 # 3 A 50 ASP B 152 ASP.? 19.99 C8 C2E B 301 A 55 TYR B 179 TYR.? 13.89 O6 C2E B 301 A 84 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo 11.09 42.89 24.44 11.32 42.06 22.49 2.18 32.86 -17.28 0.63 33.43 -15.93 coo 4.60 40.33 20.42 7.25 39.50 20.05 2.36 25.70 -10.99 3.98 25.02 -13.14 coo 9.71 44.83 15.47 10.13 41.43 19.93 8.81 26.59 -11.72 7.46 31.56 -12.94 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 4 3 # 4 A 50 ASP B 183 ASP.? 14.33 O1P C2E B 301 A 55 TYR B 218 TYR^? 10.08 O6 C2E B 301 A 84 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo 11.09 42.89 24.44 11.32 42.06 22.49 -1.79 28.84 -10.63 -0.66 30.31 -9.57 coo 4.60 40.33 20.42 7.25 39.50 20.05 1.42 21.23 -8.42 3.73 22.73 -7.99 coo 9.71 44.83 15.47 10.13 41.43 19.93 8.81 26.59 -11.72 7.46 31.56 -12.94 1mrq_c02 source 1mrq ALDO-KETO REDUCTASE FAMILY 1 MEMBER C1 : 4 hits 1mrq_c02 naa= 3 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 A 142 LYS A 67 LYS.? 22.91 N21 C2E B 301 A 217 SER A 125 SER.? 23.81 N21 C2E A 301 A 241 SER A 109 SER^? 20.65 N21 C2E A 301 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 17.01 7.43 8.57 15.28 11.70 10.44 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 19.83 1.13 7.98 21.72 -0.16 7.19 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 20.92 -3.37 5.70 19.17 -2.44 7.11 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 A 142 LYS A 137 LYS.? -4.52 O2' C2E A 301s A 217 SER A 164 SER.? -3.07 N2 C2E A 301s A 241 SER A 166 SER.? -4.62 O2' C2E A 301s coo 12.59 -31.89 29.79 15.18 -27.54 26.08 4.32 -14.05 -15.33 0.72 -19.17 -16.51 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 A 142 LYS A 137 LYS.? -4.52 O2' C2E A 301s A 217 SER A 166 SER.? -4.62 O2' C2E A 301s A 241 SER A 164 SER.? -3.07 N2 C2E A 301s coo 12.59 -31.89 29.79 15.18 -27.54 26.08 4.32 -14.05 -15.33 0.72 -19.17 -16.51 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 A 142 LYS A 231 LYS~? 13.14 O2' C2E A 301 A 217 SER A 164 SER.? -3.07 N2 C2E A 301s A 241 SER A 166 SER.? -4.62 O2' C2E A 301s coo 12.59 -31.89 29.79 15.18 -27.54 26.08 -11.44 -15.22 -19.18 -8.27 -15.76 -22.64 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 A 142 LYS B 67 LYS.? 24.61 N21 C2E A 301 A 217 SER B 125 SER^? 22.05 N21 C2E B 301 A 241 SER B 109 SER^? 18.78 N21 C2E B 301 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 -0.41 -2.48 20.16 2.79 -6.43 20.83 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 -3.10 3.96 21.21 -4.91 5.28 22.14 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 -6.26 7.92 20.06 -4.06 7.18 19.35 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 A 142 LYS B 137 LYS.? -3.23 O3' C2E B 301s A 217 SER B 164 SER.? -3.05 N2 C2E B 301s A 241 SER B 166 SER.? -4.53 O2' C2E B 301s coo 12.59 -31.89 29.79 15.18 -27.54 26.08 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 -10.30 11.42 -12.93 -10.44 13.17 -11.24 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 -12.93 16.14 -12.85 -15.09 15.80 -11.81 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 A 142 LYS B 137 LYS.? -3.23 O3' C2E B 301s A 217 SER B 166 SER.? -4.53 O2' C2E B 301s A 241 SER B 164 SER.? -3.05 N2 C2E B 301s coo 12.59 -31.89 29.79 15.18 -27.54 26.08 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 -12.93 16.14 -12.85 -15.09 15.80 -11.81 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 -10.30 11.42 -12.93 -10.44 13.17 -11.24 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 A 142 LYS B 231 LYS~? 16.58 O2' C2E B 301 A 217 SER B 164 SER.? -3.05 N2 C2E B 301s A 241 SER B 166 SER.? -4.53 O2' C2E B 301s coo 12.59 -31.89 29.79 15.18 -27.54 26.08 -12.77 12.18 -20.95 -18.80 11.50 -22.86 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 -10.30 11.42 -12.93 -10.44 13.17 -11.24 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 -12.93 16.14 -12.85 -15.09 15.80 -11.81 1mt5_c00 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 8 hits 1mt5_c00 naa= 3 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 B 142 LYS A 67 LYS.? 22.91 N21 C2E B 301 B 217 SER A 125 SER.? 23.81 N21 C2E A 301 B 241 SER A 109 SER^? 20.65 N21 C2E A 301 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 17.01 7.43 8.57 15.28 11.70 10.44 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 19.83 1.13 7.98 21.72 -0.16 7.19 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 20.92 -3.37 5.70 19.17 -2.44 7.11 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 B 142 LYS A 137 LYS.? -4.52 O2' C2E A 301s B 217 SER A 164 SER.? -3.07 N2 C2E A 301s B 241 SER A 166 SER.? -4.62 O2' C2E A 301s coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 4.32 -14.05 -15.33 0.72 -19.17 -16.51 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 B 142 LYS A 137 LYS.? -4.52 O2' C2E A 301s B 217 SER A 166 SER.? -4.62 O2' C2E A 301s B 241 SER A 164 SER.? -3.07 N2 C2E A 301s coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 4.32 -14.05 -15.33 0.72 -19.17 -16.51 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 B 142 LYS A 231 LYS~? 13.14 O2' C2E A 301 B 217 SER A 164 SER.? -3.07 N2 C2E A 301s B 241 SER A 166 SER.? -4.62 O2' C2E A 301s coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 -11.44 -15.22 -19.18 -8.27 -15.76 -22.64 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 B 142 LYS B 67 LYS.? 24.61 N21 C2E A 301 B 217 SER B 125 SER^? 22.05 N21 C2E B 301 B 241 SER B 109 SER^? 18.78 N21 C2E B 301 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 -0.41 -2.48 20.16 2.79 -6.43 20.83 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 -3.10 3.96 21.21 -4.91 5.28 22.14 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 -6.26 7.92 20.06 -4.06 7.18 19.35 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 B 142 LYS B 137 LYS.? -3.23 O3' C2E B 301s B 217 SER B 164 SER.? -3.05 N2 C2E B 301s B 241 SER B 166 SER.? -4.53 O2' C2E B 301s coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 -10.30 11.42 -12.93 -10.44 13.17 -11.24 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 -12.93 16.14 -12.85 -15.09 15.80 -11.81 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 B 142 LYS B 137 LYS.? -3.23 O3' C2E B 301s B 217 SER B 166 SER.? -4.53 O2' C2E B 301s B 241 SER B 164 SER.? -3.05 N2 C2E B 301s coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 -12.93 16.14 -12.85 -15.09 15.80 -11.81 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 -10.30 11.42 -12.93 -10.44 13.17 -11.24 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 B 142 LYS B 231 LYS~? 16.58 O2' C2E B 301 B 217 SER B 164 SER.? -3.05 N2 C2E B 301s B 241 SER B 166 SER.? -4.53 O2' C2E B 301s coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 -12.77 12.18 -20.95 -18.80 11.50 -22.86 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 -10.30 11.42 -12.93 -10.44 13.17 -11.24 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 -12.93 16.14 -12.85 -15.09 15.80 -11.81 1mt5_c01 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 8 hits 1mt5_c01 naa= 3 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 C 142 LYS A 67 LYS.? 22.91 N21 C2E B 301 C 217 SER A 125 SER.? 23.81 N21 C2E A 301 C 241 SER A 109 SER^? 20.65 N21 C2E A 301 coo -12.07 2.83 63.52 -8.95 7.56 61.01 17.01 7.43 8.57 15.28 11.70 10.44 coo -11.64 10.12 58.62 -9.34 9.31 58.79 19.83 1.13 7.98 21.72 -0.16 7.19 coo -9.31 12.91 61.58 -8.56 11.90 59.50 20.92 -3.37 5.70 19.17 -2.44 7.11 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 C 142 LYS A 137 LYS.? -4.52 O2' C2E A 301s C 217 SER A 164 SER.? -3.07 N2 C2E A 301s C 241 SER A 166 SER.? -4.62 O2' C2E A 301s coo -12.07 2.83 63.52 -8.95 7.56 61.01 4.32 -14.05 -15.33 0.72 -19.17 -16.51 coo -11.64 10.12 58.62 -9.34 9.31 58.79 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 coo -9.31 12.91 61.58 -8.56 11.90 59.50 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 C 142 LYS A 137 LYS.? -4.52 O2' C2E A 301s C 217 SER A 166 SER.? -4.62 O2' C2E A 301s C 241 SER A 164 SER.? -3.07 N2 C2E A 301s coo -12.07 2.83 63.52 -8.95 7.56 61.01 4.32 -14.05 -15.33 0.72 -19.17 -16.51 coo -11.64 10.12 58.62 -9.34 9.31 58.79 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 coo -9.31 12.91 61.58 -8.56 11.90 59.50 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 C 142 LYS A 231 LYS~? 13.14 O2' C2E A 301 C 217 SER A 164 SER.? -3.07 N2 C2E A 301s C 241 SER A 166 SER.? -4.62 O2' C2E A 301s coo -12.07 2.83 63.52 -8.95 7.56 61.01 -11.44 -15.22 -19.18 -8.27 -15.76 -22.64 coo -11.64 10.12 58.62 -9.34 9.31 58.79 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 coo -9.31 12.91 61.58 -8.56 11.90 59.50 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 C 142 LYS B 67 LYS.? 24.61 N21 C2E A 301 C 217 SER B 125 SER^? 22.05 N21 C2E B 301 C 241 SER B 109 SER^? 18.78 N21 C2E B 301 coo -12.07 2.83 63.52 -8.95 7.56 61.01 -0.41 -2.48 20.16 2.79 -6.43 20.83 coo -11.64 10.12 58.62 -9.34 9.31 58.79 -3.10 3.96 21.21 -4.91 5.28 22.14 coo -9.31 12.91 61.58 -8.56 11.90 59.50 -6.26 7.92 20.06 -4.06 7.18 19.35 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 C 142 LYS B 137 LYS.? -3.23 O3' C2E B 301s C 217 SER B 164 SER.? -3.05 N2 C2E B 301s C 241 SER B 166 SER.? -4.53 O2' C2E B 301s coo -12.07 2.83 63.52 -8.95 7.56 61.01 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo -11.64 10.12 58.62 -9.34 9.31 58.79 -10.30 11.42 -12.93 -10.44 13.17 -11.24 coo -9.31 12.91 61.58 -8.56 11.90 59.50 -12.93 16.14 -12.85 -15.09 15.80 -11.81 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 C 142 LYS B 137 LYS.? -3.23 O3' C2E B 301s C 217 SER B 166 SER.? -4.53 O2' C2E B 301s C 241 SER B 164 SER.? -3.05 N2 C2E B 301s coo -12.07 2.83 63.52 -8.95 7.56 61.01 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo -11.64 10.12 58.62 -9.34 9.31 58.79 -12.93 16.14 -12.85 -15.09 15.80 -11.81 coo -9.31 12.91 61.58 -8.56 11.90 59.50 -10.30 11.42 -12.93 -10.44 13.17 -11.24 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 C 142 LYS B 231 LYS~? 16.58 O2' C2E B 301 C 217 SER B 164 SER.? -3.05 N2 C2E B 301s C 241 SER B 166 SER.? -4.53 O2' C2E B 301s coo -12.07 2.83 63.52 -8.95 7.56 61.01 -12.77 12.18 -20.95 -18.80 11.50 -22.86 coo -11.64 10.12 58.62 -9.34 9.31 58.79 -10.30 11.42 -12.93 -10.44 13.17 -11.24 coo -9.31 12.91 61.58 -8.56 11.90 59.50 -12.93 16.14 -12.85 -15.09 15.80 -11.81 1mt5_c02 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 8 hits 1mt5_c02 naa= 3 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 D 142 LYS A 67 LYS.? 22.91 N21 C2E B 301 D 217 SER A 125 SER.? 23.81 N21 C2E A 301 D 241 SER A 109 SER^? 20.65 N21 C2E A 301 coo 32.93 17.78 71.88 30.89 13.50 67.83 17.01 7.43 8.57 15.28 11.70 10.44 coo 34.38 11.17 66.10 32.18 12.14 65.65 19.83 1.13 7.98 21.72 -0.16 7.19 coo 31.34 7.96 67.74 31.44 9.08 65.62 20.92 -3.37 5.70 19.17 -2.44 7.11 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 D 142 LYS A 137 LYS.? -4.52 O2' C2E A 301s D 217 SER A 164 SER.? -3.07 N2 C2E A 301s D 241 SER A 166 SER.? -4.62 O2' C2E A 301s coo 32.93 17.78 71.88 30.89 13.50 67.83 4.32 -14.05 -15.33 0.72 -19.17 -16.51 coo 34.38 11.17 66.10 32.18 12.14 65.65 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 coo 31.34 7.96 67.74 31.44 9.08 65.62 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 D 142 LYS A 137 LYS.? -4.52 O2' C2E A 301s D 217 SER A 166 SER.? -4.62 O2' C2E A 301s D 241 SER A 164 SER.? -3.07 N2 C2E A 301s coo 32.93 17.78 71.88 30.89 13.50 67.83 4.32 -14.05 -15.33 0.72 -19.17 -16.51 coo 34.38 11.17 66.10 32.18 12.14 65.65 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 coo 31.34 7.96 67.74 31.44 9.08 65.62 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 D 142 LYS A 231 LYS~? 13.14 O2' C2E A 301 D 217 SER A 164 SER.? -3.07 N2 C2E A 301s D 241 SER A 166 SER.? -4.62 O2' C2E A 301s coo 32.93 17.78 71.88 30.89 13.50 67.83 -11.44 -15.22 -19.18 -8.27 -15.76 -22.64 coo 34.38 11.17 66.10 32.18 12.14 65.65 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 coo 31.34 7.96 67.74 31.44 9.08 65.62 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 D 142 LYS B 67 LYS.? 24.61 N21 C2E A 301 D 217 SER B 125 SER^? 22.05 N21 C2E B 301 D 241 SER B 109 SER^? 18.78 N21 C2E B 301 coo 32.93 17.78 71.88 30.89 13.50 67.83 -0.41 -2.48 20.16 2.79 -6.43 20.83 coo 34.38 11.17 66.10 32.18 12.14 65.65 -3.10 3.96 21.21 -4.91 5.28 22.14 coo 31.34 7.96 67.74 31.44 9.08 65.62 -6.26 7.92 20.06 -4.06 7.18 19.35 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 D 142 LYS B 137 LYS.? -3.23 O3' C2E B 301s D 217 SER B 164 SER.? -3.05 N2 C2E B 301s D 241 SER B 166 SER.? -4.53 O2' C2E B 301s coo 32.93 17.78 71.88 30.89 13.50 67.83 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo 34.38 11.17 66.10 32.18 12.14 65.65 -10.30 11.42 -12.93 -10.44 13.17 -11.24 coo 31.34 7.96 67.74 31.44 9.08 65.62 -12.93 16.14 -12.85 -15.09 15.80 -11.81 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 D 142 LYS B 137 LYS.? -3.23 O3' C2E B 301s D 217 SER B 166 SER.? -4.53 O2' C2E B 301s D 241 SER B 164 SER.? -3.05 N2 C2E B 301s coo 32.93 17.78 71.88 30.89 13.50 67.83 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo 34.38 11.17 66.10 32.18 12.14 65.65 -12.93 16.14 -12.85 -15.09 15.80 -11.81 coo 31.34 7.96 67.74 31.44 9.08 65.62 -10.30 11.42 -12.93 -10.44 13.17 -11.24 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 D 142 LYS B 231 LYS~? 16.58 O2' C2E B 301 D 217 SER B 164 SER.? -3.05 N2 C2E B 301s D 241 SER B 166 SER.? -4.53 O2' C2E B 301s coo 32.93 17.78 71.88 30.89 13.50 67.83 -12.77 12.18 -20.95 -18.80 11.50 -22.86 coo 34.38 11.17 66.10 32.18 12.14 65.65 -10.30 11.42 -12.93 -10.44 13.17 -11.24 coo 31.34 7.96 67.74 31.44 9.08 65.62 -12.93 16.14 -12.85 -15.09 15.80 -11.81 1mt5_c03 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 8 hits 1mt5_c03 naa= 3 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 E 142 LYS A 67 LYS.? 22.91 N21 C2E B 301 E 217 SER A 125 SER.? 23.81 N21 C2E A 301 E 241 SER A 109 SER^? 20.65 N21 C2E A 301 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 17.01 7.43 8.57 15.28 11.70 10.44 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 19.83 1.13 7.98 21.72 -0.16 7.19 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 20.92 -3.37 5.70 19.17 -2.44 7.11 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 E 142 LYS A 137 LYS.? -4.52 O2' C2E A 301s E 217 SER A 164 SER.? -3.07 N2 C2E A 301s E 241 SER A 166 SER.? -4.62 O2' C2E A 301s coo 75.33 -22.06 34.43 71.44 -18.39 37.56 4.32 -14.05 -15.33 0.72 -19.17 -16.51 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 E 142 LYS A 137 LYS.? -4.52 O2' C2E A 301s E 217 SER A 166 SER.? -4.62 O2' C2E A 301s E 241 SER A 164 SER.? -3.07 N2 C2E A 301s coo 75.33 -22.06 34.43 71.44 -18.39 37.56 4.32 -14.05 -15.33 0.72 -19.17 -16.51 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 E 142 LYS A 231 LYS~? 13.14 O2' C2E A 301 E 217 SER A 164 SER.? -3.07 N2 C2E A 301s E 241 SER A 166 SER.? -4.62 O2' C2E A 301s coo 75.33 -22.06 34.43 71.44 -18.39 37.56 -11.44 -15.22 -19.18 -8.27 -15.76 -22.64 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 E 142 LYS B 67 LYS.? 24.61 N21 C2E A 301 E 217 SER B 125 SER^? 22.05 N21 C2E B 301 E 241 SER B 109 SER^? 18.78 N21 C2E B 301 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 -0.41 -2.48 20.16 2.79 -6.43 20.83 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 -3.10 3.96 21.21 -4.91 5.28 22.14 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 -6.26 7.92 20.06 -4.06 7.18 19.35 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 E 142 LYS B 137 LYS.? -3.23 O3' C2E B 301s E 217 SER B 164 SER.? -3.05 N2 C2E B 301s E 241 SER B 166 SER.? -4.53 O2' C2E B 301s coo 75.33 -22.06 34.43 71.44 -18.39 37.56 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 -10.30 11.42 -12.93 -10.44 13.17 -11.24 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 -12.93 16.14 -12.85 -15.09 15.80 -11.81 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 E 142 LYS B 137 LYS.? -3.23 O3' C2E B 301s E 217 SER B 166 SER.? -4.53 O2' C2E B 301s E 241 SER B 164 SER.? -3.05 N2 C2E B 301s coo 75.33 -22.06 34.43 71.44 -18.39 37.56 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 -12.93 16.14 -12.85 -15.09 15.80 -11.81 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 -10.30 11.42 -12.93 -10.44 13.17 -11.24 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 E 142 LYS B 231 LYS~? 16.58 O2' C2E B 301 E 217 SER B 164 SER.? -3.05 N2 C2E B 301s E 241 SER B 166 SER.? -4.53 O2' C2E B 301s coo 75.33 -22.06 34.43 71.44 -18.39 37.56 -12.77 12.18 -20.95 -18.80 11.50 -22.86 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 -10.30 11.42 -12.93 -10.44 13.17 -11.24 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 -12.93 16.14 -12.85 -15.09 15.80 -11.81 1mt5_c04 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 8 hits 1mt5_c04 naa= 3 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 F 142 LYS A 67 LYS.? 22.91 N21 C2E B 301 F 217 SER A 125 SER.? 23.81 N21 C2E A 301 F 241 SER A 109 SER^? 20.65 N21 C2E A 301 coo 85.78 13.19 64.96 85.47 13.47 58.63 17.01 7.43 8.57 15.28 11.70 10.44 coo 87.43 17.13 57.15 85.84 15.39 56.76 19.83 1.13 7.98 21.72 -0.16 7.19 coo 89.69 13.60 54.86 87.60 14.67 54.46 20.92 -3.37 5.70 19.17 -2.44 7.11 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 F 142 LYS A 137 LYS.? -4.52 O2' C2E A 301s F 217 SER A 164 SER.? -3.07 N2 C2E A 301s F 241 SER A 166 SER.? -4.62 O2' C2E A 301s coo 85.78 13.19 64.96 85.47 13.47 58.63 4.32 -14.05 -15.33 0.72 -19.17 -16.51 coo 87.43 17.13 57.15 85.84 15.39 56.76 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 coo 89.69 13.60 54.86 87.60 14.67 54.46 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 F 142 LYS A 137 LYS.? -4.52 O2' C2E A 301s F 217 SER A 166 SER.? -4.62 O2' C2E A 301s F 241 SER A 164 SER.? -3.07 N2 C2E A 301s coo 85.78 13.19 64.96 85.47 13.47 58.63 4.32 -14.05 -15.33 0.72 -19.17 -16.51 coo 87.43 17.13 57.15 85.84 15.39 56.76 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 coo 89.69 13.60 54.86 87.60 14.67 54.46 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 F 142 LYS A 231 LYS~? 13.14 O2' C2E A 301 F 217 SER A 164 SER.? -3.07 N2 C2E A 301s F 241 SER A 166 SER.? -4.62 O2' C2E A 301s coo 85.78 13.19 64.96 85.47 13.47 58.63 -11.44 -15.22 -19.18 -8.27 -15.76 -22.64 coo 87.43 17.13 57.15 85.84 15.39 56.76 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 coo 89.69 13.60 54.86 87.60 14.67 54.46 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 F 142 LYS B 67 LYS.? 24.61 N21 C2E A 301 F 217 SER B 125 SER^? 22.05 N21 C2E B 301 F 241 SER B 109 SER^? 18.78 N21 C2E B 301 coo 85.78 13.19 64.96 85.47 13.47 58.63 -0.41 -2.48 20.16 2.79 -6.43 20.83 coo 87.43 17.13 57.15 85.84 15.39 56.76 -3.10 3.96 21.21 -4.91 5.28 22.14 coo 89.69 13.60 54.86 87.60 14.67 54.46 -6.26 7.92 20.06 -4.06 7.18 19.35 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 F 142 LYS B 137 LYS.? -3.23 O3' C2E B 301s F 217 SER B 164 SER.? -3.05 N2 C2E B 301s F 241 SER B 166 SER.? -4.53 O2' C2E B 301s coo 85.78 13.19 64.96 85.47 13.47 58.63 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo 87.43 17.13 57.15 85.84 15.39 56.76 -10.30 11.42 -12.93 -10.44 13.17 -11.24 coo 89.69 13.60 54.86 87.60 14.67 54.46 -12.93 16.14 -12.85 -15.09 15.80 -11.81 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 F 142 LYS B 137 LYS.? -3.23 O3' C2E B 301s F 217 SER B 166 SER.? -4.53 O2' C2E B 301s F 241 SER B 164 SER.? -3.05 N2 C2E B 301s coo 85.78 13.19 64.96 85.47 13.47 58.63 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo 87.43 17.13 57.15 85.84 15.39 56.76 -12.93 16.14 -12.85 -15.09 15.80 -11.81 coo 89.69 13.60 54.86 87.60 14.67 54.46 -10.30 11.42 -12.93 -10.44 13.17 -11.24 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 F 142 LYS B 231 LYS~? 16.58 O2' C2E B 301 F 217 SER B 164 SER.? -3.05 N2 C2E B 301s F 241 SER B 166 SER.? -4.53 O2' C2E B 301s coo 85.78 13.19 64.96 85.47 13.47 58.63 -12.77 12.18 -20.95 -18.80 11.50 -22.86 coo 87.43 17.13 57.15 85.84 15.39 56.76 -10.30 11.42 -12.93 -10.44 13.17 -11.24 coo 89.69 13.60 54.86 87.60 14.67 54.46 -12.93 16.14 -12.85 -15.09 15.80 -11.81 1mt5_c05 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 8 hits 1mt5_c05 naa= 3 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 G 142 LYS A 67 LYS.? 22.91 N21 C2E B 301 G 217 SER A 125 SER.? 23.81 N21 C2E A 301 G 241 SER A 109 SER^? 20.65 N21 C2E A 301 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 17.01 7.43 8.57 15.28 11.70 10.44 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 19.83 1.13 7.98 21.72 -0.16 7.19 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 20.92 -3.37 5.70 19.17 -2.44 7.11 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 G 142 LYS A 137 LYS.? -4.52 O2' C2E A 301s G 217 SER A 164 SER.? -3.07 N2 C2E A 301s G 241 SER A 166 SER.? -4.62 O2' C2E A 301s coo 89.44 13.59 -3.79 85.15 17.81 -2.15 4.32 -14.05 -15.33 0.72 -19.17 -16.51 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 G 142 LYS A 137 LYS.? -4.52 O2' C2E A 301s G 217 SER A 166 SER.? -4.62 O2' C2E A 301s G 241 SER A 164 SER.? -3.07 N2 C2E A 301s coo 89.44 13.59 -3.79 85.15 17.81 -2.15 4.32 -14.05 -15.33 0.72 -19.17 -16.51 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 G 142 LYS A 231 LYS~? 13.14 O2' C2E A 301 G 217 SER A 164 SER.? -3.07 N2 C2E A 301s G 241 SER A 166 SER.? -4.62 O2' C2E A 301s coo 89.44 13.59 -3.79 85.15 17.81 -2.15 -11.44 -15.22 -19.18 -8.27 -15.76 -22.64 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 G 142 LYS B 67 LYS.? 24.61 N21 C2E A 301 G 217 SER B 125 SER^? 22.05 N21 C2E B 301 G 241 SER B 109 SER^? 18.78 N21 C2E B 301 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 -0.41 -2.48 20.16 2.79 -6.43 20.83 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 -3.10 3.96 21.21 -4.91 5.28 22.14 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 -6.26 7.92 20.06 -4.06 7.18 19.35 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 G 142 LYS B 137 LYS.? -3.23 O3' C2E B 301s G 217 SER B 164 SER.? -3.05 N2 C2E B 301s G 241 SER B 166 SER.? -4.53 O2' C2E B 301s coo 89.44 13.59 -3.79 85.15 17.81 -2.15 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 -10.30 11.42 -12.93 -10.44 13.17 -11.24 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 -12.93 16.14 -12.85 -15.09 15.80 -11.81 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 G 142 LYS B 137 LYS.? -3.23 O3' C2E B 301s G 217 SER B 166 SER.? -4.53 O2' C2E B 301s G 241 SER B 164 SER.? -3.05 N2 C2E B 301s coo 89.44 13.59 -3.79 85.15 17.81 -2.15 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 -12.93 16.14 -12.85 -15.09 15.80 -11.81 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 -10.30 11.42 -12.93 -10.44 13.17 -11.24 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 G 142 LYS B 231 LYS~? 16.58 O2' C2E B 301 G 217 SER B 164 SER.? -3.05 N2 C2E B 301s G 241 SER B 166 SER.? -4.53 O2' C2E B 301s coo 89.44 13.59 -3.79 85.15 17.81 -2.15 -12.77 12.18 -20.95 -18.80 11.50 -22.86 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 -10.30 11.42 -12.93 -10.44 13.17 -11.24 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 -12.93 16.14 -12.85 -15.09 15.80 -11.81 1mt5_c06 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 8 hits 1mt5_c06 naa= 3 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 H 142 LYS A 67 LYS.? 22.91 N21 C2E B 301 H 217 SER A 125 SER.? 23.81 N21 C2E A 301 H 241 SER A 109 SER^? 20.65 N21 C2E A 301 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 17.01 7.43 8.57 15.28 11.70 10.44 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 19.83 1.13 7.98 21.72 -0.16 7.19 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 20.92 -3.37 5.70 19.17 -2.44 7.11 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 H 142 LYS A 137 LYS.? -4.52 O2' C2E A 301s H 217 SER A 164 SER.? -3.07 N2 C2E A 301s H 241 SER A 166 SER.? -4.62 O2' C2E A 301s coo 42.27 12.37 -13.24 45.60 9.85 -8.67 4.32 -14.05 -15.33 0.72 -19.17 -16.51 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 H 142 LYS A 137 LYS.? -4.52 O2' C2E A 301s H 217 SER A 166 SER.? -4.62 O2' C2E A 301s H 241 SER A 164 SER.? -3.07 N2 C2E A 301s coo 42.27 12.37 -13.24 45.60 9.85 -8.67 4.32 -14.05 -15.33 0.72 -19.17 -16.51 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 H 142 LYS A 231 LYS~? 13.14 O2' C2E A 301 H 217 SER A 164 SER.? -3.07 N2 C2E A 301s H 241 SER A 166 SER.? -4.62 O2' C2E A 301s coo 42.27 12.37 -13.24 45.60 9.85 -8.67 -11.44 -15.22 -19.18 -8.27 -15.76 -22.64 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 H 142 LYS B 67 LYS.? 24.61 N21 C2E A 301 H 217 SER B 125 SER^? 22.05 N21 C2E B 301 H 241 SER B 109 SER^? 18.78 N21 C2E B 301 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 -0.41 -2.48 20.16 2.79 -6.43 20.83 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 -3.10 3.96 21.21 -4.91 5.28 22.14 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 -6.26 7.92 20.06 -4.06 7.18 19.35 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 H 142 LYS B 137 LYS.? -3.23 O3' C2E B 301s H 217 SER B 164 SER.? -3.05 N2 C2E B 301s H 241 SER B 166 SER.? -4.53 O2' C2E B 301s coo 42.27 12.37 -13.24 45.60 9.85 -8.67 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 -10.30 11.42 -12.93 -10.44 13.17 -11.24 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 -12.93 16.14 -12.85 -15.09 15.80 -11.81 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 H 142 LYS B 137 LYS.? -3.23 O3' C2E B 301s H 217 SER B 166 SER.? -4.53 O2' C2E B 301s H 241 SER B 164 SER.? -3.05 N2 C2E B 301s coo 42.27 12.37 -13.24 45.60 9.85 -8.67 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 -12.93 16.14 -12.85 -15.09 15.80 -11.81 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 -10.30 11.42 -12.93 -10.44 13.17 -11.24 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 H 142 LYS B 231 LYS~? 16.58 O2' C2E B 301 H 217 SER B 164 SER.? -3.05 N2 C2E B 301s H 241 SER B 166 SER.? -4.53 O2' C2E B 301s coo 42.27 12.37 -13.24 45.60 9.85 -8.67 -12.77 12.18 -20.95 -18.80 11.50 -22.86 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 -10.30 11.42 -12.93 -10.44 13.17 -11.24 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 -12.93 16.14 -12.85 -15.09 15.80 -11.81 1mt5_c07 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 8 hits 1mt5_c07 naa= 3 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 I 142 LYS A 67 LYS.? 22.91 N21 C2E B 301 I 217 SER A 125 SER.? 23.81 N21 C2E A 301 I 241 SER A 109 SER^? 20.65 N21 C2E A 301 coo -5.05 91.11 27.04 -1.24 87.39 30.21 17.01 7.43 8.57 15.28 11.70 10.44 coo 2.83 88.63 29.54 1.30 86.82 30.03 19.83 1.13 7.98 21.72 -0.16 7.19 coo 2.37 88.32 34.25 2.82 86.58 32.61 20.92 -3.37 5.70 19.17 -2.44 7.11 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 I 142 LYS A 137 LYS.? -4.52 O2' C2E A 301s I 217 SER A 164 SER.? -3.07 N2 C2E A 301s I 241 SER A 166 SER.? -4.62 O2' C2E A 301s coo -5.05 91.11 27.04 -1.24 87.39 30.21 4.32 -14.05 -15.33 0.72 -19.17 -16.51 coo 2.83 88.63 29.54 1.30 86.82 30.03 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 coo 2.37 88.32 34.25 2.82 86.58 32.61 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 I 142 LYS A 137 LYS.? -4.52 O2' C2E A 301s I 217 SER A 166 SER.? -4.62 O2' C2E A 301s I 241 SER A 164 SER.? -3.07 N2 C2E A 301s coo -5.05 91.11 27.04 -1.24 87.39 30.21 4.32 -14.05 -15.33 0.72 -19.17 -16.51 coo 2.83 88.63 29.54 1.30 86.82 30.03 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 coo 2.37 88.32 34.25 2.82 86.58 32.61 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 I 142 LYS A 231 LYS~? 13.14 O2' C2E A 301 I 217 SER A 164 SER.? -3.07 N2 C2E A 301s I 241 SER A 166 SER.? -4.62 O2' C2E A 301s coo -5.05 91.11 27.04 -1.24 87.39 30.21 -11.44 -15.22 -19.18 -8.27 -15.76 -22.64 coo 2.83 88.63 29.54 1.30 86.82 30.03 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 coo 2.37 88.32 34.25 2.82 86.58 32.61 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 I 142 LYS B 67 LYS.? 24.61 N21 C2E A 301 I 217 SER B 125 SER^? 22.05 N21 C2E B 301 I 241 SER B 109 SER^? 18.78 N21 C2E B 301 coo -5.05 91.11 27.04 -1.24 87.39 30.21 -0.41 -2.48 20.16 2.79 -6.43 20.83 coo 2.83 88.63 29.54 1.30 86.82 30.03 -3.10 3.96 21.21 -4.91 5.28 22.14 coo 2.37 88.32 34.25 2.82 86.58 32.61 -6.26 7.92 20.06 -4.06 7.18 19.35 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 I 142 LYS B 137 LYS.? -3.23 O3' C2E B 301s I 217 SER B 164 SER.? -3.05 N2 C2E B 301s I 241 SER B 166 SER.? -4.53 O2' C2E B 301s coo -5.05 91.11 27.04 -1.24 87.39 30.21 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo 2.83 88.63 29.54 1.30 86.82 30.03 -10.30 11.42 -12.93 -10.44 13.17 -11.24 coo 2.37 88.32 34.25 2.82 86.58 32.61 -12.93 16.14 -12.85 -15.09 15.80 -11.81 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 I 142 LYS B 137 LYS.? -3.23 O3' C2E B 301s I 217 SER B 166 SER.? -4.53 O2' C2E B 301s I 241 SER B 164 SER.? -3.05 N2 C2E B 301s coo -5.05 91.11 27.04 -1.24 87.39 30.21 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo 2.83 88.63 29.54 1.30 86.82 30.03 -12.93 16.14 -12.85 -15.09 15.80 -11.81 coo 2.37 88.32 34.25 2.82 86.58 32.61 -10.30 11.42 -12.93 -10.44 13.17 -11.24 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 I 142 LYS B 231 LYS~? 16.58 O2' C2E B 301 I 217 SER B 164 SER.? -3.05 N2 C2E B 301s I 241 SER B 166 SER.? -4.53 O2' C2E B 301s coo -5.05 91.11 27.04 -1.24 87.39 30.21 -12.77 12.18 -20.95 -18.80 11.50 -22.86 coo 2.83 88.63 29.54 1.30 86.82 30.03 -10.30 11.42 -12.93 -10.44 13.17 -11.24 coo 2.37 88.32 34.25 2.82 86.58 32.61 -12.93 16.14 -12.85 -15.09 15.80 -11.81 1mt5_c08 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 8 hits 1mt5_c08 naa= 3 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 J 142 LYS A 137 LYS.? -4.52 O2' C2E A 301s J 217 SER A 164 SER.? -3.07 N2 C2E A 301s J 241 SER A 166 SER.? -4.62 O2' C2E A 301s coo -16.11 59.78 61.53 -15.92 58.68 55.43 4.32 -14.05 -15.33 0.72 -19.17 -16.51 coo -17.65 54.92 54.17 -15.81 56.46 53.79 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 coo -19.92 58.10 51.57 -17.75 57.08 51.34 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 J 142 LYS A 137 LYS.? -4.52 O2' C2E A 301s J 217 SER A 166 SER.? -4.62 O2' C2E A 301s J 241 SER A 164 SER.? -3.07 N2 C2E A 301s coo -16.11 59.78 61.53 -15.92 58.68 55.43 4.32 -14.05 -15.33 0.72 -19.17 -16.51 coo -17.65 54.92 54.17 -15.81 56.46 53.79 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 coo -19.92 58.10 51.57 -17.75 57.08 51.34 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 J 142 LYS A 231 LYS~? 13.14 O2' C2E A 301 J 217 SER A 164 SER.? -3.07 N2 C2E A 301s J 241 SER A 166 SER.? -4.62 O2' C2E A 301s coo -16.11 59.78 61.53 -15.92 58.68 55.43 -11.44 -15.22 -19.18 -8.27 -15.76 -22.64 coo -17.65 54.92 54.17 -15.81 56.46 53.79 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 coo -19.92 58.10 51.57 -17.75 57.08 51.34 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 J 142 LYS B 67 LYS.? 24.61 N21 C2E A 301 J 217 SER B 125 SER^? 22.05 N21 C2E B 301 J 241 SER B 109 SER^? 18.78 N21 C2E B 301 coo -16.11 59.78 61.53 -15.92 58.68 55.43 -0.41 -2.48 20.16 2.79 -6.43 20.83 coo -17.65 54.92 54.17 -15.81 56.46 53.79 -3.10 3.96 21.21 -4.91 5.28 22.14 coo -19.92 58.10 51.57 -17.75 57.08 51.34 -6.26 7.92 20.06 -4.06 7.18 19.35 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 J 142 LYS B 137 LYS.? -3.23 O3' C2E B 301s J 217 SER B 164 SER.? -3.05 N2 C2E B 301s J 241 SER B 166 SER.? -4.53 O2' C2E B 301s coo -16.11 59.78 61.53 -15.92 58.68 55.43 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo -17.65 54.92 54.17 -15.81 56.46 53.79 -10.30 11.42 -12.93 -10.44 13.17 -11.24 coo -19.92 58.10 51.57 -17.75 57.08 51.34 -12.93 16.14 -12.85 -15.09 15.80 -11.81 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 J 142 LYS B 137 LYS.? -3.23 O3' C2E B 301s J 217 SER B 166 SER.? -4.53 O2' C2E B 301s J 241 SER B 164 SER.? -3.05 N2 C2E B 301s coo -16.11 59.78 61.53 -15.92 58.68 55.43 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo -17.65 54.92 54.17 -15.81 56.46 53.79 -12.93 16.14 -12.85 -15.09 15.80 -11.81 coo -19.92 58.10 51.57 -17.75 57.08 51.34 -10.30 11.42 -12.93 -10.44 13.17 -11.24 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 J 142 LYS B 231 LYS~? 16.58 O2' C2E B 301 J 217 SER B 164 SER.? -3.05 N2 C2E B 301s J 241 SER B 166 SER.? -4.53 O2' C2E B 301s coo -16.11 59.78 61.53 -15.92 58.68 55.43 -12.77 12.18 -20.95 -18.80 11.50 -22.86 coo -17.65 54.92 54.17 -15.81 56.46 53.79 -10.30 11.42 -12.93 -10.44 13.17 -11.24 coo -19.92 58.10 51.57 -17.75 57.08 51.34 -12.93 16.14 -12.85 -15.09 15.80 -11.81 1mt5_c09 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 7 hits 1mt5_c09 naa= 3 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 K 142 LYS A 67 LYS.? 22.91 N21 C2E B 301 K 217 SER A 125 SER.? 23.81 N21 C2E A 301 K 241 SER A 109 SER^? 20.65 N21 C2E A 301 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 17.01 7.43 8.57 15.28 11.70 10.44 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 19.83 1.13 7.98 21.72 -0.16 7.19 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 20.92 -3.37 5.70 19.17 -2.44 7.11 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 K 142 LYS A 137 LYS.? -4.52 O2' C2E A 301s K 217 SER A 164 SER.? -3.07 N2 C2E A 301s K 241 SER A 166 SER.? -4.62 O2' C2E A 301s coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 4.32 -14.05 -15.33 0.72 -19.17 -16.51 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 K 142 LYS A 137 LYS.? -4.52 O2' C2E A 301s K 217 SER A 166 SER.? -4.62 O2' C2E A 301s K 241 SER A 164 SER.? -3.07 N2 C2E A 301s coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 4.32 -14.05 -15.33 0.72 -19.17 -16.51 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 K 142 LYS A 231 LYS~? 13.14 O2' C2E A 301 K 217 SER A 164 SER.? -3.07 N2 C2E A 301s K 241 SER A 166 SER.? -4.62 O2' C2E A 301s coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 -11.44 -15.22 -19.18 -8.27 -15.76 -22.64 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 K 142 LYS B 67 LYS.? 24.61 N21 C2E A 301 K 217 SER B 125 SER^? 22.05 N21 C2E B 301 K 241 SER B 109 SER^? 18.78 N21 C2E B 301 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 -0.41 -2.48 20.16 2.79 -6.43 20.83 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 -3.10 3.96 21.21 -4.91 5.28 22.14 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 -6.26 7.92 20.06 -4.06 7.18 19.35 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 K 142 LYS B 137 LYS.? -3.23 O3' C2E B 301s K 217 SER B 164 SER.? -3.05 N2 C2E B 301s K 241 SER B 166 SER.? -4.53 O2' C2E B 301s coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 -10.30 11.42 -12.93 -10.44 13.17 -11.24 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 -12.93 16.14 -12.85 -15.09 15.80 -11.81 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 K 142 LYS B 137 LYS.? -3.23 O3' C2E B 301s K 217 SER B 166 SER.? -4.53 O2' C2E B 301s K 241 SER B 164 SER.? -3.05 N2 C2E B 301s coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 -12.93 16.14 -12.85 -15.09 15.80 -11.81 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 -10.30 11.42 -12.93 -10.44 13.17 -11.24 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 K 142 LYS B 231 LYS~? 16.58 O2' C2E B 301 K 217 SER B 164 SER.? -3.05 N2 C2E B 301s K 241 SER B 166 SER.? -4.53 O2' C2E B 301s coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 -12.77 12.18 -20.95 -18.80 11.50 -22.86 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 -10.30 11.42 -12.93 -10.44 13.17 -11.24 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 -12.93 16.14 -12.85 -15.09 15.80 -11.81 1mt5_c10 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 8 hits 1mt5_c10 naa= 3 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 L 142 LYS A 67 LYS.? 22.91 N21 C2E B 301 L 217 SER A 125 SER.? 23.81 N21 C2E A 301 L 241 SER A 109 SER^? 20.65 N21 C2E A 301 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 17.01 7.43 8.57 15.28 11.70 10.44 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 19.83 1.13 7.98 21.72 -0.16 7.19 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 20.92 -3.37 5.70 19.17 -2.44 7.11 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 L 142 LYS A 137 LYS.? -4.52 O2' C2E A 301s L 217 SER A 164 SER.? -3.07 N2 C2E A 301s L 241 SER A 166 SER.? -4.62 O2' C2E A 301s coo 28.16 48.07 -15.34 25.35 51.49 -11.15 4.32 -14.05 -15.33 0.72 -19.17 -16.51 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 L 142 LYS A 137 LYS.? -4.52 O2' C2E A 301s L 217 SER A 166 SER.? -4.62 O2' C2E A 301s L 241 SER A 164 SER.? -3.07 N2 C2E A 301s coo 28.16 48.07 -15.34 25.35 51.49 -11.15 4.32 -14.05 -15.33 0.72 -19.17 -16.51 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 L 142 LYS A 231 LYS~? 13.14 O2' C2E A 301 L 217 SER A 164 SER.? -3.07 N2 C2E A 301s L 241 SER A 166 SER.? -4.62 O2' C2E A 301s coo 28.16 48.07 -15.34 25.35 51.49 -11.15 -11.44 -15.22 -19.18 -8.27 -15.76 -22.64 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 L 142 LYS B 67 LYS.? 24.61 N21 C2E A 301 L 217 SER B 125 SER^? 22.05 N21 C2E B 301 L 241 SER B 109 SER^? 18.78 N21 C2E B 301 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 -0.41 -2.48 20.16 2.79 -6.43 20.83 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 -3.10 3.96 21.21 -4.91 5.28 22.14 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 -6.26 7.92 20.06 -4.06 7.18 19.35 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 L 142 LYS B 137 LYS.? -3.23 O3' C2E B 301s L 217 SER B 164 SER.? -3.05 N2 C2E B 301s L 241 SER B 166 SER.? -4.53 O2' C2E B 301s coo 28.16 48.07 -15.34 25.35 51.49 -11.15 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 -10.30 11.42 -12.93 -10.44 13.17 -11.24 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 -12.93 16.14 -12.85 -15.09 15.80 -11.81 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 L 142 LYS B 137 LYS.? -3.23 O3' C2E B 301s L 217 SER B 166 SER.? -4.53 O2' C2E B 301s L 241 SER B 164 SER.? -3.05 N2 C2E B 301s coo 28.16 48.07 -15.34 25.35 51.49 -11.15 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 -12.93 16.14 -12.85 -15.09 15.80 -11.81 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 -10.30 11.42 -12.93 -10.44 13.17 -11.24 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 L 142 LYS B 231 LYS~? 16.58 O2' C2E B 301 L 217 SER B 164 SER.? -3.05 N2 C2E B 301s L 241 SER B 166 SER.? -4.53 O2' C2E B 301s coo 28.16 48.07 -15.34 25.35 51.49 -11.15 -12.77 12.18 -20.95 -18.80 11.50 -22.86 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 -10.30 11.42 -12.93 -10.44 13.17 -11.24 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 -12.93 16.14 -12.85 -15.09 15.80 -11.81 1mt5_c11 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 8 hits 1mt5_c11 naa= 3 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 M 142 LYS A 67 LYS.? 22.91 N21 C2E B 301 M 217 SER A 125 SER.? 23.81 N21 C2E A 301 M 241 SER A 109 SER^? 20.65 N21 C2E A 301 coo 57.83 99.61 24.25 54.90 95.14 20.60 17.01 7.43 8.57 15.28 11.70 10.44 coo 51.07 94.66 21.52 53.18 93.49 22.20 19.83 1.13 7.98 21.72 -0.16 7.19 coo 51.67 94.23 16.93 51.60 92.47 18.57 20.92 -3.37 5.70 19.17 -2.44 7.11 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 M 142 LYS A 137 LYS.? -4.52 O2' C2E A 301s M 217 SER A 164 SER.? -3.07 N2 C2E A 301s M 241 SER A 166 SER.? -4.62 O2' C2E A 301s coo 57.83 99.61 24.25 54.90 95.14 20.60 4.32 -14.05 -15.33 0.72 -19.17 -16.51 coo 51.07 94.66 21.52 53.18 93.49 22.20 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 coo 51.67 94.23 16.93 51.60 92.47 18.57 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 M 142 LYS A 137 LYS.? -4.52 O2' C2E A 301s M 217 SER A 166 SER.? -4.62 O2' C2E A 301s M 241 SER A 164 SER.? -3.07 N2 C2E A 301s coo 57.83 99.61 24.25 54.90 95.14 20.60 4.32 -14.05 -15.33 0.72 -19.17 -16.51 coo 51.07 94.66 21.52 53.18 93.49 22.20 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 coo 51.67 94.23 16.93 51.60 92.47 18.57 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 M 142 LYS B 67 LYS.? 24.61 N21 C2E A 301 M 217 SER B 125 SER^? 22.05 N21 C2E B 301 M 241 SER B 109 SER^? 18.78 N21 C2E B 301 coo 57.83 99.61 24.25 54.90 95.14 20.60 -0.41 -2.48 20.16 2.79 -6.43 20.83 coo 51.07 94.66 21.52 53.18 93.49 22.20 -3.10 3.96 21.21 -4.91 5.28 22.14 coo 51.67 94.23 16.93 51.60 92.47 18.57 -6.26 7.92 20.06 -4.06 7.18 19.35 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 M 142 LYS B 137 LYS.? -3.23 O3' C2E B 301s M 217 SER B 164 SER.? -3.05 N2 C2E B 301s M 241 SER B 166 SER.? -4.53 O2' C2E B 301s coo 57.83 99.61 24.25 54.90 95.14 20.60 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo 51.07 94.66 21.52 53.18 93.49 22.20 -10.30 11.42 -12.93 -10.44 13.17 -11.24 coo 51.67 94.23 16.93 51.60 92.47 18.57 -12.93 16.14 -12.85 -15.09 15.80 -11.81 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 M 142 LYS B 137 LYS.? -3.23 O3' C2E B 301s M 217 SER B 166 SER.? -4.53 O2' C2E B 301s M 241 SER B 164 SER.? -3.05 N2 C2E B 301s coo 57.83 99.61 24.25 54.90 95.14 20.60 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo 51.07 94.66 21.52 53.18 93.49 22.20 -12.93 16.14 -12.85 -15.09 15.80 -11.81 coo 51.67 94.23 16.93 51.60 92.47 18.57 -10.30 11.42 -12.93 -10.44 13.17 -11.24 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 M 142 LYS B 231 LYS~? 16.58 O2' C2E B 301 M 217 SER B 164 SER.? -3.05 N2 C2E B 301s M 241 SER B 166 SER.? -4.53 O2' C2E B 301s coo 57.83 99.61 24.25 54.90 95.14 20.60 -12.77 12.18 -20.95 -18.80 11.50 -22.86 coo 51.07 94.66 21.52 53.18 93.49 22.20 -10.30 11.42 -12.93 -10.44 13.17 -11.24 coo 51.67 94.23 16.93 51.60 92.47 18.57 -12.93 16.14 -12.85 -15.09 15.80 -11.81 1mt5_c12 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 7 hits 1mt5_c12 naa= 3 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 N 142 LYS A 67 LYS.? 22.91 N21 C2E B 301 N 217 SER A 125 SER.? 23.81 N21 C2E A 301 N 241 SER A 109 SER^? 20.65 N21 C2E A 301 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 17.01 7.43 8.57 15.28 11.70 10.44 coo 81.67 67.31 -0.58 79.53 68.28 0.00 19.83 1.13 7.98 21.72 -0.16 7.19 coo 82.47 71.15 2.07 80.82 69.44 2.28 20.92 -3.37 5.70 19.17 -2.44 7.11 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 N 142 LYS A 137 LYS.? -4.52 O2' C2E A 301s N 217 SER A 164 SER.? -3.07 N2 C2E A 301s N 241 SER A 166 SER.? -4.62 O2' C2E A 301s coo 79.06 71.19 -8.17 79.37 70.55 -1.89 4.32 -14.05 -15.33 0.72 -19.17 -16.51 coo 81.67 67.31 -0.58 79.53 68.28 0.00 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 coo 82.47 71.15 2.07 80.82 69.44 2.28 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 N 142 LYS A 137 LYS.? -4.52 O2' C2E A 301s N 217 SER A 166 SER.? -4.62 O2' C2E A 301s N 241 SER A 164 SER.? -3.07 N2 C2E A 301s coo 79.06 71.19 -8.17 79.37 70.55 -1.89 4.32 -14.05 -15.33 0.72 -19.17 -16.51 coo 81.67 67.31 -0.58 79.53 68.28 0.00 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 coo 82.47 71.15 2.07 80.82 69.44 2.28 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 N 142 LYS A 231 LYS~? 13.14 O2' C2E A 301 N 217 SER A 164 SER.? -3.07 N2 C2E A 301s N 241 SER A 166 SER.? -4.62 O2' C2E A 301s coo 79.06 71.19 -8.17 79.37 70.55 -1.89 -11.44 -15.22 -19.18 -8.27 -15.76 -22.64 coo 81.67 67.31 -0.58 79.53 68.28 0.00 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 coo 82.47 71.15 2.07 80.82 69.44 2.28 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 N 142 LYS B 67 LYS.? 24.61 N21 C2E A 301 N 217 SER B 125 SER^? 22.05 N21 C2E B 301 N 241 SER B 109 SER^? 18.78 N21 C2E B 301 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 -0.41 -2.48 20.16 2.79 -6.43 20.83 coo 81.67 67.31 -0.58 79.53 68.28 0.00 -3.10 3.96 21.21 -4.91 5.28 22.14 coo 82.47 71.15 2.07 80.82 69.44 2.28 -6.26 7.92 20.06 -4.06 7.18 19.35 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 N 142 LYS B 137 LYS.? -3.23 O3' C2E B 301s N 217 SER B 164 SER.? -3.05 N2 C2E B 301s N 241 SER B 166 SER.? -4.53 O2' C2E B 301s coo 79.06 71.19 -8.17 79.37 70.55 -1.89 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo 81.67 67.31 -0.58 79.53 68.28 0.00 -10.30 11.42 -12.93 -10.44 13.17 -11.24 coo 82.47 71.15 2.07 80.82 69.44 2.28 -12.93 16.14 -12.85 -15.09 15.80 -11.81 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 N 142 LYS B 137 LYS.? -3.23 O3' C2E B 301s N 217 SER B 166 SER.? -4.53 O2' C2E B 301s N 241 SER B 164 SER.? -3.05 N2 C2E B 301s coo 79.06 71.19 -8.17 79.37 70.55 -1.89 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo 81.67 67.31 -0.58 79.53 68.28 0.00 -12.93 16.14 -12.85 -15.09 15.80 -11.81 coo 82.47 71.15 2.07 80.82 69.44 2.28 -10.30 11.42 -12.93 -10.44 13.17 -11.24 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 N 142 LYS B 231 LYS~? 16.58 O2' C2E B 301 N 217 SER B 164 SER.? -3.05 N2 C2E B 301s N 241 SER B 166 SER.? -4.53 O2' C2E B 301s coo 79.06 71.19 -8.17 79.37 70.55 -1.89 -12.77 12.18 -20.95 -18.80 11.50 -22.86 coo 81.67 67.31 -0.58 79.53 68.28 0.00 -10.30 11.42 -12.93 -10.44 13.17 -11.24 coo 82.47 71.15 2.07 80.82 69.44 2.28 -12.93 16.14 -12.85 -15.09 15.80 -11.81 1mt5_c13 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 8 hits 1mt5_c13 naa= 3 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 O 142 LYS A 67 LYS.? 22.91 N21 C2E B 301 O 217 SER A 125 SER.? 23.81 N21 C2E A 301 O 241 SER A 109 SER^? 20.65 N21 C2E A 301 coo 81.67 70.12 58.71 78.82 64.87 57.22 17.01 7.43 8.57 15.28 11.70 10.44 coo 81.62 62.23 55.05 79.32 62.93 55.20 19.83 1.13 7.98 21.72 -0.16 7.19 coo 79.39 59.54 58.42 78.72 60.00 56.11 20.92 -3.37 5.70 19.17 -2.44 7.11 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 O 142 LYS A 137 LYS.? -4.52 O2' C2E A 301s O 217 SER A 164 SER.? -3.07 N2 C2E A 301s O 241 SER A 166 SER.? -4.62 O2' C2E A 301s coo 81.67 70.12 58.71 78.82 64.87 57.22 4.32 -14.05 -15.33 0.72 -19.17 -16.51 coo 81.62 62.23 55.05 79.32 62.93 55.20 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 coo 79.39 59.54 58.42 78.72 60.00 56.11 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 O 142 LYS A 137 LYS.? -4.52 O2' C2E A 301s O 217 SER A 166 SER.? -4.62 O2' C2E A 301s O 241 SER A 164 SER.? -3.07 N2 C2E A 301s coo 81.67 70.12 58.71 78.82 64.87 57.22 4.32 -14.05 -15.33 0.72 -19.17 -16.51 coo 81.62 62.23 55.05 79.32 62.93 55.20 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 coo 79.39 59.54 58.42 78.72 60.00 56.11 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 O 142 LYS A 231 LYS~? 13.14 O2' C2E A 301 O 217 SER A 164 SER.? -3.07 N2 C2E A 301s O 241 SER A 166 SER.? -4.62 O2' C2E A 301s coo 81.67 70.12 58.71 78.82 64.87 57.22 -11.44 -15.22 -19.18 -8.27 -15.76 -22.64 coo 81.62 62.23 55.05 79.32 62.93 55.20 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 coo 79.39 59.54 58.42 78.72 60.00 56.11 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 O 142 LYS B 67 LYS.? 24.61 N21 C2E A 301 O 217 SER B 125 SER^? 22.05 N21 C2E B 301 O 241 SER B 109 SER^? 18.78 N21 C2E B 301 coo 81.67 70.12 58.71 78.82 64.87 57.22 -0.41 -2.48 20.16 2.79 -6.43 20.83 coo 81.62 62.23 55.05 79.32 62.93 55.20 -3.10 3.96 21.21 -4.91 5.28 22.14 coo 79.39 59.54 58.42 78.72 60.00 56.11 -6.26 7.92 20.06 -4.06 7.18 19.35 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 O 142 LYS B 137 LYS.? -3.23 O3' C2E B 301s O 217 SER B 164 SER.? -3.05 N2 C2E B 301s O 241 SER B 166 SER.? -4.53 O2' C2E B 301s coo 81.67 70.12 58.71 78.82 64.87 57.22 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo 81.62 62.23 55.05 79.32 62.93 55.20 -10.30 11.42 -12.93 -10.44 13.17 -11.24 coo 79.39 59.54 58.42 78.72 60.00 56.11 -12.93 16.14 -12.85 -15.09 15.80 -11.81 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 O 142 LYS B 137 LYS.? -3.23 O3' C2E B 301s O 217 SER B 166 SER.? -4.53 O2' C2E B 301s O 241 SER B 164 SER.? -3.05 N2 C2E B 301s coo 81.67 70.12 58.71 78.82 64.87 57.22 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo 81.62 62.23 55.05 79.32 62.93 55.20 -12.93 16.14 -12.85 -15.09 15.80 -11.81 coo 79.39 59.54 58.42 78.72 60.00 56.11 -10.30 11.42 -12.93 -10.44 13.17 -11.24 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 O 142 LYS B 231 LYS~? 16.58 O2' C2E B 301 O 217 SER B 164 SER.? -3.05 N2 C2E B 301s O 241 SER B 166 SER.? -4.53 O2' C2E B 301s coo 81.67 70.12 58.71 78.82 64.87 57.22 -12.77 12.18 -20.95 -18.80 11.50 -22.86 coo 81.62 62.23 55.05 79.32 62.93 55.20 -10.30 11.42 -12.93 -10.44 13.17 -11.24 coo 79.39 59.54 58.42 78.72 60.00 56.11 -12.93 16.14 -12.85 -15.09 15.80 -11.81 1mt5_c14 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 8 hits 1mt5_c14 naa= 3 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 P 142 LYS A 67 LYS.? 22.91 N21 C2E B 301 P 217 SER A 125 SER.? 23.81 N21 C2E A 301 P 241 SER A 109 SER^? 20.65 N21 C2E A 301 coo 37.29 55.72 69.54 38.73 59.85 65.07 17.01 7.43 8.57 15.28 11.70 10.44 coo 35.55 61.40 62.96 37.72 60.41 62.66 19.83 1.13 7.98 21.72 -0.16 7.19 coo 38.60 64.77 64.10 38.63 63.28 62.26 20.92 -3.37 5.70 19.17 -2.44 7.11 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 P 142 LYS A 137 LYS.? -4.52 O2' C2E A 301s P 217 SER A 164 SER.? -3.07 N2 C2E A 301s P 241 SER A 166 SER.? -4.62 O2' C2E A 301s coo 37.29 55.72 69.54 38.73 59.85 65.07 4.32 -14.05 -15.33 0.72 -19.17 -16.51 coo 35.55 61.40 62.96 37.72 60.41 62.66 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 coo 38.60 64.77 64.10 38.63 63.28 62.26 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 P 142 LYS A 137 LYS.? -4.52 O2' C2E A 301s P 217 SER A 166 SER.? -4.62 O2' C2E A 301s P 241 SER A 164 SER.? -3.07 N2 C2E A 301s coo 37.29 55.72 69.54 38.73 59.85 65.07 4.32 -14.05 -15.33 0.72 -19.17 -16.51 coo 35.55 61.40 62.96 37.72 60.41 62.66 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 coo 38.60 64.77 64.10 38.63 63.28 62.26 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 P 142 LYS A 231 LYS~? 13.14 O2' C2E A 301 P 217 SER A 164 SER.? -3.07 N2 C2E A 301s P 241 SER A 166 SER.? -4.62 O2' C2E A 301s coo 37.29 55.72 69.54 38.73 59.85 65.07 -11.44 -15.22 -19.18 -8.27 -15.76 -22.64 coo 35.55 61.40 62.96 37.72 60.41 62.66 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 coo 38.60 64.77 64.10 38.63 63.28 62.26 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 P 142 LYS B 67 LYS.? 24.61 N21 C2E A 301 P 217 SER B 125 SER^? 22.05 N21 C2E B 301 P 241 SER B 109 SER^? 18.78 N21 C2E B 301 coo 37.29 55.72 69.54 38.73 59.85 65.07 -0.41 -2.48 20.16 2.79 -6.43 20.83 coo 35.55 61.40 62.96 37.72 60.41 62.66 -3.10 3.96 21.21 -4.91 5.28 22.14 coo 38.60 64.77 64.10 38.63 63.28 62.26 -6.26 7.92 20.06 -4.06 7.18 19.35 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 P 142 LYS B 137 LYS.? -3.23 O3' C2E B 301s P 217 SER B 164 SER.? -3.05 N2 C2E B 301s P 241 SER B 166 SER.? -4.53 O2' C2E B 301s coo 37.29 55.72 69.54 38.73 59.85 65.07 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo 35.55 61.40 62.96 37.72 60.41 62.66 -10.30 11.42 -12.93 -10.44 13.17 -11.24 coo 38.60 64.77 64.10 38.63 63.28 62.26 -12.93 16.14 -12.85 -15.09 15.80 -11.81 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 P 142 LYS B 137 LYS.? -3.23 O3' C2E B 301s P 217 SER B 166 SER.? -4.53 O2' C2E B 301s P 241 SER B 164 SER.? -3.05 N2 C2E B 301s coo 37.29 55.72 69.54 38.73 59.85 65.07 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo 35.55 61.40 62.96 37.72 60.41 62.66 -12.93 16.14 -12.85 -15.09 15.80 -11.81 coo 38.60 64.77 64.10 38.63 63.28 62.26 -10.30 11.42 -12.93 -10.44 13.17 -11.24 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 P 142 LYS B 231 LYS~? 16.58 O2' C2E B 301 P 217 SER B 164 SER.? -3.05 N2 C2E B 301s P 241 SER B 166 SER.? -4.53 O2' C2E B 301s coo 37.29 55.72 69.54 38.73 59.85 65.07 -12.77 12.18 -20.95 -18.80 11.50 -22.86 coo 35.55 61.40 62.96 37.72 60.41 62.66 -10.30 11.42 -12.93 -10.44 13.17 -11.24 coo 38.60 64.77 64.10 38.63 63.28 62.26 -12.93 16.14 -12.85 -15.09 15.80 -11.81 1mt5_c15 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 8 hits 1mt5_c15 naa= 3 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 1 3 # 1 A 167 LYS A 243 LYS.? 15.17 N2 C2E A 301 A 169 LYS A 238 LYS^? 19.93 N2 C2E B 301 A 327 GLU B 101 GLU.? 9.43 O11 C2E B 301 coo 20.73 15.53 25.54 22.09 15.64 19.40 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo 24.31 10.25 23.71 29.02 12.05 20.75 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 coo 21.86 20.40 18.59 22.12 18.33 18.33 -14.64 6.09 -5.71 -16.72 5.82 -5.44 1muc_c00 source 1muc MUCONATE LACTONIZING ENZYME : 1 hits 1muc_c00 naa= 3 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 1 3 # 1 B 167 LYS A 243 LYS.? 15.17 N2 C2E A 301 B 169 LYS A 238 LYS^? 19.93 N2 C2E B 301 B 327 GLU B 101 GLU.? 9.43 O11 C2E B 301 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -14.64 6.09 -5.71 -16.72 5.82 -5.44 1muc_c01 source 1muc MUCONATE LACTONIZING ENZYME : 1 hits 1muc_c01 naa= 3 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 A 114 HIS B 64 HIS^? 22.95 N21 C2E A 301 A 197 ASP B 66 ASP.? 24.37 N21 C2E A 301 A 223 ALA B 34 ALA~? 16.17 O61 C2E A 301 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 5.28 -3.23 17.72 6.30 -4.93 18.40 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -3.12 -5.44 17.43 -2.91 -6.73 19.08 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -4.24 -1.51 6.29 -4.80 -2.92 6.14 1n2t_c02 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 1 hits 1n2t_c02 naa= 3 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 B 114 HIS B 64 HIS^? 22.95 N21 C2E A 301 B 197 ASP B 66 ASP.? 24.37 N21 C2E A 301 B 223 ALA B 34 ALA~? 16.17 O61 C2E A 301 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 5.28 -3.23 17.72 6.30 -4.93 18.40 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -3.12 -5.44 17.43 -2.91 -6.73 19.08 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -4.24 -1.51 6.29 -4.80 -2.92 6.14 1n2t_c03 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 1 hits 1n2t_c03 naa= 3 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 1 3 # 1 B 59 GLU A 41 GLU^? 8.66 N21 C2E A 301 B 128 HIS A 38 HIS.? 16.46 O61 C2E B 301 C 263 HIS B 64 HIS^? 22.95 N21 C2E A 301 coo 6.12 5.94 82.00 7.16 6.32 83.81 7.09 -12.35 6.79 6.46 -14.38 6.77 coo 12.51 16.35 80.99 13.16 14.90 82.37 1.46 -0.40 7.20 -0.57 -0.26 7.72 coo 11.58 14.94 93.26 12.25 14.03 91.50 5.28 -3.23 17.72 6.30 -4.93 18.40 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 2 3 # 2 B 59 GLU A 72 GLU^? 18.63 N21 C2E A 301 B 128 HIS A 38 HIS.? 16.46 O61 C2E B 301 C 263 HIS A 64 HIS^? 21.50 N21 C2E B 301 coo 6.12 5.94 82.00 7.16 6.32 83.81 6.69 -5.58 14.73 4.83 -6.56 14.45 coo 12.51 16.35 80.99 13.16 14.90 82.37 1.46 -0.40 7.20 -0.57 -0.26 7.72 coo 11.58 14.94 93.26 12.25 14.03 91.50 11.95 7.99 12.22 11.86 9.83 13.23 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 3 3 # 3 B 59 GLU A 72 GLU^? 18.63 N21 C2E A 301 B 128 HIS B 38 HIS.? 15.97 O61 C2E B 301 C 263 HIS A 64 HIS^? 21.50 N21 C2E B 301 coo 6.12 5.94 82.00 7.16 6.32 83.81 6.69 -5.58 14.73 4.83 -6.56 14.45 coo 12.51 16.35 80.99 13.16 14.90 82.37 4.87 2.64 4.63 6.30 2.30 3.13 coo 11.58 14.94 93.26 12.25 14.03 91.50 11.95 7.99 12.22 11.86 9.83 13.23 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 4 3 # 4 B 59 GLU B 41 GLU^? 7.72 N21 C2E B 301 B 128 HIS B 38 HIS.? 15.97 O61 C2E B 301 C 263 HIS A 64 HIS^? 21.50 N21 C2E B 301 coo 6.12 5.94 82.00 7.16 6.32 83.81 0.46 14.98 6.85 0.80 16.86 5.93 coo 12.51 16.35 80.99 13.16 14.90 82.37 4.87 2.64 4.63 6.30 2.30 3.13 coo 11.58 14.94 93.26 12.25 14.03 91.50 11.95 7.99 12.22 11.86 9.83 13.23 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 5 3 # 5 B 59 GLU B 72 GLU^? 16.96 N21 C2E B 301 B 128 HIS A 38 HIS.? 16.46 O61 C2E B 301 C 263 HIS B 64 HIS^? 22.95 N21 C2E A 301 coo 6.12 5.94 82.00 7.16 6.32 83.81 8.42 10.26 11.58 8.84 10.78 9.58 coo 12.51 16.35 80.99 13.16 14.90 82.37 1.46 -0.40 7.20 -0.57 -0.26 7.72 coo 11.58 14.94 93.26 12.25 14.03 91.50 5.28 -3.23 17.72 6.30 -4.93 18.40 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 6 3 # 6 B 59 GLU B 72 GLU^? 16.96 N21 C2E B 301 B 128 HIS B 38 HIS.? 15.97 O61 C2E B 301 C 263 HIS B 64 HIS^? 22.95 N21 C2E A 301 coo 6.12 5.94 82.00 7.16 6.32 83.81 8.42 10.26 11.58 8.84 10.78 9.58 coo 12.51 16.35 80.99 13.16 14.90 82.37 4.87 2.64 4.63 6.30 2.30 3.13 coo 11.58 14.94 93.26 12.25 14.03 91.50 5.28 -3.23 17.72 6.30 -4.93 18.40 1ni4_c00 source 1ni4 PYRUVATE DEHYDROGENASE E1 COMPONENT: ALPHA SUB: 6 hits 1ni4_c00 naa= 3 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 1 3 # 1 A 263 HIS A 64 HIS^? 21.50 N21 C2E B 301 D 59 GLU A 72 GLU^? 18.63 N21 C2E A 301 D 128 HIS B 38 HIS.? 15.97 O61 C2E B 301 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 11.95 7.99 12.22 11.86 9.83 13.23 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 6.69 -5.58 14.73 4.83 -6.56 14.45 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 4.87 2.64 4.63 6.30 2.30 3.13 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 2 3 # 2 A 263 HIS A 64 HIS^? 21.50 N21 C2E B 301 D 59 GLU B 41 GLU^? 7.72 N21 C2E B 301 D 128 HIS B 38 HIS.? 15.97 O61 C2E B 301 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 11.95 7.99 12.22 11.86 9.83 13.23 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 0.46 14.98 6.85 0.80 16.86 5.93 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 4.87 2.64 4.63 6.30 2.30 3.13 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 3 3 # 3 A 263 HIS B 64 HIS^? 22.95 N21 C2E A 301 D 59 GLU A 41 GLU^? 8.66 N21 C2E A 301 D 128 HIS A 38 HIS.? 16.46 O61 C2E B 301 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 5.28 -3.23 17.72 6.30 -4.93 18.40 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 7.09 -12.35 6.79 6.46 -14.38 6.77 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 1.46 -0.40 7.20 -0.57 -0.26 7.72 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 4 3 # 4 A 263 HIS B 64 HIS^? 22.95 N21 C2E A 301 D 59 GLU B 72 GLU^? 16.96 N21 C2E B 301 D 128 HIS A 38 HIS.? 16.46 O61 C2E B 301 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 5.28 -3.23 17.72 6.30 -4.93 18.40 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 8.42 10.26 11.58 8.84 10.78 9.58 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 1.46 -0.40 7.20 -0.57 -0.26 7.72 1ni4_c01 source 1ni4 PYRUVATE DEHYDROGENASE E1 COMPONENT: ALPHA SUB: 4 hits 1ni4_c01 naa= 3 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 1 3 # 1 549 LYS A 238 LYS^? 19.93 N2 C2E B 301 631 LYS A 148 LYS^? 21.30 O6 C2E A 301 708 LYS B 238 LYS^? 16.50 N2 C2E A 301 coo 8.61 33.06 11.15 10.12 29.19 8.82 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 coo 18.16 32.86 9.85 16.06 28.20 13.56 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 2 3 # 2 549 LYS A 243 LYS.? 15.17 N2 C2E A 301 631 LYS A 148 LYS^? 21.30 O6 C2E A 301 708 LYS B 243 LYS.? 13.43 N1 C2E B 301 coo 8.61 33.06 11.15 10.12 29.19 8.82 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 coo 18.16 32.86 9.85 16.06 28.20 13.56 -2.53 1.27 -13.25 2.13 3.70 -10.70 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 3 3 # 3 549 LYS A 243 LYS.? 15.17 N2 C2E A 301 631 LYS A 197 LYS.? 27.35 N2 C2E A 301 708 LYS B 243 LYS.? 13.43 N1 C2E B 301 coo 8.61 33.06 11.15 10.12 29.19 8.82 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -26.95 -17.54 -10.03 -31.23 -18.41 -12.60 coo 18.16 32.86 9.85 16.06 28.20 13.56 -2.53 1.27 -13.25 2.13 3.70 -10.70 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 4 3 # 4 549 LYS B 238 LYS^? 16.50 N2 C2E A 301 631 LYS B 148 LYS^? 21.33 O6 C2E B 301 708 LYS A 238 LYS^? 19.93 N2 C2E B 301 coo 8.61 33.06 11.15 10.12 29.19 8.82 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 coo -11.99 27.40 17.14 -13.60 24.52 11.71 4.64 19.42 -20.28 9.89 19.27 -22.17 coo 18.16 32.86 9.85 16.06 28.20 13.56 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 5 3 # 5 549 LYS B 243 LYS.? 13.43 N1 C2E B 301 631 LYS B 148 LYS^? 21.33 O6 C2E B 301 708 LYS A 243 LYS.? 15.17 N2 C2E A 301 coo 8.61 33.06 11.15 10.12 29.19 8.82 -2.53 1.27 -13.25 2.13 3.70 -10.70 coo -11.99 27.40 17.14 -13.60 24.52 11.71 4.64 19.42 -20.28 9.89 19.27 -22.17 coo 18.16 32.86 9.85 16.06 28.20 13.56 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 6 3 # 6 549 LYS B 243 LYS.? 13.43 N1 C2E B 301 631 LYS B 197 LYS.? 24.97 N2 C2E B 301 708 LYS A 243 LYS.? 15.17 N2 C2E A 301 coo 8.61 33.06 11.15 10.12 29.19 8.82 -2.53 1.27 -13.25 2.13 3.70 -10.70 coo -11.99 27.40 17.14 -13.60 24.52 11.71 2.66 14.16 -30.11 -0.83 11.74 -34.04 coo 18.16 32.86 9.85 16.06 28.20 13.56 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 1nsf_c00 source 1nsf N-ETHYLMALEIMIDE SENSITIVE FACTOR : 6 hits 1nsf_c00 naa= 3 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 1 3 # 1 A 62 SER A 97 SER^? 9.23 O61 C2E A 301 A 154 ASP A 162 ASP^? -3.09 N1 C2E A 301s A 261 ARG A 99 ARG.? 13.59 O61 C2E B 301 coo 16.10 74.10 3.11 17.18 73.52 5.20 5.13 -5.92 -3.45 4.74 -3.92 -4.71 coo 16.07 84.71 8.14 15.20 82.81 8.14 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 10.59 77.85 4.81 13.09 76.36 5.76 -1.29 -2.34 -4.97 -2.19 0.30 -6.23 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 2 3 # 2 A 62 SER B 97 SER^? 9.09 O61 C2E B 301 A 154 ASP B 162 ASP^? -3.04 N1 C2E B 301s A 261 ARG B 99 ARG.? 13.88 O61 C2E A 301 coo 16.10 74.10 3.11 17.18 73.52 5.20 -6.95 5.73 2.13 -8.07 3.68 1.50 coo 16.07 84.71 8.14 15.20 82.81 8.14 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 10.59 77.85 4.81 13.09 76.36 5.76 -4.81 1.09 -3.04 -5.37 -1.84 -3.80 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 3 3 # 3 A 62 SER B 97 SER^? 9.09 O61 C2E B 301 A 154 ASP B 162 ASP^? -3.04 N1 C2E B 301s A 261 ARG B 136 ARG.? -3.89 O61 C2E B 301s coo 16.10 74.10 3.11 17.18 73.52 5.20 -6.95 5.73 2.13 -8.07 3.68 1.50 coo 16.07 84.71 8.14 15.20 82.81 8.14 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 10.59 77.85 4.81 13.09 76.36 5.76 -10.39 10.75 -3.93 -7.55 9.68 -3.54 1o98_c00 source 1o98 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT PHOSPHOGLY: 3 hits 1o98_c00 naa= 3 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 1 3 # 1 A 1 CYH A 56 CYH^? 16.49 N21 C2E A 301 A 903 GLU A 221 GLU^? -4.32 C4' C2E A 301s A 972 LYS A 137 LYS.? -4.52 O2' C2E A 301s coo 88.42 112.53 24.94 87.72 110.88 27.11 14.08 -15.43 10.17 15.14 -13.33 11.76 coo 61.58 117.15 13.99 62.31 115.51 15.12 -2.05 -23.28 -12.44 -0.03 -23.89 -12.66 coo 60.18 107.64 21.53 58.13 110.55 17.14 4.32 -14.05 -15.33 0.72 -19.17 -16.51 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 2 3 # 2 A 1 CYH A 158 CYH^? 12.92 O6 C2E A 301 A 903 GLU B 142 GLU^? 10.78 N1 C2E B 301 A 972 LYS B 238 LYS^? 16.50 N2 C2E A 301 coo 88.42 112.53 24.94 87.72 110.88 27.11 -15.53 -18.41 0.03 -15.42 -19.19 -2.71 coo 61.58 117.15 13.99 62.31 115.51 15.12 -2.97 5.35 -8.71 -1.84 4.27 -7.29 coo 60.18 107.64 21.53 58.13 110.55 17.14 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 3 3 # 3 A 1 CYH A 207 CYH^? -4.01 O4' C2E A 301s A 903 GLU B 142 GLU^? 10.78 N1 C2E B 301 A 972 LYS B 238 LYS^? 16.50 N2 C2E A 301 coo 88.42 112.53 24.94 87.72 110.88 27.11 -0.78 -24.34 -5.34 -0.81 -23.96 -8.11 coo 61.58 117.15 13.99 62.31 115.51 15.12 -2.97 5.35 -8.71 -1.84 4.27 -7.29 coo 60.18 107.64 21.53 58.13 110.55 17.14 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 4 3 # 4 A 1 CYH B 158 CYH^? 12.89 O6 C2E B 301 A 903 GLU A 142 GLU^? 10.87 N1 C2E A 301 A 972 LYS A 238 LYS^? 19.93 N2 C2E B 301 coo 88.42 112.53 24.94 87.72 110.88 27.11 5.78 17.15 -15.63 3.32 17.67 -16.92 coo 61.58 117.15 13.99 62.31 115.51 15.12 -5.78 -6.60 -5.54 -5.25 -5.49 -3.81 coo 60.18 107.64 21.53 58.13 110.55 17.14 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 5 3 # 5 A 1 CYH B 207 CYH^? -4.01 O1P C2E B 301s A 903 GLU A 142 GLU^? 10.87 N1 C2E A 301 A 972 LYS A 238 LYS^? 19.93 N2 C2E B 301 coo 88.42 112.53 24.94 87.72 110.88 27.11 -6.32 22.95 -5.82 -8.77 22.45 -7.09 coo 61.58 117.15 13.99 62.31 115.51 15.12 -5.78 -6.60 -5.54 -5.25 -5.49 -3.81 coo 60.18 107.64 21.53 58.13 110.55 17.14 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 1ofd_c02 source 1ofd FERREDOXIN-DEPENDENT GLUTAMATE SYNTHASE 2 : 5 hits 1ofd_c02 naa= 3 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 1 3 # 1 B 1 CYH A 56 CYH^? 16.49 N21 C2E A 301 B 903 GLU A 221 GLU^? -4.32 C4' C2E A 301s B 972 LYS A 137 LYS.? -4.52 O2' C2E A 301s coo 31.47 38.87 24.90 30.94 36.98 26.93 14.08 -15.43 10.17 15.14 -13.33 11.76 coo 4.13 40.53 14.21 5.06 38.89 15.19 -2.05 -23.28 -12.44 -0.03 -23.89 -12.66 coo 4.08 30.40 21.12 1.62 33.28 16.83 4.32 -14.05 -15.33 0.72 -19.17 -16.51 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 2 3 # 2 B 1 CYH A 158 CYH^? 12.92 O6 C2E A 301 B 903 GLU B 142 GLU^? 10.78 N1 C2E B 301 B 972 LYS B 238 LYS^? 16.50 N2 C2E A 301 coo 31.47 38.87 24.90 30.94 36.98 26.93 -15.53 -18.41 0.03 -15.42 -19.19 -2.71 coo 4.13 40.53 14.21 5.06 38.89 15.19 -2.97 5.35 -8.71 -1.84 4.27 -7.29 coo 4.08 30.40 21.12 1.62 33.28 16.83 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 3 3 # 3 B 1 CYH A 207 CYH^? -4.01 O4' C2E A 301s B 903 GLU B 142 GLU^? 10.78 N1 C2E B 301 B 972 LYS B 238 LYS^? 16.50 N2 C2E A 301 coo 31.47 38.87 24.90 30.94 36.98 26.93 -0.78 -24.34 -5.34 -0.81 -23.96 -8.11 coo 4.13 40.53 14.21 5.06 38.89 15.19 -2.97 5.35 -8.71 -1.84 4.27 -7.29 coo 4.08 30.40 21.12 1.62 33.28 16.83 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 4 3 # 4 B 1 CYH B 158 CYH^? 12.89 O6 C2E B 301 B 903 GLU A 142 GLU^? 10.87 N1 C2E A 301 B 972 LYS A 238 LYS^? 19.93 N2 C2E B 301 coo 31.47 38.87 24.90 30.94 36.98 26.93 5.78 17.15 -15.63 3.32 17.67 -16.92 coo 4.13 40.53 14.21 5.06 38.89 15.19 -5.78 -6.60 -5.54 -5.25 -5.49 -3.81 coo 4.08 30.40 21.12 1.62 33.28 16.83 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 5 3 # 5 B 1 CYH B 207 CYH^? -4.01 O1P C2E B 301s B 903 GLU A 142 GLU^? 10.87 N1 C2E A 301 B 972 LYS A 238 LYS^? 19.93 N2 C2E B 301 coo 31.47 38.87 24.90 30.94 36.98 26.93 -6.32 22.95 -5.82 -8.77 22.45 -7.09 coo 4.13 40.53 14.21 5.06 38.89 15.19 -5.78 -6.60 -5.54 -5.25 -5.49 -3.81 coo 4.08 30.40 21.12 1.62 33.28 16.83 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 1ofd_c03 source 1ofd FERREDOXIN-DEPENDENT GLUTAMATE SYNTHASE 2 : 5 hits 1ofd_c03 naa= 3 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 A 24 ASP A 152 ASP.? 20.83 C8 C2E A 301 A 146 TYR A 179 TYR.? 13.95 N7 C2E A 301 A 177 LYS A 205 LYS^? 11.81 O1P C2E A 301 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo 1.87 119.38 16.45 1.41 122.11 16.84 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -5.45 -27.16 -8.25 -2.71 -32.35 -10.76 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 A 24 ASP B 152 ASP.? 19.99 C8 C2E B 301 A 146 TYR B 179 TYR.? 13.89 O6 C2E B 301 A 177 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo -3.50 124.89 25.05 -2.25 124.77 23.26 2.18 32.86 -17.28 0.63 33.43 -15.93 coo 1.87 119.38 16.45 1.41 122.11 16.84 2.36 25.70 -10.99 3.98 25.02 -13.14 coo -2.59 124.07 12.67 -0.91 126.17 18.42 8.81 26.59 -11.72 7.46 31.56 -12.94 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 A 24 ASP B 152 ASP.? 19.99 C8 C2E B 301 A 146 TYR B 179 TYR.? 13.89 O6 C2E B 301 A 177 LYS B 205 LYS^? -10.36 O1P C2E B 301s coo -3.50 124.89 25.05 -2.25 124.77 23.26 2.18 32.86 -17.28 0.63 33.43 -15.93 coo 1.87 119.38 16.45 1.41 122.11 16.84 2.36 25.70 -10.99 3.98 25.02 -13.14 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -6.87 25.33 -11.52 -10.34 29.58 -9.49 1ok4_c00 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 3 hits 1ok4_c00 naa= 3 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 B 24 ASP A 152 ASP.? 20.83 C8 C2E A 301 B 146 TYR A 179 TYR.? 13.95 N7 C2E A 301 B 177 LYS A 205 LYS^? 11.81 O1P C2E A 301 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -5.45 -27.16 -8.25 -2.71 -32.35 -10.76 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 B 24 ASP B 152 ASP.? 19.99 C8 C2E B 301 B 146 TYR B 179 TYR.? 13.89 O6 C2E B 301 B 177 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo -7.43 109.06 51.23 -5.84 110.54 50.86 2.18 32.86 -17.28 0.63 33.43 -15.93 coo 0.22 114.56 44.62 -0.76 115.18 47.18 2.36 25.70 -10.99 3.98 25.02 -13.14 coo -4.18 120.17 46.85 -4.02 115.31 51.00 8.81 26.59 -11.72 7.46 31.56 -12.94 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 B 24 ASP B 152 ASP.? 19.99 C8 C2E B 301 B 146 TYR B 179 TYR.? 13.89 O6 C2E B 301 B 177 LYS B 205 LYS^? -10.36 O1P C2E B 301s coo -7.43 109.06 51.23 -5.84 110.54 50.86 2.18 32.86 -17.28 0.63 33.43 -15.93 coo 0.22 114.56 44.62 -0.76 115.18 47.18 2.36 25.70 -10.99 3.98 25.02 -13.14 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -6.87 25.33 -11.52 -10.34 29.58 -9.49 1ok4_c01 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 3 hits 1ok4_c01 naa= 3 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 C 24 ASP A 152 ASP.? 20.83 C8 C2E A 301 C 146 TYR A 179 TYR.? 13.95 N7 C2E A 301 C 177 LYS A 205 LYS^? 11.81 O1P C2E A 301 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -5.45 -27.16 -8.25 -2.71 -32.35 -10.76 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 C 24 ASP B 152 ASP.? 19.99 C8 C2E B 301 C 146 TYR B 179 TYR.? 13.89 O6 C2E B 301 C 177 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo -13.49 79.65 43.90 -12.13 80.29 45.45 2.18 32.86 -17.28 0.63 33.43 -15.93 coo -5.65 86.78 48.49 -7.16 84.72 49.65 2.36 25.70 -10.99 3.98 25.02 -13.14 coo -11.22 87.18 53.49 -10.94 81.64 50.31 8.81 26.59 -11.72 7.46 31.56 -12.94 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 C 24 ASP B 152 ASP.? 19.99 C8 C2E B 301 C 146 TYR B 179 TYR.? 13.89 O6 C2E B 301 C 177 LYS B 205 LYS^? -10.36 O1P C2E B 301s coo -13.49 79.65 43.90 -12.13 80.29 45.45 2.18 32.86 -17.28 0.63 33.43 -15.93 coo -5.65 86.78 48.49 -7.16 84.72 49.65 2.36 25.70 -10.99 3.98 25.02 -13.14 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -6.87 25.33 -11.52 -10.34 29.58 -9.49 1ok4_c02 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 3 hits 1ok4_c02 naa= 3 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 D 24 ASP A 152 ASP.? 20.83 C8 C2E A 301 D 146 TYR A 179 TYR.? 13.95 N7 C2E A 301 D 177 LYS A 205 LYS^? 11.81 O1P C2E A 301 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -5.45 -27.16 -8.25 -2.71 -32.35 -10.76 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 D 24 ASP B 152 ASP.? 19.99 C8 C2E B 301 D 146 TYR B 179 TYR.? 13.89 O6 C2E B 301 D 177 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo -13.44 77.36 13.12 -12.53 75.97 14.48 2.18 32.86 -17.28 0.63 33.43 -15.93 coo -7.85 74.44 22.75 -9.22 72.86 20.89 2.36 25.70 -10.99 3.98 25.02 -13.14 coo -14.24 70.61 23.48 -12.55 71.73 17.42 8.81 26.59 -11.72 7.46 31.56 -12.94 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 D 24 ASP B 152 ASP.? 19.99 C8 C2E B 301 D 146 TYR B 179 TYR.? 13.89 O6 C2E B 301 D 177 LYS B 205 LYS^? -10.36 O1P C2E B 301s coo -13.44 77.36 13.12 -12.53 75.97 14.48 2.18 32.86 -17.28 0.63 33.43 -15.93 coo -7.85 74.44 22.75 -9.22 72.86 20.89 2.36 25.70 -10.99 3.98 25.02 -13.14 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -6.87 25.33 -11.52 -10.34 29.58 -9.49 1ok4_c03 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 3 hits 1ok4_c03 naa= 3 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 E 24 ASP A 152 ASP.? 20.83 C8 C2E A 301 E 146 TYR A 179 TYR.? 13.95 N7 C2E A 301 E 177 LYS A 205 LYS^? 11.81 O1P C2E A 301 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -5.45 -27.16 -8.25 -2.71 -32.35 -10.76 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 E 24 ASP B 152 ASP.? 19.99 C8 C2E B 301 E 146 TYR B 179 TYR.? 13.89 O6 C2E B 301 E 177 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo -7.12 105.25 1.43 -6.30 103.34 0.77 2.18 32.86 -17.28 0.63 33.43 -15.93 coo -3.11 94.55 3.01 -3.83 95.92 0.66 2.36 25.70 -10.99 3.98 25.02 -13.14 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 8.81 26.59 -11.72 7.46 31.56 -12.94 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 E 24 ASP B 152 ASP.? 19.99 C8 C2E B 301 E 146 TYR B 179 TYR.? 13.89 O6 C2E B 301 E 177 LYS B 205 LYS^? -10.36 O1P C2E B 301s coo -7.12 105.25 1.43 -6.30 103.34 0.77 2.18 32.86 -17.28 0.63 33.43 -15.93 coo -3.11 94.55 3.01 -3.83 95.92 0.66 2.36 25.70 -10.99 3.98 25.02 -13.14 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -6.87 25.33 -11.52 -10.34 29.58 -9.49 1ok4_c04 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 3 hits 1ok4_c04 naa= 3 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 F 24 ASP A 152 ASP.? 20.83 C8 C2E A 301 F 146 TYR A 179 TYR.? 13.95 N7 C2E A 301 F 177 LYS A 205 LYS^? 11.81 O1P C2E A 301 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -5.45 -27.16 -8.25 -2.71 -32.35 -10.76 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 F 24 ASP B 152 ASP.? 19.99 C8 C2E B 301 F 146 TYR B 179 TYR.? 13.89 O6 C2E B 301 F 177 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo -44.75 128.15 10.28 -45.68 129.67 11.55 2.18 32.86 -17.28 0.63 33.43 -15.93 coo -50.43 131.90 19.60 -49.04 133.31 17.60 2.36 25.70 -10.99 3.98 25.02 -13.14 coo -44.10 135.86 19.99 -45.67 134.21 14.07 8.81 26.59 -11.72 7.46 31.56 -12.94 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 F 24 ASP B 152 ASP.? 19.99 C8 C2E B 301 F 146 TYR B 179 TYR.? 13.89 O6 C2E B 301 F 177 LYS B 205 LYS^? -10.36 O1P C2E B 301s coo -44.75 128.15 10.28 -45.68 129.67 11.55 2.18 32.86 -17.28 0.63 33.43 -15.93 coo -50.43 131.90 19.60 -49.04 133.31 17.60 2.36 25.70 -10.99 3.98 25.02 -13.14 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -6.87 25.33 -11.52 -10.34 29.58 -9.49 1ok4_c05 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 3 hits 1ok4_c05 naa= 3 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 G 24 ASP A 152 ASP.? 20.83 C8 C2E A 301 G 146 TYR A 179 TYR.? 13.95 N7 C2E A 301 G 177 LYS A 205 LYS^? 11.81 O1P C2E A 301 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -5.45 -27.16 -8.25 -2.71 -32.35 -10.76 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 G 24 ASP B 152 ASP.? 19.99 C8 C2E B 301 G 146 TYR B 179 TYR.? 13.89 O6 C2E B 301 G 177 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo -44.97 128.78 41.20 -46.32 128.26 42.83 2.18 32.86 -17.28 0.63 33.43 -15.93 coo -52.83 122.13 46.42 -51.31 124.30 47.39 2.36 25.70 -10.99 3.98 25.02 -13.14 coo -47.30 122.24 51.49 -47.46 127.44 47.81 8.81 26.59 -11.72 7.46 31.56 -12.94 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 G 24 ASP B 152 ASP.? 19.99 C8 C2E B 301 G 146 TYR B 179 TYR.? 13.89 O6 C2E B 301 G 177 LYS B 205 LYS^? -10.36 O1P C2E B 301s coo -44.97 128.78 41.20 -46.32 128.26 42.83 2.18 32.86 -17.28 0.63 33.43 -15.93 coo -52.83 122.13 46.42 -51.31 124.30 47.39 2.36 25.70 -10.99 3.98 25.02 -13.14 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -6.87 25.33 -11.52 -10.34 29.58 -9.49 1ok4_c06 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 3 hits 1ok4_c06 naa= 3 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 H 24 ASP A 152 ASP.? 20.83 C8 C2E A 301 H 146 TYR A 179 TYR.? 13.95 N7 C2E A 301 H 177 LYS A 205 LYS^? 11.81 O1P C2E A 301 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -5.45 -27.16 -8.25 -2.71 -32.35 -10.76 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 H 24 ASP B 152 ASP.? 19.99 C8 C2E B 301 H 146 TYR B 179 TYR.? 13.89 O6 C2E B 301 H 177 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo -51.11 100.30 51.41 -52.67 98.82 51.12 2.18 32.86 -17.28 0.63 33.43 -15.93 coo -58.70 94.17 45.32 -57.76 93.82 47.92 2.36 25.70 -10.99 3.98 25.02 -13.14 coo -54.32 88.79 48.13 -54.61 94.04 51.74 8.81 26.59 -11.72 7.46 31.56 -12.94 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 H 24 ASP B 152 ASP.? 19.99 C8 C2E B 301 H 146 TYR B 179 TYR.? 13.89 O6 C2E B 301 H 177 LYS B 205 LYS^? -10.36 O1P C2E B 301s coo -51.11 100.30 51.41 -52.67 98.82 51.12 2.18 32.86 -17.28 0.63 33.43 -15.93 coo -58.70 94.17 45.32 -57.76 93.82 47.92 2.36 25.70 -10.99 3.98 25.02 -13.14 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -6.87 25.33 -11.52 -10.34 29.58 -9.49 1ok4_c07 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 3 hits 1ok4_c07 naa= 3 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 I 24 ASP A 152 ASP.? 20.83 C8 C2E A 301 I 146 TYR A 179 TYR.? 13.95 N7 C2E A 301 I 177 LYS A 205 LYS^? 11.81 O1P C2E A 301 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -5.45 -27.16 -8.25 -2.71 -32.35 -10.76 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 I 24 ASP B 152 ASP.? 19.99 C8 C2E B 301 I 146 TYR B 179 TYR.? 13.89 O6 C2E B 301 I 177 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo -54.65 81.97 26.87 -55.88 81.89 25.07 2.18 32.86 -17.28 0.63 33.43 -15.93 coo -59.92 86.62 17.74 -59.42 83.94 18.40 2.36 25.70 -10.99 3.98 25.02 -13.14 coo -55.38 81.61 14.50 -57.11 80.05 20.41 8.81 26.59 -11.72 7.46 31.56 -12.94 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 I 24 ASP B 152 ASP.? 19.99 C8 C2E B 301 I 146 TYR B 179 TYR.? 13.89 O6 C2E B 301 I 177 LYS B 205 LYS^? -10.36 O1P C2E B 301s coo -54.65 81.97 26.87 -55.88 81.89 25.07 2.18 32.86 -17.28 0.63 33.43 -15.93 coo -59.92 86.62 17.74 -59.42 83.94 18.40 2.36 25.70 -10.99 3.98 25.02 -13.14 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -6.87 25.33 -11.52 -10.34 29.58 -9.49 1ok4_c08 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 3 hits 1ok4_c08 naa= 3 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 J 24 ASP A 152 ASP.? 20.83 C8 C2E A 301 J 146 TYR A 179 TYR.? 13.95 N7 C2E A 301 J 177 LYS A 205 LYS^? 11.81 O1P C2E A 301 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -5.45 -27.16 -8.25 -2.71 -32.35 -10.76 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 J 24 ASP B 152 ASP.? 19.99 C8 C2E B 301 J 146 TYR B 179 TYR.? 13.89 O6 C2E B 301 J 177 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo -50.64 99.08 1.52 -51.52 100.83 0.67 2.18 32.86 -17.28 0.63 33.43 -15.93 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 2.36 25.70 -10.99 3.98 25.02 -13.14 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 8.81 26.59 -11.72 7.46 31.56 -12.94 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 J 24 ASP B 152 ASP.? 19.99 C8 C2E B 301 J 146 TYR B 179 TYR.? 13.89 O6 C2E B 301 J 177 LYS B 205 LYS^? -10.36 O1P C2E B 301s coo -50.64 99.08 1.52 -51.52 100.83 0.67 2.18 32.86 -17.28 0.63 33.43 -15.93 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 2.36 25.70 -10.99 3.98 25.02 -13.14 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -6.87 25.33 -11.52 -10.34 29.58 -9.49 1ok4_c09 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 3 hits 1ok4_c09 naa= 3 ULMN 3 1onr_c00 TRANSALDOLASE B user 1 3 # 1 A 17 ASP A 152 ASP.? 20.83 C8 C2E A 301 A 96 GLU A 188 GLU^? 19.90 N2 C2E A 301 A 132 LYS A 148 LYS^? 21.30 O6 C2E A 301 coo 31.23 12.29 16.44 30.82 11.56 18.39 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo 26.82 3.20 24.36 27.99 4.86 24.98 -20.03 -23.11 -8.39 -21.92 -24.07 -8.27 coo 29.99 0.62 22.18 30.38 6.69 20.81 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 ULMN 3 1onr_c00 TRANSALDOLASE B user 2 3 # 2 A 17 ASP A 162 ASP^? -3.09 N1 C2E A 301s A 96 GLU A 101 GLU.? 9.39 O11 C2E A 301 A 132 LYS A 137 LYS.? -4.52 O2' C2E A 301s coo 31.23 12.29 16.44 30.82 11.56 18.39 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 26.82 3.20 24.36 27.99 4.86 24.98 2.77 -8.35 -14.05 3.97 -7.83 -15.72 coo 29.99 0.62 22.18 30.38 6.69 20.81 4.32 -14.05 -15.33 0.72 -19.17 -16.51 ULMN 3 1onr_c00 TRANSALDOLASE B user 3 3 # 3 A 17 ASP A 162 ASP^? -3.09 N1 C2E A 301s A 96 GLU A 138 GLU.? 5.46 O2' C2E A 301 A 132 LYS A 137 LYS.? -4.52 O2' C2E A 301s coo 31.23 12.29 16.44 30.82 11.56 18.39 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 26.82 3.20 24.36 27.99 4.86 24.98 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 coo 29.99 0.62 22.18 30.38 6.69 20.81 4.32 -14.05 -15.33 0.72 -19.17 -16.51 ULMN 3 1onr_c00 TRANSALDOLASE B user 4 3 # 4 A 17 ASP A 192 ASP.? 23.17 N2 C2E A 301 A 96 GLU A 188 GLU^? 19.90 N2 C2E A 301 A 132 LYS A 148 LYS^? 21.30 O6 C2E A 301 coo 31.23 12.29 16.44 30.82 11.56 18.39 -26.02 -10.21 -8.74 -27.24 -11.85 -9.23 coo 26.82 3.20 24.36 27.99 4.86 24.98 -20.03 -23.11 -8.39 -21.92 -24.07 -8.27 coo 29.99 0.62 22.18 30.38 6.69 20.81 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 ULMN 3 1onr_c00 TRANSALDOLASE B user 5 3 # 5 A 17 ASP B 152 ASP.? 19.99 C8 C2E B 301 A 96 GLU B 188 GLU^? 19.78 N2 C2E B 301 A 132 LYS B 148 LYS^? 21.33 O6 C2E B 301 coo 31.23 12.29 16.44 30.82 11.56 18.39 2.18 32.86 -17.28 0.63 33.43 -15.93 coo 26.82 3.20 24.36 27.99 4.86 24.98 0.34 20.87 -23.80 1.17 21.98 -25.42 coo 29.99 0.62 22.18 30.38 6.69 20.81 4.64 19.42 -20.28 9.89 19.27 -22.17 ULMN 3 1onr_c00 TRANSALDOLASE B user 6 3 # 6 A 17 ASP B 162 ASP^? -3.04 N1 C2E B 301s A 96 GLU B 138 GLU.? 5.49 O2' C2E B 301 A 132 LYS B 137 LYS.? -3.23 O3' C2E B 301s coo 31.23 12.29 16.44 30.82 11.56 18.39 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 26.82 3.20 24.36 27.99 4.86 24.98 -14.88 11.83 -9.39 -15.29 12.85 -11.20 coo 29.99 0.62 22.18 30.38 6.69 20.81 -16.98 12.27 -5.28 -15.90 17.15 -6.49 ULMN 3 1onr_c00 TRANSALDOLASE B user 7 3 # 7 A 17 ASP B 192 ASP.? 23.13 N2 C2E B 301 A 96 GLU B 188 GLU^? 19.78 N2 C2E B 301 A 132 LYS B 148 LYS^? 21.33 O6 C2E B 301 coo 31.23 12.29 16.44 30.82 11.56 18.39 3.51 7.73 -28.40 4.69 9.27 -29.24 coo 26.82 3.20 24.36 27.99 4.86 24.98 0.34 20.87 -23.80 1.17 21.98 -25.42 coo 29.99 0.62 22.18 30.38 6.69 20.81 4.64 19.42 -20.28 9.89 19.27 -22.17 1onr_c00 source 1onr TRANSALDOLASE B : 7 hits 1onr_c00 naa= 3 ULMN 3 1onr_c01 TRANSALDOLASE B user 1 3 # 1 B 17 ASP A 152 ASP.? 20.83 C8 C2E A 301 B 96 GLU A 188 GLU^? 19.90 N2 C2E A 301 B 132 LYS A 148 LYS^? 21.30 O6 C2E A 301 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo 26.69 48.45 7.18 27.85 50.13 7.74 -20.03 -23.11 -8.39 -21.92 -24.07 -8.27 coo 29.82 45.80 5.07 30.26 51.81 3.56 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 ULMN 3 1onr_c01 TRANSALDOLASE B user 2 3 # 2 B 17 ASP A 162 ASP^? -3.09 N1 C2E A 301s B 96 GLU A 101 GLU.? 9.39 O11 C2E A 301 B 132 LYS A 137 LYS.? -4.52 O2' C2E A 301s coo 31.16 57.31 -0.94 30.73 56.64 1.01 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 26.69 48.45 7.18 27.85 50.13 7.74 2.77 -8.35 -14.05 3.97 -7.83 -15.72 coo 29.82 45.80 5.07 30.26 51.81 3.56 4.32 -14.05 -15.33 0.72 -19.17 -16.51 ULMN 3 1onr_c01 TRANSALDOLASE B user 3 3 # 3 B 17 ASP A 162 ASP^? -3.09 N1 C2E A 301s B 96 GLU A 138 GLU.? 5.46 O2' C2E A 301 B 132 LYS A 137 LYS.? -4.52 O2' C2E A 301s coo 31.16 57.31 -0.94 30.73 56.64 1.01 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 26.69 48.45 7.18 27.85 50.13 7.74 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 coo 29.82 45.80 5.07 30.26 51.81 3.56 4.32 -14.05 -15.33 0.72 -19.17 -16.51 ULMN 3 1onr_c01 TRANSALDOLASE B user 4 3 # 4 B 17 ASP A 192 ASP.? 23.17 N2 C2E A 301 B 96 GLU A 188 GLU^? 19.90 N2 C2E A 301 B 132 LYS A 148 LYS^? 21.30 O6 C2E A 301 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -26.02 -10.21 -8.74 -27.24 -11.85 -9.23 coo 26.69 48.45 7.18 27.85 50.13 7.74 -20.03 -23.11 -8.39 -21.92 -24.07 -8.27 coo 29.82 45.80 5.07 30.26 51.81 3.56 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 ULMN 3 1onr_c01 TRANSALDOLASE B user 5 3 # 5 B 17 ASP B 152 ASP.? 19.99 C8 C2E B 301 B 96 GLU B 188 GLU^? 19.78 N2 C2E B 301 B 132 LYS B 148 LYS^? 21.33 O6 C2E B 301 coo 31.16 57.31 -0.94 30.73 56.64 1.01 2.18 32.86 -17.28 0.63 33.43 -15.93 coo 26.69 48.45 7.18 27.85 50.13 7.74 0.34 20.87 -23.80 1.17 21.98 -25.42 coo 29.82 45.80 5.07 30.26 51.81 3.56 4.64 19.42 -20.28 9.89 19.27 -22.17 ULMN 3 1onr_c01 TRANSALDOLASE B user 6 3 # 6 B 17 ASP B 162 ASP^? -3.04 N1 C2E B 301s B 96 GLU B 138 GLU.? 5.49 O2' C2E B 301 B 132 LYS B 137 LYS.? -3.23 O3' C2E B 301s coo 31.16 57.31 -0.94 30.73 56.64 1.01 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 26.69 48.45 7.18 27.85 50.13 7.74 -14.88 11.83 -9.39 -15.29 12.85 -11.20 coo 29.82 45.80 5.07 30.26 51.81 3.56 -16.98 12.27 -5.28 -15.90 17.15 -6.49 ULMN 3 1onr_c01 TRANSALDOLASE B user 7 3 # 7 B 17 ASP B 192 ASP.? 23.13 N2 C2E B 301 B 96 GLU B 188 GLU^? 19.78 N2 C2E B 301 B 132 LYS B 148 LYS^? 21.33 O6 C2E B 301 coo 31.16 57.31 -0.94 30.73 56.64 1.01 3.51 7.73 -28.40 4.69 9.27 -29.24 coo 26.69 48.45 7.18 27.85 50.13 7.74 0.34 20.87 -23.80 1.17 21.98 -25.42 coo 29.82 45.80 5.07 30.26 51.81 3.56 4.64 19.42 -20.28 9.89 19.27 -22.17 1onr_c01 source 1onr TRANSALDOLASE B : 7 hits 1onr_c01 naa= 3 ULMN 3 1pbg_c00 6-PHOSPHO-BETA-D-GALACTOSIDASE user 1 3 # 1 A 160 GLU A 224 GLU~? 15.93 O2' C2E A 301 A 297 ASN A 228 ASN~? 15.04 O2' C2E A 301 A 375 GLU A 225 GLU~? 17.61 C1' C2E A 301 coo 63.94 10.02 33.47 64.31 8.24 32.38 -8.40 -25.77 -21.72 -8.05 -26.98 -23.42 coo 59.99 9.39 31.17 60.97 11.14 30.52 -12.40 -21.37 -21.10 -11.00 -22.25 -22.44 coo 61.89 10.05 27.30 63.60 9.39 28.40 -14.07 -25.95 -18.02 -15.34 -27.27 -16.96 ULMN 3 1pbg_c00 6-PHOSPHO-BETA-D-GALACTOSIDASE user 2 3 # 2 A 160 GLU A 225 GLU~? 17.61 C1' C2E A 301 A 297 ASN A 228 ASN~? 15.04 O2' C2E A 301 A 375 GLU A 224 GLU~? 15.93 O2' C2E A 301 coo 63.94 10.02 33.47 64.31 8.24 32.38 -14.07 -25.95 -18.02 -15.34 -27.27 -16.96 coo 59.99 9.39 31.17 60.97 11.14 30.52 -12.40 -21.37 -21.10 -11.00 -22.25 -22.44 coo 61.89 10.05 27.30 63.60 9.39 28.40 -8.40 -25.77 -21.72 -8.05 -26.98 -23.42 ULMN 3 1pbg_c00 6-PHOSPHO-BETA-D-GALACTOSIDASE user 3 3 # 3 A 160 GLU B 224 GLU~? 16.79 O2' C2E B 301 A 297 ASN B 228 ASN~? 15.22 O2' C2E B 301 A 375 GLU B 225 GLU~? 17.01 C1' C2E B 301 coo 63.94 10.02 33.47 64.31 8.24 32.38 -16.80 22.93 -20.90 -17.88 24.32 -22.10 coo 59.99 9.39 31.17 60.97 11.14 30.52 -14.11 18.31 -23.21 -16.11 19.01 -22.96 coo 61.89 10.05 27.30 63.60 9.39 28.40 -10.33 22.86 -23.16 -8.91 24.36 -23.62 ULMN 3 1pbg_c00 6-PHOSPHO-BETA-D-GALACTOSIDASE user 4 3 # 4 A 160 GLU B 225 GLU~? 17.01 C1' C2E B 301 A 297 ASN B 228 ASN~? 15.22 O2' C2E B 301 A 375 GLU B 224 GLU~? 16.79 O2' C2E B 301 coo 63.94 10.02 33.47 64.31 8.24 32.38 -10.33 22.86 -23.16 -8.91 24.36 -23.62 coo 59.99 9.39 31.17 60.97 11.14 30.52 -14.11 18.31 -23.21 -16.11 19.01 -22.96 coo 61.89 10.05 27.30 63.60 9.39 28.40 -16.80 22.93 -20.90 -17.88 24.32 -22.10 1pbg_c00 source 1pbg 6-PHOSPHO-BETA-D-GALACTOSIDASE : 4 hits 1pbg_c00 naa= 3 ULMN 3 1pbg_c01 6-PHOSPHO-BETA-D-GALACTOSIDASE user 1 3 # 1 B 160 GLU A 224 GLU~? 15.93 O2' C2E A 301 B 297 ASN A 228 ASN~? 15.04 O2' C2E A 301 B 375 GLU A 225 GLU~? 17.61 C1' C2E A 301 coo 23.66 16.69 85.20 24.17 18.76 84.94 -8.40 -25.77 -21.72 -8.05 -26.98 -23.42 coo 19.74 18.67 86.53 20.70 17.86 88.21 -12.40 -21.37 -21.10 -11.00 -22.25 -22.44 coo 21.67 20.74 89.92 23.35 20.55 88.67 -14.07 -25.95 -18.02 -15.34 -27.27 -16.96 ULMN 3 1pbg_c01 6-PHOSPHO-BETA-D-GALACTOSIDASE user 2 3 # 2 B 160 GLU A 225 GLU~? 17.61 C1' C2E A 301 B 297 ASN A 228 ASN~? 15.04 O2' C2E A 301 B 375 GLU A 224 GLU~? 15.93 O2' C2E A 301 coo 23.66 16.69 85.20 24.17 18.76 84.94 -14.07 -25.95 -18.02 -15.34 -27.27 -16.96 coo 19.74 18.67 86.53 20.70 17.86 88.21 -12.40 -21.37 -21.10 -11.00 -22.25 -22.44 coo 21.67 20.74 89.92 23.35 20.55 88.67 -8.40 -25.77 -21.72 -8.05 -26.98 -23.42 ULMN 3 1pbg_c01 6-PHOSPHO-BETA-D-GALACTOSIDASE user 3 3 # 3 B 160 GLU B 224 GLU~? 16.79 O2' C2E B 301 B 297 ASN B 228 ASN~? 15.22 O2' C2E B 301 B 375 GLU B 225 GLU~? 17.01 C1' C2E B 301 coo 23.66 16.69 85.20 24.17 18.76 84.94 -16.80 22.93 -20.90 -17.88 24.32 -22.10 coo 19.74 18.67 86.53 20.70 17.86 88.21 -14.11 18.31 -23.21 -16.11 19.01 -22.96 coo 21.67 20.74 89.92 23.35 20.55 88.67 -10.33 22.86 -23.16 -8.91 24.36 -23.62 ULMN 3 1pbg_c01 6-PHOSPHO-BETA-D-GALACTOSIDASE user 4 3 # 4 B 160 GLU B 225 GLU~? 17.01 C1' C2E B 301 B 297 ASN B 228 ASN~? 15.22 O2' C2E B 301 B 375 GLU B 224 GLU~? 16.79 O2' C2E B 301 coo 23.66 16.69 85.20 24.17 18.76 84.94 -10.33 22.86 -23.16 -8.91 24.36 -23.62 coo 19.74 18.67 86.53 20.70 17.86 88.21 -14.11 18.31 -23.21 -16.11 19.01 -22.96 coo 21.67 20.74 89.92 23.35 20.55 88.67 -16.80 22.93 -20.90 -17.88 24.32 -22.10 1pbg_c01 source 1pbg 6-PHOSPHO-BETA-D-GALACTOSIDASE : 4 hits 1pbg_c01 naa= 3 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 A 630 SER A 212 SER.? 13.10 O6 C2E A 301 A 709 ASP B 31 ASP~? 18.26 O6 C2E A 301 A 740 HIS A 214 HIS.? 19.24 O6 C2E A 301 coo -7.09 7.44 6.22 -7.53 5.14 5.59 -4.77 -16.86 9.45 -4.14 -15.23 7.75 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 -9.76 -4.11 8.16 -9.75 -6.21 8.42 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -9.67 -12.41 11.50 -9.18 -11.33 13.22 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 A 630 SER B 212 SER.? 13.16 O6 C2E B 301 A 709 ASP A 31 ASP~? 17.49 O6 C2E B 301 A 740 HIS B 214 HIS.? 18.94 O6 C2E B 301 coo -7.09 7.44 6.22 -7.53 5.14 5.59 8.68 16.14 -1.54 8.01 14.57 -3.30 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 10.86 4.60 -5.63 10.78 6.65 -6.14 coo -8.70 2.86 9.96 -8.03 3.92 8.29 13.04 11.66 -4.90 14.49 10.59 -3.83 1pfq_c02 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 2 hits 1pfq_c02 naa= 3 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 B 630 SER A 212 SER.? 13.10 O6 C2E A 301 B 709 ASP B 31 ASP~? 18.26 O6 C2E A 301 B 740 HIS A 214 HIS.? 19.24 O6 C2E A 301 coo 4.44 13.29 37.64 6.01 11.66 38.49 -4.77 -16.86 9.45 -4.14 -15.23 7.75 coo 10.26 2.81 31.69 11.64 4.30 32.43 -9.76 -4.11 8.16 -9.75 -6.21 8.42 coo 8.57 10.09 34.47 7.10 10.73 35.82 -9.67 -12.41 11.50 -9.18 -11.33 13.22 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 B 630 SER B 212 SER.? 13.16 O6 C2E B 301 B 709 ASP A 31 ASP~? 17.49 O6 C2E B 301 B 740 HIS B 214 HIS.? 18.94 O6 C2E B 301 coo 4.44 13.29 37.64 6.01 11.66 38.49 8.68 16.14 -1.54 8.01 14.57 -3.30 coo 10.26 2.81 31.69 11.64 4.30 32.43 10.86 4.60 -5.63 10.78 6.65 -6.14 coo 8.57 10.09 34.47 7.10 10.73 35.82 13.04 11.66 -4.90 14.49 10.59 -3.83 1pfq_c03 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 2 hits 1pfq_c03 naa= 3 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 1 3 # 1 A 225 HIS B 215 HIS.? 11.93 O6 C2E B 301 A 259 TYR B 218 TYR^? 10.08 O6 C2E B 301 A 552 ASP A 192 ASP.? 23.17 N2 C2E A 301 coo 11.34 95.90 25.54 12.13 96.42 23.67 7.81 14.24 -7.06 6.68 12.76 -6.10 coo 14.91 97.39 18.63 13.39 95.60 20.20 1.42 21.23 -8.42 3.73 22.73 -7.99 coo 46.37 82.54 38.83 45.97 84.66 38.77 -26.02 -10.21 -8.74 -27.24 -11.85 -9.23 1pj5_c00 source 1pj5 N,N-DIMETHYLGLYCINE OXIDASE : 1 hits 1pj5_c00 naa= 3 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 A 70 ALA A 95 ALA^? 10.70 N11 C2E A 301 A 126 LEU A 42 LEU^? 12.41 N21 C2E A 301 A 158 GLU A 41 GLU^? 8.66 N21 C2E A 301 coo -2.29 37.66 144.73 -1.46 37.12 145.87 10.32 -7.78 0.85 10.35 -6.28 1.11 coo -4.62 32.83 147.14 -5.50 32.85 149.12 10.87 -8.22 6.27 10.70 -6.16 5.65 coo -0.83 29.57 149.77 -0.39 31.47 148.95 7.09 -12.35 6.79 6.46 -14.38 6.77 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 A 70 ALA A 122 ALA^? 22.31 N21 C2E A 301 A 126 LEU A 111 LEU^? 24.06 N21 C2E A 301 A 158 GLU A 87 GLU.? 30.68 N21 C2E A 301 coo -2.29 37.66 144.73 -1.46 37.12 145.87 14.70 -2.94 15.56 15.28 -4.24 15.00 coo -4.62 32.83 147.14 -5.50 32.85 149.12 21.13 -4.69 13.17 19.98 -5.01 14.96 coo -0.83 29.57 149.77 -0.39 31.47 148.95 22.53 -2.75 18.16 22.63 -1.18 19.56 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 A 70 ALA B 95 ALA^? 9.50 N21 C2E B 301 A 126 LEU B 42 LEU^? 10.52 N21 C2E B 301 A 158 GLU B 41 GLU^? 7.72 N21 C2E B 301 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -5.97 9.31 8.03 -5.60 7.95 8.59 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -1.59 11.27 10.63 -1.62 9.12 10.69 coo -0.83 29.57 149.77 -0.39 31.47 148.95 0.46 14.98 6.85 0.80 16.86 5.93 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 A 70 ALA B 122 ALA^? 20.57 N21 C2E B 301 A 126 LEU B 111 LEU^? 21.86 N21 C2E B 301 A 158 GLU B 87 GLU.? 28.79 N21 C2E B 301 coo -2.29 37.66 144.73 -1.46 37.12 145.87 5.52 8.84 19.40 4.61 10.05 19.38 coo -4.62 32.83 147.14 -5.50 32.85 149.12 0.01 11.00 23.18 2.00 11.47 22.48 coo -0.83 29.57 149.77 -0.39 31.47 148.95 4.21 10.66 27.30 5.56 9.30 28.22 1pjh_c00 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 4 hits 1pjh_c00 naa= 3 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 B 70 ALA A 95 ALA^? 10.70 N11 C2E A 301 B 126 LEU A 42 LEU^? 12.41 N21 C2E A 301 B 158 GLU A 41 GLU^? 8.66 N21 C2E A 301 coo -39.79 4.61 147.27 -39.61 5.56 148.47 10.32 -7.78 0.85 10.35 -6.28 1.11 coo -34.22 5.06 149.25 -33.65 4.24 151.15 10.87 -8.22 6.27 10.70 -6.16 5.65 coo -33.03 9.93 151.71 -34.98 9.38 151.11 7.09 -12.35 6.79 6.46 -14.38 6.77 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 B 70 ALA A 122 ALA^? 22.31 N21 C2E A 301 B 126 LEU A 111 LEU^? 24.06 N21 C2E A 301 B 158 GLU A 87 GLU.? 30.68 N21 C2E A 301 coo -39.79 4.61 147.27 -39.61 5.56 148.47 14.70 -2.94 15.56 15.28 -4.24 15.00 coo -34.22 5.06 149.25 -33.65 4.24 151.15 21.13 -4.69 13.17 19.98 -5.01 14.96 coo -33.03 9.93 151.71 -34.98 9.38 151.11 22.53 -2.75 18.16 22.63 -1.18 19.56 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 B 70 ALA B 95 ALA^? 9.50 N21 C2E B 301 B 126 LEU B 42 LEU^? 10.52 N21 C2E B 301 B 158 GLU B 41 GLU^? 7.72 N21 C2E B 301 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -5.97 9.31 8.03 -5.60 7.95 8.59 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -1.59 11.27 10.63 -1.62 9.12 10.69 coo -33.03 9.93 151.71 -34.98 9.38 151.11 0.46 14.98 6.85 0.80 16.86 5.93 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 B 70 ALA B 122 ALA^? 20.57 N21 C2E B 301 B 126 LEU B 111 LEU^? 21.86 N21 C2E B 301 B 158 GLU B 87 GLU.? 28.79 N21 C2E B 301 coo -39.79 4.61 147.27 -39.61 5.56 148.47 5.52 8.84 19.40 4.61 10.05 19.38 coo -34.22 5.06 149.25 -33.65 4.24 151.15 0.01 11.00 23.18 2.00 11.47 22.48 coo -33.03 9.93 151.71 -34.98 9.38 151.11 4.21 10.66 27.30 5.56 9.30 28.22 1pjh_c01 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 4 hits 1pjh_c01 naa= 3 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 C 70 ALA A 95 ALA^? 10.70 N11 C2E A 301 C 126 LEU A 42 LEU^? 12.41 N21 C2E A 301 C 158 GLU A 41 GLU^? 8.66 N21 C2E A 301 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 10.32 -7.78 0.85 10.35 -6.28 1.11 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 10.87 -8.22 6.27 10.70 -6.16 5.65 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 7.09 -12.35 6.79 6.46 -14.38 6.77 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 C 70 ALA A 122 ALA^? 22.31 N21 C2E A 301 C 126 LEU A 111 LEU^? 24.06 N21 C2E A 301 C 158 GLU A 87 GLU.? 30.68 N21 C2E A 301 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 14.70 -2.94 15.56 15.28 -4.24 15.00 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 21.13 -4.69 13.17 19.98 -5.01 14.96 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 22.53 -2.75 18.16 22.63 -1.18 19.56 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 C 70 ALA B 95 ALA^? 9.50 N21 C2E B 301 C 126 LEU B 42 LEU^? 10.52 N21 C2E B 301 C 158 GLU B 41 GLU^? 7.72 N21 C2E B 301 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -5.97 9.31 8.03 -5.60 7.95 8.59 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -1.59 11.27 10.63 -1.62 9.12 10.69 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 0.46 14.98 6.85 0.80 16.86 5.93 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 C 70 ALA B 122 ALA^? 20.57 N21 C2E B 301 C 126 LEU B 111 LEU^? 21.86 N21 C2E B 301 C 158 GLU B 87 GLU.? 28.79 N21 C2E B 301 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 5.52 8.84 19.40 4.61 10.05 19.38 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 0.01 11.00 23.18 2.00 11.47 22.48 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 4.21 10.66 27.30 5.56 9.30 28.22 1pjh_c02 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 4 hits 1pjh_c02 naa= 3 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 1 3 # 1 A 248 ASP A 80 ASP~? 23.66 N21 C2E A 301 A 270 LYS A 75 LYS.? 21.41 N21 C2E A 301 A 382 MET A 91 MET^? 18.61 N21 C2E A 301 coo -27.63 121.99 45.48 -26.66 123.86 45.68 18.53 -17.34 17.76 18.57 -19.44 17.90 coo -32.20 115.91 49.56 -31.37 121.03 53.12 9.70 -14.41 17.00 6.16 -11.27 19.18 coo -23.75 127.89 58.42 -26.02 128.79 55.12 21.77 -8.82 6.64 18.71 -7.44 9.08 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 2 3 # 2 A 248 ASP A 162 ASP^? -3.09 N1 C2E A 301s A 270 LYS A 243 LYS.? 15.17 N2 C2E A 301 A 382 MET A 35 MET~? 13.04 O61 C2E A 301 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo -23.75 127.89 58.42 -26.02 128.79 55.12 5.85 -0.67 -3.01 8.30 -1.29 -6.34 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 3 3 # 3 A 248 ASP B 80 ASP~? 21.84 N21 C2E B 301 A 270 LYS B 75 LYS.? 16.89 N21 C2E B 301 A 382 MET B 91 MET^? 16.75 N21 C2E B 301 coo -27.63 121.99 45.48 -26.66 123.86 45.68 3.05 24.05 19.78 2.70 26.08 19.35 coo -32.20 115.91 49.56 -31.37 121.03 53.12 7.39 19.64 13.02 10.00 17.22 7.78 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -6.68 13.42 20.01 -2.84 12.51 18.72 1pjq_c02 source 1pjq SIROHEME SYNTHASE : 3 hits 1pjq_c02 naa= 3 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 1 3 # 1 B 248 ASP A 162 ASP^? -3.09 N1 C2E A 301s B 270 LYS A 243 LYS.? 15.17 N2 C2E A 301 B 382 MET B 35 MET.? 12.95 O61 C2E B 301 coo -11.82 154.51 43.38 -12.86 152.74 43.79 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo -5.09 158.39 43.41 -0.74 158.80 47.15 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -5.86 1.04 3.98 -9.99 1.13 4.50 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 2 3 # 2 B 248 ASP B 162 ASP^? -3.04 N1 C2E B 301s B 270 LYS B 243 LYS.? 13.43 N1 C2E B 301 B 382 MET A 35 MET~? 13.04 O61 C2E A 301 coo -11.82 154.51 43.38 -12.86 152.74 43.79 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo -5.09 158.39 43.41 -0.74 158.80 47.15 -2.53 1.27 -13.25 2.13 3.70 -10.70 coo -2.79 145.52 50.38 -5.75 148.14 51.66 5.85 -0.67 -3.01 8.30 -1.29 -6.34 1pjq_c03 source 1pjq SIROHEME SYNTHASE : 2 hits 1pjq_c03 naa= 3 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 1 3 # 1 111 GLN A 210 GLN^? 10.02 N21 C2E A 301 294 GLU A 41 GLU^? 8.66 N21 C2E A 301 304 ARG A 169 ARG^? -4.75 O6 C2E A 301s coo 15.89 18.45 46.53 15.82 16.91 48.02 -0.56 -17.78 5.17 0.90 -18.94 6.19 coo 22.84 13.44 52.91 20.84 13.18 52.38 7.09 -12.35 6.79 6.46 -14.38 6.77 coo 8.71 17.11 46.51 7.23 17.64 49.20 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 2 3 # 2 111 GLN A 210 GLN^? 10.02 N21 C2E A 301 294 GLU A 41 GLU^? 8.66 N21 C2E A 301 304 ARG A 211 ARG^? 16.62 O6 C2E A 301 coo 15.89 18.45 46.53 15.82 16.91 48.02 -0.56 -17.78 5.17 0.90 -18.94 6.19 coo 22.84 13.44 52.91 20.84 13.18 52.38 7.09 -12.35 6.79 6.46 -14.38 6.77 coo 8.71 17.11 46.51 7.23 17.64 49.20 -4.93 -23.64 8.57 -7.93 -23.17 9.07 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 3 3 # 3 111 GLN B 110 GLN^? 26.18 N21 C2E B 301 294 GLU B 87 GLU.? 28.79 N21 C2E B 301 304 ARG B 108 ARG^? 23.43 N21 C2E B 301 coo 15.89 18.45 46.53 15.82 16.91 48.02 -4.18 8.65 25.75 -4.85 7.68 27.53 coo 22.84 13.44 52.91 20.84 13.18 52.38 4.21 10.66 27.30 5.56 9.30 28.22 coo 8.71 17.11 46.51 7.23 17.64 49.20 -11.69 10.06 21.74 -11.10 10.14 24.76 1pmi_c00 source 1pmi PHOSPHOMANNOSE ISOMERASE : 3 hits 1pmi_c00 naa= 3 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 1 3 # 1 B 1 SER A 29 SER~? 21.07 N11 C2E A 301 B 69 ALA A 32 ALA~? 16.18 O61 C2E A 301 B 241 ASN A 28 ASN^? 20.35 O6 C2E B 301 coo 13.24 41.94 33.13 13.08 39.54 33.17 15.02 3.06 -1.55 17.13 2.40 -0.57 coo 9.15 37.89 36.69 10.55 37.76 37.22 11.16 0.68 -3.53 12.55 0.08 -3.37 coo 10.91 43.03 38.47 11.81 41.82 36.93 15.77 5.79 -5.14 13.72 6.29 -5.09 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 2 3 # 2 B 1 SER B 29 SER~? 19.81 N21 C2E B 301 B 69 ALA B 32 ALA~? 15.70 O61 C2E B 301 B 241 ASN B 28 ASN^? 21.32 O6 C2E A 301 coo 13.24 41.94 33.13 13.08 39.54 33.17 -8.69 -0.89 13.28 -8.89 0.42 15.30 coo 9.15 37.89 36.69 10.55 37.76 37.22 -8.81 0.28 8.47 -9.54 1.08 9.56 coo 10.91 43.03 38.47 11.81 41.82 36.93 -11.70 -4.36 12.92 -10.66 -5.13 11.24 1pnl_c00 source 1pnl PENICILLIN AMIDOHYDROLASE : 2 hits 1pnl_c00 naa= 3 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 A 264 ARG A 227 ARG~? 9.91 O2' C2E A 301 A 479 PHE A 222 PHE^? 7.21 N3 C2E A 301 A 483 GLU A 221 GLU^? -4.32 C4' C2E A 301s coo 17.33 52.29 2.24 18.71 54.03 0.18 -5.20 -21.14 -18.72 -4.74 -24.14 -19.17 coo 20.06 57.44 1.28 18.39 56.19 3.12 -7.93 -20.98 -13.39 -9.02 -18.86 -11.96 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -2.05 -23.28 -12.44 -0.03 -23.89 -12.66 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 3 # 2 A 264 ARG B 227 ARG~? 7.56 O2' C2E B 301 A 479 PHE B 222 PHE^? 7.18 N3 C2E B 301 A 483 GLU B 221 GLU^? -4.05 C4' C2E B 301s coo 17.33 52.29 2.24 18.71 54.03 0.18 -16.01 19.09 -16.09 -16.65 16.54 -14.51 coo 20.06 57.44 1.28 18.39 56.19 3.12 -9.78 18.64 -15.60 -7.86 16.65 -15.65 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -11.86 21.10 -10.14 -13.00 21.71 -8.45 1pow_c02 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 2 hits 1pow_c02 naa= 3 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 B 264 ARG A 227 ARG~? 9.91 O2' C2E A 301 B 479 PHE A 222 PHE^? 7.21 N3 C2E A 301 B 483 GLU A 221 GLU^? -4.32 C4' C2E A 301s coo -26.72 93.28 20.13 -28.02 93.55 17.39 -5.20 -21.14 -18.72 -4.74 -24.14 -19.17 coo -29.34 90.48 15.69 -27.62 89.95 17.80 -7.93 -20.98 -13.39 -9.02 -18.86 -11.96 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -2.05 -23.28 -12.44 -0.03 -23.89 -12.66 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 3 # 2 B 264 ARG B 227 ARG~? 7.56 O2' C2E B 301 B 479 PHE B 222 PHE^? 7.18 N3 C2E B 301 B 483 GLU B 221 GLU^? -4.05 C4' C2E B 301s coo -26.72 93.28 20.13 -28.02 93.55 17.39 -16.01 19.09 -16.09 -16.65 16.54 -14.51 coo -29.34 90.48 15.69 -27.62 89.95 17.80 -9.78 18.64 -15.60 -7.86 16.65 -15.65 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -11.86 21.10 -10.14 -13.00 21.71 -8.45 1pow_c03 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 2 hits 1pow_c03 naa= 3 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 1 3 # 1 B 74 ASN A 128 ASN.? 25.99 N21 C2E A 301 B 192 ASP A 31 ASP~? 17.49 O6 C2E B 301 B 195 HIS B 214 HIS.? 18.94 O6 C2E B 301 coo -1.08 51.41 10.34 0.65 52.62 10.17 21.53 5.18 -1.81 23.00 4.01 -2.79 coo 11.36 52.33 5.59 10.18 53.87 6.47 10.86 4.60 -5.63 10.78 6.65 -6.14 coo 7.99 56.74 7.55 6.88 55.39 8.70 13.04 11.66 -4.90 14.49 10.59 -3.83 1pp4_c03 source 1pp4 RHAMNOGALACTURONAN ACETYLESTERASE : 1 hits 1pp4_c03 naa= 3 ULMN 3 1pyl_c00 RIBONUCLEASE user 1 3 # 1 A 56 GLU A 159 GLU^? 13.73 O6 C2E A 301 A 67 ARG A 169 ARG^? -4.75 O6 C2E A 301s A 86 HIS A 215 HIS.? 12.12 O6 C2E A 301 coo 18.15 3.28 18.56 20.10 2.92 19.20 -14.60 -12.52 -1.04 -14.41 -10.88 0.31 coo 21.52 6.83 26.64 21.22 5.53 23.85 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 -8.99 -15.19 5.86 -7.58 -13.77 5.21 ULMN 3 1pyl_c00 RIBONUCLEASE user 2 3 # 2 A 56 GLU B 159 GLU^? 13.76 O6 C2E B 301 A 67 ARG B 169 ARG^? -4.70 O6 C2E B 301s A 86 HIS B 215 HIS.? 11.93 O6 C2E B 301 coo 18.15 3.28 18.56 20.10 2.92 19.20 4.99 11.22 -14.77 6.30 9.86 -13.80 coo 21.52 6.83 26.64 21.22 5.53 23.85 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 7.81 14.24 -7.06 6.68 12.76 -6.10 1pyl_c00 source 1pyl RIBONUCLEASE : 2 hits 1pyl_c00 naa= 3 ULMN 3 1pyl_c01 RIBONUCLEASE user 1 3 # 1 B 56 GLU A 159 GLU^? 13.73 O6 C2E A 301 B 67 ARG A 169 ARG^? -4.75 O6 C2E A 301s B 86 HIS A 215 HIS.? 12.12 O6 C2E A 301 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -14.60 -12.52 -1.04 -14.41 -10.88 0.31 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -8.99 -15.19 5.86 -7.58 -13.77 5.21 ULMN 3 1pyl_c01 RIBONUCLEASE user 2 3 # 2 B 56 GLU B 159 GLU^? 13.76 O6 C2E B 301 B 67 ARG B 169 ARG^? -4.70 O6 C2E B 301s B 86 HIS B 215 HIS.? 11.93 O6 C2E B 301 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 4.99 11.22 -14.77 6.30 9.86 -13.80 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 7.81 14.24 -7.06 6.68 12.76 -6.10 1pyl_c01 source 1pyl RIBONUCLEASE : 2 hits 1pyl_c01 naa= 3 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 1 3 # 1 A 48 LEU A 163 LEU^? 6.20 N2 C2E A 301 A 58 ASP A 162 ASP^? -3.09 N1 C2E A 301s A 120 LYS A 243 LYS.? 15.17 N2 C2E A 301 coo 34.02 69.29 75.26 34.82 67.82 76.74 -9.39 -13.03 -10.80 -10.62 -14.24 -12.09 coo 34.46 72.45 78.57 32.82 72.75 77.28 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 28.96 77.64 81.19 29.05 74.53 77.51 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 2 3 # 2 A 48 LEU A 193 LEU.? 23.34 N2 C2E A 301 A 58 ASP A 192 ASP.? 23.17 N2 C2E A 301 A 120 LYS A 197 LYS.? 27.35 N2 C2E A 301 coo 34.02 69.29 75.26 34.82 67.82 76.74 -26.45 -8.85 -3.82 -25.07 -7.38 -3.04 coo 34.46 72.45 78.57 32.82 72.75 77.28 -26.02 -10.21 -8.74 -27.24 -11.85 -9.23 coo 28.96 77.64 81.19 29.05 74.53 77.51 -26.95 -17.54 -10.03 -31.23 -18.41 -12.60 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 3 3 # 3 A 48 LEU B 163 LEU^? 6.10 N2 C2E B 301 A 58 ASP B 162 ASP^? -3.04 N1 C2E B 301s A 120 LYS B 243 LYS.? 13.43 N1 C2E B 301 coo 34.02 69.29 75.26 34.82 67.82 76.74 -6.29 10.87 -14.95 -6.90 12.00 -16.67 coo 34.46 72.45 78.57 32.82 72.75 77.28 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 28.96 77.64 81.19 29.05 74.53 77.51 -2.53 1.27 -13.25 2.13 3.70 -10.70 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 4 3 # 4 A 48 LEU B 193 LEU.? 21.76 N2 C2E B 301 A 58 ASP B 192 ASP.? 23.13 N2 C2E B 301 A 120 LYS B 197 LYS.? 24.97 N2 C2E B 301 coo 34.02 69.29 75.26 34.82 67.82 76.74 7.00 5.32 -25.21 5.43 4.38 -24.06 coo 34.46 72.45 78.57 32.82 72.75 77.28 3.51 7.73 -28.40 4.69 9.27 -29.24 coo 28.96 77.64 81.19 29.05 74.53 77.51 2.66 14.16 -30.11 -0.83 11.74 -34.04 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 5 3 # 5 A 48 LEU B 246 LEU^? 17.19 N2 C2E B 301 A 58 ASP B 192 ASP.? 23.13 N2 C2E B 301 A 120 LYS B 197 LYS.? 24.97 N2 C2E B 301 coo 34.02 69.29 75.26 34.82 67.82 76.74 0.29 5.07 -23.58 0.47 7.21 -23.50 coo 34.46 72.45 78.57 32.82 72.75 77.28 3.51 7.73 -28.40 4.69 9.27 -29.24 coo 28.96 77.64 81.19 29.05 74.53 77.51 2.66 14.16 -30.11 -0.83 11.74 -34.04 1pym_c00 source 1pym PHOSPHOENOLPYRUVATE MUTASE : 5 hits 1pym_c00 naa= 3 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 1 3 # 1 B 48 LEU A 163 LEU^? 6.20 N2 C2E A 301 B 58 ASP A 162 ASP^? -3.09 N1 C2E A 301s B 120 LYS A 243 LYS.? 15.17 N2 C2E A 301 coo 54.50 104.32 58.69 55.83 105.69 59.81 -9.39 -13.03 -10.80 -10.62 -14.24 -12.09 coo 57.63 101.19 59.83 56.60 100.89 57.99 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 61.58 95.88 55.22 58.18 99.30 54.71 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 2 3 # 2 B 48 LEU A 193 LEU.? 23.34 N2 C2E A 301 B 58 ASP A 192 ASP.? 23.17 N2 C2E A 301 B 120 LYS A 197 LYS.? 27.35 N2 C2E A 301 coo 54.50 104.32 58.69 55.83 105.69 59.81 -26.45 -8.85 -3.82 -25.07 -7.38 -3.04 coo 57.63 101.19 59.83 56.60 100.89 57.99 -26.02 -10.21 -8.74 -27.24 -11.85 -9.23 coo 61.58 95.88 55.22 58.18 99.30 54.71 -26.95 -17.54 -10.03 -31.23 -18.41 -12.60 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 3 3 # 3 B 48 LEU B 163 LEU^? 6.10 N2 C2E B 301 B 58 ASP B 162 ASP^? -3.04 N1 C2E B 301s B 120 LYS B 243 LYS.? 13.43 N1 C2E B 301 coo 54.50 104.32 58.69 55.83 105.69 59.81 -6.29 10.87 -14.95 -6.90 12.00 -16.67 coo 57.63 101.19 59.83 56.60 100.89 57.99 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 61.58 95.88 55.22 58.18 99.30 54.71 -2.53 1.27 -13.25 2.13 3.70 -10.70 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 4 3 # 4 B 48 LEU B 193 LEU.? 21.76 N2 C2E B 301 B 58 ASP B 192 ASP.? 23.13 N2 C2E B 301 B 120 LYS B 197 LYS.? 24.97 N2 C2E B 301 coo 54.50 104.32 58.69 55.83 105.69 59.81 7.00 5.32 -25.21 5.43 4.38 -24.06 coo 57.63 101.19 59.83 56.60 100.89 57.99 3.51 7.73 -28.40 4.69 9.27 -29.24 coo 61.58 95.88 55.22 58.18 99.30 54.71 2.66 14.16 -30.11 -0.83 11.74 -34.04 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 5 3 # 5 B 48 LEU B 246 LEU^? 17.19 N2 C2E B 301 B 58 ASP B 192 ASP.? 23.13 N2 C2E B 301 B 120 LYS B 197 LYS.? 24.97 N2 C2E B 301 coo 54.50 104.32 58.69 55.83 105.69 59.81 0.29 5.07 -23.58 0.47 7.21 -23.50 coo 57.63 101.19 59.83 56.60 100.89 57.99 3.51 7.73 -28.40 4.69 9.27 -29.24 coo 61.58 95.88 55.22 58.18 99.30 54.71 2.66 14.16 -30.11 -0.83 11.74 -34.04 1pym_c01 source 1pym PHOSPHOENOLPYRUVATE MUTASE : 5 hits 1pym_c01 naa= 3 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 1 3 # 1 A 67 ASP A 31 ASP~? 17.49 O6 C2E B 301 A 68 ALA A 32 ALA~? 16.18 O61 C2E A 301 A 72 LEU A 33 LEU~? 17.23 O61 C2E A 301 coo 46.76 7.59 18.65 45.27 6.01 18.52 10.86 4.60 -5.63 10.78 6.65 -6.14 coo 48.88 4.35 16.59 48.73 5.09 15.20 11.16 0.68 -3.53 12.55 0.08 -3.37 coo 53.89 6.25 15.09 52.88 7.92 14.14 10.50 1.44 1.21 12.15 0.60 2.32 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 2 3 # 2 A 67 ASP A 31 ASP~? 17.49 O6 C2E B 301 A 68 ALA A 34 ALA~? 15.42 O61 C2E B 301 A 72 LEU A 33 LEU~? 17.23 O61 C2E A 301 coo 46.76 7.59 18.65 45.27 6.01 18.52 10.86 4.60 -5.63 10.78 6.65 -6.14 coo 48.88 4.35 16.59 48.73 5.09 15.20 6.73 2.57 -1.21 6.74 3.77 -2.14 coo 53.89 6.25 15.09 52.88 7.92 14.14 10.50 1.44 1.21 12.15 0.60 2.32 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 3 3 # 3 A 67 ASP A 79 ASP~? 30.21 N21 C2E A 301 A 68 ALA A 78 ALA.? 28.43 N21 C2E A 301 A 72 LEU A 81 LEU~? 24.51 N21 C2E A 301 coo 46.76 7.59 18.65 45.27 6.01 18.52 19.82 -18.69 22.66 21.43 -19.12 23.96 coo 48.88 4.35 16.59 48.73 5.09 15.20 16.28 -15.52 23.39 15.92 -15.47 24.86 coo 53.89 6.25 15.09 52.88 7.92 14.14 16.80 -13.04 20.37 15.42 -11.39 20.19 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 4 3 # 4 A 67 ASP B 31 ASP~? 18.26 O6 C2E A 301 A 68 ALA B 32 ALA~? 15.70 O61 C2E B 301 A 72 LEU B 33 LEU~? 16.02 N11 C2E B 301 coo 46.76 7.59 18.65 45.27 6.01 18.52 -9.76 -4.11 8.16 -9.75 -6.21 8.42 coo 48.88 4.35 16.59 48.73 5.09 15.20 -8.81 0.28 8.47 -9.54 1.08 9.56 coo 53.89 6.25 15.09 52.88 7.92 14.14 -4.32 0.81 10.32 -4.19 2.37 11.80 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 5 3 # 5 A 67 ASP B 31 ASP~? 18.26 O6 C2E A 301 A 68 ALA B 34 ALA~? 16.17 O61 C2E A 301 A 72 LEU B 33 LEU~? 16.02 N11 C2E B 301 coo 46.76 7.59 18.65 45.27 6.01 18.52 -9.76 -4.11 8.16 -9.75 -6.21 8.42 coo 48.88 4.35 16.59 48.73 5.09 15.20 -4.24 -1.51 6.29 -4.80 -2.92 6.14 coo 53.89 6.25 15.09 52.88 7.92 14.14 -4.32 0.81 10.32 -4.19 2.37 11.80 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 6 3 # 6 A 67 ASP B 79 ASP~? 26.97 N21 C2E B 301 A 68 ALA B 78 ALA~? 26.47 N21 C2E B 301 A 72 LEU B 81 LEU~? 22.74 N21 C2E B 301 coo 46.76 7.59 18.65 45.27 6.01 18.52 6.11 26.78 22.67 4.66 27.50 24.05 coo 48.88 4.35 16.59 48.73 5.09 15.20 9.06 23.30 20.96 10.44 23.62 21.54 coo 53.89 6.25 15.09 52.88 7.92 14.14 6.79 20.39 20.97 7.64 18.60 20.14 1q6l_c05 source 1q6l 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE : 6 hits 1q6l_c05 naa= 3 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 1 3 # 1 A 191 ASN A 208 ASN^? -3.55 N7 C2E A 301s A 239 ARG A 217 ARG^? 6.70 O6 C2E A 301 A 246 TYR A 218 TYR^? 10.22 O6 C2E A 301 coo 2.50 7.27 18.06 0.76 7.28 16.81 0.54 -21.32 -2.29 -0.50 -19.83 -3.42 coo -1.16 0.95 13.41 -2.50 3.71 13.61 -3.36 -16.18 0.94 -0.54 -17.39 0.83 coo 1.59 5.18 12.30 -0.74 6.52 11.61 -6.98 -22.32 0.01 -7.64 -23.76 2.29 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 2 3 # 2 A 191 ASN B 208 ASN^? -3.47 N7 C2E B 301s A 239 ARG B 217 ARG^? 6.37 O6 C2E B 301 A 246 TYR B 218 TYR^? 10.08 O6 C2E B 301 coo 2.50 7.27 18.06 0.76 7.28 16.81 -4.15 20.35 -2.93 -4.56 18.73 -4.26 coo -1.16 0.95 13.41 -2.50 3.71 13.61 0.82 15.44 -4.45 -0.87 16.78 -2.26 coo 1.59 5.18 12.30 -0.74 6.52 11.61 1.42 21.23 -8.42 3.73 22.73 -7.99 1qaz_c00 source 1qaz ALGINATE LYASE A1-III : 2 hits 1qaz_c00 naa= 3 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 1 3 # 1 A 396 ARG A 140 ARG.? -3.36 C5 C2E A 301s A 581 ARG A 217 ARG^? 6.70 O6 C2E A 301 A 713 ARG A 161 ARG^? 11.81 O6 C2E A 301 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -3.36 -16.18 0.94 -0.54 -17.39 0.83 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 2 3 # 2 A 396 ARG A 161 ARG^? 11.81 O6 C2E A 301 A 581 ARG A 217 ARG^? 6.70 O6 C2E A 301 A 713 ARG A 140 ARG.? -3.36 C5 C2E A 301s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -3.36 -16.18 0.94 -0.54 -17.39 0.83 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 3 3 # 3 A 396 ARG A 217 ARG^? 6.70 O6 C2E A 301 A 581 ARG A 140 ARG.? -3.36 C5 C2E A 301s A 713 ARG A 161 ARG^? 11.81 O6 C2E A 301 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -3.36 -16.18 0.94 -0.54 -17.39 0.83 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 4 3 # 4 A 396 ARG A 217 ARG^? 6.70 O6 C2E A 301 A 581 ARG A 161 ARG^? 11.81 O6 C2E A 301 A 713 ARG A 140 ARG.? -3.36 C5 C2E A 301s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -3.36 -16.18 0.94 -0.54 -17.39 0.83 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 5 3 # 5 A 396 ARG B 140 ARG.? -3.40 C5 C2E B 301s A 581 ARG B 217 ARG^? 6.37 O6 C2E B 301 A 713 ARG B 161 ARG^? 11.68 O6 C2E B 301 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -7.91 11.52 -6.78 -7.96 14.04 -5.01 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 0.82 15.44 -4.45 -0.87 16.78 -2.26 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 2.96 9.64 -10.71 5.59 9.57 -9.11 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 6 3 # 6 A 396 ARG B 161 ARG^? 11.68 O6 C2E B 301 A 581 ARG B 217 ARG^? 6.37 O6 C2E B 301 A 713 ARG B 140 ARG.? -3.40 C5 C2E B 301s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 2.96 9.64 -10.71 5.59 9.57 -9.11 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 0.82 15.44 -4.45 -0.87 16.78 -2.26 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -7.91 11.52 -6.78 -7.96 14.04 -5.01 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 7 3 # 7 A 396 ARG B 217 ARG^? 6.37 O6 C2E B 301 A 581 ARG B 140 ARG.? -3.40 C5 C2E B 301s A 713 ARG B 161 ARG^? 11.68 O6 C2E B 301 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 0.82 15.44 -4.45 -0.87 16.78 -2.26 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -7.91 11.52 -6.78 -7.96 14.04 -5.01 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 2.96 9.64 -10.71 5.59 9.57 -9.11 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 8 3 # 8 A 396 ARG B 217 ARG^? 6.37 O6 C2E B 301 A 581 ARG B 161 ARG^? 11.68 O6 C2E B 301 A 713 ARG B 140 ARG.? -3.40 C5 C2E B 301s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 0.82 15.44 -4.45 -0.87 16.78 -2.26 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 2.96 9.64 -10.71 5.59 9.57 -9.11 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -7.91 11.52 -6.78 -7.96 14.04 -5.01 1qb4_c01 source 1qb4 PHOSPHOENOLPYRUVATE CARBOXYLASE : 8 hits 1qb4_c01 naa= 3 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 1 3 # 1 A 189 SER A 39 SER.? 16.45 O61 C2E A 301 A 310 GLU A 37 GLU.? 10.20 O61 C2E A 301 A 399 HIS A 38 HIS.? 16.46 O61 C2E B 301 coo 2.67 37.96 55.23 1.78 40.01 56.16 2.88 -4.86 8.38 1.14 -3.61 9.53 coo 6.61 38.44 63.61 6.69 38.31 61.50 0.90 -3.13 0.80 -0.70 -4.43 0.36 coo 4.95 41.82 59.53 3.85 40.70 58.14 1.46 -0.40 7.20 -0.57 -0.26 7.72 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 2 3 # 2 A 189 SER B 39 SER.? 15.26 O61 C2E B 301 A 310 GLU B 37 GLU.? 9.39 O61 C2E B 301 A 399 HIS B 38 HIS.? 15.97 O61 C2E B 301 coo 2.67 37.96 55.23 1.78 40.01 56.16 4.72 7.48 5.49 6.81 6.45 4.77 coo 6.61 38.44 63.61 6.69 38.31 61.50 -0.62 3.88 0.75 -0.32 4.81 -1.12 coo 4.95 41.82 59.53 3.85 40.70 58.14 4.87 2.64 4.63 6.30 2.30 3.13 1qe3_c00 source 1qe3 PARA-NITROBENZYL ESTERASE : 2 hits 1qe3_c00 naa= 3 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 155 HIS A 214 HIS.? 19.24 O6 C2E A 301 A 236 ASP A 162 ASP^? -3.09 N1 C2E A 301s A 261 LYS A 137 LYS.? -4.52 O2' C2E A 301s coo 55.45 46.76 42.08 57.34 46.16 42.75 -9.67 -12.41 11.50 -9.18 -11.33 13.22 coo 48.87 29.19 44.63 49.10 27.34 43.63 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 47.58 17.35 41.83 51.40 20.85 40.83 4.32 -14.05 -15.33 0.72 -19.17 -16.51 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 155 HIS A 214 HIS.? 19.24 O6 C2E A 301 A 236 ASP A 162 ASP^? -3.09 N1 C2E A 301s A 261 LYS A 231 LYS~? 13.14 O2' C2E A 301 coo 55.45 46.76 42.08 57.34 46.16 42.75 -9.67 -12.41 11.50 -9.18 -11.33 13.22 coo 48.87 29.19 44.63 49.10 27.34 43.63 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 47.58 17.35 41.83 51.40 20.85 40.83 -11.44 -15.22 -19.18 -8.27 -15.76 -22.64 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 155 HIS B 214 HIS.? 18.94 O6 C2E B 301 A 236 ASP B 162 ASP^? -3.04 N1 C2E B 301s A 261 LYS B 137 LYS.? -3.23 O3' C2E B 301s coo 55.45 46.76 42.08 57.34 46.16 42.75 13.04 11.66 -4.90 14.49 10.59 -3.83 coo 48.87 29.19 44.63 49.10 27.34 43.63 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 47.58 17.35 41.83 51.40 20.85 40.83 -16.98 12.27 -5.28 -15.90 17.15 -6.49 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 155 HIS B 214 HIS.? 18.94 O6 C2E B 301 A 236 ASP B 162 ASP^? -3.04 N1 C2E B 301s A 261 LYS B 231 LYS~? 16.58 O2' C2E B 301 coo 55.45 46.76 42.08 57.34 46.16 42.75 13.04 11.66 -4.90 14.49 10.59 -3.83 coo 48.87 29.19 44.63 49.10 27.34 43.63 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 47.58 17.35 41.83 51.40 20.85 40.83 -12.77 12.18 -20.95 -18.80 11.50 -22.86 1qgn_c00 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1qgn_c00 naa= 3 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 155 HIS A 214 HIS.? 19.24 O6 C2E A 301 B 236 ASP A 162 ASP^? -3.09 N1 C2E A 301s B 261 LYS A 137 LYS.? -4.52 O2' C2E A 301s coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -9.67 -12.41 11.50 -9.18 -11.33 13.22 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 4.32 -14.05 -15.33 0.72 -19.17 -16.51 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 155 HIS A 214 HIS.? 19.24 O6 C2E A 301 B 236 ASP A 162 ASP^? -3.09 N1 C2E A 301s B 261 LYS A 231 LYS~? 13.14 O2' C2E A 301 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -9.67 -12.41 11.50 -9.18 -11.33 13.22 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -11.44 -15.22 -19.18 -8.27 -15.76 -22.64 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 155 HIS B 214 HIS.? 18.94 O6 C2E B 301 B 236 ASP B 162 ASP^? -3.04 N1 C2E B 301s B 261 LYS B 137 LYS.? -3.23 O3' C2E B 301s coo 17.23 -29.05 11.63 18.63 -29.78 10.25 13.04 11.66 -4.90 14.49 10.59 -3.83 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -16.98 12.27 -5.28 -15.90 17.15 -6.49 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 155 HIS B 214 HIS.? 18.94 O6 C2E B 301 B 236 ASP B 162 ASP^? -3.04 N1 C2E B 301s B 261 LYS B 231 LYS~? 16.58 O2' C2E B 301 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 13.04 11.66 -4.90 14.49 10.59 -3.83 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -12.77 12.18 -20.95 -18.80 11.50 -22.86 1qgn_c01 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1qgn_c01 naa= 3 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 155 HIS A 214 HIS.? 19.24 O6 C2E A 301 C 236 ASP A 162 ASP^? -3.09 N1 C2E A 301s C 261 LYS A 137 LYS.? -4.52 O2' C2E A 301s coo 55.11 47.10 12.61 53.44 47.85 11.58 -9.67 -12.41 11.50 -9.18 -11.33 13.22 coo 45.78 31.11 9.51 44.25 30.06 10.53 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 37.54 22.37 12.10 37.83 27.55 13.24 4.32 -14.05 -15.33 0.72 -19.17 -16.51 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 C 155 HIS A 214 HIS.? 19.24 O6 C2E A 301 C 236 ASP A 162 ASP^? -3.09 N1 C2E A 301s C 261 LYS A 231 LYS~? 13.14 O2' C2E A 301 coo 55.11 47.10 12.61 53.44 47.85 11.58 -9.67 -12.41 11.50 -9.18 -11.33 13.22 coo 45.78 31.11 9.51 44.25 30.06 10.53 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 37.54 22.37 12.10 37.83 27.55 13.24 -11.44 -15.22 -19.18 -8.27 -15.76 -22.64 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 C 155 HIS B 214 HIS.? 18.94 O6 C2E B 301 C 236 ASP B 162 ASP^? -3.04 N1 C2E B 301s C 261 LYS B 137 LYS.? -3.23 O3' C2E B 301s coo 55.11 47.10 12.61 53.44 47.85 11.58 13.04 11.66 -4.90 14.49 10.59 -3.83 coo 45.78 31.11 9.51 44.25 30.06 10.53 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 37.54 22.37 12.10 37.83 27.55 13.24 -16.98 12.27 -5.28 -15.90 17.15 -6.49 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 C 155 HIS B 214 HIS.? 18.94 O6 C2E B 301 C 236 ASP B 162 ASP^? -3.04 N1 C2E B 301s C 261 LYS B 231 LYS~? 16.58 O2' C2E B 301 coo 55.11 47.10 12.61 53.44 47.85 11.58 13.04 11.66 -4.90 14.49 10.59 -3.83 coo 45.78 31.11 9.51 44.25 30.06 10.53 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 37.54 22.37 12.10 37.83 27.55 13.24 -12.77 12.18 -20.95 -18.80 11.50 -22.86 1qgn_c02 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1qgn_c02 naa= 3 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 155 HIS A 38 HIS.? 16.46 O61 C2E B 301 D 236 ASP B 162 ASP^? -3.04 N1 C2E B 301s D 261 LYS B 238 LYS^? 16.50 N2 C2E A 301 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 1.46 -0.40 7.20 -0.57 -0.26 7.72 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 D 155 HIS A 214 HIS.? 19.24 O6 C2E A 301 D 236 ASP A 162 ASP^? -3.09 N1 C2E A 301s D 261 LYS A 137 LYS.? -4.52 O2' C2E A 301s coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -9.67 -12.41 11.50 -9.18 -11.33 13.22 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 4.32 -14.05 -15.33 0.72 -19.17 -16.51 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 D 155 HIS A 214 HIS.? 19.24 O6 C2E A 301 D 236 ASP A 162 ASP^? -3.09 N1 C2E A 301s D 261 LYS A 231 LYS~? 13.14 O2' C2E A 301 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -9.67 -12.41 11.50 -9.18 -11.33 13.22 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -11.44 -15.22 -19.18 -8.27 -15.76 -22.64 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 D 155 HIS B 214 HIS.? 18.94 O6 C2E B 301 D 236 ASP B 162 ASP^? -3.04 N1 C2E B 301s D 261 LYS B 137 LYS.? -3.23 O3' C2E B 301s coo 21.65 -31.73 40.91 19.91 -31.10 41.91 13.04 11.66 -4.90 14.49 10.59 -3.83 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -16.98 12.27 -5.28 -15.90 17.15 -6.49 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 D 155 HIS B 214 HIS.? 18.94 O6 C2E B 301 D 236 ASP B 162 ASP^? -3.04 N1 C2E B 301s D 261 LYS B 231 LYS~? 16.58 O2' C2E B 301 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 13.04 11.66 -4.90 14.49 10.59 -3.83 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -12.77 12.18 -20.95 -18.80 11.50 -22.86 1qgn_c03 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1qgn_c03 naa= 3 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 155 HIS A 38 HIS.? 16.46 O61 C2E B 301 E 236 ASP B 162 ASP^? -3.04 N1 C2E B 301s E 261 LYS B 238 LYS^? 16.50 N2 C2E A 301 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 1.46 -0.40 7.20 -0.57 -0.26 7.72 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 155 HIS A 214 HIS.? 19.24 O6 C2E A 301 E 236 ASP A 162 ASP^? -3.09 N1 C2E A 301s E 261 LYS A 137 LYS.? -4.52 O2' C2E A 301s coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -9.67 -12.41 11.50 -9.18 -11.33 13.22 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 4.32 -14.05 -15.33 0.72 -19.17 -16.51 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 155 HIS A 214 HIS.? 19.24 O6 C2E A 301 E 236 ASP A 162 ASP^? -3.09 N1 C2E A 301s E 261 LYS A 231 LYS~? 13.14 O2' C2E A 301 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -9.67 -12.41 11.50 -9.18 -11.33 13.22 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -11.44 -15.22 -19.18 -8.27 -15.76 -22.64 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 155 HIS B 214 HIS.? 18.94 O6 C2E B 301 E 236 ASP B 162 ASP^? -3.04 N1 C2E B 301s E 261 LYS B 137 LYS.? -3.23 O3' C2E B 301s coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 13.04 11.66 -4.90 14.49 10.59 -3.83 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -16.98 12.27 -5.28 -15.90 17.15 -6.49 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 155 HIS B 214 HIS.? 18.94 O6 C2E B 301 E 236 ASP B 162 ASP^? -3.04 N1 C2E B 301s E 261 LYS B 231 LYS~? 16.58 O2' C2E B 301 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 13.04 11.66 -4.90 14.49 10.59 -3.83 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -12.77 12.18 -20.95 -18.80 11.50 -22.86 1qgn_c04 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1qgn_c04 naa= 3 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 155 HIS A 214 HIS.? 19.24 O6 C2E A 301 F 236 ASP A 162 ASP^? -3.09 N1 C2E A 301s F 261 LYS A 137 LYS.? -4.52 O2' C2E A 301s coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -9.67 -12.41 11.50 -9.18 -11.33 13.22 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 4.32 -14.05 -15.33 0.72 -19.17 -16.51 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 155 HIS A 214 HIS.? 19.24 O6 C2E A 301 F 236 ASP A 162 ASP^? -3.09 N1 C2E A 301s F 261 LYS A 231 LYS~? 13.14 O2' C2E A 301 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -9.67 -12.41 11.50 -9.18 -11.33 13.22 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -11.44 -15.22 -19.18 -8.27 -15.76 -22.64 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 155 HIS B 214 HIS.? 18.94 O6 C2E B 301 F 236 ASP B 162 ASP^? -3.04 N1 C2E B 301s F 261 LYS B 137 LYS.? -3.23 O3' C2E B 301s coo 3.13 15.54 -65.72 2.08 14.15 -66.89 13.04 11.66 -4.90 14.49 10.59 -3.83 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -16.98 12.27 -5.28 -15.90 17.15 -6.49 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 155 HIS B 214 HIS.? 18.94 O6 C2E B 301 F 236 ASP B 162 ASP^? -3.04 N1 C2E B 301s F 261 LYS B 231 LYS~? 16.58 O2' C2E B 301 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 13.04 11.66 -4.90 14.49 10.59 -3.83 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -12.77 12.18 -20.95 -18.80 11.50 -22.86 1qgn_c05 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1qgn_c05 naa= 3 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 155 HIS A 214 HIS.? 19.24 O6 C2E A 301 G 236 ASP A 162 ASP^? -3.09 N1 C2E A 301s G 261 LYS A 137 LYS.? -4.52 O2' C2E A 301s coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -9.67 -12.41 11.50 -9.18 -11.33 13.22 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 4.32 -14.05 -15.33 0.72 -19.17 -16.51 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 G 155 HIS A 214 HIS.? 19.24 O6 C2E A 301 G 236 ASP A 162 ASP^? -3.09 N1 C2E A 301s G 261 LYS A 231 LYS~? 13.14 O2' C2E A 301 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -9.67 -12.41 11.50 -9.18 -11.33 13.22 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -11.44 -15.22 -19.18 -8.27 -15.76 -22.64 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 G 155 HIS B 214 HIS.? 18.94 O6 C2E B 301 G 236 ASP B 162 ASP^? -3.04 N1 C2E B 301s G 261 LYS B 137 LYS.? -3.23 O3' C2E B 301s coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 13.04 11.66 -4.90 14.49 10.59 -3.83 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -16.98 12.27 -5.28 -15.90 17.15 -6.49 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 G 155 HIS B 214 HIS.? 18.94 O6 C2E B 301 G 236 ASP B 162 ASP^? -3.04 N1 C2E B 301s G 261 LYS B 231 LYS~? 16.58 O2' C2E B 301 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 13.04 11.66 -4.90 14.49 10.59 -3.83 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -12.77 12.18 -20.95 -18.80 11.50 -22.86 1qgn_c06 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1qgn_c06 naa= 3 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 155 HIS A 38 HIS.? 16.46 O61 C2E B 301 H 236 ASP B 162 ASP^? -3.04 N1 C2E B 301s H 261 LYS B 238 LYS^? 16.50 N2 C2E A 301 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 1.46 -0.40 7.20 -0.57 -0.26 7.72 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 H 155 HIS A 214 HIS.? 19.24 O6 C2E A 301 H 236 ASP A 162 ASP^? -3.09 N1 C2E A 301s H 261 LYS A 137 LYS.? -4.52 O2' C2E A 301s coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -9.67 -12.41 11.50 -9.18 -11.33 13.22 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 4.32 -14.05 -15.33 0.72 -19.17 -16.51 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 H 155 HIS A 214 HIS.? 19.24 O6 C2E A 301 H 236 ASP A 162 ASP^? -3.09 N1 C2E A 301s H 261 LYS A 231 LYS~? 13.14 O2' C2E A 301 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -9.67 -12.41 11.50 -9.18 -11.33 13.22 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -11.44 -15.22 -19.18 -8.27 -15.76 -22.64 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 H 155 HIS B 214 HIS.? 18.94 O6 C2E B 301 H 236 ASP B 162 ASP^? -3.04 N1 C2E B 301s H 261 LYS B 137 LYS.? -3.23 O3' C2E B 301s coo 0.50 11.68 -36.58 0.99 13.43 -35.52 13.04 11.66 -4.90 14.49 10.59 -3.83 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -16.98 12.27 -5.28 -15.90 17.15 -6.49 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 H 155 HIS B 214 HIS.? 18.94 O6 C2E B 301 H 236 ASP B 162 ASP^? -3.04 N1 C2E B 301s H 261 LYS B 231 LYS~? 16.58 O2' C2E B 301 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 13.04 11.66 -4.90 14.49 10.59 -3.83 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -12.77 12.18 -20.95 -18.80 11.50 -22.86 1qgn_c07 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1qgn_c07 naa= 3 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 83 TYR~? 30.51 N21 C2E A 301 A 236 ASP A 80 ASP~? 23.66 N21 C2E A 301 A 261 LYS A 53 LYS^? 19.63 N21 C2E A 301 coo 55.48 26.51 40.65 55.39 23.99 39.43 24.52 -15.89 20.76 25.70 -16.30 23.25 coo 48.87 29.19 44.63 49.10 27.34 43.63 18.53 -17.34 17.76 18.57 -19.44 17.90 coo 47.58 17.35 41.83 51.40 20.85 40.83 24.14 -17.55 8.54 24.93 -16.56 3.33 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR A 179 TYR.? 13.95 N7 C2E A 301 A 236 ASP A 152 ASP.? 20.83 C8 C2E A 301 A 261 LYS A 148 LYS^? 21.30 O6 C2E A 301 coo 55.48 26.51 40.65 55.39 23.99 39.43 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo 48.87 29.19 44.63 49.10 27.34 43.63 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo 47.58 17.35 41.83 51.40 20.85 40.83 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 163 TYR B 179 TYR.? 13.89 O6 C2E B 301 A 236 ASP B 152 ASP.? 19.99 C8 C2E B 301 A 261 LYS B 148 LYS^? 21.33 O6 C2E B 301 coo 55.48 26.51 40.65 55.39 23.99 39.43 2.36 25.70 -10.99 3.98 25.02 -13.14 coo 48.87 29.19 44.63 49.10 27.34 43.63 2.18 32.86 -17.28 0.63 33.43 -15.93 coo 47.58 17.35 41.83 51.40 20.85 40.83 4.64 19.42 -20.28 9.89 19.27 -22.17 1qgn_c08 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c08 naa= 3 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 83 TYR~? 30.51 N21 C2E A 301 B 236 ASP A 80 ASP~? 23.66 N21 C2E A 301 B 261 LYS A 53 LYS^? 19.63 N21 C2E A 301 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 24.52 -15.89 20.76 25.70 -16.30 23.25 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 18.53 -17.34 17.76 18.57 -19.44 17.90 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 24.14 -17.55 8.54 24.93 -16.56 3.33 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR A 179 TYR.? 13.95 N7 C2E A 301 B 236 ASP A 152 ASP.? 20.83 C8 C2E A 301 B 261 LYS A 148 LYS^? 21.30 O6 C2E A 301 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 163 TYR B 179 TYR.? 13.89 O6 C2E B 301 B 236 ASP B 152 ASP.? 19.99 C8 C2E B 301 B 261 LYS B 148 LYS^? 21.33 O6 C2E B 301 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 2.36 25.70 -10.99 3.98 25.02 -13.14 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 2.18 32.86 -17.28 0.63 33.43 -15.93 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 4.64 19.42 -20.28 9.89 19.27 -22.17 1qgn_c09 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c09 naa= 3 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 163 TYR A 83 TYR~? 30.51 N21 C2E A 301 C 236 ASP A 80 ASP~? 23.66 N21 C2E A 301 C 261 LYS A 53 LYS^? 19.63 N21 C2E A 301 coo 39.51 34.34 13.63 37.63 32.61 14.79 24.52 -15.89 20.76 25.70 -16.30 23.25 coo 45.78 31.11 9.51 44.25 30.06 10.53 18.53 -17.34 17.76 18.57 -19.44 17.90 coo 37.54 22.37 12.10 37.83 27.55 13.24 24.14 -17.55 8.54 24.93 -16.56 3.33 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 C 163 TYR A 179 TYR.? 13.95 N7 C2E A 301 C 236 ASP A 152 ASP.? 20.83 C8 C2E A 301 C 261 LYS A 148 LYS^? 21.30 O6 C2E A 301 coo 39.51 34.34 13.63 37.63 32.61 14.79 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo 45.78 31.11 9.51 44.25 30.06 10.53 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo 37.54 22.37 12.10 37.83 27.55 13.24 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 C 163 TYR B 179 TYR.? 13.89 O6 C2E B 301 C 236 ASP B 152 ASP.? 19.99 C8 C2E B 301 C 261 LYS B 148 LYS^? 21.33 O6 C2E B 301 coo 39.51 34.34 13.63 37.63 32.61 14.79 2.36 25.70 -10.99 3.98 25.02 -13.14 coo 45.78 31.11 9.51 44.25 30.06 10.53 2.18 32.86 -17.28 0.63 33.43 -15.93 coo 37.54 22.37 12.10 37.83 27.55 13.24 4.64 19.42 -20.28 9.89 19.27 -22.17 1qgn_c10 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c10 naa= 3 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 163 TYR A 83 TYR~? 30.51 N21 C2E A 301 D 236 ASP A 80 ASP~? 23.66 N21 C2E A 301 D 261 LYS A 53 LYS^? 19.63 N21 C2E A 301 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 24.52 -15.89 20.76 25.70 -16.30 23.25 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 18.53 -17.34 17.76 18.57 -19.44 17.90 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 24.14 -17.55 8.54 24.93 -16.56 3.33 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 D 163 TYR A 179 TYR.? 13.95 N7 C2E A 301 D 236 ASP A 152 ASP.? 20.83 C8 C2E A 301 D 261 LYS A 148 LYS^? 21.30 O6 C2E A 301 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 D 163 TYR B 179 TYR.? 13.89 O6 C2E B 301 D 236 ASP B 152 ASP.? 19.99 C8 C2E B 301 D 261 LYS B 148 LYS^? 21.33 O6 C2E B 301 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 2.36 25.70 -10.99 3.98 25.02 -13.14 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 2.18 32.86 -17.28 0.63 33.43 -15.93 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 4.64 19.42 -20.28 9.89 19.27 -22.17 1qgn_c11 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c11 naa= 3 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 83 TYR~? 30.51 N21 C2E A 301 E 236 ASP A 80 ASP~? 23.66 N21 C2E A 301 E 261 LYS A 53 LYS^? 19.63 N21 C2E A 301 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 24.52 -15.89 20.76 25.70 -16.30 23.25 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 18.53 -17.34 17.76 18.57 -19.44 17.90 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 24.14 -17.55 8.54 24.93 -16.56 3.33 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR A 179 TYR.? 13.95 N7 C2E A 301 E 236 ASP A 152 ASP.? 20.83 C8 C2E A 301 E 261 LYS A 148 LYS^? 21.30 O6 C2E A 301 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 163 TYR B 179 TYR.? 13.89 O6 C2E B 301 E 236 ASP B 152 ASP.? 19.99 C8 C2E B 301 E 261 LYS B 148 LYS^? 21.33 O6 C2E B 301 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 2.36 25.70 -10.99 3.98 25.02 -13.14 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 2.18 32.86 -17.28 0.63 33.43 -15.93 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 4.64 19.42 -20.28 9.89 19.27 -22.17 1qgn_c12 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c12 naa= 3 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 83 TYR~? 30.51 N21 C2E A 301 F 236 ASP A 80 ASP~? 23.66 N21 C2E A 301 F 261 LYS A 53 LYS^? 19.63 N21 C2E A 301 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 24.52 -15.89 20.76 25.70 -16.30 23.25 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 18.53 -17.34 17.76 18.57 -19.44 17.90 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 24.14 -17.55 8.54 24.93 -16.56 3.33 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR A 179 TYR.? 13.95 N7 C2E A 301 F 236 ASP A 152 ASP.? 20.83 C8 C2E A 301 F 261 LYS A 148 LYS^? 21.30 O6 C2E A 301 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 163 TYR B 179 TYR.? 13.89 O6 C2E B 301 F 236 ASP B 152 ASP.? 19.99 C8 C2E B 301 F 261 LYS B 148 LYS^? 21.33 O6 C2E B 301 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 2.36 25.70 -10.99 3.98 25.02 -13.14 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 2.18 32.86 -17.28 0.63 33.43 -15.93 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 4.64 19.42 -20.28 9.89 19.27 -22.17 1qgn_c13 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c13 naa= 3 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 163 TYR A 83 TYR~? 30.51 N21 C2E A 301 G 236 ASP A 80 ASP~? 23.66 N21 C2E A 301 G 261 LYS A 53 LYS^? 19.63 N21 C2E A 301 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 24.52 -15.89 20.76 25.70 -16.30 23.25 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 18.53 -17.34 17.76 18.57 -19.44 17.90 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 24.14 -17.55 8.54 24.93 -16.56 3.33 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 G 163 TYR A 179 TYR.? 13.95 N7 C2E A 301 G 236 ASP A 152 ASP.? 20.83 C8 C2E A 301 G 261 LYS A 148 LYS^? 21.30 O6 C2E A 301 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 G 163 TYR B 179 TYR.? 13.89 O6 C2E B 301 G 236 ASP B 152 ASP.? 19.99 C8 C2E B 301 G 261 LYS B 148 LYS^? 21.33 O6 C2E B 301 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 2.36 25.70 -10.99 3.98 25.02 -13.14 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 2.18 32.86 -17.28 0.63 33.43 -15.93 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 4.64 19.42 -20.28 9.89 19.27 -22.17 1qgn_c14 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c14 naa= 3 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 163 TYR A 83 TYR~? 30.51 N21 C2E A 301 H 236 ASP A 80 ASP~? 23.66 N21 C2E A 301 H 261 LYS A 53 LYS^? 19.63 N21 C2E A 301 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 24.52 -15.89 20.76 25.70 -16.30 23.25 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 18.53 -17.34 17.76 18.57 -19.44 17.90 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 24.14 -17.55 8.54 24.93 -16.56 3.33 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 H 163 TYR A 179 TYR.? 13.95 N7 C2E A 301 H 236 ASP A 152 ASP.? 20.83 C8 C2E A 301 H 261 LYS A 148 LYS^? 21.30 O6 C2E A 301 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 H 163 TYR B 179 TYR.? 13.89 O6 C2E B 301 H 236 ASP B 152 ASP.? 19.99 C8 C2E B 301 H 261 LYS B 148 LYS^? 21.33 O6 C2E B 301 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 2.36 25.70 -10.99 3.98 25.02 -13.14 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 2.18 32.86 -17.28 0.63 33.43 -15.93 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 4.64 19.42 -20.28 9.89 19.27 -22.17 1qgn_c15 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c15 naa= 3 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 110 ARG A 169 ARG^? -4.75 O6 C2E A 301s C 163 TYR A 218 TYR^? 10.22 O6 C2E A 301 C 236 ASP A 183 ASP.? 14.57 O1P C2E A 301 coo 39.01 29.77 22.02 37.48 31.30 19.84 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 coo 39.51 34.34 13.63 37.63 32.61 14.79 -6.98 -22.32 0.01 -7.64 -23.76 2.29 coo 45.78 31.11 9.51 44.25 30.06 10.53 -7.06 -30.30 -3.03 -6.77 -31.63 -1.43 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 110 ARG A 211 ARG^? 16.62 O6 C2E A 301 C 163 TYR A 218 TYR^? 10.22 O6 C2E A 301 C 236 ASP A 183 ASP.? 14.57 O1P C2E A 301 coo 39.01 29.77 22.02 37.48 31.30 19.84 -4.93 -23.64 8.57 -7.93 -23.17 9.07 coo 39.51 34.34 13.63 37.63 32.61 14.79 -6.98 -22.32 0.01 -7.64 -23.76 2.29 coo 45.78 31.11 9.51 44.25 30.06 10.53 -7.06 -30.30 -3.03 -6.77 -31.63 -1.43 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 110 ARG B 169 ARG^? -4.70 O6 C2E B 301s C 163 TYR B 218 TYR^? 10.08 O6 C2E B 301 C 236 ASP B 183 ASP.? 14.33 O1P C2E B 301 coo 39.01 29.77 22.02 37.48 31.30 19.84 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo 39.51 34.34 13.63 37.63 32.61 14.79 1.42 21.23 -8.42 3.73 22.73 -7.99 coo 45.78 31.11 9.51 44.25 30.06 10.53 -1.79 28.84 -10.63 -0.66 30.31 -9.57 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 110 ARG B 211 ARG^? 16.78 O6 C2E B 301 C 163 TYR B 218 TYR^? 10.08 O6 C2E B 301 C 236 ASP B 183 ASP.? 14.33 O1P C2E B 301 coo 39.01 29.77 22.02 37.48 31.30 19.84 8.09 22.99 -2.57 10.13 22.73 -4.88 coo 39.51 34.34 13.63 37.63 32.61 14.79 1.42 21.23 -8.42 3.73 22.73 -7.99 coo 45.78 31.11 9.51 44.25 30.06 10.53 -1.79 28.84 -10.63 -0.66 30.31 -9.57 1qgn_c16 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1qgn_c16 naa= 3 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 110 ARG A 169 ARG^? -4.75 O6 C2E A 301s D 163 TYR A 218 TYR^? 10.22 O6 C2E A 301 D 236 ASP A 183 ASP.? 14.57 O1P C2E A 301 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -6.98 -22.32 0.01 -7.64 -23.76 2.29 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -7.06 -30.30 -3.03 -6.77 -31.63 -1.43 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 110 ARG A 211 ARG^? 16.62 O6 C2E A 301 D 163 TYR A 218 TYR^? 10.22 O6 C2E A 301 D 236 ASP A 183 ASP.? 14.57 O1P C2E A 301 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -4.93 -23.64 8.57 -7.93 -23.17 9.07 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -6.98 -22.32 0.01 -7.64 -23.76 2.29 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -7.06 -30.30 -3.03 -6.77 -31.63 -1.43 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 110 ARG B 169 ARG^? -4.70 O6 C2E B 301s D 163 TYR B 218 TYR^? 10.08 O6 C2E B 301 D 236 ASP B 183 ASP.? 14.33 O1P C2E B 301 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 1.42 21.23 -8.42 3.73 22.73 -7.99 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -1.79 28.84 -10.63 -0.66 30.31 -9.57 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 110 ARG B 211 ARG^? 16.78 O6 C2E B 301 D 163 TYR B 218 TYR^? 10.08 O6 C2E B 301 D 236 ASP B 183 ASP.? 14.33 O1P C2E B 301 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 8.09 22.99 -2.57 10.13 22.73 -4.88 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 1.42 21.23 -8.42 3.73 22.73 -7.99 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -1.79 28.84 -10.63 -0.66 30.31 -9.57 1qgn_c17 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1qgn_c17 naa= 3 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 218 TYR^? 10.22 O6 C2E A 301 A 236 ASP A 183 ASP.? 14.57 O1P C2E A 301 C 110 ARG A 211 ARG^? 16.62 O6 C2E A 301 coo 55.48 26.51 40.65 55.39 23.99 39.43 -6.98 -22.32 0.01 -7.64 -23.76 2.29 coo 48.87 29.19 44.63 49.10 27.34 43.63 -7.06 -30.30 -3.03 -6.77 -31.63 -1.43 coo 52.39 23.42 32.10 54.51 23.27 34.29 -4.93 -23.64 8.57 -7.93 -23.17 9.07 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR B 218 TYR^? 10.08 O6 C2E B 301 A 236 ASP B 183 ASP.? 14.33 O1P C2E B 301 C 110 ARG B 211 ARG^? 16.78 O6 C2E B 301 coo 55.48 26.51 40.65 55.39 23.99 39.43 1.42 21.23 -8.42 3.73 22.73 -7.99 coo 48.87 29.19 44.63 49.10 27.34 43.63 -1.79 28.84 -10.63 -0.66 30.31 -9.57 coo 52.39 23.42 32.10 54.51 23.27 34.29 8.09 22.99 -2.57 10.13 22.73 -4.88 1qgn_c18 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c18 naa= 3 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 218 TYR^? 10.22 O6 C2E A 301 B 236 ASP A 183 ASP.? 14.57 O1P C2E A 301 D 110 ARG A 169 ARG^? -4.75 O6 C2E A 301s coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -6.98 -22.32 0.01 -7.64 -23.76 2.29 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -7.06 -30.30 -3.03 -6.77 -31.63 -1.43 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR A 218 TYR^? 10.22 O6 C2E A 301 B 236 ASP A 183 ASP.? 14.57 O1P C2E A 301 D 110 ARG A 211 ARG^? 16.62 O6 C2E A 301 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -6.98 -22.32 0.01 -7.64 -23.76 2.29 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -7.06 -30.30 -3.03 -6.77 -31.63 -1.43 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -4.93 -23.64 8.57 -7.93 -23.17 9.07 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 163 TYR B 218 TYR^? 10.08 O6 C2E B 301 B 236 ASP B 183 ASP.? 14.33 O1P C2E B 301 D 110 ARG B 169 ARG^? -4.70 O6 C2E B 301s coo 32.99 -16.32 11.66 35.01 -14.70 12.72 1.42 21.23 -8.42 3.73 22.73 -7.99 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -1.79 28.84 -10.63 -0.66 30.31 -9.57 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -0.88 13.03 -7.12 -1.56 12.92 -4.13 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 163 TYR B 218 TYR^? 10.08 O6 C2E B 301 B 236 ASP B 183 ASP.? 14.33 O1P C2E B 301 D 110 ARG B 211 ARG^? 16.78 O6 C2E B 301 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 1.42 21.23 -8.42 3.73 22.73 -7.99 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -1.79 28.84 -10.63 -0.66 30.31 -9.57 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 8.09 22.99 -2.57 10.13 22.73 -4.88 1qgn_c19 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1qgn_c19 naa= 3 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 110 ARG A 169 ARG^? -4.75 O6 C2E A 301s G 163 TYR A 218 TYR^? 10.22 O6 C2E A 301 G 236 ASP A 183 ASP.? 14.57 O1P C2E A 301 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -6.98 -22.32 0.01 -7.64 -23.76 2.29 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -7.06 -30.30 -3.03 -6.77 -31.63 -1.43 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 110 ARG A 211 ARG^? 16.62 O6 C2E A 301 G 163 TYR A 218 TYR^? 10.22 O6 C2E A 301 G 236 ASP A 183 ASP.? 14.57 O1P C2E A 301 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -4.93 -23.64 8.57 -7.93 -23.17 9.07 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -6.98 -22.32 0.01 -7.64 -23.76 2.29 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -7.06 -30.30 -3.03 -6.77 -31.63 -1.43 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 110 ARG B 169 ARG^? -4.70 O6 C2E B 301s G 163 TYR B 218 TYR^? 10.08 O6 C2E B 301 G 236 ASP B 183 ASP.? 14.33 O1P C2E B 301 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 1.42 21.23 -8.42 3.73 22.73 -7.99 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -1.79 28.84 -10.63 -0.66 30.31 -9.57 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 110 ARG B 211 ARG^? 16.78 O6 C2E B 301 G 163 TYR B 218 TYR^? 10.08 O6 C2E B 301 G 236 ASP B 183 ASP.? 14.33 O1P C2E B 301 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 8.09 22.99 -2.57 10.13 22.73 -4.88 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 1.42 21.23 -8.42 3.73 22.73 -7.99 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -1.79 28.84 -10.63 -0.66 30.31 -9.57 1qgn_c20 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1qgn_c20 naa= 3 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 110 ARG A 169 ARG^? -4.75 O6 C2E A 301s H 163 TYR A 218 TYR^? 10.22 O6 C2E A 301 H 236 ASP A 183 ASP.? 14.57 O1P C2E A 301 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -6.98 -22.32 0.01 -7.64 -23.76 2.29 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -7.06 -30.30 -3.03 -6.77 -31.63 -1.43 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 110 ARG A 211 ARG^? 16.62 O6 C2E A 301 H 163 TYR A 218 TYR^? 10.22 O6 C2E A 301 H 236 ASP A 183 ASP.? 14.57 O1P C2E A 301 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -4.93 -23.64 8.57 -7.93 -23.17 9.07 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -6.98 -22.32 0.01 -7.64 -23.76 2.29 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -7.06 -30.30 -3.03 -6.77 -31.63 -1.43 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 110 ARG B 169 ARG^? -4.70 O6 C2E B 301s H 163 TYR B 218 TYR^? 10.08 O6 C2E B 301 H 236 ASP B 183 ASP.? 14.33 O1P C2E B 301 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 1.42 21.23 -8.42 3.73 22.73 -7.99 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -1.79 28.84 -10.63 -0.66 30.31 -9.57 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 110 ARG B 211 ARG^? 16.78 O6 C2E B 301 H 163 TYR B 218 TYR^? 10.08 O6 C2E B 301 H 236 ASP B 183 ASP.? 14.33 O1P C2E B 301 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 8.09 22.99 -2.57 10.13 22.73 -4.88 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 1.42 21.23 -8.42 3.73 22.73 -7.99 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -1.79 28.84 -10.63 -0.66 30.31 -9.57 1qgn_c21 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1qgn_c21 naa= 3 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 218 TYR^? 10.22 O6 C2E A 301 E 236 ASP A 183 ASP.? 14.57 O1P C2E A 301 G 110 ARG A 211 ARG^? 16.62 O6 C2E A 301 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -6.98 -22.32 0.01 -7.64 -23.76 2.29 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -7.06 -30.30 -3.03 -6.77 -31.63 -1.43 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -4.93 -23.64 8.57 -7.93 -23.17 9.07 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR B 218 TYR^? 10.08 O6 C2E B 301 E 236 ASP B 183 ASP.? 14.33 O1P C2E B 301 G 110 ARG B 211 ARG^? 16.78 O6 C2E B 301 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 1.42 21.23 -8.42 3.73 22.73 -7.99 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -1.79 28.84 -10.63 -0.66 30.31 -9.57 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 8.09 22.99 -2.57 10.13 22.73 -4.88 1qgn_c22 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c22 naa= 3 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 218 TYR^? 10.22 O6 C2E A 301 F 236 ASP A 183 ASP.? 14.57 O1P C2E A 301 H 110 ARG A 169 ARG^? -4.75 O6 C2E A 301s coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -6.98 -22.32 0.01 -7.64 -23.76 2.29 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -7.06 -30.30 -3.03 -6.77 -31.63 -1.43 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR A 218 TYR^? 10.22 O6 C2E A 301 F 236 ASP A 183 ASP.? 14.57 O1P C2E A 301 H 110 ARG A 211 ARG^? 16.62 O6 C2E A 301 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -6.98 -22.32 0.01 -7.64 -23.76 2.29 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -7.06 -30.30 -3.03 -6.77 -31.63 -1.43 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -4.93 -23.64 8.57 -7.93 -23.17 9.07 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 163 TYR B 218 TYR^? 10.08 O6 C2E B 301 F 236 ASP B 183 ASP.? 14.33 O1P C2E B 301 H 110 ARG B 169 ARG^? -4.70 O6 C2E B 301s coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 1.42 21.23 -8.42 3.73 22.73 -7.99 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -1.79 28.84 -10.63 -0.66 30.31 -9.57 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -0.88 13.03 -7.12 -1.56 12.92 -4.13 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 163 TYR B 218 TYR^? 10.08 O6 C2E B 301 F 236 ASP B 183 ASP.? 14.33 O1P C2E B 301 H 110 ARG B 211 ARG^? 16.78 O6 C2E B 301 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 1.42 21.23 -8.42 3.73 22.73 -7.99 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -1.79 28.84 -10.63 -0.66 30.31 -9.57 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 8.09 22.99 -2.57 10.13 22.73 -4.88 1qgn_c23 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1qgn_c23 naa= 3 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 1 3 # 1 A 49 ASP A 31 ASP~? 17.49 O6 C2E B 301 A 147 THR A 129 THR^? 23.05 N11 C2E A 301 A 294 ASP A 66 ASP.? 23.33 N21 C2E B 301 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 10.86 4.60 -5.63 10.78 6.65 -6.14 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 19.06 1.74 -3.58 20.59 2.04 -5.10 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 15.60 9.37 4.44 16.85 10.89 5.23 1qgx_c02 source 1qgx 3',5'-ADENOSINE BISPHOSPHATASE : 1 hits 1qgx_c02 naa= 3 ULMN 3 1qho_c07 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 183 ASP.? 14.57 O1P C2E A 301 A 260 ASP A 157 ASP^? 20.06 O6 C2E A 301 A 329 ASP A 152 ASP.? 20.83 C8 C2E A 301 coo 28.46 69.88 26.74 30.40 70.70 26.53 -7.06 -30.30 -3.03 -6.77 -31.63 -1.43 coo 30.73 81.29 37.61 31.23 82.07 35.69 -19.05 -19.29 2.64 -21.12 -19.53 2.92 coo 37.87 70.12 31.80 36.61 69.74 30.15 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 1qho_c07 source 1qho ALPHA-AMYLASE : 1 hits 1qho_c07 naa= 3 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 1 3 # 1 A 145 THR A 172 THR^? 12.93 O6 C2E A 301 A 182 TYR A 179 TYR.? 13.95 N7 C2E A 301 A 186 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo 69.38 87.38 24.64 71.11 88.47 25.40 -12.64 -19.39 3.41 -11.97 -21.32 2.68 coo 73.61 90.42 31.12 71.36 89.66 29.64 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo 73.54 84.00 28.64 69.01 86.68 29.71 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 2 3 # 2 A 145 THR B 172 THR^? 12.75 O6 C2E B 301 A 182 TYR B 179 TYR.? 13.89 O6 C2E B 301 A 186 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo 69.38 87.38 24.64 71.11 88.47 25.40 7.41 18.34 -11.48 6.25 20.16 -11.39 coo 73.61 90.42 31.12 71.36 89.66 29.64 2.36 25.70 -10.99 3.98 25.02 -13.14 coo 73.54 84.00 28.64 69.01 86.68 29.71 8.81 26.59 -11.72 7.46 31.56 -12.94 1qrr_c01 source 1qrr SULFOLIPID BIOSYNTHESIS (SQD1) PROTEIN : 2 hits 1qrr_c01 naa= 3 ULMN 3 1qrz_c12 PLASMINOGEN user 1 3 # 1 A 603 HIS B 214 HIS.? 18.94 O6 C2E B 301 A 646 ASP A 31 ASP~? 17.49 O6 C2E B 301 A 741 SER B 212 SER.? 13.16 O6 C2E B 301 coo -20.72 2.99 34.37 -21.94 1.82 35.61 13.04 11.66 -4.90 14.49 10.59 -3.83 coo -18.83 7.68 26.86 -20.89 7.78 26.56 10.86 4.60 -5.63 10.78 6.65 -6.14 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 8.68 16.14 -1.54 8.01 14.57 -3.30 ULMN 3 1qrz_c12 PLASMINOGEN user 2 3 # 2 A 603 HIS B 214 HIS.? 18.94 O6 C2E B 301 A 646 ASP A 66 ASP.? 23.33 N21 C2E B 301 A 741 SER B 212 SER.? 13.16 O6 C2E B 301 coo -20.72 2.99 34.37 -21.94 1.82 35.61 13.04 11.66 -4.90 14.49 10.59 -3.83 coo -18.83 7.68 26.86 -20.89 7.78 26.56 15.60 9.37 4.44 16.85 10.89 5.23 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 8.68 16.14 -1.54 8.01 14.57 -3.30 ULMN 3 1qrz_c12 PLASMINOGEN user 3 3 # 3 A 603 HIS B 215 HIS.? 11.93 O6 C2E B 301 A 646 ASP A 31 ASP~? 17.49 O6 C2E B 301 A 741 SER B 212 SER.? 13.16 O6 C2E B 301 coo -20.72 2.99 34.37 -21.94 1.82 35.61 7.81 14.24 -7.06 6.68 12.76 -6.10 coo -18.83 7.68 26.86 -20.89 7.78 26.56 10.86 4.60 -5.63 10.78 6.65 -6.14 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 8.68 16.14 -1.54 8.01 14.57 -3.30 1qrz_c12 source 1qrz PLASMINOGEN : 3 hits 1qrz_c12 naa= 3 ULMN 3 1qrz_c13 PLASMINOGEN user 1 3 # 1 B 603 HIS B 214 HIS.? 18.94 O6 C2E B 301 B 646 ASP A 31 ASP~? 17.49 O6 C2E B 301 B 741 SER B 212 SER.? 13.16 O6 C2E B 301 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 13.04 11.66 -4.90 14.49 10.59 -3.83 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 10.86 4.60 -5.63 10.78 6.65 -6.14 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 8.68 16.14 -1.54 8.01 14.57 -3.30 ULMN 3 1qrz_c13 PLASMINOGEN user 2 3 # 2 B 603 HIS B 214 HIS.? 18.94 O6 C2E B 301 B 646 ASP A 66 ASP.? 23.33 N21 C2E B 301 B 741 SER B 212 SER.? 13.16 O6 C2E B 301 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 13.04 11.66 -4.90 14.49 10.59 -3.83 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 15.60 9.37 4.44 16.85 10.89 5.23 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 8.68 16.14 -1.54 8.01 14.57 -3.30 ULMN 3 1qrz_c13 PLASMINOGEN user 3 3 # 3 B 603 HIS B 215 HIS.? 11.93 O6 C2E B 301 B 646 ASP A 31 ASP~? 17.49 O6 C2E B 301 B 741 SER B 212 SER.? 13.16 O6 C2E B 301 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 7.81 14.24 -7.06 6.68 12.76 -6.10 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 10.86 4.60 -5.63 10.78 6.65 -6.14 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 8.68 16.14 -1.54 8.01 14.57 -3.30 1qrz_c13 source 1qrz PLASMINOGEN : 3 hits 1qrz_c13 naa= 3 ULMN 3 1qrz_c14 PLASMINOGEN user 1 3 # 1 C 603 HIS B 214 HIS.? 18.94 O6 C2E B 301 C 646 ASP A 31 ASP~? 17.49 O6 C2E B 301 C 741 SER B 212 SER.? 13.16 O6 C2E B 301 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 13.04 11.66 -4.90 14.49 10.59 -3.83 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 10.86 4.60 -5.63 10.78 6.65 -6.14 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 8.68 16.14 -1.54 8.01 14.57 -3.30 ULMN 3 1qrz_c14 PLASMINOGEN user 2 3 # 2 C 603 HIS B 214 HIS.? 18.94 O6 C2E B 301 C 646 ASP A 66 ASP.? 23.33 N21 C2E B 301 C 741 SER B 212 SER.? 13.16 O6 C2E B 301 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 13.04 11.66 -4.90 14.49 10.59 -3.83 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 15.60 9.37 4.44 16.85 10.89 5.23 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 8.68 16.14 -1.54 8.01 14.57 -3.30 ULMN 3 1qrz_c14 PLASMINOGEN user 3 3 # 3 C 603 HIS B 215 HIS.? 11.93 O6 C2E B 301 C 646 ASP A 31 ASP~? 17.49 O6 C2E B 301 C 741 SER B 212 SER.? 13.16 O6 C2E B 301 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 7.81 14.24 -7.06 6.68 12.76 -6.10 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 10.86 4.60 -5.63 10.78 6.65 -6.14 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 8.68 16.14 -1.54 8.01 14.57 -3.30 1qrz_c14 source 1qrz PLASMINOGEN : 3 hits 1qrz_c14 naa= 3 ULMN 3 1qrz_c15 PLASMINOGEN user 1 3 # 1 D 603 HIS B 214 HIS.? 18.94 O6 C2E B 301 D 646 ASP A 31 ASP~? 17.49 O6 C2E B 301 D 741 SER B 212 SER.? 13.16 O6 C2E B 301 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 13.04 11.66 -4.90 14.49 10.59 -3.83 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 10.86 4.60 -5.63 10.78 6.65 -6.14 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 8.68 16.14 -1.54 8.01 14.57 -3.30 ULMN 3 1qrz_c15 PLASMINOGEN user 2 3 # 2 D 603 HIS B 214 HIS.? 18.94 O6 C2E B 301 D 646 ASP A 66 ASP.? 23.33 N21 C2E B 301 D 741 SER B 212 SER.? 13.16 O6 C2E B 301 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 13.04 11.66 -4.90 14.49 10.59 -3.83 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 15.60 9.37 4.44 16.85 10.89 5.23 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 8.68 16.14 -1.54 8.01 14.57 -3.30 ULMN 3 1qrz_c15 PLASMINOGEN user 3 3 # 3 D 603 HIS B 215 HIS.? 11.93 O6 C2E B 301 D 646 ASP A 31 ASP~? 17.49 O6 C2E B 301 D 741 SER B 212 SER.? 13.16 O6 C2E B 301 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 7.81 14.24 -7.06 6.68 12.76 -6.10 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 10.86 4.60 -5.63 10.78 6.65 -6.14 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 8.68 16.14 -1.54 8.01 14.57 -3.30 1qrz_c15 source 1qrz PLASMINOGEN : 3 hits 1qrz_c15 naa= 3 ULMN 3 1qrz_c20 PLASMINOGEN user 1 3 # 1 A 603 HIS A 154 HIS^? 21.74 O6 C2E A 301 A 646 ASP A 183 ASP.? 14.57 O1P C2E A 301 A 739 GLY A 147 GLY^? 15.77 N1 C2E A 301 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -16.69 -30.86 2.00 -15.94 -32.47 3.12 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -7.06 -30.30 -3.03 -6.77 -31.63 -1.43 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -18.95 -17.47 -3.92 -18.81 -17.49 -3.10 ULMN 3 1qrz_c20 PLASMINOGEN user 2 3 # 2 A 603 HIS B 154 HIS^? 20.45 O6 C2E B 301 A 646 ASP B 152 ASP.? 19.99 C8 C2E B 301 A 739 GLY B 147 GLY^? 15.80 N1 C2E B 301 coo -20.72 2.99 34.37 -21.94 1.82 35.61 7.78 28.08 -17.01 9.24 26.69 -16.42 coo -18.83 7.68 26.86 -20.89 7.78 26.56 2.18 32.86 -17.28 0.63 33.43 -15.93 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 4.21 15.66 -20.42 4.84 15.79 -19.91 1qrz_c20 source 1qrz PLASMINOGEN : 2 hits 1qrz_c20 naa= 3 ULMN 3 1qrz_c21 PLASMINOGEN user 1 3 # 1 B 603 HIS B 154 HIS^? 20.45 O6 C2E B 301 B 646 ASP B 152 ASP.? 19.99 C8 C2E B 301 B 739 GLY B 147 GLY^? 15.80 N1 C2E B 301 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 7.78 28.08 -17.01 9.24 26.69 -16.42 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 2.18 32.86 -17.28 0.63 33.43 -15.93 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 4.21 15.66 -20.42 4.84 15.79 -19.91 1qrz_c21 source 1qrz PLASMINOGEN : 1 hits 1qrz_c21 naa= 3 ULMN 3 1qrz_c22 PLASMINOGEN user 1 3 # 1 C 603 HIS B 154 HIS^? 20.45 O6 C2E B 301 C 646 ASP B 152 ASP.? 19.99 C8 C2E B 301 C 739 GLY B 147 GLY^? 15.80 N1 C2E B 301 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 7.78 28.08 -17.01 9.24 26.69 -16.42 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 2.18 32.86 -17.28 0.63 33.43 -15.93 coo 7.82 1.25 3.03 7.30 1.31 3.65 4.21 15.66 -20.42 4.84 15.79 -19.91 1qrz_c22 source 1qrz PLASMINOGEN : 1 hits 1qrz_c22 naa= 3 ULMN 3 1qrz_c23 PLASMINOGEN user 1 3 # 1 D 603 HIS A 154 HIS^? 21.74 O6 C2E A 301 D 646 ASP A 183 ASP.? 14.57 O1P C2E A 301 D 739 GLY A 147 GLY^? 15.77 N1 C2E A 301 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -16.69 -30.86 2.00 -15.94 -32.47 3.12 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -7.06 -30.30 -3.03 -6.77 -31.63 -1.43 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -18.95 -17.47 -3.92 -18.81 -17.49 -3.10 ULMN 3 1qrz_c23 PLASMINOGEN user 2 3 # 2 D 603 HIS B 154 HIS^? 20.45 O6 C2E B 301 D 646 ASP B 152 ASP.? 19.99 C8 C2E B 301 D 739 GLY B 147 GLY^? 15.80 N1 C2E B 301 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 7.78 28.08 -17.01 9.24 26.69 -16.42 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 2.18 32.86 -17.28 0.63 33.43 -15.93 coo -45.82 1.31 41.67 -46.38 1.39 42.31 4.21 15.66 -20.42 4.84 15.79 -19.91 1qrz_c23 source 1qrz PLASMINOGEN : 2 hits 1qrz_c23 naa= 3 ULMN 3 1qz9_c02 KYNURENINASE user 1 3 # 1 A 129 PHE A 84 PHE.? 23.41 N21 C2E A 301 A 201 ASP A 79 ASP~? 30.21 N21 C2E A 301 A 227 LYS A 75 LYS.? 21.41 N21 C2E A 301 coo 23.39 49.81 32.16 21.33 51.68 32.26 22.11 -15.87 14.74 23.34 -18.33 14.34 coo 25.52 45.12 37.98 23.98 46.65 37.85 19.82 -18.69 22.66 21.43 -19.12 23.96 coo 12.68 46.83 36.69 18.26 48.67 34.51 9.70 -14.41 17.00 6.16 -11.27 19.18 ULMN 3 1qz9_c02 KYNURENINASE user 2 3 # 2 A 129 PHE A 141 PHE^? 8.60 N2 C2E A 301 A 201 ASP A 162 ASP^? -3.09 N1 C2E A 301s A 227 LYS A 137 LYS.? -4.52 O2' C2E A 301s coo 23.39 49.81 32.16 21.33 51.68 32.26 -6.62 -7.97 -12.78 -5.32 -7.70 -15.23 coo 25.52 45.12 37.98 23.98 46.65 37.85 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 12.68 46.83 36.69 18.26 48.67 34.51 4.32 -14.05 -15.33 0.72 -19.17 -16.51 ULMN 3 1qz9_c02 KYNURENINASE user 3 3 # 3 A 129 PHE A 141 PHE^? 8.60 N2 C2E A 301 A 201 ASP A 162 ASP^? -3.09 N1 C2E A 301s A 227 LYS A 231 LYS~? 13.14 O2' C2E A 301 coo 23.39 49.81 32.16 21.33 51.68 32.26 -6.62 -7.97 -12.78 -5.32 -7.70 -15.23 coo 25.52 45.12 37.98 23.98 46.65 37.85 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 12.68 46.83 36.69 18.26 48.67 34.51 -11.44 -15.22 -19.18 -8.27 -15.76 -22.64 ULMN 3 1qz9_c02 KYNURENINASE user 4 3 # 4 A 129 PHE A 141 PHE^? 8.60 N2 C2E A 301 A 201 ASP A 162 ASP^? -3.09 N1 C2E A 301s A 227 LYS B 243 LYS.? 13.43 N1 C2E B 301 coo 23.39 49.81 32.16 21.33 51.68 32.26 -6.62 -7.97 -12.78 -5.32 -7.70 -15.23 coo 25.52 45.12 37.98 23.98 46.65 37.85 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 12.68 46.83 36.69 18.26 48.67 34.51 -2.53 1.27 -13.25 2.13 3.70 -10.70 ULMN 3 1qz9_c02 KYNURENINASE user 5 3 # 5 A 129 PHE A 199 PHE.? 15.97 N2 C2E A 301 A 201 ASP A 192 ASP.? 23.17 N2 C2E A 301 A 227 LYS A 148 LYS^? 21.30 O6 C2E A 301 coo 23.39 49.81 32.16 21.33 51.68 32.26 -19.51 -15.48 -13.25 -19.97 -12.76 -13.56 coo 25.52 45.12 37.98 23.98 46.65 37.85 -26.02 -10.21 -8.74 -27.24 -11.85 -9.23 coo 12.68 46.83 36.69 18.26 48.67 34.51 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 ULMN 3 1qz9_c02 KYNURENINASE user 6 3 # 6 A 129 PHE A 199 PHE.? 15.97 N2 C2E A 301 A 201 ASP A 192 ASP.? 23.17 N2 C2E A 301 A 227 LYS A 238 LYS^? 19.93 N2 C2E B 301 coo 23.39 49.81 32.16 21.33 51.68 32.26 -19.51 -15.48 -13.25 -19.97 -12.76 -13.56 coo 25.52 45.12 37.98 23.98 46.65 37.85 -26.02 -10.21 -8.74 -27.24 -11.85 -9.23 coo 12.68 46.83 36.69 18.26 48.67 34.51 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 ULMN 3 1qz9_c02 KYNURENINASE user 7 3 # 7 A 129 PHE B 84 PHE~? 21.91 N21 C2E B 301 A 201 ASP B 79 ASP~? 26.97 N21 C2E B 301 A 227 LYS B 75 LYS.? 16.89 N21 C2E B 301 coo 23.39 49.81 32.16 21.33 51.68 32.26 -0.90 22.18 22.15 -2.04 24.70 22.44 coo 25.52 45.12 37.98 23.98 46.65 37.85 6.11 26.78 22.67 4.66 27.50 24.05 coo 12.68 46.83 36.69 18.26 48.67 34.51 7.39 19.64 13.02 10.00 17.22 7.78 ULMN 3 1qz9_c02 KYNURENINASE user 8 3 # 8 A 129 PHE B 141 PHE^? 8.74 N2 C2E B 301 A 201 ASP B 162 ASP^? -3.04 N1 C2E B 301s A 227 LYS A 243 LYS.? 15.17 N2 C2E A 301 coo 23.39 49.81 32.16 21.33 51.68 32.26 -8.98 5.65 -12.86 -11.68 5.00 -12.74 coo 25.52 45.12 37.98 23.98 46.65 37.85 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 12.68 46.83 36.69 18.26 48.67 34.51 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 ULMN 3 1qz9_c02 KYNURENINASE user 9 3 # 9 A 129 PHE B 141 PHE^? 8.74 N2 C2E B 301 A 201 ASP B 162 ASP^? -3.04 N1 C2E B 301s A 227 LYS B 137 LYS.? -3.23 O3' C2E B 301s coo 23.39 49.81 32.16 21.33 51.68 32.26 -8.98 5.65 -12.86 -11.68 5.00 -12.74 coo 25.52 45.12 37.98 23.98 46.65 37.85 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 12.68 46.83 36.69 18.26 48.67 34.51 -16.98 12.27 -5.28 -15.90 17.15 -6.49 ULMN 3 1qz9_c02 KYNURENINASE user 10 3 # 10 A 129 PHE B 141 PHE^? 8.74 N2 C2E B 301 A 201 ASP B 162 ASP^? -3.04 N1 C2E B 301s A 227 LYS B 231 LYS~? 16.58 O2' C2E B 301 coo 23.39 49.81 32.16 21.33 51.68 32.26 -8.98 5.65 -12.86 -11.68 5.00 -12.74 coo 25.52 45.12 37.98 23.98 46.65 37.85 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 12.68 46.83 36.69 18.26 48.67 34.51 -12.77 12.18 -20.95 -18.80 11.50 -22.86 ULMN 3 1qz9_c02 KYNURENINASE user 11 3 # 11 A 129 PHE B 199 PHE.? 15.78 N2 C2E B 301 A 201 ASP B 192 ASP.? 23.13 N2 C2E B 301 A 227 LYS B 148 LYS^? 21.33 O6 C2E B 301 coo 23.39 49.81 32.16 21.33 51.68 32.26 -3.38 12.46 -25.06 -2.84 9.73 -25.01 coo 25.52 45.12 37.98 23.98 46.65 37.85 3.51 7.73 -28.40 4.69 9.27 -29.24 coo 12.68 46.83 36.69 18.26 48.67 34.51 4.64 19.42 -20.28 9.89 19.27 -22.17 ULMN 3 1qz9_c02 KYNURENINASE user 12 3 # 12 A 129 PHE B 199 PHE.? 15.78 N2 C2E B 301 A 201 ASP B 192 ASP.? 23.13 N2 C2E B 301 A 227 LYS B 238 LYS^? 16.50 N2 C2E A 301 coo 23.39 49.81 32.16 21.33 51.68 32.26 -3.38 12.46 -25.06 -2.84 9.73 -25.01 coo 25.52 45.12 37.98 23.98 46.65 37.85 3.51 7.73 -28.40 4.69 9.27 -29.24 coo 12.68 46.83 36.69 18.26 48.67 34.51 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 1qz9_c02 source 1qz9 KYNURENINASE : 12 hits 1qz9_c02 naa= 3 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 1 3 # 1 A 10 ASP A 66 ASP.? 23.33 N21 C2E B 301 A 186 ASN A 128 ASN.? 25.99 N21 C2E A 301 A 260 ALA A 32 ALA~? 16.18 O61 C2E A 301 coo 11.81 33.10 11.71 13.07 31.45 11.40 15.60 9.37 4.44 16.85 10.89 5.23 coo 11.43 26.53 7.41 13.01 27.56 8.43 21.53 5.18 -1.81 23.00 4.01 -2.79 coo 21.53 26.33 6.96 20.26 25.69 7.52 11.16 0.68 -3.53 12.55 0.08 -3.37 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 2 3 # 2 A 10 ASP B 66 ASP.? 24.37 N21 C2E A 301 A 186 ASN B 28 ASN^? 21.32 O6 C2E A 301 A 260 ALA B 34 ALA~? 16.17 O61 C2E A 301 coo 11.81 33.10 11.71 13.07 31.45 11.40 -3.12 -5.44 17.43 -2.91 -6.73 19.08 coo 11.43 26.53 7.41 13.01 27.56 8.43 -11.70 -4.36 12.92 -10.66 -5.13 11.24 coo 21.53 26.33 6.96 20.26 25.69 7.52 -4.24 -1.51 6.29 -4.80 -2.92 6.14 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 3 3 # 3 A 10 ASP B 66 ASP.? 24.37 N21 C2E A 301 A 186 ASN B 128 ASN.? 26.38 N21 C2E B 301 A 260 ALA B 32 ALA~? 15.70 O61 C2E B 301 coo 11.81 33.10 11.71 13.07 31.45 11.40 -3.12 -5.44 17.43 -2.91 -6.73 19.08 coo 11.43 26.53 7.41 13.01 27.56 8.43 -11.93 -1.97 19.36 -11.20 -2.52 21.28 coo 21.53 26.33 6.96 20.26 25.69 7.52 -8.81 0.28 8.47 -9.54 1.08 9.56 1r4f_c00 source 1r4f IAG-NUCLEOSIDE HYDROLASE : 3 hits 1r4f_c00 naa= 3 ULMN 3 1ro7_c03 ALPHA-2,3/8-SIALYLTRANSFERASE user 1 3 # 1 D 129 ARG B 155 ARG^? 22.81 O6 C2E B 301 D 156 TYR B 179 TYR.? 13.89 O6 C2E B 301 D 188 HIS B 154 HIS^? 20.45 O6 C2E B 301 coo -19.99 -38.81 30.91 -19.99 -39.90 28.04 6.63 24.44 -23.88 7.74 21.82 -25.04 coo -32.96 -44.88 30.49 -32.31 -42.65 28.92 2.36 25.70 -10.99 3.98 25.02 -13.14 coo -25.33 -42.26 31.79 -24.77 -40.56 30.70 7.78 28.08 -17.01 9.24 26.69 -16.42 1ro7_c03 source 1ro7 ALPHA-2,3/8-SIALYLTRANSFERASE : 1 hits 1ro7_c03 naa= 3 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 1 3 # 1 B 57 HIS A 154 HIS^? 21.74 O6 C2E A 301 B 102 ASP A 152 ASP.? 20.83 C8 C2E A 301 B 193 GLY A 176 GLY.? 18.56 O6 C2E A 301 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -16.69 -30.86 2.00 -15.94 -32.47 3.12 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -14.50 -24.46 6.89 -13.82 -24.67 7.29 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 2 3 # 2 B 57 HIS B 154 HIS^? 20.45 O6 C2E B 301 B 102 ASP B 152 ASP.? 19.99 C8 C2E B 301 B 193 GLY B 176 GLY.? 18.62 O6 C2E B 301 coo -4.60 27.52 42.88 -4.63 27.41 40.76 7.78 28.08 -17.01 9.24 26.69 -16.42 coo -0.27 31.24 43.51 -1.49 29.62 42.98 2.18 32.86 -17.28 0.63 33.43 -15.93 coo -6.81 22.81 34.74 -6.42 23.54 34.62 11.24 23.68 -11.63 11.16 23.89 -10.85 1rtf_c06 source 1rtf TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR : 2 hits 1rtf_c06 naa= 3 ULMN 3 1rtu_c00 RIBONUCLEASE U2 user 1 3 # 1 41 HIS A 64 HIS^? 21.50 N21 C2E B 301 62 GLU B 72 GLU^? 16.96 N21 C2E B 301 101 HIS B 38 HIS.? 15.97 O61 C2E B 301 coo 13.91 26.31 13.70 14.98 27.08 12.06 11.95 7.99 12.22 11.86 9.83 13.23 coo 9.15 26.32 13.85 8.75 28.20 13.02 8.42 10.26 11.58 8.84 10.78 9.58 coo 7.90 34.31 7.89 9.24 33.73 9.42 4.87 2.64 4.63 6.30 2.30 3.13 ULMN 3 1rtu_c00 RIBONUCLEASE U2 user 2 3 # 2 41 HIS B 64 HIS^? 22.95 N21 C2E A 301 62 GLU A 72 GLU^? 18.63 N21 C2E A 301 101 HIS A 38 HIS.? 16.46 O61 C2E B 301 coo 13.91 26.31 13.70 14.98 27.08 12.06 5.28 -3.23 17.72 6.30 -4.93 18.40 coo 9.15 26.32 13.85 8.75 28.20 13.02 6.69 -5.58 14.73 4.83 -6.56 14.45 coo 7.90 34.31 7.89 9.24 33.73 9.42 1.46 -0.40 7.20 -0.57 -0.26 7.72 1rtu_c00 source 1rtu RIBONUCLEASE U2 : 2 hits 1rtu_c00 naa= 3 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 1 3 # 1 A 57 HIS A 154 HIS^? 21.74 O6 C2E A 301 A 102 ASP A 152 ASP.? 20.83 C8 C2E A 301 A 193 GLY A 176 GLY.? 18.56 O6 C2E A 301 coo 15.02 29.17 19.44 15.63 29.96 17.60 -16.69 -30.86 2.00 -15.94 -32.47 3.12 coo 19.67 30.58 22.61 18.30 29.87 21.17 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo 14.52 29.10 10.01 15.08 29.66 10.19 -14.50 -24.46 6.89 -13.82 -24.67 7.29 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 2 3 # 2 A 57 HIS B 154 HIS^? 20.45 O6 C2E B 301 A 102 ASP B 152 ASP.? 19.99 C8 C2E B 301 A 193 GLY B 176 GLY.? 18.62 O6 C2E B 301 coo 15.02 29.17 19.44 15.63 29.96 17.60 7.78 28.08 -17.01 9.24 26.69 -16.42 coo 19.67 30.58 22.61 18.30 29.87 21.17 2.18 32.86 -17.28 0.63 33.43 -15.93 coo 14.52 29.10 10.01 15.08 29.66 10.19 11.24 23.68 -11.63 11.16 23.89 -10.85 1ssx_c02 source 1ssx ALPHA-LYTIC PROTEASE : 2 hits 1ssx_c02 naa= 3 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 1 3 # 1 E 166 ASP A 157 ASP^? 20.06 O6 C2E A 301 E 168 LYS A 148 LYS^? 21.30 O6 C2E A 301 E 201 THR A 172 THR^? 12.93 O6 C2E A 301 coo 5.36 16.20 22.10 3.88 17.00 23.31 -19.05 -19.29 2.64 -21.12 -19.53 2.92 coo 5.06 22.32 18.11 1.02 22.08 22.74 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 coo -1.79 18.29 19.05 -1.19 20.28 19.71 -12.64 -19.39 3.41 -11.97 -21.32 2.68 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 2 3 # 2 E 166 ASP B 157 ASP^? 20.00 O6 C2E B 301 E 168 LYS B 148 LYS^? 21.33 O6 C2E B 301 E 201 THR B 172 THR^? 12.75 O6 C2E B 301 coo 5.36 16.20 22.10 3.88 17.00 23.31 9.70 18.14 -17.54 10.97 18.31 -19.23 coo 5.06 22.32 18.11 1.02 22.08 22.74 4.64 19.42 -20.28 9.89 19.27 -22.17 coo -1.79 18.29 19.05 -1.19 20.28 19.71 7.41 18.34 -11.48 6.25 20.16 -11.39 1stc_c02 source 1stc CAMP-DEPENDENT PROTEIN KINASE : 2 hits 1stc_c02 naa= 3 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 1 3 # 1 B 8 HIS A 64 HIS^? 21.50 N21 C2E B 301 B 80 GLU B 72 GLU^? 16.96 N21 C2E B 301 B 223 ARG A 136 ARG.? -3.92 O61 C2E A 301s coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 11.95 7.99 12.22 11.86 9.83 13.23 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 8.42 10.26 11.58 8.84 10.78 9.58 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 2.11 -12.17 -9.13 1.08 -10.80 -6.58 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 2 3 # 2 B 8 HIS A 64 HIS^? 21.50 N21 C2E B 301 B 80 GLU B 72 GLU^? 16.96 N21 C2E B 301 B 223 ARG A 140 ARG.? -3.36 C5 C2E A 301s coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 11.95 7.99 12.22 11.86 9.83 13.23 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 8.42 10.26 11.58 8.84 10.78 9.58 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 3 3 # 3 B 8 HIS A 64 HIS^? 21.50 N21 C2E B 301 B 80 GLU B 72 GLU^? 16.96 N21 C2E B 301 B 223 ARG A 161 ARG^? 11.81 O6 C2E A 301 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 11.95 7.99 12.22 11.86 9.83 13.23 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 8.42 10.26 11.58 8.84 10.78 9.58 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 4 3 # 4 B 8 HIS A 64 HIS^? 21.50 N21 C2E B 301 B 80 GLU B 72 GLU^? 16.96 N21 C2E B 301 B 223 ARG A 169 ARG^? -4.75 O6 C2E A 301s coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 11.95 7.99 12.22 11.86 9.83 13.23 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 8.42 10.26 11.58 8.84 10.78 9.58 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 5 3 # 5 B 8 HIS A 64 HIS^? 21.50 N21 C2E B 301 B 80 GLU B 72 GLU^? 16.96 N21 C2E B 301 B 223 ARG A 217 ARG^? 6.70 O6 C2E A 301 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 11.95 7.99 12.22 11.86 9.83 13.23 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 8.42 10.26 11.58 8.84 10.78 9.58 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -3.36 -16.18 0.94 -0.54 -17.39 0.83 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 6 3 # 6 B 8 HIS A 113 HIS^? 30.12 N21 C2E A 301 B 80 GLU A 87 GLU.? 30.68 N21 C2E A 301 B 223 ARG A 99 ARG.? 13.59 O61 C2E B 301 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 19.70 2.48 16.98 21.09 4.00 16.57 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 22.53 -2.75 18.16 22.63 -1.18 19.56 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -1.29 -2.34 -4.97 -2.19 0.30 -6.23 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 7 3 # 7 B 8 HIS A 154 HIS^? 21.74 O6 C2E A 301 B 80 GLU A 153 GLU.? 24.63 N7 C2E A 301 B 223 ARG A 165 ARG.? 12.45 N2 C2E A 301 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -16.69 -30.86 2.00 -15.94 -32.47 3.12 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -19.21 -34.41 1.40 -17.40 -35.49 1.72 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -4.47 -13.19 -19.45 -6.66 -12.47 -21.46 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 8 3 # 8 B 8 HIS B 64 HIS^? 22.95 N21 C2E A 301 B 80 GLU A 72 GLU^? 18.63 N21 C2E A 301 B 223 ARG B 140 ARG.? -3.40 C5 C2E B 301s coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 5.28 -3.23 17.72 6.30 -4.93 18.40 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 6.69 -5.58 14.73 4.83 -6.56 14.45 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -7.91 11.52 -6.78 -7.96 14.04 -5.01 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 9 3 # 9 B 8 HIS B 64 HIS^? 22.95 N21 C2E A 301 B 80 GLU A 72 GLU^? 18.63 N21 C2E A 301 B 223 ARG B 211 ARG^? 16.78 O6 C2E B 301 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 5.28 -3.23 17.72 6.30 -4.93 18.40 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 6.69 -5.58 14.73 4.83 -6.56 14.45 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 8.09 22.99 -2.57 10.13 22.73 -4.88 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 10 3 # 10 B 8 HIS B 113 HIS^? 28.48 N21 C2E B 301 B 80 GLU B 87 GLU.? 28.79 N21 C2E B 301 B 223 ARG B 99 ARG.? 13.88 O61 C2E A 301 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 4.95 4.79 25.73 4.34 3.55 27.31 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 4.21 10.66 27.30 5.56 9.30 28.22 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -4.81 1.09 -3.04 -5.37 -1.84 -3.80 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 11 3 # 11 B 8 HIS B 113 HIS^? 28.48 N21 C2E B 301 B 80 GLU B 87 GLU.? 28.79 N21 C2E B 301 B 223 ARG B 217 ARG^? 6.37 O6 C2E B 301 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 4.95 4.79 25.73 4.34 3.55 27.31 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 4.21 10.66 27.30 5.56 9.30 28.22 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 0.82 15.44 -4.45 -0.87 16.78 -2.26 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 12 3 # 12 B 8 HIS B 154 HIS^? 20.45 O6 C2E B 301 B 80 GLU B 153 GLU.? 24.55 N7 C2E B 301 B 223 ARG B 165 ARG.? 10.70 O2' C2E B 301 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 7.78 28.08 -17.01 9.24 26.69 -16.42 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 6.34 34.05 -19.47 5.09 35.29 -18.27 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -16.44 10.61 -14.72 -19.33 11.67 -14.77 1t0u_c01 source 1t0u URIDINE PHOSPHORYLASE : 12 hits 1t0u_c01 naa= 3 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 1 3 # 1 A 261 GLY A 88 GLY.? 28.11 N21 C2E A 301 B 17 GLN A 86 GLN.? 29.68 N21 C2E A 301 B 140 GLU A 87 GLU.? 30.68 N21 C2E A 301 coo 61.49 19.86 5.96 61.52 19.46 5.16 26.28 -3.75 13.64 25.68 -4.30 13.54 coo 63.76 11.90 7.93 65.18 13.07 6.77 24.23 -9.58 18.83 26.07 -10.44 19.45 coo 66.44 19.00 7.38 67.69 17.67 8.37 22.53 -2.75 18.16 22.63 -1.18 19.56 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 2 3 # 2 A 261 GLY B 88 GLY.? 26.44 N21 C2E B 301 B 17 GLN B 86 GLN.? 28.67 N21 C2E B 301 B 140 GLU B 87 GLU.? 28.79 N21 C2E B 301 coo 61.49 19.86 5.96 61.52 19.46 5.16 -1.80 10.93 28.25 -1.68 11.29 27.51 coo 63.76 11.90 7.93 65.18 13.07 6.77 3.32 16.92 27.38 4.39 16.59 29.20 coo 66.44 19.00 7.38 67.69 17.67 8.37 4.21 10.66 27.30 5.56 9.30 28.22 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 3 3 # 3 A 261 GLY B 102 GLY.? 6.96 N71 C2E B 301 B 17 GLN B 134 GLN.? 7.53 O11 C2E B 301 B 140 GLU B 101 GLU.? 9.43 O11 C2E B 301 coo 61.49 19.86 5.96 61.52 19.46 5.16 -10.38 6.68 -1.43 -11.18 6.52 -1.49 coo 63.76 11.90 7.93 65.18 13.07 6.77 -17.55 9.98 -0.31 -19.35 10.60 -1.25 coo 66.44 19.00 7.38 67.69 17.67 8.37 -14.64 6.09 -5.71 -16.72 5.82 -5.44 1t4c_c02 source 1t4c FORMYL-COENZYME A TRANSFERASE : 3 hits 1t4c_c02 naa= 3 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 1 3 # 1 A 88 SER A 109 SER^? 20.65 N21 C2E A 301 A 90 SER A 125 SER.? 23.81 N21 C2E A 301 A 145 LYS A 67 LYS.? 22.91 N21 C2E B 301 coo -3.31 40.95 15.56 -0.94 40.79 14.97 20.92 -3.37 5.70 19.17 -2.44 7.11 coo 1.47 40.03 18.48 2.45 41.37 16.68 19.83 1.13 7.98 21.72 -0.16 7.19 coo 7.35 44.71 16.29 4.71 40.98 14.52 17.01 7.43 8.57 15.28 11.70 10.44 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 2 3 # 2 A 88 SER A 164 SER.? -3.07 N2 C2E A 301s A 90 SER A 166 SER.? -4.62 O2' C2E A 301s A 145 LYS A 137 LYS.? -4.52 O2' C2E A 301s coo -3.31 40.95 15.56 -0.94 40.79 14.97 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 coo 1.47 40.03 18.48 2.45 41.37 16.68 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 coo 7.35 44.71 16.29 4.71 40.98 14.52 4.32 -14.05 -15.33 0.72 -19.17 -16.51 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 3 3 # 3 A 88 SER B 109 SER^? 18.78 N21 C2E B 301 A 90 SER B 125 SER^? 22.05 N21 C2E B 301 A 145 LYS B 67 LYS.? 24.61 N21 C2E A 301 coo -3.31 40.95 15.56 -0.94 40.79 14.97 -6.26 7.92 20.06 -4.06 7.18 19.35 coo 1.47 40.03 18.48 2.45 41.37 16.68 -3.10 3.96 21.21 -4.91 5.28 22.14 coo 7.35 44.71 16.29 4.71 40.98 14.52 -0.41 -2.48 20.16 2.79 -6.43 20.83 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 4 3 # 4 A 88 SER B 164 SER.? -3.05 N2 C2E B 301s A 90 SER B 166 SER.? -4.53 O2' C2E B 301s A 145 LYS B 137 LYS.? -3.23 O3' C2E B 301s coo -3.31 40.95 15.56 -0.94 40.79 14.97 -10.30 11.42 -12.93 -10.44 13.17 -11.24 coo 1.47 40.03 18.48 2.45 41.37 16.68 -12.93 16.14 -12.85 -15.09 15.80 -11.81 coo 7.35 44.71 16.29 4.71 40.98 14.52 -16.98 12.27 -5.28 -15.90 17.15 -6.49 1t7d_c00 source 1t7d SIGNAL PEPTIDASE I : 4 hits 1t7d_c00 naa= 3 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 1 3 # 1 B 88 SER A 109 SER^? 20.65 N21 C2E A 301 B 90 SER A 125 SER.? 23.81 N21 C2E A 301 B 145 LYS A 67 LYS.? 22.91 N21 C2E B 301 coo 61.01 10.03 12.97 58.78 10.97 12.69 20.92 -3.37 5.70 19.17 -2.44 7.11 coo 56.85 12.22 16.37 55.62 11.34 14.45 19.83 1.13 7.98 21.72 -0.16 7.19 coo 49.80 9.51 14.88 53.14 11.99 12.77 17.01 7.43 8.57 15.28 11.70 10.44 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 2 3 # 2 B 88 SER A 164 SER.? -3.07 N2 C2E A 301s B 90 SER A 166 SER.? -4.62 O2' C2E A 301s B 145 LYS A 137 LYS.? -4.52 O2' C2E A 301s coo 61.01 10.03 12.97 58.78 10.97 12.69 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 coo 56.85 12.22 16.37 55.62 11.34 14.45 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 coo 49.80 9.51 14.88 53.14 11.99 12.77 4.32 -14.05 -15.33 0.72 -19.17 -16.51 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 3 3 # 3 B 88 SER B 109 SER^? 18.78 N21 C2E B 301 B 90 SER B 125 SER^? 22.05 N21 C2E B 301 B 145 LYS B 67 LYS.? 24.61 N21 C2E A 301 coo 61.01 10.03 12.97 58.78 10.97 12.69 -6.26 7.92 20.06 -4.06 7.18 19.35 coo 56.85 12.22 16.37 55.62 11.34 14.45 -3.10 3.96 21.21 -4.91 5.28 22.14 coo 49.80 9.51 14.88 53.14 11.99 12.77 -0.41 -2.48 20.16 2.79 -6.43 20.83 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 4 3 # 4 B 88 SER B 164 SER.? -3.05 N2 C2E B 301s B 90 SER B 166 SER.? -4.53 O2' C2E B 301s B 145 LYS B 137 LYS.? -3.23 O3' C2E B 301s coo 61.01 10.03 12.97 58.78 10.97 12.69 -10.30 11.42 -12.93 -10.44 13.17 -11.24 coo 56.85 12.22 16.37 55.62 11.34 14.45 -12.93 16.14 -12.85 -15.09 15.80 -11.81 coo 49.80 9.51 14.88 53.14 11.99 12.77 -16.98 12.27 -5.28 -15.90 17.15 -6.49 1t7d_c01 source 1t7d SIGNAL PEPTIDASE I : 4 hits 1t7d_c01 naa= 3 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 1 3 # 1 217 SER A 39 SER.? 16.45 O61 C2E A 301 354 GLU A 37 GLU.? 10.20 O61 C2E A 301 463 HIS A 38 HIS.? 16.46 O61 C2E B 301 coo 48.87 13.74 2.81 48.49 11.54 3.93 2.88 -4.86 8.38 1.14 -3.61 9.53 coo 39.95 14.43 3.01 41.55 14.10 1.63 0.90 -3.13 0.80 -0.70 -4.43 0.36 coo 43.90 10.50 2.81 45.63 11.48 3.27 1.46 -0.40 7.20 -0.57 -0.26 7.72 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 2 3 # 2 217 SER B 39 SER.? 15.26 O61 C2E B 301 354 GLU B 37 GLU.? 9.39 O61 C2E B 301 463 HIS B 38 HIS.? 15.97 O61 C2E B 301 coo 48.87 13.74 2.81 48.49 11.54 3.93 4.72 7.48 5.49 6.81 6.45 4.77 coo 39.95 14.43 3.01 41.55 14.10 1.63 -0.62 3.88 0.75 -0.32 4.81 -1.12 coo 43.90 10.50 2.81 45.63 11.48 3.27 4.87 2.64 4.63 6.30 2.30 3.13 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 3 3 # 3 217 SER B 40 SER.? 9.12 N11 C2E B 301 354 GLU B 37 GLU.? 9.39 O61 C2E B 301 463 HIS B 38 HIS.? 15.97 O61 C2E B 301 coo 48.87 13.74 2.81 48.49 11.54 3.93 1.49 9.31 4.61 -0.48 7.96 5.14 coo 39.95 14.43 3.01 41.55 14.10 1.63 -0.62 3.88 0.75 -0.32 4.81 -1.12 coo 43.90 10.50 2.81 45.63 11.48 3.27 4.87 2.64 4.63 6.30 2.30 3.13 1thg_c00 source 1thg LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROL HYDROLASE: 3 hits 1thg_c00 naa= 3 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 1 3 # 1 A 250 ALA B 146 ALA^? 17.04 N1 C2E B 301 A 251 GLY B 147 GLY^? 15.80 N1 C2E B 301 A 252 ASP B 157 ASP^? 20.00 O6 C2E B 301 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 5.20 12.25 -19.11 6.53 11.88 -19.77 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 4.21 15.66 -20.42 4.84 15.79 -19.91 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 9.70 18.14 -17.54 10.97 18.31 -19.23 1tz3_c02 source 1tz3 PUTATIVE SUGAR KINASE : 1 hits 1tz3_c02 naa= 3 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 1 3 # 1 B 250 ALA B 146 ALA^? 17.04 N1 C2E B 301 B 251 GLY B 147 GLY^? 15.80 N1 C2E B 301 B 252 ASP B 157 ASP^? 20.00 O6 C2E B 301 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 5.20 12.25 -19.11 6.53 11.88 -19.77 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 4.21 15.66 -20.42 4.84 15.79 -19.91 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 9.70 18.14 -17.54 10.97 18.31 -19.23 1tz3_c03 source 1tz3 PUTATIVE SUGAR KINASE : 1 hits 1tz3_c03 naa= 3 ULMN 3 1uaq_c00 CYTOSINE DEAMINASE user 1 3 # 1 A 64 GLU A 221 GLU^? -4.32 C4' C2E A 301s A 89 SER A 166 SER.? -4.62 O2' C2E A 301s A 91 CYH A 168 CYH^? -6.21 C2 C2E A 301s coo -18.27 -3.12 10.92 -16.30 -3.26 10.07 -2.05 -23.28 -12.44 -0.03 -23.89 -12.66 coo -16.83 -3.83 3.62 -17.28 -5.61 2.05 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 coo -13.84 -8.33 7.58 -13.00 -8.13 10.24 -6.81 -16.95 -8.49 -9.12 -18.59 -8.00 ULMN 3 1uaq_c00 CYTOSINE DEAMINASE user 2 3 # 2 A 64 GLU B 221 GLU^? -4.05 C4' C2E B 301s A 89 SER B 166 SER.? -4.53 O2' C2E B 301s A 91 CYH B 168 CYH^? -6.16 C2 C2E B 301s coo -18.27 -3.12 10.92 -16.30 -3.26 10.07 -11.86 21.10 -10.14 -13.00 21.71 -8.45 coo -16.83 -3.83 3.62 -17.28 -5.61 2.05 -12.93 16.14 -12.85 -15.09 15.80 -11.81 coo -13.84 -8.33 7.58 -13.00 -8.13 10.24 -5.71 15.10 -12.03 -4.45 16.77 -13.95 1uaq_c00 source 1uaq CYTOSINE DEAMINASE : 2 hits 1uaq_c00 naa= 3 ULMN 3 1uaq_c01 CYTOSINE DEAMINASE user 1 3 # 1 B 64 GLU A 221 GLU^? -4.32 C4' C2E A 301s B 89 SER A 166 SER.? -4.62 O2' C2E A 301s B 91 CYH A 168 CYH^? -6.21 C2 C2E A 301s coo -13.67 -17.67 21.70 -15.74 -17.78 22.24 -2.05 -23.28 -12.44 -0.03 -23.89 -12.66 coo -17.71 -23.81 20.93 -18.57 -24.92 18.94 -4.12 -18.47 -15.14 -2.19 -18.29 -16.62 coo -20.38 -18.31 18.13 -20.06 -15.64 18.96 -6.81 -16.95 -8.49 -9.12 -18.59 -8.00 ULMN 3 1uaq_c01 CYTOSINE DEAMINASE user 2 3 # 2 B 64 GLU B 221 GLU^? -4.05 C4' C2E B 301s B 89 SER B 166 SER.? -4.53 O2' C2E B 301s B 91 CYH B 168 CYH^? -6.16 C2 C2E B 301s coo -13.67 -17.67 21.70 -15.74 -17.78 22.24 -11.86 21.10 -10.14 -13.00 21.71 -8.45 coo -17.71 -23.81 20.93 -18.57 -24.92 18.94 -12.93 16.14 -12.85 -15.09 15.80 -11.81 coo -20.38 -18.31 18.13 -20.06 -15.64 18.96 -5.71 15.10 -12.03 -4.45 16.77 -13.95 1uaq_c01 source 1uaq CYTOSINE DEAMINASE : 2 hits 1uaq_c01 naa= 3 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 A 46 GLU A 159 GLU^? 13.73 O6 C2E A 301 A 126 LYS A 148 LYS^? 21.30 O6 C2E A 301 A 171 ALA A 146 ALA^? 17.10 N1 C2E A 301 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -14.60 -12.52 -1.04 -14.41 -10.88 0.31 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -18.53 -13.88 -2.80 -19.77 -13.48 -2.02 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 2 3 # 2 A 46 GLU B 159 GLU^? 13.76 O6 C2E B 301 A 126 LYS B 148 LYS^? 21.33 O6 C2E B 301 A 171 ALA B 146 ALA^? 17.04 N1 C2E B 301 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 4.99 11.22 -14.77 6.30 9.86 -13.80 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 4.64 19.42 -20.28 9.89 19.27 -22.17 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 5.20 12.25 -19.11 6.53 11.88 -19.77 1uf7_c00 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 2 hits 1uf7_c00 naa= 3 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 B 46 GLU A 159 GLU^? 13.73 O6 C2E A 301 B 126 LYS A 148 LYS^? 21.30 O6 C2E A 301 B 171 ALA A 146 ALA^? 17.10 N1 C2E A 301 coo 20.47 87.42 16.54 20.16 87.17 14.45 -14.60 -12.52 -1.04 -14.41 -10.88 0.31 coo 24.73 94.37 14.59 21.08 89.84 11.98 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 coo 24.38 86.32 12.71 22.88 86.54 12.71 -18.53 -13.88 -2.80 -19.77 -13.48 -2.02 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 2 3 # 2 B 46 GLU B 159 GLU^? 13.76 O6 C2E B 301 B 126 LYS B 148 LYS^? 21.33 O6 C2E B 301 B 171 ALA B 146 ALA^? 17.04 N1 C2E B 301 coo 20.47 87.42 16.54 20.16 87.17 14.45 4.99 11.22 -14.77 6.30 9.86 -13.80 coo 24.73 94.37 14.59 21.08 89.84 11.98 4.64 19.42 -20.28 9.89 19.27 -22.17 coo 24.38 86.32 12.71 22.88 86.54 12.71 5.20 12.25 -19.11 6.53 11.88 -19.77 1uf7_c01 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 2 hits 1uf7_c01 naa= 3 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 1 3 # 1 86 HIS A 64 HIS^? 21.50 N21 C2E B 301 89 GLU B 72 GLU^? 16.96 N21 C2E B 301 243 ASN A 28 ASN^? 20.35 O6 C2E B 301 coo 5.83 15.74 17.38 6.41 17.70 17.86 11.95 7.99 12.22 11.86 9.83 13.23 coo 3.11 16.19 13.44 4.96 17.09 13.42 8.42 10.26 11.58 8.84 10.78 9.58 coo 0.53 21.81 31.33 1.05 20.47 29.70 15.77 5.79 -5.14 13.72 6.29 -5.09 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 2 3 # 2 86 HIS A 64 HIS^? 21.50 N21 C2E B 301 89 GLU B 72 GLU^? 16.96 N21 C2E B 301 243 ASN A 128 ASN.? 25.99 N21 C2E A 301 coo 5.83 15.74 17.38 6.41 17.70 17.86 11.95 7.99 12.22 11.86 9.83 13.23 coo 3.11 16.19 13.44 4.96 17.09 13.42 8.42 10.26 11.58 8.84 10.78 9.58 coo 0.53 21.81 31.33 1.05 20.47 29.70 21.53 5.18 -1.81 23.00 4.01 -2.79 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 3 3 # 3 86 HIS B 64 HIS^? 22.95 N21 C2E A 301 89 GLU A 72 GLU^? 18.63 N21 C2E A 301 243 ASN B 28 ASN^? 21.32 O6 C2E A 301 coo 5.83 15.74 17.38 6.41 17.70 17.86 5.28 -3.23 17.72 6.30 -4.93 18.40 coo 3.11 16.19 13.44 4.96 17.09 13.42 6.69 -5.58 14.73 4.83 -6.56 14.45 coo 0.53 21.81 31.33 1.05 20.47 29.70 -11.70 -4.36 12.92 -10.66 -5.13 11.24 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 4 3 # 4 86 HIS B 64 HIS^? 22.95 N21 C2E A 301 89 GLU A 72 GLU^? 18.63 N21 C2E A 301 243 ASN B 128 ASN.? 26.38 N21 C2E B 301 coo 5.83 15.74 17.38 6.41 17.70 17.86 5.28 -3.23 17.72 6.30 -4.93 18.40 coo 3.11 16.19 13.44 4.96 17.09 13.42 6.69 -5.58 14.73 4.83 -6.56 14.45 coo 0.53 21.81 31.33 1.05 20.47 29.70 -11.93 -1.97 19.36 -11.20 -2.52 21.28 1ula_c00 source 1ula PURINE NUCLEOSIDE PHOSPHORYLASE (E.C.2.4.2.1) : 4 hits 1ula_c00 naa= 3 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 66 ASP.? 23.33 N21 C2E B 301 218 GLU B 138 GLU.? 5.49 O2' C2E B 301 329 ASP A 31 ASP~? 17.49 O6 C2E B 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 15.60 9.37 4.44 16.85 10.89 5.23 coo 70.09 11.71 8.46 70.56 12.89 6.77 -14.88 11.83 -9.39 -15.29 12.85 -11.20 coo 59.16 37.82 13.95 57.63 37.03 15.12 10.86 4.60 -5.63 10.78 6.65 -6.14 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 66 ASP.? 23.33 N21 C2E B 301 218 GLU B 221 GLU^? -4.05 C4' C2E B 301s 329 ASP A 31 ASP~? 17.49 O6 C2E B 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 15.60 9.37 4.44 16.85 10.89 5.23 coo 70.09 11.71 8.46 70.56 12.89 6.77 -11.86 21.10 -10.14 -13.00 21.71 -8.45 coo 59.16 37.82 13.95 57.63 37.03 15.12 10.86 4.60 -5.63 10.78 6.65 -6.14 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP B 66 ASP.? 24.37 N21 C2E A 301 218 GLU A 138 GLU.? 5.46 O2' C2E A 301 329 ASP B 31 ASP~? 18.26 O6 C2E A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -3.12 -5.44 17.43 -2.91 -6.73 19.08 coo 70.09 11.71 8.46 70.56 12.89 6.77 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 coo 59.16 37.82 13.95 57.63 37.03 15.12 -9.76 -4.11 8.16 -9.75 -6.21 8.42 1uok_c04 source 1uok OLIGO-1,6-GLUCOSIDASE : 3 hits 1uok_c04 naa= 3 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 31 ASP~? 17.49 O6 C2E B 301 242 GLU A 142 GLU^? 10.87 N1 C2E A 301 329 ASP A 66 ASP.? 23.33 N21 C2E B 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 10.86 4.60 -5.63 10.78 6.65 -6.14 coo 30.42 34.74 5.00 29.09 35.09 3.38 -5.78 -6.60 -5.54 -5.25 -5.49 -3.81 coo 59.16 37.82 13.95 57.63 37.03 15.12 15.60 9.37 4.44 16.85 10.89 5.23 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 183 ASP.? 14.57 O1P C2E A 301 242 GLU A 138 GLU.? 5.46 O2' C2E A 301 329 ASP A 152 ASP.? 20.83 C8 C2E A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -7.06 -30.30 -3.03 -6.77 -31.63 -1.43 coo 30.42 34.74 5.00 29.09 35.09 3.38 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 coo 59.16 37.82 13.95 57.63 37.03 15.12 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP B 183 ASP.? 14.33 O1P C2E B 301 242 GLU B 41 GLU^? 7.72 N21 C2E B 301 329 ASP B 152 ASP.? 19.99 C8 C2E B 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -1.79 28.84 -10.63 -0.66 30.31 -9.57 coo 30.42 34.74 5.00 29.09 35.09 3.38 0.46 14.98 6.85 0.80 16.86 5.93 coo 59.16 37.82 13.95 57.63 37.03 15.12 2.18 32.86 -17.28 0.63 33.43 -15.93 1uok_c05 source 1uok OLIGO-1,6-GLUCOSIDASE : 3 hits 1uok_c05 naa= 3 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 1 3 # 1 A 581 GLU A 41 GLU^? 8.66 N21 C2E A 301 A 596 ARG A 57 ARG^? 7.03 N21 C2E A 301 A 647 ARG A 94 ARG^? 4.68 N21 C2E A 301 coo 69.13 32.20 28.58 68.39 32.96 30.44 7.09 -12.35 6.79 6.46 -14.38 6.77 coo 70.89 37.31 29.70 69.54 36.29 32.39 10.26 -15.76 6.84 9.68 -16.90 4.07 coo 66.09 40.54 34.70 66.92 37.69 35.49 12.55 -12.80 -0.72 10.33 -14.85 -0.21 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 2 3 # 2 A 581 GLU A 138 GLU.? 5.46 O2' C2E A 301 A 596 ARG A 165 ARG.? 12.45 N2 C2E A 301 A 647 ARG A 227 ARG~? 9.91 O2' C2E A 301 coo 69.13 32.20 28.58 68.39 32.96 30.44 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 coo 70.89 37.31 29.70 69.54 36.29 32.39 -4.47 -13.19 -19.45 -6.66 -12.47 -21.46 coo 66.09 40.54 34.70 66.92 37.69 35.49 -5.20 -21.14 -18.72 -4.74 -24.14 -19.17 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 3 3 # 3 A 581 GLU A 159 GLU^? 13.73 O6 C2E A 301 A 596 ARG A 161 ARG^? 11.81 O6 C2E A 301 A 647 ARG A 169 ARG^? -4.75 O6 C2E A 301s coo 69.13 32.20 28.58 68.39 32.96 30.44 -14.60 -12.52 -1.04 -14.41 -10.88 0.31 coo 70.89 37.31 29.70 69.54 36.29 32.39 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 coo 66.09 40.54 34.70 66.92 37.69 35.49 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 4 3 # 4 A 581 GLU A 159 GLU^? 13.73 O6 C2E A 301 A 596 ARG A 161 ARG^? 11.81 O6 C2E A 301 A 647 ARG A 217 ARG^? 6.70 O6 C2E A 301 coo 69.13 32.20 28.58 68.39 32.96 30.44 -14.60 -12.52 -1.04 -14.41 -10.88 0.31 coo 70.89 37.31 29.70 69.54 36.29 32.39 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 coo 66.09 40.54 34.70 66.92 37.69 35.49 -3.36 -16.18 0.94 -0.54 -17.39 0.83 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 5 3 # 5 A 581 GLU A 221 GLU^? -4.32 C4' C2E A 301s A 596 ARG A 227 ARG~? 9.91 O2' C2E A 301 A 647 ARG A 165 ARG.? 12.45 N2 C2E A 301 coo 69.13 32.20 28.58 68.39 32.96 30.44 -2.05 -23.28 -12.44 -0.03 -23.89 -12.66 coo 70.89 37.31 29.70 69.54 36.29 32.39 -5.20 -21.14 -18.72 -4.74 -24.14 -19.17 coo 66.09 40.54 34.70 66.92 37.69 35.49 -4.47 -13.19 -19.45 -6.66 -12.47 -21.46 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 6 3 # 6 A 581 GLU B 138 GLU.? 5.49 O2' C2E B 301 A 596 ARG B 165 ARG.? 10.70 O2' C2E B 301 A 647 ARG B 227 ARG~? 7.56 O2' C2E B 301 coo 69.13 32.20 28.58 68.39 32.96 30.44 -14.88 11.83 -9.39 -15.29 12.85 -11.20 coo 70.89 37.31 29.70 69.54 36.29 32.39 -16.44 10.61 -14.72 -19.33 11.67 -14.77 coo 66.09 40.54 34.70 66.92 37.69 35.49 -16.01 19.09 -16.09 -16.65 16.54 -14.51 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 7 3 # 7 A 581 GLU B 159 GLU^? 13.76 O6 C2E B 301 A 596 ARG B 161 ARG^? 11.68 O6 C2E B 301 A 647 ARG B 169 ARG^? -4.70 O6 C2E B 301s coo 69.13 32.20 28.58 68.39 32.96 30.44 4.99 11.22 -14.77 6.30 9.86 -13.80 coo 70.89 37.31 29.70 69.54 36.29 32.39 2.96 9.64 -10.71 5.59 9.57 -9.11 coo 66.09 40.54 34.70 66.92 37.69 35.49 -0.88 13.03 -7.12 -1.56 12.92 -4.13 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 8 3 # 8 A 581 GLU B 159 GLU^? 13.76 O6 C2E B 301 A 596 ARG B 161 ARG^? 11.68 O6 C2E B 301 A 647 ARG B 217 ARG^? 6.37 O6 C2E B 301 coo 69.13 32.20 28.58 68.39 32.96 30.44 4.99 11.22 -14.77 6.30 9.86 -13.80 coo 70.89 37.31 29.70 69.54 36.29 32.39 2.96 9.64 -10.71 5.59 9.57 -9.11 coo 66.09 40.54 34.70 66.92 37.69 35.49 0.82 15.44 -4.45 -0.87 16.78 -2.26 1v0e_c00 source 1v0e ENDO-ALPHA-SIALIDASE : 8 hits 1v0e_c00 naa= 3 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 1 3 # 1 B 581 GLU A 41 GLU^? 8.66 N21 C2E A 301 B 596 ARG A 57 ARG^? 7.03 N21 C2E A 301 B 647 ARG A 94 ARG^? 4.68 N21 C2E A 301 coo 38.22 57.83 70.36 36.82 56.74 69.18 7.09 -12.35 6.79 6.46 -14.38 6.77 coo 34.24 60.89 68.08 33.31 57.93 67.63 10.26 -15.76 6.84 9.68 -16.90 4.07 coo 31.43 57.38 61.97 31.90 55.58 64.41 12.55 -12.80 -0.72 10.33 -14.85 -0.21 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 2 3 # 2 B 581 GLU A 138 GLU.? 5.46 O2' C2E A 301 B 596 ARG A 165 ARG.? 12.45 N2 C2E A 301 B 647 ARG A 227 ARG~? 9.91 O2' C2E A 301 coo 38.22 57.83 70.36 36.82 56.74 69.18 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 coo 34.24 60.89 68.08 33.31 57.93 67.63 -4.47 -13.19 -19.45 -6.66 -12.47 -21.46 coo 31.43 57.38 61.97 31.90 55.58 64.41 -5.20 -21.14 -18.72 -4.74 -24.14 -19.17 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 3 3 # 3 B 581 GLU A 159 GLU^? 13.73 O6 C2E A 301 B 596 ARG A 161 ARG^? 11.81 O6 C2E A 301 B 647 ARG A 169 ARG^? -4.75 O6 C2E A 301s coo 38.22 57.83 70.36 36.82 56.74 69.18 -14.60 -12.52 -1.04 -14.41 -10.88 0.31 coo 34.24 60.89 68.08 33.31 57.93 67.63 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 coo 31.43 57.38 61.97 31.90 55.58 64.41 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 4 3 # 4 B 581 GLU A 159 GLU^? 13.73 O6 C2E A 301 B 596 ARG A 161 ARG^? 11.81 O6 C2E A 301 B 647 ARG A 217 ARG^? 6.70 O6 C2E A 301 coo 38.22 57.83 70.36 36.82 56.74 69.18 -14.60 -12.52 -1.04 -14.41 -10.88 0.31 coo 34.24 60.89 68.08 33.31 57.93 67.63 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 coo 31.43 57.38 61.97 31.90 55.58 64.41 -3.36 -16.18 0.94 -0.54 -17.39 0.83 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 5 3 # 5 B 581 GLU A 221 GLU^? -4.32 C4' C2E A 301s B 596 ARG A 227 ARG~? 9.91 O2' C2E A 301 B 647 ARG A 165 ARG.? 12.45 N2 C2E A 301 coo 38.22 57.83 70.36 36.82 56.74 69.18 -2.05 -23.28 -12.44 -0.03 -23.89 -12.66 coo 34.24 60.89 68.08 33.31 57.93 67.63 -5.20 -21.14 -18.72 -4.74 -24.14 -19.17 coo 31.43 57.38 61.97 31.90 55.58 64.41 -4.47 -13.19 -19.45 -6.66 -12.47 -21.46 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 6 3 # 6 B 581 GLU B 138 GLU.? 5.49 O2' C2E B 301 B 596 ARG B 165 ARG.? 10.70 O2' C2E B 301 B 647 ARG B 227 ARG~? 7.56 O2' C2E B 301 coo 38.22 57.83 70.36 36.82 56.74 69.18 -14.88 11.83 -9.39 -15.29 12.85 -11.20 coo 34.24 60.89 68.08 33.31 57.93 67.63 -16.44 10.61 -14.72 -19.33 11.67 -14.77 coo 31.43 57.38 61.97 31.90 55.58 64.41 -16.01 19.09 -16.09 -16.65 16.54 -14.51 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 7 3 # 7 B 581 GLU B 159 GLU^? 13.76 O6 C2E B 301 B 596 ARG B 161 ARG^? 11.68 O6 C2E B 301 B 647 ARG B 169 ARG^? -4.70 O6 C2E B 301s coo 38.22 57.83 70.36 36.82 56.74 69.18 4.99 11.22 -14.77 6.30 9.86 -13.80 coo 34.24 60.89 68.08 33.31 57.93 67.63 2.96 9.64 -10.71 5.59 9.57 -9.11 coo 31.43 57.38 61.97 31.90 55.58 64.41 -0.88 13.03 -7.12 -1.56 12.92 -4.13 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 8 3 # 8 B 581 GLU B 159 GLU^? 13.76 O6 C2E B 301 B 596 ARG B 161 ARG^? 11.68 O6 C2E B 301 B 647 ARG B 217 ARG^? 6.37 O6 C2E B 301 coo 38.22 57.83 70.36 36.82 56.74 69.18 4.99 11.22 -14.77 6.30 9.86 -13.80 coo 34.24 60.89 68.08 33.31 57.93 67.63 2.96 9.64 -10.71 5.59 9.57 -9.11 coo 31.43 57.38 61.97 31.90 55.58 64.41 0.82 15.44 -4.45 -0.87 16.78 -2.26 1v0e_c01 source 1v0e ENDO-ALPHA-SIALIDASE : 8 hits 1v0e_c01 naa= 3 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 1 3 # 1 C 581 GLU A 41 GLU^? 8.66 N21 C2E A 301 C 596 ARG A 57 ARG^? 7.03 N21 C2E A 301 C 647 ARG A 94 ARG^? 4.68 N21 C2E A 301 coo 11.31 31.26 27.00 13.31 30.71 26.58 7.09 -12.35 6.79 6.46 -14.38 6.77 coo 13.44 32.78 22.07 15.56 30.91 23.37 10.26 -15.76 6.84 9.68 -16.90 4.07 coo 21.00 33.35 22.82 19.83 30.82 24.09 12.55 -12.80 -0.72 10.33 -14.85 -0.21 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 2 3 # 2 C 581 GLU A 138 GLU.? 5.46 O2' C2E A 301 C 596 ARG A 165 ARG.? 12.45 N2 C2E A 301 C 647 ARG A 227 ARG~? 9.91 O2' C2E A 301 coo 11.31 31.26 27.00 13.31 30.71 26.58 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 coo 13.44 32.78 22.07 15.56 30.91 23.37 -4.47 -13.19 -19.45 -6.66 -12.47 -21.46 coo 21.00 33.35 22.82 19.83 30.82 24.09 -5.20 -21.14 -18.72 -4.74 -24.14 -19.17 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 3 3 # 3 C 581 GLU A 159 GLU^? 13.73 O6 C2E A 301 C 596 ARG A 161 ARG^? 11.81 O6 C2E A 301 C 647 ARG A 169 ARG^? -4.75 O6 C2E A 301s coo 11.31 31.26 27.00 13.31 30.71 26.58 -14.60 -12.52 -1.04 -14.41 -10.88 0.31 coo 13.44 32.78 22.07 15.56 30.91 23.37 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 coo 21.00 33.35 22.82 19.83 30.82 24.09 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 4 3 # 4 C 581 GLU A 159 GLU^? 13.73 O6 C2E A 301 C 596 ARG A 161 ARG^? 11.81 O6 C2E A 301 C 647 ARG A 217 ARG^? 6.70 O6 C2E A 301 coo 11.31 31.26 27.00 13.31 30.71 26.58 -14.60 -12.52 -1.04 -14.41 -10.88 0.31 coo 13.44 32.78 22.07 15.56 30.91 23.37 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 coo 21.00 33.35 22.82 19.83 30.82 24.09 -3.36 -16.18 0.94 -0.54 -17.39 0.83 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 5 3 # 5 C 581 GLU A 221 GLU^? -4.32 C4' C2E A 301s C 596 ARG A 227 ARG~? 9.91 O2' C2E A 301 C 647 ARG A 165 ARG.? 12.45 N2 C2E A 301 coo 11.31 31.26 27.00 13.31 30.71 26.58 -2.05 -23.28 -12.44 -0.03 -23.89 -12.66 coo 13.44 32.78 22.07 15.56 30.91 23.37 -5.20 -21.14 -18.72 -4.74 -24.14 -19.17 coo 21.00 33.35 22.82 19.83 30.82 24.09 -4.47 -13.19 -19.45 -6.66 -12.47 -21.46 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 6 3 # 6 C 581 GLU B 138 GLU.? 5.49 O2' C2E B 301 C 596 ARG B 165 ARG.? 10.70 O2' C2E B 301 C 647 ARG B 227 ARG~? 7.56 O2' C2E B 301 coo 11.31 31.26 27.00 13.31 30.71 26.58 -14.88 11.83 -9.39 -15.29 12.85 -11.20 coo 13.44 32.78 22.07 15.56 30.91 23.37 -16.44 10.61 -14.72 -19.33 11.67 -14.77 coo 21.00 33.35 22.82 19.83 30.82 24.09 -16.01 19.09 -16.09 -16.65 16.54 -14.51 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 7 3 # 7 C 581 GLU B 142 GLU^? 10.78 N1 C2E B 301 C 596 ARG B 161 ARG^? 11.68 O6 C2E B 301 C 647 ARG B 217 ARG^? 6.37 O6 C2E B 301 coo 11.31 31.26 27.00 13.31 30.71 26.58 -2.97 5.35 -8.71 -1.84 4.27 -7.29 coo 13.44 32.78 22.07 15.56 30.91 23.37 2.96 9.64 -10.71 5.59 9.57 -9.11 coo 21.00 33.35 22.82 19.83 30.82 24.09 0.82 15.44 -4.45 -0.87 16.78 -2.26 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 8 3 # 8 C 581 GLU B 159 GLU^? 13.76 O6 C2E B 301 C 596 ARG B 161 ARG^? 11.68 O6 C2E B 301 C 647 ARG B 169 ARG^? -4.70 O6 C2E B 301s coo 11.31 31.26 27.00 13.31 30.71 26.58 4.99 11.22 -14.77 6.30 9.86 -13.80 coo 13.44 32.78 22.07 15.56 30.91 23.37 2.96 9.64 -10.71 5.59 9.57 -9.11 coo 21.00 33.35 22.82 19.83 30.82 24.09 -0.88 13.03 -7.12 -1.56 12.92 -4.13 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 9 3 # 9 C 581 GLU B 159 GLU^? 13.76 O6 C2E B 301 C 596 ARG B 161 ARG^? 11.68 O6 C2E B 301 C 647 ARG B 217 ARG^? 6.37 O6 C2E B 301 coo 11.31 31.26 27.00 13.31 30.71 26.58 4.99 11.22 -14.77 6.30 9.86 -13.80 coo 13.44 32.78 22.07 15.56 30.91 23.37 2.96 9.64 -10.71 5.59 9.57 -9.11 coo 21.00 33.35 22.82 19.83 30.82 24.09 0.82 15.44 -4.45 -0.87 16.78 -2.26 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 10 3 # 10 C 581 GLU B 221 GLU^? -4.05 C4' C2E B 301s C 596 ARG B 227 ARG~? 7.56 O2' C2E B 301 C 647 ARG B 165 ARG.? 10.70 O2' C2E B 301 coo 11.31 31.26 27.00 13.31 30.71 26.58 -11.86 21.10 -10.14 -13.00 21.71 -8.45 coo 13.44 32.78 22.07 15.56 30.91 23.37 -16.01 19.09 -16.09 -16.65 16.54 -14.51 coo 21.00 33.35 22.82 19.83 30.82 24.09 -16.44 10.61 -14.72 -19.33 11.67 -14.77 1v0e_c02 source 1v0e ENDO-ALPHA-SIALIDASE : 10 hits 1v0e_c02 naa= 3 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 1 3 # 1 D 581 GLU A 41 GLU^? 8.66 N21 C2E A 301 D 596 ARG A 57 ARG^? 7.03 N21 C2E A 301 D 647 ARG A 94 ARG^? 4.68 N21 C2E A 301 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 7.09 -12.35 6.79 6.46 -14.38 6.77 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 10.26 -15.76 6.84 9.68 -16.90 4.07 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 12.55 -12.80 -0.72 10.33 -14.85 -0.21 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 2 3 # 2 D 581 GLU A 138 GLU.? 5.46 O2' C2E A 301 D 596 ARG A 165 ARG.? 12.45 N2 C2E A 301 D 647 ARG A 227 ARG~? 9.91 O2' C2E A 301 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -4.47 -13.19 -19.45 -6.66 -12.47 -21.46 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -5.20 -21.14 -18.72 -4.74 -24.14 -19.17 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 3 3 # 3 D 581 GLU A 159 GLU^? 13.73 O6 C2E A 301 D 596 ARG A 161 ARG^? 11.81 O6 C2E A 301 D 647 ARG A 169 ARG^? -4.75 O6 C2E A 301s coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -14.60 -12.52 -1.04 -14.41 -10.88 0.31 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 4 3 # 4 D 581 GLU A 159 GLU^? 13.73 O6 C2E A 301 D 596 ARG A 161 ARG^? 11.81 O6 C2E A 301 D 647 ARG A 217 ARG^? 6.70 O6 C2E A 301 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -14.60 -12.52 -1.04 -14.41 -10.88 0.31 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -3.36 -16.18 0.94 -0.54 -17.39 0.83 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 5 3 # 5 D 581 GLU A 221 GLU^? -4.32 C4' C2E A 301s D 596 ARG A 227 ARG~? 9.91 O2' C2E A 301 D 647 ARG A 165 ARG.? 12.45 N2 C2E A 301 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -2.05 -23.28 -12.44 -0.03 -23.89 -12.66 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -5.20 -21.14 -18.72 -4.74 -24.14 -19.17 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -4.47 -13.19 -19.45 -6.66 -12.47 -21.46 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 6 3 # 6 D 581 GLU B 138 GLU.? 5.49 O2' C2E B 301 D 596 ARG B 165 ARG.? 10.70 O2' C2E B 301 D 647 ARG B 227 ARG~? 7.56 O2' C2E B 301 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -14.88 11.83 -9.39 -15.29 12.85 -11.20 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -16.44 10.61 -14.72 -19.33 11.67 -14.77 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -16.01 19.09 -16.09 -16.65 16.54 -14.51 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 7 3 # 7 D 581 GLU B 159 GLU^? 13.76 O6 C2E B 301 D 596 ARG B 161 ARG^? 11.68 O6 C2E B 301 D 647 ARG B 169 ARG^? -4.70 O6 C2E B 301s coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 4.99 11.22 -14.77 6.30 9.86 -13.80 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 2.96 9.64 -10.71 5.59 9.57 -9.11 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -0.88 13.03 -7.12 -1.56 12.92 -4.13 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 8 3 # 8 D 581 GLU B 159 GLU^? 13.76 O6 C2E B 301 D 596 ARG B 161 ARG^? 11.68 O6 C2E B 301 D 647 ARG B 217 ARG^? 6.37 O6 C2E B 301 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 4.99 11.22 -14.77 6.30 9.86 -13.80 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 2.96 9.64 -10.71 5.59 9.57 -9.11 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 0.82 15.44 -4.45 -0.87 16.78 -2.26 1v0e_c03 source 1v0e ENDO-ALPHA-SIALIDASE : 8 hits 1v0e_c03 naa= 3 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 1 3 # 1 E 581 GLU A 41 GLU^? 8.66 N21 C2E A 301 E 596 ARG A 57 ARG^? 7.03 N21 C2E A 301 E 647 ARG A 94 ARG^? 4.68 N21 C2E A 301 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 7.09 -12.35 6.79 6.46 -14.38 6.77 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 10.26 -15.76 6.84 9.68 -16.90 4.07 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 12.55 -12.80 -0.72 10.33 -14.85 -0.21 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 2 3 # 2 E 581 GLU A 138 GLU.? 5.46 O2' C2E A 301 E 596 ARG A 165 ARG.? 12.45 N2 C2E A 301 E 647 ARG A 227 ARG~? 9.91 O2' C2E A 301 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -4.47 -13.19 -19.45 -6.66 -12.47 -21.46 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -5.20 -21.14 -18.72 -4.74 -24.14 -19.17 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 3 3 # 3 E 581 GLU A 159 GLU^? 13.73 O6 C2E A 301 E 596 ARG A 161 ARG^? 11.81 O6 C2E A 301 E 647 ARG A 169 ARG^? -4.75 O6 C2E A 301s coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -14.60 -12.52 -1.04 -14.41 -10.88 0.31 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 4 3 # 4 E 581 GLU A 159 GLU^? 13.73 O6 C2E A 301 E 596 ARG A 161 ARG^? 11.81 O6 C2E A 301 E 647 ARG A 217 ARG^? 6.70 O6 C2E A 301 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -14.60 -12.52 -1.04 -14.41 -10.88 0.31 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -3.36 -16.18 0.94 -0.54 -17.39 0.83 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 5 3 # 5 E 581 GLU A 221 GLU^? -4.32 C4' C2E A 301s E 596 ARG A 227 ARG~? 9.91 O2' C2E A 301 E 647 ARG A 165 ARG.? 12.45 N2 C2E A 301 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -2.05 -23.28 -12.44 -0.03 -23.89 -12.66 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -5.20 -21.14 -18.72 -4.74 -24.14 -19.17 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -4.47 -13.19 -19.45 -6.66 -12.47 -21.46 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 6 3 # 6 E 581 GLU B 138 GLU.? 5.49 O2' C2E B 301 E 596 ARG B 165 ARG.? 10.70 O2' C2E B 301 E 647 ARG B 227 ARG~? 7.56 O2' C2E B 301 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -14.88 11.83 -9.39 -15.29 12.85 -11.20 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -16.44 10.61 -14.72 -19.33 11.67 -14.77 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -16.01 19.09 -16.09 -16.65 16.54 -14.51 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 7 3 # 7 E 581 GLU B 159 GLU^? 13.76 O6 C2E B 301 E 596 ARG B 161 ARG^? 11.68 O6 C2E B 301 E 647 ARG B 169 ARG^? -4.70 O6 C2E B 301s coo 13.14 -15.80 20.26 11.08 -15.36 20.42 4.99 11.22 -14.77 6.30 9.86 -13.80 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 2.96 9.64 -10.71 5.59 9.57 -9.11 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -0.88 13.03 -7.12 -1.56 12.92 -4.13 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 8 3 # 8 E 581 GLU B 159 GLU^? 13.76 O6 C2E B 301 E 596 ARG B 161 ARG^? 11.68 O6 C2E B 301 E 647 ARG B 217 ARG^? 6.37 O6 C2E B 301 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 4.99 11.22 -14.77 6.30 9.86 -13.80 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 2.96 9.64 -10.71 5.59 9.57 -9.11 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 0.82 15.44 -4.45 -0.87 16.78 -2.26 1v0e_c04 source 1v0e ENDO-ALPHA-SIALIDASE : 8 hits 1v0e_c04 naa= 3 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 1 3 # 1 F 581 GLU A 41 GLU^? 8.66 N21 C2E A 301 F 596 ARG A 57 ARG^? 7.03 N21 C2E A 301 F 647 ARG A 94 ARG^? 4.68 N21 C2E A 301 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 7.09 -12.35 6.79 6.46 -14.38 6.77 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 10.26 -15.76 6.84 9.68 -16.90 4.07 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 12.55 -12.80 -0.72 10.33 -14.85 -0.21 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 2 3 # 2 F 581 GLU A 138 GLU.? 5.46 O2' C2E A 301 F 596 ARG A 165 ARG.? 12.45 N2 C2E A 301 F 647 ARG A 227 ARG~? 9.91 O2' C2E A 301 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -4.47 -13.19 -19.45 -6.66 -12.47 -21.46 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -5.20 -21.14 -18.72 -4.74 -24.14 -19.17 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 3 3 # 3 F 581 GLU A 159 GLU^? 13.73 O6 C2E A 301 F 596 ARG A 161 ARG^? 11.81 O6 C2E A 301 F 647 ARG A 169 ARG^? -4.75 O6 C2E A 301s coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -14.60 -12.52 -1.04 -14.41 -10.88 0.31 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 4 3 # 4 F 581 GLU A 159 GLU^? 13.73 O6 C2E A 301 F 596 ARG A 161 ARG^? 11.81 O6 C2E A 301 F 647 ARG A 217 ARG^? 6.70 O6 C2E A 301 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -14.60 -12.52 -1.04 -14.41 -10.88 0.31 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -3.36 -16.18 0.94 -0.54 -17.39 0.83 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 5 3 # 5 F 581 GLU B 138 GLU.? 5.49 O2' C2E B 301 F 596 ARG B 165 ARG.? 10.70 O2' C2E B 301 F 647 ARG B 227 ARG~? 7.56 O2' C2E B 301 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -14.88 11.83 -9.39 -15.29 12.85 -11.20 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -16.44 10.61 -14.72 -19.33 11.67 -14.77 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -16.01 19.09 -16.09 -16.65 16.54 -14.51 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 6 3 # 6 F 581 GLU B 159 GLU^? 13.76 O6 C2E B 301 F 596 ARG B 161 ARG^? 11.68 O6 C2E B 301 F 647 ARG B 169 ARG^? -4.70 O6 C2E B 301s coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 4.99 11.22 -14.77 6.30 9.86 -13.80 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 2.96 9.64 -10.71 5.59 9.57 -9.11 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -0.88 13.03 -7.12 -1.56 12.92 -4.13 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 7 3 # 7 F 581 GLU B 159 GLU^? 13.76 O6 C2E B 301 F 596 ARG B 161 ARG^? 11.68 O6 C2E B 301 F 647 ARG B 217 ARG^? 6.37 O6 C2E B 301 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 4.99 11.22 -14.77 6.30 9.86 -13.80 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 2.96 9.64 -10.71 5.59 9.57 -9.11 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 0.82 15.44 -4.45 -0.87 16.78 -2.26 1v0e_c05 source 1v0e ENDO-ALPHA-SIALIDASE : 7 hits 1v0e_c05 naa= 3 ULMN 3 1vom_c00 MYOSIN user 1 3 # 1 233 ASN A 223 ASN~? 12.71 O4' C2E A 301 457 GLY A 167 GLY^? -3.74 N3 C2E A 301s 459 GLU A 221 GLU^? -4.32 C4' C2E A 301s coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -7.68 -27.50 -15.35 -9.79 -27.31 -15.11 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -5.31 -18.58 -11.54 -5.51 -17.84 -11.78 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -2.05 -23.28 -12.44 -0.03 -23.89 -12.66 ULMN 3 1vom_c00 MYOSIN user 2 3 # 2 233 ASN A 232 ASN~? 17.05 N2 C2E A 301 457 GLY A 226 GLY~? 11.67 C1' C2E A 301 459 GLU A 225 GLU~? 17.61 C1' C2E A 301 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -16.23 -15.79 -19.65 -16.12 -16.52 -21.66 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -10.93 -22.84 -15.51 -10.72 -22.76 -16.32 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -14.07 -25.95 -18.02 -15.34 -27.27 -16.96 ULMN 3 1vom_c00 MYOSIN user 3 3 # 3 233 ASN B 223 ASN~? 12.46 O4' C2E B 301 457 GLY B 167 GLY^? -3.69 N3 C2E B 301s 459 GLU B 221 GLU^? -4.05 C4' C2E B 301s coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -12.01 24.89 -16.85 -10.55 24.64 -18.38 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -9.22 16.51 -12.20 -9.30 15.75 -12.43 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -11.86 21.10 -10.14 -13.00 21.71 -8.45 ULMN 3 1vom_c00 MYOSIN user 4 3 # 4 233 ASN B 232 ASN~? 16.84 N2 C2E B 301 457 GLY B 226 GLY~? 11.47 O2' C2E B 301 459 GLU B 225 GLU~? 17.01 C1' C2E B 301 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -10.52 12.92 -25.16 -9.28 12.34 -26.79 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -10.34 20.15 -19.24 -11.11 20.04 -19.49 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -10.33 22.86 -23.16 -8.91 24.36 -23.62 1vom_c00 source 1vom MYOSIN : 4 hits 1vom_c00 naa= 3 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 1 3 # 1 A 100 PHE A 199 PHE.? 15.97 N2 C2E A 301 A 197 ASN A 229 ASN~? 15.85 N2 C2E A 301 A 198 PRO A 201 PRO.? 16.79 N2 C2E A 301 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 -19.51 -15.48 -13.25 -19.97 -12.76 -13.56 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 -14.86 -20.46 -16.50 -16.06 -21.98 -17.43 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 -18.72 -24.82 -12.49 -17.62 -22.89 -12.74 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 2 3 # 2 A 100 PHE A 222 PHE^? 7.21 N3 C2E A 301 A 197 ASN A 229 ASN~? 15.85 N2 C2E A 301 A 198 PRO A 200 PRO.? 16.97 N2 C2E A 301 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 -7.93 -20.98 -13.39 -9.02 -18.86 -11.96 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 -14.86 -20.46 -16.50 -16.06 -21.98 -17.43 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 -18.78 -19.95 -16.50 -19.70 -20.49 -14.54 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 3 3 # 3 A 100 PHE A 222 PHE^? 7.21 N3 C2E A 301 A 197 ASN A 229 ASN~? 15.85 N2 C2E A 301 A 198 PRO A 201 PRO.? 16.79 N2 C2E A 301 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 -7.93 -20.98 -13.39 -9.02 -18.86 -11.96 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 -14.86 -20.46 -16.50 -16.06 -21.98 -17.43 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 -18.72 -24.82 -12.49 -17.62 -22.89 -12.74 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 4 3 # 4 A 100 PHE B 199 PHE.? 15.78 N2 C2E B 301 A 197 ASN B 229 ASN~? 15.65 N2 C2E B 301 A 198 PRO B 201 PRO.? 16.16 N2 C2E B 301 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 -3.38 12.46 -25.06 -2.84 9.73 -25.01 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 -8.99 17.44 -22.98 -9.26 18.88 -24.54 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 -5.23 21.60 -24.52 -4.75 19.54 -23.83 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 5 3 # 5 A 100 PHE B 222 PHE^? 7.18 N3 C2E B 301 A 197 ASN B 229 ASN~? 15.65 N2 C2E B 301 A 198 PRO B 200 PRO.? 17.33 N2 C2E B 301 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 -9.78 18.64 -15.60 -7.86 16.65 -15.65 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 -8.99 17.44 -22.98 -9.26 18.88 -24.54 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 -7.10 16.45 -27.58 -5.34 17.02 -26.33 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 6 3 # 6 A 100 PHE B 222 PHE^? 7.18 N3 C2E B 301 A 197 ASN B 229 ASN~? 15.65 N2 C2E B 301 A 198 PRO B 201 PRO.? 16.16 N2 C2E B 301 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 -9.78 18.64 -15.60 -7.86 16.65 -15.65 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 -8.99 17.44 -22.98 -9.26 18.88 -24.54 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 -5.23 21.60 -24.52 -4.75 19.54 -23.83 1vq1_c00 source 1vq1 N5-GLUTAMINE METHYLTRANSFERASE, HEMK : 6 hits 1vq1_c00 naa= 3 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 1 3 # 1 B 100 PHE A 199 PHE.? 15.97 N2 C2E A 301 B 197 ASN A 229 ASN~? 15.85 N2 C2E A 301 B 198 PRO A 201 PRO.? 16.79 N2 C2E A 301 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 -19.51 -15.48 -13.25 -19.97 -12.76 -13.56 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -14.86 -20.46 -16.50 -16.06 -21.98 -17.43 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 -18.72 -24.82 -12.49 -17.62 -22.89 -12.74 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 2 3 # 2 B 100 PHE A 222 PHE^? 7.21 N3 C2E A 301 B 197 ASN A 229 ASN~? 15.85 N2 C2E A 301 B 198 PRO A 200 PRO.? 16.97 N2 C2E A 301 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 -7.93 -20.98 -13.39 -9.02 -18.86 -11.96 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -14.86 -20.46 -16.50 -16.06 -21.98 -17.43 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 -18.78 -19.95 -16.50 -19.70 -20.49 -14.54 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 3 3 # 3 B 100 PHE A 222 PHE^? 7.21 N3 C2E A 301 B 197 ASN A 229 ASN~? 15.85 N2 C2E A 301 B 198 PRO A 201 PRO.? 16.79 N2 C2E A 301 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 -7.93 -20.98 -13.39 -9.02 -18.86 -11.96 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -14.86 -20.46 -16.50 -16.06 -21.98 -17.43 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 -18.72 -24.82 -12.49 -17.62 -22.89 -12.74 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 4 3 # 4 B 100 PHE B 199 PHE.? 15.78 N2 C2E B 301 B 197 ASN B 229 ASN~? 15.65 N2 C2E B 301 B 198 PRO B 201 PRO.? 16.16 N2 C2E B 301 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 -3.38 12.46 -25.06 -2.84 9.73 -25.01 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -8.99 17.44 -22.98 -9.26 18.88 -24.54 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 -5.23 21.60 -24.52 -4.75 19.54 -23.83 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 5 3 # 5 B 100 PHE B 222 PHE^? 7.18 N3 C2E B 301 B 197 ASN B 229 ASN~? 15.65 N2 C2E B 301 B 198 PRO B 200 PRO.? 17.33 N2 C2E B 301 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 -9.78 18.64 -15.60 -7.86 16.65 -15.65 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -8.99 17.44 -22.98 -9.26 18.88 -24.54 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 -7.10 16.45 -27.58 -5.34 17.02 -26.33 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 6 3 # 6 B 100 PHE B 222 PHE^? 7.18 N3 C2E B 301 B 197 ASN B 229 ASN~? 15.65 N2 C2E B 301 B 198 PRO B 201 PRO.? 16.16 N2 C2E B 301 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 -9.78 18.64 -15.60 -7.86 16.65 -15.65 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -8.99 17.44 -22.98 -9.26 18.88 -24.54 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 -5.23 21.60 -24.52 -4.75 19.54 -23.83 1vq1_c01 source 1vq1 N5-GLUTAMINE METHYLTRANSFERASE, HEMK : 6 hits 1vq1_c01 naa= 3 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 218 TYR^? 10.22 O6 C2E A 301 A 40 ASP A 162 ASP^? -3.09 N1 C2E A 301s A 103 LEU A 220 LEU^? -7.07 C8 C2E A 301s coo 12.09 16.13 10.57 11.28 18.80 10.73 -6.98 -22.32 0.01 -7.64 -23.76 2.29 coo 7.55 25.51 14.34 9.65 25.73 14.24 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 11.83 18.73 16.99 10.99 19.71 15.26 -6.63 -21.76 -7.28 -8.08 -23.33 -7.55 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR B 218 TYR^? 10.08 O6 C2E B 301 A 40 ASP B 162 ASP^? -3.04 N1 C2E B 301s A 103 LEU B 220 LEU^? -7.07 C8 C2E B 301s coo 12.09 16.13 10.57 11.28 18.80 10.73 1.42 21.23 -8.42 3.73 22.73 -7.99 coo 7.55 25.51 14.34 9.65 25.73 14.24 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 11.83 18.73 16.99 10.99 19.71 15.26 -5.07 20.07 -11.69 -4.58 21.68 -13.02 1vzz_c00 source 1vzz STEROID DELTA-ISOMERASE : 2 hits 1vzz_c00 naa= 3 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 218 TYR^? 10.22 O6 C2E A 301 B 40 ASP A 162 ASP^? -3.09 N1 C2E A 301s B 103 LEU A 220 LEU^? -7.07 C8 C2E A 301s coo 14.25 20.09 37.35 13.48 17.40 37.38 -6.98 -22.32 0.01 -7.64 -23.76 2.29 coo 9.39 10.77 34.53 11.50 10.63 34.41 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 12.89 17.60 31.13 12.34 16.51 32.90 -6.63 -21.76 -7.28 -8.08 -23.33 -7.55 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR B 218 TYR^? 10.08 O6 C2E B 301 B 40 ASP B 162 ASP^? -3.04 N1 C2E B 301s B 103 LEU B 220 LEU^? -7.07 C8 C2E B 301s coo 14.25 20.09 37.35 13.48 17.40 37.38 1.42 21.23 -8.42 3.73 22.73 -7.99 coo 9.39 10.77 34.53 11.50 10.63 34.41 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 12.89 17.60 31.13 12.34 16.51 32.90 -5.07 20.07 -11.69 -4.58 21.68 -13.02 1vzz_c01 source 1vzz STEROID DELTA-ISOMERASE : 2 hits 1vzz_c01 naa= 3 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 1 3 # 1 A 105 HIS A 154 HIS^? 21.74 O6 C2E A 301 A 169 ASP A 157 ASP^? 20.06 O6 C2E A 301 A 288 GLU A 159 GLU^? 13.73 O6 C2E A 301 coo 67.72 35.99 30.87 69.77 36.13 31.33 -16.69 -30.86 2.00 -15.94 -32.47 3.12 coo 73.17 30.66 22.56 72.87 30.30 20.46 -19.05 -19.29 2.64 -21.12 -19.53 2.92 coo 74.06 28.51 15.92 73.77 29.56 17.73 -14.60 -12.52 -1.04 -14.41 -10.88 0.31 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 2 3 # 2 A 105 HIS B 154 HIS^? 20.45 O6 C2E B 301 A 169 ASP B 157 ASP^? 20.00 O6 C2E B 301 A 288 GLU B 159 GLU^? 13.76 O6 C2E B 301 coo 67.72 35.99 30.87 69.77 36.13 31.33 7.78 28.08 -17.01 9.24 26.69 -16.42 coo 73.17 30.66 22.56 72.87 30.30 20.46 9.70 18.14 -17.54 10.97 18.31 -19.23 coo 74.06 28.51 15.92 73.77 29.56 17.73 4.99 11.22 -14.77 6.30 9.86 -13.80 1w1o_c00 source 1w1o CYTOKININ DEHYDROGENASE 1 : 2 hits 1w1o_c00 naa= 3 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 1 3 # 1 A 183 GLY A 100 GLY.? 9.32 N2 C2E A 301 B 419 GLY A 102 GLY.? 6.44 O61 C2E A 301 B 420 ALA A 103 ALA^? 9.21 O61 C2E A 301 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -0.32 -6.55 -10.22 0.00 -7.00 -9.65 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 4.07 -8.14 -8.05 4.42 -7.93 -8.77 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 7.72 -7.57 -7.26 7.99 -6.07 -7.40 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 2 3 # 2 A 183 GLY B 100 GLY.? 9.19 N2 C2E B 301 B 419 GLY B 102 GLY.? 6.96 N71 C2E B 301 B 420 ALA B 103 ALA^? 9.52 O61 C2E B 301 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -9.60 5.07 -6.19 -9.37 5.54 -5.60 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -10.38 6.68 -1.43 -11.18 6.52 -1.49 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -11.71 6.99 2.09 -11.93 5.56 2.58 1xny_c00 source 1xny PROPIONYL-COA CARBOXYLASE COMPLEX B SUBUNIT : 2 hits 1xny_c00 naa= 3 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 1 3 # 1 A 243 THR A 48 THR.? 25.84 N21 C2E A 301 A 345 PHE A 54 PHE^? 19.63 N21 C2E A 301 A 352 CYH A 56 CYH^? 16.49 N21 C2E A 301 coo 9.58 21.79 21.50 11.25 23.03 20.90 27.62 -12.76 11.61 27.36 -14.59 12.73 coo 19.40 19.75 18.58 17.39 17.81 18.80 19.69 -16.80 12.43 17.45 -17.09 14.05 coo 21.57 22.52 22.79 19.20 21.13 23.26 14.08 -15.43 10.17 15.14 -13.33 11.76 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 2 3 # 2 A 243 THR A 178 THR.? 17.14 O6 C2E A 301 A 345 PHE A 170 PHE^? 8.91 O6 C2E A 301 A 352 CYH A 158 CYH^? 12.92 O6 C2E A 301 coo 9.58 21.79 21.50 11.25 23.03 20.90 -9.47 -27.26 4.39 -8.59 -27.66 6.32 coo 19.40 19.75 18.58 17.39 17.81 18.80 -10.47 -19.67 -2.91 -9.94 -22.37 -2.52 coo 21.57 22.52 22.79 19.20 21.13 23.26 -15.53 -18.41 0.03 -15.42 -19.19 -2.71 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 3 3 # 3 A 243 THR A 203 THR^? 13.87 C1' C2E A 301 A 345 PHE A 170 PHE^? 8.91 O6 C2E A 301 A 352 CYH A 158 CYH^? 12.92 O6 C2E A 301 coo 9.58 21.79 21.50 11.25 23.03 20.90 -11.63 -25.21 -11.66 -12.74 -26.43 -13.05 coo 19.40 19.75 18.58 17.39 17.81 18.80 -10.47 -19.67 -2.91 -9.94 -22.37 -2.52 coo 21.57 22.52 22.79 19.20 21.13 23.26 -15.53 -18.41 0.03 -15.42 -19.19 -2.71 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 4 3 # 4 A 243 THR B 48 THR.? 24.30 N21 C2E B 301 A 345 PHE B 54 PHE^? 17.95 N21 C2E B 301 A 352 CYH B 56 CYH^? 14.73 N21 C2E B 301 coo 9.58 21.79 21.50 11.25 23.03 20.90 -5.61 19.04 26.16 -4.64 20.96 26.06 coo 19.40 19.75 18.58 17.39 17.81 18.80 -1.86 22.37 18.66 0.47 22.95 17.25 coo 21.57 22.52 22.79 19.20 21.13 23.26 -0.90 19.58 13.61 0.17 17.94 15.62 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 5 3 # 5 A 243 THR B 178 THR.? 16.80 O6 C2E B 301 A 345 PHE B 170 PHE^? 8.84 O6 C2E B 301 A 352 CYH B 158 CYH^? 12.89 O6 C2E B 301 coo 9.58 21.79 21.50 11.25 23.03 20.90 6.21 26.30 -8.92 7.28 26.85 -7.15 coo 19.40 19.75 18.58 17.39 17.81 18.80 0.78 18.23 -12.65 0.68 20.98 -12.20 coo 21.57 22.52 22.79 19.20 21.13 23.26 5.78 17.15 -15.63 3.32 17.67 -16.92 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 6 3 # 6 A 243 THR B 203 THR^? 13.68 C1' C2E B 301 A 345 PHE B 170 PHE^? 8.84 O6 C2E B 301 A 352 CYH B 158 CYH^? 12.89 O6 C2E B 301 coo 9.58 21.79 21.50 11.25 23.03 20.90 -6.70 22.59 -18.31 -7.42 23.42 -20.17 coo 19.40 19.75 18.58 17.39 17.81 18.80 0.78 18.23 -12.65 0.68 20.98 -12.20 coo 21.57 22.52 22.79 19.20 21.13 23.26 5.78 17.15 -15.63 3.32 17.67 -16.92 1xqd_c02 source 1xqd CYTOCHROME P450 55A1 : 6 hits 1xqd_c02 naa= 3 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 B 124 ALA B 230 ALA~? 8.79 N2 C2E B 301 B 126 ARG B 165 ARG.? 10.70 O2' C2E B 301 B 138 GLU B 225 GLU~? 17.01 C1' C2E B 301 coo 2.11 4.00 19.31 3.14 4.86 19.99 -9.83 14.28 -19.75 -10.16 14.73 -18.33 coo 2.45 5.53 11.28 3.59 7.56 13.29 -16.44 10.61 -14.72 -19.33 11.67 -14.77 coo 6.10 2.00 25.24 6.12 1.84 23.13 -10.33 22.86 -23.16 -8.91 24.36 -23.62 1xs1_c07 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 1 hits 1xs1_c07 naa= 3 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 C 124 ALA B 230 ALA~? 8.79 N2 C2E B 301 C 126 ARG B 165 ARG.? 10.70 O2' C2E B 301 C 138 GLU B 225 GLU~? 17.01 C1' C2E B 301 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -9.83 14.28 -19.75 -10.16 14.73 -18.33 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -16.44 10.61 -14.72 -19.33 11.67 -14.77 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -10.33 22.86 -23.16 -8.91 24.36 -23.62 1xs1_c08 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 1 hits 1xs1_c08 naa= 3 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 D 124 ALA B 230 ALA~? 8.79 N2 C2E B 301 D 126 ARG B 165 ARG.? 10.70 O2' C2E B 301 D 138 GLU B 225 GLU~? 17.01 C1' C2E B 301 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -9.83 14.28 -19.75 -10.16 14.73 -18.33 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -16.44 10.61 -14.72 -19.33 11.67 -14.77 coo 6.23 0.50 57.10 5.93 0.72 59.19 -10.33 22.86 -23.16 -8.91 24.36 -23.62 1xs1_c09 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 1 hits 1xs1_c09 naa= 3 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 E 124 ALA A 230 ALA~? 8.84 N2 C2E A 301 E 126 ARG A 165 ARG.? 12.45 N2 C2E A 301 E 138 GLU A 225 GLU~? 17.61 C1' C2E A 301 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -11.86 -16.98 -15.84 -10.42 -17.26 -15.41 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -4.47 -13.19 -19.45 -6.66 -12.47 -21.46 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -14.07 -25.95 -18.02 -15.34 -27.27 -16.96 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 E 124 ALA B 230 ALA~? 8.79 N2 C2E B 301 E 126 ARG B 165 ARG.? 10.70 O2' C2E B 301 E 138 GLU B 225 GLU~? 17.01 C1' C2E B 301 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -9.83 14.28 -19.75 -10.16 14.73 -18.33 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -16.44 10.61 -14.72 -19.33 11.67 -14.77 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -10.33 22.86 -23.16 -8.91 24.36 -23.62 1xs1_c10 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 2 hits 1xs1_c10 naa= 3 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 F 124 ALA B 230 ALA~? 8.79 N2 C2E B 301 F 126 ARG B 165 ARG.? 10.70 O2' C2E B 301 F 138 GLU B 225 GLU~? 17.01 C1' C2E B 301 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -9.83 14.28 -19.75 -10.16 14.73 -18.33 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -16.44 10.61 -14.72 -19.33 11.67 -14.77 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -10.33 22.86 -23.16 -8.91 24.36 -23.62 1xs1_c11 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 1 hits 1xs1_c11 naa= 3 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 1 3 # 1 B 137 GLY A 167 GLY^? -3.74 N3 C2E A 301s B 175 ARG A 169 ARG^? -4.75 O6 C2E A 301s B 242 TYR A 218 TYR^? 10.22 O6 C2E A 301 coo 99.45 58.28 3.33 99.57 58.61 4.10 -5.31 -18.58 -11.54 -5.51 -17.84 -11.78 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 coo 100.93 69.04 4.38 99.52 68.48 2.09 -6.98 -22.32 0.01 -7.64 -23.76 2.29 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 2 3 # 2 B 137 GLY A 176 GLY.? 18.56 O6 C2E A 301 B 175 ARG A 211 ARG^? 16.62 O6 C2E A 301 B 242 TYR A 179 TYR.? 13.95 N7 C2E A 301 coo 99.45 58.28 3.33 99.57 58.61 4.10 -14.50 -24.46 6.89 -13.82 -24.67 7.29 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -4.93 -23.64 8.57 -7.93 -23.17 9.07 coo 100.93 69.04 4.38 99.52 68.48 2.09 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 3 3 # 3 B 137 GLY A 176 GLY.? 18.56 O6 C2E A 301 B 175 ARG A 211 ARG^? 16.62 O6 C2E A 301 B 242 TYR A 218 TYR^? 10.22 O6 C2E A 301 coo 99.45 58.28 3.33 99.57 58.61 4.10 -14.50 -24.46 6.89 -13.82 -24.67 7.29 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -4.93 -23.64 8.57 -7.93 -23.17 9.07 coo 100.93 69.04 4.38 99.52 68.48 2.09 -6.98 -22.32 0.01 -7.64 -23.76 2.29 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 4 3 # 4 B 137 GLY B 167 GLY^? -3.69 N3 C2E B 301s B 175 ARG B 169 ARG^? -4.70 O6 C2E B 301s B 242 TYR B 218 TYR^? 10.08 O6 C2E B 301 coo 99.45 58.28 3.33 99.57 58.61 4.10 -9.22 16.51 -12.20 -9.30 15.75 -12.43 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo 100.93 69.04 4.38 99.52 68.48 2.09 1.42 21.23 -8.42 3.73 22.73 -7.99 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 5 3 # 5 B 137 GLY B 176 GLY.? 18.62 O6 C2E B 301 B 175 ARG B 211 ARG^? 16.78 O6 C2E B 301 B 242 TYR B 218 TYR^? 10.08 O6 C2E B 301 coo 99.45 58.28 3.33 99.57 58.61 4.10 11.24 23.68 -11.63 11.16 23.89 -10.85 coo 106.37 63.53 0.89 108.02 63.40 -1.62 8.09 22.99 -2.57 10.13 22.73 -4.88 coo 100.93 69.04 4.38 99.52 68.48 2.09 1.42 21.23 -8.42 3.73 22.73 -7.99 1xva_c03 source 1xva GLYCINE N-METHYLTRANSFERASE : 5 hits 1xva_c03 naa= 3 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS A 238 LYS^? 19.93 N2 C2E B 301 A 74 LYS A 243 LYS.? 15.17 N2 C2E A 301 A 165 GLU B 138 GLU.? 5.49 O2' C2E B 301 coo 18.28 7.83 36.39 22.82 8.75 39.52 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 coo 14.16 13.09 37.03 20.00 12.44 37.49 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo 22.22 16.06 48.76 23.94 15.33 49.78 -14.88 11.83 -9.39 -15.29 12.85 -11.20 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 A 14 LYS A 243 LYS.? 15.17 N2 C2E A 301 A 74 LYS A 238 LYS^? 19.93 N2 C2E B 301 A 165 GLU B 138 GLU.? 5.49 O2' C2E B 301 coo 18.28 7.83 36.39 22.82 8.75 39.52 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo 14.16 13.09 37.03 20.00 12.44 37.49 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 coo 22.22 16.06 48.76 23.94 15.33 49.78 -14.88 11.83 -9.39 -15.29 12.85 -11.20 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 A 14 LYS B 238 LYS^? 16.50 N2 C2E A 301 A 74 LYS B 243 LYS.? 13.43 N1 C2E B 301 A 165 GLU A 138 GLU.? 5.46 O2' C2E A 301 coo 18.28 7.83 36.39 22.82 8.75 39.52 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 coo 14.16 13.09 37.03 20.00 12.44 37.49 -2.53 1.27 -13.25 2.13 3.70 -10.70 coo 22.22 16.06 48.76 23.94 15.33 49.78 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 A 14 LYS B 238 LYS^? 16.50 N2 C2E A 301 A 74 LYS B 243 LYS.? 13.43 N1 C2E B 301 A 165 GLU B 159 GLU^? 13.76 O6 C2E B 301 coo 18.28 7.83 36.39 22.82 8.75 39.52 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 coo 14.16 13.09 37.03 20.00 12.44 37.49 -2.53 1.27 -13.25 2.13 3.70 -10.70 coo 22.22 16.06 48.76 23.94 15.33 49.78 4.99 11.22 -14.77 6.30 9.86 -13.80 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 A 14 LYS B 243 LYS.? 13.43 N1 C2E B 301 A 74 LYS B 238 LYS^? 16.50 N2 C2E A 301 A 165 GLU A 138 GLU.? 5.46 O2' C2E A 301 coo 18.28 7.83 36.39 22.82 8.75 39.52 -2.53 1.27 -13.25 2.13 3.70 -10.70 coo 14.16 13.09 37.03 20.00 12.44 37.49 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 coo 22.22 16.06 48.76 23.94 15.33 49.78 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 1ylu_c00 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 5 hits 1ylu_c00 naa= 3 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS A 238 LYS^? 19.93 N2 C2E B 301 B 74 LYS A 243 LYS.? 15.17 N2 C2E A 301 B 165 GLU B 138 GLU.? 5.49 O2' C2E B 301 coo 13.51 0.92 76.10 12.98 6.13 74.68 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo 21.39 11.56 68.52 20.24 13.13 67.73 -14.88 11.83 -9.39 -15.29 12.85 -11.20 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 B 14 LYS A 243 LYS.? 15.17 N2 C2E A 301 B 74 LYS A 238 LYS^? 19.93 N2 C2E B 301 B 165 GLU B 138 GLU.? 5.49 O2' C2E B 301 coo 13.51 0.92 76.10 12.98 6.13 74.68 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 coo 21.39 11.56 68.52 20.24 13.13 67.73 -14.88 11.83 -9.39 -15.29 12.85 -11.20 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 B 14 LYS B 238 LYS^? 16.50 N2 C2E A 301 B 74 LYS B 243 LYS.? 13.43 N1 C2E B 301 B 165 GLU A 138 GLU.? 5.46 O2' C2E A 301 coo 13.51 0.92 76.10 12.98 6.13 74.68 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -2.53 1.27 -13.25 2.13 3.70 -10.70 coo 21.39 11.56 68.52 20.24 13.13 67.73 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 B 14 LYS B 243 LYS.? 13.43 N1 C2E B 301 B 74 LYS B 238 LYS^? 16.50 N2 C2E A 301 B 165 GLU A 138 GLU.? 5.46 O2' C2E A 301 coo 13.51 0.92 76.10 12.98 6.13 74.68 -2.53 1.27 -13.25 2.13 3.70 -10.70 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 coo 21.39 11.56 68.52 20.24 13.13 67.73 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 1ylu_c01 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 4 hits 1ylu_c01 naa= 3 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 1 3 # 1 A 369 ASP A 157 ASP^? 20.06 O6 C2E A 301 A 371 LYS A 148 LYS^? 21.30 O6 C2E A 301 A 407 THR A 172 THR^? 12.93 O6 C2E A 301 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -19.05 -19.29 2.64 -21.12 -19.53 2.92 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -12.64 -19.39 3.41 -11.97 -21.32 2.68 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 2 3 # 2 A 369 ASP B 157 ASP^? 20.00 O6 C2E B 301 A 371 LYS B 148 LYS^? 21.33 O6 C2E B 301 A 407 THR B 172 THR^? 12.75 O6 C2E B 301 coo -5.17 31.09 15.73 -7.07 31.12 16.73 9.70 18.14 -17.54 10.97 18.31 -19.23 coo -4.43 30.92 22.89 -6.61 31.91 19.71 4.64 19.42 -20.28 9.89 19.27 -22.17 coo -8.38 36.02 19.06 -8.83 34.10 19.89 7.41 18.34 -11.48 6.25 20.16 -11.39 1zrz_c02 source 1zrz PROTEIN KINASE C, IOTA : 2 hits 1zrz_c02 naa= 3 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 1 3 # 1 200 SER A 39 SER.? 16.45 O61 C2E A 301 327 GLU A 37 GLU.? 10.20 O61 C2E A 301 440 HIS A 38 HIS.? 16.46 O61 C2E B 301 coo 6.96 64.04 57.84 6.74 63.69 60.26 2.88 -4.86 8.38 1.14 -3.61 9.53 coo 14.82 64.63 62.37 13.47 65.72 61.17 0.90 -3.13 0.80 -0.70 -4.43 0.36 coo 9.52 66.51 63.07 8.75 65.02 61.81 1.46 -0.40 7.20 -0.57 -0.26 7.72 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 2 3 # 2 200 SER B 39 SER.? 15.26 O61 C2E B 301 327 GLU B 37 GLU.? 9.39 O61 C2E B 301 440 HIS B 38 HIS.? 15.97 O61 C2E B 301 coo 6.96 64.04 57.84 6.74 63.69 60.26 4.72 7.48 5.49 6.81 6.45 4.77 coo 14.82 64.63 62.37 13.47 65.72 61.17 -0.62 3.88 0.75 -0.32 4.81 -1.12 coo 9.52 66.51 63.07 8.75 65.02 61.81 4.87 2.64 4.63 6.30 2.30 3.13 2ace_c00 source 2ace ACETYLCHOLINESTERASE : 2 hits 2ace_c00 naa= 3 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 1 3 # 1 B 46 HIS A 214 HIS.? 19.24 O6 C2E A 301 B 163 ALA A 216 ALA^? 12.73 O6 C2E A 301 B 182 SER A 212 SER.? 13.10 O6 C2E A 301 coo 30.42 1.98 4.36 29.07 0.41 4.68 -9.67 -12.41 11.50 -9.18 -11.33 13.22 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -7.81 -19.62 5.34 -8.33 -21.05 5.33 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -4.77 -16.86 9.45 -4.14 -15.23 7.75 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 2 3 # 2 B 46 HIS B 214 HIS.? 18.94 O6 C2E B 301 B 163 ALA B 216 ALA^? 12.62 O6 C2E B 301 B 182 SER B 212 SER.? 13.16 O6 C2E B 301 coo 30.42 1.98 4.36 29.07 0.41 4.68 13.04 11.66 -4.90 14.49 10.59 -3.83 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 6.72 18.80 -6.41 6.88 20.24 -6.90 coo 24.00 -0.17 2.07 24.51 1.00 0.04 8.68 16.14 -1.54 8.01 14.57 -3.30 2bhg_c02 source 2bhg FOOT-AND-MOUTH DISEASE VIRUS 3C PROTEASE : 2 hits 2bhg_c02 naa= 3 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 1 3 # 1 A 14 ARG A 155 ARG^? 21.80 N1 C2E A 301 A 161 ASP A 183 ASP.? 14.57 O1P C2E A 301 A 174 TYR A 218 TYR^? 10.22 O6 C2E A 301 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -22.65 -25.75 -3.25 -23.90 -23.07 -4.10 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -7.06 -30.30 -3.03 -6.77 -31.63 -1.43 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -6.98 -22.32 0.01 -7.64 -23.76 2.29 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 2 3 # 2 A 14 ARG B 155 ARG^? 22.81 O6 C2E B 301 A 161 ASP B 183 ASP.? 14.33 O1P C2E B 301 A 174 TYR B 179 TYR.? 13.89 O6 C2E B 301 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 6.63 24.44 -23.88 7.74 21.82 -25.04 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -1.79 28.84 -10.63 -0.66 30.31 -9.57 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 2.36 25.70 -10.99 3.98 25.02 -13.14 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 3 3 # 3 A 14 ARG B 155 ARG^? 22.81 O6 C2E B 301 A 161 ASP B 183 ASP.? 14.33 O1P C2E B 301 A 174 TYR B 218 TYR^? 10.08 O6 C2E B 301 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 6.63 24.44 -23.88 7.74 21.82 -25.04 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -1.79 28.84 -10.63 -0.66 30.31 -9.57 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 1.42 21.23 -8.42 3.73 22.73 -7.99 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 4 3 # 4 A 14 ARG B 169 ARG^? -4.70 O6 C2E B 301s A 161 ASP B 183 ASP.? 14.33 O1P C2E B 301 A 174 TYR B 179 TYR.? 13.89 O6 C2E B 301 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -1.79 28.84 -10.63 -0.66 30.31 -9.57 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 2.36 25.70 -10.99 3.98 25.02 -13.14 2c7v_c08 source 2c7v PTERIDINE REDUCTASE : 4 hits 2c7v_c08 naa= 3 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 1 3 # 1 B 14 ARG A 155 ARG^? 21.80 N1 C2E A 301 B 161 ASP A 183 ASP.? 14.57 O1P C2E A 301 B 174 TYR A 218 TYR^? 10.22 O6 C2E A 301 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -22.65 -25.75 -3.25 -23.90 -23.07 -4.10 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -7.06 -30.30 -3.03 -6.77 -31.63 -1.43 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -6.98 -22.32 0.01 -7.64 -23.76 2.29 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 2 3 # 2 B 14 ARG B 155 ARG^? 22.81 O6 C2E B 301 B 161 ASP B 183 ASP.? 14.33 O1P C2E B 301 B 174 TYR B 179 TYR.? 13.89 O6 C2E B 301 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 6.63 24.44 -23.88 7.74 21.82 -25.04 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -1.79 28.84 -10.63 -0.66 30.31 -9.57 coo -21.46 12.70 8.53 -19.04 12.30 7.24 2.36 25.70 -10.99 3.98 25.02 -13.14 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 3 3 # 3 B 14 ARG B 169 ARG^? -4.70 O6 C2E B 301s B 161 ASP B 183 ASP.? 14.33 O1P C2E B 301 B 174 TYR B 179 TYR.? 13.89 O6 C2E B 301 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -1.79 28.84 -10.63 -0.66 30.31 -9.57 coo -21.46 12.70 8.53 -19.04 12.30 7.24 2.36 25.70 -10.99 3.98 25.02 -13.14 2c7v_c09 source 2c7v PTERIDINE REDUCTASE : 3 hits 2c7v_c09 naa= 3 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 1 3 # 1 C 14 ARG A 155 ARG^? 21.80 N1 C2E A 301 C 161 ASP A 183 ASP.? 14.57 O1P C2E A 301 C 174 TYR A 218 TYR^? 10.22 O6 C2E A 301 coo 2.84 19.43 40.34 1.59 20.35 37.65 -22.65 -25.75 -3.25 -23.90 -23.07 -4.10 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -7.06 -30.30 -3.03 -6.77 -31.63 -1.43 coo 5.94 13.28 27.17 3.53 13.05 28.58 -6.98 -22.32 0.01 -7.64 -23.76 2.29 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 2 3 # 2 C 14 ARG B 155 ARG^? 22.81 O6 C2E B 301 C 161 ASP B 183 ASP.? 14.33 O1P C2E B 301 C 174 TYR B 179 TYR.? 13.89 O6 C2E B 301 coo 2.84 19.43 40.34 1.59 20.35 37.65 6.63 24.44 -23.88 7.74 21.82 -25.04 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -1.79 28.84 -10.63 -0.66 30.31 -9.57 coo 5.94 13.28 27.17 3.53 13.05 28.58 2.36 25.70 -10.99 3.98 25.02 -13.14 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 3 3 # 3 C 14 ARG B 155 ARG^? 22.81 O6 C2E B 301 C 161 ASP B 183 ASP.? 14.33 O1P C2E B 301 C 174 TYR B 218 TYR^? 10.08 O6 C2E B 301 coo 2.84 19.43 40.34 1.59 20.35 37.65 6.63 24.44 -23.88 7.74 21.82 -25.04 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -1.79 28.84 -10.63 -0.66 30.31 -9.57 coo 5.94 13.28 27.17 3.53 13.05 28.58 1.42 21.23 -8.42 3.73 22.73 -7.99 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 4 3 # 4 C 14 ARG B 169 ARG^? -4.70 O6 C2E B 301s C 161 ASP B 183 ASP.? 14.33 O1P C2E B 301 C 174 TYR B 179 TYR.? 13.89 O6 C2E B 301 coo 2.84 19.43 40.34 1.59 20.35 37.65 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -1.79 28.84 -10.63 -0.66 30.31 -9.57 coo 5.94 13.28 27.17 3.53 13.05 28.58 2.36 25.70 -10.99 3.98 25.02 -13.14 2c7v_c10 source 2c7v PTERIDINE REDUCTASE : 4 hits 2c7v_c10 naa= 3 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 1 3 # 1 D 14 ARG A 155 ARG^? 21.80 N1 C2E A 301 D 161 ASP A 183 ASP.? 14.57 O1P C2E A 301 D 174 TYR A 218 TYR^? 10.22 O6 C2E A 301 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -22.65 -25.75 -3.25 -23.90 -23.07 -4.10 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -7.06 -30.30 -3.03 -6.77 -31.63 -1.43 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -6.98 -22.32 0.01 -7.64 -23.76 2.29 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 2 3 # 2 D 14 ARG B 155 ARG^? 22.81 O6 C2E B 301 D 161 ASP B 183 ASP.? 14.33 O1P C2E B 301 D 174 TYR B 179 TYR.? 13.89 O6 C2E B 301 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 6.63 24.44 -23.88 7.74 21.82 -25.04 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -1.79 28.84 -10.63 -0.66 30.31 -9.57 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 2.36 25.70 -10.99 3.98 25.02 -13.14 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 3 3 # 3 D 14 ARG B 155 ARG^? 22.81 O6 C2E B 301 D 161 ASP B 183 ASP.? 14.33 O1P C2E B 301 D 174 TYR B 218 TYR^? 10.08 O6 C2E B 301 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 6.63 24.44 -23.88 7.74 21.82 -25.04 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -1.79 28.84 -10.63 -0.66 30.31 -9.57 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 1.42 21.23 -8.42 3.73 22.73 -7.99 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 4 3 # 4 D 14 ARG B 169 ARG^? -4.70 O6 C2E B 301s D 161 ASP B 183 ASP.? 14.33 O1P C2E B 301 D 174 TYR B 179 TYR.? 13.89 O6 C2E B 301 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -1.79 28.84 -10.63 -0.66 30.31 -9.57 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 2.36 25.70 -10.99 3.98 25.02 -13.14 2c7v_c11 source 2c7v PTERIDINE REDUCTASE : 4 hits 2c7v_c11 naa= 3 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 1 3 # 1 65 THR A 47 THR^? 22.10 N21 C2E A 301 242 CYH A 56 CYH^? 16.49 N21 C2E A 301 270 PHE A 54 PHE^? 19.63 N21 C2E A 301 coo 12.97 28.35 3.84 11.81 28.07 2.09 25.51 -12.99 8.45 26.36 -13.29 6.49 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 14.08 -15.43 10.17 15.14 -13.33 11.76 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 19.69 -16.80 12.43 17.45 -17.09 14.05 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 2 3 # 2 65 THR A 178 THR.? 17.14 O6 C2E A 301 242 CYH A 158 CYH^? 12.92 O6 C2E A 301 270 PHE A 170 PHE^? 8.91 O6 C2E A 301 coo 12.97 28.35 3.84 11.81 28.07 2.09 -9.47 -27.26 4.39 -8.59 -27.66 6.32 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 -15.53 -18.41 0.03 -15.42 -19.19 -2.71 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 -10.47 -19.67 -2.91 -9.94 -22.37 -2.52 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 3 3 # 3 65 THR A 203 THR^? 13.87 C1' C2E A 301 242 CYH A 168 CYH^? -6.21 C2 C2E A 301s 270 PHE A 170 PHE^? 8.91 O6 C2E A 301 coo 12.97 28.35 3.84 11.81 28.07 2.09 -11.63 -25.21 -11.66 -12.74 -26.43 -13.05 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 -6.81 -16.95 -8.49 -9.12 -18.59 -8.00 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 -10.47 -19.67 -2.91 -9.94 -22.37 -2.52 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 4 3 # 4 65 THR B 47 THR^? 21.06 N21 C2E B 301 242 CYH B 56 CYH^? 14.73 N21 C2E B 301 270 PHE B 54 PHE^? 17.95 N21 C2E B 301 coo 12.97 28.35 3.84 11.81 28.07 2.09 -7.68 18.64 22.99 -9.83 18.75 22.86 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 -0.90 19.58 13.61 0.17 17.94 15.62 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 -1.86 22.37 18.66 0.47 22.95 17.25 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 5 3 # 5 65 THR B 48 THR.? 24.30 N21 C2E B 301 242 CYH B 56 CYH^? 14.73 N21 C2E B 301 270 PHE B 54 PHE^? 17.95 N21 C2E B 301 coo 12.97 28.35 3.84 11.81 28.07 2.09 -5.61 19.04 26.16 -4.64 20.96 26.06 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 -0.90 19.58 13.61 0.17 17.94 15.62 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 -1.86 22.37 18.66 0.47 22.95 17.25 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 6 3 # 6 65 THR B 52 THR.? 24.73 N21 C2E B 301 242 CYH B 56 CYH^? 14.73 N21 C2E B 301 270 PHE B 54 PHE^? 17.95 N21 C2E B 301 coo 12.97 28.35 3.84 11.81 28.07 2.09 -7.42 23.88 24.59 -5.77 25.17 25.11 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 -0.90 19.58 13.61 0.17 17.94 15.62 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 -1.86 22.37 18.66 0.47 22.95 17.25 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 7 3 # 7 65 THR B 178 THR.? 16.80 O6 C2E B 301 242 CYH B 158 CYH^? 12.89 O6 C2E B 301 270 PHE B 170 PHE^? 8.84 O6 C2E B 301 coo 12.97 28.35 3.84 11.81 28.07 2.09 6.21 26.30 -8.92 7.28 26.85 -7.15 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 5.78 17.15 -15.63 3.32 17.67 -16.92 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 0.78 18.23 -12.65 0.68 20.98 -12.20 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 8 3 # 8 65 THR B 203 THR^? 13.68 C1' C2E B 301 242 CYH B 168 CYH^? -6.16 C2 C2E B 301s 270 PHE B 170 PHE^? 8.84 O6 C2E B 301 coo 12.97 28.35 3.84 11.81 28.07 2.09 -6.70 22.59 -18.31 -7.42 23.42 -20.17 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 -5.71 15.10 -12.03 -4.45 16.77 -13.95 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 0.78 18.23 -12.65 0.68 20.98 -12.20 2cnd_c01 source 2cnd NADH-DEPENDENT NITRATE REDUCTASE (CYTOCHROME B: 8 hits 2cnd_c01 naa= 3 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 1 3 # 1 A 197 ASP A 162 ASP^? -3.09 N1 C2E A 301s A 233 GLU A 142 GLU^? 10.87 N1 C2E A 301 A 300 ASN A 144 ASN^? 13.31 N1 C2E A 301 coo 12.51 17.07 49.46 12.44 16.89 47.35 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 6.52 19.14 48.16 7.77 18.42 46.61 -5.78 -6.60 -5.54 -5.25 -5.49 -3.81 coo 9.30 22.40 41.76 10.10 20.96 40.36 -14.15 -8.19 -2.40 -12.36 -7.37 -1.59 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 2 3 # 2 A 197 ASP B 162 ASP^? -3.04 N1 C2E B 301s A 233 GLU B 142 GLU^? 10.78 N1 C2E B 301 A 300 ASN B 144 ASN^? 13.28 N1 C2E B 301 coo 12.51 17.07 49.46 12.44 16.89 47.35 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 6.52 19.14 48.16 7.77 18.42 46.61 -2.97 5.35 -8.71 -1.84 4.27 -7.29 coo 9.30 22.40 41.76 10.10 20.96 40.36 3.74 6.70 -14.80 3.60 6.07 -12.77 2cpu_c01 source 2cpu ALPHA-AMYLASE : 2 hits 2cpu_c01 naa= 3 ULMN 3 2dbt_c00 CHITINASE C user 1 3 # 1 A 147 GLU A 142 GLU^? 10.87 N1 C2E A 301 A 156 GLU B 142 GLU^? 10.78 N1 C2E B 301 A 194 ASN A 240 ASN.? 14.36 O21 C2E B 301 coo 74.14 15.91 8.55 72.08 15.36 8.63 -5.78 -6.60 -5.54 -5.25 -5.49 -3.81 coo 67.47 20.07 1.34 65.99 20.06 2.88 -2.97 5.35 -8.71 -1.84 4.27 -7.29 coo 67.44 25.26 13.91 67.54 23.65 15.28 -14.12 0.95 -8.98 -13.19 0.02 -7.31 ULMN 3 2dbt_c00 CHITINASE C user 2 3 # 2 A 147 GLU A 142 GLU^? 10.87 N1 C2E A 301 A 156 GLU B 142 GLU^? 10.78 N1 C2E B 301 A 194 ASN B 240 ASN.? 15.10 N2 C2E A 301 coo 74.14 15.91 8.55 72.08 15.36 8.63 -5.78 -6.60 -5.54 -5.25 -5.49 -3.81 coo 67.47 20.07 1.34 65.99 20.06 2.88 -2.97 5.35 -8.71 -1.84 4.27 -7.29 coo 67.44 25.26 13.91 67.54 23.65 15.28 -1.20 -3.05 -17.04 -0.29 -1.75 -15.62 ULMN 3 2dbt_c00 CHITINASE C user 3 3 # 3 A 147 GLU A 221 GLU^? -4.32 C4' C2E A 301s A 156 GLU A 138 GLU.? 5.46 O2' C2E A 301 A 194 ASN A 228 ASN~? 15.04 O2' C2E A 301 coo 74.14 15.91 8.55 72.08 15.36 8.63 -2.05 -23.28 -12.44 -0.03 -23.89 -12.66 coo 67.47 20.07 1.34 65.99 20.06 2.88 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 coo 67.44 25.26 13.91 67.54 23.65 15.28 -12.40 -21.37 -21.10 -11.00 -22.25 -22.44 ULMN 3 2dbt_c00 CHITINASE C user 4 3 # 4 A 147 GLU B 142 GLU^? 10.78 N1 C2E B 301 A 156 GLU A 142 GLU^? 10.87 N1 C2E A 301 A 194 ASN A 240 ASN.? 14.36 O21 C2E B 301 coo 74.14 15.91 8.55 72.08 15.36 8.63 -2.97 5.35 -8.71 -1.84 4.27 -7.29 coo 67.47 20.07 1.34 65.99 20.06 2.88 -5.78 -6.60 -5.54 -5.25 -5.49 -3.81 coo 67.44 25.26 13.91 67.54 23.65 15.28 -14.12 0.95 -8.98 -13.19 0.02 -7.31 ULMN 3 2dbt_c00 CHITINASE C user 5 3 # 5 A 147 GLU B 142 GLU^? 10.78 N1 C2E B 301 A 156 GLU A 142 GLU^? 10.87 N1 C2E A 301 A 194 ASN B 240 ASN.? 15.10 N2 C2E A 301 coo 74.14 15.91 8.55 72.08 15.36 8.63 -2.97 5.35 -8.71 -1.84 4.27 -7.29 coo 67.47 20.07 1.34 65.99 20.06 2.88 -5.78 -6.60 -5.54 -5.25 -5.49 -3.81 coo 67.44 25.26 13.91 67.54 23.65 15.28 -1.20 -3.05 -17.04 -0.29 -1.75 -15.62 ULMN 3 2dbt_c00 CHITINASE C user 6 3 # 6 A 147 GLU B 221 GLU^? -4.05 C4' C2E B 301s A 156 GLU B 138 GLU.? 5.49 O2' C2E B 301 A 194 ASN B 228 ASN~? 15.22 O2' C2E B 301 coo 74.14 15.91 8.55 72.08 15.36 8.63 -11.86 21.10 -10.14 -13.00 21.71 -8.45 coo 67.47 20.07 1.34 65.99 20.06 2.88 -14.88 11.83 -9.39 -15.29 12.85 -11.20 coo 67.44 25.26 13.91 67.54 23.65 15.28 -14.11 18.31 -23.21 -16.11 19.01 -22.96 2dbt_c00 source 2dbt CHITINASE C : 6 hits 2dbt_c00 naa= 3 ULMN 3 2dbt_c01 CHITINASE C user 1 3 # 1 B 147 GLU A 221 GLU^? -4.32 C4' C2E A 301s B 156 GLU A 138 GLU.? 5.46 O2' C2E A 301 B 194 ASN A 228 ASN~? 15.04 O2' C2E A 301 coo 45.64 63.11 17.20 47.48 62.43 16.45 -2.05 -23.28 -12.44 -0.03 -23.89 -12.66 coo 54.43 67.89 19.82 55.62 67.90 18.07 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 coo 49.79 70.75 7.78 50.10 68.90 6.86 -12.40 -21.37 -21.10 -11.00 -22.25 -22.44 2dbt_c01 source 2dbt CHITINASE C : 1 hits 2dbt_c01 naa= 3 ULMN 3 2dbt_c02 CHITINASE C user 1 3 # 1 C 147 GLU A 142 GLU^? 10.87 N1 C2E A 301 C 156 GLU A 159 GLU^? 13.73 O6 C2E A 301 C 194 ASN A 240 ASN.? 14.36 O21 C2E B 301 coo 41.23 29.31 13.28 43.03 29.85 12.29 -5.78 -6.60 -5.54 -5.25 -5.49 -3.81 coo 44.75 23.09 5.51 46.77 22.91 6.12 -14.60 -12.52 -1.04 -14.41 -10.88 0.31 coo 49.75 21.00 18.12 50.45 23.02 18.26 -14.12 0.95 -8.98 -13.19 0.02 -7.31 ULMN 3 2dbt_c02 CHITINASE C user 2 3 # 2 C 147 GLU A 221 GLU^? -4.32 C4' C2E A 301s C 156 GLU A 138 GLU.? 5.46 O2' C2E A 301 C 194 ASN A 228 ASN~? 15.04 O2' C2E A 301 coo 41.23 29.31 13.28 43.03 29.85 12.29 -2.05 -23.28 -12.44 -0.03 -23.89 -12.66 coo 44.75 23.09 5.51 46.77 22.91 6.12 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 coo 49.75 21.00 18.12 50.45 23.02 18.26 -12.40 -21.37 -21.10 -11.00 -22.25 -22.44 ULMN 3 2dbt_c02 CHITINASE C user 3 3 # 3 C 147 GLU B 221 GLU^? -4.05 C4' C2E B 301s C 156 GLU B 138 GLU.? 5.49 O2' C2E B 301 C 194 ASN B 228 ASN~? 15.22 O2' C2E B 301 coo 41.23 29.31 13.28 43.03 29.85 12.29 -11.86 21.10 -10.14 -13.00 21.71 -8.45 coo 44.75 23.09 5.51 46.77 22.91 6.12 -14.88 11.83 -9.39 -15.29 12.85 -11.20 coo 49.75 21.00 18.12 50.45 23.02 18.26 -14.11 18.31 -23.21 -16.11 19.01 -22.96 2dbt_c02 source 2dbt CHITINASE C : 3 hits 2dbt_c02 naa= 3 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 1 3 # 1 B 182 LYS A 238 LYS^? 19.93 N2 C2E B 301 B 184 LYS A 243 LYS.? 15.17 N2 C2E A 301 B 345 ASP A 192 ASP.? 23.17 N2 C2E A 301 coo 38.76 2.27 4.00 34.00 5.99 4.37 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 coo 40.63 7.13 9.06 35.85 7.36 8.95 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -26.02 -10.21 -8.74 -27.24 -11.85 -9.23 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 2 3 # 2 B 182 LYS A 243 LYS.? 15.17 N2 C2E A 301 B 184 LYS A 238 LYS^? 19.93 N2 C2E B 301 B 345 ASP B 162 ASP^? -3.04 N1 C2E B 301s coo 38.76 2.27 4.00 34.00 5.99 4.37 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo 40.63 7.13 9.06 35.85 7.36 8.95 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -3.96 9.86 -10.13 -4.46 11.57 -9.02 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 3 3 # 3 B 182 LYS B 238 LYS^? 16.50 N2 C2E A 301 B 184 LYS B 243 LYS.? 13.43 N1 C2E B 301 B 345 ASP B 192 ASP.? 23.13 N2 C2E B 301 coo 38.76 2.27 4.00 34.00 5.99 4.37 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 coo 40.63 7.13 9.06 35.85 7.36 8.95 -2.53 1.27 -13.25 2.13 3.70 -10.70 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 3.51 7.73 -28.40 4.69 9.27 -29.24 2dw7_c33 source 2dw7 BLL6730 PROTEIN : 3 hits 2dw7_c33 naa= 3 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 1 3 # 1 L 182 LYS A 238 LYS^? 19.93 N2 C2E B 301 L 184 LYS A 243 LYS.? 15.17 N2 C2E A 301 L 345 ASP A 192 ASP.? 23.17 N2 C2E A 301 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -26.02 -10.21 -8.74 -27.24 -11.85 -9.23 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 2 3 # 2 L 182 LYS A 243 LYS.? 15.17 N2 C2E A 301 L 184 LYS A 238 LYS^? 19.93 N2 C2E B 301 L 345 ASP B 162 ASP^? -3.04 N1 C2E B 301s coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -3.96 9.86 -10.13 -4.46 11.57 -9.02 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 3 3 # 3 L 182 LYS B 238 LYS^? 16.50 N2 C2E A 301 L 184 LYS B 243 LYS.? 13.43 N1 C2E B 301 L 345 ASP B 192 ASP.? 23.13 N2 C2E B 301 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -2.53 1.27 -13.25 2.13 3.70 -10.70 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 3.51 7.73 -28.40 4.69 9.27 -29.24 2dw7_c43 source 2dw7 BLL6730 PROTEIN : 3 hits 2dw7_c43 naa= 3 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 1 3 # 1 M 182 LYS A 238 LYS^? 19.93 N2 C2E B 301 M 184 LYS A 243 LYS.? 15.17 N2 C2E A 301 M 345 ASP A 192 ASP.? 23.17 N2 C2E A 301 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -26.02 -10.21 -8.74 -27.24 -11.85 -9.23 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 2 3 # 2 M 182 LYS A 243 LYS.? 15.17 N2 C2E A 301 M 184 LYS A 238 LYS^? 19.93 N2 C2E B 301 M 345 ASP B 162 ASP^? -3.04 N1 C2E B 301s coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -3.96 9.86 -10.13 -4.46 11.57 -9.02 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 3 3 # 3 M 182 LYS B 238 LYS^? 16.50 N2 C2E A 301 M 184 LYS B 243 LYS.? 13.43 N1 C2E B 301 M 345 ASP B 192 ASP.? 23.13 N2 C2E B 301 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -2.53 1.27 -13.25 2.13 3.70 -10.70 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 3.51 7.73 -28.40 4.69 9.27 -29.24 2dw7_c44 source 2dw7 BLL6730 PROTEIN : 3 hits 2dw7_c44 naa= 3 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 1 3 # 1 P 182 LYS A 238 LYS^? 19.93 N2 C2E B 301 P 184 LYS A 243 LYS.? 15.17 N2 C2E A 301 P 345 ASP A 192 ASP.? 23.17 N2 C2E A 301 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -26.02 -10.21 -8.74 -27.24 -11.85 -9.23 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 2 3 # 2 P 182 LYS A 243 LYS.? 15.17 N2 C2E A 301 P 184 LYS A 238 LYS^? 19.93 N2 C2E B 301 P 345 ASP B 162 ASP^? -3.04 N1 C2E B 301s coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -3.96 9.86 -10.13 -4.46 11.57 -9.02 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 3 3 # 3 P 182 LYS B 238 LYS^? 16.50 N2 C2E A 301 P 184 LYS B 243 LYS.? 13.43 N1 C2E B 301 P 345 ASP B 192 ASP.? 23.13 N2 C2E B 301 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -2.53 1.27 -13.25 2.13 3.70 -10.70 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 3.51 7.73 -28.40 4.69 9.27 -29.24 2dw7_c47 source 2dw7 BLL6730 PROTEIN : 3 hits 2dw7_c47 naa= 3 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 150 TYR A 179 TYR.? 13.95 N7 C2E A 301 A 245 ASP A 152 ASP.? 20.83 C8 C2E A 301 A 273 LYS A 148 LYS^? 21.30 O6 C2E A 301 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 2gsa_c02 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 1 hits 2gsa_c02 naa= 3 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 157 PHE A 190 PHE.? 19.81 N2 C2E A 301 A 245 ASP A 157 ASP^? 20.06 O6 C2E A 301 A 273 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -22.98 -15.99 -5.30 -23.67 -18.09 -3.62 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -19.05 -19.29 2.64 -21.12 -19.53 2.92 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 3 # 2 A 157 PHE B 190 PHE.? 19.75 N2 C2E B 301 A 245 ASP B 157 ASP^? 20.00 O6 C2E B 301 A 273 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 4.85 13.66 -24.57 6.61 15.81 -24.45 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 9.70 18.14 -17.54 10.97 18.31 -19.23 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 8.81 26.59 -11.72 7.46 31.56 -12.94 2gsa_c04 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 2 hits 2gsa_c04 naa= 3 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 1 3 # 1 A 57 HIS A 154 HIS^? 21.74 O6 C2E A 301 A 102 ASP A 152 ASP.? 20.83 C8 C2E A 301 A 193 GLY A 176 GLY.? 18.56 O6 C2E A 301 coo 14.96 29.22 19.55 15.62 29.93 17.67 -16.69 -30.86 2.00 -15.94 -32.47 3.12 coo 19.64 30.69 22.61 18.18 29.94 21.25 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 coo 14.54 28.99 9.76 15.06 29.59 10.02 -14.50 -24.46 6.89 -13.82 -24.67 7.29 2lpr_c02 source 2lpr ALPHA-LYTIC PROTEASE : 1 hits 2lpr_c02 naa= 3 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 177 PHE A 84 PHE.? 23.41 N21 C2E A 301 A 263 ASP A 79 ASP~? 30.21 N21 C2E A 301 A 292 LYS A 75 LYS.? 21.41 N21 C2E A 301 coo 51.51 50.32 16.39 52.13 49.68 13.75 22.11 -15.87 14.74 23.34 -18.33 14.34 coo 54.43 44.82 23.74 55.21 45.06 21.80 19.82 -18.69 22.66 21.43 -19.12 23.96 coo 63.95 45.30 16.71 59.11 49.15 16.05 9.70 -14.41 17.00 6.16 -11.27 19.18 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 A 177 PHE A 85 PHE.? 21.18 N21 C2E A 301 A 263 ASP A 80 ASP~? 23.66 N21 C2E A 301 A 292 LYS A 53 LYS^? 19.63 N21 C2E A 301 coo 51.51 50.32 16.39 52.13 49.68 13.75 18.09 -9.55 15.63 16.44 -8.05 13.97 coo 54.43 44.82 23.74 55.21 45.06 21.80 18.53 -17.34 17.76 18.57 -19.44 17.90 coo 63.95 45.30 16.71 59.11 49.15 16.05 24.14 -17.55 8.54 24.93 -16.56 3.33 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 A 177 PHE A 170 PHE^? 8.91 O6 C2E A 301 A 263 ASP A 157 ASP^? 20.06 O6 C2E A 301 A 292 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo 51.51 50.32 16.39 52.13 49.68 13.75 -10.47 -19.67 -2.91 -9.94 -22.37 -2.52 coo 54.43 44.82 23.74 55.21 45.06 21.80 -19.05 -19.29 2.64 -21.12 -19.53 2.92 coo 63.95 45.30 16.71 59.11 49.15 16.05 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 A 177 PHE A 170 PHE^? 8.91 O6 C2E A 301 A 263 ASP A 183 ASP.? 14.57 O1P C2E A 301 A 292 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo 51.51 50.32 16.39 52.13 49.68 13.75 -10.47 -19.67 -2.91 -9.94 -22.37 -2.52 coo 54.43 44.82 23.74 55.21 45.06 21.80 -7.06 -30.30 -3.03 -6.77 -31.63 -1.43 coo 63.95 45.30 16.71 59.11 49.15 16.05 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 A 177 PHE B 84 PHE~? 21.91 N21 C2E B 301 A 263 ASP B 79 ASP~? 26.97 N21 C2E B 301 A 292 LYS B 75 LYS.? 16.89 N21 C2E B 301 coo 51.51 50.32 16.39 52.13 49.68 13.75 -0.90 22.18 22.15 -2.04 24.70 22.44 coo 54.43 44.82 23.74 55.21 45.06 21.80 6.11 26.78 22.67 4.66 27.50 24.05 coo 63.95 45.30 16.71 59.11 49.15 16.05 7.39 19.64 13.02 10.00 17.22 7.78 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 A 177 PHE B 85 PHE~? 19.52 N21 C2E B 301 A 263 ASP B 80 ASP~? 21.84 N21 C2E B 301 A 292 LYS B 53 LYS^? 20.29 N21 C2E B 301 coo 51.51 50.32 16.39 52.13 49.68 13.75 3.00 15.73 20.69 2.87 13.51 19.06 coo 54.43 44.82 23.74 55.21 45.06 21.80 3.05 24.05 19.78 2.70 26.08 19.35 coo 63.95 45.30 16.71 59.11 49.15 16.05 -7.36 22.58 21.02 -13.56 21.56 20.17 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 A 177 PHE B 170 PHE^? 8.84 O6 C2E B 301 A 263 ASP B 157 ASP^? 20.00 O6 C2E B 301 A 292 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo 51.51 50.32 16.39 52.13 49.68 13.75 0.78 18.23 -12.65 0.68 20.98 -12.20 coo 54.43 44.82 23.74 55.21 45.06 21.80 9.70 18.14 -17.54 10.97 18.31 -19.23 coo 63.95 45.30 16.71 59.11 49.15 16.05 8.81 26.59 -11.72 7.46 31.56 -12.94 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 A 177 PHE B 170 PHE^? 8.84 O6 C2E B 301 A 263 ASP B 183 ASP.? 14.33 O1P C2E B 301 A 292 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo 51.51 50.32 16.39 52.13 49.68 13.75 0.78 18.23 -12.65 0.68 20.98 -12.20 coo 54.43 44.82 23.74 55.21 45.06 21.80 -1.79 28.84 -10.63 -0.66 30.31 -9.57 coo 63.95 45.30 16.71 59.11 49.15 16.05 8.81 26.59 -11.72 7.46 31.56 -12.94 2oat_c03 source 2oat ORNITHINE AMINOTRANSFERASE : 8 hits 2oat_c03 naa= 3 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 B 177 PHE A 54 PHE^? 19.63 N21 C2E A 301 B 263 ASP A 79 ASP~? 30.21 N21 C2E A 301 B 292 LYS A 75 LYS.? 21.41 N21 C2E A 301 coo 49.99 26.05 6.28 51.46 26.87 8.49 19.69 -16.80 12.43 17.45 -17.09 14.05 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 19.82 -18.69 22.66 21.43 -19.12 23.96 coo 60.53 31.67 0.97 57.79 27.51 3.63 9.70 -14.41 17.00 6.16 -11.27 19.18 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 B 177 PHE A 84 PHE.? 23.41 N21 C2E A 301 B 263 ASP A 79 ASP~? 30.21 N21 C2E A 301 B 292 LYS A 75 LYS.? 21.41 N21 C2E A 301 coo 49.99 26.05 6.28 51.46 26.87 8.49 22.11 -15.87 14.74 23.34 -18.33 14.34 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 19.82 -18.69 22.66 21.43 -19.12 23.96 coo 60.53 31.67 0.97 57.79 27.51 3.63 9.70 -14.41 17.00 6.16 -11.27 19.18 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 B 177 PHE A 85 PHE.? 21.18 N21 C2E A 301 B 263 ASP A 80 ASP~? 23.66 N21 C2E A 301 B 292 LYS A 53 LYS^? 19.63 N21 C2E A 301 coo 49.99 26.05 6.28 51.46 26.87 8.49 18.09 -9.55 15.63 16.44 -8.05 13.97 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 18.53 -17.34 17.76 18.57 -19.44 17.90 coo 60.53 31.67 0.97 57.79 27.51 3.63 24.14 -17.55 8.54 24.93 -16.56 3.33 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 B 177 PHE A 170 PHE^? 8.91 O6 C2E A 301 B 263 ASP A 157 ASP^? 20.06 O6 C2E A 301 B 292 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo 49.99 26.05 6.28 51.46 26.87 8.49 -10.47 -19.67 -2.91 -9.94 -22.37 -2.52 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -19.05 -19.29 2.64 -21.12 -19.53 2.92 coo 60.53 31.67 0.97 57.79 27.51 3.63 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 B 177 PHE A 170 PHE^? 8.91 O6 C2E A 301 B 263 ASP A 183 ASP.? 14.57 O1P C2E A 301 B 292 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo 49.99 26.05 6.28 51.46 26.87 8.49 -10.47 -19.67 -2.91 -9.94 -22.37 -2.52 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -7.06 -30.30 -3.03 -6.77 -31.63 -1.43 coo 60.53 31.67 0.97 57.79 27.51 3.63 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 B 177 PHE B 54 PHE^? 17.95 N21 C2E B 301 B 263 ASP B 79 ASP~? 26.97 N21 C2E B 301 B 292 LYS B 75 LYS.? 16.89 N21 C2E B 301 coo 49.99 26.05 6.28 51.46 26.87 8.49 -1.86 22.37 18.66 0.47 22.95 17.25 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 6.11 26.78 22.67 4.66 27.50 24.05 coo 60.53 31.67 0.97 57.79 27.51 3.63 7.39 19.64 13.02 10.00 17.22 7.78 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 B 177 PHE B 84 PHE~? 21.91 N21 C2E B 301 B 263 ASP B 79 ASP~? 26.97 N21 C2E B 301 B 292 LYS B 75 LYS.? 16.89 N21 C2E B 301 coo 49.99 26.05 6.28 51.46 26.87 8.49 -0.90 22.18 22.15 -2.04 24.70 22.44 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 6.11 26.78 22.67 4.66 27.50 24.05 coo 60.53 31.67 0.97 57.79 27.51 3.63 7.39 19.64 13.02 10.00 17.22 7.78 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 B 177 PHE B 85 PHE~? 19.52 N21 C2E B 301 B 263 ASP B 80 ASP~? 21.84 N21 C2E B 301 B 292 LYS B 53 LYS^? 20.29 N21 C2E B 301 coo 49.99 26.05 6.28 51.46 26.87 8.49 3.00 15.73 20.69 2.87 13.51 19.06 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 3.05 24.05 19.78 2.70 26.08 19.35 coo 60.53 31.67 0.97 57.79 27.51 3.63 -7.36 22.58 21.02 -13.56 21.56 20.17 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 9 3 # 9 B 177 PHE B 170 PHE^? 8.84 O6 C2E B 301 B 263 ASP B 157 ASP^? 20.00 O6 C2E B 301 B 292 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo 49.99 26.05 6.28 51.46 26.87 8.49 0.78 18.23 -12.65 0.68 20.98 -12.20 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 9.70 18.14 -17.54 10.97 18.31 -19.23 coo 60.53 31.67 0.97 57.79 27.51 3.63 8.81 26.59 -11.72 7.46 31.56 -12.94 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 10 3 # 10 B 177 PHE B 170 PHE^? 8.84 O6 C2E B 301 B 263 ASP B 183 ASP.? 14.33 O1P C2E B 301 B 292 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo 49.99 26.05 6.28 51.46 26.87 8.49 0.78 18.23 -12.65 0.68 20.98 -12.20 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -1.79 28.84 -10.63 -0.66 30.31 -9.57 coo 60.53 31.67 0.97 57.79 27.51 3.63 8.81 26.59 -11.72 7.46 31.56 -12.94 2oat_c04 source 2oat ORNITHINE AMINOTRANSFERASE : 10 hits 2oat_c04 naa= 3 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 177 PHE A 84 PHE.? 23.41 N21 C2E A 301 C 263 ASP A 79 ASP~? 30.21 N21 C2E A 301 C 292 LYS A 75 LYS.? 21.41 N21 C2E A 301 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 22.11 -15.87 14.74 23.34 -18.33 14.34 coo 19.84 12.02 9.33 18.68 11.23 7.75 19.82 -18.69 22.66 21.43 -19.12 23.96 coo 12.82 3.49 4.98 17.80 5.59 1.90 9.70 -14.41 17.00 6.16 -11.27 19.18 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 C 177 PHE A 85 PHE.? 21.18 N21 C2E A 301 C 263 ASP A 80 ASP~? 23.66 N21 C2E A 301 C 292 LYS A 53 LYS^? 19.63 N21 C2E A 301 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 18.09 -9.55 15.63 16.44 -8.05 13.97 coo 19.84 12.02 9.33 18.68 11.23 7.75 18.53 -17.34 17.76 18.57 -19.44 17.90 coo 12.82 3.49 4.98 17.80 5.59 1.90 24.14 -17.55 8.54 24.93 -16.56 3.33 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 C 177 PHE A 170 PHE^? 8.91 O6 C2E A 301 C 263 ASP A 157 ASP^? 20.06 O6 C2E A 301 C 292 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -10.47 -19.67 -2.91 -9.94 -22.37 -2.52 coo 19.84 12.02 9.33 18.68 11.23 7.75 -19.05 -19.29 2.64 -21.12 -19.53 2.92 coo 12.82 3.49 4.98 17.80 5.59 1.90 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 C 177 PHE A 170 PHE^? 8.91 O6 C2E A 301 C 263 ASP A 183 ASP.? 14.57 O1P C2E A 301 C 292 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -10.47 -19.67 -2.91 -9.94 -22.37 -2.52 coo 19.84 12.02 9.33 18.68 11.23 7.75 -7.06 -30.30 -3.03 -6.77 -31.63 -1.43 coo 12.82 3.49 4.98 17.80 5.59 1.90 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 C 177 PHE B 84 PHE~? 21.91 N21 C2E B 301 C 263 ASP B 79 ASP~? 26.97 N21 C2E B 301 C 292 LYS B 75 LYS.? 16.89 N21 C2E B 301 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -0.90 22.18 22.15 -2.04 24.70 22.44 coo 19.84 12.02 9.33 18.68 11.23 7.75 6.11 26.78 22.67 4.66 27.50 24.05 coo 12.82 3.49 4.98 17.80 5.59 1.90 7.39 19.64 13.02 10.00 17.22 7.78 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 C 177 PHE B 85 PHE~? 19.52 N21 C2E B 301 C 263 ASP B 80 ASP~? 21.84 N21 C2E B 301 C 292 LYS B 53 LYS^? 20.29 N21 C2E B 301 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 3.00 15.73 20.69 2.87 13.51 19.06 coo 19.84 12.02 9.33 18.68 11.23 7.75 3.05 24.05 19.78 2.70 26.08 19.35 coo 12.82 3.49 4.98 17.80 5.59 1.90 -7.36 22.58 21.02 -13.56 21.56 20.17 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 C 177 PHE B 170 PHE^? 8.84 O6 C2E B 301 C 263 ASP B 157 ASP^? 20.00 O6 C2E B 301 C 292 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 0.78 18.23 -12.65 0.68 20.98 -12.20 coo 19.84 12.02 9.33 18.68 11.23 7.75 9.70 18.14 -17.54 10.97 18.31 -19.23 coo 12.82 3.49 4.98 17.80 5.59 1.90 8.81 26.59 -11.72 7.46 31.56 -12.94 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 C 177 PHE B 170 PHE^? 8.84 O6 C2E B 301 C 263 ASP B 183 ASP.? 14.33 O1P C2E B 301 C 292 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 0.78 18.23 -12.65 0.68 20.98 -12.20 coo 19.84 12.02 9.33 18.68 11.23 7.75 -1.79 28.84 -10.63 -0.66 30.31 -9.57 coo 12.82 3.49 4.98 17.80 5.59 1.90 8.81 26.59 -11.72 7.46 31.56 -12.94 2oat_c05 source 2oat ORNITHINE AMINOTRANSFERASE : 8 hits 2oat_c05 naa= 3 ULMN 3 2phk_c02 MC-PEPTIDE user 1 3 # 1 A 149 ASP A 157 ASP^? 20.06 O6 C2E A 301 A 151 LYS A 148 LYS^? 21.30 O6 C2E A 301 A 186 THR A 172 THR^? 12.93 O6 C2E A 301 coo 41.42 17.90 44.98 43.39 18.36 45.61 -19.05 -19.29 2.64 -21.12 -19.53 2.92 coo 45.75 16.58 39.61 47.43 18.26 45.54 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 coo 45.88 23.02 44.72 46.99 21.16 44.68 -12.64 -19.39 3.41 -11.97 -21.32 2.68 ULMN 3 2phk_c02 MC-PEPTIDE user 2 3 # 2 A 149 ASP B 157 ASP^? 20.00 O6 C2E B 301 A 151 LYS B 148 LYS^? 21.33 O6 C2E B 301 A 186 THR B 172 THR^? 12.75 O6 C2E B 301 coo 41.42 17.90 44.98 43.39 18.36 45.61 9.70 18.14 -17.54 10.97 18.31 -19.23 coo 45.75 16.58 39.61 47.43 18.26 45.54 4.64 19.42 -20.28 9.89 19.27 -22.17 coo 45.88 23.02 44.72 46.99 21.16 44.68 7.41 18.34 -11.48 6.25 20.16 -11.39 2phk_c02 source 2phk MC-PEPTIDE : 2 hits 2phk_c02 naa= 3 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 1 3 # 1 B 12 HIS A 215 HIS.? 12.12 O6 C2E A 301 B 40 LYS A 177 LYS.? 20.27 N7 C2E A 301 B 116 HIS A 214 HIS.? 19.24 O6 C2E A 301 coo -6.35 21.42 14.69 -6.06 23.46 15.04 -8.99 -15.19 5.86 -7.58 -13.77 5.21 coo -10.61 31.45 9.72 -8.75 26.69 13.45 -13.21 -27.52 5.04 -11.69 -32.72 3.81 coo -0.95 25.22 19.68 -0.68 26.73 18.24 -9.67 -12.41 11.50 -9.18 -11.33 13.22 2rnf_c03 source 2rnf RIBONUCLEASE 4 : 1 hits 2rnf_c03 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A 31 ASP~? 17.49 O6 C2E B 301 166 GLY A 100 GLY.? 9.32 N2 C2E A 301 169 GLU A 138 GLU.? 5.46 O2' C2E A 301 coo 8.28 6.87 1.62 10.08 5.77 1.34 10.86 4.60 -5.63 10.78 6.65 -6.14 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -0.32 -6.55 -10.22 0.00 -7.00 -9.65 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 2 3 # 2 141 ASP A 31 ASP~? 17.49 O6 C2E B 301 166 GLY B 62 GLY^? 17.93 N11 C2E B 301 169 GLU A 72 GLU^? 18.63 N21 C2E A 301 coo 8.28 6.87 1.62 10.08 5.77 1.34 10.86 4.60 -5.63 10.78 6.65 -6.14 coo -8.58 13.22 3.21 -8.90 13.15 4.05 3.30 2.24 10.89 3.32 2.70 11.63 coo -16.67 7.89 2.78 -17.65 6.56 1.49 6.69 -5.58 14.73 4.83 -6.56 14.45 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 3 3 # 3 141 ASP A 31 ASP~? 17.49 O6 C2E B 301 166 GLY B 241 GLY.? 11.12 N2 C2E A 301 169 GLU A 138 GLU.? 5.46 O2' C2E A 301 coo 8.28 6.87 1.62 10.08 5.77 1.34 10.86 4.60 -5.63 10.78 6.65 -6.14 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -3.59 -4.49 -13.18 -3.25 -3.75 -13.28 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 4 3 # 4 141 ASP A 157 ASP^? 20.06 O6 C2E A 301 166 GLY A 167 GLY^? -3.74 N3 C2E A 301s 169 GLU A 138 GLU.? 5.46 O2' C2E A 301 coo 8.28 6.87 1.62 10.08 5.77 1.34 -19.05 -19.29 2.64 -21.12 -19.53 2.92 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -5.31 -18.58 -11.54 -5.51 -17.84 -11.78 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 5 3 # 5 141 ASP A 157 ASP^? 20.06 O6 C2E A 301 166 GLY A 219 GLY^? -3.43 N7 C2E A 301s 169 GLU A 221 GLU^? -4.32 C4' C2E A 301s coo 8.28 6.87 1.62 10.08 5.77 1.34 -19.05 -19.29 2.64 -21.12 -19.53 2.92 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -3.71 -19.90 -4.28 -4.11 -20.70 -4.09 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -2.05 -23.28 -12.44 -0.03 -23.89 -12.66 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 6 3 # 6 141 ASP A 162 ASP^? -3.09 N1 C2E A 301s 166 GLY B 100 GLY.? 9.19 N2 C2E B 301 169 GLU B 138 GLU.? 5.49 O2' C2E B 301 coo 8.28 6.87 1.62 10.08 5.77 1.34 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -9.60 5.07 -6.19 -9.37 5.54 -5.60 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -14.88 11.83 -9.39 -15.29 12.85 -11.20 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 7 3 # 7 141 ASP A 162 ASP^? -3.09 N1 C2E A 301s 166 GLY B 102 GLY.? 6.96 N71 C2E B 301 169 GLU B 138 GLU.? 5.49 O2' C2E B 301 coo 8.28 6.87 1.62 10.08 5.77 1.34 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -10.38 6.68 -1.43 -11.18 6.52 -1.49 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -14.88 11.83 -9.39 -15.29 12.85 -11.20 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 8 3 # 8 141 ASP B 31 ASP~? 18.26 O6 C2E A 301 166 GLY A 62 GLY^? 19.40 O61 C2E A 301 169 GLU B 72 GLU^? 16.96 N21 C2E B 301 coo 8.28 6.87 1.62 10.08 5.77 1.34 -9.76 -4.11 8.16 -9.75 -6.21 8.42 coo -8.58 13.22 3.21 -8.90 13.15 4.05 7.60 1.25 8.50 8.28 1.00 8.94 coo -16.67 7.89 2.78 -17.65 6.56 1.49 8.42 10.26 11.58 8.84 10.78 9.58 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 9 3 # 9 141 ASP B 31 ASP~? 18.26 O6 C2E A 301 166 GLY A 241 GLY.? 10.63 N2 C2E B 301 169 GLU B 138 GLU.? 5.49 O2' C2E B 301 coo 8.28 6.87 1.62 10.08 5.77 1.34 -9.76 -4.11 8.16 -9.75 -6.21 8.42 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -9.65 2.76 -9.37 -9.85 2.02 -9.06 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -14.88 11.83 -9.39 -15.29 12.85 -11.20 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 10 3 # 10 141 ASP B 31 ASP~? 18.26 O6 C2E A 301 166 GLY B 100 GLY.? 9.19 N2 C2E B 301 169 GLU B 138 GLU.? 5.49 O2' C2E B 301 coo 8.28 6.87 1.62 10.08 5.77 1.34 -9.76 -4.11 8.16 -9.75 -6.21 8.42 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -9.60 5.07 -6.19 -9.37 5.54 -5.60 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -14.88 11.83 -9.39 -15.29 12.85 -11.20 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 11 3 # 11 141 ASP B 157 ASP^? 20.00 O6 C2E B 301 166 GLY B 167 GLY^? -3.69 N3 C2E B 301s 169 GLU B 138 GLU.? 5.49 O2' C2E B 301 coo 8.28 6.87 1.62 10.08 5.77 1.34 9.70 18.14 -17.54 10.97 18.31 -19.23 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -9.22 16.51 -12.20 -9.30 15.75 -12.43 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -14.88 11.83 -9.39 -15.29 12.85 -11.20 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 12 3 # 12 141 ASP B 162 ASP^? -3.04 N1 C2E B 301s 166 GLY A 100 GLY.? 9.32 N2 C2E A 301 169 GLU A 138 GLU.? 5.46 O2' C2E A 301 coo 8.28 6.87 1.62 10.08 5.77 1.34 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -0.32 -6.55 -10.22 0.00 -7.00 -9.65 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 13 3 # 13 141 ASP B 162 ASP^? -3.04 N1 C2E B 301s 166 GLY A 102 GLY.? 6.44 O61 C2E A 301 169 GLU A 138 GLU.? 5.46 O2' C2E A 301 coo 8.28 6.87 1.62 10.08 5.77 1.34 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo -8.58 13.22 3.21 -8.90 13.15 4.05 4.07 -8.14 -8.05 4.42 -7.93 -8.77 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -0.51 -13.89 -15.40 -1.76 -15.14 -16.54 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 13 hits 2tdt_c00 naa= 3 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 A 59 ARG A 99 ARG.? 13.59 O61 C2E B 301 A 130 SER B 97 SER^? 9.09 O61 C2E B 301 A 159 LYS A 243 LYS.? 15.17 N2 C2E A 301 coo 18.35 45.84 20.99 16.20 47.83 21.89 -1.29 -2.34 -4.97 -2.19 0.30 -6.23 coo 15.14 43.67 10.77 15.61 44.43 13.04 -6.95 5.73 2.13 -8.07 3.68 1.50 coo 11.57 48.49 22.18 13.51 49.99 17.21 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 A 59 ARG A 136 ARG.? -3.92 O61 C2E A 301s A 130 SER A 97 SER^? 9.23 O61 C2E A 301 A 159 LYS A 137 LYS.? -4.52 O2' C2E A 301s coo 18.35 45.84 20.99 16.20 47.83 21.89 2.11 -12.17 -9.13 1.08 -10.80 -6.58 coo 15.14 43.67 10.77 15.61 44.43 13.04 5.13 -5.92 -3.45 4.74 -3.92 -4.71 coo 11.57 48.49 22.18 13.51 49.99 17.21 4.32 -14.05 -15.33 0.72 -19.17 -16.51 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 3 3 # 3 A 59 ARG A 136 ARG.? -3.92 O61 C2E A 301s A 130 SER A 133 SER^? 10.46 O4A C2E A 301 A 159 LYS A 137 LYS.? -4.52 O2' C2E A 301s coo 18.35 45.84 20.99 16.20 47.83 21.89 2.11 -12.17 -9.13 1.08 -10.80 -6.58 coo 15.14 43.67 10.77 15.61 44.43 13.04 12.55 -8.09 -9.84 13.31 -9.86 -8.34 coo 11.57 48.49 22.18 13.51 49.99 17.21 4.32 -14.05 -15.33 0.72 -19.17 -16.51 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 4 3 # 4 A 59 ARG A 140 ARG.? -3.36 C5 C2E A 301s A 130 SER A 97 SER^? 9.23 O61 C2E A 301 A 159 LYS A 137 LYS.? -4.52 O2' C2E A 301s coo 18.35 45.84 20.99 16.20 47.83 21.89 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 coo 15.14 43.67 10.77 15.61 44.43 13.04 5.13 -5.92 -3.45 4.74 -3.92 -4.71 coo 11.57 48.49 22.18 13.51 49.99 17.21 4.32 -14.05 -15.33 0.72 -19.17 -16.51 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 5 3 # 5 A 59 ARG B 136 ARG.? -3.89 O61 C2E B 301s A 130 SER B 133 SER^? 10.32 O4A C2E B 301 A 159 LYS B 137 LYS.? -3.23 O3' C2E B 301s coo 18.35 45.84 20.99 16.20 47.83 21.89 -10.39 10.75 -3.93 -7.55 9.68 -3.54 coo 15.14 43.67 10.77 15.61 44.43 13.04 -16.34 7.76 5.39 -15.62 9.78 6.51 coo 11.57 48.49 22.18 13.51 49.99 17.21 -16.98 12.27 -5.28 -15.90 17.15 -6.49 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 6 3 # 6 A 59 ARG B 140 ARG.? -3.40 C5 C2E B 301s A 130 SER B 97 SER^? 9.09 O61 C2E B 301 A 159 LYS B 137 LYS.? -3.23 O3' C2E B 301s coo 18.35 45.84 20.99 16.20 47.83 21.89 -7.91 11.52 -6.78 -7.96 14.04 -5.01 coo 15.14 43.67 10.77 15.61 44.43 13.04 -6.95 5.73 2.13 -8.07 3.68 1.50 coo 11.57 48.49 22.18 13.51 49.99 17.21 -16.98 12.27 -5.28 -15.90 17.15 -6.49 2tps_c00 source 2tps THIAMIN PHOSPHATE SYNTHASE : 6 hits 2tps_c00 naa= 3 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 B 59 ARG A 99 ARG.? 13.59 O61 C2E B 301 B 130 SER B 97 SER^? 9.09 O61 C2E B 301 B 159 LYS A 243 LYS.? 15.17 N2 C2E A 301 coo 58.72 31.58 20.45 60.80 29.39 20.94 -1.29 -2.34 -4.97 -2.19 0.30 -6.23 coo 61.66 35.17 10.39 61.29 34.14 12.56 -6.95 5.73 2.13 -8.07 3.68 1.50 coo 65.38 28.77 21.17 63.49 28.03 16.12 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 B 59 ARG A 136 ARG.? -3.92 O61 C2E A 301s B 130 SER A 133 SER^? 10.46 O4A C2E A 301 B 159 LYS A 137 LYS.? -4.52 O2' C2E A 301s coo 58.72 31.58 20.45 60.80 29.39 20.94 2.11 -12.17 -9.13 1.08 -10.80 -6.58 coo 61.66 35.17 10.39 61.29 34.14 12.56 12.55 -8.09 -9.84 13.31 -9.86 -8.34 coo 65.38 28.77 21.17 63.49 28.03 16.12 4.32 -14.05 -15.33 0.72 -19.17 -16.51 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 3 3 # 3 B 59 ARG A 140 ARG.? -3.36 C5 C2E A 301s B 130 SER A 97 SER^? 9.23 O61 C2E A 301 B 159 LYS A 137 LYS.? -4.52 O2' C2E A 301s coo 58.72 31.58 20.45 60.80 29.39 20.94 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 coo 61.66 35.17 10.39 61.29 34.14 12.56 5.13 -5.92 -3.45 4.74 -3.92 -4.71 coo 65.38 28.77 21.17 63.49 28.03 16.12 4.32 -14.05 -15.33 0.72 -19.17 -16.51 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 4 3 # 4 B 59 ARG B 136 ARG.? -3.89 O61 C2E B 301s B 130 SER B 133 SER^? 10.32 O4A C2E B 301 B 159 LYS B 137 LYS.? -3.23 O3' C2E B 301s coo 58.72 31.58 20.45 60.80 29.39 20.94 -10.39 10.75 -3.93 -7.55 9.68 -3.54 coo 61.66 35.17 10.39 61.29 34.14 12.56 -16.34 7.76 5.39 -15.62 9.78 6.51 coo 65.38 28.77 21.17 63.49 28.03 16.12 -16.98 12.27 -5.28 -15.90 17.15 -6.49 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 5 3 # 5 B 59 ARG B 140 ARG.? -3.40 C5 C2E B 301s B 130 SER B 97 SER^? 9.09 O61 C2E B 301 B 159 LYS B 137 LYS.? -3.23 O3' C2E B 301s coo 58.72 31.58 20.45 60.80 29.39 20.94 -7.91 11.52 -6.78 -7.96 14.04 -5.01 coo 61.66 35.17 10.39 61.29 34.14 12.56 -6.95 5.73 2.13 -8.07 3.68 1.50 coo 65.38 28.77 21.17 63.49 28.03 16.12 -16.98 12.27 -5.28 -15.90 17.15 -6.49 2tps_c01 source 2tps THIAMIN PHOSPHATE SYNTHASE : 5 hits 2tps_c01 naa= 3 ULMN 3 2xis_c00 XYLOSE ISOMERASE (E.C.5.3.1.5) COMPLuser 1 3 # 1 183 LYS A 177 LYS.? 20.27 N7 C2E A 301 220 HIS A 154 HIS^? 21.74 O6 C2E A 301 255 ASP A 152 ASP.? 20.83 C8 C2E A 301 coo 11.94 40.77 50.56 7.67 36.15 49.76 -13.21 -27.52 5.04 -11.69 -32.72 3.81 coo 10.50 40.09 46.76 10.54 37.99 46.56 -16.69 -30.86 2.00 -15.94 -32.47 3.12 coo 4.47 38.05 47.65 5.63 36.87 46.50 -15.35 -34.35 -1.82 -13.48 -35.18 -2.37 2xis_c00 source 2xis XYLOSE ISOMERASE (E.C.5.3.1.5) COMPLEX WITH XY: 1 hits 2xis_c00 naa= 3 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 1 3 # 1 71 ARG A 136 ARG.? -3.92 O61 C2E A 301s 127 ARG A 140 ARG.? -3.36 C5 C2E A 301s 270 GLU A 37 GLU.? 10.20 O61 C2E A 301 coo -1.14 25.72 1.64 0.76 28.10 1.50 2.11 -12.17 -9.13 1.08 -10.80 -6.58 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 0.90 -3.13 0.80 -0.70 -4.43 0.36 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 2 3 # 2 71 ARG A 136 ARG.? -3.92 O61 C2E A 301s 127 ARG A 140 ARG.? -3.36 C5 C2E A 301s 270 GLU A 221 GLU^? -4.32 C4' C2E A 301s coo -1.14 25.72 1.64 0.76 28.10 1.50 2.11 -12.17 -9.13 1.08 -10.80 -6.58 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -2.05 -23.28 -12.44 -0.03 -23.89 -12.66 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 3 3 # 3 71 ARG A 140 ARG.? -3.36 C5 C2E A 301s 127 ARG A 136 ARG.? -3.92 O61 C2E A 301s 270 GLU A 37 GLU.? 10.20 O61 C2E A 301 coo -1.14 25.72 1.64 0.76 28.10 1.50 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 2.11 -12.17 -9.13 1.08 -10.80 -6.58 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 0.90 -3.13 0.80 -0.70 -4.43 0.36 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 4 3 # 4 71 ARG A 140 ARG.? -3.36 C5 C2E A 301s 127 ARG A 136 ARG.? -3.92 O61 C2E A 301s 270 GLU A 221 GLU^? -4.32 C4' C2E A 301s coo -1.14 25.72 1.64 0.76 28.10 1.50 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 2.11 -12.17 -9.13 1.08 -10.80 -6.58 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -2.05 -23.28 -12.44 -0.03 -23.89 -12.66 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 5 3 # 5 71 ARG A 140 ARG.? -3.36 C5 C2E A 301s 127 ARG A 169 ARG^? -4.75 O6 C2E A 301s 270 GLU A 37 GLU.? 10.20 O61 C2E A 301 coo -1.14 25.72 1.64 0.76 28.10 1.50 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 0.90 -3.13 0.80 -0.70 -4.43 0.36 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 6 3 # 6 71 ARG A 140 ARG.? -3.36 C5 C2E A 301s 127 ARG A 169 ARG^? -4.75 O6 C2E A 301s 270 GLU A 221 GLU^? -4.32 C4' C2E A 301s coo -1.14 25.72 1.64 0.76 28.10 1.50 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -2.05 -23.28 -12.44 -0.03 -23.89 -12.66 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 7 3 # 7 71 ARG A 161 ARG^? 11.81 O6 C2E A 301 127 ARG A 169 ARG^? -4.75 O6 C2E A 301s 270 GLU A 37 GLU.? 10.20 O61 C2E A 301 coo -1.14 25.72 1.64 0.76 28.10 1.50 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 0.90 -3.13 0.80 -0.70 -4.43 0.36 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 8 3 # 8 71 ARG A 169 ARG^? -4.75 O6 C2E A 301s 127 ARG A 140 ARG.? -3.36 C5 C2E A 301s 270 GLU A 37 GLU.? 10.20 O61 C2E A 301 coo -1.14 25.72 1.64 0.76 28.10 1.50 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 0.90 -3.13 0.80 -0.70 -4.43 0.36 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 9 3 # 9 71 ARG A 169 ARG^? -4.75 O6 C2E A 301s 127 ARG A 140 ARG.? -3.36 C5 C2E A 301s 270 GLU A 221 GLU^? -4.32 C4' C2E A 301s coo -1.14 25.72 1.64 0.76 28.10 1.50 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -2.05 -23.28 -12.44 -0.03 -23.89 -12.66 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 10 3 # 10 71 ARG A 169 ARG^? -4.75 O6 C2E A 301s 127 ARG A 161 ARG^? 11.81 O6 C2E A 301 270 GLU A 37 GLU.? 10.20 O61 C2E A 301 coo -1.14 25.72 1.64 0.76 28.10 1.50 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 0.90 -3.13 0.80 -0.70 -4.43 0.36 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 11 3 # 11 71 ARG A 169 ARG^? -4.75 O6 C2E A 301s 127 ARG A 217 ARG^? 6.70 O6 C2E A 301 270 GLU A 37 GLU.? 10.20 O61 C2E A 301 coo -1.14 25.72 1.64 0.76 28.10 1.50 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -3.36 -16.18 0.94 -0.54 -17.39 0.83 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 0.90 -3.13 0.80 -0.70 -4.43 0.36 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 12 3 # 12 71 ARG A 217 ARG^? 6.70 O6 C2E A 301 127 ARG A 169 ARG^? -4.75 O6 C2E A 301s 270 GLU A 37 GLU.? 10.20 O61 C2E A 301 coo -1.14 25.72 1.64 0.76 28.10 1.50 -3.36 -16.18 0.94 -0.54 -17.39 0.83 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 0.90 -3.13 0.80 -0.70 -4.43 0.36 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 13 3 # 13 71 ARG B 136 ARG.? -3.89 O61 C2E B 301s 127 ARG B 140 ARG.? -3.40 C5 C2E B 301s 270 GLU B 37 GLU.? 9.39 O61 C2E B 301 coo -1.14 25.72 1.64 0.76 28.10 1.50 -10.39 10.75 -3.93 -7.55 9.68 -3.54 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -7.91 11.52 -6.78 -7.96 14.04 -5.01 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -0.62 3.88 0.75 -0.32 4.81 -1.12 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 14 3 # 14 71 ARG B 136 ARG.? -3.89 O61 C2E B 301s 127 ARG B 140 ARG.? -3.40 C5 C2E B 301s 270 GLU B 221 GLU^? -4.05 C4' C2E B 301s coo -1.14 25.72 1.64 0.76 28.10 1.50 -10.39 10.75 -3.93 -7.55 9.68 -3.54 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -7.91 11.52 -6.78 -7.96 14.04 -5.01 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -11.86 21.10 -10.14 -13.00 21.71 -8.45 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 15 3 # 15 71 ARG B 140 ARG.? -3.40 C5 C2E B 301s 127 ARG B 136 ARG.? -3.89 O61 C2E B 301s 270 GLU B 37 GLU.? 9.39 O61 C2E B 301 coo -1.14 25.72 1.64 0.76 28.10 1.50 -7.91 11.52 -6.78 -7.96 14.04 -5.01 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -10.39 10.75 -3.93 -7.55 9.68 -3.54 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -0.62 3.88 0.75 -0.32 4.81 -1.12 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 16 3 # 16 71 ARG B 140 ARG.? -3.40 C5 C2E B 301s 127 ARG B 136 ARG.? -3.89 O61 C2E B 301s 270 GLU B 221 GLU^? -4.05 C4' C2E B 301s coo -1.14 25.72 1.64 0.76 28.10 1.50 -7.91 11.52 -6.78 -7.96 14.04 -5.01 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -10.39 10.75 -3.93 -7.55 9.68 -3.54 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -11.86 21.10 -10.14 -13.00 21.71 -8.45 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 17 3 # 17 71 ARG B 140 ARG.? -3.40 C5 C2E B 301s 127 ARG B 169 ARG^? -4.70 O6 C2E B 301s 270 GLU B 37 GLU.? 9.39 O61 C2E B 301 coo -1.14 25.72 1.64 0.76 28.10 1.50 -7.91 11.52 -6.78 -7.96 14.04 -5.01 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -0.62 3.88 0.75 -0.32 4.81 -1.12 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 18 3 # 18 71 ARG B 140 ARG.? -3.40 C5 C2E B 301s 127 ARG B 169 ARG^? -4.70 O6 C2E B 301s 270 GLU B 221 GLU^? -4.05 C4' C2E B 301s coo -1.14 25.72 1.64 0.76 28.10 1.50 -7.91 11.52 -6.78 -7.96 14.04 -5.01 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -11.86 21.10 -10.14 -13.00 21.71 -8.45 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 19 3 # 19 71 ARG B 161 ARG^? 11.68 O6 C2E B 301 127 ARG B 169 ARG^? -4.70 O6 C2E B 301s 270 GLU B 37 GLU.? 9.39 O61 C2E B 301 coo -1.14 25.72 1.64 0.76 28.10 1.50 2.96 9.64 -10.71 5.59 9.57 -9.11 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -0.62 3.88 0.75 -0.32 4.81 -1.12 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 20 3 # 20 71 ARG B 169 ARG^? -4.70 O6 C2E B 301s 127 ARG B 140 ARG.? -3.40 C5 C2E B 301s 270 GLU B 37 GLU.? 9.39 O61 C2E B 301 coo -1.14 25.72 1.64 0.76 28.10 1.50 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -7.91 11.52 -6.78 -7.96 14.04 -5.01 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -0.62 3.88 0.75 -0.32 4.81 -1.12 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 21 3 # 21 71 ARG B 169 ARG^? -4.70 O6 C2E B 301s 127 ARG B 140 ARG.? -3.40 C5 C2E B 301s 270 GLU B 221 GLU^? -4.05 C4' C2E B 301s coo -1.14 25.72 1.64 0.76 28.10 1.50 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -7.91 11.52 -6.78 -7.96 14.04 -5.01 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -11.86 21.10 -10.14 -13.00 21.71 -8.45 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 22 3 # 22 71 ARG B 169 ARG^? -4.70 O6 C2E B 301s 127 ARG B 161 ARG^? 11.68 O6 C2E B 301 270 GLU B 37 GLU.? 9.39 O61 C2E B 301 coo -1.14 25.72 1.64 0.76 28.10 1.50 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 2.96 9.64 -10.71 5.59 9.57 -9.11 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -0.62 3.88 0.75 -0.32 4.81 -1.12 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 23 3 # 23 71 ARG B 169 ARG^? -4.70 O6 C2E B 301s 127 ARG B 217 ARG^? 6.37 O6 C2E B 301 270 GLU B 37 GLU.? 9.39 O61 C2E B 301 coo -1.14 25.72 1.64 0.76 28.10 1.50 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 0.82 15.44 -4.45 -0.87 16.78 -2.26 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -0.62 3.88 0.75 -0.32 4.81 -1.12 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 24 3 # 24 71 ARG B 169 ARG^? -4.70 O6 C2E B 301s 127 ARG B 217 ARG^? 6.37 O6 C2E B 301 270 GLU B 41 GLU^? 7.72 N21 C2E B 301 coo -1.14 25.72 1.64 0.76 28.10 1.50 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 0.82 15.44 -4.45 -0.87 16.78 -2.26 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 0.46 14.98 6.85 0.80 16.86 5.93 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 25 3 # 25 71 ARG B 217 ARG^? 6.37 O6 C2E B 301 127 ARG B 169 ARG^? -4.70 O6 C2E B 301s 270 GLU B 37 GLU.? 9.39 O61 C2E B 301 coo -1.14 25.72 1.64 0.76 28.10 1.50 0.82 15.44 -4.45 -0.87 16.78 -2.26 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -0.62 3.88 0.75 -0.32 4.81 -1.12 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 26 3 # 26 71 ARG B 217 ARG^? 6.37 O6 C2E B 301 127 ARG B 169 ARG^? -4.70 O6 C2E B 301s 270 GLU B 41 GLU^? 7.72 N21 C2E B 301 coo -1.14 25.72 1.64 0.76 28.10 1.50 0.82 15.44 -4.45 -0.87 16.78 -2.26 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -0.88 13.03 -7.12 -1.56 12.92 -4.13 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 0.46 14.98 6.85 0.80 16.86 5.93 5cpa_c01 source 5cpa CARBOXYPEPTIDASE A=ALPHA= (COX) (E.C.3.4.17.1): 26 hits 5cpa_c01 naa= 3 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 1 3 # 1 83 GLN A 210 GLN^? 10.02 N21 C2E A 301 94 HIS A 214 HIS.? 19.24 O6 C2E A 301 96 HIS A 215 HIS.? 12.12 O6 C2E A 301 coo 12.06 13.83 19.61 9.96 13.82 20.00 -0.56 -17.78 5.17 0.90 -18.94 6.19 coo 15.69 26.32 19.80 17.39 27.17 20.68 -9.67 -12.41 11.50 -9.18 -11.33 13.22 coo 14.38 20.59 22.16 12.49 20.21 21.35 -8.99 -15.19 5.86 -7.58 -13.77 5.21 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 2 3 # 2 83 GLN B 210 GLN^? 10.10 N21 C2E B 301 94 HIS B 214 HIS.? 18.94 O6 C2E B 301 96 HIS B 215 HIS.? 11.93 O6 C2E B 301 coo 12.06 13.83 19.61 9.96 13.82 20.00 3.27 17.31 -0.03 3.59 18.55 1.68 coo 15.69 26.32 19.80 17.39 27.17 20.68 13.04 11.66 -4.90 14.49 10.59 -3.83 coo 14.38 20.59 22.16 12.49 20.21 21.35 7.81 14.24 -7.06 6.68 12.76 -6.10 5fit_c00 source 5fit FRAGILE HISTIDINE TRIAD PROTEIN : 2 hits 5fit_c00 naa= 3 ULMN 3 7atj_c00 PEROXIDASE C1A user 1 3 # 1 A 38 ARG A 94 ARG^? 4.68 N21 C2E A 301 A 42 HIS A 106 HIS^? 11.03 N21 C2E A 301 A 70 ASN A 92 ASN^? 17.86 N21 C2E A 301 coo 1.39 6.34 11.43 0.09 6.19 8.61 12.55 -12.80 -0.72 10.33 -14.85 -0.21 coo 5.40 8.25 8.15 4.09 6.62 7.93 16.26 -9.68 -2.62 15.33 -11.56 -2.56 coo 1.54 10.80 4.23 3.44 10.57 5.15 20.53 -10.46 2.38 22.65 -10.55 2.18 ULMN 3 7atj_c00 PEROXIDASE C1A user 2 3 # 2 A 38 ARG B 94 ARG^? 9.81 N31 C2E B 301 A 42 HIS B 106 HIS^? 12.57 N21 C2E B 301 A 70 ASN B 92 ASN^? 16.92 N21 C2E B 301 coo 1.39 6.34 11.43 0.09 6.19 8.61 -10.06 14.66 9.70 -12.88 15.81 9.44 coo 5.40 8.25 8.15 4.09 6.62 7.93 -12.23 11.16 12.34 -12.16 12.93 13.45 coo 1.54 10.80 4.23 3.44 10.57 5.15 -10.13 13.62 16.73 -11.46 13.70 18.39 7atj_c00 source 7atj PEROXIDASE C1A : 2 hits 7atj_c00 naa= 3 ULMN 3 1k12_p00 LECTIN user 1 3 # 1 A 52 HIS A 215 HIS.? 12.12 O6 C2E A 301 A 79 ARG A 161 ARG^? 11.81 O6 C2E A 301 A 86 ARG A 169 ARG^? -4.75 O6 C2E A 301s coo -5.53 26.98 5.69 -5.98 25.70 4.09 -8.99 -15.19 5.86 -7.58 -13.77 5.21 coo -12.15 26.35 6.05 -10.94 27.19 3.35 -10.10 -10.87 -0.83 -10.13 -10.47 2.22 coo -9.59 20.48 4.28 -9.21 22.28 1.82 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 ULMN 3 1k12_p00 LECTIN user 2 3 # 2 A 52 HIS B 215 HIS.? 11.93 O6 C2E B 301 A 79 ARG B 161 ARG^? 11.68 O6 C2E B 301 A 86 ARG B 169 ARG^? -4.70 O6 C2E B 301s coo -5.53 26.98 5.69 -5.98 25.70 4.09 7.81 14.24 -7.06 6.68 12.76 -6.10 coo -12.15 26.35 6.05 -10.94 27.19 3.35 2.96 9.64 -10.71 5.59 9.57 -9.11 coo -9.59 20.48 4.28 -9.21 22.28 1.82 -0.88 13.03 -7.12 -1.56 12.92 -4.13 1k12_p00 source 1k12 LECTIN : 2 hits 1k12_p00 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 28 ASN^? 20.35 O6 C2E B 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 15.77 5.79 -5.14 13.72 6.29 -5.09 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 92 ASN^? 17.86 N21 C2E A 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 20.53 -10.46 2.38 22.65 -10.55 2.18 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN A 128 ASN.? 25.99 N21 C2E A 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 21.53 5.18 -1.81 23.00 4.01 -2.79 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN A 144 ASN^? 13.31 N1 C2E A 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 -14.15 -8.19 -2.40 -12.36 -7.37 -1.59 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 5 1 # 5 A 461 ASN A 208 ASN^? -3.55 N7 C2E A 301s coo 5.80 63.03 55.85 5.52 65.03 56.45 0.54 -21.32 -2.29 -0.50 -19.83 -3.42 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 6 1 # 6 A 461 ASN A 223 ASN~? 12.71 O4' C2E A 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 -7.68 -27.50 -15.35 -9.79 -27.31 -15.11 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 7 1 # 7 A 461 ASN A 228 ASN~? 15.04 O2' C2E A 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 -12.40 -21.37 -21.10 -11.00 -22.25 -22.44 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 8 1 # 8 A 461 ASN A 229 ASN~? 15.85 N2 C2E A 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 -14.86 -20.46 -16.50 -16.06 -21.98 -17.43 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 9 1 # 9 A 461 ASN A 232 ASN~? 17.05 N2 C2E A 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 -16.23 -15.79 -19.65 -16.12 -16.52 -21.66 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 10 1 # 10 A 461 ASN A 240 ASN.? 14.36 O21 C2E B 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 -14.12 0.95 -8.98 -13.19 0.02 -7.31 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 11 1 # 11 A 461 ASN A 247 ASN.? 20.89 N2 C2E A 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 -22.93 -5.45 -13.51 -21.77 -5.11 -15.27 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 12 1 # 12 A 461 ASN B 28 ASN^? 21.32 O6 C2E A 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 -11.70 -4.36 12.92 -10.66 -5.13 11.24 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 13 1 # 13 A 461 ASN B 92 ASN^? 16.92 N21 C2E B 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 -10.13 13.62 16.73 -11.46 13.70 18.39 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 14 1 # 14 A 461 ASN B 128 ASN.? 26.38 N21 C2E B 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 -11.93 -1.97 19.36 -11.20 -2.52 21.28 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 15 1 # 15 A 461 ASN B 144 ASN^? 13.28 N1 C2E B 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 3.74 6.70 -14.80 3.60 6.07 -12.77 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 16 1 # 16 A 461 ASN B 208 ASN^? -3.47 N7 C2E B 301s coo 5.80 63.03 55.85 5.52 65.03 56.45 -4.15 20.35 -2.93 -4.56 18.73 -4.26 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 17 1 # 17 A 461 ASN B 223 ASN~? 12.46 O4' C2E B 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 -12.01 24.89 -16.85 -10.55 24.64 -18.38 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 18 1 # 18 A 461 ASN B 228 ASN~? 15.22 O2' C2E B 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 -14.11 18.31 -23.21 -16.11 19.01 -22.96 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 19 1 # 19 A 461 ASN B 229 ASN~? 15.65 N2 C2E B 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 -8.99 17.44 -22.98 -9.26 18.88 -24.54 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 20 1 # 20 A 461 ASN B 232 ASN~? 16.84 N2 C2E B 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 -10.52 12.92 -25.16 -9.28 12.34 -26.79 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 21 1 # 21 A 461 ASN B 240 ASN.? 15.10 N2 C2E A 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 -1.20 -3.05 -17.04 -0.29 -1.75 -15.62 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 22 1 # 22 A 461 ASN B 247 ASN.? 19.62 N2 C2E B 301 coo 5.80 63.03 55.85 5.52 65.03 56.45 -3.12 1.72 -26.52 -4.85 1.23 -25.38 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 22 hits 1kbk_p00 naa= 1 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 1 3 # 1 A 44 ASN A 232 ASN~? 17.05 N2 C2E A 301 A 213 PRO A 200 PRO.? 16.97 N2 C2E A 301 A 219 ASN A 247 ASN.? 20.89 N2 C2E A 301 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 -16.23 -15.79 -19.65 -16.12 -16.52 -21.66 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 -18.78 -19.95 -16.50 -19.70 -20.49 -14.54 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 -22.93 -5.45 -13.51 -21.77 -5.11 -15.27 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 2 3 # 2 A 44 ASN A 240 ASN.? 14.36 O21 C2E B 301 A 213 PRO B 139 PRO.? 8.10 O21 C2E B 301 A 219 ASN A 247 ASN.? 20.89 N2 C2E A 301 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 -14.12 0.95 -8.98 -13.19 0.02 -7.31 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 -13.87 6.40 -9.82 -13.12 7.94 -8.40 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 -22.93 -5.45 -13.51 -21.77 -5.11 -15.27 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 3 3 # 3 A 44 ASN B 232 ASN~? 16.84 N2 C2E B 301 A 213 PRO B 200 PRO.? 17.33 N2 C2E B 301 A 219 ASN B 247 ASN.? 19.62 N2 C2E B 301 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 -10.52 12.92 -25.16 -9.28 12.34 -26.79 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 -7.10 16.45 -27.58 -5.34 17.02 -26.33 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 -3.12 1.72 -26.52 -4.85 1.23 -25.38 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 4 3 # 4 A 44 ASN B 240 ASN.? 15.10 N2 C2E A 301 A 213 PRO A 139 PRO.? 8.20 O21 C2E A 301 A 219 ASN B 247 ASN.? 19.62 N2 C2E B 301 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 -1.20 -3.05 -17.04 -0.29 -1.75 -15.62 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 -1.56 -8.49 -15.18 -0.50 -9.89 -13.81 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 -3.12 1.72 -26.52 -4.85 1.23 -25.38 1wbf_p00 source 1wbf PROTEIN (AGGLUTININ) : 4 hits 1wbf_p00 naa= 3 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 1 3 # 1 A 26 HIS A 214 HIS.? 19.24 O6 C2E A 301 A 76 ASN B 28 ASN^? 21.32 O6 C2E A 301 A 81 ASP B 31 ASP~? 18.26 O6 C2E A 301 coo 4.09 43.69 67.89 2.45 42.40 68.10 -9.67 -12.41 11.50 -9.18 -11.33 13.22 coo 4.75 48.17 75.81 4.99 47.30 77.74 -11.70 -4.36 12.92 -10.66 -5.13 11.24 coo 0.57 50.41 73.18 0.46 48.28 73.56 -9.76 -4.11 8.16 -9.75 -6.21 8.42 2c3x_p00 source 2c3x ALPHA-AMYLASE G-6 : 1 hits 2c3x_p00 naa= 3 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 1 3 # 1 A 459 ASN A 228 ASN~? 15.04 O2' C2E A 301 A 460 GLY A 226 GLY~? 11.67 C1' C2E A 301 A 461 ASN A 229 ASN~? 15.85 N2 C2E A 301 coo 15.00 94.38 6.97 13.00 93.59 6.99 -12.40 -21.37 -21.10 -11.00 -22.25 -22.44 coo 19.48 94.04 5.03 19.26 94.00 5.78 -10.93 -22.84 -15.51 -10.72 -22.76 -16.32 coo 20.23 95.69 9.16 21.55 97.37 9.20 -14.86 -20.46 -16.50 -16.06 -21.98 -17.43 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 2 3 # 2 A 459 ASN A 229 ASN~? 15.85 N2 C2E A 301 A 460 GLY A 226 GLY~? 11.67 C1' C2E A 301 A 461 ASN A 228 ASN~? 15.04 O2' C2E A 301 coo 15.00 94.38 6.97 13.00 93.59 6.99 -14.86 -20.46 -16.50 -16.06 -21.98 -17.43 coo 19.48 94.04 5.03 19.26 94.00 5.78 -10.93 -22.84 -15.51 -10.72 -22.76 -16.32 coo 20.23 95.69 9.16 21.55 97.37 9.20 -12.40 -21.37 -21.10 -11.00 -22.25 -22.44 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 3 3 # 3 A 459 ASN B 228 ASN~? 15.22 O2' C2E B 301 A 460 GLY B 226 GLY~? 11.47 O2' C2E B 301 A 461 ASN B 229 ASN~? 15.65 N2 C2E B 301 coo 15.00 94.38 6.97 13.00 93.59 6.99 -14.11 18.31 -23.21 -16.11 19.01 -22.96 coo 19.48 94.04 5.03 19.26 94.00 5.78 -10.34 20.15 -19.24 -11.11 20.04 -19.49 coo 20.23 95.69 9.16 21.55 97.37 9.20 -8.99 17.44 -22.98 -9.26 18.88 -24.54 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 4 3 # 4 A 459 ASN B 229 ASN~? 15.65 N2 C2E B 301 A 460 GLY B 226 GLY~? 11.47 O2' C2E B 301 A 461 ASN B 228 ASN~? 15.22 O2' C2E B 301 coo 15.00 94.38 6.97 13.00 93.59 6.99 -8.99 17.44 -22.98 -9.26 18.88 -24.54 coo 19.48 94.04 5.03 19.26 94.00 5.78 -10.34 20.15 -19.24 -11.11 20.04 -19.49 coo 20.23 95.69 9.16 21.55 97.37 9.20 -14.11 18.31 -23.21 -16.11 19.01 -22.96 2qv4_p00 source 2qv4 PANCREATIC ALPHA-AMYLASE : 4 hits 2qv4_p00 naa= 3 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 1 3 # 1 A 270 ASN A 208 ASN^? -3.55 N7 C2E A 301s A 384 ASN A 228 ASN~? 15.04 O2' C2E A 301 A 385 GLU A 224 GLU~? 15.93 O2' C2E A 301 coo 22.28 63.17 110.61 22.47 65.06 111.53 0.54 -21.32 -2.29 -0.50 -19.83 -3.42 coo 7.06 50.07 96.17 8.50 48.54 96.31 -12.40 -21.37 -21.10 -11.00 -22.25 -22.44 coo 11.59 49.83 99.41 10.92 47.97 100.16 -8.40 -25.77 -21.72 -8.05 -26.98 -23.42 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 2 3 # 2 A 270 ASN A 208 ASN^? -3.55 N7 C2E A 301s A 384 ASN A 228 ASN~? 15.04 O2' C2E A 301 A 385 GLU A 225 GLU~? 17.61 C1' C2E A 301 coo 22.28 63.17 110.61 22.47 65.06 111.53 0.54 -21.32 -2.29 -0.50 -19.83 -3.42 coo 7.06 50.07 96.17 8.50 48.54 96.31 -12.40 -21.37 -21.10 -11.00 -22.25 -22.44 coo 11.59 49.83 99.41 10.92 47.97 100.16 -14.07 -25.95 -18.02 -15.34 -27.27 -16.96 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 3 3 # 3 A 270 ASN A 223 ASN~? 12.71 O4' C2E A 301 A 384 ASN A 144 ASN^? 13.31 N1 C2E A 301 A 385 GLU A 159 GLU^? 13.73 O6 C2E A 301 coo 22.28 63.17 110.61 22.47 65.06 111.53 -7.68 -27.50 -15.35 -9.79 -27.31 -15.11 coo 7.06 50.07 96.17 8.50 48.54 96.31 -14.15 -8.19 -2.40 -12.36 -7.37 -1.59 coo 11.59 49.83 99.41 10.92 47.97 100.16 -14.60 -12.52 -1.04 -14.41 -10.88 0.31 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 4 3 # 4 A 270 ASN A 223 ASN~? 12.71 O4' C2E A 301 A 384 ASN B 240 ASN.? 15.10 N2 C2E A 301 A 385 GLU A 101 GLU.? 9.39 O11 C2E A 301 coo 22.28 63.17 110.61 22.47 65.06 111.53 -7.68 -27.50 -15.35 -9.79 -27.31 -15.11 coo 7.06 50.07 96.17 8.50 48.54 96.31 -1.20 -3.05 -17.04 -0.29 -1.75 -15.62 coo 11.59 49.83 99.41 10.92 47.97 100.16 2.77 -8.35 -14.05 3.97 -7.83 -15.72 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 5 3 # 5 A 270 ASN A 228 ASN~? 15.04 O2' C2E A 301 A 384 ASN A 144 ASN^? 13.31 N1 C2E A 301 A 385 GLU A 159 GLU^? 13.73 O6 C2E A 301 coo 22.28 63.17 110.61 22.47 65.06 111.53 -12.40 -21.37 -21.10 -11.00 -22.25 -22.44 coo 7.06 50.07 96.17 8.50 48.54 96.31 -14.15 -8.19 -2.40 -12.36 -7.37 -1.59 coo 11.59 49.83 99.41 10.92 47.97 100.16 -14.60 -12.52 -1.04 -14.41 -10.88 0.31 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 6 3 # 6 A 270 ASN B 223 ASN~? 12.46 O4' C2E B 301 A 384 ASN A 240 ASN.? 14.36 O21 C2E B 301 A 385 GLU B 101 GLU.? 9.43 O11 C2E B 301 coo 22.28 63.17 110.61 22.47 65.06 111.53 -12.01 24.89 -16.85 -10.55 24.64 -18.38 coo 7.06 50.07 96.17 8.50 48.54 96.31 -14.12 0.95 -8.98 -13.19 0.02 -7.31 coo 11.59 49.83 99.41 10.92 47.97 100.16 -14.64 6.09 -5.71 -16.72 5.82 -5.44 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 7 3 # 7 A 270 ASN B 223 ASN~? 12.46 O4' C2E B 301 A 384 ASN B 144 ASN^? 13.28 N1 C2E B 301 A 385 GLU B 159 GLU^? 13.76 O6 C2E B 301 coo 22.28 63.17 110.61 22.47 65.06 111.53 -12.01 24.89 -16.85 -10.55 24.64 -18.38 coo 7.06 50.07 96.17 8.50 48.54 96.31 3.74 6.70 -14.80 3.60 6.07 -12.77 coo 11.59 49.83 99.41 10.92 47.97 100.16 4.99 11.22 -14.77 6.30 9.86 -13.80 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 8 3 # 8 A 270 ASN B 228 ASN~? 15.22 O2' C2E B 301 A 384 ASN B 144 ASN^? 13.28 N1 C2E B 301 A 385 GLU B 159 GLU^? 13.76 O6 C2E B 301 coo 22.28 63.17 110.61 22.47 65.06 111.53 -14.11 18.31 -23.21 -16.11 19.01 -22.96 coo 7.06 50.07 96.17 8.50 48.54 96.31 3.74 6.70 -14.80 3.60 6.07 -12.77 coo 11.59 49.83 99.41 10.92 47.97 100.16 4.99 11.22 -14.77 6.30 9.86 -13.80 2v3r_p00 source 2v3r EXOGLUCANASE 1 : 8 hits 2v3r_p00 naa= 3 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 1 3 # 1 A 82 HIS A 38 HIS.? 16.46 O61 C2E B 301 A 166 SER B 39 SER.? 15.26 O61 C2E B 301 A 168 HIS B 38 HIS.? 15.97 O61 C2E B 301 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 1.46 -0.40 7.20 -0.57 -0.26 7.72 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 4.72 7.48 5.49 6.81 6.45 4.77 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 4.87 2.64 4.63 6.30 2.30 3.13 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 2 3 # 2 A 82 HIS A 214 HIS.? 19.24 O6 C2E A 301 A 166 SER A 212 SER.? 13.10 O6 C2E A 301 A 168 HIS A 215 HIS.? 12.12 O6 C2E A 301 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -9.67 -12.41 11.50 -9.18 -11.33 13.22 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -4.77 -16.86 9.45 -4.14 -15.23 7.75 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -8.99 -15.19 5.86 -7.58 -13.77 5.21 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 3 3 # 3 A 82 HIS A 215 HIS.? 12.12 O6 C2E A 301 A 166 SER A 212 SER.? 13.10 O6 C2E A 301 A 168 HIS A 214 HIS.? 19.24 O6 C2E A 301 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -8.99 -15.19 5.86 -7.58 -13.77 5.21 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -4.77 -16.86 9.45 -4.14 -15.23 7.75 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -9.67 -12.41 11.50 -9.18 -11.33 13.22 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 4 3 # 4 A 82 HIS B 38 HIS.? 15.97 O61 C2E B 301 A 166 SER A 39 SER.? 16.45 O61 C2E A 301 A 168 HIS A 38 HIS.? 16.46 O61 C2E B 301 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 4.87 2.64 4.63 6.30 2.30 3.13 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 2.88 -4.86 8.38 1.14 -3.61 9.53 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 1.46 -0.40 7.20 -0.57 -0.26 7.72 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 5 3 # 5 A 82 HIS B 214 HIS.? 18.94 O6 C2E B 301 A 166 SER B 212 SER.? 13.16 O6 C2E B 301 A 168 HIS B 215 HIS.? 11.93 O6 C2E B 301 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 13.04 11.66 -4.90 14.49 10.59 -3.83 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 8.68 16.14 -1.54 8.01 14.57 -3.30 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 7.81 14.24 -7.06 6.68 12.76 -6.10 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 6 3 # 6 A 82 HIS B 215 HIS.? 11.93 O6 C2E B 301 A 166 SER B 212 SER.? 13.16 O6 C2E B 301 A 168 HIS B 214 HIS.? 18.94 O6 C2E B 301 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 7.81 14.24 -7.06 6.68 12.76 -6.10 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 8.68 16.14 -1.54 8.01 14.57 -3.30 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 13.04 11.66 -4.90 14.49 10.59 -3.83 2vmg_p00 source 2vmg FIBRONECTIN TYPE III DOMAIN PROTEIN : 6 hits 2vmg_p00 naa= 3 ULMN 3 1b01_d00 GENE REGULATION/DNA user 1 3 # 1 B 4 ARG A 94 ARG^? 4.68 N21 C2E A 301 B 6 THR A 43 THR^? 9.03 N21 C2E A 301 B 8 THR A 58 THR^? 15.78 N21 C2E A 301 coo 40.52 16.08 100.90 37.97 16.41 102.60 12.55 -12.80 -0.72 10.33 -14.85 -0.21 coo 36.11 13.64 95.03 34.54 14.86 95.91 12.75 -12.19 5.35 12.59 -13.99 4.18 coo 32.72 8.05 92.39 31.25 9.11 91.35 9.36 -10.55 10.87 10.66 -9.09 11.81 ULMN 3 1b01_d00 GENE REGULATION/DNA user 2 3 # 2 B 4 ARG A 108 ARG^? 23.83 N21 C2E A 301 B 6 THR A 47 THR^? 22.10 N21 C2E A 301 B 8 THR A 52 THR.? 26.25 N21 C2E A 301 coo 40.52 16.08 100.90 37.97 16.41 102.60 25.12 -6.17 2.65 27.73 -7.47 3.61 coo 36.11 13.64 95.03 34.54 14.86 95.91 25.51 -12.99 8.45 26.36 -13.29 6.49 coo 32.72 8.05 92.39 31.25 9.11 91.35 27.49 -18.11 10.27 27.95 -18.15 12.39 ULMN 3 1b01_d00 GENE REGULATION/DNA user 3 3 # 3 B 4 ARG B 94 ARG^? 9.81 N31 C2E B 301 B 6 THR B 43 THR^? 7.45 N21 C2E B 301 B 8 THR B 58 THR^? 14.00 N21 C2E B 301 coo 40.52 16.08 100.90 37.97 16.41 102.60 -10.06 14.66 9.70 -12.88 15.81 9.44 coo 36.11 13.64 95.03 34.54 14.86 95.91 -3.93 15.11 10.84 -5.11 16.57 9.76 coo 32.72 8.05 92.39 31.25 9.11 91.35 2.82 14.44 10.97 3.39 13.43 12.79 ULMN 3 1b01_d00 GENE REGULATION/DNA user 4 3 # 4 B 4 ARG B 108 ARG^? 23.43 N21 C2E B 301 B 6 THR B 47 THR^? 21.06 N21 C2E B 301 B 8 THR B 52 THR.? 24.73 N21 C2E B 301 coo 40.52 16.08 100.90 37.97 16.41 102.60 -11.69 10.06 21.74 -11.10 10.14 24.76 coo 36.11 13.64 95.03 34.54 14.86 95.91 -7.68 18.64 22.99 -9.83 18.75 22.86 coo 32.72 8.05 92.39 31.25 9.11 91.35 -7.42 23.88 24.59 -5.77 25.17 25.11 ULMN 3 1b01_d00 GENE REGULATION/DNA user 5 3 # 5 B 4 ARG B 194 ARG.? 29.24 O11 C2E A 301 B 6 THR B 196 THR.? 25.64 N2 C2E B 301 B 8 THR B 198 THR.? 19.53 N2 C2E B 301 coo 40.52 16.08 100.90 37.97 16.41 102.60 9.25 6.39 -30.72 9.33 3.86 -32.46 coo 36.11 13.64 95.03 34.54 14.86 95.91 5.95 12.44 -30.91 5.74 10.48 -31.76 coo 32.72 8.05 92.39 31.25 9.11 91.35 0.36 15.27 -27.32 1.27 17.22 -26.97 1b01_d00 source 1b01 GENE REGULATION/DNA : 5 hits 1b01_d00 naa= 3 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 1 3 # 1 C 70 ARG A 155 ARG^? 21.80 N1 C2E A 301 C 71 LYS A 148 LYS^? 21.30 O6 C2E A 301 C 72 VAL A 149 VAL^? 14.56 O6 C2E A 301 coo 23.89 33.54 29.21 26.59 34.86 28.68 -22.65 -25.75 -3.25 -23.90 -23.07 -4.10 coo 25.82 26.89 29.68 23.33 22.98 25.84 -18.93 -21.14 -3.03 -22.92 -21.05 0.91 coo 28.86 29.08 30.37 28.04 31.02 29.93 -16.05 -23.61 -3.17 -14.44 -23.99 -1.73 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 2 3 # 2 C 70 ARG B 155 ARG^? 22.81 O6 C2E B 301 C 71 LYS B 148 LYS^? 21.33 O6 C2E B 301 C 72 VAL B 149 VAL^? 14.42 O6 C2E B 301 coo 23.89 33.54 29.21 26.59 34.86 28.68 6.63 24.44 -23.88 7.74 21.82 -25.04 coo 25.82 26.89 29.68 23.33 22.98 25.84 4.64 19.42 -20.28 9.89 19.27 -22.17 coo 28.86 29.08 30.37 28.04 31.02 29.93 3.05 21.90 -17.90 3.47 22.36 -15.79 1hwt_d00 source 1hwt GENE REGULATION/DNA : 2 hits 1hwt_d00 naa= 3 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 1 3 # 1 E 40 ARG A 211 ARG^? 16.62 O6 C2E A 301 E 41 TYR A 218 TYR^? 10.22 O6 C2E A 301 E 83 ARG B 211 ARG^? 16.78 O6 C2E B 301 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -4.93 -23.64 8.57 -7.93 -23.17 9.07 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -6.98 -22.32 0.01 -7.64 -23.76 2.29 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 8.09 22.99 -2.57 10.13 22.73 -4.88 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 2 3 # 2 E 40 ARG B 211 ARG^? 16.78 O6 C2E B 301 E 41 TYR B 218 TYR^? 10.08 O6 C2E B 301 E 83 ARG A 211 ARG^? 16.62 O6 C2E A 301 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 8.09 22.99 -2.57 10.13 22.73 -4.88 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 1.42 21.23 -8.42 3.73 22.73 -7.99 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -4.93 -23.64 8.57 -7.93 -23.17 9.07 1id3_d00 source 1id3 STRUCTURAL PROTEIN/DNA : 2 hits 1id3_d00 naa= 3 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 1 3 # 1 D 23 LYS A 67 LYS.? 22.91 N21 C2E B 301 D 25 THR A 63 THR^? 19.64 O61 C2E B 301 D 27 SER B 39 SER.? 15.26 O61 C2E B 301 coo 86.60 33.38 44.00 87.05 39.52 42.71 17.01 7.43 8.57 15.28 11.70 10.44 coo 81.20 31.58 48.03 79.23 32.24 47.54 10.28 3.87 8.02 10.33 3.89 5.86 coo 79.09 29.82 54.20 77.17 28.90 53.05 4.72 7.48 5.49 6.81 6.45 4.77 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 2 3 # 2 D 23 LYS A 67 LYS.? 22.91 N21 C2E B 301 D 25 THR A 65 THR.? 20.67 N21 C2E B 301 D 27 SER B 39 SER.? 15.26 O61 C2E B 301 coo 86.60 33.38 44.00 87.05 39.52 42.71 17.01 7.43 8.57 15.28 11.70 10.44 coo 81.20 31.58 48.03 79.23 32.24 47.54 12.12 9.75 7.64 13.14 10.86 9.19 coo 79.09 29.82 54.20 77.17 28.90 53.05 4.72 7.48 5.49 6.81 6.45 4.77 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 3 3 # 3 D 23 LYS A 75 LYS.? 21.41 N21 C2E A 301 D 25 THR A 58 THR^? 15.78 N21 C2E A 301 D 27 SER A 40 SER.? 10.73 O61 C2E A 301 coo 86.60 33.38 44.00 87.05 39.52 42.71 9.70 -14.41 17.00 6.16 -11.27 19.18 coo 81.20 31.58 48.03 79.23 32.24 47.54 9.36 -10.55 10.87 10.66 -9.09 11.81 coo 79.09 29.82 54.20 77.17 28.90 53.05 3.90 -7.17 5.51 5.27 -5.92 3.90 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 4 3 # 4 D 23 LYS B 67 LYS.? 24.61 N21 C2E A 301 D 25 THR B 63 THR^? 19.59 N11 C2E B 301 D 27 SER A 39 SER.? 16.45 O61 C2E A 301 coo 86.60 33.38 44.00 87.05 39.52 42.71 -0.41 -2.48 20.16 2.79 -6.43 20.83 coo 81.20 31.58 48.03 79.23 32.24 47.54 1.98 0.04 13.69 0.05 -0.43 12.85 coo 79.09 29.82 54.20 77.17 28.90 53.05 2.88 -4.86 8.38 1.14 -3.61 9.53 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 5 3 # 5 D 23 LYS B 67 LYS.? 24.61 N21 C2E A 301 D 25 THR B 65 THR.? 22.03 N21 C2E A 301 D 27 SER A 39 SER.? 16.45 O61 C2E A 301 coo 86.60 33.38 44.00 87.05 39.52 42.71 -0.41 -2.48 20.16 2.79 -6.43 20.83 coo 81.20 31.58 48.03 79.23 32.24 47.54 1.41 -5.60 16.09 2.39 -6.35 17.87 coo 79.09 29.82 54.20 77.17 28.90 53.05 2.88 -4.86 8.38 1.14 -3.61 9.53 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 6 3 # 6 D 23 LYS B 75 LYS.? 16.89 N21 C2E B 301 D 25 THR B 58 THR^? 14.00 N21 C2E B 301 D 27 SER B 40 SER.? 9.12 N11 C2E B 301 coo 86.60 33.38 44.00 87.05 39.52 42.71 7.39 19.64 13.02 10.00 17.22 7.78 coo 81.20 31.58 48.03 79.23 32.24 47.54 2.82 14.44 10.97 3.39 13.43 12.79 coo 79.09 29.82 54.20 77.17 28.90 53.05 1.49 9.31 4.61 -0.48 7.96 5.14 1mjo_d00 source 1mjo TRANSCRIPTION/DNA : 6 hits 1mjo_d00 naa= 3 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 1 3 # 1 A1290 LYS A 231 LYS~? 13.14 O2' C2E A 301 A1294 ASN A 228 ASN~? 15.04 O2' C2E A 301 A1297 GLU A 224 GLU~? 15.93 O2' C2E A 301 coo 39.24 18.84-161.99 36.62 21.47-165.99 -11.44 -15.22 -19.18 -8.27 -15.76 -22.64 coo 33.53 17.37-161.81 34.31 17.81-163.76 -12.40 -21.37 -21.10 -11.00 -22.25 -22.44 coo 29.78 23.31-161.30 31.23 23.66-162.84 -8.40 -25.77 -21.72 -8.05 -26.98 -23.42 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 2 3 # 2 A1290 LYS A 231 LYS~? 13.14 O2' C2E A 301 A1294 ASN A 228 ASN~? 15.04 O2' C2E A 301 A1297 GLU A 225 GLU~? 17.61 C1' C2E A 301 coo 39.24 18.84-161.99 36.62 21.47-165.99 -11.44 -15.22 -19.18 -8.27 -15.76 -22.64 coo 33.53 17.37-161.81 34.31 17.81-163.76 -12.40 -21.37 -21.10 -11.00 -22.25 -22.44 coo 29.78 23.31-161.30 31.23 23.66-162.84 -14.07 -25.95 -18.02 -15.34 -27.27 -16.96 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 3 3 # 3 A1290 LYS A 231 LYS~? 13.14 O2' C2E A 301 A1294 ASN A 229 ASN~? 15.85 N2 C2E A 301 A1297 GLU A 225 GLU~? 17.61 C1' C2E A 301 coo 39.24 18.84-161.99 36.62 21.47-165.99 -11.44 -15.22 -19.18 -8.27 -15.76 -22.64 coo 33.53 17.37-161.81 34.31 17.81-163.76 -14.86 -20.46 -16.50 -16.06 -21.98 -17.43 coo 29.78 23.31-161.30 31.23 23.66-162.84 -14.07 -25.95 -18.02 -15.34 -27.27 -16.96 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 4 3 # 4 A1290 LYS A 243 LYS.? 15.17 N2 C2E A 301 A1294 ASN A 240 ASN.? 14.36 O21 C2E B 301 A1297 GLU B 101 GLU.? 9.43 O11 C2E B 301 coo 39.24 18.84-161.99 36.62 21.47-165.99 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo 33.53 17.37-161.81 34.31 17.81-163.76 -14.12 0.95 -8.98 -13.19 0.02 -7.31 coo 29.78 23.31-161.30 31.23 23.66-162.84 -14.64 6.09 -5.71 -16.72 5.82 -5.44 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 5 3 # 5 A1290 LYS B 205 LYS^? -10.36 O1P C2E B 301s A1294 ASN B 223 ASN~? 12.46 O4' C2E B 301 A1297 GLU B 225 GLU~? 17.01 C1' C2E B 301 coo 39.24 18.84-161.99 36.62 21.47-165.99 -6.87 25.33 -11.52 -10.34 29.58 -9.49 coo 33.53 17.37-161.81 34.31 17.81-163.76 -12.01 24.89 -16.85 -10.55 24.64 -18.38 coo 29.78 23.31-161.30 31.23 23.66-162.84 -10.33 22.86 -23.16 -8.91 24.36 -23.62 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 6 3 # 6 A1290 LYS B 231 LYS~? 16.58 O2' C2E B 301 A1294 ASN B 228 ASN~? 15.22 O2' C2E B 301 A1297 GLU B 224 GLU~? 16.79 O2' C2E B 301 coo 39.24 18.84-161.99 36.62 21.47-165.99 -12.77 12.18 -20.95 -18.80 11.50 -22.86 coo 33.53 17.37-161.81 34.31 17.81-163.76 -14.11 18.31 -23.21 -16.11 19.01 -22.96 coo 29.78 23.31-161.30 31.23 23.66-162.84 -16.80 22.93 -20.90 -17.88 24.32 -22.10 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 7 3 # 7 A1290 LYS B 231 LYS~? 16.58 O2' C2E B 301 A1294 ASN B 228 ASN~? 15.22 O2' C2E B 301 A1297 GLU B 225 GLU~? 17.01 C1' C2E B 301 coo 39.24 18.84-161.99 36.62 21.47-165.99 -12.77 12.18 -20.95 -18.80 11.50 -22.86 coo 33.53 17.37-161.81 34.31 17.81-163.76 -14.11 18.31 -23.21 -16.11 19.01 -22.96 coo 29.78 23.31-161.30 31.23 23.66-162.84 -10.33 22.86 -23.16 -8.91 24.36 -23.62 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 8 3 # 8 A1290 LYS B 231 LYS~? 16.58 O2' C2E B 301 A1294 ASN B 229 ASN~? 15.65 N2 C2E B 301 A1297 GLU B 225 GLU~? 17.01 C1' C2E B 301 coo 39.24 18.84-161.99 36.62 21.47-165.99 -12.77 12.18 -20.95 -18.80 11.50 -22.86 coo 33.53 17.37-161.81 34.31 17.81-163.76 -8.99 17.44 -22.98 -9.26 18.88 -24.54 coo 29.78 23.31-161.30 31.23 23.66-162.84 -10.33 22.86 -23.16 -8.91 24.36 -23.62 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 9 3 # 9 A1290 LYS B 243 LYS.? 13.43 N1 C2E B 301 A1294 ASN B 240 ASN.? 15.10 N2 C2E A 301 A1297 GLU A 101 GLU.? 9.39 O11 C2E A 301 coo 39.24 18.84-161.99 36.62 21.47-165.99 -2.53 1.27 -13.25 2.13 3.70 -10.70 coo 33.53 17.37-161.81 34.31 17.81-163.76 -1.20 -3.05 -17.04 -0.29 -1.75 -15.62 coo 29.78 23.31-161.30 31.23 23.66-162.84 2.77 -8.35 -14.05 3.97 -7.83 -15.72 1xpx_d00 source 1xpx TRANSCRIPTION REGULATION/DNA : 9 hits 1xpx_d00 naa= 3 ULMN 3 2er8_d00 TRANSCRIPTION ACTIVATOR/DNA user 1 3 # 1 C 43 GLN A 134 GLN^? 8.75 O11 C2E A 301 C 44 LYS A 137 LYS.? -4.52 O2' C2E A 301s C 75 ARG A 136 ARG.? -3.92 O61 C2E A 301s coo 34.33 34.01 1.06 32.24 34.35 1.22 7.72 -9.60 -13.41 7.57 -9.44 -15.52 coo 36.27 30.15 5.40 32.93 24.83 5.96 4.32 -14.05 -15.33 0.72 -19.17 -16.51 coo 30.88 29.31 6.12 29.39 29.02 3.47 2.11 -12.17 -9.13 1.08 -10.80 -6.58 ULMN 3 2er8_d00 TRANSCRIPTION ACTIVATOR/DNA user 2 3 # 2 C 43 GLN B 134 GLN.? 7.53 O11 C2E B 301 C 44 LYS B 137 LYS.? -3.23 O3' C2E B 301s C 75 ARG B 136 ARG.? -3.89 O61 C2E B 301s coo 34.33 34.01 1.06 32.24 34.35 1.22 -17.55 9.98 -0.31 -19.35 10.60 -1.25 coo 36.27 30.15 5.40 32.93 24.83 5.96 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo 30.88 29.31 6.12 29.39 29.02 3.47 -10.39 10.75 -3.93 -7.55 9.68 -3.54 2er8_d00 source 2er8 TRANSCRIPTION ACTIVATOR/DNA : 2 hits 2er8_d00 naa= 3 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 5 ARG A 99 ARG.? 13.59 O61 C2E B 301 A 50 LYS B 238 LYS^? 16.50 N2 C2E A 301 A 51 ASN B 240 ASN.? 15.10 N2 C2E A 301 coo 28.68 23.77 42.74 27.76 26.72 42.93 -1.29 -2.34 -4.97 -2.19 0.30 -6.23 coo 14.40 30.33 40.28 14.25 28.31 45.36 -5.87 0.39 -20.54 -8.13 -3.69 -20.92 coo 19.09 30.55 41.51 19.09 28.89 42.82 -1.20 -3.05 -17.04 -0.29 -1.75 -15.62 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 2 3 # 2 A 5 ARG A 136 ARG.? -3.92 O61 C2E A 301s A 50 LYS B 243 LYS.? 13.43 N1 C2E B 301 A 51 ASN B 240 ASN.? 15.10 N2 C2E A 301 coo 28.68 23.77 42.74 27.76 26.72 42.93 2.11 -12.17 -9.13 1.08 -10.80 -6.58 coo 14.40 30.33 40.28 14.25 28.31 45.36 -2.53 1.27 -13.25 2.13 3.70 -10.70 coo 19.09 30.55 41.51 19.09 28.89 42.82 -1.20 -3.05 -17.04 -0.29 -1.75 -15.62 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 3 3 # 3 A 5 ARG A 140 ARG.? -3.36 C5 C2E A 301s A 50 LYS B 243 LYS.? 13.43 N1 C2E B 301 A 51 ASN B 240 ASN.? 15.10 N2 C2E A 301 coo 28.68 23.77 42.74 27.76 26.72 42.93 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 coo 14.40 30.33 40.28 14.25 28.31 45.36 -2.53 1.27 -13.25 2.13 3.70 -10.70 coo 19.09 30.55 41.51 19.09 28.89 42.82 -1.20 -3.05 -17.04 -0.29 -1.75 -15.62 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 4 3 # 4 A 5 ARG A 165 ARG.? 12.45 N2 C2E A 301 A 50 LYS B 243 LYS.? 13.43 N1 C2E B 301 A 51 ASN B 240 ASN.? 15.10 N2 C2E A 301 coo 28.68 23.77 42.74 27.76 26.72 42.93 -4.47 -13.19 -19.45 -6.66 -12.47 -21.46 coo 14.40 30.33 40.28 14.25 28.31 45.36 -2.53 1.27 -13.25 2.13 3.70 -10.70 coo 19.09 30.55 41.51 19.09 28.89 42.82 -1.20 -3.05 -17.04 -0.29 -1.75 -15.62 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 5 3 # 5 A 5 ARG B 99 ARG.? 13.88 O61 C2E A 301 A 50 LYS A 238 LYS^? 19.93 N2 C2E B 301 A 51 ASN A 240 ASN.? 14.36 O21 C2E B 301 coo 28.68 23.77 42.74 27.76 26.72 42.93 -4.81 1.09 -3.04 -5.37 -1.84 -3.80 coo 14.40 30.33 40.28 14.25 28.31 45.36 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 coo 19.09 30.55 41.51 19.09 28.89 42.82 -14.12 0.95 -8.98 -13.19 0.02 -7.31 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 6 3 # 6 A 5 ARG B 136 ARG.? -3.89 O61 C2E B 301s A 50 LYS A 243 LYS.? 15.17 N2 C2E A 301 A 51 ASN A 240 ASN.? 14.36 O21 C2E B 301 coo 28.68 23.77 42.74 27.76 26.72 42.93 -10.39 10.75 -3.93 -7.55 9.68 -3.54 coo 14.40 30.33 40.28 14.25 28.31 45.36 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo 19.09 30.55 41.51 19.09 28.89 42.82 -14.12 0.95 -8.98 -13.19 0.02 -7.31 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 7 3 # 7 A 5 ARG B 140 ARG.? -3.40 C5 C2E B 301s A 50 LYS A 238 LYS^? 19.93 N2 C2E B 301 A 51 ASN A 240 ASN.? 14.36 O21 C2E B 301 coo 28.68 23.77 42.74 27.76 26.72 42.93 -7.91 11.52 -6.78 -7.96 14.04 -5.01 coo 14.40 30.33 40.28 14.25 28.31 45.36 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 coo 19.09 30.55 41.51 19.09 28.89 42.82 -14.12 0.95 -8.98 -13.19 0.02 -7.31 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 8 3 # 8 A 5 ARG B 140 ARG.? -3.40 C5 C2E B 301s A 50 LYS A 243 LYS.? 15.17 N2 C2E A 301 A 51 ASN A 240 ASN.? 14.36 O21 C2E B 301 coo 28.68 23.77 42.74 27.76 26.72 42.93 -7.91 11.52 -6.78 -7.96 14.04 -5.01 coo 14.40 30.33 40.28 14.25 28.31 45.36 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo 19.09 30.55 41.51 19.09 28.89 42.82 -14.12 0.95 -8.98 -13.19 0.02 -7.31 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 9 3 # 9 A 5 ARG B 165 ARG.? 10.70 O2' C2E B 301 A 50 LYS A 238 LYS^? 19.93 N2 C2E B 301 A 51 ASN A 240 ASN.? 14.36 O21 C2E B 301 coo 28.68 23.77 42.74 27.76 26.72 42.93 -16.44 10.61 -14.72 -19.33 11.67 -14.77 coo 14.40 30.33 40.28 14.25 28.31 45.36 -14.71 -3.19 -14.38 -18.35 -1.58 -18.12 coo 19.09 30.55 41.51 19.09 28.89 42.82 -14.12 0.95 -8.98 -13.19 0.02 -7.31 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 10 3 # 10 A 5 ARG B 165 ARG.? 10.70 O2' C2E B 301 A 50 LYS A 243 LYS.? 15.17 N2 C2E A 301 A 51 ASN A 240 ASN.? 14.36 O21 C2E B 301 coo 28.68 23.77 42.74 27.76 26.72 42.93 -16.44 10.61 -14.72 -19.33 11.67 -14.77 coo 14.40 30.33 40.28 14.25 28.31 45.36 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo 19.09 30.55 41.51 19.09 28.89 42.82 -14.12 0.95 -8.98 -13.19 0.02 -7.31 2hos_d00 source 2hos TRANSCRIPTION/DNA : 10 hits 2hos_d00 naa= 3 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 24 ARG A 136 ARG.? -3.92 O61 C2E A 301s A 32 LYS A 137 LYS.? -4.52 O2' C2E A 301s A 46 ARG A 99 ARG.? 13.59 O61 C2E B 301 coo -8.00 4.27 27.74 -7.09 2.66 30.09 2.11 -12.17 -9.13 1.08 -10.80 -6.58 coo -5.15 8.65 26.69 -4.26 5.48 32.02 4.32 -14.05 -15.33 0.72 -19.17 -16.51 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 -1.29 -2.34 -4.97 -2.19 0.30 -6.23 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 2 3 # 2 A 24 ARG A 165 ARG.? 12.45 N2 C2E A 301 A 32 LYS A 231 LYS~? 13.14 O2' C2E A 301 A 46 ARG A 140 ARG.? -3.36 C5 C2E A 301s coo -8.00 4.27 27.74 -7.09 2.66 30.09 -4.47 -13.19 -19.45 -6.66 -12.47 -21.46 coo -5.15 8.65 26.69 -4.26 5.48 32.02 -11.44 -15.22 -19.18 -8.27 -15.76 -22.64 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 3 3 # 3 A 24 ARG B 136 ARG.? -3.89 O61 C2E B 301s A 32 LYS B 137 LYS.? -3.23 O3' C2E B 301s A 46 ARG B 94 ARG^? 9.81 N31 C2E B 301 coo -8.00 4.27 27.74 -7.09 2.66 30.09 -10.39 10.75 -3.93 -7.55 9.68 -3.54 coo -5.15 8.65 26.69 -4.26 5.48 32.02 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 -10.06 14.66 9.70 -12.88 15.81 9.44 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 4 3 # 4 A 24 ARG B 136 ARG.? -3.89 O61 C2E B 301s A 32 LYS B 137 LYS.? -3.23 O3' C2E B 301s A 46 ARG B 99 ARG.? 13.88 O61 C2E A 301 coo -8.00 4.27 27.74 -7.09 2.66 30.09 -10.39 10.75 -3.93 -7.55 9.68 -3.54 coo -5.15 8.65 26.69 -4.26 5.48 32.02 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 -4.81 1.09 -3.04 -5.37 -1.84 -3.80 2ky8_d00 source 2ky8 TRANSCRIPTION/DNA : 4 hits 2ky8_d00 naa= 3 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 B 34 SER A 45 SER^? 13.73 N21 C2E A 301 B 37 ASN A 92 ASN^? 17.86 N21 C2E A 301 B 45 THR A 129 THR^? 23.05 N11 C2E A 301 coo -19.49 41.97 71.08 -17.37 40.80 71.17 19.13 -13.30 6.25 18.28 -14.32 4.23 coo -23.05 39.62 69.74 -22.86 39.59 67.61 20.53 -10.46 2.38 22.65 -10.55 2.18 coo -30.87 34.84 80.57 -28.94 34.51 81.49 19.06 1.74 -3.58 20.59 2.04 -5.10 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 B 34 SER B 45 SER^? 12.51 N21 C2E B 301 B 37 ASN B 92 ASN^? 16.92 N21 C2E B 301 B 45 THR B 129 THR^? 22.45 N21 C2E B 301 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -6.50 17.30 16.50 -7.95 17.62 14.58 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -10.13 13.62 16.73 -11.46 13.70 18.39 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -12.76 0.32 15.64 -14.76 -0.03 16.38 2z3x_d00 source 2z3x DNA BINDING PROTEIN/DNA : 2 hits 2z3x_d00 naa= 3 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 A 18 SER A 40 SER.? 10.73 O61 C2E A 301 A 20 HIS A 38 HIS.? 16.46 O61 C2E B 301 A 22 LEU B 33 LEU~? 16.02 N11 C2E B 301 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 3.90 -7.17 5.51 5.27 -5.92 3.90 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 1.46 -0.40 7.20 -0.57 -0.26 7.72 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -4.32 0.81 10.32 -4.19 2.37 11.80 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 A 18 SER A 40 SER.? 10.73 O61 C2E A 301 A 20 HIS A 38 HIS.? 16.46 O61 C2E B 301 A 22 LEU B 70 LEU^? 21.12 N21 C2E B 301 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 3.90 -7.17 5.51 5.27 -5.92 3.90 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 1.46 -0.40 7.20 -0.57 -0.26 7.72 coo -14.55 2.62 13.63 -14.94 2.66 11.50 5.08 4.11 15.20 5.63 2.29 16.22 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 A 18 SER A 125 SER.? 23.81 N21 C2E A 301 A 20 HIS A 113 HIS^? 30.12 N21 C2E A 301 A 22 LEU A 115 LEU^? 29.16 N21 C2E A 301 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 19.83 1.13 7.98 21.72 -0.16 7.19 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 19.70 2.48 16.98 21.09 4.00 16.57 coo -14.55 2.62 13.63 -14.94 2.66 11.50 13.92 -0.15 21.34 14.59 1.68 20.44 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 A 18 SER B 40 SER.? 9.12 N11 C2E B 301 A 20 HIS B 38 HIS.? 15.97 O61 C2E B 301 A 22 LEU A 33 LEU~? 17.23 O61 C2E A 301 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 1.49 9.31 4.61 -0.48 7.96 5.14 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 4.87 2.64 4.63 6.30 2.30 3.13 coo -14.55 2.62 13.63 -14.94 2.66 11.50 10.50 1.44 1.21 12.15 0.60 2.32 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 5 3 # 5 A 18 SER B 40 SER.? 9.12 N11 C2E B 301 A 20 HIS B 38 HIS.? 15.97 O61 C2E B 301 A 22 LEU A 70 LEU^? 23.00 N21 C2E A 301 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 1.49 9.31 4.61 -0.48 7.96 5.14 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 4.87 2.64 4.63 6.30 2.30 3.13 coo -14.55 2.62 13.63 -14.94 2.66 11.50 10.68 0.68 12.25 11.24 2.69 12.80 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 6 3 # 6 A 18 SER B 125 SER^? 22.05 N21 C2E B 301 A 20 HIS B 113 HIS^? 28.48 N21 C2E B 301 A 22 LEU B 115 LEU^? 27.62 N21 C2E B 301 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -3.10 3.96 21.21 -4.91 5.28 22.14 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 4.95 4.79 25.73 4.34 3.55 27.31 coo -14.55 2.62 13.63 -14.94 2.66 11.50 11.09 7.27 21.85 11.06 5.37 22.87 3gxq_d00 source 3gxq DNA BINDING PROTEIN/DNA : 6 hits 3gxq_d00 naa= 3 ULMN 3 3kmp_d00 TRANSCRIPTION REGULATOR/DNA user 1 3 # 1 A 74 ARG A 136 ARG.? -3.92 O61 C2E A 301s A 76 GLN A 134 GLN^? 8.75 O11 C2E A 301 A 81 LYS A 137 LYS.? -4.52 O2' C2E A 301s coo -17.53 -1.82 -11.90 -18.53 0.50 -13.59 2.11 -12.17 -9.13 1.08 -10.80 -6.58 coo -11.64 3.92 -10.28 -12.34 5.87 -10.62 7.72 -9.60 -13.41 7.57 -9.44 -15.52 coo -12.79 -0.17 -12.32 -15.96 3.61 -9.93 4.32 -14.05 -15.33 0.72 -19.17 -16.51 ULMN 3 3kmp_d00 TRANSCRIPTION REGULATOR/DNA user 2 3 # 2 A 74 ARG B 136 ARG.? -3.89 O61 C2E B 301s A 76 GLN B 134 GLN.? 7.53 O11 C2E B 301 A 81 LYS B 137 LYS.? -3.23 O3' C2E B 301s coo -17.53 -1.82 -11.90 -18.53 0.50 -13.59 -10.39 10.75 -3.93 -7.55 9.68 -3.54 coo -11.64 3.92 -10.28 -12.34 5.87 -10.62 -17.55 9.98 -0.31 -19.35 10.60 -1.25 coo -12.79 -0.17 -12.32 -15.96 3.61 -9.93 -16.98 12.27 -5.28 -15.90 17.15 -6.49 3kmp_d00 source 3kmp TRANSCRIPTION REGULATOR/DNA : 2 hits 3kmp_d00 naa= 3 ULMN 4 3odc_d00 DNA BINDING PROTEIN/DNA user 1 4 # 1 B 122 ARG B 140 ARG.? -3.40 C5 C2E B 301s B 148 LYS B 148 LYS^? 21.33 O6 C2E B 301 B 151 LEU B 187 LEU^? 11.13 N1 C2E B 301 B 154 ILE B 189 ILE^? 12.93 N2 C2E B 301 coo 13.00 32.05 60.31 16.02 31.73 59.80 -7.91 11.52 -6.78 -7.96 14.04 -5.01 coo 11.05 44.13 44.68 12.77 44.45 49.56 4.64 19.42 -20.28 9.89 19.27 -22.17 coo 11.72 38.91 44.77 13.11 39.67 46.23 -1.19 18.96 -18.18 -0.81 19.12 -16.06 coo 7.03 36.97 46.99 7.83 37.90 47.52 -0.61 14.05 -21.34 -0.01 13.94 -20.03 3odc_d00 source 3odc DNA BINDING PROTEIN/DNA : 1 hits 3odc_d00 naa= 4 ULMN 3 3qrf_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 G 386 ARG A 217 ARG^? 6.70 O6 C2E A 301 G 387 HIS A 215 HIS.? 12.12 O6 C2E A 301 G 390 SER A 212 SER.? 13.10 O6 C2E A 301 coo 93.17 52.97 31.81 95.66 54.71 32.14 -3.36 -16.18 0.94 -0.54 -17.39 0.83 coo 95.60 53.07 40.31 97.10 52.52 41.67 -8.99 -15.19 5.86 -7.58 -13.77 5.21 coo 93.25 46.91 38.79 94.12 47.43 36.62 -4.77 -16.86 9.45 -4.14 -15.23 7.75 ULMN 3 3qrf_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 G 386 ARG B 217 ARG^? 6.37 O6 C2E B 301 G 387 HIS B 215 HIS.? 11.93 O6 C2E B 301 G 390 SER B 212 SER.? 13.16 O6 C2E B 301 coo 93.17 52.97 31.81 95.66 54.71 32.14 0.82 15.44 -4.45 -0.87 16.78 -2.26 coo 95.60 53.07 40.31 97.10 52.52 41.67 7.81 14.24 -7.06 6.68 12.76 -6.10 coo 93.25 46.91 38.79 94.12 47.43 36.62 8.68 16.14 -1.54 8.01 14.57 -3.30 3qrf_d00 source 3qrf DNA BINDING PROTEIN/DNA : 2 hits 3qrf_d00 naa= 3 ULMN 3 3qsv_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 81 ARG A 136 ARG.? -3.92 O61 C2E A 301s A 83 GLN A 134 GLN^? 8.75 O11 C2E A 301 A 88 LYS A 137 LYS.? -4.52 O2' C2E A 301s coo 19.97 2.61 -45.02 18.79 3.68 -42.41 2.11 -12.17 -9.13 1.08 -10.80 -6.58 coo 24.10 10.39 -42.90 23.65 10.53 -40.83 7.72 -9.60 -13.41 7.57 -9.44 -15.52 coo 20.32 8.01 -45.76 23.08 6.63 -41.24 4.32 -14.05 -15.33 0.72 -19.17 -16.51 ULMN 3 3qsv_d00 TRANSCRIPTION/DNA user 2 3 # 2 A 81 ARG B 136 ARG.? -3.89 O61 C2E B 301s A 83 GLN B 134 GLN.? 7.53 O11 C2E B 301 A 88 LYS B 137 LYS.? -3.23 O3' C2E B 301s coo 19.97 2.61 -45.02 18.79 3.68 -42.41 -10.39 10.75 -3.93 -7.55 9.68 -3.54 coo 24.10 10.39 -42.90 23.65 10.53 -40.83 -17.55 9.98 -0.31 -19.35 10.60 -1.25 coo 20.32 8.01 -45.76 23.08 6.63 -41.24 -16.98 12.27 -5.28 -15.90 17.15 -6.49 3qsv_d00 source 3qsv TRANSCRIPTION/DNA : 2 hits 3qsv_d00 naa= 3 ULMN 3 3s57_d00 OXIDOREDUCTASE/DNA user 1 3 # 1 A 101 VAL A 71 VAL^? 18.38 N21 C2E A 301 A 102 PHE A 60 PHE^? 15.77 N11 C2E A 301 A 169 CYH A 56 CYH^? 16.49 N21 C2E A 301 coo -0.48 2.03 12.21 0.64 0.32 12.97 10.75 -3.93 12.08 12.52 -4.82 11.15 coo 0.51 5.20 15.97 0.26 4.09 18.50 7.85 -3.00 6.49 8.28 -0.45 5.43 coo 4.56 -7.03 18.26 5.32 -4.76 16.88 14.08 -15.43 10.17 15.14 -13.33 11.76 ULMN 3 3s57_d00 OXIDOREDUCTASE/DNA user 2 3 # 2 A 101 VAL A 185 VAL^? 12.77 N7 C2E A 301 A 102 PHE A 151 PHE^? 17.01 N7 C2E A 301 A 169 CYH A 158 CYH^? 12.92 O6 C2E A 301 coo -0.48 2.03 12.21 0.64 0.32 12.97 -11.48 -27.66 -6.39 -10.55 -26.49 -4.80 coo 0.51 5.20 15.97 0.26 4.09 18.50 -12.54 -30.65 -2.04 -10.44 -32.44 -1.68 coo 4.56 -7.03 18.26 5.32 -4.76 16.88 -15.53 -18.41 0.03 -15.42 -19.19 -2.71 ULMN 3 3s57_d00 OXIDOREDUCTASE/DNA user 3 3 # 3 A 101 VAL A 185 VAL^? 12.77 N7 C2E A 301 A 102 PHE A 151 PHE^? 17.01 N7 C2E A 301 A 169 CYH A 207 CYH^? -4.01 O4' C2E A 301s coo -0.48 2.03 12.21 0.64 0.32 12.97 -11.48 -27.66 -6.39 -10.55 -26.49 -4.80 coo 0.51 5.20 15.97 0.26 4.09 18.50 -12.54 -30.65 -2.04 -10.44 -32.44 -1.68 coo 4.56 -7.03 18.26 5.32 -4.76 16.88 -0.78 -24.34 -5.34 -0.81 -23.96 -8.11 ULMN 3 3s57_d00 OXIDOREDUCTASE/DNA user 4 3 # 4 A 101 VAL B 71 VAL^? 16.50 N21 C2E B 301 A 102 PHE B 60 PHE^? 14.21 N11 C2E B 301 A 169 CYH B 56 CYH^? 14.73 N21 C2E B 301 coo -0.48 2.03 12.21 0.64 0.32 12.97 4.24 8.48 14.16 2.41 9.29 15.03 coo 0.51 5.20 15.97 0.26 4.09 18.50 0.84 5.95 9.35 0.07 3.28 9.69 coo 4.56 -7.03 18.26 5.32 -4.76 16.88 -0.90 19.58 13.61 0.17 17.94 15.62 ULMN 3 3s57_d00 OXIDOREDUCTASE/DNA user 5 3 # 5 A 101 VAL B 185 VAL^? 12.63 C8 C2E B 301 A 102 PHE B 151 PHE^? 16.57 N7 C2E B 301 A 169 CYH B 158 CYH^? 12.89 O6 C2E B 301 coo -0.48 2.03 12.21 0.64 0.32 12.97 -2.40 25.76 -15.87 -1.43 24.84 -14.15 coo 0.51 5.20 15.97 0.26 4.09 18.50 1.51 29.09 -14.69 0.48 30.92 -12.87 coo 4.56 -7.03 18.26 5.32 -4.76 16.88 5.78 17.15 -15.63 3.32 17.67 -16.92 ULMN 3 3s57_d00 OXIDOREDUCTASE/DNA user 6 3 # 6 A 101 VAL B 185 VAL^? 12.63 C8 C2E B 301 A 102 PHE B 151 PHE^? 16.57 N7 C2E B 301 A 169 CYH B 207 CYH^? -4.01 O1P C2E B 301s coo -0.48 2.03 12.21 0.64 0.32 12.97 -2.40 25.76 -15.87 -1.43 24.84 -14.15 coo 0.51 5.20 15.97 0.26 4.09 18.50 1.51 29.09 -14.69 0.48 30.92 -12.87 coo 4.56 -7.03 18.26 5.32 -4.76 16.88 -6.32 22.95 -5.82 -8.77 22.45 -7.09 3s57_d00 source 3s57 OXIDOREDUCTASE/DNA : 6 hits 3s57_d00 naa= 3 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 A 21 GLN A 210 GLN^? 10.02 N21 C2E A 301 A 41 TYR A 218 TYR^? 10.22 O6 C2E A 301 A 43 ASN A 208 ASN^? -3.55 N7 C2E A 301s coo 22.03 6.35 12.16 20.71 6.08 10.54 -0.56 -17.78 5.17 0.90 -18.94 6.19 coo 18.67 0.21 9.03 16.70 -1.66 8.55 -6.98 -22.32 0.01 -7.64 -23.76 2.29 coo 14.90 7.30 8.78 14.25 8.14 6.97 0.54 -21.32 -2.29 -0.50 -19.83 -3.42 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 A 21 GLN B 210 GLN^? 10.10 N21 C2E B 301 A 41 TYR B 218 TYR^? 10.08 O6 C2E B 301 A 43 ASN B 208 ASN^? -3.47 N7 C2E B 301s coo 22.03 6.35 12.16 20.71 6.08 10.54 3.27 17.31 -0.03 3.59 18.55 1.68 coo 18.67 0.21 9.03 16.70 -1.66 8.55 1.42 21.23 -8.42 3.73 22.73 -7.99 coo 14.90 7.30 8.78 14.25 8.14 6.97 -4.15 20.35 -2.93 -4.56 18.73 -4.26 3ssc_d00 source 3ssc DNA BINDING PROTEIN/DNA : 2 hits 3ssc_d00 naa= 3 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 A 78 ARG A 136 ARG.? -3.92 O61 C2E A 301s A 82 LYS A 137 LYS.? -4.52 O2' C2E A 301s A 97 ARG A 169 ARG^? -4.75 O6 C2E A 301s coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 2.11 -12.17 -9.13 1.08 -10.80 -6.58 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 4.32 -14.05 -15.33 0.72 -19.17 -16.51 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 -4.99 -14.17 -2.16 -2.05 -13.85 -1.33 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 A 78 ARG A 165 ARG.? 12.45 N2 C2E A 301 A 82 LYS A 231 LYS~? 13.14 O2' C2E A 301 A 97 ARG A 140 ARG.? -3.36 C5 C2E A 301s coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 -4.47 -13.19 -19.45 -6.66 -12.47 -21.46 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 -11.44 -15.22 -19.18 -8.27 -15.76 -22.64 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 -1.50 -13.13 -8.21 0.28 -15.40 -7.16 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 A 78 ARG B 99 ARG.? 13.88 O61 C2E A 301 A 82 LYS A 243 LYS.? 15.17 N2 C2E A 301 A 97 ARG B 136 ARG.? -3.89 O61 C2E B 301s coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 -4.81 1.09 -3.04 -5.37 -1.84 -3.80 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 -10.39 10.75 -3.93 -7.55 9.68 -3.54 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 A 78 ARG B 99 ARG.? 13.88 O61 C2E A 301 A 82 LYS A 243 LYS.? 15.17 N2 C2E A 301 A 97 ARG B 140 ARG.? -3.40 C5 C2E B 301s coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 -4.81 1.09 -3.04 -5.37 -1.84 -3.80 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 -10.07 -3.12 -7.64 -14.33 -4.79 -4.42 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 -7.91 11.52 -6.78 -7.96 14.04 -5.01 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 5 3 # 5 A 78 ARG B 136 ARG.? -3.89 O61 C2E B 301s A 82 LYS B 137 LYS.? -3.23 O3' C2E B 301s A 97 ARG B 169 ARG^? -4.70 O6 C2E B 301s coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 -10.39 10.75 -3.93 -7.55 9.68 -3.54 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 -16.98 12.27 -5.28 -15.90 17.15 -6.49 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 -0.88 13.03 -7.12 -1.56 12.92 -4.13 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 6 3 # 6 A 78 ARG B 165 ARG.? 10.70 O2' C2E B 301 A 82 LYS B 231 LYS~? 16.58 O2' C2E B 301 A 97 ARG B 140 ARG.? -3.40 C5 C2E B 301s coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 -16.44 10.61 -14.72 -19.33 11.67 -14.77 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 -12.77 12.18 -20.95 -18.80 11.50 -22.86 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 -7.91 11.52 -6.78 -7.96 14.04 -5.01 4er8_d00 source 4er8 DNA BINDING PROTEIN/DNA : 6 hits 4er8_d00 naa= 3 ULMN 4 1e3w_o00 SHORT CHAIN 3-HYDROXYACYL-COA DEHYDRuser 1 4 # 1 A 41 ASP A 162 ASP^? -3.09 N1 C2E A 301s A 64 ASN A 144 ASN^? 13.31 N1 C2E A 301 A 168 TYR A 179 TYR.? 13.95 N7 C2E A 301 A 172 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo 29.31 2.47 30.64 27.42 3.34 30.67 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 28.76 0.05 39.20 27.05 1.09 39.77 -14.15 -8.19 -2.40 -12.36 -7.37 -1.59 coo 18.34 15.14 38.14 19.89 15.29 35.79 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo 23.68 18.08 40.55 24.55 14.70 36.44 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 4 1e3w_o00 SHORT CHAIN 3-HYDROXYACYL-COA DEHYDRuser 2 4 # 2 A 41 ASP B 162 ASP^? -3.04 N1 C2E B 301s A 64 ASN B 144 ASN^? 13.28 N1 C2E B 301 A 168 TYR B 179 TYR.? 13.89 O6 C2E B 301 A 172 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo 29.31 2.47 30.64 27.42 3.34 30.67 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 28.76 0.05 39.20 27.05 1.09 39.77 3.74 6.70 -14.80 3.60 6.07 -12.77 coo 18.34 15.14 38.14 19.89 15.29 35.79 2.36 25.70 -10.99 3.98 25.02 -13.14 coo 23.68 18.08 40.55 24.55 14.70 36.44 8.81 26.59 -11.72 7.46 31.56 -12.94 1e3w_o00 source 1E3W SHORT CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE : 2 hits 1e3w_o00 naa= 4 ULMN 4 1e3w_o02 SHORT CHAIN 3-HYDROXYACYL-COA DEHYDRuser 1 4 # 1 C 41 ASP A 162 ASP^? -3.09 N1 C2E A 301s C 64 ASN A 144 ASN^? 13.31 N1 C2E A 301 C 168 TYR A 179 TYR.? 13.95 N7 C2E A 301 C 172 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo 40.69 50.52 19.33 41.33 50.42 21.37 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 34.72 56.95 21.18 34.76 56.91 23.30 -14.15 -8.19 -2.40 -12.36 -7.37 -1.59 coo 35.94 47.42 36.81 37.06 45.66 35.01 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo 30.46 44.57 34.70 34.50 45.03 31.11 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 4 1e3w_o02 SHORT CHAIN 3-HYDROXYACYL-COA DEHYDRuser 2 4 # 2 C 41 ASP B 162 ASP^? -3.04 N1 C2E B 301s C 64 ASN B 144 ASN^? 13.28 N1 C2E B 301 C 168 TYR B 179 TYR.? 13.89 O6 C2E B 301 C 172 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo 40.69 50.52 19.33 41.33 50.42 21.37 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 34.72 56.95 21.18 34.76 56.91 23.30 3.74 6.70 -14.80 3.60 6.07 -12.77 coo 35.94 47.42 36.81 37.06 45.66 35.01 2.36 25.70 -10.99 3.98 25.02 -13.14 coo 30.46 44.57 34.70 34.50 45.03 31.11 8.81 26.59 -11.72 7.46 31.56 -12.94 1e3w_o02 source 1E3W SHORT CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE : 2 hits 1e3w_o02 naa= 4 ULMN 4 1e3w_o03 SHORT CHAIN 3-HYDROXYACYL-COA DEHYDRuser 1 4 # 1 D 41 ASP A 162 ASP^? -3.09 N1 C2E A 301s D 64 ASN A 144 ASN^? 13.31 N1 C2E A 301 D 168 TYR A 179 TYR.? 13.95 N7 C2E A 301 D 172 LYS A 177 LYS.? 20.27 N7 C2E A 301 coo 9.77 60.85 45.83 9.14 59.48 44.33 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 15.92 64.33 40.44 15.87 63.01 38.79 -14.15 -8.19 -2.40 -12.36 -7.37 -1.59 coo 14.20 46.99 34.69 13.14 46.88 37.21 -9.39 -27.05 -0.05 -12.07 -26.36 0.14 coo 19.65 46.02 38.25 15.67 48.80 40.68 -13.21 -27.52 5.04 -11.69 -32.72 3.81 ULMN 4 1e3w_o03 SHORT CHAIN 3-HYDROXYACYL-COA DEHYDRuser 2 4 # 2 D 41 ASP B 162 ASP^? -3.04 N1 C2E B 301s D 64 ASN B 144 ASN^? 13.28 N1 C2E B 301 D 168 TYR B 179 TYR.? 13.89 O6 C2E B 301 D 172 LYS B 177 LYS.? 21.12 N7 C2E B 301 coo 9.77 60.85 45.83 9.14 59.48 44.33 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 15.92 64.33 40.44 15.87 63.01 38.79 3.74 6.70 -14.80 3.60 6.07 -12.77 coo 14.20 46.99 34.69 13.14 46.88 37.21 2.36 25.70 -10.99 3.98 25.02 -13.14 coo 19.65 46.02 38.25 15.67 48.80 40.68 8.81 26.59 -11.72 7.46 31.56 -12.94 1e3w_o03 source 1E3W SHORT CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE : 2 hits 1e3w_o03 naa= 4 ULMN 3 2odj_o00 PORIN D user 1 3 # 1 A 156 HIS A 38 HIS.? 16.46 O61 C2E B 301 A 208 ASP B 66 ASP.? 24.37 N21 C2E A 301 A 296 SER B 45 SER^? 12.51 N21 C2E B 301 coo 12.72 17.48 24.71 12.80 19.37 23.81 1.46 -0.40 7.20 -0.57 -0.26 7.72 coo 18.47 29.19 29.68 19.30 29.17 27.75 -3.12 -5.44 17.43 -2.91 -6.73 19.08 coo 6.89 17.22 46.63 5.08 16.21 47.91 -6.50 17.30 16.50 -7.95 17.62 14.58 ULMN 3 2odj_o00 PORIN D user 2 3 # 2 A 156 HIS A 106 HIS^? 11.03 N21 C2E A 301 A 208 ASP A 31 ASP~? 17.49 O6 C2E B 301 A 296 SER A 164 SER.? -3.07 N2 C2E A 301s coo 12.72 17.48 24.71 12.80 19.37 23.81 16.26 -9.68 -2.62 15.33 -11.56 -2.56 coo 18.47 29.19 29.68 19.30 29.17 27.75 10.86 4.60 -5.63 10.78 6.65 -6.14 coo 6.89 17.22 46.63 5.08 16.21 47.91 -5.52 -13.71 -13.16 -3.99 -15.49 -12.49 ULMN 3 2odj_o00 PORIN D user 3 3 # 3 A 156 HIS A 113 HIS^? 30.12 N21 C2E A 301 A 208 ASP A 66 ASP.? 23.33 N21 C2E B 301 A 296 SER B 125 SER^? 22.05 N21 C2E B 301 coo 12.72 17.48 24.71 12.80 19.37 23.81 19.70 2.48 16.98 21.09 4.00 16.57 coo 18.47 29.19 29.68 19.30 29.17 27.75 15.60 9.37 4.44 16.85 10.89 5.23 coo 6.89 17.22 46.63 5.08 16.21 47.91 -3.10 3.96 21.21 -4.91 5.28 22.14 ULMN 3 2odj_o00 PORIN D user 4 3 # 4 A 156 HIS A 215 HIS.? 12.12 O6 C2E A 301 A 208 ASP A 162 ASP^? -3.09 N1 C2E A 301s A 296 SER B 25 SER^? 17.21 N71 C2E B 301 coo 12.72 17.48 24.71 12.80 19.37 23.81 -8.99 -15.19 5.86 -7.58 -13.77 5.21 coo 18.47 29.19 29.68 19.30 29.17 27.75 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 6.89 17.22 46.63 5.08 16.21 47.91 -19.35 2.63 8.48 -17.89 1.61 6.84 ULMN 3 2odj_o00 PORIN D user 5 3 # 5 A 156 HIS A 215 HIS.? 12.12 O6 C2E A 301 A 208 ASP A 162 ASP^? -3.09 N1 C2E A 301s A 296 SER B 133 SER^? 10.32 O4A C2E B 301 coo 12.72 17.48 24.71 12.80 19.37 23.81 -8.99 -15.19 5.86 -7.58 -13.77 5.21 coo 18.47 29.19 29.68 19.30 29.17 27.75 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo 6.89 17.22 46.63 5.08 16.21 47.91 -16.34 7.76 5.39 -15.62 9.78 6.51 ULMN 3 2odj_o00 PORIN D user 6 3 # 6 A 156 HIS B 38 HIS.? 15.97 O61 C2E B 301 A 208 ASP A 31 ASP~? 17.49 O6 C2E B 301 A 296 SER A 45 SER^? 13.73 N21 C2E A 301 coo 12.72 17.48 24.71 12.80 19.37 23.81 4.87 2.64 4.63 6.30 2.30 3.13 coo 18.47 29.19 29.68 19.30 29.17 27.75 10.86 4.60 -5.63 10.78 6.65 -6.14 coo 6.89 17.22 46.63 5.08 16.21 47.91 19.13 -13.30 6.25 18.28 -14.32 4.23 ULMN 3 2odj_o00 PORIN D user 7 3 # 7 A 156 HIS B 38 HIS.? 15.97 O61 C2E B 301 A 208 ASP A 66 ASP.? 23.33 N21 C2E B 301 A 296 SER A 45 SER^? 13.73 N21 C2E A 301 coo 12.72 17.48 24.71 12.80 19.37 23.81 4.87 2.64 4.63 6.30 2.30 3.13 coo 18.47 29.19 29.68 19.30 29.17 27.75 15.60 9.37 4.44 16.85 10.89 5.23 coo 6.89 17.22 46.63 5.08 16.21 47.91 19.13 -13.30 6.25 18.28 -14.32 4.23 ULMN 3 2odj_o00 PORIN D user 8 3 # 8 A 156 HIS B 113 HIS^? 28.48 N21 C2E B 301 A 208 ASP B 66 ASP.? 24.37 N21 C2E A 301 A 296 SER A 125 SER.? 23.81 N21 C2E A 301 coo 12.72 17.48 24.71 12.80 19.37 23.81 4.95 4.79 25.73 4.34 3.55 27.31 coo 18.47 29.19 29.68 19.30 29.17 27.75 -3.12 -5.44 17.43 -2.91 -6.73 19.08 coo 6.89 17.22 46.63 5.08 16.21 47.91 19.83 1.13 7.98 21.72 -0.16 7.19 ULMN 3 2odj_o00 PORIN D user 9 3 # 9 A 156 HIS B 215 HIS.? 11.93 O6 C2E B 301 A 208 ASP A 66 ASP.? 23.33 N21 C2E B 301 A 296 SER A 133 SER^? 10.46 O4A C2E A 301 coo 12.72 17.48 24.71 12.80 19.37 23.81 7.81 14.24 -7.06 6.68 12.76 -6.10 coo 18.47 29.19 29.68 19.30 29.17 27.75 15.60 9.37 4.44 16.85 10.89 5.23 coo 6.89 17.22 46.63 5.08 16.21 47.91 12.55 -8.09 -9.84 13.31 -9.86 -8.34 ULMN 3 2odj_o00 PORIN D user 10 3 # 10 A 156 HIS B 215 HIS.? 11.93 O6 C2E B 301 A 208 ASP B 162 ASP^? -3.04 N1 C2E B 301s A 296 SER A 133 SER^? 10.46 O4A C2E A 301 coo 12.72 17.48 24.71 12.80 19.37 23.81 7.81 14.24 -7.06 6.68 12.76 -6.10 coo 18.47 29.19 29.68 19.30 29.17 27.75 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo 6.89 17.22 46.63 5.08 16.21 47.91 12.55 -8.09 -9.84 13.31 -9.86 -8.34 2odj_o00 source 2ODJ PORIN D : 10 hits 2odj_o00 naa= 3 ULMN 3 2odj_o01 PORIN D user 1 3 # 1 B 156 HIS A 38 HIS.? 16.46 O61 C2E B 301 B 208 ASP B 66 ASP.? 24.37 N21 C2E A 301 B 296 SER B 45 SER^? 12.51 N21 C2E B 301 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 1.46 -0.40 7.20 -0.57 -0.26 7.72 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -3.12 -5.44 17.43 -2.91 -6.73 19.08 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -6.50 17.30 16.50 -7.95 17.62 14.58 ULMN 3 2odj_o01 PORIN D user 2 3 # 2 B 156 HIS A 215 HIS.? 12.12 O6 C2E A 301 B 208 ASP A 162 ASP^? -3.09 N1 C2E A 301s B 296 SER B 133 SER^? 10.32 O4A C2E B 301 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -8.99 -15.19 5.86 -7.58 -13.77 5.21 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -6.26 -11.42 -6.54 -4.88 -13.01 -6.28 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -16.34 7.76 5.39 -15.62 9.78 6.51 ULMN 3 2odj_o01 PORIN D user 3 3 # 3 B 156 HIS B 38 HIS.? 15.97 O61 C2E B 301 B 208 ASP A 31 ASP~? 17.49 O6 C2E B 301 B 296 SER A 45 SER^? 13.73 N21 C2E A 301 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 4.87 2.64 4.63 6.30 2.30 3.13 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 10.86 4.60 -5.63 10.78 6.65 -6.14 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 19.13 -13.30 6.25 18.28 -14.32 4.23 ULMN 3 2odj_o01 PORIN D user 4 3 # 4 B 156 HIS B 38 HIS.? 15.97 O61 C2E B 301 B 208 ASP A 31 ASP~? 17.49 O6 C2E B 301 B 296 SER B 164 SER.? -3.05 N2 C2E B 301s coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 4.87 2.64 4.63 6.30 2.30 3.13 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 10.86 4.60 -5.63 10.78 6.65 -6.14 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -10.30 11.42 -12.93 -10.44 13.17 -11.24 ULMN 3 2odj_o01 PORIN D user 5 3 # 5 B 156 HIS B 38 HIS.? 15.97 O61 C2E B 301 B 208 ASP A 66 ASP.? 23.33 N21 C2E B 301 B 296 SER A 45 SER^? 13.73 N21 C2E A 301 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 4.87 2.64 4.63 6.30 2.30 3.13 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 15.60 9.37 4.44 16.85 10.89 5.23 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 19.13 -13.30 6.25 18.28 -14.32 4.23 ULMN 3 2odj_o01 PORIN D user 6 3 # 6 B 156 HIS B 214 HIS.? 18.94 O6 C2E B 301 B 208 ASP B 157 ASP^? 20.00 O6 C2E B 301 B 296 SER B 164 SER.? -3.05 N2 C2E B 301s coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 13.04 11.66 -4.90 14.49 10.59 -3.83 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 9.70 18.14 -17.54 10.97 18.31 -19.23 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -10.30 11.42 -12.93 -10.44 13.17 -11.24 ULMN 3 2odj_o01 PORIN D user 7 3 # 7 B 156 HIS B 215 HIS.? 11.93 O6 C2E B 301 B 208 ASP A 66 ASP.? 23.33 N21 C2E B 301 B 296 SER A 133 SER^? 10.46 O4A C2E A 301 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 7.81 14.24 -7.06 6.68 12.76 -6.10 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 15.60 9.37 4.44 16.85 10.89 5.23 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 12.55 -8.09 -9.84 13.31 -9.86 -8.34 ULMN 3 2odj_o01 PORIN D user 8 3 # 8 B 156 HIS B 215 HIS.? 11.93 O6 C2E B 301 B 208 ASP B 162 ASP^? -3.04 N1 C2E B 301s B 296 SER A 133 SER^? 10.46 O4A C2E A 301 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 7.81 14.24 -7.06 6.68 12.76 -6.10 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -3.96 9.86 -10.13 -4.46 11.57 -9.02 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 12.55 -8.09 -9.84 13.31 -9.86 -8.34 2odj_o01 source 2ODJ PORIN D : 8 hits 2odj_o01 naa= 3 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 1 3 # 1 A 130 SER A 109 SER^? 20.65 N21 C2E A 301 A 166 PHE A 85 PHE.? 21.18 N21 C2E A 301 A 182 PHE A 54 PHE^? 19.63 N21 C2E A 301 coo -46.28 37.24 81.97 -44.96 39.32 82.40 20.92 -3.37 5.70 19.17 -2.44 7.11 coo -36.62 39.62 84.60 -38.76 41.24 85.25 18.09 -9.55 15.63 16.44 -8.05 13.97 coo -36.55 45.66 79.22 -38.34 43.94 80.53 19.69 -16.80 12.43 17.45 -17.09 14.05 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 2 3 # 2 A 130 SER A 109 SER^? 20.65 N21 C2E A 301 A 166 PHE A 89 PHE.? 26.99 N21 C2E A 301 A 182 PHE A 54 PHE^? 19.63 N21 C2E A 301 coo -46.28 37.24 81.97 -44.96 39.32 82.40 20.92 -3.37 5.70 19.17 -2.44 7.11 coo -36.62 39.62 84.60 -38.76 41.24 85.25 25.71 -8.99 13.78 27.35 -10.29 15.61 coo -36.55 45.66 79.22 -38.34 43.94 80.53 19.69 -16.80 12.43 17.45 -17.09 14.05 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 3 3 # 3 A 130 SER A 109 SER^? 20.65 N21 C2E A 301 A 166 PHE A 89 PHE.? 26.99 N21 C2E A 301 A 182 PHE A 85 PHE.? 21.18 N21 C2E A 301 coo -46.28 37.24 81.97 -44.96 39.32 82.40 20.92 -3.37 5.70 19.17 -2.44 7.11 coo -36.62 39.62 84.60 -38.76 41.24 85.25 25.71 -8.99 13.78 27.35 -10.29 15.61 coo -36.55 45.66 79.22 -38.34 43.94 80.53 18.09 -9.55 15.63 16.44 -8.05 13.97 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 4 3 # 4 A 130 SER B 109 SER^? 18.78 N21 C2E B 301 A 166 PHE B 85 PHE~? 19.52 N21 C2E B 301 A 182 PHE B 54 PHE^? 17.95 N21 C2E B 301 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -6.26 7.92 20.06 -4.06 7.18 19.35 coo -36.62 39.62 84.60 -38.76 41.24 85.25 3.00 15.73 20.69 2.87 13.51 19.06 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -1.86 22.37 18.66 0.47 22.95 17.25 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 5 3 # 5 A 130 SER B 109 SER^? 18.78 N21 C2E B 301 A 166 PHE B 89 PHE.? 25.06 N21 C2E B 301 A 182 PHE B 54 PHE^? 17.95 N21 C2E B 301 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -6.26 7.92 20.06 -4.06 7.18 19.35 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -2.05 15.78 26.25 -1.17 17.76 27.98 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -1.86 22.37 18.66 0.47 22.95 17.25 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 6 3 # 6 A 130 SER B 109 SER^? 18.78 N21 C2E B 301 A 166 PHE B 89 PHE.? 25.06 N21 C2E B 301 A 182 PHE B 85 PHE~? 19.52 N21 C2E B 301 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -6.26 7.92 20.06 -4.06 7.18 19.35 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -2.05 15.78 26.25 -1.17 17.76 27.98 coo -36.55 45.66 79.22 -38.34 43.94 80.53 3.00 15.73 20.69 2.87 13.51 19.06 2r11_o00 source 2R11 CARBOXYLESTERASE NP : 6 hits 2r11_o00 naa= 3 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 1 3 # 1 B 130 SER A 109 SER^? 20.65 N21 C2E A 301 B 166 PHE A 85 PHE.? 21.18 N21 C2E A 301 B 182 PHE A 54 PHE^? 19.63 N21 C2E A 301 coo -19.94 46.29 97.83 -22.38 46.56 97.60 20.92 -3.37 5.70 19.17 -2.44 7.11 coo -29.59 43.40 95.66 -28.22 45.54 94.50 18.09 -9.55 15.63 16.44 -8.05 13.97 coo -32.72 50.15 98.46 -30.32 48.85 97.77 19.69 -16.80 12.43 17.45 -17.09 14.05 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 2 3 # 2 B 130 SER A 109 SER^? 20.65 N21 C2E A 301 B 166 PHE A 89 PHE.? 26.99 N21 C2E A 301 B 182 PHE A 54 PHE^? 19.63 N21 C2E A 301 coo -19.94 46.29 97.83 -22.38 46.56 97.60 20.92 -3.37 5.70 19.17 -2.44 7.11 coo -29.59 43.40 95.66 -28.22 45.54 94.50 25.71 -8.99 13.78 27.35 -10.29 15.61 coo -32.72 50.15 98.46 -30.32 48.85 97.77 19.69 -16.80 12.43 17.45 -17.09 14.05 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 3 3 # 3 B 130 SER A 109 SER^? 20.65 N21 C2E A 301 B 166 PHE A 89 PHE.? 26.99 N21 C2E A 301 B 182 PHE A 85 PHE.? 21.18 N21 C2E A 301 coo -19.94 46.29 97.83 -22.38 46.56 97.60 20.92 -3.37 5.70 19.17 -2.44 7.11 coo -29.59 43.40 95.66 -28.22 45.54 94.50 25.71 -8.99 13.78 27.35 -10.29 15.61 coo -32.72 50.15 98.46 -30.32 48.85 97.77 18.09 -9.55 15.63 16.44 -8.05 13.97 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 4 3 # 4 B 130 SER B 109 SER^? 18.78 N21 C2E B 301 B 166 PHE B 85 PHE~? 19.52 N21 C2E B 301 B 182 PHE B 54 PHE^? 17.95 N21 C2E B 301 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -6.26 7.92 20.06 -4.06 7.18 19.35 coo -29.59 43.40 95.66 -28.22 45.54 94.50 3.00 15.73 20.69 2.87 13.51 19.06 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -1.86 22.37 18.66 0.47 22.95 17.25 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 5 3 # 5 B 130 SER B 109 SER^? 18.78 N21 C2E B 301 B 166 PHE B 85 PHE~? 19.52 N21 C2E B 301 B 182 PHE B 84 PHE~? 21.91 N21 C2E B 301 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -6.26 7.92 20.06 -4.06 7.18 19.35 coo -29.59 43.40 95.66 -28.22 45.54 94.50 3.00 15.73 20.69 2.87 13.51 19.06 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -0.90 22.18 22.15 -2.04 24.70 22.44 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 6 3 # 6 B 130 SER B 109 SER^? 18.78 N21 C2E B 301 B 166 PHE B 89 PHE.? 25.06 N21 C2E B 301 B 182 PHE B 84 PHE~? 21.91 N21 C2E B 301 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -6.26 7.92 20.06 -4.06 7.18 19.35 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -2.05 15.78 26.25 -1.17 17.76 27.98 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -0.90 22.18 22.15 -2.04 24.70 22.44 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 7 3 # 7 B 130 SER B 109 SER^? 18.78 N21 C2E B 301 B 166 PHE B 89 PHE.? 25.06 N21 C2E B 301 B 182 PHE B 85 PHE~? 19.52 N21 C2E B 301 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -6.26 7.92 20.06 -4.06 7.18 19.35 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -2.05 15.78 26.25 -1.17 17.76 27.98 coo -32.72 50.15 98.46 -30.32 48.85 97.77 3.00 15.73 20.69 2.87 13.51 19.06 2r11_o01 source 2R11 CARBOXYLESTERASE NP : 7 hits 2r11_o01 naa= 3 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 1 3 # 1 C 130 SER A 109 SER^? 20.65 N21 C2E A 301 C 166 PHE A 85 PHE.? 21.18 N21 C2E A 301 C 182 PHE A 54 PHE^? 19.63 N21 C2E A 301 coo -2.19 64.27 51.12 -3.34 62.10 50.60 20.92 -3.37 5.70 19.17 -2.44 7.11 coo -11.14 61.91 46.89 -9.88 60.30 48.76 18.09 -9.55 15.63 16.44 -8.05 13.97 coo -7.71 55.92 42.70 -7.18 57.60 44.85 19.69 -16.80 12.43 17.45 -17.09 14.05 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 2 3 # 2 C 130 SER A 109 SER^? 20.65 N21 C2E A 301 C 166 PHE A 89 PHE.? 26.99 N21 C2E A 301 C 182 PHE A 54 PHE^? 19.63 N21 C2E A 301 coo -2.19 64.27 51.12 -3.34 62.10 50.60 20.92 -3.37 5.70 19.17 -2.44 7.11 coo -11.14 61.91 46.89 -9.88 60.30 48.76 25.71 -8.99 13.78 27.35 -10.29 15.61 coo -7.71 55.92 42.70 -7.18 57.60 44.85 19.69 -16.80 12.43 17.45 -17.09 14.05 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 3 3 # 3 C 130 SER A 109 SER^? 20.65 N21 C2E A 301 C 166 PHE A 89 PHE.? 26.99 N21 C2E A 301 C 182 PHE A 85 PHE.? 21.18 N21 C2E A 301 coo -2.19 64.27 51.12 -3.34 62.10 50.60 20.92 -3.37 5.70 19.17 -2.44 7.11 coo -11.14 61.91 46.89 -9.88 60.30 48.76 25.71 -8.99 13.78 27.35 -10.29 15.61 coo -7.71 55.92 42.70 -7.18 57.60 44.85 18.09 -9.55 15.63 16.44 -8.05 13.97 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 4 3 # 4 C 130 SER B 109 SER^? 18.78 N21 C2E B 301 C 166 PHE B 89 PHE.? 25.06 N21 C2E B 301 C 182 PHE B 85 PHE~? 19.52 N21 C2E B 301 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -6.26 7.92 20.06 -4.06 7.18 19.35 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -2.05 15.78 26.25 -1.17 17.76 27.98 coo -7.71 55.92 42.70 -7.18 57.60 44.85 3.00 15.73 20.69 2.87 13.51 19.06 2r11_o02 source 2R11 CARBOXYLESTERASE NP : 4 hits 2r11_o02 naa= 3 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 1 3 # 1 D 130 SER A 109 SER^? 20.65 N21 C2E A 301 D 166 PHE A 85 PHE.? 21.18 N21 C2E A 301 D 182 PHE A 54 PHE^? 19.63 N21 C2E A 301 coo -32.42 55.27 46.18 -30.51 54.94 47.67 20.92 -3.37 5.70 19.17 -2.44 7.11 coo -23.62 58.20 50.84 -23.76 56.14 48.96 18.09 -9.55 15.63 16.44 -8.05 13.97 coo -23.08 51.44 54.96 -24.43 52.71 52.88 19.69 -16.80 12.43 17.45 -17.09 14.05 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 2 3 # 2 D 130 SER A 109 SER^? 20.65 N21 C2E A 301 D 166 PHE A 89 PHE.? 26.99 N21 C2E A 301 D 182 PHE A 85 PHE.? 21.18 N21 C2E A 301 coo -32.42 55.27 46.18 -30.51 54.94 47.67 20.92 -3.37 5.70 19.17 -2.44 7.11 coo -23.62 58.20 50.84 -23.76 56.14 48.96 25.71 -8.99 13.78 27.35 -10.29 15.61 coo -23.08 51.44 54.96 -24.43 52.71 52.88 18.09 -9.55 15.63 16.44 -8.05 13.97 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 3 3 # 3 D 130 SER B 109 SER^? 18.78 N21 C2E B 301 D 166 PHE B 85 PHE~? 19.52 N21 C2E B 301 D 182 PHE B 54 PHE^? 17.95 N21 C2E B 301 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -6.26 7.92 20.06 -4.06 7.18 19.35 coo -23.62 58.20 50.84 -23.76 56.14 48.96 3.00 15.73 20.69 2.87 13.51 19.06 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -1.86 22.37 18.66 0.47 22.95 17.25 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 4 3 # 4 D 130 SER B 109 SER^? 18.78 N21 C2E B 301 D 166 PHE B 85 PHE~? 19.52 N21 C2E B 301 D 182 PHE B 84 PHE~? 21.91 N21 C2E B 301 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -6.26 7.92 20.06 -4.06 7.18 19.35 coo -23.62 58.20 50.84 -23.76 56.14 48.96 3.00 15.73 20.69 2.87 13.51 19.06 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -0.90 22.18 22.15 -2.04 24.70 22.44 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 5 3 # 5 D 130 SER B 109 SER^? 18.78 N21 C2E B 301 D 166 PHE B 89 PHE.? 25.06 N21 C2E B 301 D 182 PHE B 84 PHE~? 21.91 N21 C2E B 301 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -6.26 7.92 20.06 -4.06 7.18 19.35 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -2.05 15.78 26.25 -1.17 17.76 27.98 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -0.90 22.18 22.15 -2.04 24.70 22.44 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 6 3 # 6 D 130 SER B 109 SER^? 18.78 N21 C2E B 301 D 166 PHE B 89 PHE.? 25.06 N21 C2E B 301 D 182 PHE B 85 PHE~? 19.52 N21 C2E B 301 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -6.26 7.92 20.06 -4.06 7.18 19.35 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -2.05 15.78 26.25 -1.17 17.76 27.98 coo -23.08 51.44 54.96 -24.43 52.71 52.88 3.00 15.73 20.69 2.87 13.51 19.06 2r11_o03 source 2R11 CARBOXYLESTERASE NP : 6 hits 2r11_o03 naa= 3 ULMN 3 3hde_o00 LYSOZYME user 1 3 # 1 A 35 GLU A 159 GLU^? 13.73 O6 C2E A 301 A 44 ASP A 157 ASP^? 20.06 O6 C2E A 301 A 50 THR A 172 THR^? 12.93 O6 C2E A 301 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -14.60 -12.52 -1.04 -14.41 -10.88 0.31 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -19.05 -19.29 2.64 -21.12 -19.53 2.92 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -12.64 -19.39 3.41 -11.97 -21.32 2.68 ULMN 3 3hde_o00 LYSOZYME user 2 3 # 2 A 35 GLU B 159 GLU^? 13.76 O6 C2E B 301 A 44 ASP B 157 ASP^? 20.00 O6 C2E B 301 A 50 THR B 172 THR^? 12.75 O6 C2E B 301 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 4.99 11.22 -14.77 6.30 9.86 -13.80 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 9.70 18.14 -17.54 10.97 18.31 -19.23 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 7.41 18.34 -11.48 6.25 20.16 -11.39 3hde_o00 source 3HDE LYSOZYME : 2 hits 3hde_o00 naa= 3 ULMN 3 3hde_o01 LYSOZYME user 1 3 # 1 B 35 GLU B 37 GLU.? 9.39 O61 C2E B 301 B 44 ASP A 31 ASP~? 17.49 O6 C2E B 301 B 50 THR A 30 THR~? 18.62 O61 C2E B 301 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -0.62 3.88 0.75 -0.32 4.81 -1.12 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 10.86 4.60 -5.63 10.78 6.65 -6.14 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 12.18 5.53 -1.07 11.95 7.63 -0.66 3hde_o01 source 3HDE LYSOZYME : 1 hits 3hde_o01 naa= 3 ULMN 3 3hde_o02 LYSOZYME user 1 3 # 1 C 35 GLU A 153 GLU.? 24.63 N7 C2E A 301 C 44 ASP A 183 ASP.? 14.57 O1P C2E A 301 C 50 THR A 178 THR.? 17.14 O6 C2E A 301 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -19.21 -34.41 1.40 -17.40 -35.49 1.72 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -7.06 -30.30 -3.03 -6.77 -31.63 -1.43 coo 25.48 4.87 1.60 23.90 4.95 0.15 -9.47 -27.26 4.39 -8.59 -27.66 6.32 3hde_o02 source 3HDE LYSOZYME : 1 hits 3hde_o02 naa= 3 ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 1 3 # 1 A 29 ASP A 157 ASP^? 20.06 O6 C2E A 301 A 117 LYS A 177 LYS.? 20.27 N7 C2E A 301 A 150 CYH A 158 CYH^? 12.92 O6 C2E A 301 coo 37.97 47.82 5.46 38.65 48.02 7.40 -19.05 -19.29 2.64 -21.12 -19.53 2.92 coo 41.02 51.33 13.36 40.18 47.06 9.99 -13.21 -27.52 5.04 -11.69 -32.72 3.81 coo 39.17 42.30 8.54 40.94 44.26 7.78 -15.53 -18.41 0.03 -15.42 -19.19 -2.71 ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 2 3 # 2 A 29 ASP B 157 ASP^? 20.00 O6 C2E B 301 A 117 LYS B 177 LYS.? 21.12 N7 C2E B 301 A 150 CYH B 158 CYH^? 12.89 O6 C2E B 301 coo 37.97 47.82 5.46 38.65 48.02 7.40 9.70 18.14 -17.54 10.97 18.31 -19.23 coo 41.02 51.33 13.36 40.18 47.06 9.99 8.81 26.59 -11.72 7.46 31.56 -12.94 coo 39.17 42.30 8.54 40.94 44.26 7.78 5.78 17.15 -15.63 3.32 17.67 -16.92 3uao_o00 source 3UAO PUTATIVE ISOCHORISMATASE : 2 hits 3uao_o00 naa= 3 ULMN 3 3uao_o01 PUTATIVE ISOCHORISMATASE user 1 3 # 1 B 29 ASP A 157 ASP^? 20.06 O6 C2E A 301 B 117 LYS A 177 LYS.? 20.27 N7 C2E A 301 B 150 CYH A 158 CYH^? 12.92 O6 C2E A 301 coo 33.94 43.16 45.29 35.02 43.05 43.47 -19.05 -19.29 2.64 -21.12 -19.53 2.92 coo 38.53 39.60 38.22 36.76 43.89 41.37 -13.21 -27.52 5.04 -11.69 -32.72 3.81 coo 35.77 48.61 42.57 37.40 46.62 43.48 -15.53 -18.41 0.03 -15.42 -19.19 -2.71 ULMN 3 3uao_o01 PUTATIVE ISOCHORISMATASE user 2 3 # 2 B 29 ASP B 157 ASP^? 20.00 O6 C2E B 301 B 117 LYS B 177 LYS.? 21.12 N7 C2E B 301 B 150 CYH B 158 CYH^? 12.89 O6 C2E B 301 coo 33.94 43.16 45.29 35.02 43.05 43.47 9.70 18.14 -17.54 10.97 18.31 -19.23 coo 38.53 39.60 38.22 36.76 43.89 41.37 8.81 26.59 -11.72 7.46 31.56 -12.94 coo 35.77 48.61 42.57 37.40 46.62 43.48 5.78 17.15 -15.63 3.32 17.67 -16.92 3uao_o01 source 3UAO PUTATIVE ISOCHORISMATASE : 2 hits 3uao_o01 naa= 3 ULMN 3 3uao_o02 PUTATIVE ISOCHORISMATASE user 1 3 # 1 C 29 ASP B 80 ASP~? 21.84 N21 C2E B 301 C 117 LYS B 53 LYS^? 20.29 N21 C2E B 301 C 150 CYH B 56 CYH^? 14.73 N21 C2E B 301 coo 54.62 -9.81 68.84 52.97 -9.23 67.61 3.05 24.05 19.78 2.70 26.08 19.35 coo 46.74 -10.34 64.36 51.80 -7.96 65.19 -7.36 22.58 21.02 -13.56 21.56 20.17 coo 55.78 -5.03 64.48 55.52 -7.79 64.07 -0.90 19.58 13.61 0.17 17.94 15.62 3uao_o02 source 3UAO PUTATIVE ISOCHORISMATASE : 1 hits 3uao_o02 naa= 3 ULMN 3 3uao_o03 PUTATIVE ISOCHORISMATASE user 1 3 # 1 D 29 ASP A 157 ASP^? 20.06 O6 C2E A 301 D 117 LYS A 177 LYS.? 20.27 N7 C2E A 301 D 150 CYH A 158 CYH^? 12.92 O6 C2E A 301 coo 25.05 13.27 54.10 26.66 12.10 53.60 -19.05 -19.29 2.64 -21.12 -19.53 2.92 coo 33.45 10.03 51.76 28.31 9.37 53.37 -13.21 -27.52 5.04 -11.69 -32.72 3.81 coo 24.32 7.20 55.59 24.80 8.07 53.08 -15.53 -18.41 0.03 -15.42 -19.19 -2.71 ULMN 3 3uao_o03 PUTATIVE ISOCHORISMATASE user 2 3 # 2 D 29 ASP B 157 ASP^? 20.00 O6 C2E B 301 D 117 LYS B 177 LYS.? 21.12 N7 C2E B 301 D 150 CYH B 158 CYH^? 12.89 O6 C2E B 301 coo 25.05 13.27 54.10 26.66 12.10 53.60 9.70 18.14 -17.54 10.97 18.31 -19.23 coo 33.45 10.03 51.76 28.31 9.37 53.37 8.81 26.59 -11.72 7.46 31.56 -12.94 coo 24.32 7.20 55.59 24.80 8.07 53.08 5.78 17.15 -15.63 3.32 17.67 -16.92 3uao_o03 source 3UAO PUTATIVE ISOCHORISMATASE : 2 hits 3uao_o03 naa= 3 ULMN 3 3uao_o04 PUTATIVE ISOCHORISMATASE user 1 3 # 1 E 29 ASP A 157 ASP^? 20.06 O6 C2E A 301 E 117 LYS A 177 LYS.? 20.27 N7 C2E A 301 E 150 CYH A 158 CYH^? 12.92 O6 C2E A 301 coo 54.17 11.77 49.20 52.64 11.40 50.63 -19.05 -19.29 2.64 -21.12 -19.53 2.92 coo 45.83 11.66 53.42 50.97 10.25 52.77 -13.21 -27.52 5.04 -11.69 -32.72 3.81 coo 55.28 7.50 53.67 54.71 10.14 54.01 -15.53 -18.41 0.03 -15.42 -19.19 -2.71 ULMN 3 3uao_o04 PUTATIVE ISOCHORISMATASE user 2 3 # 2 E 29 ASP B 157 ASP^? 20.00 O6 C2E B 301 E 117 LYS B 177 LYS.? 21.12 N7 C2E B 301 E 150 CYH B 158 CYH^? 12.89 O6 C2E B 301 coo 54.17 11.77 49.20 52.64 11.40 50.63 9.70 18.14 -17.54 10.97 18.31 -19.23 coo 45.83 11.66 53.42 50.97 10.25 52.77 8.81 26.59 -11.72 7.46 31.56 -12.94 coo 55.28 7.50 53.67 54.71 10.14 54.01 5.78 17.15 -15.63 3.32 17.67 -16.92 3uao_o04 source 3UAO PUTATIVE ISOCHORISMATASE : 2 hits 3uao_o04 naa= 3 ULMN 3 3uao_o05 PUTATIVE ISOCHORISMATASE user 1 3 # 1 F 29 ASP A 157 ASP^? 20.06 O6 C2E A 301 F 117 LYS A 177 LYS.? 20.27 N7 C2E A 301 F 150 CYH A 158 CYH^? 12.92 O6 C2E A 301 coo 41.67 65.37 28.64 40.76 63.70 27.74 -19.05 -19.29 2.64 -21.12 -19.53 2.92 coo 38.34 58.97 23.05 39.26 61.42 28.02 -13.21 -27.52 5.04 -11.69 -32.72 3.81 coo 39.64 61.25 32.92 38.08 62.62 31.22 -15.53 -18.41 0.03 -15.42 -19.19 -2.71 ULMN 3 3uao_o05 PUTATIVE ISOCHORISMATASE user 2 3 # 2 F 29 ASP B 157 ASP^? 20.00 O6 C2E B 301 F 117 LYS B 177 LYS.? 21.12 N7 C2E B 301 F 150 CYH B 158 CYH^? 12.89 O6 C2E B 301 coo 41.67 65.37 28.64 40.76 63.70 27.74 9.70 18.14 -17.54 10.97 18.31 -19.23 coo 38.34 58.97 23.05 39.26 61.42 28.02 8.81 26.59 -11.72 7.46 31.56 -12.94 coo 39.64 61.25 32.92 38.08 62.62 31.22 5.78 17.15 -15.63 3.32 17.67 -16.92 3uao_o05 source 3UAO PUTATIVE ISOCHORISMATASE : 2 hits 3uao_o05 naa= 3 ULMN 3 3uao_o06 PUTATIVE ISOCHORISMATASE user 1 3 # 1 G 29 ASP A 157 ASP^? 20.06 O6 C2E A 301 G 117 LYS A 177 LYS.? 20.27 N7 C2E A 301 G 150 CYH A 158 CYH^? 12.92 O6 C2E A 301 coo 26.53 -14.13 63.27 28.07 -12.63 63.49 -19.05 -19.29 2.64 -21.12 -19.53 2.92 coo 34.28 -10.03 65.81 29.08 -9.98 63.85 -13.21 -27.52 5.04 -11.69 -32.72 3.81 coo 25.24 -8.30 61.46 25.55 -9.17 63.98 -15.53 -18.41 0.03 -15.42 -19.19 -2.71 ULMN 3 3uao_o06 PUTATIVE ISOCHORISMATASE user 2 3 # 2 G 29 ASP B 157 ASP^? 20.00 O6 C2E B 301 G 117 LYS B 177 LYS.? 21.12 N7 C2E B 301 G 150 CYH B 158 CYH^? 12.89 O6 C2E B 301 coo 26.53 -14.13 63.27 28.07 -12.63 63.49 9.70 18.14 -17.54 10.97 18.31 -19.23 coo 34.28 -10.03 65.81 29.08 -9.98 63.85 8.81 26.59 -11.72 7.46 31.56 -12.94 coo 25.24 -8.30 61.46 25.55 -9.17 63.98 5.78 17.15 -15.63 3.32 17.67 -16.92 3uao_o06 source 3UAO PUTATIVE ISOCHORISMATASE : 2 hits 3uao_o06 naa= 3 ULMN 3 3uao_o07 PUTATIVE ISOCHORISMATASE user 1 3 # 1 H 28 VAL A 149 VAL^? 14.56 O6 C2E A 301 H 117 LYS A 177 LYS.? 20.27 N7 C2E A 301 H 150 CYH A 158 CYH^? 12.92 O6 C2E A 301 coo 45.82 27.58 23.40 45.30 28.87 21.66 -16.05 -23.61 -3.17 -14.44 -23.99 -1.73 coo 38.01 32.08 28.20 39.46 29.85 23.57 -13.21 -27.52 5.04 -11.69 -32.72 3.81 coo 41.19 29.62 18.76 39.21 28.51 20.32 -15.53 -18.41 0.03 -15.42 -19.19 -2.71 ULMN 3 3uao_o07 PUTATIVE ISOCHORISMATASE user 2 3 # 2 H 28 VAL B 149 VAL^? 14.42 O6 C2E B 301 H 117 LYS B 177 LYS.? 21.12 N7 C2E B 301 H 150 CYH B 158 CYH^? 12.89 O6 C2E B 301 coo 45.82 27.58 23.40 45.30 28.87 21.66 3.05 21.90 -17.90 3.47 22.36 -15.79 coo 38.01 32.08 28.20 39.46 29.85 23.57 8.81 26.59 -11.72 7.46 31.56 -12.94 coo 41.19 29.62 18.76 39.21 28.51 20.32 5.78 17.15 -15.63 3.32 17.67 -16.92 3uao_o07 source 3UAO PUTATIVE ISOCHORISMATASE : 2 hits 3uao_o07 naa= 3